2016 SynapsePublicationsReport

2016 SYNAPSE PUBLICATIONS REPORT
Title MEMORIAL SLOAN KETTERING CANCER CENTER
LIBRARY
MAKE THE CONNECTION
2016 Synapse
Publications
Report
1 OF 324
Contents
Director’s Welcome. . . . . . . . . . . . . . . . . . . . . . . . . . 3 Works. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

Highly-Cited Papers . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Top-Scoring Papers via Altmetric . . . . . . . . . . . . . . . 25
About Synapse. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
New Features. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Bibliography of Works. . . . . . . . . . . . . . . . . . . . . . . 26
Journal Articles (2,893). . . . . . . . . . . . . . . . . . . . . . . . 27
People . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Conference Papers (206) . . . . . . . . . . . . . . . . . . . . . 248
Top Authors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Meeting Abstracts (891). . . . . . . . . . . . . . . . . . . . . . . . 251
New Authors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Book Sections (37). . . . . . . . . . . . . . . . . . . . . . . . . . . . 318
Publications (Serial). . . . . . . . . . . . . . . . . . . . . . . . . 21 Book Wholes (4). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 322
Top Synapse Journals. . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Contact Information. . . . . . . . . . . . . . . . . . . . . . . . 324
For Journal Articles. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
For Meeting Abstracts. . . . . . . . . . . . . . . . . . . . . . . . . 22
Top Journals by Subject Category. . . . . . . . . . . . . . 23
2 OF 324
Director's Welcome
It is my pleasure to share with staff and the communities we support, the

first annual MSK Synapse Publications Report. This report highlights the
meaningful contributions to their fields from our researchers, clinicians,
nurses, and healthcare professionals in 2016. We want to showcase our
authors’ research and draw attention to the database in which we manage
their intellectual output and the knowledge they contribute to the scholarly
communication ecosystem.
Led by Bernadette Joe, the Synapse team carefully reviewed and vetted 3,851
(as of 02/17/17) works pulled from five different commercial bibliographic
databases. This includes journal articles, conference papers, meeting abstracts,
books, and book sections. In addition, the database has grown and 652 new
author profiles were added.
Librarians have always been a part of the scholarly communication process --

describing, organizing, curating, and providing access to published literature.
Synapse is a public facing resource and the authoritative bibliographic repository
developed and maintain by a skilled team of information professionals. Their
Christopher Boire, Eric Muzzy, Fatoma Rad*, Marina Rosenfield, Bernadette Joe.
* indicates no longer at MSK ultimate goal is to track the wealth of knowledge attributed to Memorial Sloan
Kettering Cancer Center.
As you peruse this publication report, I hope that you will get a sense of the
breadth and depth of works by our many authors, as well as, the dedication
required to produce this valuable resource.
Donna Gibson
Director of Library Services
3 OF 324
Introduction
2016 Works
About Synapse 4
(3,851) book wholes
Synapse is a collection of author profiles, providing access 37
to publications that are the result of research conducted at book sections
or by Memorial Sloan Kettering. The MSK Library developed
Synapse in order to increase the visibility of and promote
the work and collaboration of MSK researchers, clinicians, 891
nurses, and healthcare professionals, ensuring that their meeting abstracts
publications are discoverable.
To populate Synapse, the following commercial databases

are searched for publications with an affiliation of “Memorial 206
conference papers
Sloan Kettering Cancer Center” and other name variations:
• Scopus – technical and medical science 2,893

journal articles
• Web of Science – science and social science
• Biosis Citation Index – biomedical and life science

1,647 (57%)
• CINAHL – nursing and allied health of 2016’s journal articles are NIH-funded.
• PsycINFO – behavioral and social science
Librarians then manually vet each record to eliminate

duplicates, verify citation details, add identifiers (DOI, PMID,
PMCID), standardize metadata, and identify the appropriate In Synapse, a “journal article”
MSK authors. New content is added on a monthly may refer to a research article,
basis, excluding in-press, epub, and online before print. review/survey, editorial, letter, or
Retrospective content dating back to 1884 is scheduled for chapter in a monographic series.
inclusion. As of February 2, 2017, Synapse contains content
dating back to 1998. Only peer-reviewed articles are
required to cite NIH funding.
4 OF 324
New Features
In 2016, the following features were added to Synapse:
• Link From Author Profiles to ORCID Records 758 (23% of) authors currently employed at MSK have
When MSK authors use the Library’s ORCID@MSK service registered their ORCID iD’s with the Library.
to create and submit their ORCID iD’s, links to their ORCID
records will appear on their Synapse profiles, showcasing
their unique digital identifiers which distinguish them from
ORCID is a non-proprietary organization and initiative
other researchers.
providing unique identifiers and profile pages for
scientific researchers.
• Export Works to NCBI’s My Bibliography (via PubMed)
In addition to creating on-screen bibliographies and
exporting works to RIS (EndNote), MSK authors can now Create and register your ORCID iD with the Library using
export their works to PubMed for further analysis or to add ORCID@MSK!
appropriate works to their NCBI’s My Bibliography, a useful
tool for monitoring NIH Public Access Policy compliance.
• Search Works by the Date Ingested into Synapse

To track the progress of a group or author, or to see
what’s recently been added to Synapse, users can now
Author Profiles
search by “Import Date,” the date that works were 3,308 current
created in Synapse. (11,303) employees
7,995 former
employees
5 OF 324
People
When new works are added to Synapse, the Synapse team consults the original published documents to find out which authors listed
MSK as an affiliation. We then use resources provided by Human Resources and Public Affairs to identify which employees match each of
the named authors. When a match is confirmed, we “verify” the author on the work so that it becomes linked to the author’s profile page.
New authors may be discovered at this point. If so, profile pages are created and the author is notified by email.
Top Authors
The top 10 prolific authors of 2016 include:
Michael F. Berger, PhD. . . . . . . . . . . . . . . . . . . . . 72 David S. Klimstra, MD. . . . . . . . . . . . . . . . . . . . . . 52

Associate Director, Marie-Josée and Chair, Department of Pathology; James Ewing
Henry R. Kravis Center for Molecular Oncology Alumni Chair of Pathology
Jedd D. Wolchok, MD, PhD . . . . . . . . . . . . . . . . . 57

Lloyd J. Old/Virginia and Daniel K. Ludwig Chair Monica Morrow, MD, FACS. . . . . . . . . . . . . . . . . . 52
in Clinical Investigation; Chief, Melanoma & Chief, Breast Service, Department of Surgery;
Immunotherapeutics Service; Associate Director, Anne Burnett Windfohr Chair of Clinical Oncology
Ludwig Center for Cancer Immunotherapy
Nancy Y. Lee, MD . . . . . . . . . . . . . . . . . . . . . . . . . 52
Clifford A. Hudis, MD. . . . . . . . . . . . . . . . . . . . . . 54
Vice Chair, Department of Radiation Oncology,
Former Employee (Chief of the Breast Medicine
Experimental Therapeutics
Service from 1998 to 2016)
José Baselga, MD, PhD. . . . . . . . . . . . . . . . . . . . . 54 Robert J. Motzer, MD . . . . . . . . . . . . . . . . . . . . . . 52

Physician-in-Chief and Chief Medical Officer, Medical Oncologist, Genitourinary
Memorial Hospital Oncology Service
Miguel-Angel Perales, MD. . . . . . . . . . . . . . . . . . 54

Deputy Chief, Adult Bone Marrow Transplant Sergio A. Giralt, MD . . . . . . . . . . . . . . . . . . . . . . . 52
Service; Director, Adult Bone Marrow Chief, Adult Bone Marrow Transplant Service;
Transplantation Fellowship Program Melvin Berlin Family Chair in Multiple Myeloma
6 OF 324
New Authors
In 2016, Synapse Abbate, Kelly Teresa (Medicine) Armenia, Joshua (Human Oncology & Pathogenesis)
profiles were created Ackerman, Jill A (Pediatrics) Aryeequaye, Ruth Kailey Ayitey (Pathology)
for the following MSK
employees (652): Ackermann, Sarah Elizabeth (Cancer Biology and Genetics) Attiyeh, Marc (SKI - Surgery)
Adams, Nicholas M (Graduate Studies) Ayash, Claudia Lori (Counseling Center)
Agostini, Andrea (SKI - Radiology) Ayob, George (Pathology)
Akalay, Intissar (Cell Biology) Azevedo, Mafalda (Developmental Biology)
Al Efishat, Mohammad (SKI - Surgery) Balakrishna, Shreya (SKI - Surgery)
Albanese, Steven Kyle (Student Stipends (Phd and SURP)) Balakrishnan Rema, Anoop (Pathology)
Alcantara, Sheila (Cancer Biology and Genetics) Balakrishnan, Mridula (Graduate Studies)
Aldeborgh, Hannah Nicole Janet Annmarie (SKI - Radiology) Baldwin-Medsker, Abigail Elaine (Off Site: MSK 53rd Street)
Alex, Deepu (Graduate Medical Education) Ballesteros, Ivan (Immunology)
Alexander, Aeri Joannah (Medicine) Balletti, Jennifer (Medicine)
Aliyev, Nurlan (SKI - Surgery) Balmer, Sophie (Developmental Biology)
Allaj, Viola (SKI - Medicine) Banaji, Arpitha (Molecular Phrmclgy & Chemistry)
Allen Jr, Robert J (Surgery) Bandyopadhyay, Urmi (Cell Biology)
Allen, Jennifer D (Pediatrics/Nurses) Baradaran, Rozbeh (Structural Biology)
Alperovich, Anna (SKI - Medicine) Barrios, Dulce M (Graduate Medical Education)
Amaya, Beau (Urology Outpatient Center) Barton-Burke, Margaret (Nursing)
Amir, Jawaria (Graduate Medical Education) Basal, Coby R (Integrative Medicine)
Anderson, Erik Steven (Graduate Medical Education) Baslan, Taimour Ghassan (Cancer Biology and Genetics)
Andronico, Jaclyn R (Off Site: MSK 53rd Street) Basnet, Harihar (Cancer Biology and Genetics)
Aneja, Amandeep (Graduate Medical Education) Battiato, Kristen Evelyn (Nursing)
Argueta, Stephanie (Pathology) Becattini, Simone (Immunology)
7 OF 324
New Authors
Becerra, Maria Fernanda (SKI - Surgery) Boyce, Lindsay Marie (I.S. - Medical Library)
Behling, Katja (Molecular Phrmclgy & Chemistry) Brachfeld, Alexandra (SKI - Medicine)
Bekes, Miklos (Structural Biology) Brady, Paul James (Radiation Oncology)
Belluardo, Josephine L (Graduate Studies) Braghiroli, Maria Ignez Freitas Melro (Graduate Medical Education)
Beluco Corradi Fonseca, Renato (SKI - Surgery) Brea, Elliott Joseph (Graduate Medical Education)
Benfante, Nicole E (SKI - Surgery) Brien, Gerard Laurence (Cancer Biology and Genetics)
Bhagavath, Anita (Graduate Medical Education) Briggs, Andrew (SKI - Epidemiology-Biostatis)
Bhatt, Trusha (Human Oncology & Pathogenesis) Brite, Jennifer (Medicine)
Biel, Karen (Urology Outpatient Center) Brito Campana, Juan Pablo (Graduate Medical Education)
Blazic, Ivana (SKI - Radiology) Broach, Vance Andrew (Graduate Medical Education)
Blecua Carrillo Albornoz, Pedro (SKI - Radiation Oncology) Bromme, Elisa Anne (Main Campus Outpatient)
Blumberg, Lauren Esther (Radiation Oncology) Brooks, Eric David Kenny (Graduate Medical Education)
Boccamazzo, Donna M (Disease Management) Brown, Sabrina (Nursing)
Bodei, Lisa (Radiology) Buckley, Mary Elizabeth (Breast and Imaging Center)
Bohm, Mathieu (Immunology) Buechel, Gabriel Emanuel (SKI - Radiology)
Borg, Kim L (Nursing) Bugov, Dona (Graduate Medical Education)
Borgheresi, Alessandra (SKI - Radiology) Buonocore, Darren Joseph (Pathology)
Borrill, Taylor Wray (Medicine) Burias, Clare Tanallon (Nursing)
Bose, Promita (Human Oncology & Pathogenesis) Burke, Kathleen (SKI - Pathology)
Bose, Rohit (Medicine) Burke, Michelle (Nursing)
Both, Stefan (West Harrison) Burns, Jacquelyn (Nursing)
Boulad, Mathieu Nadim (Medicine) Byun, David Jaihun (SKI - Radiation Oncology)
Bowers, Leah Magdeline (Graduate Medical Education) Cabot, Jennifer Cox (Graduate Medical Education)
8 OF 324
New Authors
Cai, Xiaochuan (Chemical Biology Program) Chaudhry, Mohammed Suhail (Immunology)
Callahan, Christine Marie (Nursing) Cheavers, Christopher Edward (Department of Quality & Safety)
Callahan, Scott James (Student Stipends (Phd and SURP)) Chen, Feng (SKI - Radiology)
Camacho Ordonez, Niedzica Nadia (Human Oncology & Pathogenesis) Chen, Mo (Cancer Biology and Genetics)
Cameron, Michael Clark (Graduate Medical Education) Chen, Sonja Dianne Julia Kimchoy (Graduate Medical Education)
Canonica, Carolyn Marie (Medicine) Chhangawala, Sagar (Graduate Studies)
Carroll, Courtney M (Graduate Studies) Chin, Chelsea Carrie (Social Work)
Carroll, Cristi Ann (Medicine) Chintala, Navin Kumar (SKI - Surgery)
Castillo, Carmen (Case Management) Chiok, Michael (Graduate Medical Education)
Castillo, Raychel (Diversity Prgrms/Womens Facult) Chiriac, Maria Irina (Chemical Biology Program)
Casuscelli, Jozefina (Human Oncology & Pathogenesis) Cho, Gene Young (SKI - Radiology)
Cavalcanti, Marcela Santos (Graduate Medical Education) Cho, Hyunwoo (Graduate Studies)
Cavalli, Michele Riccardo (SKI - Surgery) Cho, Sun Min (Laboratory Medicine)
Cavuoto, Michelle (Nursing) Choi, Wookjin (SKI - Medical Physics)
Chabon, Jonathan (Cancer Biology and Genetics) Chow, Arthur W (Molecular Phrmclgy & Chemistry)
Chakraborty, Jayasree (SKI - Surgery) Chowell Puente, Diego (Human Oncology & Pathogenesis)
Chan, Andrew Tin-Ho (SKI - Medicine) Chu, Bae Philavan (Medical Physics)
Chandhanayingyong, Chandhanarat (Graduate Medical Education) Chu, Jennifer (Graduate Medical Education)
Chandwani, Rohit (Human Oncology & Pathogenesis) Chung Jr, You (Nursing)
Chang, Aaron (Graduate Studies) Chung, Ja Young (Graduate Medical Education)
Chang, Kevin (SKI - Surgery) Chung, Sun Young (Developmental Biology)
Chapman, Katherine Logan (Medical Physics) Cimera, Robert Sime (Pathology)
Chatterjee, Debashree (Molecular Biology) Claeys Bouuaert, Corentin Francois (Molecular Biology)
9 OF 324
New Authors
Clark, Varina Rene (Medicine) de Bruijn, Ino (SKI - Pathology)
Clarke, Richard (Pathology) De La Ossa, Michelle Varona (Nursing)
Cleary, Cristian Ryan (Radiation Oncology) Dela Cruz, Filemon (Pediatrics)
Connors, Scott W (Neurosurgery) DeLuca, Jennifer M (Disease Management)
Conti-Harrigan, Laura Anne (MSK-60th Street) Demoin, Dustin Wayne (SKI - Radiology)
Cook, Brendon Ellery (SKI - Radiology) Dhara, Surajit (Human Oncology & Pathogenesis)
Correa Geyer, Felipe (SKI - Pathology) Di Gialleonardo, Valentina (SKI - Radiology)
Cowan, Renee Antonette Woodburn (Graduate Medical Education) Dierov, Djamilia (Medicine)
Crane, Christopher (Radiation Oncology) DiMattia, Michael Alfred (Structural Biology)
Cronin, Patricia Ann (Graduate Medical Education) Diolaiti, Daniel (SKI - Pediatrics)
Crozet, Lucile (Immunology) Dixit, Payal G (Medicine)
Cruz, Ramona (Off Site: MSK 53rd Street) Djesevic, Almedina (Medicine)
Cunanan, Kristen (SKI - Epidemiology-Biostatis) Do, Mytrang (Graduate Studies)
Curtin, Christina Elise (SKI - Surgery) Donlon, Danielle Mary (Nursing)
Da Silva, Edaise Maria (SKI - Pathology) Du, Mengmeng (Epidemiology-Biostatistics)
Dadi, Saida (Immunology) Duggan, Erika Gabrielle (Department of Quality & Safety)
Dalin, Martin Gustav (Human Oncology & Pathogenesis) Dutton, Inde (Nursing)
Dalvi, Nagma (Graduate Medical Education) Edwards, Kimberly Joanna (SKI - Radiology)
Daniel, Tanisha Dee (Pathology) Eisold, Meghan Elizabeth (Cancer Biology and Genetics)
Dannaoui, Aimee (Pediatrics/Nurses) Elias, Harold Kunal (Graduate Medical Education)
Das, Tuhin (Cell Biology) Encarnacion, Elizabeth Marie (SKI - Surgery)
Davis, Morie (Nursing) Er, Ekrem Emrah (Cancer Biology and Genetics)
Dayan, Joseph Henry (Surgery) Erez, Amir (Immunology)
10 OF 324
New Authors
Eskandari, Roozbeh (SKI - Radiology) Geary, Clair (Graduate Studies)
Eubank, Michael (Data & Information Service) Geissmann, Frederic (Immunology)
Eyquem, Justin Gabriel Andre Francois (Immunology) Gejman, Ron Shlomo (Graduate Studies)
Famulare, Christopher A (Collaborative Research Centers) Gelb, Emily Helene (Radiation Oncology)
Fan, Jun (SKI - Pathology) Getta, Bartlomiej Marcin (Graduate Medical Education)
Fan, Xiying (Graduate Studies) Ghanaat, Mazyar (Graduate Medical Education)
Farhang Khoee, Hana (Graduate Medical Education) Giacalone, Joseph (Research Facilities)
Fatovic, Robin (Radiology) Gibson, Dede (Pediatrics/Nurses)
Feng, Zhaohui (Cancer Biology and Genetics) Goldberg, Aaron David (Graduate Medical Education)
Feucht, Judith Carolin (Immunology) Golia Pernicka, Jennifer S (Radiology)
Findley, Keisha A (Nursing) Gomez-Gelvez, Juan Camilo (Graduate Medical Education)
Fingerhood, Michael Loth (Graduate Medical Education) Gonzalez Aguirre, Adrian Jose (Radiology)
Fischer, Sara Elisa (Epidemiology-Biostatistics) Gonzalez, Carlos J (Counseling Center)
Fleming, Christopher (Graduate Medical Education) Gonzalez, Cynthia Eugenia (Medicine)
Forrest, Kadeen S (Radiation Oncology) Gonzalez-Diaz, Julio E (Nursing)
Franco, Kara Ann (SKI - Psychiatry/Counseling) Goss, Cheryl (Laboratory Medicine)
Freiin Von Reibnitz, Donata Ana Theodora (SKI - Radiation Oncology) Guan, Youxin (Human Oncology & Pathogenesis)
Freites Martinez, Azael David (SKI - Medicine) Guney, Tezcan (Chemical Biology Program)
Fuchs, Thomas (Medical Physics) Gur, Hatice Deniz (Graduate Medical Education)
Fung, Edward Komin (Graduate Medical Education) Gutiontov, Stanley (Graduate Medical Education)
Gadiya, Mayur M (Graduate Studies) Haeggstroem, Ida (SKI - Medical Physics)
Gandu, Srinivasa Reddy (Chemical Biology Program) Hamilton, Celeste N (Nursing)
Gangangari, Kishore Kumar (SKI - Radiology) Han, Song (Human Oncology & Pathogenesis)
11 OF 324
New Authors
Hao, Xueli (Graduate Medical Education) Huerga Sanchez, Iker (Data & Information Service)
Haque, Mohammad Haque (Pathology) Hultcrantz, Malin Lisa (Graduate Medical Education)
Harneja, Niyati Swaroop (Clinical Research) Inda Garcia, Maria del Carmen (Chemical Biology Program)
Harris, Amanda Julia (Pediatrics/Nurses) Ingenito, Joanne (Research Facilities)
Harris, Bianca (Medicine) Ingrassia Campesato, Luis Felipe (SKI - Medicine)
Haseltine, Justin Mark (SKI - Radiation Oncology) Inoue, Daichi (Human Oncology & Pathogenesis)
Hashimoto, Takeshi (SKI - Surgery) Iqbal, Afsheen Naz (Medicine)
Hauver, Jesse J. (Graduate Studies) Isaka, Mayumi (Research Facilities)
He, Lan (Cancer Biology and Genetics) Iyer, Saipriya (Diversity Prgrms/Womens Facult)
He, Taojun (SKI - Clinical Laboratories) Jacome-Galarza, Christian Eduardo (Immunology)
Heins, Zachary Joseph (Collaborative Research Centers) Jain, Manu (Medicine)
Henderson, Peter (Graduate Medical Education) James, Sandra E (Nursing)
Herrera Almario, Gabriel Eduardo (Graduate Medical Education) Jarvis, Casey (Molecular Phrmclgy & Chemistry)
Ho, Caleb (Pathology) Javier, Breanna M (SKI - Pathology)
Ho, Tzu Chieh (Molecular Phrmclgy & Chemistry) Jay, Hillary Victoria (Immunology)
Hoang, Lien N (Graduate Medical Education) Jebiwott, Sylvia (SKI - Surgery)
Hodge, Monique A (Nursing) Joergens, Jacob (Human Oncology & Pathogenesis)
Hoshii, Takayuki (Cancer Biology and Genetics) Johnsen, Hannah Christina (Student Stipends (Phd and SURP))
Hu, Jing (Cancer Biology and Genetics) Johnson, Thomas William (Research Facilities)
Hu, Wei (Immunology) Kadempour, Arvin Medi (Graduate Medical Education)
Huang, Cong (Graduate Studies) Kalra, Gurpreet K (SKI - Psychiatry/Counseling)
Huang, Huei Chung (Epidemiology-Biostatistics) Kang, Helen H (Graduate Studies)
Huang, Jung Ju (SKI - Surgery) Kantoff, Philip Wayne (Medicine)
12 OF 324
New Authors
Kao, Yu-Chien (SKI - Pathology) Kim, Minhee (Graduate Studies)
Kapilashrami, Kanishk (Chemical Biology Program) Kim, Seong Jin (SKI - Medicine)
Kaplan, Janice E (Medicine) Kim, Soo Jung (Nursing)
Kaplan, Samuel Eliot (Laboratory Medicine) Kim, Sung Eun (Graduate Studies)
Karassawa Zanoni, Daniella (SKI - Radiology) Kim, Young Joon Joon (Human Oncology & Pathogenesis)
Kash, Natalie Nata (Graduate Medical Education) King, Amber Courtney (Pharmacy)
Kashan, Mahyar (HOPP) King, Martin T (Graduate Medical Education)
Kashikar, Shruti (Graduate Medical Education) Kinsley, Karen (Basking Ridge)
Kazzaz, Sarah Allison (SKI - Medicine) Kirane, Amanda Robinson (Graduate Medical Education)
Keith JR, James Whiteside (Student Stipends (Phd and SURP)) Kitzler, Robina (Nursing)
Keller, Leah Marie (MSK-60th Street) Klebanoff, Christopher A (Medicine)
Keller, Lisa A (Basking Ridge) Komura, Kazumasa (SKI - Medicine)
Kelly, Amelia Gale (Graduate Medical Education) Koranteng, Lauren Akua (Pharmacy)
Kelly, Ciara Marie (Graduate Medical Education) Kozlowski, Paul (SKI - Radiology)
Kelly, Daniel William (Data & Information Service) Krebs, Simone Susanne (Graduate Medical Education)
Kelly, Stefanie Lynn (Nursing) Krist, Nicole Marian (Nursing)
Kendall, Sviatoslav Michael (Human Oncology & Pathogenesis) Kuhn, Nicholas Frederik (Student Stipends (Phd and SURP))
Kennedy, Jennifer Ann (Medicine) Kumar, Charanya (Molecular Biology)
Khan, Nabeela Ali (Graduate Medical Education) Kundra, Ritika (Collaborative Research Centers)
Kheterpal, Meenal (Medicine) Kung, Andrew L (Pediatrics)
Khutti, Seema Devshi (Graduate Medical Education) Kurtzman, Rachel Taylor (Medicine)
Kiecka, Iwona J (Pathology) Laffey, Maureen (Nursing)
Killian, Jonathan Keith (Graduate Medical Education) Laguna, Joseph Lorenzo (West Harrison)
13 OF 324
New Authors
Lambert, Courtney Rose (Medicine) Loizou, Evangelia (Cancer Biology and Genetics)
Lazarov, Tomi (Immunology) Long, Emily J (Pediatrics/Nurses)
Lederhandler, Margo H (Graduate Medical Education) Long, Niamh (Radiology)
Lee, Jun Ho (SKI - Surgery) Lopez Garaulet, Daniel Santiago (Developmental Biology)
Lee, Ken-Wing (Human Oncology & Pathogenesis) Lopez Puebla, Jose Carlos (Graduate Medical Education)
Lee, Lik Hang (Graduate Medical Education) Lou, William (Graduate Medical Education)
Lee, Meghan Elizabeth (SKI - Surgery) Lowe, Michael Charles (Graduate Medical Education)
Lee, Robert (Radiology) Lu, Shaohua (SKI - Surgery)
Levine, Andrew Gould (Graduate Studies) Lu, Wei (Medical Physics)
Lewis, Brittany (Graduate Studies) Lubimov, Elena (Nursing)
Li, Hongyan (SKI - Radiation Oncology) Ly, Catherine L (SKI - Surgery)
Li, Qiang (Graduate Medical Education) Lynch, Sharon M (Main Campus Outpatient)
Li, Xiaoyi (Student Stipends (Phd and SURP)) Lyubchik, Anna (SKI - Surgery)
Lim, Pei Xin (Developmental Biology) Mahmood, Usman Ahmad (Medical Physics)
Lin, Andrew Lee (Neurology) Mallek, Christine Denise (Medicine)
Lin, Andrew Pei-En (Pharmacy) Mamtani, Anita (SKI - Surgery)
Lin, Mary (Radiation Oncology) Mandal, Rajarsi (Graduate Medical Education)
Liu, Dazhi (Pharmacy) Mandapathil, Magis Mathew (Graduate Medical Education)
Liu, Nick Wei-En (Graduate Medical Education) Mandelker, Diana Lauren (Pathology)
Liu, Wenying (Graduate Studies) Manley, Brandon John (Graduate Medical Education)
Llerandi, Diane M (Nursing) Mao, Jun J (Integrative Medicine)
Lochner, Caroline (Off Site: MSK 53rd Street) Mao, Ninghui (Human Oncology & Pathogenesis)
Lockau, Hannah (Molecular Phrmclgy & Chemistry) Mara, Elton (Medicine)
14 OF 324
New Authors
Marcell, Vanessa J (Medicine) Miale-Mayer, Donna (Nursing)
Marino Alvarez, Maria Liliana del Pilar (SKI - Medicine) Michael, Chelsea Lyn (Pathology)
Mass, Elvira (Immunology) Michaud, Laure (SKI - Surgery)
Matsoukas, Konstantina (I.S. - Medical Library) Miller-Sobel, Jacob David (SKI - Psychiatry/Counseling)
Mattar, Marissa (Research Facilities) Miloushev, Vesselin (Radiology)
Mauguen, Audrey (SKI - Epidemiology-Biostatis) Mimae, Takahiro (SKI - Surgery)
Mayor, Marissa Anne (SKI - Surgery) Mitchell, Maika G (Medicine)
Mazo, Gregory (Student Stipends (Phd and SURP)) Mo, George (Molecular Phrmclgy & Chemistry)
Mc Cartan, Damian (Graduate Medical Education) Modzelewski, Beata (SKI - Pediatrics)
McAuliffe, John Christopher (Graduate Medical Education) Mondesire-Crump, Ijah (SKI - Surgery)
McDonough, Mary E (Case Management) Montecalvo, Joseph (SKI - Pathology)
McGee, Erin Anne (SKI - Surgery) Moore, Amanda Roxanne (Graduate Studies)
McKenzie, Connie (Nursing) Moore, Jennifer Ilissa (West Harrison)
McLaughlin, Brigit (Medicine) Morgani, Sophie Maria Christina (Developmental Biology)
McMillan, Laurina (Nursing) Morris, Martin Pender (SKI - Surgery)
McSweeney, Margaret (Nursing) Mullaney, Kerry A (Pathology)
McTague, Patricia A. (Nursing) Muller, Linda (Nursing)
Mead, Elena (Anesthesiology-Critical Care) Musinsky, Jacob (Medicine)
Melnic, Irina (Counseling Center) Nagata, Masanori (Neurology)
Mendonca, Shawn James (Graduate Medical Education) Namuduri, Manjusha Van (Pediatrics)
Meng, Fanli (Collaborative Research Centers) Narain, Wazim Raja (Disease Management)
Meyer, Jan-Philip (SKI - Radiology) Narayan, Ankita (Molecular Phrmclgy & Chemistry)
Meyerholz, Samantha Mary (Department of Quality & Safety) Neil, Elizabeth Catherine (Graduate Medical Education)
15 OF 324
New Authors
Nelson, Paul (Finance) Panchoo, Kelly H (Clinical Research)
Nemieboka, Brandon (Student Stipends (Phd and SURP)) Panzarino, Alexandra Marie (Developmental Biology)
Neuschmelting, Volker (SKI - Radiology) Papaemmanuil, Elli (Epidemiology-Biostatistics)
Ng, Shu Yi (SKI - Radiation Oncology) Parada, Luis F (Cancer Biology and Genetics)
Nguyen, Victoria Ngoc (Medicine) Parada, Nicole Andrea (Medicine)
Ni, Ai (Epidemiology-Biostatistics) Paresi, Chelsea Jordan (Graduate Studies)
Ntiamoah, Peter (Pathology) Paris, Manuel A (Radiology)
Ogando, Yudelca (SKI - Pediatrics) Parra, Carlos (SKI - Medical Physics)
Oh, Claire (Graduate Studies) Pastore, Alessandro (Human Oncology & Pathogenesis)
Ojeda Seijas, Virginia (Molecular Phrmclgy & Chemistry) Patane, Michael Gene (Surgery)
O'Leary, Justin (Nursing) Patel, Miteshkumar V (Molecular Phrmclgy & Chemistry)
Olek, Devin J (Medical Physics) Patel, Priya (Graduate Medical Education)
Olm-Shipman, Molly K (Radiation Oncology/Nurses) Patterson, Emily N (Main Campus Outpatient)
O'Neill, Gerald P (Pharmacy) Patterson, Jacqueline (Nursing)
Ontoso Picon, David (Molecular Biology) Paulson, Jennifer Beth (Medicine)
Orlando, Evelyn Hastings (Medicine) Pelto, Debra J (Counseling Center)
O'Rourke, Brian Patrick (Cell Biology) Pena, Derwin M (Pathology)
O'Rourke, Kevin Patrick (Graduate Studies) Pennicooke, Brenton H (Graduate Medical Education)
Ortiz, Michael Vincent (Graduate Medical Education) Penson, Alexander Vincent (Human Oncology & Pathogenesis)
Ozkaya, Neval (SKI - Pathology) Peterson, Lisa Michelle (SKI - Psychiatry/Counseling)
Pagan, Carlos Alberto (Graduate Medical Education) Pham, Hanh My (Radiology)
Pamer, Erika (Medicine) Philip, Mary (Immunology)
Pan, Qiuhui (Cell Biology) Phung, Anh Xuan (Radiation Oncology)
Panchal, Palak (Chemical Biology Program) Pietzak, Eugene J (Graduate Medical Education)
16 OF 324
New Authors
Pinero, Maria Cristina Malabuyoc (Pediatrics/Nurses) Riegman, Michelle Marthe Elizabeth (Student Stipends (Phd and SURP))
Pittella Silva, Fabio (Chemical Biology Program) Rios, Kelly Marie (Pathology)
Politikos, Ioannis (Graduate Medical Education) Rivera, Andrew (Graduate Medical Education)
Popper, Steven Michael (Medicine) Robertson, Nicola Lindsay (SKI - Radiology)
Porinchak, Marypat (MSK-64th Street) Rodriguez Laureano, Lucelenie (Computational Biology)
Porosnicu-Rodriguez, Kori (Immunology) Roehrl, Michael H (Pathology)
Pourat, Jacob (SKI - Radiology) Rogers, Tova (Graduate Medical Education)
Powell, Eleanor Anne (Graduate Medical Education) Rojas, Carlos Alberto (Nursing)
Price, Eric William (SKI - Radiology) Romanoff, Sonya Julene (Office of Physician-In-Chief)
Pritchett, Wendy (Basking Ridge) Romero, Fabian Andres (Graduate Medical Education)
Pritykin, Yury (Computational Biology) Rosa, William (Medicine)
Proli II, Anthony Joseph (Pharmacy) Rosamilia, Melody L (Nursing)
Ptashkin, Ryan Nathan (Pathology) Rosario Quinones, Frances Lucianne (Graduate Medical Education)
Raciti, Patricia Marie (Graduate Medical Education) Rosenberg, Haley Isabel (SKI - Surgery)
Rafikh, Salima (Urology Outpatient Center) Rosenberger, Laura H (Graduate Medical Education)
Rahnamay Farnoud, Noushin (Collaborative Research Centers) Rosenfeld, Hope Amiri (SKI - Surgery)
Rainey, Allison (SKI - Pediatrics) Rosowicz, Andrew (Medicine)
Ramnarine, Kiran (Research Facilities) Roxburgh, Campbell Stuart (Graduate Medical Education)
Ramos, Marcel (SKI - Psychiatry/Counseling) Rubel, Jennifer Brooke (Neurology)
Randazzo, Joseph Daniel (Surgery) Ruiz, Terri Lynn Cruz (Nursing)
Ranganath, Rohit (SKI - Surgery) Rupesh Kumar, Fnu (Molecular Biology)
Ravichandran, Vignesh (SKI - Medicine) Ryan, Christopher (Neurosurgery)
Rebeiz, Karim Jean (Graduate Medical Education) Rybkin, Alisa (Radiation Oncology)
Ren, Si-Qiang (Developmental Biology) Sabari, Joshua K (Graduate Medical Education)
17 OF 324
New Authors
Sakamoto, Hitomi (SKI - Pathology) Sekhri, Neha (Medicine)
Salloum, Darin (Cancer Biology and Genetics) Selcuklu, Sadan Duygu (Collaborative Research Centers)
Sanchez Vega, Francisco (Human Oncology & Pathogenesis) Sen, Filiz (Pathology)
Sanchez, Liza (Nursing) Shaffer, Brian Carl (Medicine)
Santagostino, Sara (Research Facilities) Shagabayeva, Larisa (Diversity Prgrms/Womens Facult)
Santich, Brian Horacio (Student Stipends (Phd and SURP)) Shah, Hardik M (SKI - Pediatrics)
Santopolo, Suzanne (Pediatrics) Shaha, Manish A (SKI - Surgery)
Santos, Natalie Ishak (Social Work) Shamay, Yosef (Molecular Phrmclgy & Chemistry)
Saqcena, Mahesh (Human Oncology & Pathogenesis) Sharma, Sai Kiran (SKI - Radiology)
Saravia, Deonie Nickeisha (Medicine) Sharma, Sneh (SKI - Medicine)
Sarparanta, Mirkka Paevikki (SKI - Radiology) Shen, Yawei (SKI - Surgery)
Satasivam, Prassannah (Graduate Medical Education) Sher, Jessica (Human Oncology & Pathogenesis)
Saulan, Mary May (Nursing) Shi, Chengyu (Basking Ridge)
Saurat, Nathalie Gael (Developmental Biology) Shurell, Elizabeth Marie (Graduate Medical Education)
Scardino, Teresa G (Medicine) Sigurdsson, Hrafn Oli (Nursing)
Schlappe, Brooke Amber (Graduate Medical Education) Simoes, Priya Karen (Graduate Medical Education)
Schleicher, Stephen Matthew (Graduate Medical Education) Singh, Ranjodh (Graduate Medical Education)
Schlottmann, Francisco (SKI - Surgery) Singh-Kandah, Shahnaz Vilanta (Medicine)
Schluter, Jonas (Computational Biology) Sioulas, Vasileios (Graduate Medical Education)
Schmitt, Adam Michael (Radiation Oncology) Slingerland, Ann Elizabeth (SKI - Medicine)
Schneeberger, Valentina Elisabeth (SKI - Medicine) Soh, Chew-Li (Developmental Biology)
Schofield, Elizabeth A (Counseling Center) Sokoli, Desiree Ann (Nursing)
Schweber, Sarah Joan Meyers (Medicine) Soliman, Mohamed Ahmed (Developmental Biology)
18 OF 324
New Authors
Somma, Alexander Joseph (SKI - Surgery) Tennenbaum, Daniel (Human Oncology & Pathogenesis)
Song, Evelyn Junyao (Cancer Biology and Genetics) Teo, Min Yuen (Graduate Medical Education)
Soni, Rekha (Collaborative Research Centers) Thachuthara-George, Joseph Kurian (Graduate Medical Education)
Soumerai, Jacob Drobnyk (Graduate Medical Education) Thampi, Linta M (Pathology)
Spencer, Alison Kate Laine (Student Stipends (Phd and SURP)) Thomas, Lorna Verona (Off Site: MSK 53rd Street)
Srikumar, Caroline (Nursing) Thomas, Rozario Ilaventhan (Graduate Studies)
Staible, Abigail Gordon (Medicine) Tin, Amy Lam Ling (Epidemiology-Biostatistics)
Stamatiades, Efstathios (Immunology) Toure, Ahmed (Immunology)
Stasi, Kristen Genevieve (Off Site: MSK 53rd Street) Tray, Nancy J (Medicine)
Stopol, Carolyn R (Social Work) Trottier, Magan Desiree (Medicine)
Straight, Celeste Emily (Graduate Medical Education) Tse, Kin (PCCTC Operations)
Sue, Jillian Joo-Ae (Pathology) Tseng, Jill (Graduate Medical Education)
Sukhadia, Purvil (Pathology) Tsui, Wai Yi (Pathology)
Sun, Jie (Immunology) Vachha, Behroze Adi (Radiology)
Sun, Liping (Collaborative Research Centers) Valerio, Daria Gianina (Cancer Biology and Genetics)
Syed, Mustafa H (Pathology) Van Voorthuysen, Martine (Medicine)
Takahashi, Yusuke (SKI - Surgery) Varda, Melissa Joi (Pediatrics/Nurses)
Takeda, Toshikazu (SKI - Surgery) Velez, Ana Maria (SKI - Surgery)
Tanner, Lanier R (Medicine) Venigalla, Praveen (SKI - Radiation Oncology)
Tanzi, Elizabeth M (Pediatrics/Nurses) Vogel, Robert Michael (Graduate Studies)
Tarasova, Valentina Dmitriyevna (Graduate Medical Education) Walczak, Edward Gregory (Human Oncology & Pathogenesis)
Taylor, Damani Colin (Pediatrics) Walland, Jonathan Steven (Office of General Counsel)
Taylor, Justin (Graduate Medical Education) Walsh, Johanne Patricia (Nursing)
Teng, Howard (Anesthesiology-Critical Care) Wan, Bingbing (Molecular Biology)
19 OF 324
New Authors
Wang, Guanshi (Graduate Studies) Yamada, Shintaro (Molecular Biology)
Wang, Junyi (Chemical Biology Program) Yang, Ciyu (Pathology)
Wang, Qingguo (Human Oncology & Pathogenesis) Yang, Hui (Structural Biology)
Wang, Shangqian (Human Oncology & Pathogenesis) Yang, Wendy (Graduate Medical Education)
Wang, Tai (Chemical Biology Program) Yeahia, Rubaya (Diversity Prgrms/Womens Facult)
Wang, Yijie (Research Facilities) Yelamos Pena, Oriol (SKI - Medicine)
Warner, Evelyn (Graduate Studies) Yelskaya, Zarina (Pathology)
Weber, Joseph John (Graduate Medical Education) Yewdell, William Theodore (Immunology)
Weinrich, Jarret A P (Graduate Studies) Yoo, Yeon (Medicine)
Weizman, Orrel (Immunology) Yoshimi, Akihide (Human Oncology & Pathogenesis)
Werneck Krauss Silva, Vitor (Graduate Medical Education) Yu, Angela M (Graduate Studies)
White, Pascale Marthe (Graduate Medical Education) Yu, Jessie Zexi (Graduate Medical Education)
Whitlock, Benjamin M (Graduate Studies) Yu, Wayne (Pathology)
Wilgucki, Molly (Radiation Oncology) Yuan, Han (Graduate Studies)
Woods, Meghan (Epidemiology-Biostatistics) Yun, Tao (Cell Biology)
Woody, Kamille Aeisha (Nursing) Zarnegar, Sara (Graduate Medical Education)
Woolthuis, Carolien Marthe (Human Oncology & Pathogenesis) Zecco, Glenn David (Nursing)
Wu, Karshook (Nursing) Zeltsman, Masha (SKI - Surgery)
Wu, Kenmin (SKI - Surgery) Zhan, Yu (Human Oncology & Pathogenesis)
Wu, Raymond (Student Stipends (Phd and SURP)) Zhang, Ming (Graduate Medical Education)
Xianyu, Anjin (Graduate Studies) Zheng, Xiaoyong (Graduate Medical Education)
Xu, Amy Jia (Graduate Medical Education) Zhou, Fang (Graduate Medical Education)
Xu, Chao (Chemical Biology Program) Zhovmer, Alexander (Molecular Biology)
Yadav, Tejas (Graduate Studies) Zinder, John C (Graduate Studies)
20 OF 324
Publications (Serial)
Top Synapse Journals Top Journals (For Articles) MSK-affiliated "journal
articles" published in 2016
In 2016, MSK authors published works in
852 different journal titles, covering topics
such as: Cancer Genetics & Genomics,
Journal of Clinical Oncology
20.982 104
Cancer Immunotherapy & Vaccines, Cancer impact factor
Metabolism, Cell Signaling & Regulation,
Cell-Based Therapy, Chemical Biology,
Clinical Cancer Research
8.738 48
Computational Oncology, Developmental impact factor
Biology, Epidemiology, Statistics & Health
Outcomes, Epigenetics, Genome Integrity,
Hematologic Malignancies, Imaging, Annals of Surgical Oncology 3.655 47
impact factor
Immunology, Metastasis & Drug Resistance,
Microbiome & Inflammation, Molecular
Pathology & Diagnostics, Nanotechnology, Cancer
5.649 46
impact factor
Neuroscience & Neuro-Oncology, Solid
Tumor Oncogenesis, Stem Cells, Structural
Biology, Systems Biology, Targeted Therapy, Oncotarget
5.008 35
impact factor
Tumor Microenvironment.
Journal of the National 4.262 33

Comprehensive Cancer Network impact factor
For Journal Articles
The following chart shows the top 10 journal PLoS ONE
3.057 32
impact factor
titles (by number of 2016 Synapse works)
that MSK authors published journal articles
in. In Synapse, a “journal article” may refer Lancet Oncology
26.509 32
impact factor
to a research article, review/survey, editorial,
letter, or chapter in a monographic series.
Journal of Nuclear Medicine
5.849 29
impact factor
* Impact factors were retrieved on 3/17/2017 from

Journal Citation Reports, a product of Thomson Reuters Nature Communications
11.329 28
impact factor
21 OF 324
For Meeting Abstracts

The following chart shows the top 10 Top Journals (For Abstracts) MSK-affiliated "meeting
journal titles (by number of 2016 Synapse abstracts" published in 2016
works) that MSK authors published meeting
abstracts in.
Modern Pathology 109
Laboratory Investigation 108
Journal of Clinical Oncology 84
International Journal of Radiation

83
Oncology, Biology, Physics
Cancer Research 64
Biology of Blood and

54
Marrow Transplantation
Haematologica 35
Oncology Nursing Forum 28
Annals of Surgical Oncology 21
BJU International 18
22 OF 324
Top Journals by Subject Category

The impact factor (IF) of an academic
journal is a quality metric commonly used
to measure the importance or prestige of a
journal. Revised annually by Journal Citation
Reports (JCR), the impact factor calculation
is largely based on the average number of
times the journal’s articles have been cited Cell
by other publications over the previous
Oncology
two years, while correcting for inter-journal Nature Reviews Cancer, Biology
variability (for example, number or articles Lancet Oncology, Cancer Cell, Nature Reviews
per issue and frequency of publication). Journal of Clinical Oncology Molecular Cell Biology,
When considered in relation to other journals Nature Medicine, Cell,
within a specific subject category or field,
243 Cancer Cell
53
the impact factor provides a means for
comparing two or more journals and for
ranking them by degree of impact relative to
each other.
This illustration represents the number of

2016 Synapse works published in top journals
within their respective JCR subject category.
General
and Internal Multidisciplinary
Medicine Sciences
New England Journal Nature, Science,
of Medicine, Nature Communications,
Lancet, JAMA PNAS
38 72
23 OF 324
Works
Highly-Cited Papers
The following represent the top highly-cited papers with an MSK affiliation according to Scopus on 5/8/2017.
MSK-Affiliated Article Citation Count
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid
Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid. 26(1): 1-133. �� 551
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following
treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial
The Lancet. 387(10031): 1909-1920. �� 175
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Science. 351(6280): 1463-1469. �� 171
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Blood. 127(20): 2375-2390. �� 150
Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia
New England Journal of Medicine. 374(4): 311-322. �� 134
Genomic analyses identify molecular subtypes of pancreatic cancer
Nature. 531(7592): 47-52. �� 133
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy. 12(1): 1-222. �� 122
The Emerging Hallmarks of Cancer Metabolism
Cell Metabolism. 23(1): 27-47. �� 100
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial
The Lancet Oncology. 17(2): 234-242. ��92
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
European Urology. 69(3): 428-435.. ��89
24 OF 324
Top-Scoring Papers via Altmetric

The Altmetric Attention Score is derived from an automated algorithm and represents a weighted count of the amount of attention
a research output receives on the Internet. It gives a guide to the overall attention at that moment in time. The colors of the donut
also have significance. Each color represents the source in which mentions of the paper were found (e.g. red for news outlets, blue for
Twitter, yellow for blogs, etc.).
Nomenclature Revision for Encapsulated Follicular Variant Overspending driven by oversized single dose
of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce vials of cancer drugs (British Medical Journal)
1211 Overtreatment of Indolent Tumors (JAMA Oncology) 800 Peter Bach, Raymond J. Muller, Geoffrey
Robert M. Tuttle, Ronald A. Ghossein C. Schnorr, Leonard B. Saltz
Inherited DNA-Repair Gene Mutations in Men with Metastatic Recreational physical inactivity and mortality in women with
Prostate Cancer (New England Journal of Medicine) invasive epithelial ovarian cancer: evidence from the Ovarian
1161 Michael Francis Walsh, Wassim Abida, Michael Forman 736 Cancer Association Consortium (British Journal of Cancer)
Berger, Liying Zhang, Ahmet Zehir, Vijai Joseph, Howard Malcolm Pike
Scher, Charles L Sawyers, Nikolaus D. Schultz, Philip Wayne
Kantoff, David Solit, Mark E. Robson, Kenneth Offit Clonal neoantigens elicit T cell immunoreactivity and
sensitivity to immune checkpoint blockade (Science)
Trends in Dietary Supplement Use Among US Adults From
1082 1999-2012 (JAMA: Journal of the American Medical Association) 701 Vladimir Makarov, Alexandra Elizabeth Snyder
Charen, Matthew David Hellmann, Taha Merghoub,
Elizabeth David Kantor, Mengmeng Du Jedd D. Wolchok, Timothy Chan
Postmastectomy Radiotherapy: An American Society

Landscape of somatic mutations in 560 breast cancer of Clinical Oncology, American Society for Radiation
923 whole-genome sequences (Nature) 681 Oncology, and Society of Surgical Oncology Focused
Tari King Guideline Update (Journal of Clinical Oncology)
Elizabeth Comen, Alice Yoosun Ho, Clifford Hudis, Monica Morrow
Genomic analyses identify molecular subtypes Genomic Classification and Prognosis in Acute Myeloid
833 of pancreatic cancer (Nature) 635 Leukemia (New England Journal of Medicine)
Christine Anne Iacobuzio-Donahue Elli Papaemmanuil
LEGEND
Policy Documents Post-Publication Peer-Reviews Google+ Q&A (stack overflow) *Altmetric Attention Scores are provided in real time
News Facebook Linkedin Youtube and can change based on new mentions. The scores
Blogs Sina Weibo Reddit Pinterest shown are current as of February 20, 2017.
Twitter Wikipedia Faculty1000
25 OF 324
Bibliography of Works
The following bibliography consists of 2016 works Journal Articles
that were ingested into Synapse as of 2/17/2017. Works published in a serial publication, including but not limited to:
Based on the submission schedules of different • Research papers
publishers and commercial databases, there may • Reviews/surveys
be delays in 2016 content getting added to Synapse. • Editorials
• Letters
The comprehensive bibliography is divided into • Chapters from a monographic series
sections which may be further defined as follows:
Conference Papers
Original articles published for or presented at a conference, symposium or
other professional gathering
Meeting Abstracts
Published abstracts of presentations held at a conference, symposium or
other professional gathering, including but not limited to:
• Poster presentations
• Oral presentations
• Panel discussions
Book Sections
Chapters or sections of a monograph or book. Occasionally, these will be
represented in Synapse as journal articles (if they’re part of a monographic
series) or conference papers/meeting abstracts (if they’re part of a
proceedings booklet)
Book Wholes
Whole monographs or entire books
26 OF 324
Title
Journal
Articles
(2,893)
27 OF 324
Journal Articles
Abdel Latif AM, Souweidane MM. Extruded contents of colloid cysts after Laurenzio L, Lee R, Yen CJ. Randomized phase II placebo controlled
endoscopic removal. Journal of Neurosurgery. 2016;125(3):570-575. study of codrituzumab in previously treated patients with advanced
hepatocellular carcinoma. Journal of Hepatology. 2016;65(2):289-295.
Abdel-Misih SRZ, Wei L, Benson AB III, Cohen S, Lai L, Skibber J, Wilkinson
N, Weiser M, Schrag D, Bekaii-Saab T. Neoadjuvant therapy for rectal Abou-Alfa GK. Preface: Special issue on biliary cancer. Chinese Clinical
cancer affects lymph node yield and status without clear implications Oncology. 2016;5(5):E2.
on outcome: The case for eliminating a metric and using preoperative
staging to guide therapy. Journal of the National Comprehensive Cancer Abramian A, Zivanovic O, Kuhn W, Weber S, Schaefer N, Keyver-Paik
Network. 2016;14(12):1528-1534. PMCID: PMC5292039 MD, Kiefer N. Introducing hyperthermic intraperitoneal chemotherapy
into gynecological oncology practice - Feasibility and safety
Abdul Razak AR, Mau-Soerensen M, Gabrail NY, Gerecitano JF, Shields considerations: Single-center experience. Oncology Research and
AF, Unger TJ, Saint-Martin JR, Carlson R, Landesman Y, McCauley D, Treatment. 2016;39(4):178-184.
Rashal T, Lassen U, Kim R, Stayner LA, Mirza MR, Kauffman M, Shacham
S, Mahipal A. First-in-class, first-in-human phase I study of selinexor, Abramson DH, Daniels AB, Marr BP, Francis JH, Brodie SE, Dunkel
a selective inhibitor of nuclear export, in patients with advanced solid IJ, Gobin YP. Intra-arterial chemotherapy (ophthalmic artery
tumors. Journal of Clinical Oncology. 2016;34(34):4142-4150. chemosurgery) for group D retinoblastoma. PLoS ONE. 2016;11(1):
e0146582. PMCID: PMC4710506
Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DLJ. Whole-
body and microenvironmental localization of Radium-223 in naïve Abramson DH, Marr BP, Francis JH, Dunkel IJ, Fabius AWM, Brodie
and mouse models of prostate cancer metastasis. JNCI: Journal of the SE, Mondesire-Crump I, Gobin YP. Simultaneous bilateral ophthalmic
National Cancer Institute. 2016;108(5):djv380. PMCID: PMC4849807 artery chemosurgery for bilateral retinoblastoma (tandem therapy). PLoS
ONE. 2016;11(6):e0156806. PMCID: PMC4892546
Abou-Alfa G. Interview with Dr Ghassan K Abou-Alfa.
Immunotherapy. 2016;8(11):1277-1279. Abramson DH, Marr BP, Francis JH. Intra-arterial chemotherapy for
retinoblastoma. JAMA Ophthalmology. 2016;134(10):1202.
Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores
GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, Kelley RK, Kwong Abt MC, Buffie CG, Sušac B, Becattini S, Carter RA, Leiner
LN, Lowery M, Merrell A, Miyabe K, Rhim A, Saha S, Sia D, Tanasanvimon I, Keith JW, Artis D, Osborne LC, Pamer EG. TLR-7 activation
S, Venook A, Valle JW, Walesky C, Whetstine J, Willenbring H, Zhu enhances IL-22-mediated colonization resistance against
AX, Mayer D, Stanger BZ. Advances in cholangiocarcinoma research: vancomycin-resistant enterococcus. Science Translational
Report from the third cholangiocarcinoma foundation annual Medicine. 2016;8(327):327ra25. PMCID: PMC4991618
conference. Journal of Gastrointestinal Oncology. 2016;7(6):819-
827. PMCID: PMC5177567 Abt MC, McKenney PT, Pamer EG. Clostridium difficile
colitis: Pathogenesis and host defence. Nature Reviews
Abou-Alfa GK, Puig O, Daniele B, Kudo M, Merle P, Park JW, Ross Microbiology. 2016;14(10):609-620. PMCID: PMC5109054
P, Peron JM, Ebert O, Chan S, Poon TP, Colombo M, Okusaka T,
Ryoo BY, Minguez B, Tanaka T, Ohtomo T, Ukrainskyj S, Boisserie F, Abt MC. Acute gastroenteritis leaves a lasting impression. Cell Host &
Rutman O, Chen YC, Xu C, Shochat E, Jukofsky L, Reis B, Chen G, Di Microbe. 2016;19(1):3-5.
28 OF 324
Journal Articles
Abu-Zeinah GF, Weisman P, Ganesh K, Katz SS, Dogan A, Abou-Alfa immunoconjugates for molecular imaging - Part 1: Cysteine residues
GK, Stein EM, Jarnagin W, Mauro MJ, Harding JJ. Acute myeloid and glycans. Molecular Imaging and Biology. 2016;18(1):1-17. PMCID:
leukemia masquerading as hepatocellular carcinoma. Journal of PMC4722084
Gastrointestinal Oncology. 2016;7(3):E31-E35. PMCID: PMC4880775
Adusumilli PS. Spread through alveolar spaces: An aerogenous invasion
Acharyya S, Massague J. Arresting supporters: Targeting neutrophils in in pulmonary adenocarcinomas. Journal of Thoracic and Cardiovascular
metastasis. Cell Research. 2016;26(3):273-274. PMCID: PMC4783468 Surgery. 2016;152(1):73-74. PMCID: PMC4976066
Ackermann U, Lewis JS, Young K, Morris MJ, Weickhardt A, Advani RH, Ansell SM, Lechowicz MJ, Beaven AW, Loberiza F, Carson
Davis ID, Scott AM. Fully automated synthesis of [18F]fluoro- KR, Evens AM, Foss F, Horwitz S, Pro B, Pinter-Brown LC, Smith SM,
dihydrotestosterone ([18F]FDHT) using the FlexLab module. Journal Shustov AR, Savage KJ, Vose JM. A phase II study of cyclophosphamide,
of Labelled Compounds and Radiopharmaceuticals. 2016;59(10):424- etoposide, vincristine and prednisone (CEOP) alternating with
428. PMCID: PMC4990449 pralatrexate (P) as front line therapy for patients with peripheral T-cell
lymphoma (PTCL): Final results from the T-cell consortium trial. British
Adams NM, O’Sullivan TE, Geary CD, Karo JM, Amezquita RA, Joshi Journal of Haematology. 2016;172(4):535-544.
NS, Kaech SM, Sun JC. NK cell responses redefine immunological
memory. Journal of Immunology. 2016;197(8):2963-2970. Ady J, Thayanithy V, Mojica K, Wong P, Carson J, Rao P, Fong Y, Lou
E. Tunneling nanotubes: An alternate route for propagation of the
Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, bystander effect following oncolytic viral infection. Molecular Therapy -
Marchegiani G, Bassi C, Salvia R, Malleo G, Paiella S, Wolfgang CL, Oncolytics. 2016;3:16029. PMCID: PMC5142513
Matthaei H, Offerhaus GJ, Adham M, Bruno MJ, Reid MD, Krasinskas
A, Klöppel G, Ohike N, Tajiri T, Jang KT, Roa JC, Allen P, Fernández- Afaneh C, Levy A, Selby L, Ku G, Tang L, Yoon SS, Coit D, Strong
Del Castillo C, Jang JY, Klimstra DS, Hruban RH. Pathologic evaluation VE. Ex vivo lymphadenectomy during gastrectomy for adenocarcinoma
and reporting of intraductal papillary mucinous neoplasms of the optimizes lymph node yield. Journal of Gastrointestinal
pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary Surgery. 2016;20(1):165-171. PMCID: PMC4862875
tract: Recommendations of Verona Consensus Meeting. Annals of
Surgery. 2016;263(1):162-177. PMCID: PMC4568174 Afifi S, Michael A, Lesokhin A. Immunotherapy: A new approach to
treating multiple myeloma with daratumumab and elotuzumab. Annals of
Adumeau P, Sharma SK, Brent C, Zeglis BM. Site-specifically labeled Pharmacotherapy. 2016;50(7):555-568.
immunoconjugates for molecular imaging - Part 2: Peptide tags and
unnatural amino acids. Molecular Imaging and Biology. 2016;18(2):153- Afifi S, Adel NG, Devlin S, Duck E, Vanak J, Landau H, Chung DJ, Lendvai
165. PMCID: PMC4842939 N, Lesokhin A, Korde N, Reich L, Landgren O, Giralt S, Hassoun
H. Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF
Adumeau P, Carnazza KE, Brand C, Carlin SD, Reiner T, Agnew BJ, Lewis for stem cell mobilization in multiple myeloma: Efficacy and cost analysis
JS, Zeglis BM. A pretargeted approach for the multimodal PET/NIRF study. Bone Marrow Transplantation. 2016;51(4):546-552.
imaging of colorectal cancer. Theranostics. 2016;6(12):2267-2277.
Agaram NP, Zhang L, LeLoarer F, Silk T, Sung YS, Scott SN, Kuk D, Qin
Adumeau P, Sharma SK, Brent C, Zeglis BM. Site-specifically labeled LX, Berger MF, Antonescu CR, Singer S. Targeted exome sequencing
29 OF 324
Journal Articles
profiles genetic alterations in leiomyosarcoma. Genes Chromosomes and KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration
Cancer. 2016;55(2):124-130. PMCID: PMC4715662 and dissemination. Oncogene. 2016;35(35):4653-4662. PMCID: PMC4985511
Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Ailon T, Torabi R, Fisher CG, Rhines LD, Clarke MJ, Bettegowda C, Boriani
Fletcher CDM. Recurrent NTRK1 gene fusions define a novel subset of S, Yamada YJ, Kawahara N, Varga PP, Shin JH, Saghal A, Gokaslan
locally aggressive lipofibromatosis-like neural tumors. American Journal ZL. Management of locally recurrent chordoma of the mobile spine and
of Surgical Pathology. 2016;40(10):1407-1416. PMCID: PMC5023452 sacrum: A systematic review. Spine. 2016;41(Suppl. 20):S193-S198.
Agarwal R, Schwer B, Shuman S. Structure-function analysis and genetic Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger
interactions of the Luc7 subunit of the Saccharomyces cerevisiae U1 CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE,
snRNP. RNA. 2016;22(9):1302-1310. PMCID: PMC4986886 Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D,
Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C,
Agostini A, Kircher MF, Do R, Borgheresi A, Monti S, Giovagnoni Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA,
A, Mannelli L. Magnetic resonance imaging of the liver (including Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright
biliary contrast agents) part 1: Technical considerations and contrast CD, Zelman D, McMillian N, Sundar H. Gastric cancer, version 3.2016:
materials. Seminars in Roentgenology. 2016;51(4):308-316. NCCN Clinical Practice Guidelines in Oncology. Journal of the National
Comprehensive Cancer Network. 2016;14(10):1286-1312.
Agostini A, Kircher MF, Do RKG, Borgheresi A, Monti S, Giovagnoni
A, Mannelli L. Magnetic resonanance imaging of the liver (including Ajayi A, Hwang WT, Vapiwala N, Rosen M, Chapman CH, Both S, Shah
biliary contrast agents) - Part 2: Protocols for liver magnetic resonanance M, Wang X, Agawu A, Gabriel P, Christodouleas J, Tochner Z, Deville
imaging and characterization of common focal liver lesions. Seminars in C. Disparities in staging prostate magnetic resonance imaging utilization
Roentgenology. 2016;51(4):317-333. PMCID: PMC5117432 for nonmetastatic prostate cancer patients undergoing definitive
radiation therapy. Advances in Radiation Oncology. 2016;1(4):325-332.
Agozzino M, Gonzalez S, Ardigò M. Reflectance confocal microscopy for
inflammatory skin diseases. Actas Dermo-Sifiliográficas. 2016;107(8):631-639. Ajise OE, Roshal M, Wang L, Sukhram GN, Smith KM, Maslak P, Dogan
A. Clinical utility of morphology, immunohistochemistry, flow cytometry,
Aguiar PN, Pimentel Muniz T, Rodrigues Miranda R, Tadokoro H, Forones and FISH analysis in monitoring of plasma cell neoplasms in the bone
NM, Monteiro IDP, Castelo-Branco P, Janjigian YY, De Mello RA. Current marrow. Journal of Hematopathology. 2016;9(1):9-18.
advances in targeted therapies for metastatic gastric cancer: Improving
patient care. Future Oncology. 2016;12(6):839-854. Akkari L, Gocheva V, Quick ML, Kester JC, Spencer AK, Garfall
AL, Bowman RL, Joyce JA. Combined deletion of cathepsin protease
Ahmad U, Huang J. Induction therapy for thymoma. Thoracic Surgery family members reveals compensatory mechanisms in cancer. Genes and
Clinics. 2016;26(3):325-332. Development. 2016;30(2):220-232. PMCID: PMC4719311
Ahn IE, Mailankody S. Controversies in multiple myeloma: Evidence- Al Efishat M, Allen PJ. Therapeutic approach to cystic neoplasms of the
based update. Seminars in Oncology. 2016;43(6):666-675. pancreas. Surgical Oncology Clinics of North America. 2016;25(2):351-
361. PMCID: PMC4991876
Ahronian LG, Zhu LJ, Chen YW, Chu HC, Klimstra DS, Lewis BC. A novel
30 OF 324
Journal Articles
Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy DC, Rini B I, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN,
Huang XJ, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup
J, June C, Ai HS, Luznik L, Mavilio D, Lugli E, van den Brink MRM, AJ, Furberg H, Fay AP, De Velasco G, Preston MA, Wilson KM, Cho
Champlin RE, Ciurea SO. Proceedings from the Second Haploidentical E, McDermott DF, Signoretti S, Heng DYC, Choueiri TK. Body mass
Stem Cell Transplantation Symposium—Haplo2014, San Francisco, index and metastatic renal cell carcinoma: Clinical and biological
California, December 4, 2014. Biology of Blood and Marrow correlations. Journal of Clinical Oncology. 2016;34(30):3655-
Transplantation. 2016;22(4):594-604. 3663. PMCID: PMC5065111
Alabi RO, Glomski K, Haxaire C, Weskamp G, Monette S, Blobel Albornoz CR, Cohen WA, Razdan SN, Mehrara BJ, McCarthy CM, Disa
CP. ADAM10-dependent signaling through notchl and notch4 JJ, Dayan JH, Pusic AL, Cordeiro PG, Matros E. The impact of travel
controls development of organ-specific vascular beds. Circulation distance on breast reconstruction in the United States. Plastic and
Research. 2016;119(4):519-531. PMCID: PMC4975635 Reconstructive Surgery. 2016;137(1):12-18. PMCID: PMC4776632
Alaggio R, Zhang L, Sung YS, Huang SC, Chen CL, Bisogno G, Zin Aldawsari FS, Aguayo-Ortiz R, Kapilashrami K, Yoo J, Luo M, Medina-
A, Agaram NP, LaQuaglia MP, Wexler LH, Antonescu CR. A molecular Franco JL, Velázquez-Martínez CA. Resveratrol-salicylate derivatives
study of pediatric spindle and sclerosing rhabdomyosarcoma: as selective DNMT3 inhibitors and anticancer agents. Journal of
Identification of novel and recurrent VGLL2-related fusions in infantile Enzyme Inhibition and Medicinal Chemistry. 2016;31(5):695-703. PMCID:
cases. American Journal of Surgical Pathology. 2016;40(2):224- PMC4828318
235. PMCID: PMC4712098
Alderman A, Pusic A, Murphy DK. Prospective analysis of primary
Al-Ahmadie H. PD-L1 expression in penile cancer: A new frontier for breast augmentation on body image using the BREAST-Q:
immune checkpoint inhibitors?. Annals of Oncology. 2016;27(9):1658-1659. Results from a nationwide study. Plastic and Reconstructive
Surgery. 2016;137(6):954e-960e. PMCID: PMC4879787
Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan
EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya Aldoss I, Douer D, Behrendt CE, Chaudhary P, Mohrbacher A, Vrona
I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale J, Pullarkat V. Toxicity profile of repeated doses of PEG-asparaginase
A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger incorporated into a pediatric-type regimen for adult acute lymphoblastic
MF, Reuter VE, Taylor BS, Solit DB. Frequent somatic CDH1 loss-of- leukemia. European Journal of Haematology. 2016;96(4):375-380.
function mutations in plasmacytoid variant bladder cancer. Nature
Genetics. 2016;48(4):356-358. PMCID: PMC4827439 Alexander K, Goldberg J, Korc-Grodzicki B. Palliative care and
symptom management in older patients with cancer. Clinics in Geriatric
Alanee SR, Carver BS, Feldman DR, Motzer RJ, Bosl GJ, Sheinfeld Medicine. 2016;32(1):45-62. PMCID: PMC5032900
J. Pelvic lymph node dissection in patients treated for
testis cancer: The Memorial Sloan Kettering Cancer Center Alexander K, Shahrokni A, Mahmoudzadeh Pournaki S, Korc-Grodzicki
experience. Urology. 2016;95:128-131. PMCID: PMC5012113 B. Skilled care utilization after abdominal and pelvic cancer surgery in
older patients. European Geriatric Medicine. 2016;7(5):438-442.
Albiges L, Ari Hakimi A, Xie W, McKay RR, Simantov R, Lin X, Lee JL,
31 OF 324
Journal Articles
Algazi AP, Tsai KK, Shoushtari AN, Munhoz RR, Eroglu Z, Piulats Aliyev N, Takahashi Y, Lu S, Mayor M, Adusumilli PS. Intraoperative
JM, Ott PA, Johnson DB, Hwang J, Daud A I, Sosman JA, Carvajal subtyping of lung adenocarcinoma: An unmet need. Translational Cancer
RD, Chmielowski B, Postow MA, Weber JS, Sullivan RJ. Clinical Research. 2016;5(Suppl.):S40-S43.
outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1
antibodies. Cancer. 2016;122(21):3344-3353. Allen BB, Charles JA, Papadopoulos E, Avila EK. Neurogenic
orthostatic hypotension with critical illness neuropathy treated with
Ali SM, Hensing T, Schrock AB, Allen J, Sanford E, Gowen K, Kulkarni droxidopa. Autonomic Neuroscience-Basic & Clinical. 2016;198:8-9.
A, He J, Suh JH, Lipson D, Elvin JA, Yelensky R, Chalmers Z, Chmielecki
J, Peled N, Klempner SJ, Firozvi K, Frampton GM, Molina JR, Amenon Allen JD. When and how to treat childhood immune
S, Brahmer JR, MacMahon H, Nowak J, Ignatius Ou SH, Zauderer thrombocytopenia. Nurse Practitioner. 2016;41(7):18-25.
M, Ladanyi M, Zakowski M, Fischbach N, Ross JS, Stephens PJ, Miller
VA, Wakelee H, Ganesan S, Salgia R. Comprehensive genomic profiling Allen PJ, Iacobuzio-Donahue CA, Klimstra DS. Cyst fluid analysis in
identifies a subset of crizotinib- responsive ALK-rearranged non-small pancreatic intraductal papillary mucinous neoplasms. Clinical Cancer
cell lung cancer not detected by fluorescence in situ hybridization. The Research. 2016;22(20):4966-4967.
Oncologist. 2016;21(6):762-770. PMCID: PMC4912370
Allen RJ Jr, Disa JJ. Discussion: Suprafascial anterolateral thigh
Alici Y. Protracted versus new-onset delirium: Diagnostic flap harvest: A better way to minimize donor-site morbidity
challenges. Journal of the American Geriatrics Society. 2016;64(5):1149. in head and neck reconstruction. Plastic and Reconstructive
Surgery. 2016;138(3):699-700.
Alidori S, Akhavein N, Thorek DLJ, Behling K, Romin
Y, Queen D, Beattie BJ, Manova-Todorova K, Bergkvist Alnaghy S, Loo KJ, Cutajar DL, Jalayer M, Tenconi C, Favoino M, Rietti
M, Scheinberg DA, McDevitt MR. Targeted fibrillar nanocarbon R, Tartaglia M, Carriero F, Safavi-Naeini M, Bucci J, Jakubek J, Pospisil
RNAi treatment of acute kidney injury. Science Translational S, Zaider M, Lerch MLF, Rosenfeld AB, Petasecca M. BrachyView: Multiple
Medicine. 2016;8(331):331ra39. PMCID: PMC5004247 seed position reconstruction and comparison with CT post-implant
dosimetry. Journal of Instrumentation. 2016;11(5):P05002.
Alidori S, Bowman RL, Yarilin D, Romin Y, Barlas A, Mulvey JJ, Fujisawa
S, Xu K, Ruggiero A, Riabov V, Thorek DLJ, Ulmert HDS, Brea EJ, Behling Alperovich A, Younes A. Targeting CD30 using brentuximab vedotin in
K, Kzhyshkowska J, Manova-Todorova K, Scheinberg DA, McDevitt the treatment of Hodgkin lymphoma. The Cancer Journal. 2016;22(1):23-
MR. Deconvoluting hepatic processing of carbon nanotubes. Nature 26. PMCID: PMC5042201
Communications. 2016;7:12343. PMCID: PMC4974572
Alshiekh-Nasany R, Douer D. L-carnitine for treatment
Alinezhad S, Väänänen RM, Ochoa NT, Vertosick EA, Bjartell A, Boström of pegasparaginase-induced hepatotoxicity. Acta
PJ, Taimen P, Pettersson K. Global expression of AMACR transcripts Haematologica. 2016;135(4):208-210.
predicts risk for prostate cancer — A systematic comparison of
Altaf F, Weber M, Dea N, Boriani S, Ames C, Williams R, Verlaan JJ, Laufer
AMACR protein and mRNA expression in cancerous and noncancerous
I, Fisher CG. Evidence-based review and survey of expert opinion
prostate. BMC Urology. 2016;16:10. PMCID: PMC4772680
of reconstruction of metastatic spine tumors. Spine. 2016;41(Suppl.
20):S254-S261.
32 OF 324
Journal Articles
Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, association between allergies and glioma risk: A report from the glioma
Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris international case-control study. Cancer Epidemiology Biomarkers and
LE Jr, Thompson J, Horowitz MM, Mendizabal A, Levine A, Krishnan A, Prevention. 2016;25(2):282-290. PMCID: PMC4874516
Forman SJ, Navarro WH, Ambinder R. Autologous hematopoietic cell
transplantation for HIV-related lymphoma: Results of the BMT CTN 0803/ Anand A, Morris MJ, Kaboteh R, Bath L, Sadik M, Gjertsson P, Lomsky M,
AMC 071 trial. Blood. 2016;128(8):1050-1058. PMCID: PMC5000843 Edenbrandt L, Minarik D, Bjartell A. Analytic validation of the automated
bone scan index as an imaging biomarker to standardize quantitative
Amar D. Postoperative atrial fibrillation: Is there a need changes in bone scans of patients with metastatic prostate cancer. Journal
for prevention?. Journal of Thoracic and Cardiovascular of Nuclear Medicine. 2016;57(1):41-45. PMCID: PMC4975929
Surgery. 2016;151(4):913-915.
Anand A, Morris MJ, Kaboteh R, Reza M, Trägardh E, Matsunaga
Ambati SR, Shieh JH, Pera B, Lopes EC, Chaudhry A, Wong EW, Saxena N, Edenbrandt L, Bjartell A, Larson SM, Minarik D. A preanalytic
A, Su TL, Moore MA. BO-1055, a novel DNA cross-linking agent with validation study of automated bone scan index: Effect on accuracy and
remarkable low myelotoxicity shows potent activity in sarcoma reproducibility due to the procedural variabilities in bone scan image
models. Oncotarget. 2016;7(28):43062-43075. PMCID: 27248664 acquisition. Journal of Nuclear Medicine. 2016;57(12):1865-1871.
Amirian ES, Armstrong GN, Zhou R, Lau CC, Claus EB, Barnholtz-Sloan JS, Anand A, Morris MJ, Larson SM, Minarik D, Josefsson A, Helgstrand
Il’yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston JT, Oturai PS, Edenbrandt L, Røder MA, Bjartell A. Automated
RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch Bone Scan Index as a quantitative imaging biomarker in metastatic
MR, Davis FG, Lai R, Shete S, Amos C I, Scheurer ME, Aldape K, Alafuzoff I, castration-resistant prostate cancer patients being treated with
Brännström T, Broholm H, Collins P, Giannini C, Rosenblum M, Tihan T, Melin enzalutamide. EJNMMI Research. 2016;6(1):23. PMCID: PMC4785173
BS, Bondy ML. The Glioma International Case-Control Study: A report from
the Genetic Epidemiology of Glioma International Consortium. American Anderlini P, Saliba RM, Ledesma C, Plair T, Alousi AM, Hosing CM,
Journal of Epidemiology. 2016;183(2):85-91. PMCID: PMC4706682 Khouri IF, Nieto Y, Popat UR, Shpall EJ, Fanale MA, Hagemeister
FB, Oki Y, Neelapu S, Romaguera JE, Younes A, Champlin
Amirian ES, Scheurer ME, Zhou R, Wrensch MR, Armstrong G, Lachance RE. Gemcitabine, fludarabine, and melphalan for reduced-intensity
D, Olson SH, Lau CC, Claus EB, Barnholtz-Sloan J, Il’yasova D, Schildkraut conditioning and allogeneic stem cell transplantation for relapsed
J, Ali-Osman F, Sadetzki S, Jenkins RB, Bernstein JL, Merrell RT, Davis and refractory Hodgkin lymphoma. Biology of Blood and Marrow
FG, Lai R, Shete S, Amos C I, Melin BS, Bondy ML. History of chickenpox Transplantation. 2016;22(7):1333-1337. PMCID: PMC5193224
in glioma risk: A report from the Glioma International Case-Control Study
(GICC). Cancer Medicine. 2016;5(6):1352-1358. PMCID: PMC4924393 Anderson C, Weber R, Patel D, Lowrance W, Mellis A, Cookson M,
Lang M, Barocas D, Chang S, Newberger E, Montgomery JS, Weizer
Amirian ES, Zhou R, Wrensch MR, Olson SH, Scheurer ME, Il’yasova D, AZ, Lee CT, Kava BR, Jackson M, Meraney A, Sjoberg D, Bochner B,
Lachance D, Armstrong GN, McCoy LS, Lau CC, Claus EB, Barnholtz- Dalbagni G, Donat M, Herr H. A 10-item checklist improves reporting of
Sloan JS, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston critical procedural elements during transurethral resection of bladder
RS, Jenkins RB, Bernstein JL, Merrell RT, Davis FG, Lai R, Shete S, Amos tumor. Journal of Urology. 2016;196(4):1014-1020.
C I, Melin BS, Bondy ML. Approaching a scientific consensus on the
33 OF 324
Journal Articles
Anderson CB, Atoria CL, Touijer K, Ehdaie B, Elkin EB. Surgeon options. Journal of Surgical Oncology. 2016;113(1):55-61.
adoption of minimally invasive radical prostatectomy. Urology
Practice. 2016;3(6):505-510. Angarone MP, Sheahan A, Kamboj M. Norovirus in
transplantation. Current Infectious Disease Reports. 2016;18(6):17.
Anderson CB, Tin AL, Sjoberg DD, Mulhall JP, Sandhu J, Touijer
K, Laudone VP, Eastham JA, Scardino PT, Ehdaie B. Association Ansa-Addo EA, Thaxton J, Hong F, Wu BX, Zhang Y, Fugle CW, Metelli A,
between number of prostate biopsies and patient-reported functional Riesenberg B, Williams K, Gewirth DT, Chiosis G, Liu B, Li Z. Clients and
outcomes after radical prostatectomy: Implications for active surveillance oncogenic roles of molecular chaperone gp96/grp94. Current Topics in
protocols. BJU International. 2016;117(6B):E46-E51. PMCID: PMC4991927 Medicinal Chemistry. 2016;16(25):2765-2778. PMCID: PMC5041304
Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Antczak C, Djaballah H. A high-content assay to screen for modulators
Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister of EGFR function. Methods in Molecular Biology. 2016;1360:97-106.
C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK,
Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl- Antonia S, Goldberg SB, Balmanoukian A, Chaft JE, Sanborn RE,
Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R. NCCN Gupta A, Narwal R, Steele K, Gu Y, Karakunnel JJ, Rizvi NA. Safety
Guidelines insights - Multiple myeloma, version 3.2016 featured updates and antitumour activity of durvalumab plus tremelimumab in
to the NCCN Guidelines. Journal of the National Comprehensive Cancer non-small cell lung cancer: A multicentre, phase 1b study. Lancet
Network. 2016;14(4):389-400. Oncology. 2016;17(3):299-308.
Andolina D, Di Segni M, Bisicchia E, D’Alessandro F, Cestari V, Ventura Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger
A, Concepcion C, Puglisi-Allegra S, Ventura R. Effects of lack of D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A,
microRNA-34 on the neural circuitry underlying the stress response and Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS,
anxiety. Neuropharmacology. 2016;107:305-316. Christensen O, Calvo E. Nivolumab alone and nivolumab plus ipilimumab
in recurrent small-cell lung cancer (CheckMate 032): A multicentre, open-
Andreotti C, Root JC, Schagen SB, McDonald BC, Saykin AJ, Atkinson label, phase 1/2 trial. Lancet Oncology. 2016;17(7):883-895.
TM, Li Y, Ahles TA. Reliable change in neuropsychological assessment
of breast cancer survivors. Psycho-Oncology. 2016;25(1):43-50. PMCID: Antony-Debre I, Duployez N, Bucci M, Geffroy S, Micol JB, Renneville A,
PMC4580503 Boissel N, Dhedin N, Rea D, Nelken B, Berthon C, Leblanc T, Mozziconacci
MJ, Favier R, Heller PG, Abdel-Wahab O, Raslova H, Latger-Cannard V,
Andreou C, Neuschmelting V, Tschaharganeh DF, Huang Preudhomme C. Somatic mutations associated with leukemic progression
CH, Oseledchyk A, Iacono P, Karabeber H, Colen RR, Mannelli of familial platelet disorder with predisposition to acute myeloid
L, Lowe SW, Kircher MF. Imaging of liver tumors using surface- leukemia. Leukemia. 2016;30(4):999-1002.
enhanced raman scattering nanoparticles. ACS Nano. 2016;10(5):5015-
5026. PMCID: PMC4884645 Applebaum AJ, Bevans M, Son T, Evans K, Hernandez M, Giralt
S, DuHamel K. A scoping review of caregiver burden during
Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, allogeneic HSCT: Lessons learned and future directions. Bone Marrow
Yee NS, Abou-Alfa GK. Comprehensive multiplatform biomarker analysis Transplantation. 2016;51(11):1416-1422.
of 350 hepatocellular carcinomas identifies potential novel therapeutic
34 OF 324
Journal Articles
Aragones A, Genoff M, Gonzalez C, Shuk E, Gany F. HPV vaccine and Argani P, Reuter VE, Zhang L, Sung YS, Ning Y, Epstein J I, Netto
Latino immigrant parents: If they offer it, we will get it. Journal of GJ, Antonescu CR. TFEB-amplified renal cell carcinomas: An aggressive
Immigrant and Minority Health. 2016;18(5):1060-1065. PMCID: PMC4656145 molecular subset demonstrating variable melanocytic marker expression
and morphologic heterogeneity. American Journal of Surgical
Aras O, Takan G, Yurt Kilcar A, Biber Muftuler FZ. Extraction Pathology. 2016;40(11):1484-1495. PMCID: PMC5069163
and radioiodination of Gingko flavonoids and monitoring the
cellular incorporation. Journal of Radioanalytical and Nuclear Argolo DF, Hudis CA, Iyengar NM. Obesity and cancer - Opportunities to
Chemistry. 2016;310(1):271-278. break the link. Current Breast Cancer Reports. 2016;8(1):22-31.
Araya C, Carmona-Fontaine C, Clarke JDW. Extracellular matrix Argyropoulos K V, Vogel R, Ziegler C, Altan-Bonnet G, Velardi
couples the convergence movements of mesoderm and neural E, Calafiore M, Dogan A, Arcila M, Patel M, Knapp K, Mallek C, Hunter ZR,
plate during the early stages of neurulation. Developmental Treon SP, van den Brink MRM, Palomba ML. Clonal B cells in Waldenstrom’s
Dynamics. 2016;245(5):580-589. macroglobulinemia exhibit functional features of chronic active B-cell
receptor signaling. Leukemia. 2016;30(5):1116-1125. PMCID: PMC4858584
Ardigò M, Agozzino M, Franceschini C, Donadio C, Abraham LS, Barbieri
L, Sperduti I, Berardesca E, González S. Reflectance confocal microscopy Ariyan C. Complete lymph node dissection in melanoma. Lancet
for scarring and non-scarring alopecia real-time assessment. Archives of Oncology. 2016;17(6):688-689.
Dermatological Research. 2016;308(5):309-318.
Armand P, Shipp MA, Ribrag V, Michot JM, Zinzani PL, Kuruvilla J, Snyder
Ardigo M, Longo C, Gonzalez S, The International Confocal Working ES, Ricart AD, Balakumaran A, Rose S, Moskowitz CH. Programmed
Group Inflammatory Skin Diseases Project. Multicentre study on death-1 blockade with pembrolizumab in patients with classical
inflammatory skin diseases from The International Confocal Working Hodgkin lymphoma after brentuximab vedotin failure. Journal of Clinical
Group: Specific confocal microscopy features and an algorithmic method Oncology. 2016;34(31):3733-3739.
of diagnosis. British Journal of Dermatology. 2016;175(2):364-374.
Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens
Arevalo Perez J, Paris M, Graham MM, Osborne JR. A perspective of the AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, Nathan PC, Neglia
future of nuclear medicine training and certification. Seminars in Nuclear JP, Green DM, Hudson MM, Robison LL. Reduction in late mortality
Medicine. 2016;46(1):88-96. PMCID: PMC4913701 among 5-year survivors of childhood cancer. New England Journal of
Medicine. 2016;374(9):833-842. PMCID: PMC4786452
Arevalo-Perez J, Kebede AA, Peck KK, Diamond E, Holodny
A I, Rosenblum M, Rubel J, Gaal J, Hatzoglou V. Dynamic Arnold B, Mitchell SA, Lent L, Mendoza TR, Rogak LJ, Barragán NM,
contrast-enhanced MRI in low-grade versus anaplastic Willis G, Medina M, Lechner S, Penedo FJ, Harness JK, Basch EM,
oligodendrogliomas. Journal of Neuroimaging. 2016;26(3):366-371. for the PRO-CTCAE Spanish Translation, Linguistic Validation Study
Group. Linguistic validation of the Spanish version of the National
Argani P, Zhong M, Reuter VE, Fallon JT, Epstein J I, Netto GJ, Antonescu Cancer Institute’s Patient-Reported Outcomes version of the Common
CR. TFE3-fusion variant analysis defines specific clinicopathologic Terminology Criteria for Adverse Events (PRO-CTCAE). Supportive Care
associations among Xp11 translocation cancers. American Journal of in Cancer. 2016;24(7):2843-2851.
Surgical Pathology. 2016;40(6):723-737. PMCID: PMC4864095
35 OF 324
Journal Articles
Arora M, Lee SJ, Spellman SR, Weisdorf DJ, Guan W, Haagenson M, report from the “Melanoma Bridge”. Napoli, December 1st-4th 2015. Journal
Wang T, Horowitz MH, Verneris MR, Fleischhauer K, Hsu K, Thyagarajan of Translational Medicine. 2016;14(1):313. PMCID: PMC5111349
B. Validation study failed to confirm an association between genetic
variants in the base excision repair pathway and transplant-related Ashcraft KA, Peace RM, Betof AS, Dewhirst MW, Jones LW. Efficacy and
mortality and relapse after hematopoietic cell transplantation. Biology of mechanisms of aerobic exercise on cancer initiation, progression, and
Blood and Marrow Transplantation. 2016;22(8):1531-1532. metastasis: A critical systematic review of in vivo preclinical data. Cancer
Research. 2016;76(14):4032-4050.
Arreba-Tutusaus P, Mack TS, Bullinger L, Schnoder TM, Polanetzki A, Weinert
S, Ballaschk A, Wang Z, Deshpande AJ, Armstrong SA, Dohner K, Fischer T, Askan G, Deshpande V, Klimstra DS, Adsay V, Sigel C, Shia J, Basturk
Heidel FH. Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro O. Expression of markers of hepatocellular differentiation in pancreatic
and in vivo. Leukemia. 2016;30(5):1220-1225. PMCID: PMC4840097 acinar cell neoplasms: A potential diagnostic pitfall. American Journal of
Clinical Pathology. 2016;146(2):163-169.
Arun G, Diermeier S, Akerman M, Chang KC, Wilkinson JE, Hearn S,
Kim Y, Macleod AR, Krainer AR, Norton L, Brogi E, Egeblad M, Spector Asuzu CC, Akin-Odanye EO, Philip EJ. The effect of pilot cognitive
DL. Differentiation of mammary tumors and reduction in metastasis upon restructuring therapy intervention on depression in female cancer
Malat1 lncRNA loss. Genes and Development. 2016;30(1):34-51. PMCID: patients. Psycho-Oncology. 2016;25(6):732-736.
PMC4701977
Ataie N, Xiang J, Cheng N, Brea EJ, Lu W, Scheinberg DA, Liu C,
Arvan P, Fish S. 86th Annual Meeting of the American Thyroid Ng HL. Structure of a TCR-mimic antibody with target predicts
Association. Thyroid. 2016;26(9):1154-1155. pharmacogenetics. Journal of Molecular Biology. 2016;428(1):194-
205. PMCID: PMC4738012
Asai T, Hatlen MA, Lossos C, Ndiaye-Lobry D, Deblasio A, Murata
K, Fleisher M, Cortizas EM, Verdun RE, Petrini J, Nimer SD. Generation of Atapattu L, Saha N, Chheang C, Eissman MF, Xu K, Vail ME, Hii L,
a novel, multi-stage, progressive, and transplantable model of plasma cell Llerena C, Liu Z, Horvay K, Abud HE, Kusebauch U, Moritz RL, Ding
neoplasms. Scientific Reports. 2016;6:22760. PMCID: PMC4785351 BS, Cao Z, Rafii S, Ernst M, Scott AM, Nikolov DB, Lackmann M, Janes
PW. An activated form of ADAM10 is tumor selective and regulates
Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, cancer stem-like cells and tumor growth. Journal of Experimental
Kakar S, Weiser MR, Overman MJ. The impact of stage, grade, and Medicine. 2016;213(9):1741-1757. PMCID: PMC4995075
mucinous histology on the efficacy of systemic chemotherapy in
adenocarcinomas of the appendix: Analysis of the National Cancer Data Atkins L, Hunkeler EM, Jensen CD, Michie S, Lee JK, Doubeni CA, Zauber
Base. Cancer. 2016;122(2):213-221. PMCID: PMC4860278 AG, Levin TR, Quinn VP, Corley DA. Factors influencing variation in
physician adenoma detection rates: A theory-based approach for
Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria performance improvement. Gastrointestinal Endoscopy. 2016;83(3):617-
S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, 626.e2. PMCID: PMC4762744
Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow
M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori Atkinson TM, Rodríguez VM, Gordon M, Avildsen IK, Emanu JC, Jewell
A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, ST, Anselmi KA, Ginex PK. The association between patient-reported
Marincola FM, Thurin M. Future perspectives in melanoma research: Meeting and objective oral anticancer medication adherence measures: A
36 OF 324
Journal Articles
systematic review. Oncology Nursing Forum. 2016;43(5):576-582. PMCID: versus automated methods for hematopoietic progenitor cell apheresis
PMC5008846 products. Transfusion. 2016;56(2):528-532. PMCID: PMC4980147
Atkinson TM, Ryan SJ, Bennett A V, Stover AM, Saracino RM, Rogak LJ, Avogadri F, Gnjatic S, Tassello J, Frosina D, Hanson N, Laudenbach
Jewell ST, Matsoukas K, Li Y, Basch E. The association between clinician- M, Ritter E, Merghoub T, Busam KJ, Jungbluth AA. Protein expression
based common terminology criteria for adverse events (CTCAE) and analysis of melanocyte differentiation antigen TRP-2. American Journal
patient-reported outcomes (PRO): A systematic review. Supportive Care of Dermatopathology. 2016;38(3):201-207.
in Cancer. 2016;24(8):3669-3676. PMCID: PMC4919215
Azad BB, Lisok A, Chatterjee S, Poirier JT, Pullambhatla M, Luker GD,
Atkinson TM, Salz T, Hay JL. Conflating colorectal cancer screening Pomper MG, Nimmagadda S. Targeted imaging of the atypical chemokine
and diagnostic testing - Letter. Cancer Epidemiology Biomarkers and receptor 3 (ACKR3/CXCR7) in human cancer xenografts. Journal of
Prevention. 2016;25(2):425. PMCID: PMC4767641 Nuclear Medicine. 2016;57(6):981-988. PMCID: PMC5261856
Ausoni S, Boscolo-Rizzo P, Singh B, Da Mosto MC, Spinato G, Tirelli G, Azevedo M, Schulman VK, Folker E, Balakrishnan M, Baylies M. Imaging
Spinato R, Azzarello G. Targeting cellular and molecular drivers of head approaches to investigate myonuclear positioning in drosophila. Methods
and neck squamous cell carcinoma: Current options and emerging in Molecular Biology. 2016;1411:291-312. PMCID: PMC4939885
perspectives. Cancer and Metastasis Reviews. 2016;35(3):413-426.
Azhar RA, Bochner B, Catto J, Goh AC, Kelly J, Patel HD, Pruthi RS,
Auvinen A, Moss SM, Tammela TLJ, Taari K, Roobol MJ, Schröder FH, Thalmann GN, Desai M. Enhanced recovery after urological surgery:
Bangma CH, Carlsson S, Aus G, Zappa M, Puliti D, Denis LJ, Nelen V, A contemporary systematic review of outcomes, key elements, and
Kwiatkowski M, Randazzo M, Páez A, Lujan M, Hugosson J. Absolute effect research needs. European Urology. 2016;70(1):176-187.
of prostate cancer screening: Balance of benefits and harms by center within
the European Randomized Study of Prostate Cancer Screening. Clinical Azoulay E, Kentish-Barnes N, Nelson J. Communication with family
Cancer Research. 2016;22(1):243-249. PMCID: PMC4951205 caregivers in the intensive care unit - Answers and questions. JAMA -
Journal of the American Medical Association. 2016;315(19):2075-2077.
Avallone G, Forlani A, Tecilla M, Riccardi E, Belluco S, Santagostino SF,
Grilli G, Khadivi K, Roccabianca P. Neoplastic diseases in the domestic Azzopardi S, Pang S, Klimstra DS, Du YCN. p53 and p16(Ink4a)/p19(Arf)
ferret (Mustela putorius furo) in Italy: Classification and tissue distribution loss promotes different pancreatic tumor types from PyMT-expressing
of 856 cases (2000-2010). BMC Veterinary Research. 2016;12:275. PMCID: progenitor cells. NeoPlasia. 2016;18(10):610-617. PMCID: PMC5035259
PMC5139086
Babady NE. Hospital-associated infections. Microbiology
Avecilla ST, Goss C, Bleau S, Tonon JA, Meagher RC. How do I perform Spectrum. 2016;4(3):DMIH2-0003-2015.
hematopoietic progenitor cell selection?. Transfusion. 2016;56(5):1008-
1013. PMCID: PMC4934655 Babady NE. Laboratory diagnosis of infections in cancer
patients: Challenges and opportunities. Journal of Clinical
Avecilla ST, Marionneaux SM, Leiva TD, Tonon JA, Chan VT, Moung Microbiology. 2016;54(11):2635-2646. PMCID: PMC5078537
C, Meagher RC, Maslak P. Comparison of manual hematocrit determinations
37 OF 324
Journal Articles
Bach PB, Conti RM, Muller RJ, Schnorr GC, Saltz LB. Overspending Bahng S, Hayama R, Marians KJ. MukB-mediated catenation
driven by oversized single dose vials of cancer drugs. BMJ: British of DNA is ATP and MukEF independent. Journal of Biological
Medical Journal (International Edition). 2016;352:i788. Chemistry. 2016;291(46):23999-24008. PMCID: PMC5104925
Bach PB. Should the American Society of Clinical Oncology ask for Bai H, Harmanci AS, Erson-Omay EZ, Li J, Coskun S, Simon M, Krischek
peer review before publishing its advocacy research?. Journal of Clinical B, Özduman K, Omay SB, Sorensen EA, Turcan S, Bakirciglu M, Carrion-
Oncology. 2016;34(36):4447-4448. Grant G, Murray PB, Clark VE, Ercan-Sencicek AG, Knight J, Sencar L,
Altinok S, Kaulen LD, Gulez B, Timmer M, Schramm J, Mishra-Gorur
Bach PB. Walking the tightrope between treatment efficacy and K, Henegariu O, Moliterno J, Louvi A, Chan TA, Tannheimer SL, Pamir
price. Journal of Clinical Oncology. 2016;34(9):889-890. MN, Vortmeyer AO, Bilgüvar K, Yasuno K, Günel M. Integrated genomic
characterization of IDH1-mutant glioma malignant progression. Nature
Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper Genetics. 2016;48(1):59-66. PMCID: PMC4829945
C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito
J I, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Baig MR, Levin TT, Lichtenthal WG, Boland PJ, Breitbart WS. Factitious
Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, disorder (Munchausen’s syndrome) in oncology: Case report and
Smith C. Prevention and treatment of cancer-related infections, version literature review. Psycho-Oncology. 2016;25(6):707-711.
2.2016: Clinical practice guidelines in oncology. Journal of the National
Comprehensive Cancer Network. 2016;14(7):882-913. Bailey DL, Lee A, Li BT, Clarke SJ. PET monitoring of liver directed
selective internal radionuclide therapy for metastatic gastro-oesophageal
Bago R, Sommer E, Castel P, Crafter C, Bailey FP, Shpiro N, Baselga J, Cross cancer. BMJ Case Reports. 2016;2016:215645. PMCID: PMC4932355
D, Eyers PA, Alessi DR. The hVps34-SGK3 pathway alleviates sustained
PI3K/Akt inhibition by stimulating mTORC1 and tumour growth. EMBO Bailey JM, Hendley AM, Lafaro KJ, Pruski MA, Jones NC, Alsina J,
Journal. 2016;35(17):1902-1922. PMCID: PMC5007552 Younes M, Maitra A, McAllister F, Iacobuzio-Donahue CA, Leach SD. P53
mutations cooperate with oncogenic Kras to promote adenocarcinoma
Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie from pancreatic ductal cells. Oncogene. 2016;35(32):4282-4288.
HA, Solit DB, Coleman JA. Genomic biomarkers for the prediction of
stage and prognosis of upper tract urothelial carcinoma. Journal of Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC,
Urology. 2016;195(6):1684-1689. PMCID: PMC4871772 Miller DK, Christ AN, Bruxner TJC, Quinn MC, Nourse C, Murtaugh
LC, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Fink
Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak L, Holmes O, Chin V, Anderson MJ, Kazakoff S, Leonard C, Newell F,
EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed Waddell N, Wood S, Xu Q, Wilson PJ, Cloonan N, Kassahn KS, Taylor
A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, D, Quek K, Robertson A, Pantano L, Mincarelli L, Sanchez LN, Evers
Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz L, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM,
N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M,
DB, Feldman DR. Genetic determinants of cisplatin resistance Scarlett CJ, Pinho A V, Giry-Laterriere M, Rooman I, Samra JS, Kench
in patients with advanced germ cell tumors. Journal of Clinical JG, Lovell JA, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour
Oncology. 2016;34(33):4000-4007. A, Zeps N, Moran-Jones K, Jamieson NB, Graham JS, Duthie F, Oien
38 OF 324
Journal Articles
K, Hair J, Grützmann R, Maitra A, Iacobuzio-Donahue CA, Wolfgang Kislinger T, Muthuswamy SK. Scribble is required for pregnancy-in-
CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Rusev B, Capelli P, duced alveologenesis in the adult mammary gland. Journal of Cell Sci-
Salvia R, Tortora G, Mukhopadhyay D, Petersen GM, Australian ence. 2016;129(12):2307-2315. PMCID: PMC4920253
Pancreatic Cancer Genome Initiative, Munzy DM, Fisher WE, Karim SA,
Eshleman JR, Hruban RH, Pilarsky C, Morton JP, Sansom OJ, Scarpa Bakhsh S, Kinloch M, Hoang LN, Soslow RA, Köbel M, Lee CH, McAlpine
A, Musgrove EA, Bailey UMH, Hofmann O, Sutherland RL, Wheeler JN, McConechy MK, Gilks CB. Histopathological features of endometrial
DA, Gill AJ, Gibbs RA, Pearson J V, Waddell N, Biankin A V, Grimmond carcinomas associated with POLE mutations: Implications for decisions
SM. Genomic analyses identify molecular subtypes of pancreatic about adjuvant therapy. Histopathology. 2016;68(6):916-924.
cancer. Nature. 2016;531(7592):47-52.
Bakst RL, Wong RJ. Mechanisms of perineural invasion. Journal of Neuro-
Bain CC, Hawley CA, Garner H, Scott CL, Schridde A, Steers NJ, logical Surgery. Part B: Skull Base. 2016;77(2):96-106. PMCID: PMC4846411
Mack M, Joshi A, Guilliams M, Mowat AM I, Geissmann F, Jenkins
SJ. Long-lived self-renewing bone marrow-derived macrophages Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane
displace embryo-derived cells to inhabit adult serous cavities. Nature CH, Javle MM, Eads JR, Allen P, Ko AH, Engebretson A, Herman JM,
Communications. 2016;7:11852. PMCID: PMC4910019 Strickler JH, Benson AB, Urba S, Yee NS. Locally advanced, unresectable
pancreatic cancer: American Society of Clinical Oncology Clinical
Baiocchi GL, D’Ugo D, Coit D, Hardwick R, Kassab P, Nashimoto A, Mar- Practice Guideline. Journal of Clinical Oncology. 2016;34(22):2654-2668.
relli D, Allum W, Berruti A, Chandramohan SM, Coburn N, Gonzàlez-More-
no S, Hoelscher A, Jansen E, Leja M, Mariette C, Meyer HJ, Mönig S, Balachandar S, La Quaglia M, Tuttle RM, Heller G, Ghossein RA, Sklar
Morgagni P, Ott K, Preston S, Rha SY, Roviello F, Sano T, Sasako M, Shi- CA. Pediatric differentiated thyroid carcinoma of follicular cell origin:
mada H, Schuhmacher C, So Bok-yan J, Strong V, Yoshikawa T, Terashi- Prognostic significance of histologic subtypes. Thyroid. 2016;26(2):219-
ma M, Ter-Ovanesov M, Van der Velde C, Memo M, Castelli F, Pecorelli 226. PMCID: PMC4855728
S, Detogni C, Kodera Y, De Manzoni G. Follow-up after gastrectomy
Balachandran VP, Arora A, Gönen M, Ito H, Turcotte S, Shia J, Viale A,
for cancer: The Charter Scaligero Consensus Conference. Gastric Can-
Snoeren N, van Hooff SR, Borel Rinkes IHM, Adam R, Kingham TP, Allen
cer. 2016;19(1):15-20. PMCID: PMC4890702
PJ, DeMatteo RP, Jarnagin WR, D’Angelica M I. A validated prognostic
Bajaj S, Chen CSJ. Patch splinting for atrophic or tight skin excision multigene expression assay for overall survival in resected colorectal
wounds. Dermatologic Surgery. 2016;42(10):1225-1227. cancer liver metastases. Clinical Cancer Research. 2016;22(10):2575-
2582. PMCID: PMC4978939
Bajaj S, Hibler B, Rossi A. Painful violaceous purpura on a 44-year-old
woman. American Journal of Medicine. 2016;129(6):E5-E7. Balaguer A, Monforte-Royo C, Porta-Sales J, Alonso-Babarro A, Altisent
R, Aradilla-Herrero A, Bellido-Pérez M, Breitbart W, Centeno C, Cuervo
Bajaj S, Marchetti MA, Navarrete-Dechent C, Dusza SW, Kose K, Mar- MA, Deliens L, Frerich G, Gastmans C, Lichtenfeld S, Limonero JT, Maier
ghoob AA. The role of color and morphologic characteristics in dermo- MA, Materstvedt LJ, Nabal M, Rodin G, Rosenfeld B, Schroepfer T, Tomás-
scopic diagnosis. JAMA Dermatology. 2016;152(6):676-682. Sábado J, Trelis J, Villavicencio-Chávez C, Voltz R. An international
consensus definition of the wish to hasten death and its related
Baker L, BeGora M, Yeung FA, Feigin ME, Rosenberg AZ, Lowe SW, factors. PLoS ONE. 2016;11(1):e0146184. PMCID: PMC4700969
39 OF 324
Journal Articles
Balch CM, Poston GJ, Coit D, Audisio R. Training a new generation Ballard TNS, Chen X, Kim HM, Hamill JB, Pusic AL, Wilkins EG, Roth
of surgeons worldwide who are also oncologists. Chinese Clinical RS. Managing suicidal ideation in a breast cancer cohort seeking
Oncology. 2016;5(4):58. reconstructive surgery. Psycho-Oncology. 2016;25(12):1515-1518. PMCID:
PMC4841736
Balch CM, Coit DG, Berman RS. 2015 James Ewing lecture: 75-year
history of the Society of Surgical Oncology—Part III: The transformative Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C, Celada-Álvarez
years (1991-2015). Annals of Surgical Oncology. 2016;23(5):1409-1417. FJ, Barker CA, Tormo-Micó A, Pérez-Calatayud J, Botella-Estrada
R. Electronic brachytherapy for superficial and nodular basal cell
Balch CM, Coit DG, Berman RS. 2015 James Ewing lecture: The 75-year carcinoma: A report of two prospective pilot trials using different
history of the Society of Surgical Oncology—Part I: The traditional years doses. Journal of Contemporary Brachytherapy. 2016;8(1):48-55. PMCID:
(1940–1965). Annals of Surgical Oncology. 2016;23(1):16-22. PMC4793064
Balch CM, Coit DG, Berman RS. 2015 James Ewing lecture: The 75-year Balmaña J, Digiovanni L, Gaddam P, Walsh MF, Joseph V, Stadler ZK,
history of the Society of Surgical Oncology—Part II: The transitional years Nathanson KL, Garber JE, Couch FJ, Offit K, Robson ME, Domchek
(1966–1990). Annals of Surgical Oncology. 2016;23(2):358-364. SM. Conflicting interpretation of genetic variants and cancer risk by
commercial laboratories as assessed by the prospective registry of
Baldwin A, Rodriguez ES. Improving patient safety with error multiplex testing. Journal of Clinical Oncology. 2016;34(34):4071-4078.
identification in chemotherapy orders by verification nurses. Clinical
Journal of Oncology Nursing. 2016;20(1):59-66. PMCID: PMC5021514 Balmer S, Nowotschin S, Hadjantonakis AK. Notochord morphogenesis
in mice: Current understanding & open questions. Developmental
Baldwin-Medsker A, Rodriguez ES. Response to “Improving Dynamics. 2016;245(5):547-557. PMCID: PMC4844759
patient safety with error identification in chemotherapy orders by
verification nurses”. The author responds. Clinical Journal of Oncology Bambury RM, Rathkopf DE. Novel and next-generation androgen
Nursing. 2016;20(6):582. receptor-directed therapies for prostate cancer: Beyond abiraterone
and enzalutamide. Urologic Oncology: Seminars and Original
Balestrini A, Nicolas L, Yang-Lott K, Guryanova OA, Levine RL, Bassing Investigations. 2016;34(8):348-355.
CH, Chaudhuri J, Petrini JHJ. Defining ATM-independent functions
of the mre11 complex with a novel mouse model. Molecular Cancer Bandyopadhyay U, Overholtzer M. LAP: The protector against
Research. 2016;14(2):185-195. PMCID: PMC4755792 autoimmunity. Cell Research. 2016;26(8):865-866. PMCID: PMC4973329
Baljevic M, Dumitriu B, Lee JW, Paietta EM, Wiernik PH, Racevskis J, Banerjee SC, Greene K, Li Y, Ostroff JS. The effect of comparatively-
Chen C, Stein EM, Gallagher RE, Rowe JM, Appelbaum FR, Powell BL, framed versus similarity-framed e-cigarette and snus print ads on
Larson RA, Coutré SE, Lancet J, Litzow MR, Luger SM, Young NS, Tallman young adults’ ad and product perceptions. Tobacco Regulatory
MS. Telomere length recovery: A strong predictor of overall survival in Science. 2016;2(3):214-229. PMCID: PMC5201191
acute promyelocytic leukemia. Acta Haematologica. 2016;136(4):210-
218. PMCID: PMC5198772 Banerjee SC, Manna R, Coyle N, Shen MJ, Pehrson C, Zaider T, Hammonds
S, Krueger CA, Parker PA, Bylund CL. Oncology nurses’ communication
40 OF 324
Journal Articles
challenges with patients and families: A qualitative study. Nurse Education TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland
in Practice. 2016;16(1):193-201. PMCID: PMC4961044 JG, Ohl CA, Samore MH, Seo SK, Trivedi KK. Implementing an antibiotic
stewardship program: Guidelines by the Infectious Diseases Society of
Banuchi VE, Dooley L, Lee NY, Pfister DG, McBride S, Riaz N, Bilsky America and the Society for Healthcare Epidemiology of America. Clinical
MH, Ganly I, Shah JP, Kraus DH, Morris LGT. Patterns of regional and distant Infectious Diseases. 2016;62(10):e51-e77. PMCID: PMC5006285
metastasis in esthesioneuroblastoma. Laryngoscope. 2016;126(7):1556-
1561. PMCID: PMC4914404 Barnett M, McDonnell G, DeRosa A, Schuler T, Philip E, Peterson L,
Touza K, Jhanwar S, Atkinson TM, Ford JS. Psychosocial outcomes and
Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term interventions among cancer survivors diagnosed during adolescence
chemotherapy-induced peripheral neuropathy among breast cancer and young adulthood (AYA): A systematic review. Journal of Cancer
survivors: Prevalence, risk factors, and fall risk. Breast Cancer Research Survivorship. 2016;10(5):814-831. PMCID: PMC5001943
and Treatment. 2016;159(2):327-333.
Barnett SA, Downey RJ, Zheng J, Plourde G, Shen R, Chaft J, Akhurst
Barba P, Burns LJ, Litzow MR, Juckett MB, Komanduri K V, Lee SJ, Devlin T, Park BJ, Rusch VW. Utility of routine PET imaging to predict response
SM, Costa LJ, Khan S, King A, Klein A, Krishnan A, Malone A, Mir MA, and survival after induction therapy for non-small cell lung cancer. Annals
Moravec C, Selby G, Roy V, Cochran M, Stricherz MK, Westmoreland of Thoracic Surgery. 2016;101(3):1052-1059. PMCID: PMC4837652
MD, Perales MA, Wood WA. Success of an international learning health
care system in hematopoietic cell transplantation: The American Society Barrio A V, Mamtani A, Edelweiss M, Eaton A, Stempel M, Murray
of Blood and Marrow Transplantation Clinical Case Forum. Biology MP, Morrow M. How often is treatment effect identified in axillary
of Blood and Marrow Transplantation. 2016;22(3):564-570. PMCID: nodes with a pathologic complete response after neoadjuvant
PMC4965270 chemotherapy?. Annals of Surgical Oncology. 2016;23(11):3475-
3480. PMCID: PMC5070656
Barchi M, Cohen P, Keeney S. Special issue on “Recent
advances in meiotic chromosome structure, recombination and Barrio A V, Morrow M. Appropriate margin for lumpectomy excision of
segregation”. Chromosoma. 2016;125(2):173-175. invasive breast cancer. Chinese Clinical Oncology. 2016;5(3):35. PMCID:
PMC4939766
Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN,
Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Barta SK, Joshi J, Mounier N, Xue X, Wang D, Ribera JM, Navarro JT,
Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Hoffmann C, Dunleavy K, Little RF, Wilson WH, Spina M, Galicier L, Noy
Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi A, Sparano JA. Central nervous system involvement in AIDS-related
KK. Executive summary: Implementing an antibiotic stewardship lymphomas. British Journal of Haematology. 2016;173(6):857-866. PMCID:
program: Guidelines by the Infectious Diseases Society of America and PMC4900917
the Society for Healthcare Epidemiology of America. Clinical Infectious
Diseases. 2016;62(10):1197-1202. Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson
AB 3rd, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker
Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN, Septimus EJ, C, Tang L, Troxell M, Ajani JA. HER2 testing and clinical decision making
Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins in gastroesophageal adenocarcinoma: Guideline from the College
41 OF 324
Journal Articles
of American Pathologists, American Society for Clinical Pathology, Archiv. 2016;469(5):523-532. PMCID: PMC5083199
and American Society of Clinical Oncology. Archives of Pathology &
Laboratory Medicine. 2016;140(12):1345-1363. Basturk O, Tan M, Bhanot U, Allen P, Adsay V, Scott SN, Shah
R, Berger MF, Askan G, Dikoglu E, Jobanputra V, Wrzeszczynski KO,
Barton-Burke M. Building capacity for evidenced-based practice Sigel C, Iacobuzio-Donahue C, Klimstra DS. The oncocytic subtype is
at the unit level using Oncology Nursing Society Putting Evidence genetically distinct from other pancreatic intraductal papillary mucinous
Practice. Asia-Pacific Journal of Oncology Nursing. 2016;3(1):17-21. neoplasm subtypes. Modern Pathology. 2016;29(9):1058-1069.
Basch E, Deal AM, Kris MG, Scher H I, Hudis CA, Sabbatini P, Rogak Basturk O, Askan G. Benign tumors and tumorlike lesions of the
L, Bennett A V, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, pancreas. Surgical Pathology Clinics. 2016;9(4):619-641.
Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom
monitoring with patient-reported outcomes during routine cancer Basu D, Salgado CM, Bauer BS, Johnson D, Rundell V, Nikiforova
treatment: A randomized controlled trial. Journal of Clinical M, Khakoo Y, Gunwaldt LJ, Panigrahy A, Reyes-Múgica M. Nevospheres
Oncology. 2016;34(6):557-563. PMCID: PMC4872028 from neurocutaneous melanocytosis cells show reduced viability when
treated with specific inhibitors of NRAS signaling pathway. Neuro-
Basch E, Wood WA, Schrag D, Sima CS, Shaw M, Rogak LJ, Kris Oncology. 2016;18(4):528-537. PMCID: PMC4799680
MG, Shouery M, Bennett A, Atkinson T, Pietanza MC. Feasibility and
clinical impact of sharing patient-reported symptom toxicities and Basu R, Whitlock BM, Husson J, Le Floc’h A, Jin W, Oyler-Yaniv A,
performance status with clinical investigators during a phase 2 cancer Dotiwala F, Giannone G, Hivroz C, Biais N, Lieberman J, Kam LC, Huse
treatment trial. Clinical Trials. 2016;13(3):331-337. PMCID: PMC5228492 M. Cytotoxic T cells use mechanical force to potentiate target cell
killing. Cell. 2016;165(1):100-110. PMCID: PMC4808403
Basch E, Rogak LJ, Dueck AC. Methods for implementing and reporting
patient-reported outcome (PRO) measures of symptomatic adverse Batlevi CL, Kasamon Y, Bociek RG, Lee P, Gore L, Copeland A,
events in cancer clinical trials. Clinical Therapeutics. 2016;38(4):821- Sorensen R, Ordentlich P, Cruickshank S, Kunkel L, Buglio D,
830. PMCID: PMC4851916 Hernandez-Ilizaliturri F, Younes A. ENGAGE-501: Phase II study
of entinostat (SNDX-275) in relapsed and refractory Hodgkin
Baselga J, Phillips GDL, Verma S, Ro J, Huober J, Guardino AE, Samant lymphoma. Haematologica. 2016;101(8):968-975. PMCID: PMC4967576
MK, Olsen S, De Haas SL, Pegram MD. Relationship between tumor
biomarkers and efficacy in EMILIA, a phase III study of trastuzumab Batlevi CL, Matsuki E, Brentjens RJ, Younes A. Novel
immunotherapies in lymphoid malignancies. Nature Reviews Clinical
emtansine in HER2-Positive metastatic breast cancer. Clinical Cancer Oncology. 2016;13(1):25-40. PMCID: PMC4916838
Research. 2016;22(15):3755-3763.
Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Herr HW, Lerner
Basturk O, Chung SM, Hruban RH, Adsay N V, Askan G, Iacobuzio- SP, Guzzo TJ, Malkowicz SB, Christodouleas JP. Validating a local failure
Donahue C, Balci S, Zee SY, Memis B, Shia J, Klimstra DS. Distinct risk stratification for use in prospective studies of adjuvant radiation
pathways of pathogenesis of intraductal oncocytic papillary neoplasms therapy for bladder cancer. International Journal of Radiation Oncology,
and intraductal papillary mucinous neoplasms of the pancreas. Virchows Biology, Physics. 2016;95(2):703-706. PMCID: PMC5126649
42 OF 324
Journal Articles
Bauml JM, Troxel A, Epperson CN, Cohen RB, Schmitz K, Stricker Hackshaw MD, Motzer RJ, Cella D. Quality-adjusted time without
C, Shulman LN, Bradbury A, Mao JJ, Langer CJ. Scan-associated symptoms or toxicity analysis of pazopanib versus sunitinib in patients
distress in lung cancer: Quantifying the impact of “scanxiety”. Lung with renal cell carcinoma. Cancer. 2016;122(7):1108-1115. PMCID:
Cancer. 2016;100:110-113. PMC4996632
Baxi SS, O’Neill C, Sherman EJ, Atoria CL, Lee NY, Pfister DG, Elkin Becattini S, Taur Y, Pamer EG. Antibiotic-induced changes
EB. Trends in chemoradiation use in elderly patients with head and in the intestinal microbiota and disease. Trends in Molecular
neck cancer: Changing treatment patterns with cetuximab. Head and Medicine. 2016;22(6):458-478. PMCID: PMC4885777
Neck. 2016;38:E165-E171. PMCID: PMC4970459
Begg CB, Ostrovnaya I, Scarpa Carniello J V, Sakr RA, Giri D, Towers
Baxi SS, Dunn LA, Burtness BA. Amidst the excitement: A cautionary tale R, Schizas M, De Brot M, Andrade VP, Mauguen A, Seshan VE, King
of immunotherapy, pseudoprogression and head and neck squamous cell TA. Clonal relationships between lobular carcinoma in situ and other breast
carcinoma. Oral Oncology. 2016;62:147-148. malignancies. Breast Cancer Research. 2016;18(1):66. PMCID: PMC4918003
Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, Sabari B, Begg CB. Editorial. Clinical Trials. 2016;13(4):371.
Margol AS, Panwalkar P, Parolia A, Pekmezci M, McEachin RC, Cieslik
M, Tamrazi B, Garcia BA, La Rocca G, Santi M, Lewis PW, Hawkins C, Begg CB. Editorial. Clinical Trials. 2016;13(6):573.
Melnick A, Allis CD, Thompson CB, Chinnaiyan AM, Judkins AR, Venneti
S. Lowered H3K27me3 and DNA hypomethylation define poorly Béguelin W, Teater M, Gearhart MD, Calvo Fernández MT, Goldstein
prognostic pediatric posterior fossa ependymomas. Science Translational RL, Cárdenas MG, Hatzi K, Rosen M, Shen H, Corcoran CM, Hamline
Medicine. 2016;8(366):6904. PMCID: PMC5123566 MY, Gascoyne RD, Levine RL, Abdel-Wahab O, Licht JD, Shaknovich
R, Elemento O, Bardwell VJ, Melnick AM. EZH2 and BCL6 cooperate
Bazzi WM, Tin AL, Sjoberg DD, Bernstein M, Russo P. The prognostic to assemble CBX8-BCOR complex to repress bivalent promoters,
utility of preoperative neutrophil-to-lymphocyte ratio in localized clear mediate germinal center formation and lymphomagenesis. Cancer
cell renal cell carcinoma. Canadian Journal of Urology. 2016;23(1):8151- Cell. 2016;30(2):197-213. PMCID: PMC5000552
8154. PMCID: PMC4826724
Behling K, Maguire WF, Di Gialleonardo V, Heeb LEM, Hassan IF, Veach
Beaber EF, Tosteson ANA, Haas JS, Onega T, Sprague BL, Weaver DR, Keshari KR, Gutin PH, Scheinberg DA, McDevitt MR. Remodeling the
DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, vascular microenvironment of glioblastoma with α-particles. Journal of
Barlow WE. Breast cancer screening initiation after turning 40 years Nuclear Medicine. 2016;57(11):1771-1777. PMCID: PMC5093034
of age within the PROSPR consortium. Breast Cancer Research and
Treatment. 2016;160(2):323-331. Behling K, Maguire WF, Puebla JCL, Sprinkle SR, Ruggiero
A, O’Donoghue J, Gutin PH, Scheinberg DA, McDevitt
Beaulieu AM, Sun JC. Tracking effector and memory NK cells during MR. Vascular targeted radioimmunotherapy for the treatment
MCMV infection. Methods in Molecular Biology. 2016;1441:1-12. of glioblastoma. Journal of Nuclear Medicine. 2016;57(10):1576-
1582. PMCID: PMC5050148
Beaumont JL, Salsman JM, Diaz J, Deen KC, McCann L, Powles T,
43 OF 324
Journal Articles
Békés M, van der Heden van Noort GJ, Ekkebus R, Ovaa H, R, Scher H I. The initial detection and partial characterization of
Huang TT, Lima CD. Recognition of Lys48-linked di-ubiquitin and circulating tumor cells in neuroendocrine prostate cancer. Clinical Cancer
deubiquitinating activities of the SARS coronavirus papain-like Research. 2016;22(6):1510-1519. PMCID: PMC4990782
protease. Molecular Cell. 2016;62(4):572-585. PMCID: PMC4875570
Belum VR, Silva GD, Laloni MT, Ciccolini K, Goldfarb SB, Norton
Belanger M, Saleh Z, Volpe T, Margiasso R, Li X, Chan M, Zhu X, Tang L, Sklarin NT, Lacouture ME. Cold thermal injury from cold caps used
X. Validation of the calypso surface beacon transponder. Journal of for the prevention of chemotherapy-induced alopecia. Breast Cancer
Applied Clinical Medical Physics . 2016;17(4):223-234. Research and Treatment. 2016;157(2):395-400.
Belani CP, Dahlberg SE, Rudin CM, Fleisher M, Chen HX, Takebe N, Belum VR, Benhuri B, Postow MA, Hellmann MD, Lesokhin
Velasco MR Jr, Tester WJ, Sturtz K, Hann CL, Shanks JC, Monga M, AM, Segal NH, Motzer RJ, Wu S, Busam KJ, Wolchok JD, Lacouture
Ramalingam SS, Schiller JH. Vismodegib or cixutumumab in combination ME. Characterisation and management of dermatologic adverse
with standard chemotherapy for patients with extensive-stage small events to agents targeting the PD-1 receptor. European Journal of
cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group Cancer. 2016;60:12-25. PMCID: PMC4998047
(E1508). Cancer. 2016;122(15):2371-2378. PMCID: PMC4956531
Belum VR, Serna-Tamayo C, Wu S, Lacouture ME. Incidence and risk of
Bell-McGuinn KM, Konner JA, Tew WP, Hensley ML, Iasonos A, hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor:
Charpentier E, Mironov S, Sabbatini P, Aghajanian C. A phase 2, single A meta-analysis. Clinical and Experimental Dermatology. 2016;41(1):8-
arm study of iniparib in patients with BRCA1 or BRCA2 associated 15. PMCID: PMC5066302
advanced epithelial ovarian, fallopian tube, or primary peritoneal
cancer. International Journal of Gynecological Cancer. 2016;26(2):255- Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G,
260. PMCID: PMC5009457 Racchumi G, Lingo L, Pamer EG, Iadecola C, Anrather J. Commensal
microbiota affects ischemic stroke outcome by regulating intestinal γδ T
Bellmunt J, Kheoh T, Yu MK, Smith MR, Small EJ, Mulders PFA, Fizazi cells. Nature Medicine. 2016;22(5):516-523. PMCID: PMC4860105
K, Rathkopf DE, Saad F, Scher H I, Taplin ME, Davis ID, Schrijvers
D, Protheroe A, Molina A, De Porre P, Griffin TW, De Bono JS, Benard O, Lim J, Apontes P, Jing X, Angeletti RH, Chi Y. Impact of
Ryan CJ, Oudard S. Prior endocrine therapy impact on abiraterone high-fat diet on the proteome of mouse liver. Journal of Nutritional
acetate clinical efficacy in metastatic castration-resistant prostate Biochemistry. 2016;31:10-19.
cancer: Post-hoc analysis of randomised phase 3 studies. European
Urology. 2016;69(5):924-932. Ben-Arye E, Mahajna J, Aly R, Ali-Shtayeh MS, Bentur Y, Lev E, Deng
G, Samuels N. Exploring an herbal “wonder cure” for cancer: A
Beltran H, Antonarakis ES, Morris MJ, Attard G. Emerging molecular multidisciplinary approach. Journal of Cancer Research and Clinical
biomarkers in advanced prostate cancer: Translation to the clinic. American Oncology. 2016;142(7):1499-1508.
Society of Clinical Oncology Educational Book. 2016;36:131-141.
Benedict C, Philip EJ, Baser RE, Carter J, Schuler TA, Jandorf
Beltran H, Jendrisak A, Landers M, Mosquera JM, Kossai M, Louw J, Krupa L, Duhamel K, Nelson C. Body image and sexual function in women after
R, Graf RP, Schreiber NA, Nanus DM, Tagawa ST, Marrinucci D, Dittamore treatment for anal and rectal cancer. Psycho-Oncology. 2016;25(3):316-
323. PMCID: PMC4961045
44 OF 324
Journal Articles
Benedict C, Rodriguez VM, Carter J, Temple L, Nelson C, DuHamel Benz MR, Vargas HA, Sala E. Functional MR imaging techniques in
K. Investigation of body image as a mediator of the effects of bowel and oncology in the era of personalized medicine. Magnetic Resonance
GI symptoms on psychological distress in female survivors of rectal and Imaging Clinics of North America. 2016;24(1):1-10. PMCID:
anal cancer. Supportive Care in Cancer. 2016;24(4):1795-1802. PMCID: PMC5031083
PMC4862400
Berber E, Bernet V, Fahey TJ, Kebebew E, Shaha A, Stack BC, Stang M,
Benedict C, Shuk E, Ford JS. Fertility issues in adolescent and young Steward DL, Terris DJ, for the American Thyroid Association Surgical
adult cancer survivors. Journal of Adolescent and Young Adult Affairs Committee. American Thyroid Association statement on
Oncology. 2016;5(1):48-57. PMCID: PMC4779291 remote-access thyroid surgery. Thyroid. 2016;26(3):331-337. PMCID:
PMC4994052
Benedict C, Thom B, Friedman DN, Diotallevi D, Pottenger
EM, Raghunathan NJ, Kelvin JF. Young adult female cancer Berger MF, Van Allen EM. Delivering on the promise of precision cancer
survivors’ unmet information needs and reproductive concerns medicine. Genome Medicine. 2016;8(1):110. PMCID: PMC5078954
contribute to decisional conflict regarding posttreatment fertility
preservation. Cancer. 2016;122(13):2101-2109. PMCID: PMC4911318 Berman E, Jhanwar S, Hedvat C, Arcila ME, Wahab OA, Levine
R, Maloy M, Ma W, Albitar M. Resistance to imatinib in patients
Benedict C, Thom B, Kelvin JF. Fertility preservation and cancer: with chronic myelogenous leukemia and the splice variant BCR-
Challenges for adolescent and young adult patients. Current ABL1(35INS). Leukemia Research. 2016;49:108-112.
Opinion in Supportive and Palliative Care. 2016;10(1):87-94. PMCID:
PMC4752165 Berman E, Maloy M, Devlin S, Jhanwar S, Papadopoulos E, Jakubowski
A. Stem cell transplantation in adults with acute myelogenous
Bennett A V, Dueck AC, Mitchell SA, Mendoza TR, Reeve BB, Atkinson leukemia, normal cytogenetics, and the FLT3-ITD mutation. Leukemia
TM, Castro KM, Denicoff A, Rogak LJ, Harness JK, Bearden JD, Research. 2016;40:33-37. PMCID: PMC5053396
Bryant D, Siegel RD, Schrag D, Basch E, on behalf of the National
Cancer Institute PRO-CTCAE Study Group. Mode equivalence and Berndt S I, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly
acceptability of tablet computer-, interactive voice response system-, RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras
and paper-based administration of the U.S. National Cancer Institute’s LR, Machado M, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP,
Patient-Reported Outcomes version of the Common Terminology Birmann BM, Vajdic CM, Cocco P, Zhang Y, Giles GG, Zeleniuch-Jacquotte
Criteria for Adverse Events (PRO-CTCAE). Health and Quality of Life A, Lawrence C, Montalvan R, Burdett L, Hutchinson A, Ye Y, Call TG,
Outcomes. 2016;14(1):24. PMCID: PMC4759776 Shanafelt TD, Novak AJ, Kay NE, Liebow M, Cunningham JM, Allmer
C, Hjalgrim H, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M,
Bennett A V, Keenoy K, Shouery M, Basch E, Temple LK. Evaluation Curtin K, Cannon-Albright LA, Diver WR, Link BK, Weiner GJ, Conde
of mode equivalence of the MSKCC Bowel Function Instrument, L, Bracci PM, Riby J, Arnett DK, Zhi D, Leach JM, Holly EA, Jackson
LASA Quality of Life, and Subjective Significance Questionnaire items RD, Tinker LF, Benavente Y, Sala N, Casabonne D, Becker N, Boffetta
administered by Web, interactive voice response system (IVRS), P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Chaffee KG,
and paper. Quality of Life Research. 2016;25(5):1123-1130. PMCID: Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Leis JF, Weinberg
PMC4841708 JB, Caporaso NE, Norman AD, De Roos AJ, Morton LM, Severson RK,
45 OF 324
Journal Articles
Riboli E, Vineis P, Kaaks R, Masala G, Weiderpass E, Chirlaque MD, Bertani E, Fazio N, Radice D, Zardini C, Grana C, Bodei L, Funicelli
Vermeulen RCH, Travis RC, Southey MC, Milne RL, Albanes D, Virtamo L, Ferrari C, Spada F, Partelli S, Falconi M. Resection of the primary
J, Weinstein S, Clavel J, Zheng T, Holford TR, Villano DJ, Maria A, tumor followed by peptide receptor radionuclide therapy as upfront
Spinelli JJ, Gascoyne RD, Connors JM, Bertrand KA, Giovannucci E, strategy for the treatment of G1–G2 pancreatic neuroendocrine
Kraft P, Kricker A, Turner J, Ennas MG, Ferri GM, Miligi L, Liang L, Ma tumors with unresectable liver metastases. Annals of Surgical
B, Huang J, Crouch S, Park JH, Chatterjee N, North KE, Snowden JA, Oncology. 2016;23(Suppl. 5):981-989.
Wright J, Fraumeni JF, Offit K, Wu X, De Sanjose S, Cerhan JR, Chanock
SJ, Rothman N, Slager SL. Meta-analysis of genome-wide association Beveridge TS, Allman BL, Johnson M, Power A, Sheinfeld J,
studies discovers multiple loci for chronic lymphocytic leukemia. Nature Power NE. Retroperitoneal lymph node dissection: Anatomical
Communications. 2016;7:10933. PMCID: PMC4786871 and technical considerations from a cadaveric study. Journal of
Urology. 2016;196(6):1764-1771.
Berney DM, Beltran L, Fisher G, North B V, Greenberg D, Møller
H, Soosay G, Scardino P, Cuzick J, on behalf of the Transatlantic Bevers T, Bibbins-Domingo K, Oeffinger KC, Smith ML. Controversies
Prostate Group. Validation of a contemporary prostate cancer grading in breast cancer screening strategies. Journal of the National
system using prostate cancer death as outcome. British Journal of Comprehensive Cancer Network. 2016;14(5S):651-653.
Cancer. 2016;114(10):1078-1083. PMCID: PMC4865975
Bhatia N, Santos M, Jones LW, Beckman JA, Penson DF, Morgans AK,
Berrisford JM, Baradaran R, Sazanov LA. Structure of bacterial Moslehi J. Cardiovascular effects of androgen deprivation therapy for
respiratory complex I. Biochimica et Biophysica Acta (BBA) - the treatment of prostate cancer: ABCDE Steps to reduce cardiovascular
Bioenergetics. 2016;1857(7):892-901. disease in patients with prostate cancer. Circulation. 2016;133(5):537-
541. PMCID: PMC5029929
Berry SL, Boczkowski A, Ma R, Mechalakos J, Hunt M. Interobserver
variability in radiation therapy plan output: Results of a single-institution Bhatia S, Gibson TM, Ness KK, Liu Q, Oeffinger KC, Krull KR, Nathan PC,
study. Practical Radiation Oncology. 2016;6(6):442-449. PMCID: Neglia JP, Leisenring W, Yasui Y, Robison LL, Armstrong GT. Childhood
PMC5099085 cancer survivorship research in minority populations: A position paper
from the Childhood Cancer Survivor Study. Cancer. 2016;122(15):2426-
Berry SL, Ma R, Boczkowski A, Jackson A, Zhang P, Hunt M. Evaluating 2439. PMCID: PMC4956492
inter-campus plan consistency using a knowledge based planning
model. Radiotherapy and Oncology. 2016;120(2):349-355. PMCID: Bhatt V, Lin A, Beyer K, Proli A, Yoo Y, Ponce D, Barker J. Analysis
PMC5003669 of cyclosporine A levels supports new dosing guidelines in
adult double-unit cord blood transplant recipients to optimize
Bersani F, Lingua MF, Morena D, Foglizzo V, Miretti S, Lanzetti L, Carrà immunosuppression early post-transplant. Biology of Blood and Marrow
G, Morotti A, Ala U, Provero P, Chiarle R, Singer S, Ladanyi M, Tuschl T, Transplantation. 2016;22(8):1533-1534.
Ponzetto C, Taulli R. Deep sequencing reveals a novel miR-22 regulatory
network with therapeutic potential in rhabdomyosarcoma. Cancer Bhatt V, Shune L, Lauer E, Lubin M, Devlin SM, Scaradavou
Research. 2016;76(20):6095-6106. PMCID: PMC5207039 A, Parameswaran R, Perales MA, Ponce DM, Mantha S, Kernan
NA, Barker JN. Autoimmune hemolysis and immune thrombocytopenic
46 OF 324
Journal Articles
purpura after cord blood transplantation may be life-threatening 255. PMCID: PMC4917284
and warrants early therapy with rituximab. Bone Marrow
Transplantation. 2016;51(12):1579-1583. Bindra RS, Wolden SL. Advances in radiation therapy in pediatric neuro-
oncology. Journal of Child Neurology. 2016;31(4):506-516.
Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja
N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Birn CS, Vance PH, Weissfeld AS. Carbapenemase-resistant
Minter AR, Weiss BM, Mena E, Lindenberg L, Calvo KR, Maric I, Usmani enterobacteriaceae and duodenoscopes: An unholy alliance. Clinical
SZ, Choyke PL, Kurdziel K, Landgren O. Bone marrow abnormalities Microbiology Newsletter. 2016;38(24):195-201.
and early bone lesions in multiple myeloma and its precursor disease: A
prospective study using functional and morphologic imaging. Leukemia Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz
and Lymphoma. 2016;57(5):1114-1121. CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou
AJ. Assessing the prognostic significance of histologic response
Bialer PA, McIntosh CA. Discrimination, stigma, and hate: The impact on in osteosarcoma: A comparison of outcomes on CCG-782 and
the mental health and well-being of LGBT people. Journal of Gay and INT0133 - A report from the Children’s Oncology Group Bone Tumor
Lesbian Mental Health. 2016;20(4):297-298. Committee. Pediatric Blood and Cancer. 2016;63(10):1737-1743. PMCID:
PMC5136499
Bialer PA, McIntosh CA. Distress associated with being a sexual
minority: Is there reason for hope?. Journal of Gay and Lesbian Mental Bisikirska B, Bansal M, Shen Y, Teruya-Feldstein J, Chaganti R, Califano
Health. 2016;20(2):97-98. A. Elucidation and pharmacological targeting of novel molecular drivers
of follicular lymphoma progression. Cancer Research. 2016;76(3):664-
Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, 674. PMCID: PMC4738055
Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman
K, Higgins SA, Ho AL, Lewis KD, Lydiatt DD, Nehal KS, Nghiem Bittner M I, Wiedenmann N, Bucher S, Hentschel M, Mix M,
P, Olsen EA, Schmults CD, Sekulic A, Shaha AR, Thorstad WL, Rücker G, Weber WA, Meyer PT, Werner M, Grosu AL, Kayser
Tuli M, Urist MM, Wang TS, Wong SL, Zic JA, Hoffmann KG, Engh G. Analysis of relation between hypoxia PET imaging and tissue-
A. Basal cell skin cancer, version 1.2016, Clinical Practice Guidelines based biomarkers during head and neck radiochemotherapy. Acta
in Oncology. Journal of the National Comprehensive Cancer Oncologica. 2016;55(11):1299-1304.
Network. 2016;14(5):574-597.
Blackler L. Compromised autonomy when families pressure
Billè A, Ahmad U, Woo KM, Suzuki K, Adusumilli P, Huang J, Jones patients to change their wishes. Journal of Hospice & Palliative
DR, Rizk NP. Detection of recurrence patterns after wedge resection for Nursing. 2016;18(4):284-289.
early stage lung cancer: Rationale for radiologic follow-up. Annals of
Thoracic Surgery. 2016;102(4):1067-1073. Blanke CD, DeMatteo RP. Duration of adjuvant therapy for patients
with gastrointestinal stromal tumors: Where is Goldilocks when we
Billé A, Krug LM, Woo KM, Rusch VW, Zauderer MG. Contemporary need her?. JAMA Oncology. 2016;2(6):721-722.
analysis of prognostic factors in patients with unresectable malignant
pleural mesothelioma. Journal of Thoracic Oncology. 2016;11(2):249- Blazekovic F, Odukoya D, Butler SN, Mauro JA, Ramsamooj M, Puleo
E, Szekeres K, Dana D, Kumar S, Ragupathi G, Blanck G. HLA-DR
47 OF 324
Journal Articles
peptide occupancy can be regulated with a wide variety of small Gascoyne RD, Cogné M, Tarte K, Wendel HG. Loss of the HVEM
molecules. Human Vaccines & Immunotherapeutics. 2016;12(3):593- tumor suppressor in lymphoma and restoration by modified CAR-T
598. PMCID: PMC4964726 cells. Cell. 2016;167(2):405-418.e13. PMCID: PMC5221752
Blazic IM, Campbell NM, Gollub MJ. MRI for evaluation Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S,
of treatment response in rectal cancer. British Journal of Trent JC, Von Mehren M, Wright JA, Schiffman JD, Raygada M, Pacak K,
Radiology. 2016;89(1064):20150964. PMCID: PMC5124873 Meltzer PS, Miettinen MM, Stratakis C, Janeway KA, Helman LJ. Molecular
subtypes of KIT/PDGFRA wild-type gastrointestinal stromal tumors: A
Bledsoe JR, Redd RA, Hasserjian RP, Soumerai JD, Nishino HT, Report From the National Institutes of Health gastrointestinal stromal
Boyer DF, Ferry JA, Zukerberg LR, Harris NL, Abramson JS, Sohani tumor clinic. JAMA Oncology. 2016;2(7):922-928.
AR. The immunophenotypic spectrum of primary mediastinal large
B-cell lymphoma reveals prognostic biomarkers associated with Bokhorst LP, Zappa M, Carlsson S V, Kwiatkowski M, Denis L,
outcome. American Journal of Hematology. 2016;91(10):E436-E441. Paez A, Hugosson J, Moss S, Auvinen A, Roobol MJ. Correlation
between stage shift and differences in mortality in the European
Bloomquist E V, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio A V. A Randomised study of Screening for Prostate Cancer (ERSPC). BJU
randomized prospective comparison of patient-assessed satisfaction International. 2016;118(5):677-680. PMCID: PMC5072450
and clinical outcomes with radioactive seed localization versus wire
localization. Breast Journal. 2016;22(2):151-157. PMCID: PMC4775408 Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ. Toxicity
and management in CAR T-cell therapy. Molecular Therapy -
Boas FE, Brody LA, Erinjeri JP, Yarmohammadi H, Shady W, Kishore Oncolytics. 2016;3:16011.
S, Sofocleous CT. Quantitative measurements of enhancement
on preprocedure triphasic ct can predict response of colorectal Bonner J, Giralt J, Harari P, Spencer S, Schulten J, Hossain A, Chang SC,
liver metastases to radioembolization. American Journal of Chin S, Baselga J. Cetuximab and radiotherapy in laryngeal preservation
Roentgenology. 2016;207(3):671-675. PMCID: PMC5003600 for cancers of the larynx and hypopharynx: A secondary analysis of
a randomized clinical trial. JAMA Otolaryngology - Head and Neck
Bober SL, Reese JB, Barbera L, Bradford A, Carpenter KM, Goldfarb Surgery. 2016;142(9):842-849. PMCID: PMC5025385
S, Carter J. How to ask and what to do: A guide for clinical inquiry and
intervention regarding female sexual health after cancer. Current Opinion Bonner JA, Giralt J, Harari PM, Baselga J, Spencer S, Bell D, Raben
in Supportive and Palliative Care. 2016;10(1):44-54. PMCID: PMC4984532 D, Liu J, Schulten J, Ang KK, Rosenthal D I. Association of human
papillomavirus and p16 status with mucositis and dysphagia for head
Bodei L, Modlin IM, Luster M, Forrer F, Cremonesi M, Hicks RJ, Ezziddin S, and neck cancer patients treated with radiotherapy with or without
Kidd M, Chiti A. Myeloid neoplasms after chemotherapy and PRRT: Myth cetuximab: Assessment from a phase 3 registration trial. European
and reality. Endocrine-Related Cancer. 2016;23(8):C1-C7. Journal of Cancer. 2016;64:1-11. PMCID: PMC5027878
Boice M, Salloum D, Mourcin F, Sanghvi V, Amin R, Oricchio E, Jiang Bonner JN, Choi K, Xue X, Torres NP, Szakal B, Wei L, Wan B, Arter
M, Mottok A, Denis-Lagache N, Ciriello G, Tam W, Teruya-Feldstein M, Matos J, Sung P, Brown GW, Branzei D, Zhao X. Smc5/6 mediated
J, de Stanchina E, Chan WC, Malek SN, Ennishi D, Brentjens RJ, sumoylation of the Sgs1-Top3-Rmi1 complex promotes removal of
48 OF 324
Journal Articles
recombination intermediates. Cell Reports. 2016;16(2):368-378. PMCID: Boudreau JE, Wouters MCA, Krawczyk CM. 8th Annual Canadian
PMC5051638 Cancer Immunotherapy Consortium (CCIC) Symposium
2015—May 20–22, Vancouver, Canada. Cancer Immunology,
Bonner JN, Zhao X. Replication-associated recombinational Immunotherapy. 2016;65(2):235-241.
repair: Lessons from budding yeast. Genes. 2016;7(8):48. PMCID:
PMC4999836 Boudreau JE, Liu XR, Zhao Z, Zhang A, Shultz LD, Greiner DL, Dupont
B, Hsu KC. Cell-extrinsic MHC class I molecule engagement augments
Bono P, Oudard S, Bodrogi I, Hutson TE, Escudier B, Machiels JP, human NK cell education programmed by cell-intrinsic MHC class
Thompson JA, Figlin RA, Ravaud A, Basaran M, Porta C, Bracarda S, I. Immunity. 2016;45(2):280-291. PMCID: PMC5003427
Brechenmacher T, Lin C, Voi M, Grunwald V, Motzer RJ. Outcomes in
patients with metastatic renal cell carcinoma who develop everolimus- Boudreau JE, Mulrooney TJ, Le Luduec JB, Barker E, Hsu KC. KIR3DL1
related hyperglycemia and hypercholesterolemia: Combined subgroup and HLA-B density and binding calibrate NK education and response
analyses of the RECORD-1 and REACT Trials. Clinical Genitourinary to HIV. Journal of Immunology. 2016;196(8):3398-3410. PMCID:
Cancer. 2016;14(5):406-414. PMCID: PMC5063024 PMC4868784
Borsu L, Intrieri J, Thampi L, Yu H, Riely G, Nafa K, Chandramohan Bouffet E, Larouche V, Campbell BB, Merico D, de Borja R, Aronson
R, Ladanyi M, Arcila ME. Clinical application of picodroplet digital PCR M, Durno C, Krueger J, Cabric V, Ramaswamy V, Zhukova N, Mason
technology for rapid detection of EGFR T790M in next-generation G, Farah R, Afzal S, Yalon M, Rechavi G, Magimairajan V, Walsh MF,
sequencing libraries and DNA from limited tumor samples. Journal of Constantini S, Dvir R, Elhasid R, Reddy A, Osborn M, Sullivan M, Hansford
Molecular Diagnostics. 2016;18(6):903-911. J, Dodgshun A, Klauber-Demore N, Peterson L, Patel S, Lindhorst S,
Atkinson J, Cohen Z, Laframboise R, Dirks P, Taylor M, Malkin D, Albrecht
Bosl GJ. Recurrent germ cell tumors: Let’s try to cure them all. Journal of S, Dudley RWR, Jabado N, Hawkins CE, Shlien A, Tabori U. Immune
Oncology Practice. 2016;12(5):445-447. checkpoint inhibition for hypermutant glioblastoma multiforme resulting
from germline biallelic mismatch repair deficiency. Journal of Clinical
Bothe I, Baylies MK. Drosophila myogenesis. Current Oncology. 2016;34(19):2206-2211.
Biology. 2016;26(17):R786-R791. PMCID: PMC5204462
Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM,
Bott MJ. Pedicled pericardial flap for esophagorespiratory fistula: Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F,
A helpful tool for a difficult problem. Journal of Thoracic and Margenthaler JA, Song DH, Staley AC, Wilke LG, Willey SC, Yao
Cardiovascular Surgery. 2016;151(6):e99. KA. Contralateral prophylactic mastectomy consensus statement from
the American Society of Breast Surgeons: Additional considerations
Bottai G, Raschioni C, Losurdo A, Di Tommaso L, Tinterri C, Torrisi
and a framework for shared decision making. Annals of Surgical
R, Reis-Filho JS, Roncalli M, Sotiriou C, Santoro A, Mantovani A, Loi
Oncology. 2016;23(10):3106-3111. PMCID: PMC4999472
S, Santarpia L. An immune stratification reveals a subset of PD-1/
LAG-3 double-positive triple-negative breast cancers. Breast Cancer Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM,
Research. 2016;18:121. PMCID: PMC5135782 Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F,
Song DH, Staley AC, Wilke LG, Willey SC, Yao KA, Margenthaler
49 OF 324
Journal Articles
JA. Contralateral prophylactic mastectomy (CPM) consensus statement for Immunotherapy of Cancer. 2016;4(1):90. PMCID: PMC5168808
from the American Society of Breast Surgeons: Data on CPM outcomes
and risks. Annals of Surgical Oncology. 2016;23(10):3100-3105. PMCID: Bracamontes CG, Lopez-Valdez R, Subramani R, Arumugam A, Nandy
PMC4999465 S, Rajamanickam V, Ravichandran V, Lakshmanaswamy R. The serum
protein profile of early parity which induces protection against breast
Bourla AB, Zamarin D. Immunotherapy: New strategies for the treatment cancer. Oncotarget. 2016;7(50):82538-82553.
of gynecologic malignancies. Oncology (Norwalk). 2016;30(1):59-
66. PMCID: PMC4995772 Bradbury MS, Pauliah M, Zanzonico P, Wiesner U, Patel S. Intraoperative
mapping of sentinel lymph node metastases using a clinically translated
Boutzen H, Saland E, Larrue C, de Toni F, Gales L, Castelli FA, Cathebas M, ultrasmall silica nanoparticle. Wiley Interdisciplinary Reviews: Nanomedicine
Zaghdoudi S, Stuani L, Kaoma T, Riscal R, Yang G, Hirsch P, David M, De and Nanobiotechnology. 2016;8(4):535-553. PMCID: PMC4902785
Mas-Mansat V, Delabesse E, Vallar L, Delhommeau F, Jouanin I, Ouerfelli
O, Le Cam L, Linares LK, Junot C, Portais JC, Vergez F, Recher C, Sarry Brami C, Bao T, Deng G. Natural products and complementary therapies
JE. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid for chemotherapy-induced peripheral neuropathy: A systematic
myeloid differentiation pathway in acute myeloid leukemia. Journal of review. Critical Reviews in Oncology Hematology. 2016;98:325-
Experimental Medicine. 2016;213(4):483-497. PMCID: PMC4821643 334. PMCID: PMC4727999
Bowman RL, Klemm F, Akkari L, Pyonteck SM, Sevenich L, Quail Brasó-Maristany F, Filosto S, Catchpole S, Marlow R, Quist J, Francesch-
DF, Dhara S, Simpson K, Gardner EE, Iacobuzio-Donahue CA, Brennan Domenech E, Plumb DA, Zakka L, Gazinska P, Liccardi G, Meier P, Gris-
CW, Tabar V, Gutin PH, Joyce JA. Macrophage ontogeny underlies Oliver A, Cheang MCU, Perdrix-Rosell A, Shafat M, Noël E, Patel N,
differences in tumor-specific education in brain malignancies. Cell McEachern K, Scaltriti M, Castel P, Noor F, Buus R, Mathew S, Watkins J,
Reports. 2016;17(9):2445-2459. Serra V, Marra P, Grigoriadis A, Tutt AN. PIM1 kinase regulates cell death,
tumor growth and chemotherapy response in triple-negative breast
Boyce LM. Play it, learn it, make it last: Developing an online game cancer. Nature Medicine. 2016;22(11):1303-1313.
to create self-sufficient library information users. Medical Reference
Services Quarterly. 2016;35(3):274-284. Braun K, Sjoberg DD, Vickers AJ, Lilja H, Bjartell AS. A four-kallikrein
panel predicts high-grade cancer on biopsy: Independent validation
Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan in a community cohort. European Urology. 2016;69(3):505-511. PMCID:
D, Barbarotta L, Barrett AJ, Besien K, Bergsagel PL, Borrello I, Brody J, PMC4643413
Brufsky J, Cairo M, Chari A, Cohen A, Cortes J, Forman SJ, Friedberg JW,
Fuchs EJ, Gore SD, Jagannath S, Kahl BS, Kline J, Kochenderfer JN, Kwak Brea EJ, Oh CY, Manchado E, Budhu S, Gejman RS, Mo G, Mondello
LW, Levy R, Lima M, Litzow MR, Mahindra A, Miller J, Munshi NC, Orlowski P, Han JE, Jarvis CA, Ulmert D, Xiang Q, Chang AY, Garippa
RZ, Pagel JM, Porter DL, Russell SJ, Schwartz K, Shipp MA, Siegel D, Stone RJ, Merghoub T, Wolchok JD, Rosen N, Lowe SW, Scheinberg
RM, Tallman MS, Timmerman JM, Rhee F, Waller EK, Welsh A, Werner M, DA. Kinase regulation of human MHC class I molecule expression on
Wiernik PH, Dhodapkar M V. The society for immunotherapy of cancer cancer cells. Cancer Immunology Research. 2016;4(11):936-947. PMCID:
consensus statement on immunotherapy for the treatment of hematologic PMC5110210
malignancies: Multiple myeloma, lymphoma, and acute leukemia. Journal
50 OF 324
Journal Articles
Breitbart W. A new milestone for Palliative & Supportive Care. Palliative Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical framework to
and Supportive Care. 2016;14(1):1-2. facilitate risk stratification when considering an active surveillance
alternative to immediate biopsy and surgery in papillary
Breitbart W. Balancing responsibility and freedom. Palliative and microcarcinoma. Thyroid. 2016;26(1):144-149. PMCID: PMC4842944
Supportive Care. 2016;14(4):317-318.
Brito JP, Singh-Ospina N, Gionfriddo MR, Maraka S, Espinosa De
Breitbart W. It’s a struggle: That’s the nature of life. Palliative and Ycaza A, Rodriguez-Gutierrez R, Morris JC, Montori VM, Tuttle
Supportive Care. 2016;14(3):175-176. RM. Restricting ultrasound thyroid fine needle aspiration biopsy
by nodule size: Which tumors are we missing? A population-based
Breitbart W. Legacy in palliative care: Legacy that is lived. Palliative and study. Endocrine. 2016;51(3):499-505. PMCID: PMC5131717
Supportive Care. 2016;14(5):453-454.
Brock G, Ni X, Oelke M, Mulhall J, Rosenberg M, Seftel A, D’Souza D,
Brennan NP, Peck KK, Holodny A. Language mapping using fMRI and Barry J. Efficacy of continuous dosing of tadalafil once daily vs tadalafil
direct cortical stimulation for brain tumor surgery the good, the bad, and on demand in clinical subgroups of men with erectile dysfunction: A
the questionable. Topics in Magnetic Resonance Imaging. 2016;25(1):1- descriptive comparison using the integrated tadalafil databases. Journal
9. PMCID: PMC4966674 of Sexual Medicine. 2016;13(5):860-875.
Brentjens RJ. Are chimeric antigen receptor T cells ready for prime Brooks ED, Schoenhals JE, Tang C, Micevic G, Gomez DR, Chang JY,
time?. Clinical Advances in Hematology & Oncology. 2016;14(1):17- Welsh JW. Stereotactic ablative radiation therapy combined with
19. PMCID: PMC5238717 immunotherapy for solid tumors. The Cancer Journal. 2016;22(4):257-266.
Bretthauer M, Kaminski MF, Løberg M, Zauber AG, Regula J, Kuipers Brooks JD, John EM, Mellemkjær L, Lynch CF, Knight JA, Malone
EJ, Hernán MA, McFadden E, Sunde A, Kalager M, Dekker E, Lansdorp- KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M, WECARE
Vogelaar I, Garborg K, Rupinski M, Spaander MCW, Bugajski M, Høie Study Collaborative Group, Bernstein JL. Body mass index, weight
O, Stefansson T, Hoff G, Adami HO, for the Nordic-European Initiative change, and risk of second primary breast cancer in the WECARE study:
on Colorectal Cancer (NordICC) Study Group. Population-based Influence of estrogen receptor status of the first breast cancer. Cancer
colonoscopy screening for colorectal cancer: A randomized clinical Medicine. 2016;5(11):3282-3291. PMCID: PMC5119984
trial. JAMA Internal Medicine. 2016;176(7):894-902.
Brose MS, Cabanillas ME, Cohen EEW, Wirth LJ, Riehl T, Yue H, Sherman
Brien GL, Bracken AP. The PCL1-p53 axis promotes cellular S I, Sherman EJ. Vemurafenib in patients with BRAF(V600E)-positive
quiescence. Cell Cycle. 2016;15(3):305-306. PMCID: PMC4943685 metastatic or unresectable papillary thyroid cancer refractory to
radioactive iodine: A non-randomised, multicentre, open-label, phase 2
Brien GL, Valerio DG, Armstrong SA. Exploiting the epigenome
trial. Lancet Oncology. 2016;17(9):1272-1282.
to control cancer-promoting gene-expression programs. Cancer
Cell. 2016;29(4):464-476. PMCID: PMC4889129 Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C,
Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka
Briggs A. A view from the bridge: Health economic evaluation — A value-
DC. Room for improvement: An examination of advance care planning
based framework?. Health Economics. 2016;25(12):1499-1502.
51 OF 324
Journal Articles
documentation among gynecologic oncology patients. Gynecologic Sciences. 2016;153(1):70-78.
Oncology. 2016;142(3):525-530.
Bruna A, Rueda OM, Greenwood W, Batra AS, Callari M, Batra RN,
Brown AM, Nagala S, McLean MA, Lu YG, Scoffings D, Apte A, Gonen Pogrebniak K, Sandoval J, Cassidy JW, Tufegdzic-Vidakovic A,
M, Stambuk HE, Shaha AR, Tuttle RM, Deasy JO, Priest AN, Jani Sammut SJ, Jones L, Provenzano E, Baird R, Eirew P, Hadfield J,
P, Shukla-Dave A, Griffiths J. Multi-institutional validation of a novel Eldridge M, McLaren-Douglas A, Barthorpe A, Lightfoot H, O’Connor
textural analysis tool for preoperative stratification of suspected MJ, Gray J, Cortes J, Baselga J, Marangoni E, Welm AL, Aparicio S,
thyroid tumors on diffusion-weighted MRI. Magnetic Resonance in Serra V, Garnett MJ, Caldas C. A biobank of breast cancer explants
Medicine. 2016;75(4):1708-1716. PMCID: PMC4654719 with preserved intra-tumor heterogeneity to screen anticancer
compounds. Cell. 2016;167(1):260-274.e22. PMCID: PMC5037319
Brown CE, Adusumilli PS. Next frontiers in CAR T-cell therapy. Molecular
Therapy - Oncolytics. 2016;3:16028. PMCID: PMC5129836 Brunner TH, DiFortuna K, LeTang M, Murphy J, Stemplewicz K, Kovacs
M, DeRosa AP, Gibson DS, Ginex PK. Using technology to give patients
Brown KT, Do RK, Gonen M, Covey AM, Getrajdman G I, Sofocleous a voice after surgery for head and neck cancer. Clinical Journal of
CT, Jarnagin WR, D’Angelica M I, Allen PJ, Erinjeri JP, Brody LA, O’Neill Oncology Nursing. 2016;20(5):474-476.
GP, Johnson KN, Garcia AR, Beattie C, Zhao BS, Solomon SB,
Schwartz LH, DeMatteo R, Abou-Alfa GK. Randomized trial of hepatic Bruno J, Brumfield A, Chaudhary N, Iaea D, McGraw TE. SEC 16A is a
artery embolization for hepatocellular carcinoma using doxorubicin- RAB 10 effector required for insulin-stimulated GLUT4 trafficking in
eluting microspheres compared with embolization with microspheres adipocytes. Journal of Cell Biology. 2016;214(1):61-76. PMCID: PMC4932369
alone. Journal of Clinical Oncology. 2016;34(17):2046-2053. PMCID:
PMC4966514 Brzezinski K, Oliver JF, Gillam J, Rafecas M, Studen A, Grkovski M, Kagan
H, Smith S, Llosa G, Lacasta C, Clinthorne NH. Experimental evaluation of
Brown KT, Do RK, Gonen M, Covey AM, Getrajdman G I, Sofocleous the resolution improvement provided by a silicon PET probe. Journal of
CT, Jarnagin WR, D’Angelica M I, Allen PJ, Erinjeri JP, Brody Instrumentation. 2016;11:P09016.
LA, Solomon SB, Schwartz LH, DeMatteo RP, Abou-Alfa GK. Trans-
arterial embolization for hepatocellular carcinoma: Doxorubicin Buchbinder D, Oeffinger K, Franco-Villalobos C, Yasui Y, Alderfer MA,
is not necessary. Translational Cancer Research. 2016;5(Suppl. Armstrong GT, Casillas J, Ford J, Krull KR, Leisenring W, Recklitis C,
6):S1299-S1301. Robison LL, Zeltzer LK, Lown EA. Tobacco use among siblings of
childhood cancer survivors: A report from the Childhood Cancer Survivor
Brown TR, Krogh-Madsen T, Christini DJ. Illuminating myocyte- Study. Pediatric Blood and Cancer. 2016;63(2) PMCID: PMC4715577
fibroblast homotypic and heterotypic gap junction dynamics using
dynamic clamp. Biophysical Journal. 2016;111(4):785-797. PMCID: Büchel GE, Carney B, Shaffer TM, Tang J, Austin C, Arora M, Zeglis
PMC5002081 BM, Grimm J, Eppinger J, Reiner T. Near-infrared intraoperative
chemiluminescence imaging. ChemMedChem. 2016;11(18):1978-
Browning CL, Qin Q, Kelly DF, Prakash R, Vanoli F, Jasin M, Wise JP 1982. PMCID: PMC5061038
Sr. Prolonged particulate hexavalent chromium exposure suppresses
homologous recombination repair in human lung cells. Toxicological Bunn PA Jr, Minna JD, Augustyn A, Gazdar AF, Ouadah Y, Krasnow
52 OF 324
Journal Articles
MA, Berns A, Brambilla E, Rekhtman N, Massion PP, Niederst M, ML. Using computer-extracted image phenotypes from tumors on
Peifer M, Yokota J, Govindan R, Poirier JT, Byers LA, Wynes MW, breast magnetic resonance imaging to predict breast cancer pathologic
McFadden DG, MacPherson D, Hann CL, Farago AF, Dive C, Teicher stage. Cancer. 2016;122(5):748-757. PMCID: PMC4764425
BA, Peacock CD, Johnson JE, Cobb MH, Wendel HG, Spigel D, Sage J,
Yang P, Pietanza MC, Krug LM, Heymach J, Ujhazy P, Zhou C, Goto K, Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon
Dowlati A, Christensen CL, Park K, Einhorn LH, Edelman MJ, Giaccone KE, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs
G, Gerber DE, Salgia R, Owonikoko T, Malik S, Karachaliou N, Gandara JJ. Adjuvant endocrine therapy for women with hormone receptor-
DR, Slotman BJ, Blackhall F, Goss G, Thomas R, Rudin CM, Hirsch positive breast cancer: American Society of Clinical Oncology Clinical
FR. Small cell lung cancer: Can recent advances in biology and molecular Practice Guideline Update on Ovarian Suppression. Journal of Clinical
biology be translated into improved outcomes?. Journal of Thoracic Oncology. 2016;34(14):1689-1701.
Busam KJ, Vilain RE, Lum T, Busam JA, Hollmann TJ, Saw RPM, Coit DC,
Buono M, Facchini R, Matsuoka S, Thongjuea S, Waithe D, Luis TC, Scolyer RA, Wiesner T. Primary and metastatic cutaneous melanomas
Giustacchini A, Besmer P, Mead AJ, Jacobsen SEW, Nerlov C. A express ALK through alternative transcriptional initiation. American
dynamic niche provides Kit ligand in a stage-specific manner to the Journal of Surgical Pathology. 2016;40(6):786-795. PMCID:
earliest thymocyte progenitors. Nature Cell Biology. 2016;18(2):157- PMC5037961
167. PMCID: PMC4972409
Butler K V, Ma A, Yu W, Li F, Tempel W, Babault N, Pittella-Silva F, Shao
Burger IA, Casanova R, Steiger S, Husmann L, Stolzmann P, Huellner J, Wang J, Luo M, Vedadi M, Brown PJ, Arrowsmith CH, Jin J. Structure-
MW, Curioni A, Hillinger S, Schmidtlein CR, Soltermann A. (18) based design of a covalent inhibitor of the SET domain-containing
F-FDG PET/CT of non-small cell lung carcinoma under neoadjuvant protein 8 (SETD8) lysine methyltransferase. Journal of Medicinal
chemotherapy: Background-based adaptive-volume metrics outperform Chemistry. 2016;59(21):9881-9889. PMCID: PMC5148670
TLG and MTV in predicting histopathologic response. Journal of Nuclear
Medicine. 2016;57(6):849-854. Butnor KJ, Asamura H, Travis WD. Node doubt: Rigorous surgical nodal
procurement combined with thorough pathologic evaluation improves
Burkhalter JE, Margolies L, Sigurdsson HO, Walland J, Radix A, Rice non-small cell lung carcinoma staging accuracy. Annals of Thoracic
D, Buchting FO, Sanchez NF, Bare MG, Boehmer U, Cahill S, Griebling Surgery. 2016;102(2):353-356.
TL, Bruessow D, Maingi S. The National LGBT Cancer Action Plan:
A white paper of the 2014 National Summit on Cancer in the LGBT Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY,
communities. LGBT Health. 2016;3(1):19-31. PMCID: PMC4770841 Cloughesy TF, Marimuthu A, Haidar S, Perry A, Huse J, Phillips J, West BL,
Nolop KB, Hsu HH, Ligon KL, Molinaro AM, Prados M. Orally administered
Burnett ME, Hibler BP, Wang SQ. Reconstruction of a lower conchal bowl colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent
defect. Dermatologic Surgery. 2016;42(10):1209-1212. glioblastoma: An Ivy Foundation Early Phase Clinical Trials Consortium
phase II study. Neuro-Oncology. 2016;18(4):557-564. PMCID: PMC4799682
Burnside ES, Drukker K, Li H, Bonaccio E, Zuley M, Ganott M, Net
JM, Sutton EJ, Brandt KR, Whitman GJ, Conzen SD, Lan L, Ji Y, Zhu Cadoo KA, Morris PG, Cowell EP, Patil S, Hudis CA, McArthur
Y, Jaffe CC, Huang EP, Freymann JB, Kirby JS, Morris EA, Giger HL. Adjuvant chemotherapy and trastuzumab is safe and effective in
53 OF 324
Journal Articles
older women with small, node-negative, HER2-positive early-stage breast Calzavara-Pinton PG, Rossi MT, Zanca A, Arisi M, Gonzalez S, Venturini
cancer. Clinical Breast Cancer. 2016;16(6):487-493. M. Oral Polypodium leucomotos increases the anti-inflammatory
and melanogenic responses of the skin to different modalities of sun
Cai XC, Kapilashrami K, Luo M. Synthesis and assays of inhibitors of exposures: A pilot study. Photodermatology Photoimmunology and
methyltransferases. Methods in Enzymology. 2016;574:245-308. Photomedicine. 2016;32(1):22-27.
Caley MP, King H, Shah N, Wang K, Rodriguez-Teja M, Gronau JH, Cameron MC, Swift R, Wysong A, Rossi AM. Laser revision and
Waxman J, Sturge J. Tumor-associated Endo180 requires stromal-derived rehabilitation of Mohs micrographic surgical scars. Current Dermatology
LOX to promote metastatic prostate cancer cell migration on human Reports. 2016;5(3):200-207.
ECM surfaces. Clinical and Experimental Metastasis. 2016;33(2):151-
165. PMCID: PMC4761374 Cameron MC, Rossi AM. Reflectance confocal microscopy for skin cancer
margins: How it works. Current Dermatology Reports. 2016;5(3):172-178.
Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, Mell
LK, Thomas CR, Jabbour SK, Miller RC. Intensity-modulated radiation Campbell C. Resources for addressing cognitive issues in connection
therapy for anal cancer results from a multi-institutional retrospective with lymphedema management. OT Practice. 2016;21(11):17-18.
cohort study. American Journal of Clinical Oncology: Cancer Clinical
Trials. 2016;39(1):8-12. Candela JL. Cardiotoxicity and breast cancer as late effects of pediatric
and adolescent Hodgkin lymphoma treatment. American Journal of
Callahan MK, Flaherty CR, Postow MA. Checkpoint blockade for Nursing. 2016;116(4):32-42.
the treatment of advanced melanoma. Cancer Treatment and
Research. 2016;167:231-250. Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE,
Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower
Callahan MK, Postow MA, Wolchok JD. Targeting T cell co-receptors for E, Minlikeeva AN, Zirpoli G, Bandera E V, Berchuck A, Cramer D, Doherty
cancer therapy. Immunity. 2016;44(5):1069-1078. JA, Edwards RP, Fridley BL, Goode EL, Goodman MT, Hogdall E, Hosono
S, Jensen A, Jordan S, Kjaer SK, Matsuo K, Ness RB, Olsen CM, Olson
Callahan MK. Immune checkpoint therapy in melanoma. The Cancer SH, Pearce CL, Pike MC, Rossing MA, Szamreta EA, Thompson PJ, Tseng
Journal. 2016;22(2):73-80. CC, Vierkant RA, Webb PM, Wentzensen N, Wicklund KG, Winham SJ,
Wu AH, Modugno F, Schildkraut JM, Terry KL, Kelemen LE, Moysich
Callahan SJ, Mica Y, Studer L. Feeder-free derivation of melanocytes KB. Chronic recreational physical inactivity and epithelial
from human pluripotent stem cells. Journal of Visualized
Experiments. 2016;109:e53806. PMCID: PMC4828213 ovarian cancer risk: Evidence from the Ovarian Cancer Association
Consortium. Obstetrical and Gynecological Survey. 2016;71(9):528-530.
Callegari AJ, Kelly TJ. Coordination of DNA damage tolerance
mechanisms with cell cycle progression in fission yeast. Cell Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE,
Cycle. 2016;15(2):261-273. PMCID: PMC5007584 Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E,
Minlikeeva AN, Zirpoli GR, Bandera E V, Berchuck A, Cramer D, Doherty
Callegari AJ. Does transcription-associated DNA damage limit JA, Edwards RP, Fridley BL, Goode EL, Goodman MT, Hogdall E, Hosono
lifespan?. DNA Repair. 2016;41:1-7. S, Jensen A, Jordan S, on behalf of The Australian Ovarian Cancer Study
54 OF 324
Journal Articles
Group, Kjaer SK, Matsuo K, Ness RB, Olsen CM, Olson SH, Pearce CL, Pike Clinical Oncology. 2016;34(6):542-549. PMCID: PMC4980567
MC, Rossing MA, Szamreta EA, Thompson PJ, Tseng CC, Vierkant RA,
Webb PM, Wentzensen N, Wicklund KG, Winham SJ, Wu AH, Modugno F, Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park
Schildkraut JM, Terry KL, Kelemen LE, Moysich KB. Chronic recreational KJ, McCluggage WG. A detailed immunohistochemical analysis of a large
physical inactivity and epithelial ovarian cancer risk: Evidence from series of cervical and vaginal gastric-type adenocarcinomas. American
the Ovarian Cancer Association Consortium. Cancer Epidemiology Journal of Surgical Pathology. 2016;40(5):636-644.
Biomarkers and Prevention. 2016;25(7):1114-1124. PMCID: PMC4930728
Carlo M I, Molina AM, Lakhman Y, Patil S, Woo K, Deluca J, Lee
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva CH, Hsieh JJ, Feldman DR, Motzer RJ, Voss MH. A phase Ib study of
AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and
A, Chang-Claude J, Cramer DW, DeFazio A, on behalf of The Australian mammalian target of rapamycin (mTOR), in patients with advanced renal
Ovarian Cancer Study Group, Diergaarde B, Dörk T, Doherty JA, Edwards cell carcinoma. The Oncologist. 2016;21(7):787-788. PMCID: PMC4943396
RP, Fridley BL, Friel G, Goode EL, Goodman MT, Hillemanns P, Hogdall E,
Hosono S, Kelley JL, Kjaer SK, Klapdor R, Matsuo K, Odunsi K, Nagle CM, Carlo M I, Feldman DR. Response to nivolumab in a patient with
Olsen CM, Paddock LE, Pearce CL, Pike MC, Rossing MA, Schmalfeldt B, metastatic clear cell renal cell carcinoma and end-stage renal disease on
Segal BH, Szamreta EA, Thompson PJ, Tseng CC, Vierkant R, Schildkraut dialysis. European Urology. 2016;70(6):1082-1083.
JM, Wentzensen N, Wicklund KG, Winham SJ, Wu AH, Modugno F, Ness
Carlo M I, Voss MH, Motzer RJ. Checkpoint inhibitors and other novel
RB, Jensen A, Webb PM, Terry K, Bandera E V, Moysich KB. Recreational
immunotherapies for advanced renal cell carcinoma. Nature Reviews
physical inactivity and mortality in women with invasive epithelial ovarian
Urology. 2016;13(7):420-431.
cancer: Evidence from the Ovarian Cancer Association Consortium. British
Journal of Cancer. 2016;115(1):95-101. PMCID: PMC4931371 Carlow DC, Shi H, Schofield RC. Simultaneous quantitation of lamotrigine,
levetiracetam, 10-hydroxycarbazepine, topiramate, and zonisamide in
Canonica CM. An overview of hematopoietic stem cell
serum using HPLC-MS/MS. Methods in Molecular Biology. 2016;1383:29-37.
transplantation. Physician Assistant Clinics. 2016;1(3):409-418.
Carlow DC, Schofield RC, Denburg M. Quantitation of 25-OH-vitamin-D(2)
Cao L, Selby L V, Hu X, Zhang Y, Janjigian YY, Tang L, Coit DG, Brennan
and 25-OH-Vitamin-D(3) in urine using LC-MS/MS. Methods in Molecular
MF, Strong VE. Risk factors for recurrence in T1-2N0 gastric cancer in the
Biology. 2016;1378:321-329.
United States and China. Journal of Surgical Oncology. 2016;113(7):745-
749. PMCID: PMC5087986 Carlsson S V, de Carvalho TM, Roobol MJ, Hugosson J, Auvinen A,
Kwiatkowski M, Villers A, Zappa M, Nelen V, Páez A, Eastham JA, Lilja
Carey LA, Berry DA, Cirrincione CT, Barry WT, Pitcher BN, Harris LN,
H, de Koning HJ, Vickers AJ, Heijnsdijk EAM. Estimating the harms
Ollila DW, Krop IE, Henry NL, Weckstein DJ, Anders CK, Singh B, Hoadley
and benefits of prostate cancer screening as used in common practice
KA, Iglesia M, Cheang MCU, Perou CM, Winer EP, Hudis CA. Molecular
versus recommended good practice: A microsimulation screening
heterogeneity and response to neoadjuvant human epidermal growth
analysis. Cancer. 2016;122(21):3386-3393. PMCID: PMC5073010
factor receptor 2 targeting in CALGB 40601, a randomized phase III
trial of paclitaxel plus trastuzumab with or without lapatinib. Journal of Carlsson S V, Kattan MW. On risk estimation versus risk stratification
55 OF 324
Journal Articles
in early prostate cancer. PLoS Medicine. 2016;13(8):e1002100. PMCID: Carney B, Carlucci G, Salinas B, Di Gialleonardo V, Kossatz S, Vansteene
PMC4970733 A, Longo VA, Bolaender A, Chiosis G, Keshari KR, Weber WA, Reiner
T. Non-invasive PET imaging of PARP1 expression in glioblastoma
Carlsson S V, Kattan MW. Prostate cancer: Personalized risk - Stratified models. Molecular Imaging and Biology. 2016;18(3):386-392. PMCID:
screening or abandoning it altogether?. Nature Reviews Clinical PMC4841747
Oncology. 2016;13(3):140-142.
Carrasquillo JA, Pandit-Taskar N, Chen CC. I-131
Carlsson S V, Kattan MW. The STHLM3 prostate cancer diagnostic metaiodobenzylguanidine therapy of pheochromocytoma and
study: Calibration, clarification, and comments. Nature Reviews Clinical paraganglioma. Seminars in Nuclear Medicine. 2016;46(3):203-214.
Oncology. 2016;13(6):394.
Carrera C, Marchetti MA, Dusza SW, Argenziano G, Braun RP, Halpern
Carlsson S V, Roobol MJ. What’s new in screening in 2015?. Current AC, Jaimes N, Kittler HJ, Malvehy J, Menzies SW, Pellacani G, Puig
Opinion in Urology. 2016;26(5):447-458. PMCID: PMC5082833 S, Rabinovitz HS, Scope A, Peter Soyer H, Stolz W, Hofmann-
Wellenhof R, Zalaudek I, Marghoob AA. Validity and reliability of
Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, dermoscopic criteria used to differentiate nevi from melanoma
Johansson E, Stattin P, Fransson P. Population-based study of long- aweb-based international dermoscopy society study. JAMA
term functional outcomes after prostate cancer treatment. BJU Dermatology. 2016;152(7):798-806.
International. 2016;117(6B):E36-E45. PMCID: PMC4637260
Carrera C, Marghoob AA. Discriminating nevi from melanomas: Clues and
Carlsson S, Jäderling F, Wallerstedt A, Nyberg T, Stranne J, pitfalls. Dermatologic Clinics. 2016;34(4):395-409.
Thorsteinsdottir T, Carlsson S V, Bjartell A, Hugosson J, Haglind E,
Steineck G. Oncological and functional outcomes 1 year after radical Carroll CM, Li YM. Physiological and pathological roles of the γ-secretase
prostatectomy for very-low-risk prostate cancer: Results from the complex. Brain Research Bulletin. 2016;126(2):199-206.
prospective LAPPRO trial. BJU International. 2016;118(2):205-212. PMCID:
PMC4947001 Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona
WJ, Dahl DM, Davis JW, Epstein J I, Etzioni RB, Farrington T, Hemstreet
Carlsson S. Editorial comment. Journal of Urology. 2016;196(4):1051. GP, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P,
Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt
Carmi Y, Prestwood TR, Spitzer MH, Linde IL, Chabon J, Reticker-Flynn TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA,
NE, Bhattacharya N, Zhang H, Zhang X, Basto PA, Burt BM, Alonso MN, Freedman-Cass DA. NCCN Guidelines Insights: Prostate cancer early
Engleman EG. Akt and SHP-1 are DC-intrinsic checkpoints for tumor detection, version 2.2016. Journal of the National Comprehensive Cancer
immunity. JCI Insight. 2016;1(18):e89020. PMCID: PMC5085602 Network. 2016;14(5):509-519.
Carmona FJ, Montemurro F, Kannan S, Rossi V, Verma C, Baselga J, Scaltriti Carson SS, Cox CE, Wallenstein S, Hanson LC, Danis M, Tulsky JA, Chai
M. AKT signaling in ERBB2-amplified breast cancer. Pharmacology & E, Nelson JE. Effect of palliative care-led meetings for families of patients
Therapeutics. 2016;158:63-70. PMCID: PMC4747800 with chronic critical illness: A randomized clinical trial. JAMA - Journal of
the American Medical Association. 2016;316(1):51-62.
56 OF 324
Journal Articles
Carty MA, Elemento O. Practical analysis of genome contact interaction Castillo JJ, Hunter ZR, Yang G, Argyropoulos K, Palomba ML, Treon
experiments. Methods in Molecular Biology. 2016;1418:177-189. SP. Future therapeutic options for patients with Waldenström
macroglobulinemia. Best Practice and Research: Clinical
Carver BS. Defining and targeting the oncogenic drivers of Haematology. 2016;29(2):206-215.
neuroendocrine prostate cancer. Cancer Cell. 2016;29(4):431-432.
Castillo JJ, Glezerman IG, Boklage SH, Chiodo J, Tidwell BA, Lamerato
Cascales-Campos P, López-López V, Gil J, Arévalo-Pérez J, Nieto A, LE, Schulman KL. The occurrence of hyponatremia and its importance
Barceló F, Gil E, Parrilla P. Hyperthermic intraperitoneal chemotherapy as a prognostic factor in a cross-section of cancer patients. BMC
with paclitaxel or cisplatin in patients with stage III-C/IV ovarian cancer. Cancer. 2016;16(1):564. PMCID: PMC4966824
Is there any difference?. Surgical Oncology. 2016;25(3):164-170.
Castillo JJ, Palomba ML, Advani R, Treon SP. Ibrutinib in
Casellas R, Basu U, Yewdell WT, Chaudhuri J, Robbiani DF, Di Noia Waldenstrom macroglobulinemia: Latest evidence and clinical
JM. Mutations, kataegis and translocations in B cells: Understanding experience. Therapeutic Advances in Hematology. 2016;7(4):179-
AID promiscuous activity. Nature Reviews Immunology. 2016;16(3):164- 186. PMCID: PMC4959643
176. PMCID: PMC4871114
Castro E, Mikropoulos C, Bancroft EK, Dadaev T, Goh C, Taylor N,
Casey DL, Kushner BH, Cheung NK V, Modak S, LaQuaglia Saunders E, Borley N, Keating D, Page EC, Saya S, Hazell S, Livni N,
MP, Wolden SL. Local control with 21-Gy radiation therapy for high-risk Desouza N, Neal D, Hamdy FC, Kumar P, Antoniou AC, Kote-Jarai Z, The
neuroblastoma. International Journal of Radiation Oncology, Biology, PROFILE Study Steering Committee, Eeles RA. The PROFILE feasibility
Physics. 2016;96(2):393-400. study: Targeted screening of men with a family history of prostate
cancer. The Oncologist. 2016;21(6):716-722. PMCID: PMC4912360
Castel P, Carmona FJ, Grego-Bessa J, Berger MF, Viale A, Anderson K
V, Bague S, Scaltriti M, Antonescu CR, Baselga E, Baselga J. Somatic Cavalcanti MS, Gönen M, Klimstra DS. The ENETS/WHO grading
PIK3CA mutations as a driver of sporadic venous malformations. Science system for neuroendocrine neoplasms of the gastroenteropancreatic
Translational Medicine. 2016;8(332):332ra42. PMCID: PMC4962922 system: A review of the current state, limitations and
proposals for modifications. International Journal of Endocrine
Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, Kannan S, Oncology. 2016;3(3):203-219.
Verma CS, Dickler M, Chandarlapaty S, Brogi E, Alessi DR, Baselga
J, Scaltriti M. PDK1-SGK1 signaling sustains AKT-independent Cazap E, Magrath I, Kingham TP, Elzawawy A. Structural barriers
mTORC1 activation and confers resistance to PI3Kα inhibition. Cancer to diagnosis and treatment of cancer in low- and middle-income
Cell. 2016;30(2):229-242. PMCID: PMC4982440 countries: The urgent need for scaling up. Journal of Clinical
Castillo JJ, D’Sa S, Lunn MP, Minnema MC, Tedeschi A, Lansigan
F, Palomba ML, Varettoni M, Garcia-Sanz R, Nayak L, Lee EQ, Rinne Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA,
ML, Norden AD, Ghobrial IM, Treon SP. Central nervous system Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang
involvement by Waldenström macroglobulinaemia (Bing-Neel J, Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD,
syndrome): A multi-institutional retrospective study. British Journal of Zhang H, Poisson L, Carlotti CG Jr, Tirapelli DPDC, Rao A, Mikkelsen
Haematology. 2016;172(5):709-715. T, Lau CC, Yung WKA, Rabadan R, Huse J, Brat DJ, Lehman NL,
57 OF 324
Journal Articles
Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim Chandarlapaty S, Chen D, He W, Sung P, Samoila A, You D, Bhatt T, Patel
R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW, P, Voi M, Gnant M, Hortobagyi G, Baselga J, Moynahan ME. Prevalence
Gutmann DH, TCGA Research Network, Noushmehr H, Iavarone A, of ESR1 mutations in cell-free DNA and outcomes in metastatic breast
Verhaak RGW. Molecular profiling reveals biologically discrete subsets cancer: A secondary analysis of the BOLERO-2 clinical trial. JAMA
and pathways of progression in diffuse glioma. Cell. 2016;164(3):550- Oncology. 2016;2(10):1310-1315. PMCID: PMC5063698
563. PMCID: PMC4754110
Chandwani R, Allen PJ. Cystic neoplasms of the pancreas. Annual Review
Cella D, Grünwald V, Nathan P, Doan J, Dastani H, Taylor F, Bennett B, of Medicine. 2016;67:45-57.
DeRosa M, Berry S, Broglio K, Berghorn E, Motzer RJ. Quality of life in
patients with advanced renal cell carcinoma given nivolumab versus Chang AY, Gejman RS, Brea EJ, Oh CY, Mathias MD, Pankov D, Casey
everolimus in CheckMate 025: A randomised, open-label, phase 3 E, Dao T, Scheinberg DA. Opportunities and challenges for TCR
trial. Lancet Oncology. 2016;17(7):994-1003. mimic antibodies in cancer therapy. Expert Opinion on Biological
Therapy. 2016;16(8):979-987. PMCID: PMC4936943
Cercek A, Boucher TM, Gluskin JS, Aguiló A, Chou JF, Connell
LC, Capanu M, Reidy-Lagunes D, D’Angelica M, Kemeny NE. Response Chang E, Pourmal S, Zhou C, Kumar R, Teplova M, Pavletich NP, Marians
rates of hepatic arterial infusion pump therapy in patients with KJ, Erdjument-Bromage H. N-terminal amino acid sequence determination
metastatic colorectal cancer liver metastases refractory to all standard of proteins by N-terminal dimethyl labeling: Pitfalls and advantages
chemotherapies. Journal of Surgical Oncology. 2016;114(6):655-663. when compared with Edman degradation sequence analysis. Journal of
Biomolecular Techniques. 2016;27(2):61-74. PMCID: PMC4802820
Cercek A, Park V, Yaeger R, Reidy-Lagunes D, Kemeny NE, Stadler
ZK, Segal NH, Varghese A, Saltz LB. Faster FOLFOX: Oxaliplatin can Chang JH, Shin JH, Yamada YJ, Mesfin A, Fehlings MG, Rhines LD, Sahgal
be safely infused at a rate of 1 mg/m(2)/min. Journal of Oncology A. Stereotactic body radiotherapy for spinal metastases: What are the
Practice. 2016;12(5):e548-e553. risks and how do we minimize them?. Spine. 2016;41(Suppl. 20):S238-S245.
Chaft JE, Dunphy M, Naidoo J, Travis WD, Hellmann M, Woo Chang KK, Park DJ, Yoon SS. Laparoscopic versus open surgery
K, Downey R, Rusch V, Ginsberg MS, Azzoli CG, Kris MG. Adaptive for gastric adenocarcinoma: Innovation continues to challenge
neoadjuvant chemotherapy guided by (18)F-FDG PET in resectable tradition. Annals of Surgery. 2016;264(2):223-225.
non-small cell lung cancers: The NEOSCAN trial. Journal of Thoracic
Oncology. 2016;11(4):537-544. PMCID: PMC4808609 Chang KK, Cho SJ, Yoon C, Lee JH, Park DJ, Yoon SS. Increased RhoA
activity predicts worse overall survival in patients undergoing surgical
Chan JM, Darke AK, Penney KL, Tangen CM, Goodman PJ, Lee resection for Lauren diffuse-type gastric adenocarcinoma. Annals of
GSM, Sun T, Peisch S, Tinianow AM, Rae JM, Klein EA, Thompson Surgical Oncology. 2016;23(13):4238-4246.
IM Jr, Kantoff PW, Mucci LA. Selenium- or vitamin E-related gene
variants, interaction with supplementation, and risk of high-grade Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao
prostate cancer in SELECT. Cancer Epidemiology Biomarkers and J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. Identifying recurrent
Prevention. 2016;25(7):1050-1058. PMCID: PMC5086806 mutations in cancer reveals widespread lineage diversity and mutational
specificity. Nature Biotechnology. 2016;34(2):155-163. PMCID: PMC4744099
58 OF 324
Journal Articles
Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Chaudhry MS, Velardi E, Dudakov JA, van den Brink MRM. Thymus: The
Sloan HL, Lai I, Wagener F, Shibuya K, Cao J, Wolchok JD, Greenberg next (re)generation. Immunological Reviews. 2016;271(1):56-71. PMCID:
PD, Yee C. Combined IL-21-primed polyclonal CTL plus CTLA4 blockade PMC4837659
controls refractory metastatic melanoma in a patient. Journal of
Experimental Medicine. 2016;213(7):1133-1139. PMCID: PMC4925025 Chauleau M, Shuman S. Kinetic mechanism and fidelity of nick sealing
by Escherichia coli NAD+-dependent DNA ligase (LigA). Nucleic Acids
Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Research. 2016;44(5):2298-2309. PMCID: PMC4797296
Sloan HL, Lai IP, Farrar EA, Wagener F, Shibuya KC, Cao J, Wolchok JD,
Greenberg PD, Yee C. T-cell therapy using interleukin-21-primed cytotoxic Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz AJ, Engert A, Jerkeman
T-cell lymphocytes combined with cytotoxic T-cell lymphocyte antigen-4 M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM,
blockade results in long-term cell persistence and durable tumor Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA. Clinical
regression. Journal of Clinical Oncology. 2016;34(31):3787-3795. characteristics and outcomes of patients with Hodgkin lymphoma
with central nervous system involvement: An international multicenter
Chargari C, Magne N, Guy JB, Rancoule C, Levy A, Goodman KA, Deutsch collaboration. American Journal of Hematology. 2016;91(9):894-899.
E. Optimize and refine therapeutic index in radiation therapy: Overview
of a century. Cancer Treatment Reviews. 2016;45:58-67. Cheal SM, Xu H, Lee SG, Guo HF, Punzalan B, Chalasani S, Fung
E, Jungbluth A, Zanzonico P, Carrasquillo J, O’Donoghue J, Smith-
Charpentier AM, Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Jones P, Wittrup K, Cheung NK, Larson S. Theranostic pretargeted
Albert-Green A, Kelly KM, Constine LS, Hodgson DC. Predictive factor radioimmunotherapy of colorectal cancer xenografts in mice using
analysis of response-adapted radiation therapy for chemotherapy- picomolar affinity (86)Y- or (177)Lu-DOTA-Bn binding scFv C825/GPA33
sensitive pediatric Hodgkin lymphoma: Analysis of the Children’s IgG bispecific immunoconjugates. European Journal of Nuclear Medicine
Oncology Group AHOD 0031 trial. International Journal of Radiation and Molecular Imaging. 2016;43(5):925-937. PMCID: PMC4814317
Oncology, Biology, Physics. 2016;96(5):943-950.
Cheema AR, O’Reilly EM. Management of metastatic pancreatic
Chatterjee D, Sanchez ANAM, Goldgur Y, Shuman S, Schwer adenocarcinoma. Surgical Clinics of North America. 2016;96(6):1391-1414.
B. Transcription of lncRNA prt, clustered prt RNA sites for Mmi1 binding,
and RNA polymerase II CTD phospho-sites govern the repression of Chegai F, Merolla S, Greco L, Nezzo M, Mannelli L, Orlacchio A. Re:
Pho1 gene expression under phosphate-replete conditions in fission Baseline and early MR apparent diffusion coefficient quantification as
yeast. RNA. 2016;22(7):1011-1025. PMCID: PMC4911910 a predictor of response of unresectable hepatocellular carcinoma to
doxorubicin drug-eluting bead chemoembolization. Journal of Vascular
Chatterjee M, Turner DC, Felip E, Lena H, Cappuzzo F, Horn L, Garon EB, and Interventional Radiology. 2016;27(9):1456-1458.
Hui R, Arkenau HT, Gubens MA, Hellmann MD, Dong D, Li C, Mayawala
K, Freshwater T, Ahamadi M, Stone J, Lubiniecki GM, Zhang J, Im E, De Chegai F, Monti S, Orlacchio A, Mannelli L. Liver and bone metastases
Alwis DP, Kondic AG, Fløtten Ø. Systematic evaluation of pembrolizumab from breast cancer: Eovist® magnetic resonance and diffusion weighted
dosing in patients with advanced non-small-cell lung cancer. Annals of imaging, 18F-FDG positron emission/computed tomography. Digestive
Oncology. 2016;27(7):1291-1298. and Liver Disease. 2016;48(2):213. PMCID: PMC4976450
59 OF 324
Journal Articles
Chellapandian D, Makras P, Kaltsas G, van den Bos C, Naccache year survival and durability results of brentuximab vedotin in patients
L, Rampal R, Carret AS, Weitzman S, Egeler RM, Abla with relapsed or refractory Hodgkin lymphoma. Blood. 2016;128(12):1562-
O. Bisphosphonates in Langerhans cell histiocytosis: An international 1566. PMCID: PMC5034737
retrospective case series. Mediterranean Journal of Hematology and
Infectious Diseases. 2016;8(1):e2016033. PMCID: PMC4928520 Chen RC, Bryan Rumble R, Andrew Loblaw D, Finelli A, Ehdaie B,
Cooperberg MR, Morgan SC, Tyldesley S, Haluschak JJ, Tan W, Justman
Chemaitilly W, Merchant TE, Li Z, Barnes N, Armstrong GT, Ness KK, S, Jain S. Active surveillance for the management of localized prostate
Pui CH, Kun LE, Robison LL, Hudson MM, Sklar CA, Gajjar A. Central cancer (Cancer Care Ontario guideline): American society of clinical
precocious puberty following the diagnosis and treatment of paediatric oncology clinical practice guideline endorsement. Journal of Clinical
cancer and central nervous system tumours: Presentation and long- Oncology. 2016;34(18):2182-2190.
term outcomes. Clinical Endocrinology. 2016;84(3):361-371. PMCID:
PMC4755813 Chen S, Deniz K, Sung YS, Zhang L, Dry S, Antonescu CR. Ewing
sarcoma with ERG gene rearrangements: A molecular study focusing on
Chen F, Zhang Y, Şenbabaoğlu Y, Ciriello G, Yang L, Reznik E, Shuch the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-
B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington ERG fusions by FISH. Genes Chromosomes and Cancer. 2016;55(4):340-
KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, 349. PMCID: PMC5006947
Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, Getz G,
Kucherlapati R, Park PJ, Sander C, Henske EP, Zhou JH, Kwiatkowski DJ, Chen SY, Molena D, Stem M, Mungo B, Lidor AO. Post-discharge
Ho TH, Choueiri TK, Hsieh JJ, Akbani R, Mills GB, Hakimi AA, Wheeler complications after esophagectomy account for high readmission
DA, Creighton CJ. Multilevel genomics-based taxonomy of renal cell rates. World Journal of Gastroenterology. 2016;22(22):5246-5253. PMCID:
carcinoma. Cell Reports. 2016;14(10):2476-2489. PMCID: PMC4794376 PMC4893471
Chen L, Lim F. Recognizing and treating vasospastic angina. Nurse Chen Y, Rini B I, Motzer RJ, Dutcher JP, Rixe O, Wilding G, Stadler
Practitioner. 2016;41(11):1-3. WM, Tarazi J, Garrett M, Pithavala YK. Effect of renal impairment
on the pharmacokinetics and safety of axitinib. Targeted
Chen L. Don’t go chasing waterfalls: Excessive fluid resuscitation in severe Oncology. 2016;11(2):229-234.
sepsis and septic shock. Critical Care Nursing Quarterly. 2016;39(1):34-37.
Chen YB, Xu J, Skanderup AJ, Dong Y, Brannon AR, Wang L, Won
Chen L. Glycocalyx in sepsis resuscitation. Critical Care Nursing HH, Wang P I, Nanjangud GJ, Jungbluth AA, Li W, Ojeda V, Hakimi
Quarterly. 2016;39(1):38-41. AA, Voss MH, Schultz N, Motzer RJ, Russo P, Cheng EH, Giancotti FG, Lee
W, Berger MF, Tickoo SK, Reuter VE, Hsieh JJ. Molecular analysis of
Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob aggressive renal cell carcinoma with unclassified histology reveals distinct
LS, Patwa R, Shah H, Xu K, Cross JR, Massague J. Carcinoma- subsets. Nature Communications. 2016;7:13131. PMCID: PMC5059781
astrocyte gap junctions promote brain metastasis by cGAMP
transfer. Nature. 2016;533(7604):493-498. PMCID: PMC5021195 Chen YCA, Stuwe E, Luo Y, Ninova M, Le Thomas A, Rozhavskaya E, Li S,
Vempati S, Laver JD, Patel DJ, Smibert CA, Lipshitz HD, Fejes Toth K, Aravin
Chen R, Gopal AK, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, AA. Cutoff suppresses RNA polymerase II termination to ensure expression
Connors JM, Engert A, Larsen EK, Huebner D, Fong A, Younes A. Five- of piRNA precursors. Molecular Cell. 2016;63(1):97-109. PMCID: PMC4980073
60 OF 324
Journal Articles
Chen Z, Thomas SN, Bolduc DM, Jiang X, Zhang X, Wolberger C, Cole Marotti JD, Soh HC, McCalip BL, Serrano J, Lim RS, Siziopikou KP, Lu S,
PA. Enzymatic analysis of PTEN ubiquitylation by WWP2 and NEDD4-1 Liu X, Hammour T, Brogi E, Snuderl M, Iafrate AJ, Reis-Filho JS, Schnitt
E3 ligases. Biochemistry. 2016;55(26):3658-3666. PMCID: PMC5102067 SJ. IDH2 mutations define a unique subtype of breast cancer with altered
nuclear polarity. Cancer Research. 2016;76(24):7118-7129.
Cheng M, Santich BH, Xu H, Ahmed M, Huse M, Cheung NK V. Successful
engineering of a highly potent single-chain variable-fragment (scFv) Chiesa F, Sacchini VS. Risk-reducing mastectomy. Minerva
bispecific antibody to target disialoganglioside (GD2) positive Ginecologica. 2016;68(5):544-547.
tumors. OncoImmunology. 2016;5(6):e1168557. PMCID: PMC4938304
Chihara D, Cheah CY, Westin JR, Fayad LE, Rodriguez MA, Hagemeister
Cherkassky L, Morello A, Villena-Vargas J, Feng Y, Dimitrov DS, Jones FB, Pro B, McLaughlin P, Younes A, Samaniego F, Goy A, Cabanillas F,
DR, Sadelain M, Adusumilli PS. Human CAR T cells with cell-intrinsic PD-1 Kantarjian H, Kwak LW, Wang ML, Romaguera JE. Rituximab plus hyper-
checkpoint blockade resist tumor-mediated inhibition. Journal of Clinical CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle
Investigation. 2016;126(8):3130-3144. PMCID: PMC4966328 cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson
Cancer Center. British Journal of Haematology. 2016;172(1):80-88.
Cheung WY, Renfro LA, Kerr D, De Gramont A, Saltz LB, Grothey A,
Alberts SR, Andre T, Guthrie KA, Labianca R, Francini G, Seitz JF, Chinen T, Kannan AK, Levine AG, Fan XY, Klein U, Zheng Y, Gasteiger
O’Callaghan C, Twelves C, Van Cutsem E, Haller DG, Yothers G, Sargent G, Feng YQ, Fontenot JD, Rudensky AY. An essential role for the IL-2
DJ. Determinants of earlymortality among 37,568 patients with colon receptor in T-reg cell function. Nature Immunology. 2016;17(11):1322-
cancer who participated in 25 clinical trials from the adjuvant colon 1333. PMCID: PMC5071159
cancer endpoints database. Journal of Clinical Oncology. 2016;34(11):1182-
1189. PMCID: PMC4933130 Chio IIC, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, Wilson
J, Sangar V, Hao Y, Öhlund D, Wright K, Filippini D, Lee EJ, Da Silva B,
Chi AC, Katabi N, Chen HS, Cheng YSL. Interobserver variation among Schoepfer C, Wilkinson JE, Buscaglia JM, DeNicola GM, Tiriac H, Hammell M,
pathologists in evaluating perineural invasion for oral squamous cell Crawford HC, Schmidt EE, Thompson CB, Pappin DJ, Sonenberg N, Tuveson
carcinoma. Head and Neck Pathology. 2016;10(4):451-464. PMCID: DA. NRF2 promotes tumor maintenance by modulating mRNA translation
PMC5082046 in pancreatic cancer. Cell. 2016;166(4):963-976. PMCID: PMC5234705
Chi KN, Kheoh T, Ryan CJ, Molina A, Bellmunt J, Vogelzang NJ, Rathkopf Chiosis G. Heat shock proteins in disease – From molecular mechanisms
DE, Fizazi K, Kantoff PW, Li J, Azad AA, Eigl BJ, Heng DYC, Joshua to therapeutics. Current Topics in Medicinal Chemistry. 2016;16(25):2727-
AM, de Bono JS, Scher H I. A prognostic index model for predicting 2728. PMCID: PMC5015686
overall survival in patients with metastatic castration-resistant prostate
cancer treated with abiraterone acetate after docetaxel. Annals of Cho C, Perales MA. Rapid identification of cytokine release syndrome
Oncology. 2016;27(3):454-460. PMCID: PMC4769990 after haploidentical PBSC transplantation and successful therapy with
tocilizumab. Bone Marrow Transplantation. 2016;51(12):1620-1621.
Chiang S, Weigelt B, Wen HC, Pareja F, Raghavendra A, Martelotto
LG, Burke KA, Basili T, Li A, Geyer FC, Piscuoglio S, Ng CKY, Jungbluth Cho JE, Huang SYN, Burgers PM, Shuman S, Pommier Y, Jinks-Robertson
AA, Balss J, Pusch S, Baker GM, Cole KS, Von Deimling A, Batten JM, S. Parallel analysis of ribonucleotide-dependent deletions produced by
61 OF 324
Journal Articles
yeast Top1 in vitro and in vivo. Nucleic Acids Research. 2016;44(16):7714- adenocarcinoma. Medical Physics. 2016;43(10):5659-5666. PMCID:
7721. PMCID: PMC5027487 PMC5035305
Cho S, Wu CJ, Yasuda T, Cruz LO, Khan AA, Lin LL, Nguyen DT, Miller M, Lee Choi YE, Meghani K, Brault ME, Leclerc L, He YZJ, Day TA, Elias KM,
HM, Kuo ML, Broide DH, Rajewsky K, Rudensky AY, Lu LF. miR-23~27~24 Drapkin R, Weinstock DM, Dao F, Shih KK, Matulonis U, Levine DA,
clusters control effector T cell differentiation and function. Journal of Konstantinopoulos PA, Chowdhury D. Platinum and PARP inhibitor
Experimental Medicine. 2016;213(2):235-249. PMCID: PMC4749926 resistance due to verexpression of microRNA-622 in BRCA1-mutant
ovarian cancer. Cell Reports. 2016;14(3):429-439. PMCID: PMC4731274
Chodera JD. A simple method for automated equilibration
detection in molecular simulations. Journal of Chemical Theory and Choueiri TK, Escudier B, Powles T, Tannir NM, Mainwaring PN, Rini
Computation. 2016;12(4):1799-1805. PMCID: PMC4945107 B I, Hammers HJ, Donskov F, Roth BJ, Peltola K, Lee JL, Heng DYC,
Schmidinger M, Agarwal N, Sternberg CN, McDermott DF, Aftab
Chodick G, Sigurdson AJ, Kleinerman RA, Sklar CA, Leisenring W, DT, Hessel C, Scheffold C, Schwab G, Hutson TE, Pal S, Motzer
Mertens AC, Stovall M, Smith SA, Weathers RE, Veiga LHS, Robison RJ. Cabozantinib versus everolimus in advanced renal cell carcinoma
LL, Inskip PD. The risk of cataract among survivors of childhood (METEOR): Final results from a randomised, open-label, phase 3
and adolescent cancer: A report from the childhood cancer survivor trial. Lancet Oncology. 2016;17(7):917-927.
study. Radiation Research. 2016;185(4):366-374. PMCID: PMC4853230
Chow EJ, Stratton KL, Leisenring WM, Oeffinger KC, Sklar CA, Donaldson
Chohan MO, Levin AM, Singh R, Zhou ZP, Green CL, Kazam JJ, SS, Ginsberg JP, Kenney LB, Levine JM, Robison LL, Shnorhavorian M,
Tsiouris AJ, Anand VK, Schwartz TH. Three-dimensional volumetric Stovall M, Armstrong GT, Green DM. Pregnancy after chemotherapy in
measurements in defining endoscope-guided giant adenoma surgery male and female survivors of childhood cancer treated between 1970 and
outcomes. Pituitary. 2016;19(3):311-321. 1999: A report from the Childhood Cancer Survivor Study cohort. Lancet
Choi S, Chen Z, Tang LH, Fang Y, Shin SJ, Panarelli NC, Chen YT, Li
Y, Jiang X, Du YCN. Bcl-xL promotes metastasis independent of its Chow OS, Kuk D, Keskin M, Smith JJ, Camacho N, Pelossof R, Chen
anti-apoptotic activity. Nature Communications. 2016;7:10384. PMCID: CT, Chen Z, Avila K, Weiser MR, Berger MF, Patil S, Bergsland
PMC4735924 E, Garcia-Aguilar J. KRAS and combined KRAS/TP53 mutations in
locally advanced rectal cancer are independently associated with
Choi SY, Venetis MK, Greene K, Magsamen-Conrad K, Checton decreased response to neoadjuvant therapy. Annals of Surgical
MG, Banerjee SC. Planning a stigmatized nonvisible illness disclosure: Oncology. 2016;23(8):2548-2555. PMCID: PMC5047012
Applying the disclosure decision-making model. Journal of Psychology:
Interdisciplinary and Applied. 2016;150(8):1004-1025. PMCID: Chowell D, Chan TA. The immunogenicity of cancer mutations
PMC5215027 and implications for T cell therapy. Translational Cancer
Research. 2016;5(Suppl. 4):S872-S874.
Choi W, Xue M, Lane BF, Kang MK, Patel K, Regine WF, Klahr P,
Wang J, Chen S, D’Souza W, Lu W. Individually optimized contrast- Chu BP, Horan C, Basu E, Dauer L, Williamson M, Carrasquillo
enhanced 4D-CT for radiotherapy simulation in pancreatic ductal JA, Pandit-Taskar N, Modak S. Feasibility of administering high-
62 OF 324
Journal Articles
dose (131)I-MIBG therapy to children with high-risk neuroblastoma Chung SS. Novel therapeutic strategies in myelodysplastic syndromes: Do
without lead-lined rooms. Pediatric Blood and Cancer. 2016;63(5):801- molecular genetics help?. Current Opinion in Hematology. 2016;23(2):79-
807. PMCID: PMC4801722 87. PMCID: PMC5053335
Chu J, Nagata M, Chen X, Solomon SB, Gonzalez-Aguirre A, Garcia- Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov
Aguilar JE, Sofocleous CT. Irreversible electroporation-induced sciatic E V, Puspita L, Valiulahi P, Sulzer D, Milner TA, Taldone T, Krainc
neuropathy observed by intraoperative neuromonitoring. Clinical D, Studer L, Shim JW. Parkin and PINK1 patient iPSC-derived midbrain
Neurophysiology. 2016;127(8):2770-2772. dopamine neurons exhibit mitochondrial dysfunction and α-synuclein
accumulation. Stem Cell Reports. 2016;7(4):664-677. PMCID: PMC5063469
Chu MW, Kulkarni AR, Matros E. Induced hypothermia: Implications
for free flap survival. Archives of Plastic Surgery. 2016;43(2):212- Churg A, Attanoos R, Borczuk AC, Chirieac LR, Galateau-Sallé
214. PMCID: PMC4807178 F, Gibbs A, Henderson D, Roggli V, Rusch V, Judge MJ, Srigley
JR. Dataset for reporting of malignant mesothelioma of the pleura or
Chuang LT, Randall TC, Denny L, Johnston CM, Schmeler KM, Covens peritoneum: Recommendations from the International Collaboration
AL, Cibula D, Bookman MA, Rawal S, DePetrillo D, Nam JH, Goodman A, on Cancer Reporting (ICCR). Archives of Pathology & Laboratory
Naik R, Manchanda R, Gaffney DK, Small W Jr, Creutzberg C, Rattray C, Medicine. 2016;140(10):1104-1110. PMCID: PMC5267638
Kesic V, Paraja R, Eiken M, Belleson K, Coleman RL, Barakat RR, Trimble
EL, Quinn M. Sister society meeting on global education development Clabbers JMK, Boers-Doets CB, Gelderblom H, Stijnen T, Lacouture ME,
and collaboration: Meeting report. International Journal of Gynecological van der Hoeven KJM, Kaptein AA. Xerosis and pruritus as major EGFRI-
Cancer. 2016;26(6):1186-1188. associated adverse events. Supportive Care in Cancer. 2016;24(2):513-
521. PMCID: PMC4689742
Chung DJ, Pronschinske KB, Shyer JA, Sharma S, Leung S, Curran
SA, Lesokhin AM, Devlin SM, Giralt SA, Young JW. T-cell exhaustion Claeys Bouuaert C, Keeney S. Breaking DNA. Science. 2016;351(6276):
in multiple myeloma relapse after autotransplant: Optimal timing of 916-917.
immunotherapy. Cancer Immunology Research. 2016;4(1):61-71. PMCID:
PMC4703436 Clark GJ, Kupresanin F, Fromm PD, Ju X, Muusers L, Silveira PA, Elgundi
Z, Gasiorowski RE, Papadimitrious MS, Bryant C, Lee KML, Clarke
Chung E, Marchetti MA, Scope A, Dusza SW, Fonseca M, DaSilva CJ, Young JW, Chan A, Harman A, Botting R, Cabezón R, Benitez-
D, Bajaj S, Geller AC, Bishop M, Marghoob AA, Halpern AC. Towards Ribas D, Brooks AES, Dunbar PR, Hart DNJ. New insights into the
three-dimensional temporal monitoring of naevi: A comparison of phenotype of human dendritic cell populations. Clinical & Translational
methodologies for assessing longitudinal changes in skin surface Immunology. 2016;5:e61. PMCID: PMC4735062
area around naevi. British Journal of Dermatology. 2016;175(6):1376-
1378. PMCID: PMC5075517 Clark HL, Jhingran A, Sun Y, Vareechon C, Carrion SD, Skaar EP,
Chazin WJ, Calera JA, Hohl TM, Pearlman E. Zinc and manganese
Chung HH, Tsyvkin E. Tumor lysis syndrome. Hospital Medicine chelation by neutrophil S100A8/A9 (calprotectin) limits extracellular
Clinics. 2016;5(3):425-438. Aspergillus fumigatus hyphal growth and corneal infection. Journal of
Immunology. 2016;196(1):336-344. PMCID: PMC4684987
63 OF 324
Journal Articles
Clark O, Yen K, Mellinghoff IK. Molecular pathways: Isocitrate AT, Goulding J, Gattinoni L, Goldrath AW, Belkaid Y, Restifo NP. Oxygen
dehydrogenase mutations in cancer. Clinical Cancer sensing by T cells establishes an immunologically tolerant metastatic
Research. 2016;22(8):1837-1842. PMCID: PMC4834266 niche. Cell. 2016;166(5):1117-1131.e14.
Clark PE, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clyde MA, Weber RP, Iversen ES, Poole EM, Doherty JA, Goodman MT,
Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore
N, Herr HW, Hoimes C, Inman BA, Kader AK, Kibel AS, Kuzel TM, Lele AS, Anton-Culver H, Bandera E V, Berchuck A, Carney ME, Cramer DW,
SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson Cunningham JM, Cushing-Haugen KL, Edwards RP, Fridley BL, Goode EL,
A, Petrylak D, Plimack ER, Pohar KS, Porter MP, Sexton WJ, Siefker- Lurie G, McGuire V, Modugno F, Moysich KB, Olson SH, Pearce CL, Pike
Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Smith C. NCCN MC, Rothstein JH, Sellers TA, Sieh W, Stram D, Thompson PJ, Vierkant
Guidelines insights: Bladder cancer, version 2.2016: Featured updates RA, Wicklund KG, Wu AH, Ziogas A, Tworoger SS, Schildkraut JM, on
to the NCCN Guidelines. Journal of the National Comprehensive Cancer behalf of the Ovarian Cancer Association Consortium. Risk prediction
Network. 2016;14(10):1213-1224. for epithelial ovarian cancer in 11 United States-based case-control
studies: Incorporation of epidemiologic risk factors and 17 confirmed
Clarkson BD. Commentary on Sandberg et al., “The in vivo chromosome genetic loci. American Journal of Epidemiology. 2016;184(8):555-
constitution of marrow”. Cancer Research. 2016;76(5):991-993. 569. PMCID: PMC5065620
Cleary C, Leeman JE, Higginson DS, Katabi N, Sherman E, Morris Coatham M, Li X, Karnezis AN, Hoang LN, Tessier-Cloutier B, Meng
L, McBride S, Lee N, Riaz N. Biological features of human B, Soslow RA, Gilks CB, Huntsman DG, Stewart CJR, Postovit LM,
papillomavirus-related head and neck cancers contributing to improved Kobel M, Lee CH. Concurrent ARID1A and ARID1B inactivation in
response. Clinical Oncology. 2016;28(7):467-474. endometrial and ovarian dedifferentiated carcinomas. Modern
Pathology. 2016;29(12):1586-1593.
Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S,
Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Coca-Pelaz A, Barnes L, Rinaldo A, Cardesa A, Shah JP, Rodrigo JP,
Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann Suárez C, Eloy JA, Bishop JA, Devaney KO, Thompson LDR, Wenig BM,
N, DiNapoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Strojan P, Hamoir M, Bradley PJ, Gnepp DR, Silver CE, Slootweg PJ,
Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete Triantafyllou A, Vander Poorten V, Williams MD, Skálová A, Hellquist H,
surgical excision is essential for the management of patients with breast Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree
implant-associated anaplastic large-cell lymphoma. Journal of Clinical R, Mendenhall WM, Takes RP, Ferlito A. Cervical lymph node metastasis
Oncology. 2016;34(2):160-168. PMCID: PMC4872006 in adenoid cystic carcinoma of the larynx: A collective international
review. Advances in Therapy. 2016;33(4):553-579. PMCID: PMC4846710
Clements LW, Collins JA, Weis JA, Simpson AL, Adams LB, Jarnagin WR,
Miga M I. Evaluation of model-based deformation correction in image- Cohen HJ, Smith D, Sun CL, Tew W, Mohile SG, Owusu C, Klepin
guided liver surgery via tracked intraoperative ultrasound. Journal of HD, Gross CP, Lichtman SM, Gajra A, Filo J, Katheria V, Hurria A,
Medical Imaging. 2016;3(1) PMCID: PMC4804127 for the Cancer and Aging Research Group. Frailty as determined
by a comprehensive geriatric assessment-derived deficit-
Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar accumulation index in older patients with cancer who receive
M, Klebanoff CA, Eil RL, Hickman HD, Yu Z, Pan JH, Palmer DC, Phan chemotherapy. Cancer. 2016;122(24):3865-3872. PMCID: PMC5138076
64 OF 324
Journal Articles
Cohen J V, Tawbi H, Margolin KA, Amravadi R, Bosenberg M, Brastianos the NCCN Guidelines. Journal of the National Comprehensive Cancer
PK, Chiang VL, de Groot J, Glitza IC, Herlyn M, Holmen SL, Jilaveanu LB, Network. 2016;14(8):945-958.
Lassman A, Moschos S, Postow MA, Thomas R, Tsiouris JA, Wen P, White
RM, Turnham T, Davies MA, Kluger HM. Melanoma central nervous system Coit DG. NCCN guidelines and quality cancer care: Where have we
metastases: Current approaches, challenges, and opportunities. Pigment come from, and where should we be going?. Journal of the National
Cell & Melanoma Research. 2016;29(6):627-642. Comprehensive Cancer Network. 2016;14(4):373-377.
Cohen WA, Ballard TNS, Hamill JB, Kim HM, Chen XX, Klassen A, Wilkins Colebeck AC, Kase MT, Nichols CB, Golden M, Huryn JM. Use of orbital
EG, Pusic AL. Understanding and optimizing the patient experience conformer to improve speech in patients with confluent maxillectomy
in breast reconstruction. Annals of Plastic Surgery. 2016;77(2):237- and orbital defects. Journal of Prosthodontics - Implant Esthetic and
241. PMCID: PMC4685029 Reconstructive Dentistry. 2016;25(3):241-246. PMCID: PMC5072583
Cohen WA, Mundy LR, Ballard TNS, Klassen A, Cano SJ, Browne Collazo-Lorduy A, Castillo-Martin M, Wang L, Patel V, Iyer G, Jordan
J, Pusic AL. The BREAST-Q in surgical research: A review of the E, Al-Ahmadie H, Leonard I, Oh WK, Zhu J, McBride RB, Cordon-Cardo
literature 2009-2015. Journal of Plastic Reconstructive and Aesthetic C, Solit DB, Sfakianos JP, Galsky MD. Urachal carcinoma shares genomic
Surgery. 2016;69(2):149-162. PMCID: PMC4995882 alterations with colorectal carcinoma and may respond to epidermal
growth factor inhibition. European Urology. 2016;70(5):771-775.
Cohen WA, Albornoz CR, Cordeiro PG, Cracchiolo J, Encarnacion
E, Lee M, Cavalli M, Patel S, Pusic AL, Matros E. Health-related quality Collymore C, Crim MJ, Lieggi C. Recommendations for
of life following reconstruction for common head and neck surgical health monitoring and reporting for zebrafish research
defects. Plastic and Reconstructive Surgery. 2016;138(6):1312-1320. facilities. Zebrafish. 2016;13(Suppl.):S138-S148. PMCID: PMC4932782
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson Conlon N, Silva A, Guerra E, Jelinic P, Schlappe BA, Olvera N, Mueller JJ,
WE III, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Tornos C, Jungbluth AA, Young RH, Oliva E, Levine D, Soslow RA. Loss
Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Joseph RW, Lange JR, of SMARCA4 expression is both sensitive and specific for the diagnosis
Martini MC, Materin MA, Olszanski AJ, Ross M I, Salama AK, Skitzki of small cell carcinoma of ovary, hypercalcemic type. American Journal
J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist of Surgical Pathology. 2016;40(3):395-403. PMCID: PMC4752399
MM, McMillian N, Engh A. Melanoma, version 2.2016 - Clinical Practice
Guidelines in Oncology. Journal of the National Comprehensive Cancer Conlon N, Howard J, Catalano J, Gallagher M, Tan LK, Corben
Network. 2016;14(4):450-473. AD. Breast carcinoma in young women: No evidence of increasing rates
of metastatic breast carcinoma in a single tertiary center review. Breast
Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Iii WEC, Journal. 2016;22(3):287-292.
Daniels GA, Dimaio D, Fields RC, Fleming MD, Gastman B, Gonzalez
R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Conlon N, Sadri N, Corben AD, Tan LK. Acinic cell carcinoma of breast:
Olszanski AJ, Ott P, Gupta AP, Ross M I, Salama AK, Skitzki J, Swetter SM, Morphologic and immunohistochemical review of a rare breast cancer
Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A. NCCN subtype. Human Pathology. 2016;51:16-24. PMCID: PMC5027139
Guidelines® insights: Melanoma, version 3.2016: Featured updates to
65 OF 324
Journal Articles
Connell LC, Harding JJ, Abou-Alfa GK. Advanced hepatocellular cancer: Coombs CC, De Angelis LM, Feusner JH, Rowe JM, Tallman
The current state of future research. Current Treatment Options in MS. Pseudotumor cerebri in acute promyelocytic leukemia patients on
Oncology. 2016;17(8):43. Intergroup Protocol 0129: Clinical description and recommendations
for new diagnostic criteria. Clinical Lymphoma, Myeloma and
Connell LC, Harding JJ, Shia J, Abou-Alfa GK. Combined intrahepatic Leukemia. 2016;16(3):146-151. PMCID: PMC5028896
cholangiocarcinoma and hepatocellular carcinoma. Chinese Clinical
Oncology. 2016;5(5):66. Coombs CC, Tallman MS, Levine RL. Molecular therapy for acute myeloid
leukaemia. Nature Reviews Clinical Oncology. 2016;13(5):305-318.
Connolly KL, Nijhawan R I, Dusza SW, Busam KJ, Nehal KS. Time to local
recurrence of lentigo maligna: Implications for future studies. Journal of Copur MS, Ramaekers R, Gönen M, Gulzow M, Hadenfeldt R, Fuller
the American Academy of Dermatology. 2016;74(6):1247-1248. C, Scott J, Einspahr S, Benzel H, Mickey M, Norvell M, PharmD, Clark
D, Gauchan D, Kurbegov D. Impact of the National Cancer Institute
Connolly KL, Nehal KS, Dusza SW, Rossi AM, Lee EH. Assessment Community Cancer Centers Program on clinical trial and related activities
of intraoperative pain during Mohs micrographic surgery (MMS): An at a community cancer center in rural Nebraska. Journal of Oncology
opportunity for improved patient care. Journal of the American Academy Practice. 2016;12(1):67-68, e44-e51. PMCID: PMC4976454
of Dermatology. 2016;75(3):590-594.
Cordeiro PG, Jazayeri L. Two-stage implant-based breast reconstruction:
Contractor T, Kobayashi S, da Silva E, Clausen R, Chan C, Vosburgh An evolution of the conceptual and technical approach over a two-
E, Tang LH, Levine AJ, Harris CR. Sexual dimorphism of liver metastasis decade period. Plastic and Reconstructive Surgery. 2016;138(1):1-
by murine pancreatic neuroendocrine tumors is affected by expression of 11. PMCID: PMC5245790
complement C5. Oncotarget. 2016;7(21):30585-30596.
Cordeiro PG. Reply: What is the optimum timing of postmastectomy
Cook BE, Adumeau P, Membreno R, Carnazza KE, Brand C, Reiner radiotherapy in two-stage prosthetic reconstruction: Radiation to the
T, Agnew BJ, Lewis JS, Zeglis BM. Pretargeted PET imaging tissue expander or permanent implant?. Plastic and Reconstructive
using a site-specifically labeled immunoconjugate. Bioconjugate Surgery. 2016;138(1):151e.
Chemistry. 2016;27(8):1789-1795. PMCID: PMC5102008
Cornelis F, Sotirchos V, Violari E, Sofocleous CT, Schoder H, Durack
Cook PJ, Thomas R, Kingsley PJ, Shimizu F, Montrose DC, Marnett JC, Siegelbaum RH, Maybody M, Humm J, Solomon SB. (18)F-FDG PET/
LJ, Tabar VS, Dannenberg AJ, Benezra R. Cox-2-derived PGE2 induces CT is an immediate imaging biomarker of treatment success after liver
Id1-dependent radiation resistance and self-renewal in experimental metastasis ablation. Journal of Nuclear Medicine. 2016;57(7):1052-1057.
glioblastoma. Neuro-Oncology. 2016;18(10):1379-1389. PMCID:
PMC5035519 Corradi PF, Corradi RB, Greene LW. Physiology of the hypothalamic
pituitary gonadal axis in the male. Urologic Clinics of North
Coombs CC, Sallman DA, Devlin SM, Dixit S, Mohanty A, Knapp K, Al America. 2016;43(2):151-162.
Ali NH, Lancet JE, List AF, Komrokji RS, Padron E, Arcila ME, Klimek
VM, Van Den Brink MRM, Tallman MS, Levine RL, Rampal RK, Rapaport Corradi RB, Martin-Malburet AG, Touijer KA. Reply from authors re:
F. Mutational correlates of response to hypomethylating agent therapy Alexandre Mottrie, Giorgio Gandaglia. Do we need a novel nephrometry
in acute myeloid leukemia. Haematologica. 2016;101(11):e457-e460. scoring system in partial nephrectomy? Eur Urol 2016;69: 80-1:
66 OF 324
Journal Articles
Nephrometry scores for partial nephrectomy: The importance of defining Cortes JE, Lipton JH, Miller CB, Busque L, Akard LP, Pinilla-Ibarz J,
a context of use. European Urology. 2016;69(1):81-83. Keir C, Warsi G, Lin FP, Mauro MJ. Evaluating the impact of a switch to
nilotinib on imatinib-related chronic low-grade adverse events in patients
Correa D, Wang Y, West J, Peck K, Root J, Baser R, Thaler H, Shore with CML-CP: The ENRICH study. Clinical Lymphoma, Myeloma and
T, Jakubowski A, Saykin A, Relkin N. Prospective assessment of white Leukemia. 2016;16(5):286-296. PMCID: PMC4965237
matter integrity in adult stem cell transplant recipients. Brain Imaging
and Behavior. 2016;10(2):486-496. PMCID: PMC4706509 Cortez VS, Cervantes-Barragan L, Robinette ML, Bando JK, Wang
Y, Geiger TL, Gilfillan S, Fuchs A, Vivier E, Sun JC, Cella M, Colonna
Correa DD, Kryza-Lacombe M, Baser RE, Beal K, DeAngelis LM. Cognitive M. Transforming growth factor-β signaling guides the differentiation
effects of donepezil therapy in patients with brain tumors: A pilot of innate lymphoid cells in salivary glands. Immunity. 2016;44(5):1127-
study. Journal of Neuro-Oncology. 2016;127(2):313-319. PMCID: 1139. PMCID: PMC5114145
PMC4966618
Costas Muniz R, Leng J, Aragones A, Ramirez J, Roberts N, Mujawar
Correa DD, Satagopan J, Cheung K, Arora AK, Kryza-Lacombe M I, Gany F. Association of socioeconomic and practical unmet needs
M, Xu Y, Karimi S, Lyo J, Deangelis LM, Orlow I. COMT, BDNF, and with self-reported nonadherence to cancer treatment appointments
DTNBP1 polymorphisms and cognitive functions in patients with brain in low-income Latino and Black cancer patients. Ethnicity &
tumors. Neuro-Oncology. 2016;18(10):1425-1433. PMCID: PMC5035520 Health. 2016;21(2):118-128. PMCID: PMC4653085
Correa-Gallego C, Maddalo D, Doussot A, Kemeny N, Kingham TP, Allen Costas-Muñiz R, Jandorf L, Philip E, Cohen N, Villagra C, Sriphanlop
PJ, D’Angelica M I, DeMatteo RP, Betel D, Klimstra D, Jarnagin WR, Ventura P, Schofield E, DuHamel K. Examining the impact of Latino nativity,
A. Circulating plasma levels of MicroRNA-21 and MicroRNA-221 are potential migration, and acculturation factors on colonoscopy screening. Journal
diagnostic markers for primary intrahepatic cholangiocarcinoma. PLoS of Community Health. 2016;41(5):903-909. PMCID: PMC5245176
ONE. 2016;11(9):e0163699. PMCID: PMC5042503
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA,
Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki
JR, Le DT, Lipson EJ, Glezerman IG, Wolchok J, Cornell LD, Feldman K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver
P, Stokes MB, Zapata SA, Hodi FS, Ott PA, Yamashita M, Leaf B, Barile M, Barkardottir RB, Barrowdale D, Beckmann L, Beckmann MW,
DE. Clinicopathological features of acute kidney injury associated with Benitez J, Blank S V, Blomqvist C, Bogdanova N V, Bojesen SE, Bolla
immune checkpoint inhibitors. Kidney International. 2016;90(3):638- MK, Bonanni B, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldes T,
647. PMCID: PMC4983464 Caligo MA, Canzian F, Carpenter J, Chang-Claude J, Chanock SJ, Chung
WK, Claes KBM, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB,
Cortes JE, Khoury HJ, Kantarjian H, Brümmendorf TH, Mauro MJ, Damiola F, Darabi H, De La Hoya M, Devilee P, Diez O, Ding YC, Dolcetti
Matczak E, Pavlov D, Aguiar JM, Fly KD, Dimitrov S, Leip E, Shapiro M, R, Domchek SM, Dorfling CM, Dos-Santos-Silva I, Dumont M, Dunning
Lipton JH, Durand JB, Gambacorti-Passerini C. Long-term evaluation of AM, Eccles DM, Ehrencrona H, Ekici AB, Eliassen H, Ellis S, Fasching
cardiac and vascular toxicity in patients with Philadelphia chromosome- PA, Figueroa J, Flesch-Janys D, Försti A, Fostira F, Foulkes WD, Friebel
positive leukemias treated with bosutinib. American Journal of T, Friedman E, Frost D, Gabrielson M, Gammon MD, Ganz PA, Gapstur
Hematology. 2016;91(6):606-616. SM, Garber J, Gaudet MM, Gayther SA, Gerdes AM, Ghoussaini M, Giles
67 OF 324
Journal Articles
GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira measuring symptoms and health-related quality of life. Gynecologic
A, Greene MH, Gronwald J, Guénel P, Gunter M, Haeberle L, Haiman Oncology. 2016;143(2):362-366.
CA, Hamann U, Hansen TVO, Hart S, Healey S, Heikkinen T, Henderson
BE, Herzog J, Hogervorst FBL, Hollestelle A, Hooning MJ, Hoover RN, Cowan RA, Black DR, Hoang LN, Park KJ, Soslow RA, Backes
Hopper JL, Humphreys K, Hunter DJ, Huzarski T, Imyanitov EN, Isaacs FJ, Gardner GJ, Abu-Rustum NR, Leitao MM Jr, Eisenhauer
C, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Jones M, EL, Chi DS. A pilot study of topical imiquimod therapy for the
Kabisch M, Kar S, Karlan BY, Khan S, Khaw KT, Kibriya MG, Knight JA, treatment of recurrent extramammary Paget’s disease. Gynecologic
Ko YD, Konstantopoulou I, Kosma VM, Kristensen V, Kwong A, Laitman Oncology. 2016;142(1):139-143. PMCID: PMC4917425
Y, Lambrechts D, Lazaro C, Lee E, Le Marchand L, Lester J, Lindblom A,
Lindor N, Lindstrom S, Liu J, Long J, Lubinski J, Mai PL, Makalic E, Malone Cowan RA, O’Cearbhaill RE, Gardner GJ, Levine DA, Long Roche
KE, Mannermaa A, Manoukian S, Margolin S, Marme F, Martens JWM, K, Sonoda Y, Zivanovic O, Tew WP, Sala E, Lakhman Y, Vargas Alvarez
McGuffog L, Meindl A, Miller A, Milne RL, Miron P, Montagna M, Mazoyer HA, Sarasohn DM, Mironov S, Abu-Rustum NR, Chi DS. Is it time to
S, Mulligan AM, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna centralize ovarian cancer care in the United States?. Annals of Surgical
H, Nordestgaard BøG, Nussbaum RL, Offit K, Olah E, Olopade O I, Oncology. 2016;23(3):989-993. PMCID: PMC4830271
Olson JE, Osorio A, Park SK, Peeters PH, Peissel B, Peterlongo P, Peto J,
Cracchiolo JR, Baxi SS, Morris LG, Ganly I, Patel SG, Cohen MA, Roman
Phelan CM, Pilarski R, Poppe B, Pylkäs K, Radice P, Rahman N, Rantala
BR. Increase in primary surgical treatment of T1 and T2 oropharyngeal
J, Rappaport C, Rennert G, Richardson A, Robson M, Romieu I, Rudolph
squamous cell carcinoma and rates of adverse pathologic features:
A, Rutgers EJ, Sanchez MJ, Santella RM, Sawyer EJ, Schmidt DF,
National Cancer Data Base. Cancer. 2016;122(10):1523-1532. PMCID:
Schmidt MK, Schmutzler RK, Schumacher F, Scott R, Senter L, Sharma
PMC4860079
P, Simard J, Singer CF, Sinilnikova OM, Soucy P, Southey M, Steinemann
D, Stenmark-Askmalm M, Stoppa-Lyonnet D, Swerdlow A, Szabo C Cracchiolo JR, Roman BR, Kutler D I, Kuhel W I, Cohen MA. Adoption
I, Tamimi R, Tapper W, Teixeira MR, Teo SH, Terry MB, Thomassen M, of transoral robotic surgery compared with other surgical modalities for
Thompson D, Tihomirova L, Toland AE, Tollenaar RAEM, Tomlinson I, treatment of oropharyngeal squamous cell carcinoma. Journal of Surgical
Truong T, Tsimiklis H, Teulé A, Tumino R, Tung N, Turnbull C, Ursin G, Oncology. 2016;114(4):405-411. PMCID: PMC5019352
Van Deurzen CHM, Van Rensburg EJ, Varon-Mateeva R, Wang Z, Wang-
Gohrke S, Weiderpass E, Weitzel JN, Whittemore A, Wildiers H, Winqvist Cracchiolo JR, Shaha AR. Parotidectomy for parotid
R, Yang XR, Yannoukakos D, Yao S, Zamora MP, Zheng W, Hall P, Kraft cancer. Otolaryngologic Clinics of North America. 2016;49(2):415-
P, Vachon C, Slager S, Chenevix-Trench G, Pharoah PDP, Monteiro AAN, 424. PMCID: PMC4821693
García-Closas M, Easton DF, Antoniou AC. Identification of four novel
susceptibility loci for oestrogen receptor negative breast cancer. Nature Crago AM, Dickson MA. Liposarcoma: Multimodality management
Communications. 2016;7:11375. PMCID: PMC4853421 and future targeted therapies. Surgical Oncology Clinics of North
America. 2016;25(4):761-773. PMCID: 27591497
Cowan RA, Suidan RS, Andikyan V, Rezk YA, Einstein MH, Chang
K, Carter J, Zivanovic O, Jewell EJ, Abu-Rustum NR, Basch E, Chi Crago AM, Lee AY. Multimodality management of soft tissue tumors
DS. Electronic patient-reported outcomes from home in patients in the extremity. Surgical Clinics of North America. 2016;96(5):977-
recovering from major gynecologic cancer surgery: A prospective study 992. PMCID: PMC4996368
68 OF 324
Journal Articles
Crane CH, Koay EJ. Another solution that enables ablative radiotherapy Cuaron JJ, Chang C, Lovelock M, Higginson DS, Mah D, Cahlon O, Powell
for large liver tumors: Percutaneous interstitial high-dose rate S. Exponential increase in relative biological effectiveness along distal
brachytherapy - Reply. Cancer. 2016;122(17):2766-2767. edge of a proton Bragg peak as measured by deoxyribonucleic acid
double-strand breaks. International Journal of Radiation Oncology,
Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Biology, Physics. 2016;95(1):62-69. PMCID: PMC5005074
Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge
M, Leapman M, Pinto P, Thompson IM Jr, Carroll P, Eastham J, Gomella Cuaron JJ, MacDonald SM, Cahlon O. Novel applications of proton
L, Klein EA. An approach using PSA levels of 1.5 ng/mL as the cutoff for therapy in breast carcinoma. Chinese Clinical Oncology. 2016;5(4):52.
prostate cancer screening in primary care. Urology. 2016;96:116-120.
Cuartero M I, De la Parra J, García-Culebras A, Ballesteros I, Lizasoain
Croglio MP, Haake JM, Ryan CP, Wang VS, Lapier J, Schlarbaum JP, I, Moro MA. The kynurenine pathway in the acute and chronic phases
Dayani Y, Artuso E, Prandi C, Koltai H, Agama K, Pommier Y, Chen Y, of cerebral ischemia. Current Pharmaceutical Design. 2016;22(8):1060-
Tricoli L, Jeannine RLaRocque, Albanese C, Yarden R I. Analogs of the 1073. PMCID: PMC4972938
novel phytohormone, strigolactone, trigger apoptosis and synergize
with PARP inhibitors by inducing DNA damage and inhibiting DNA Cuellar-Partida G, Lu Y, Dixon SC, Australian Ovarian Cancer Study,
repair. Oncotarget. 2016;7(12):13984-14001. PMCID: PMC4924693 Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van
Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA,
Cronin PA, Olcese C, Patil S, Morrow M, Van Zee KJ. Impact of age on Chang-Claude J, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova
risk of recurrence of ductal carcinoma in situ: Outcomes of 2996 women N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow
treated with breast-conserving surgery over 30 years. Annals of Surgical R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno
Oncology. 2016;23(9):2816-2824. PMCID: PMC4995886 F, Moysich KB, Ness RB, Cannioto R, Høgdall E, Høgdall C, Jensen A,
Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MAT, Liang D, Lu KH, Wu
Crump CJ, Murrey HE, Ballard TE, am Ende CW, Wu X, Gertsik N, X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS,
Johnson DS, Li YM. Development of sulfonamide photoaffinity Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof
inhibitors for probing cellular γ-secretase. ACS Chemical K, Aben KKH, Kiemeney LA, Massuger Lfag, Brooks-Wilson A, Olson
Neuroscience. 2016;7(8):1166-1173. SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND,
Gilks CB, Gronwald J, Jakubowska A, Lubinski J, Kluz T, Song H, Tyrer
Cruz AC, Ramaswamy M, Ouyang C, Klebanoff CA, Sengupta P, JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR,
Yamamoto TN, Meylan F, Thomas SK, Richoz N, Eil R, Price S, Casellas R, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I,
Rao VK, Lippincott-Schwartz J, Restifo NP, Siegel RM. Fas/CD95 prevents Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-
autoimmunity independently of lipid raft localization and efficient Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham
apoptosis induction. Nature Communications. 2016;7:13895. PMCID: JM, Fridley BL, Winham SJ, Bandera E V, Poole EM, Morgan TK, Goode
PMC5196435 EL, Schildkraut JM, Pearce CL, Berchuck A, Pharoah PDP, Webb PM,
Chenevix-Trench G, Risch HA, MacGregor S. Assessing the genetic
Cuaron J, Rao S, Wolden S, Zelefsky M, Schupak K, Mychalczak
architecture of epithelial ovarian cancer histological subtypes. Human
B, Lee N. Patterns of failure in patients with head and neck carcinoma
Genetics. 2016;135(7):741-756. PMCID: PMC4976079
of unknown primary treated with radiation therapy. Head and
Neck. 2016;38:E426-E431.
69 OF 324
Journal Articles
Culjkovic-Kraljacic B, Fernando TM, Marullo R, Calvo-Vidal N, Verma Dahi PB, Morawa E, Perales MA, Zabor EC, Devlin SM, Maloy M, Castro-
A, Yang S, Tabbò F, Gaudiano M, Zahreddine H, Goldstein RL, Patel Malaspina H, O’Reilly RJ, Papadopoulos EB, Jakubowski AA, Giralt
J, Taldone T, Chiosis G, Ladetto M, Ghione P, Machiorlatti R, Elemento O, SA. Low incidence of GvHD with T-cell depleted allografts facilitates
Inghirami G, Melnick A, Borden KLB, Cerchietti L. Combinatorial targeting further treatments for post-transplantation relapse in AML and
of nuclear export and translation of RNA inhibits aggressive B-cell MDS. Bone Marrow Transplantation. 2016;51(7):991-993.
lymphomas. Blood. 2016;127(7):858-868. PMCID: PMC4760090
Daley GQ, Hyun I, Apperley JF, Barker RA, Benvenisty N, Bredenoord AL,
Cunanan KM, Carlin BP, Peterson KA. A practical Bayesian stepped Breuer CK, Caulfield T, Cedars M I, Frey-Vasconcells J, Heslop HE, Jin Y,
wedge design for community-based cluster-randomized clinical trials: Lee RT, McCabe C, Munsie M, Murry CE, Piantadosi S, Rao M, Rooke HM,
The British Columbia Telehealth Trial. Clinical Trials. 2016;13(6):641- Sipp D, Studer L, Sugarman J, Takahashi M, Zimmerman M, Kimmelman
650. PMCID: PMC4957138 J. Setting global standards for stem cell research and clinical translation:
The 2016 ISSCR Guidelines. Stem Cell Reports. 2016;6(6):787-
Cunningham J, Sharma R, Kirzner A, Hwang S, Lefkowitz R, Greenspan 797. PMCID: PMC4912385
D, Shapoval A, Panicek DM. Acute myonecrosis on MRI: Etiologies in an
oncological cohort and assessment of interobserver variability. Skeletal Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang
Radiology. 2016;45(8):1069-1078. PMCID: PMC4912434 Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly
I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris
Cunningham JD, Plodkowski AJ, Giri DD, Hwang S. Case report of malignant LGT. Comprehensive molecular characterization of salivary duct
pulmonary parenchymal glomus tumor: imaging features and review of the carcinoma reveals actionable targets and similarity to apocrine breast
literature. Clinical Imaging. 2016;40(1):144-147. PMCID: PMC4688063 cancer. Clinical Cancer Research. 2016;22(18):4623-4633. PMCID:
PMC5026550
Curry RC, Faivre G, Akkari L, Joyce JA, Lin O, Rosenblum M, Diamond
EL, Fisher R, Omuro A. High-dose methotrexate-based chemotherapy Dalle JH, Giralt SA. Hepatic veno-occlusive disease after
as treatment for histiocytic sarcoma of the central nervous hematopoietic stem cell transplantation: Risk factors and stratification,
system. Leukemia and Lymphoma. 2016;57(8):1961-1964. prophylaxis, and treatment. Biology of Blood and Marrow
Transplantation. 2016;22(3):400-409.
Cuzick J, Stone S, Fisher G, Yang ZH, North B V, Berney DM, Beltran
L, Greenberg D, Moller H, Reid JE, Gutin A, Lanchbury JS, Brawer Dallos M, Tap WD, D’Angelo SP. Current status of engineered T-cell
M, Scardino P. Re: Validation of an RNA cell cycle progression score therapy for synovial sarcoma. Immunotherapy. 2016;8(9):1073-1080.
for predicting death from prostate cancer in a conservatively managed
needle biopsy cohort. Journal of Urology. 2016;195(6):1779-1780. Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer
M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton
Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo CT, Oh SA, Toure JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser
A, Pritykin Y, Huse M, Leslie CS, Li MO. Cancer immunosurveillance G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan
by tissue-resident innate lymphoid cells and innate-like T A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S. Genetic/familial
cells. Cell. 2016;164(3):365-377. PMCID: PMC4733424 high-risk assessment: Breast and ovarian, version 2.2015 . Journal of the
National Comprehensive Cancer Network. 2016;14(2):153-162.
70 OF 324
Journal Articles
D’Amato G, Luxán G, Del Monte-Nieto G, Martínez-Poveda B, Torroja C, Cancer Journal. 2016;22(5):315-320.
Walter W, Bochter MS, Benedito R, Cole S, Martínez F, Hadjantonakis
AK, Uemura A, Jiménez-Borreguero LJ, De La Pompa JL. Sequential Danis E, Yamauchi T, Echanique K, Zhang X, Haladyna JN, Riedel
Notch activation regulates ventricular chamber development. Nature Cell SS, Zhu N, Xie H, Orkin SH, Armstrong SA, Bernt KM, Neff T. Ezh2
Biology. 2016;18(1):7-20. PMCID: PMC4816493 controls an early hematopoietic program and growth and survival
signaling in early T cell precursor acute lymphoblastic leukemia. Cell
Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller Reports. 2016;14(8):1953-1965. PMCID: PMC4790111
K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J,
Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM. Cardiac outcomes of Daniyan AFO, Brentjens RJ. At the bench: Chimeric antigen receptor
patients receiving adjuvant weekly paclitaxel and trastuzumab for node- (CAR) T cell therapy for the treatment of B cell malignancies. Journal of
negative, ERBB2-positive breast cancer. JAMA Oncology. 2016;2(1):29-36. Leukocyte Biology. 2016;100(6):1255-1264.
Dang CT, Yu AF, Jones LW, Liu J, Steingart RM, Argolo DF, Norton L, Hudis Dao F, Schlappe BA, Tseng J, Lester J, Nick AM, Lutgendorf SK, McMeekin
CA. Cardiac surveillance guidelines for trastuzumab-containing therapy S, Coleman RL, Moore KN, Karlan BY, Sood AK, Levine DA. Characteristics
in early-stage breast cancer: Getting to the heart of the matter. Journal of of 10-year survivors of high-grade serous ovarian carcinoma. Gynecologic
Clinical Oncology. 2016;34(10):1030-1033. PMCID: PMC5070558 Oncology. 2016;141(2):260-263. PMCID: PMC4844793
Dang TO, Ogunniyi A, Barbee MS, Drilon A. Pembrolizumab for the Dardenne E, Beltran H, Benelli M, Gayvert K, Berger A, Puca L, Cyrta
treatment of PD-L1 positive advanced or metastatic non-small cell lung J, Sboner A, Noorzad Z, MacDonald T, Cheung C, Yuen KS, Gao
cancer. Expert Review of Anticancer Therapy. 2016;16(1):13-20. PMCID: D, Chen Y, Eilers M, Mosquera JM, Robinson BD, Elemento O, Rubin
PMC4993158 MA, Demichelis F, Rickman DS. N-Myc induces an EZH2-mediated
transcriptional program driving neuroendocrine prostate cancer. Cancer
D’Angelica M I, Chapman WC. HPB surgery: The specialty is Cell. 2016;30(4):563-577.
here to stay, but the training is in evolution. Annals of Surgical
Oncology. 2016;23(7):2123-2125. Das DK, Naidoo M, Ilboudo A, Park JY, Ali T, Krampis K, Robinson
BD, Osborne JR, Ogunwobi OO. miR-1207-3p regulates the androgen
D’Angelica M. Hepatic resection for metastatic breast cancer: An exercise receptor in prostate cancer via FNDC1/fibronectin. Experimental Cell
in selection bias. HPB. 2016;18(8):631-632. PMCID: PMC4972372 Research. 2016;348(2):190-200. PMCID: PMC5077722
D’Angelo SP. Manipulating the immune system with checkpoint inhibitors Das DK, Osborne JR, Lin HY, Park JY, Ogunwobi OO. miR-1207-3p
for patients with metastatic sarcoma. American Society of Clinical is a novel prognostic biomarker of prostate cancer. Translational
Oncology Educational Book. 2016;36:e558-e564. Oncology. 2016;9(3):236-241. PMCID: PMC4907897
Danila DC, Samoila A, Patel C, Schreiber N, Herkal A, Anand A, Bastos Das R, Guan P, Sprague L, Verbist K, Tedrick P, An QA, Cheng C, Kurachi
D, Heller G, Fleisher M, Scher H I. Clinical validity of detecting circulating M, Levine R, Wherry EJ, Canna SW, Behrens EM, Nichols KE. Janus kinase
tumor cells by AdnaTest assay compared with direct detection of tumor inhibition lessens inflammation and ameliorates disease in murine models
mRNA in stabilized whole blood, as a biomarker predicting overall of hemophagocytic lymphohistiocytosis. Blood. 2016;127(13):1666-
survival for metastatic castration-resistant prostate cancer patients. The 1675. PMCID: PMC4817310
71 OF 324
Journal Articles
Dasgupta S, Yang C, Castro LM, Tashima AK, Ferro ES, Moir RD, Willis Davies KR, Brewster AM, Bedrosian I, Parker PA, Crosby
IM, Fricker LD. Analysis of the yeast peptidome and comparison MA, Peterson SK, Shen Y, Volk RJ, Cantor SB. Outcomes of
with the human peptidome. PLoS ONE. 2016;11(9):e0163312. PMCID: contralateral prophylactic mastectomy in relation to familial
PMC5042401 history: A decision analysis (BRCR-D-16-00033). Breast Cancer
Research. 2016;18(1):93. PMCID: PMC5028980
Daud A I, Wolchok JD, Robert C, Hwu WJ, Weber JS, Ribas A,
Hodi FS, Joshua AM, Kefford R, Hersey P, Joseph R, Gangadhar TC, Davila ML, Brentjens RJ. CD19-targeted CAR T cells as novel cancer
Dronca R, Patnaik A, Zarour H, Roach C, Toland G, Lunceford JK, Li immunotherapy for relapsed or refractory B-cell acute lymphoblastic
XN, Emancipator K, Dolled-Filhart M, Kang SP, Ebbinghaus S, Hamid leukemia. Clinical Advances in Hematology & Oncology. 2016;14(10):802-808.
O. Programmed death-ligand 1 expression and response to the anti-
programmed death 1 antibody pembrolizumab in melanoma. Journal of Davila ML, Sadelain M. Biology and clinical application of CAR T cells for
Clinical Oncology. 2016;34(34):4102-4109. B cell malignancies. International Journal of Hematology. 2016;104(1):6-17.
Dauer LT, Ainsbury EA, Dynlacht J, Hoel D, Klein BEK, Mayer D, Prescott Davis JL, Moutinho V Jr, Panageas KS, Coit DG. A peripheral
CR, Thornton RH, Vano E, Woloschak GE, Flannery CM, Goldstein LE, blood biomarker estimates probability of survival: The neutrophil-
Hamada N, Tran PK, Grissom MP, Blakely EA. Status of NCRP Scientific lymphocyte ratio in noncancer patients. Biomarkers in
Committee 1-23 commentaryon guidance on radiation dose limits Medicine. 2016;10(9):953-957.
for the lens of the eye. Health Physics. 2016;110(2):182-184. PMCID:
PMC4697269 Davis JL, Selby L V, Chou JF, Schattner M, Ilson DH, Capanu M, Brennan
MF, Coit DG, Strong VE. Patterns and predictors of weight loss after
David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio- gastrectomy for cancer. Annals of Surgical Oncology. 2016;23(5):1639-
Donahue CA, Massagué J. TGF-β tumor suppression through a lethal 1645. PMCID: PMC4862874
EMT. Cell. 2016;164(5):1015-1030. PMCID: PMC4801341
Davis ME. Glioblastoma: Overview of disease and treatment. Clinical
David SP, Wang A, Kapphahn K, Hedlin H, Desai M, Henderson M, Yang Journal of Oncology Nursing. 2016;20(5):2-8. PMCID: PMC5123811
L, Walsh KM, Schwartz AG, Wiencke JK, Spitz MR, Wenzlaff AS, Wrensch
MR, Eaton CB, Furberg H, Mark Brown W, Goldstein BA, Assimes T, Tang Davis ME. Ocular toxicity of tyrosine kinase inhibitors. Oncology Nursing
H, Kooperberg CL, Quesenberry CP, Tindle H, Patel M I, Amos C I, Bergen Forum. 2016;43(2):235-243. PMCID: PMC4992818
AW, Swan GE, Stefanick ML. Gene by environment investigation of
Davis TD, Mohandas P, Chiriac M I, Bythrow G V, Quadri LEN, Tan
incident lung cancer risk in African-Americans. EBioMedicine. 2016;4:153-
DS. Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS
161. PMCID: PMC4776066
inhibitors of amino acid adenylation enzymes. Bioorganic & Medicinal
Davidson SE, Cui J, Kry S, Deasy JO, Ibbott GS, Vicic M, White RA, Chemistry Letters. 2016;26(21):5340-5345. PMCID: PMC5079767
Followill DS. Modification and validation of an analytical source model
Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter
for external beam radiotherapy Monte Carlo dose calculations. Medical
L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ,
Physics. 2016;43(8):4842-4853. PMCID: PMC4967077
Advani SM, Healey JH, Letson GD, Gorlick RG, Randall RL. Local
control modality and outcome for Ewing sarcoma of the femur:
72 OF 324
Journal Articles
A report from the Children’s Oncology Group. Annals of Surgical neoadjuvant therapy into survival benefits: One size does not fit
Oncology. 2016;23(11):3541-3547. PMCID: PMC5136500 all. Nature Reviews Clinical Oncology. 2016;13(9):566-579. PMCID:
PMC5118200
De Abreu VHF, Peck KK, Petrovich-Brennan NM, Woo KM, Holodny A
I. Brain tumors: The influence of tumor type and routine MR imaging de Moraes FY, Taunk NK, Laufer I, Neves-Junior WFP, Hanna SA,
characteristics at BOLD functional MR imaging in the primary motor Carvalho HA, Yamada Y. Spine radiosurgery for the local treatment of
gyrus. Radiology. 2016;281(3):876-883. spine metastases: Intensity-modulated radiotherapy, image guidance,
clinical aspects and future directions. Clinics. 2016;71(2):101-109. PMCID:
de Barros e Lima Bueno R, Ramão A, Pinheiro DG, Alves CP, Kannen PMC4760359
V, Jungbluth AA, de Araújo LF, Muys BR, Fonseca AS, Plaça JR,
Panepucci RA, Neder L, Saggioro FP, Mamede RCM, Figueiredo DLA, de Velasco G, Miao D, Voss MH, Hakimi AA, Hsieh JJ, Tannir NM, Tamboli
Silva WA Jr. HOX genes: Potential candidates for the progression of P, Appleman LJ, Rathmell WK, Van Allen EM, Choueiri TK. Tumor
laryngeal squamous cell carcinoma. Tumor Biology. 2016;37(11):15087- mutational load and immune parameters across metastatic renal cell
15096. carcinoma risk groups. Cancer Immunology Research. 2016;4(10):820-
822. PMCID: PMC5050137
De Blank PMK, Fisher MJ, Lu L, Leisenring WM, Ness KK, Sklar CA,
Stovall M, Vukadinovich C, Robison LL, Armstrong GT, Krull KR. Impact Dean JA, Wong KH, Gay H, Welsh LC, Jones AB, Schick U, Oh
of vision loss among survivors of childhood central nervous system JH, Apte A, Newbold KL, Bhide SA, Harrington KJ, Deasy JO, Nutting
astroglial tumors. Cancer. 2016;122(5):730-739. PMCID: PMC4764436 CM, Gulliford SL. Functional data analysis applied to modeling of
severe acute mucositis and dysphagia resulting from head and neck
De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman radiation therapy. International Journal of Radiation Oncology, Biology,
DH, Budhu S, Ghosh A, Pink M, Tchaicha J, Douglas M, Tibbitts T, Sharma Physics. 2016;96(4):820-831.
S, Proctor J, Kosmider N, White K, Stern H, Soglia J, Adams J, Palombella
VJ, McGovern K, Kutok JL, Wolchok JD, Merghoub T. Overcoming DeAngelo DJ, Stein EM, Ravandi F. Evolving therapies in acute myeloid
resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid leukemia: Progress at last?. American Society of Clinical Oncology
cells. Nature. 2016;539(7629):443-447. Educational Book. 2016;36:e302-e312.
de la Fuente M I, Young RJ, Rubel J, Rosenblum M, Tisnado J, Briggs Deborde S, Omelchenko T, Lyubchik A, Zhou Y, He S, McNamara
S, Arevalo-Perez J, Cross JR, Campos C, Straley K, Zhu D, Dong WF, Chernichenko N, Lee SY, Barajas F, Chen CH, Bakst RL, Vakiani E,
C, Thomas A, Omuro AA, Nolan CP, Pentsova E, Kaley TJ, Oh JH, He S, Hall A, Wong RJ. Schwann cells induce cancer cell dispersion and
Noeske R, Maher E, Choi C, Gutin PH, Holodny A I, Yen K, DeAngelis invasion. Journal of Clinical Investigation. 2016;126(4):1538-1554. PMCID:
LM, Mellinghoff IK, Thakur SB. Integration of 2-hydroxyglutarate- PMC4811155
proton magnetic resonance spectroscopy into clinical practice for
disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro- Debruyne DN, Bhatnagar N, Sharma B, Luther W, Moore NF, Cheung
Oncology. 2016;18(2):283-290. PMCID: PMC4724186 K, Gray NS, George RE. ALK inhibitor resistance in ALK(F1174L)-driven
neuroblastoma is associated with AXL activation and induction of
De Mattos-Arruda L, Shen RL, Reis-Filho JS, Cortes J. Translating EMT. Oncogene. 2016;35(28):3681-3691. PMCID: PMC4885798
73 OF 324
Journal Articles
DeFilippis EM, Mehta M, Ludwig E. A potential association between for metastatic liposarcoma or leiomyosarcoma after failure of
exposure to hepatitis B virus and small bowel adenocarcinoma. Journal conventional chemotherapy: Results of a phase III randomized
of Gastrointestinal Oncology. 2016;7(3):495-498. PMCID: PMC4880779 multicenter clinical trial. Journal of Clinical Oncology. 2016;34(8):786-
793. PMCID: PMC5070559
Dehal A, Smith JJ, Nash GM. Cytoreductive surgery and intraperitoneal
chemotherapy: An evidence-based review-past, present and Demoin DW, Wyatt LC, Edwards KJ, Abdel-Atti D, Sarparanta M, Pourat
future. Journal of Gastrointestinal Oncology. 2016;7(1):143-157. PMCID: J, Longo VA, Carlin SD, Engelman DM, Andreev OA, Reshetnyak
PMC4754310 YK, Viola-Villegas N, Lewis JS. PET imaging of extracellular pH in
tumors with (64)Cu- and (18)F-labeled pHLIP Peptides: A structure-
Del Castillo M, Lucca A, Plodkowski A, Huang YT, Kaplan J, Gilhuley activity optimization study. Bioconjugate Chemistry. 2016;27(9):2014-
K, Babady NE, Seo SK, Kamboj M. Atypical presentation of Legionella 2023. PMCID: PMC5034329
pneumonia among patients with underlying cancer: A fifteen-year
review. Journal of Infection. 2016;72(1):45-51. PMCID: PMC4938150 Demoin DW, Shindo M, Zhang H, Edwards KJ, Serganova I, Pillarsetty
NVK, Lewis JS, Blasberg RG. Synthesis and evaluation of an
Dela Cruz FS, Diolaiti D, Turk AT, Rainey AR, Ambesi-Impiombato 18F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in
A, Andrews SJ, Mansukhani MM, Nagy PL, Alvarez MJ, Califano A, gliomas. Nuclear Medicine and Biology. 2016;43(10):606-611.
Forouhar F, Modzelewski B, Mitchell CM, Yamashiro DJ, Marks LJ,
Bender JLG, Kung AL. A case study of an integrative genomic and Dempsey PJ, Ridge CA, Solomon SB. Advances in interventional
experimental therapeutic approach for rare tumors: Identification of oncology: Lung cancer. The Cancer Journal. 2016;22(6):393-400.
vulnerabilities in a pediatric poorly differentiated carcinoma. Genome
Medicine. 2016;8(1):116. PMCID: PMC5088685 Deng L, Xu-Monette ZY, Loghavi S, Manyam GC, Xia Y, Visco C, Huh
J, Zhang L, Zhai Q, Wang Y, Qiu L, Dybkær K, Chiu A, Perry AM,
Della Porta MG, Gallì A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo Zhang S, Tzankov A, Rao H, Abramson J, Sohani AR, Xu M, Hsi ED,
E, Allione B, van Lint MT, Pioltelli P, Marenco P, Bosi A, Voso MT, Zhu J, Ponzoni M, Wang S, Li L, Zhang M, Ferreri AJM, Parsons BM,
Sica S, Cuzzola M, Angelucci E, Rossi M, Ubezio M, Malovini A, Li Y, Piris MA, Medeiros LJ, Young KH. Primary testicular diffuse large
Limongelli I, Ferretti V V, Spinelli O, Tresoldi C, Pozzi S, Luchetti S, B-cell lymphoma displays distinct clinical and biological features for
Pezzetti L, Catricalà S, Milanesi C, Riva A, Bruno B, Ciceri F, Bonifazi treatment failure in rituximab era: A report from the International PTL
F, Bellazzi R, Papaemmanuil E, Santoro A, Alessandrino EP, Rambaldi Consortium. Leukemia. 2016;30(2):361-372.
A, Cazzola M. Clinical effects of driver somatic mutations on the
outcomes of patients with myelodysplastic syndromes treated with Deng S, Bothe I, Baylies M. Diaphanous regulates SCAR complex
allogeneic hematopoietic stem-cell transplantation. Journal of Clinical localization during Drosophila myoblast fusion. Fly. 2016;10(4):178-
Oncology. 2016;34(30):3627-3637. 186. PMCID: PMC5036928
Demetri GD, von Mehren M, Jones RL, Hensley ML, Schuetze SM, Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-
Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H, Van Tine BA, Spira Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH,
A, Dean A, Khokhar NZ, Park YC, Knoblauch RE, Parekh T V, Maki Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney
RG, Patel SR. Efficacy and safety of trabectedin or dacarbazine K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED,
74 OF 324
Journal Articles
Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, eighth edition of the TNM classification for lung cancer. Journal of
Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman- Thoracic Oncology. 2016;11(5):651-665.
Cass DA. NCCN Guidelines® Insights survivorship, version 1.2016. Journal
of the National Comprehensive Cancer Network. 2016;14(6):715-724. Detterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson
AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch
DeRosa AP, Keating DM. Customizing the iPad to support a clinical VW, Asamura H, Rami-Porta R, on behalf of the IASLC Staging and
fellowship in radiology: A qualitative study. Hypothesis. 2016;28(1):26-32. Prognostic Factors Committee Advisory Boards, Multiple Pulmonary
Sites Workgroup. The IASLC Lung Cancer Staging Project: Background
Dershaw DD. Preoperative MRI. Breast Journal. 2016;22(2):141-142. data and proposals for the application of TNM staging rules to lung
cancer presenting as multiple nodules with ground glass or lepidic
Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, Ramirez features or a pneumonic type of involvement in the forthcoming
R, Bagrodia A, Rosenberg JE, Bajorin DF, Berger MF, Bochner eighth edition of the TNM classification. Journal of Thoracic
BH, Zelefsky MJ, Kollmeier MA, Ostrovnaya I, Al-Ahmadie HA, Solit Oncology. 2016;11(5):666-680.
DB, Iyer G. Genomic characterization of response to chemoradiation
in urothelial bladder cancer. Cancer. 2016;122(23):3715-3723. PMCID: Detterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard
PMC5115929 N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch
VW, Crowley J, Asamura H, Rami-Porta R, on behalf of the IASLC Staging
Desrichard A, Snyder A, Chan TA. Cancer neoantigens and applications and Prognostic Factors Committee, Advisory Boards, Multiple Pulmonary
for immunotherapy. Clinical Cancer Research. 2016;22(4):807-812. Sites Workgroup, Participating Institutions. The IASLC lung cancer
staging project: Summary of proposals for revisions of the classification
Detterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS,
of lung cancers with multiple pulmonary sites of involvement in the
Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch
forthcoming eighth edition of the TNM classification. Journal of Thoracic
VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R, behalf of the
Oncology. 2016;11(5):639-650.
IASLC Staging and Prognostic Factors Committee, Advisory Boards,
Multiple Pulmonary Sites Workgroup, Participating Institutions. The Deveci S, Gotto GT, Alex B, O’Brien K, Mulhall JP. A survey of
IASLC Lung Cancer Staging Project: Background data and proposals patient expectations regarding sexual function following radical
for the classification of lung cancer with separate tumor nodules prostatectomy. BJU International. 2016;118(4):641-645.
in the forthcoming eighth edition of the TNM classification for lung
cancer. Journal of Thoracic Oncology. 2016;11(5):681-692. Devine KA, Manne SL, Mee L, Bartell AS, Sands SA, Myers-Virtue
S, Ohman-Strickland P. Barriers to psychological care among
Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg primary caregivers of children undergoing hematopoietic stem
DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch cell transplantation. Supportive Care in Cancer. 2016;24(5):2235-
VW, Asamura H, Rami-Porta R, on behalf of the IASLC Staging and 2242. PMCID: PMC4805489
Prognostic Factors Committee, Advisory Boards, Multiple Pulmonary
Sites Workgroup. The IASLC Lung Cancer Staging Project: Background Devlin SM, Ostrovnaya I, Gönen M. Boomerang: A method for recursive
data and proposed criteria to distinguish separate primary lung cancers reclassification. Biometrics. 2016;72(3):995-1002. PMCID: PMC4940305
from metastatic foci in patients with two lung tumors in the forthcoming
75 OF 324
Journal Articles
Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe Lymphoma. 2016;57(4):899-908. PMCID: PMC4963821
BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R,
Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Diaz J, Sternberg CN, Mehmud F, Delea TE, Latimer N, Pandite L, Motzer
Appropriateness Criteria ® Hodgkin lymphoma-favorable prognosis RJ. Overall survival endpoint in oncology clinical trials: Addressing
stage I and II. American Journal of Clinical Oncology: Cancer Clinical the effect of crossover - The case of pazopanib in advanced renal cell
Trials. 2016;39(6):535-544. carcinoma. Oncology. 2016;90(3):119-126.
Dhir M, Melin AA, Douaiher J, Lin C, Zhen W, Hussain SM, Geschwind JFH, Dickler MN, Barry WT, Cirrincione CT, Ellis MJ, Moynahan ME, Innocenti
Doyle MBM, Abou-Alfa GK, Are C. A review and update of treatment F, Hurria A, Rugo HS, Lake DE, Hahn O, Schneider BP, Tripathy D, Carey
options and controversies in the management of hepatocellular LA, Winer EP, Hudis CA. Phase III trial evaluating letrozole as first-line
carcinoma. Annals of Surgery. 2016;263(6):1112-1125. endocrine therapy with or without bevacizumab for the treatment of
postmenopausal women with hormone receptor-positive advanced-
Di Gialleonardo V, Tee SS, Aldeborgh HN, Miloushev VZ, Cunha stage breast cancer: CALGB 40503 (Alliance). Journal of Clinical
LS, Sukenick GD, Keshari KR. High-throughput indirect quantitation Oncology. 2016;34(22):2602-2609. PMCID: PMC5012690
of (13)C enriched metabolites using (1)H NMR. Analytical
Chemistry. 2016;88(22):11147-11153. PMCID: PMC5148664 Dickson MA, Mahoney MR, Tap WD, D’Angelo SP, Keohan ML, Van
Tine BA, Agulnik M, Horvath LE, Nair JS, Schwartz GK. Phase II study
Diamond EL, Russell D, Kryza-Lacombe M, Bowles KH, Applebaum AJ, of MLN8237 (Alisertib) in advanced/metastatic sarcoma. Annals of
Dennis J, Deangelis LM, Prigerson HG. Rates and risks for late referral Oncology. 2016;27(10):1855-1860. PMCID: PMC5035789
to hospice in patients with primary malignant brain tumors. Neuro-
Oncology. 2016;18(1):78-86. PMCID: PMC4677417 Dickson MA, Schwartz GK, Louise Keohan M, D’Angelo SP, Gounder
MM, Chi P, Antonescu CR, Landa J, Qin LX, Crago AM, Singer
Diamond EL, Abdel-Wahab O, Durham BH, Dogan A, Ozkaya N, Brody S, Koff A, Tap WD. Progression-free survival among patients
L, Arcila M, Bowers C, Fluchel M. Anakinra as efficacious therapy for 2 with well-differentiated or dedifferentiated liposarcoma treated
cases of intracranial Erdheim-Chester disease. Blood. 2016;128(14):1896- with CDK4 inhibitor palbociclib: A phase 2 clinical trial. JAMA
1898. PMCID: PMC5054701 Oncology. 2016;2(7):937-940. PMCID: PMC4991028
Diamond EL, Hatzoglou V, Patel S, Abdel-Wahab O, Rampal R, Hyman Diebo BG, Challier V, Henry JK, Oren JH, Spiegel MA, Vira S, Tanzi EM,
DM, Holodny A I, Raj A. Diffuse reduction of cerebral grey matter Liabaud B, Lafage R, Protopsaltis TS, Errico TJ, Schwab FJ, Lafage
volumes in Erdheim-Chester disease. Orphanet Journal of Rare V. Predicting cervical alignment required to maintain horizontal gaze
Diseases. 2016;11(1):109. PMCID: PMC4971748 based on global spinal alignment. Spine. 2016;41(23):1795-1800.
Dias LM, Thodima V, Friedman J, Ma C, Guttapalli A, Mendiratta Dietz AC, Chen Y, Yasui Y, Ness KK, Hagood JS, Chow EJ, Stovall M,
G, Siddiqi IN, Syrbu S, Chaganti RSK, Houldsworth J. Cross- Neglia JP, Oeffinger KC, Mertens AC, Robison LL, Armstrong GT,
platform assessment of genomic imbalance confirms the clinical Mulrooney DA. Risk and impact of pulmonary complications in survivors
relevance of genomic complexity and reveals loci with potential of childhood cancer: A report from the Childhood Cancer Survivor
pathogenic roles in diffuse large B-cell lymphoma. Leukemia and Study. Cancer. 2016;122(23):3687-3696. PMCID: PMC5115933
76 OF 324
Journal Articles
DiMaio CJ, Weis-Garcia F, Bagiella E, Tang LH, Allen PJ. Pancreatic SH, Salvesen HB, Thomsen LC, Kopperud RK, Bjorge L, Kiemeney LA,
cyst fluid concentration of high-mobility group A2 protein acts as a Massuger Lfag, Pejovic T, Cook LS, Le ND, Swenerton KD, Brooks-
differential biomarker of dysplasia in intraductal papillary mucinous Wilson A, Kelemen LE, Lubinski J, Huzarski T, Gronwald J, Menkiszak
neoplasm. Gastrointestinal Endoscopy. 2016;83(6):1205-1209. PMCID: J, Wentzensen N, Brinton L, Yang H, Lissowska J, Hogdall CK, Lundvall
PMC5015435 L, Song HL, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R,
Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod
DiMattia MA, Watts NR, Cheng N, Huang R, Heymann JB, SA, Phelan C, Risch HA, McLaughlin JR, Anton-Culver H, Ziogas A,
Grimes JM, Wingfield PT, Stuart D I, Steven AC. The structure Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pike MC,
of HIV-1 Rev filaments suggests a bilateral model for Rev-RRE Tseng CC, Kupryjanczyk J, Dansonka-Mieszkowska A, Budzilowska
assembly. Structure. 2016;24(7):1068-1080. PMCID: PMC4938712 A, Spiewankiewicz B, Webb PM, on behalf of the Ovarian Cancer
Association Consortium. Adult body mass index and risk of ovarian
DiMenna LJ, Chaudhuri J. Regulating infidelity: RNA-mediated cancer by subtype: A Mendelian randomization study. International
recruitment of AID to DNA during class switch recombination. European Journal of Epidemiology. 2016;45(3):884-895.
Journal of Immunology. 2016;46(3):523-530.
Dizon DS, Krilov L, Cohen E, Gangadhar T, Ganz PA, Hensing TA, Hunger
Dimitriou M, Woll PS, Mortera-Blanco T, Karimi M, Wedge DC, Doolittle S, Krishnamurthi SS, Lassman AB, Markham MJ, Mayer E, Neuss M, Pal
H, Douagi I, Papaemmanuil E, Jacobsen SW, Hellström-Lindberg SK, Richardson LC, Schilsky R, Schwartz GK, Spriggs DR, Villalona-
E. Perturbed hematopoietic stem and progenitor cell hierarchy in Calero MA, Villani G, Masters G. Clinical cancer advances 2016: Annual
report on progress against cancer from the American Society of Clinical
myelodysplastic syndromes patients with monosomy 7 as the sole
Oncology. Journal of Clinical Oncology. 2016;34(9):987-1011. PMCID:
cytogenetic abnormality. Oncotarget. 2016;7(45):72685-72698.
PMC5075244
Ding HT, Taur Y, Walkup JT. Gut microbiota and autism: Key
Do MH, Li MO. Metabolic control of asyMYCtric division. Cell
concepts and findings. Journal of Autism and Developmental
Research. 2016;26(8):863-864. PMCID: PMC4973327
Disorders. 2016;47(2):480-489.
Doamekpor SK, Lee JW, Hepowit NL, Wu C, Charenton C,
Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter
Leonard M, Bengtson MH, Rajashankar KR, Sachs MS, Lima CD,
JN, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D,
Joazeiro CAP. Structure and function of the yeast listerin (Ltn1)
Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty
conserved N-terminal domain in binding to stalled 60S ribosomal
JA, Wicklund KG, Chang-Claude J, Rudolph A, Moysich KB, Odunsi K,
subunits. Proceedings of the National Academy of Sciences of the United
Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dork T, Park-
States of America. 2016;113(29):E4151-E4160. PMCID: PMC4961192
Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H,
Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Dobrenkov K, Ostrovnaya I, Gu J, Cheung IY, Cheung NK V. Oncotargets
Heitz F, Karlan BY, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, GD2 and GD3 are highly expressed in sarcomas of children, adolescents,
Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey and young adults. Pediatric Blood and Cancer. 2016;63(10):1780-
MC, Hildebrandt MAT, Wu XF, Lu KH, Liang D, Levine DA, Bisogna M, 1785. PMCID: PMC5215083
Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera E V, Olson
77 OF 324
Journal Articles
Dobrolecki LE, Airhart SD, Alferez DG, Aparicio S, Behbod F, Bentires-Alj cancer. Current Problems in Surgery. 2016;53(12):559-595. PMCID:
M, Brisken C, Bult CJ, Cai S, Clarke RB, Dowst H, Ellis MJ, Gonzalez-Suarez PMC5298793
E, Iggo RD, Kabos P, Li S, Lindeman GJ, Marangoni E, McCoy A, Meric-
Bernstam F, Piwnica-Worms H, Poupon MF, Reis-Filho J, Sartorius CA, Domovitov S V, Chandhanayingyong C, Boland PJ, McKeown DG, Healey
Scabia V, Sflomos G, Tu Y, Vaillant F, Visvader JE, Welm A, Wicha MS, Lewis JH. Conservative surgery in the treatment of giant cell tumor of the
MT. Patient-derived xenograft (PDX) models in basic and translational sacrum: 35 Years’ experience. Journal of Neurosurgery. 2016;24(2):228-
breast cancer research. Cancer and Metastasis Reviews. 2016;35(4):547-573. 240. PMCID: PMC5161744
Dogan S, Wang L, Ptashkin RN, Dawson RR, Shah JP, Sherman Donahue TF, Bochner BH. Parastomal hernias after radical
EJ, Tuttle RM, Fagin JA, Klimstra DS, Katabi N, Ghossein RA. Mammary cystectomy and ileal conduit diversion. Investigative and Clinical
analog secretory carcinoma of the thyroid gland: A primary Urology. 2016;57(4):240-248. PMCID: PMC4949695
thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Modern
Pathology. 2016;29(9):985-995. PMCID: PMC5019170 Donahue TF, Cha EK, Bochner BH. Rationale and early experience with
prophylactic placement of mesh to prevent parastomal hernia formation
Dolly SO, Wagner AJ, Bendell JC, Kindler HL, Krug LM, Seiwert after ileal conduit urinary diversion and cystectomy for bladder
TY, Zauderer MG, Lolkema MP, Apt D, Yeh RF, Fredrickson JO, Spoerke cancer. Current Urology Reports. 2016;17(2):9. PMCID: PMC4803475
JM, Koeppen H, Ware JA, Lauchle JO, Burris HA 3rd, De Bono JS. Phase
I study of apitolisib (GDC-0980), dual phosphatidylinositol-3-kinase Dong JW, Brennan NMP, Izzo G, Peck KK, Holodny A I. fMRI activation
and mammalian target of rapamycin kinase inhibitor, in patients with in the middle frontal gyrus as an indicator of hemispheric dominance
advanced solid tumors. Clinical Cancer Research. 2016;22(12):2874- for language in brain tumor patients: A comparison with Broca’s
2884. PMCID: PMC4876928 area. Neuroradiology. 2016;58(5):513-520. PMCID: PMC4990063
Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh Doolittle M. Pink ribbon blues. Psycho-Oncology. 2016;25(8):999-1000.
MW, Friedlander M, Balmana J, Mitchell G, Fried G, Stemmer SM, Hubert
Doran MG, Carnazza KE, Steckler JM, Spratt DE, Truillet C, Wongvipat
A, Rosengarten O, Loman N, Robertson JD, Mann H, Kaufman B. Efficacy
J, Sawyers CL, Lewis JS, Evans MJ. Applying (89)Zr-transferrin to
and safety of olaparib monotherapy in germline BRCA1/2 mutation
study the pharmacology of inhibitors to BET bromodomain containing
carriers with advanced ovarian cancer and three or more lines of prior
proteins. Molecular Pharmaceutics. 2016;13(2):683-688. PMCID: PMC4738321
therapy. Gynecologic Oncology. 2016;140(2):199-203. PMCID: PMC4992984
Doubeni CA, Corley DA, Zauber AG. Colorectal cancer
Dominguez-Rosado I, Moutinho V Jr, DeMatteo RP, Kingham
health disparities and the role of US law and health
TP, D’Angelica M, Brennan MF. Outcomes of the Memorial
policy. Gastroenterology. 2016;150(5):1052-1055.
Sloan Kettering Cancer Center International General Surgical
Oncology Fellowship. Journal of the American College of Doubeni CA, Jensen CD, Fedewa SA, Quinn VP, Zauber AG,
Surgeons. 2016;222(5):961-966. PMCID: PMC4846489 Schottinger JE, Corley DA, Levin TR. Fecal immunochemical
test (FIT) for colon cancer screening: Variable performance with
Dominici LS, Morrow M, Mittendorf E, Bellon J, King TA. Trends and
ambient temperature. Journal of the American Board of Family
controversies in multidisciplinary care of the patient with breast
Medicine. 2016;29(6):672-681.
78 OF 324
Journal Articles
Douer D. Efficacy and safety of vincristine sulfate liposome Drilon A, Rekhtman N, Arcila M, Wang L, Ni A, Albano M, Van
injection in the treatment of adult acute lymphocytic leukemia. The Voorthuysen M, Somwar R, Smith RS, Montecalvo J, Plodkowski
Oncologist. 2016;21(7):840-847. PMCID: PMC4943385 A, Ginsberg MS, Riely GJ, Rudin CM, Ladanyi M, Kris MG. Cabozantinib
in patients with advanced RET-rearranged non-small-cell lung
Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, cancer: an open-label, single-centre, phase 2, single-arm trial. Lancet
Fuks D, Allen PJ, Farges O, Kingham TP, Regimbeau JM, D’Angelica M I, Oncology. 2016;17(12):1653-1660. PMCID: PMC5143197
Azoulay D, Jarnagin WR. Recurrence patterns and disease-free survival
after resection of intrahepatic cholangiocarcinoma: Preoperative and Drilon A, Somwar R, Wagner JP, Vellore NA, Eide CA, Zabriskie MS, Arcila
postoperative prognostic models. Journal of the American College of ME, Hechtman JF, Wang L, Smith RS, Kris MG, Riely GJ, Druker BJ,
Surgeons. 2016;223(3):493-505. PMCID: PMC5003652 O’Hare T, Ladanyi M, Davare MA. A novel crizotinib-resistant solvent-
front mutation responsive to cabozantinib therapy in a patient with
Downey RJ, Bains MS. Open surgical approaches for pulmonary ROS1-rearranged lung cancer. Clinical Cancer Research. 2016;22(10):2351-
metastasectomy. Thoracic Surgery Clinics. 2016;26(1):13-18. 2358. PMCID: PMC4867287
Drake-Pérez M, Marco de Lucas E, Lyo J, Fernández-Torre Drilon A. MET exon 14 alterations in lung cancer: Exon skipping extends half-
JL. Neuroimaging features in subacute encephalopathy with seizures in life. Clinical Cancer Research. 2016;22(12):2832-2834. PMCID: PMC4911276
alcoholics (SESA syndrome). Seizure. 2016;40:102-107.
Driscoll DR, Karim SA, Sano M, Gay DM, Jacob W, Yu J, Mizukami Y,
Drilon A, Li G, Dogan S, Gounder M, Shen R, Arcila M, Wang L, Hyman Gopinathan A, Jodrell D I, Evans TRJ, Bardeesy N, Hall MN, Quattrochi
DM, Hechtman J, Wei G, Cam NR, Christiansen J, Luo D, Maneval EC, BJ, Klimstra DS, Barry ST, Sansom OJ, Lewis BC, Morton JP. mTORC2
Bauer T, Patel M, Liu S V, Ou SH I, Farago A, Shaw A, Shoemaker RF, signaling drives the development and progression of pancreatic
Lim J, Hornby Z, Multani P, Ladanyi M, Berger M, Katabi N, Ghossein cancer. Cancer Research. 2016;76(23):6911-6923. PMCID: PMC5135633
R, Ho AL. What hides behind the MASC: Clinical response and
acquired resistance to entrectinib after ETV6-NTRK3 identification Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y,
in a mammary analogue secretory carcinoma (MASC). Annals of Clevers H. Organoid culture systems for prostate epithelial and cancer
Oncology. 2016;27(5):920-926. PMCID: PMC4843186 tissue. Nature Protocols. 2016;11(2):347-358. PMCID: PMC4793718
Drilon A, Bergagnini I, Delasos L, Sabari J, Woo KM, Plodkowski Du E, Wenig BM, Su HK, Rowe ME, Haser GC, Asa SL, Baloch Z,
A, Wang L, Hellmann MD, Joubert P, Sima CS, Smith R, Somwar Faquin WC, Fellegara G, Giordano T, Ghossein R, Livolsi VA, Lloyd
R, Rekhtman N, Ladanyi M, Riely GJ, Kris MG. Clinical outcomes R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT,
with pemetrexed-based systemic therapies in RET-rearranged lung Urken ML. Inter-observer variation in the pathologic identification
cancers. Annals of Oncology. 2016;27(7):1286-1291. PMCID: PMC4922319 of extranodal extension in nodal metastasis from papillary thyroid
carcinoma. Thyroid. 2016;26(6):816-819.
Drilon A, Eaton AA, Schindler K, Gounder MM, Spriggs DR,
Harris P, Ivy SP, Iasonos A, Lacouture ME, Hyman DM. Beyond Du H, Chen L, Chavda KD, Pandey R, Zhang H, Xie X, Tang
the dose-limiting toxicity period: Dermatologic adverse events of YW, Kreiswirth BN. Genomic characterization of Enterobacter
patients on phase 1 trials of the Cancer Therapeutics Evaluation cloacae isolates from China that coproduce KPC-
Program. Cancer. 2016;122(8):1228-1237. 3 and NDM-1 carbapenemases. Antimicrobial Agents and
79 OF 324
Journal Articles
Chemotherapy. 2016;60(4):2519-2523. PMCID: PMC4808189 55. PMCID: PMC4836291
Du H, Chen L, Tang YW, Kreiswirth BN. Emergence of the mcr-1 colistin DuHamel K, Schuler T, Nelson C, Philip E, Temple L, Schover L, Baser
resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet RE, Starr TD, Cannon K, Jennings S, Jandorf L, Carter J. The sexual
Infectious Diseases. 2016;16(3):287-288. health of female rectal and anal cancer survivors: Results of a pilot
randomized psycho-educational intervention trial. Journal of Cancer
Du M, Jiao S, Bien SA, Gala M, Abecasis G, Bezieau S, Brenner H, Survivorship. 2016;10(3):553-563. PMCID: PMC4864056
Butterbach K, Caan BJ, Carlson CS, Casey G, Chang-Claude J, Conti
D V, Curtis KR, Duggan D, Gallinger S, Haile RW, Harrison TA, Hayes Dummer AM, Su Z, Cherney R, Choi K, Denu J, Zhao X,
RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Küry S, Le Fox CA. Binding of the Fkh1 forkhead associated domain
Marchand L, Leal SM, Newcomb PA, Nickerson DA, Potter JD, Schoen to a phosphopeptide within the Mph1 DNA helicase
RE, Schumacher FR, Seminara D, Slattery ML, Hsu L, Chan AT, White regulates mating-type awitching in budding yeast. PLoS
E, Berndt S I, Peters U. Fine-mapping of common genetic variants Genetics. 2016;12(6):e1006094. PMCID: PMC4892509
associated with colorectal tumor risk identified potential functional
variants. PLoS ONE. 2016;11(7):e0157521. PMCID: PMC4933364 Dunn LA, Ho AL, Laurie SA, Pfister DG. Unmet needs for patients with
salivary gland cancer. Oral Oncology. 2016;60:142-145.
Du Z, Sun T, Hacisuleyman E, Fei T, Wang X, Brown M, Rinn JL, Lee MGS,
Chen Y, Kantoff PW, Liu XS. Integrative analyses reveal a long noncoding Dunne M, Keenan K. Late and long-term sequelae of breast cancer
RNA-mediated sponge regulatory network in prostate cancer. Nature treatment: How to recognize and help patients manage these often
Communications. 2016;7:10982. PMCID: PMC4796315 debilitating complications. American Journal of Nursing. 2016;116(6):36-45.
Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French
D, Gobourne A, Littmann E, Huttenhower C, Pamer EG, Wolchok JD, Beesley J, Healey CS, Kar S, Pooley KA, Lopez-Knowles E, Dicks E,
JD. Intestinal microbiome analyses identify melanoma patients Barrowdale D, Sinnott-Armstrong NA, Sallari RC, Hillman KM, Kaufmann
at risk for checkpoint-blockade-induced colitis. Nature S, Sivakumaran H, Marjaneh MM, Lee JS, Hills M, Jarosz M, Drury S,
Communications. 2016;7:10391. PMCID: PMC4740747 Canisius S, Kbolla M, Dennis J, Wang Q, Lhopper J, Southey MC, Broeks
A, Schmidt MK, Lophatananon A, Muir K, Beckmann MW, Fasching PA,
Dubrovsky L, Brea EJ, Pankov D, Casey E, Dao T, Liu C, Scheinberg Dos-Santos-Silva I, Peto J, Sawyer EJ, Tomlinson I, Burwinkel B, Marme
DA. Mechanisms of leukemia resistance to antibody dependent cellular F, Guénel P, Truong T, Bojesen SE, Flyger H, Gonzlez-Neira A, Perez JIA,
cytotoxicity. OncoImmunology. 2016;5(9):e1211221. PMCID: PMC5048777 Anton-Culver H, Eunjung L, Arndt V, Brenner H, Meindl A, Schmutzler
RK, Brauch H, Hamann U, Aittomki K, Blomqvist C, Ito H, Matsuo K,
Dubrovsky L, Dao T, Gejman RS, Brea EJ, Chang AY, Oh CY, Casey Bogdanova N, Dörk T, Lindblom A, Margolin S, Kosma VM, Mannermaa A,
E, Pankov D, Scheinberg DA. T cell receptor mimic antibodies for cancer Tseng CC, Wu AH, Lambrechts D, Wildiers H, Chang-Claude J, Rudolph
therapy. OncoImmunology. 2016;5(1):e1049803. A, Peterlongo P, Radice P, Eolson J, Ggiles G, Milne RL, Haiman CA,
Henderson BE, Goldberg MS, Teo SH, Yip CH, Nord S, Borresen-Dale AL,
Ducie JA, Leitao MM. The role of adjuvant therapy in uterine Kristensen V, Long J, Zheng W, Pylks K, Winqvist R, Andrulis IL, Knight
leiomyosarcoma. Expert Review of Anticancer Therapy. 2016;16(1):45- JA, Devilee P, Seynaeve C, Figueroa J, Sherman ME, Czene K, Darabi H,
80 OF 324
Journal Articles
Hollestelle A, Van Den Ouweland AMW, Humphreys K, Gao YT, Shu XO, Duployez N, Micol JB, Boissel N, Petit A, Geffroy S, Bucci M, Lapillonne H,
Cox A, Cross SS, Blot W, Cai Q, Ghoussaini M, Perkins BJ, Shah M, Choi Renneville A, Leverger G, Ifrah N, Dombret H, Abdel-Wahab O, Jourdan
JY, Kang D, Lee SC, Hartman M, Kabisch M, Torres D, Jakubowska A, E, Preudhomme C. Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations
Lubinski J, Brennan P, Sangrajrang S, Ambrosone CB, Toland AE, Shen are rare events in acute myeloid leukemia with t(8;21). Leukemia and
CY, Wu PE, Orr N, Swerdlow A, McGuffog L, Healey S, Lee A, Kapuscinski Lymphoma. 2016;57(1):199-200.
M, John EM, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R,
Tihomirova L, Tung N, Dorfling CM, Van Rensburg EJ, Neuhausen SL, Durando M, Gennaro L, Cho GY, Giri DD, Gnanasigamani MM, Patil
Ejlertsen B, Ohansen T V, Osorio A, Benitez J, Rando R, Weitzel JN, S, Sutton EJ, Deasy JO, Morris EA, Thakur SB. Quantitative apparent
Bonanni B, Peissel B, Manoukian S, Papi L, Ottini L, Konstantopoulou diffusion coefficient measurement obtained by 3.0 Tesla MRI as
I, Apostolou P, Garber J, Rashid MU, Frost D, EMBRACE, Izatt L, Ellis a potential noninvasive marker of tumor aggressiveness in breast
S, Godwin AK, Arnold N, Niederacher D, Rhiem K, Bogdanova-Markov cancer. European Journal of Radiology. 2016;85(9):1651-1658.
N, Sagne C, Stoppa-Lyonnet D, Damiola F, GEMO Study Collaborators,
Sinilnikova OM, Mazoyer S, Isaacs C, McLaes KB, De Leeneer K, De La Durham BH, Diamond EL, Abdel-Wahab O. Histiocytic neoplasms
Hoya M, Caldes T, Nevanlinna H, Khan S, Mensenkamp AR, HEBON, in the era of personalized genomic medicine. Current Opinion in
Hooning MJ, Rookus MA, Kwong A, Olah E, Diez O, Brunet J, Pujana Hematology. 2016;23(4):416-425. PMCID: PMC5112586
MA, Gronwald J, Huzarski T, Barkardottir RB, Laframboise R, Soucy P,
Duska L, Shahrokni A, Powell M. Treatment of older women with
Montagna M, Agata S, Teixeira MR, kConFab Investigators, Park SK,
endometrial cancer: Improving outcomes with personalized
Lindor N, Couch FJ, Tischkowitz M, Foretova L, Vijai J, Offit K, Singer
care. American Society of Clinical Oncology Educational
CF, Rappaport C, Mphelan C, Greene MH, Mai PL, Rennert G, Imyanitov
Book. 2016;36:164-174.
EN, Hulick PJ, Phillips KA, Piedmonte M, Mulligan AM, Glendon G,
Bojesen A, Thomassen M, Caligo MA, Yoon SY, Friedman E, Laitman Dutta PR, Riaz N, McBride S, Morris LG, Patel S, Ganly I, Wong
Y, Borg A, Von Wachenfeldt A, Ehrencrona H, Rantala J, Olopade O I, RJ, Palmer F, Schöder H, Lee N. Postoperative PET/CT and target
Ganz PA, Nussbaum RL, Gayther SA, Lnathanson K, Domchek SM, Arun delineation before adjuvant radiotherapy in patients with oral
BK, Mitchell G, Karlan BY, Lester J, Maskarinec G, Woolcott C, Scott C, cavity squamous cell carcinoma. Head and Neck. 2016;38(Suppl.
Stone J, Apicella C, Tamimi R, Luben R, Khaw KT, Helland S, Haakensen 1):E1285-E1293. PMCID: PMC4927081
V, Dowsett M, Pharoah PDP, Simard J, Hall P, Garca-Closas M, Vachon
C, Chenevix-Trench G, Antoniou AC, Easton DF, Edwards SL. Breast Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing
cancer risk variants at 6q25 display different phenotype associations and factors as oncoproteins and tumour suppressors. Nature Reviews
regulate ESR1, RMND1 and CCDC170. Nature Genetics. 2016;48(4):374- Cancer. 2016;16(7):413-430. PMCID: PMC5094465
386. PMCID: PMC4938803
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-
Duployez N, Marceau-Renaut A, Boissel N, Petit A, Bucci M, Geffroy S, Culver H, Bandera E V, Berchuck A, Cook LS, Cramer D, Doherty JA,
Lapillonne H, Renneville A, Ragu C, Figeac M, Celli-Lebras K, Lacombe Goodman MT, Levine DA, Monteiro ANA, Ness RB, Pearce CL, Rossing
C, Micol JB, Abdel-Wahab O, Cornillet P, Ifrah N, Dombret H, Leverger G, MA, Tworoger SS, Wentzensen N, Bisogna M, Brinton L, Brooks-Wilson A,
Jourdan E, Preudhomme C. Comprehensive mutational profiling of core Carney ME, Cunningham JM, Edwards RP, Fogarty ZC, Iversen ES, Kraft
binding factor acute myeloid leukemia. Blood. 2016;127(20):2451-2459. P, Larson MC, Le ND, Lin HY, Lissowska J, Modugno F, Moysich KB, Olson
81 OF 324
Journal Articles
SH, Pike MC, Poole EM, Rider DN, Terry KL, Thompson PJ, Van Den N2a nodal categories for predicting survival and recurrence in patients
Berg D, Vierkant RA, Vitonis AF, Wilkens LR, Wu AH, Yang HP, Ziogas with oral cancer: Time to acknowledge an arbitrary distinction and modify
A, Phelan CM, Schildkraut JM, Chen YA, Sellers TA, Fridley BL, Goode the system. Head and Neck. 2016;38(1):135-139. PMCID: PMC4976491
EL. A targeted genetic association study of epithelial ovarian cancer
susceptibility. Oncotarget. 2016;7(7):7381-7389. PMCID: PMC4884925 Edgington-Mitchell LE, Wartmann T, Fleming AK, Gocheva V, van der
Linden WA, Withana NP, Verdoes M, Aurelio L, Edgington-Mitchell
Eaton A, Iasonos A, Gounder MM, Pamer EG, Drilon A, Vulih D, Smith D, Lieu T, Parker BS, Graham B, Reinheckel T, Furness JB, Joyce JA,
GL, Ivy SP, Spriggs DR, Hyman DM. Toxicity attribution in phase I trials: Storz P, Halangk W, Bogyo M, Bunnett NW. Legumain is activated in
Evaluating the effect of dose on the frequency of related and unrelated macrophages during pancreatitis. American Journal of Physiology -
toxicities. Clinical Cancer Research. 2016;22(3):553-559. PMCID: PMC4819316 Gastrointestinal and Liver Physiology. 2016;311(3):G548-G560. PMCID:
PMC5075999
Eaton AA, Gonen M, Karanicolas P, Jarnagin WR, D’Angelica M
I, DeMatteo R, Kingham TP, Allen PJ. Health-related quality of life after Eggermont AMM, Chiarion-sileni V, Grob JJ, Dummer R, Wolchok
pancreatectomy: Results from a randomized controlled trial. Annals of JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé
Surgical Oncology. 2016;23(7):2137-2145. PMCID: PMC4891251 C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L,
Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, Taitt C, De Pril
Eaton AA, Sima CS, Panageas KS. Prevalence and safety of off- V, De Schaetzen G, Suciu S, Testori A. Prolonged survival in stage III
label use of chemotherapeutic agents in older patients with breast melanoma with ipilimumab adjuvant therapy. New England Journal of
cancer: Estimates from SEER-Medicare data. Journal of the National Medicine. 2016;375(19):1845-1855.
Comprehensive Cancer Network. 2016;14(1):57-65. PMCID: PMC4827612
Eguchi T, Kadota K, Chaft J, Evans B, Kidd J, Tan KS, Dycoco J,
Ebbesen SH, Scaltriti M, Bialucha CU, Morse N, Kastenhuber ER, Wen Kolquist K, Davis T, Hamilton SA, Yager K, Jones JT, Travis WD, Jones
HY, Dow LE, Baselga J, Lowe SW. Pten loss promotes MAPK pathway DR, Hartman AR, Adusumilli PS. Cell cycle progression score is a
dependency in HER2/neu breast carcinomas. Proceedings of the National marker for five-year lung cancer-specific mortality risk in patients with
Academy of Sciences of the United States of America. 2016;113(11):3030- resected stage I lung adenocarcinoma. Oncotarget. 2016;7(23):35241-
Eberle CA, Piscuoglio S, Rakha EA, Ng CKY, Geyer FC, Edelweiss M, Sakr Ehdaie B, Poon BY, Sjoberg DD, Recabal P, Laudone V, Touijer
RA, Weigelt B, Reis JS, Ellis IO. Infiltrating epitheliosis of the breast: K, Eastham J, Scardino PT. Variation in serum prostate-specific antigen
Characterization of histological features, immunophenotype and genomic levels in men with prostate cancer managed with active surveillance. BJU
profile. Histopathology. 2016;68(7):1030-1039. PMCID: PMC4957818 International. 2016;118(4):535-540.
Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chatturvedi P, Agarwal J, Ehdaie B. Active surveillance for prostate cancer: Is it too active?. BJU
Kowalski L, Kreppel M, Cernea C, Brandao J, Bachar G, Villaret AB, Fliss International. 2016;118(3):343.
D, Fridman E, Robbins KT, Shah J, Patel S, Clark J, The International
Consortium for Outcome Research (ICOR) in Head and Neck Eil R, Vodnala SK, Clever D, Klebanoff CA, Sukumar M, Pan JH, Palmer
Cancer. Comparison of the American Joint Committee on Cancer N1 versus DC, Gros A, Yamamoto TN, Patel SJ, Guittard GC, Yu Z, Carbonaro
82 OF 324
Journal Articles
V, Okkenhaug K, Schrump DS, Linehan WM, Roychoudhuri R, Restifo lung cancers. Lung Cancer. 2016;99:53-56.
NP. Ionic immune suppression within the tumour microenvironment
limits T cell effector function. Nature. 2016;537(7621):539-543. PMCID: Engdahl R, Disa J, Athanasian EA, Healey JH, Cordeiro PG, Fabbri
PMC5204372 N. Pedicled latissimus dorsi flap for shoulder soft-tissue reconstruction
after excision of a musculoskeletal neoplasm. JBJS Essential Surgical
Elias HK, Khalaj M, Park CY. Divergent roles of miR-126 in normal and Techniques. 2016;6(2):e16.
malignant stem cells. Translational Cancer Research. 2016;5(Suppl.
2):S328-S331. Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, De
Wit TD, Eichinger S, Fibbe W, Green T, De Haas F, Iolascon A, Jaffredo
Elkin EB, Hudis CA. Reply to L.A. Newman. Journal of Clinical T, Rodeghiero F, Sall Es G, Schuringa JJ, André M, Andre-Schmutz
Oncology. 2016;34(9):1015. I, Bacigalupo A, Bochud PY, Den Boer M, Bonini C, Camaschella C,
Cant A, Cappellini MD, Cazzola M, Celso CL, Dimopoulos M, Douay L,
Ellmore TM, Feng A, Ng K, Dewan L, Root JC. The effects of changing Dzierzak E, Einsele H, Ferreri A, De Franceschi L, Gaulard P, Gottgens B,
attention and context in an awake offline processing period on visual long- Greinacher A, Gresele P, Gribben J, De Haan G, Hansen JB, Hochhaus A,
term memory. Frontiers in Psychology. 2016;6:1902. PMCID: PMC4704653 Kadir R, Kaveri S, Kouskoff V, Kühne T, Kyrle P, Ljungman P, Maschmeyer
G, Méndez-Ferrer S, Milsom M, Mummery C, Ossenkoppele G, Pecci
Emanu JC, Avildsen IK, Nelson CJ. Erectile dysfunction after radical A, Peyvandi F, Philipsen S, Reitsma P, Ribera JM, Risitano A, Rivella S,
prostatectomy: Prevalence, medical treatments, and psychosocial Ruf W, Schroeder T, Scully M, Socie G, Staal F, Stanworth S, Stauder
interventions. Current Opinion in Supportive and Palliative R, Stilgenbauer S, Tamary H, Theilgaard-Mönch K, Thein SL, Tilly H,
Care. 2016;10(1):102-107. PMCID: PMC5005072 Trneny M, Vainchenker W, Vannucchi AM, Viscoli C, Vrielink H, Zaaijer H,
Zanella A, Zolla L, Zwaginga JJ, Martinez PA, Van Den Akker E, Allard
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-
S, Anagnou N, Andolfo I, Andrau JC, Angelucci E, Anstee D, Aurer I,
Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte
Avet-Loiseau H, Aydinok Y, Bakchoul T, Balduini A, Barcellini W, Baruch
F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter J I, Janku
D, Baruchel A, Bayry J, Bento C, Van Den Berg A, Bernardi R, Bianchi P,
F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A,
Bigas A, Biondi A, Bohonek M, Bonnet D, Borchmann P, Borregaard N,
Vassallo R, Weiss LM, for the Histiocyte Society. Revised classification
Brækkan S, Van Den Brink M, Brodin E, Bullinger L, Buske C, Butzeck
of histiocytoses and neoplasms of the macrophage-dendritic cell
B, Cammenga J, Campo E, Carbone A, Cervantes F, Cesaro S, Charbord
lineages. Blood. 2016;127(22):2672-2681. PMCID: PMC5161007
P, Claas F, Cohen H, Conard J, Coppo P, Vives Corron JL, Da Costa L,
Ende AR, Sedarat A, Shah P, Jhala N, Fraker DL, Drebin JRA, Metz DC, Davi F, Delwel R, Dianzani I, Domanović D, Donnelly P, Drnovšek TD,
Kochman ML. Risk factors for aggressive nonfunctional pancreatic Dreyling M, Du MQ, Dufour C, Durand C, Efremov D, Eleftheriou A, Elion
neuroendocrine tumors and the role of endoscopic ultrasound guided J, Emonts M, Engelhardt M, Ezine S, Falkenburg F, Favier R, Federico
fine-needle aspiration. Endoscopic Ultrasound. 2016;5(1):49-54. PMCID: M, Fenaux P, Fitzgibbon J, Flygare J, Foà R, Forrester L, Galacteros F,
PMC4770623 Garagiola I, Gardiner C, Garraud O, Van Geet C, Geiger H, Geissler J,
Germing U, Ghevaert C, Girelli D, Godeau B, Gökbuget N, Goldschmidt
Eng J, Hsu M, Chaft JE, Kris MG, Arcila ME, Li BT. Outcomes of H, Goodeve A, Graf T, Graziadei G, Griesshammer M, Gruel Y, Guilhot F,
chemotherapies and HER2 directed therapies in advanced HER2-mutant Von Gunten S, Gyssens I, Halter J, Harrison C, Harteveld C, Hellström-
Lindberg E, Hermine O, Higgs D, Hillmen P, Hirsch H, Hoskin P, Huls
83 OF 324
Journal Articles
G, Inati A, Johnson P, Kattamis A, Kiefel V, Kleanthous M, Klump H, Villaflor VM, Cohen SJ, Mayer RJ, Venook A, Benson AB III, Goldberg
Krause D, Hovinga JK, Lacaud G, Lacroix-Desmazes S, Landman-Parker RM. CALGB 80403 (Alliance)/E1206: A randomized phase II study
J, Legouill S, Lenz G, Von Lilienfeld-Toal M, Von Lindern M, Lopez- of three chemotherapy regimens plus cetuximab in metastatic
Guillermo A, Lopriore E, Lozano M, Macintyre E, Makris M, Mannhalter C, esophageal and gastroesophageal junction cancers. Journal of Clinical
Martens J, Mathas S, Matzdorff A, Medvinsky A, Menendez P, Migliaccio Oncology. 2016;34(23):2736-2742. PMCID: PMC5019745
AR, Miharada K, Mikulska M, Minard V, Montalbán C, De Montalembert
M, Montserrat E, Morange PE, Mountford J, Muckenthaler M, Müller- Epstein AS, Prigerson HG, O’Reilly EM, Maciejewski PK. Discussions
Tidow C, Mumford A, Nadel B, Navarro JT, El Nemer W, Noizat-Pirenne of life expectancy and changes in illness understanding in patients
F, O’Mahony B, Oldenburg J, Olsson M, Oostendorp R, Palumbo A, with advanced cancer. Journal of Clinical Oncology. 2016;34(20):2398-
Passamonti F, Patient R, De Latour RP, Pflumio F, Pierelli L, Piga A, 2403. PMCID: PMC4981977
Pollard D, Raaijmakers M, Radford J, Rambach R, Koneti Rao A, Raslova
H, Rebulla P, Rees D, Ribrag V, Rijneveld A, Rinalducci S, Robak T, Epstein J I, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-
Roberts I, Rodrigues C, Rosendaal F, Rosenwald A, Rule S, Russo R, Galluzzi C, Vickers AJ, Parwani A V, Reuter VE, Fine SW, Eastham
Saglio G, Sanchez M, Scharf RE, Schlenke P, Semple J, Sierra J, So- JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A
Osman C, Soria JM, Stamatopoulos K, Stegmayr B, Stunnenberg H, contemporary prostate cancer grading system: A validated alternative
Swinkels D, Barata JPT, Taghon T, Taher A, Terpos E, Thachil J, Tissot to the Gleason score. European Urology. 2016;69(3):428-435. PMCID:
JD, Touw I, Toye A, Trappe R, Traverse-Glehen A, Unal S, Vaulont S, PMC5002992
Viprakasit V, Vitolo U, Van Wijk R, Wójtowicz A, Zeerleder S, Zieger
Eriksson AGZ, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G,
B, Research EHARoadmapforEuropeanHematology. The European
Cliby WA, Dowdy SC, Bakkum-Gamez JN, Abu-Rustum NR, Mariani
hematology association roadmap for european hematology research:
A, Leitao MM Jr. Comparison of a sentinel lymph node and a
A consensus document. Haematologica. 2016;101(2):115-208. PMCID:
selective lymphadenectomy algorithm in patients with endometrioid
PMC4938336
endometrial carcinoma and limited myometrial invasion. Gynecologic
English PA, Williams JA, Martini JF, Motzer RJ, Valota O, Buller RE. A Oncology. 2016;140(3):394-399. PMCID: PMC4839486
case for the use of receiver operating characteristic analysis of potential
Eriksson AGZ, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum
clinical efficacy biomarkers in advanced renal cell carcinoma. Future
NR, Gardner GJ, Zivanovic O, Barakat RR, Brown CL, Levine DA, Sonoda
Oncology. 2016;12(2):175-182.
Y, Leitao MM Jr, Jewell E. Impact of obesity on sentinel lymph node
Enyedi B, Jelcic M, Niethammer P. The cell nucleus serves mapping in patients with newly diagnosed uterine cancer undergoing
as a mechanotransducer of tissue damage-induced robotic surgery. Annals of Surgical Oncology. 2016;23(8):2522-
inflammation. Cell. 2016;165(5):1160-1170. PMCID: PMC4875569 2528. PMCID: PMC4929032
Enyedi B, Niethammer P. A case for the nuclear Escalon JG, Gerst S, Porembka M, Allen PJ, Do RKG. Imaging comparison
membrane as a mechanotransducer. Cellular and Molecular of tubular and colloid pancreatic adenocarcinoma arising from
Bioengineering. 2016;9(2):247-251. PMCID: PMC4955625 intraductal papillary mucinous neoplasm on multidetector CT. Clinical
Imaging. 2016;40(6):1195-1199. PMCID: PMC5159304
Enzinger PC, Burtness BA, Niedzwiecki D, Ye X, Douglas K, Ilson DH,
84 OF 324
Journal Articles
Espi Forcén F, Espi Forcén C. Ars Moriendi: Coping with death in the Group: Does the use of Oncotype DX tumor gene expression profiling
Late Middle Ages. Palliative and Supportive Care. 2016;14(5):553-560. to guide treatment decisions improve outcomes in patients with breast
cancer?. Genetics in Medicine. 2016;18(8):770-779.
Etchin J, Montero J, Berezovskaya A, Le BT, Kentsis A, Christie AL,
Conway AS, Chen WC, Reed C, Mansour MR, Ng CEL, Adamia S, Evans CE, Matarlo JS, Tonge PJ, Tan DS. Stereoselective synthesis,
Rodig SJ, Galinsky IA, Stone RM, Klebanov B, Landesman Y, Kauffman docking, and biological evaluation of difluoroindanediol-based MenE
M, Shacham S, Kung AL, Wang JCY, Letai A, Look AT. Activity inhibitors as antibiotics. Organic Letters. 2016;18(24):6384-6387.
of a selective inhibitor of nuclear export, selinexor (KPT-330),
against AML-initiating cells engrafted into immunosuppressed NSG Evering TH, Applebaum A, Mar ML, Garmon D, Dorfman D, Markowitz
mice. Leukemia. 2016;30(1):190-199. PMCID: PMC4994896 M. Rates of non-confounded HIV-associated neurocognitive disorders
in men initiating combination antiretroviral therapy during primary
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge infection. AIDS. 2016;30(2):203-210. PMCID: PMC4685724
DR, Cheney RT, Chirieac LR, D’Amico TA, Dilling T, Dobelbower M,
Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Expert Panel on Radiation Oncology—Lymphoma, Roberts KB, Younes A,
Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe
Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM,
Sharma N, Swanson SJ, Stevenson J, Tauer K, Yang SC, Gregory K, Terezakis SA, Winkfield KM, Constine LS. ACR Appropriateness Criteria®
Hughes M. NCCN Guidelines® Insights: Malignant pleural mesothelioma, Hodgkin lymphoma — Unfavorable clinical stage I and II. American
version 3.2016. Journal of the National Comprehensive Cancer Journal of Clinical Oncology: Cancer Clinical Trials. 2016;39(4):384-395.
Network. 2016;14(7):825-836.
Fabian CJ, Meyskens FL Jr, Bajorin DF, George TJ Jr, Jeter JM, Khan S,
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge Tyne CA, William WN Jr. Barriers to a career focus in cancer prevention: A
DR, Cheney RT, Chirieac LR, D’Amico TA, Dilling TJ, Dobelbower MC, report and initial recommendations from the American Society of Clinical
Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti Oncology Cancer Prevention Workforce Pipeline Work Group. Journal of
M, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel JD, Pisters Clinical Oncology. 2016;34(2):186-193. PMCID: PMC5070551
KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Stevenson J,
Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. NCCN Guidelines® Fader AN, Java J, Tenney M, Ricci S, Gunderson CC, Temkin SM,
Insights: Non-small cell lung cancer, version 4.2016 . Journal of the Spirtos N, Kushnir CL, Pearl ML, Zivanovic O, Tewari KS, O’Malley
National Comprehensive Cancer Network. 2016;14(3):255-264. D, Hartenbach EM, Hamilton CA, Gould NS, Mannel RS, Rodgers W,
Walker JL. Impact of histology and surgical approach on survival
Eubank MH, Hyman DM, Kanakamedala AD, Gardos SM, Wills among women with early-stage, high-grade uterine cancer: An NRG
JM, Stetson PD. Automated eligibility screening and monitoring for Oncology/Gynecologic Oncology Group ancillary analysis. Gynecologic
genotype-driven precision oncology trials. Journal of the American Oncology. 2016;143(3):460-465. PMCID: PMC5116702
Medical Informatics Association. 2016;23(4):777-781.
Fagin JA, Wells SA Jr. The authors reply. New England Journal of
Evaluation of Genomic Applications in Practice and Prevention Medicine. 2016;375(23):2307.
(EGAPP) Working Group. Recommendations from the EGAPP Working
85 OF 324
Journal Articles
Fagin JA, Wells SA. Biologic and clinical perspectives on thyroid Farjah F, Wood DE, Zadworny ME, Rusch VW, Rizk NP. Resected
cancer. New England Journal of Medicine. 2016;375(11):1054-1067. lung cancer patients who would and would not have met screening
criteria. Annals of Thoracic Surgery. 2016;101(1):274-279. PMCID:
Fagin JA, Wells SA. The authors reply. New England Journal of PMC4755482
Medicine. 2016;375(23):2307-2307.
Fattahi F, Steinbeck JA, Kriks S, Tchieu J, Zimmer B, Kishinevsky
Fairweather M, Balachandran VP, D’Angelica M I. Surgical management S, Zeltner N, Mica Y, El-Nachef W, Zhao H, de Stanchina E,
of biliary tract cancers. Chinese Clinical Oncology. 2016;5(5):63. Gershon MD, Grikscheit TC, Chen S, Studer L. Deriving human
ENS lineages for cell therapy and drug discovery in Hirschsprung
Faltas BM, Prandi D, Tagawa ST, Molina AM, Nanus DM, Sternberg disease. Nature. 2016;531(7592):105-109. PMCID: PMC4846424
C, Rosenberg J, Mosquera JM, Robinson B, Elemento O, Sboner A,
Beltran H, Demichelis F, Rubin MA. Clonal evolution of chemotherapy- Fave GD, O’Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, Ferone D,
resistant urothelial carcinoma. Nature Genetics. 2016;48(12):1490-1499. Ito T, Weber W, Zheng-Pei Z, De Herder WW, Pascher A, Ruszniewski
P, all other Vienna Consensus Conference participants. ENETS
Fan J, Khanin R, Sakamoto H, Zhong Y, Michael C, Pena D, Javier consensus guidelines update for gastroduodenal neuroendocrine
B, Wood LD, Iacobuzio-Donahue CA. Quantification of nucleic neoplasms. Neuroendocrinology. 2016;103(2):119-124.
acid quality in postmortem tissues from a cancer research autopsy
program. Oncotarget. 2016;7(41):66906-66921. Fay AP, de Velasco G, Ho TH, Van Allen EM, Murray B, Albiges L,
Signoretti S, Hakimi AA, Stanton ML, Bellmunt J, McDermott DF,
Fan X, Rudensky AY. Hallmarks of tissue-resident Atkins MB, Garraway LA, Kwiatkowski DJ, Choueiri TK. Whole-
lymphocytes. Cell. 2016;164(6):1198-1211. PMCID: PMC4973889 exome sequencing in two extreme phenotypes of response to
VEGF-targeted therapies in patients with metastatic clear cell renal
Fanning SW, Mayne CG, Dharmarjan V, Carlson KE, Martin TA, Novick
cell carcinoma. Journal of the National Comprehensive Cancer
SJ, Toy W, Green B, Panchamukhi S, Katzenellenbogen BS, Tajkhorshid
Network. 2016;14(7):820-824.
E, Griffin PR, Shen Y, Chandarlapaty S, Katzenellenbogen JA, Greene
GL. Estrogen receptor alpha somatic mutations Y537S and D538G Fear JM, León-Novelo LG, Morse AM, Gerken AR, Van Lehmann K, Tower
confer breast cancer endocrine resistance by stabilizing the activating J, Nuzhdin S V, McIntyre LM. Buffering of genetic regulatory networks
function-2 binding conformation. eLife. 2016;5:e12792. PMCID: in Drosophila melanogaster. Genetics. 2016;203(3):1177-1190. PMCID:
PMC4821807 PMC4937466
Faraz S, Pannullo S, Rosenblum M, Smith A, Wernicke AG. Long-term Fedoriw Y, Dogan A. The expanding spectrum of follicular
survival in a patient with glioblastoma on antipsychotic therapy for lymphoma. Surgical Pathology Clinics. 2016;9(1):29-40.
schizophrenia: A case report and literature review. Therapeutic Advances
in Medical Oncology. 2016;8(6):421-428. PMCID: PMC5066542 Feldman DR, Hu J, Dorff TB, Lim K, Patil S, Woo KM, Carousso
M, Hughes A, Sheinfeld J, Bains M, Daneshmand S, Ketchens C, Bajorin
Farhangkhoee H, Matros E, Disa J. Trends and concepts in DF, Bosl GJ, Quinn D I, Motzer RJ. Paclitaxel, ifosfamide, and cisplatin
post-mastectomy breast reconstruction. Journal of Surgical efficacy for first-line treatment of patients with intermediate- or poor-risk
Oncology. 2016;113(8):891-894. germ cell tumors. Journal of Clinical Oncology. 2016;34(21):2478-2483.
86 OF 324
Journal Articles
Feldman DR, Lorch A, Kramar A, Albany C, Einhorn LH, Giannatempo Fernández R, Garate J, Lage S, Terés S, Higuera M, Bestard-Escalas
P, Necchi A, Flechon A, Boyle H, Chung P, Huddart RA, Bokemeyer J, Martin ML, López DH, Guardiola-Serrano F, Escribá P V, Barceló-Coblijn
C, Tryakin A, Sava T, Winquist EW, De Giorgi U, Aparicio J, Sweeney G, Fernández JA. Optimized protocol to analyze changes in the lipidome
CJ, Cedermark GC, Beyer J, Powles T. Brain metastases in patients of xenografts after treatment with 2-hydroxyoleic acid. Analytical
with germ cell tumors: Prognostic factors and treatment options - An Chemistry. 2016;88(1):1022-1029. PMCID: PMC5017204
analysis from the Global Germ Cell Cancer Group. Journal of Clinical
Oncology. 2016;34(4):345-351. PMCID: PMC5070579 Fernández-Tejada A, Tan DS, Gin DY. Development of improved vaccine
adjuvants based on the saponin natural product QS-21 through chemical
Fennell M, Simpson KJ. Society of Biomolecular Imaging and synthesis. Accounts of Chemical Research. 2016;49(9):1741-1756. PMCID:
Informatics special Issue, October 2016. Assay and Drug Development PMC5032057
Technologies. 2016;14(8):437-438.
Feucht J, Kayser S, Gorodezki D, Hamieh M, Döring M, Blaeschke
Fennell M, Simpson KJ. Society of Biomolecular Imaging F, Schlegel P, Bösmüller H, Quintanilla-Fend L, Ebinger M, Lang P,
and Informatics special issue. Assay and Drug Development Handgretinger R, Feuchtinger T. T-cell responses against CD19(+)
Technologies. 2016;14(7):365-366. pediatric acute lymphoblastic leukemia mediated by bispecific T-cell
engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on
Fenske TS, Ahn KW, Graff TM, DiGilio A, Bashir Q, Kamble RT, Ayala E, leukemic blasts. Oncotarget. 2016;7(47):76902-76919.
Bacher U, Brammer JE, Cairo M, Chen A, Chen YB, Chhabra S, D’Souza
A, Farooq U, Freytes C, Ganguly S, Hertzberg M, Inwards D, Jaglowski Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin
S, Kharfan-Dabaja MA, Lazarus HM, Nathan S, Pawarode A, Perales EB. Patterns of surveillance imaging after nephrectomy in the
MA, Reddy N, Seo S, Sureda A, Smith SM, Hamadani M. Allogeneic Medicare population. BJU International. 2016;117(2):280-286. PMCID:
transplantation provides durable remission in a subset of DLBCL PMC4426249
patients relapsing after autologous transplantation. British Journal of
Haematology. 2016;174(2):235-248. PMCID: PMC4940282 Feuerstein MA, Musser JE, Kent M, Chevinsky M, Cha EK, Kimm S, Hilton
WM, Sjoberg DD, Donahue TF, Vargas HA, Coleman JA, Russo P. Low
Fenske TS, Hamadani M, Cohen JB, Costa LJ, Kahl BS, Evens yield of surveillance imaging after surgery for T1 kidney cancer. World
AM, Hamlin PA, Lazarus HM, Petersdorf E, Bredeson C. Allogeneic Journal of Urology. 2016;34(7):949-953. PMCID: PMC4848182
hematopoietic cell transplantation as curative therapy for patients with
non-Hodgkin lymphoma: Increasingly successful application to older Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M,
patients. Biology of Blood and Marrow Transplantation. 2016;22(9):1543- Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Furberg H,
1551. PMCID: PMC4981559 Matullo G, Golka K, Gago-Dominguez M, Taylor JA, Fletcher T, Siddiq
A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J,
Fernandez FG, Kosinski AS, Burfeind W, Park B, DeCamp MM, Seder C, Porru S, Dinney CP, Malats N, Baris D, Purdue MP, Jacobs EJ, Albanes D,
Marshall B, Magee MJ, Wright CD, Kozower BD. The Society of Thoracic Wang Z, Chung CC, Vermeulen SH, Aben KK, Galesloot TE, Thorleifsson
Surgeons lung cancer resection risk model: Higher quality data and G, Sulem P, Stefansson K, Kiltie AE, Harland M, Teo M, Offit K, Vijai
superior outcomes. Annals of Thoracic Surgery. 2016;102(2):370- J, Bajorin D, Kopp R, Fiorito G, Guarrera S, Sacerdote C, Selinski S,
377. PMCID: PMC5016798 Hengstler JG, Gerullis H, Ovsiannikov D, Blaszkewicz M, Castelao JE,
87 OF 324
Journal Articles
Calaza M, Martinez ME, Cordeiro P, Xu Z, Panduri V, Kumar R, Gurzau E, pediatric neuro-oncology patients: An overview of the unique needs of
Koppova K, Bueno-De-Mesquita HB, Ljungberg B, Clavel-Chapelon F, children with brain tumors. Journal of Child Neurology. 2016;31(4):488-
Weiderpass E, Krogh V, Dorronsoro M, Travis RC, Tjønneland A, Brennan 505. PMCID: PMC5032907
P, Chang-Claude J, Riboli E, Conti D, Stern MC, Pike MC, Van Den Berg
D, Yuan JM, Hohensee C, Jeppson RP, Cancel-Tassin G, Roupret M, Fischer-Cartlidge E, Dicenso D, Buckley M, Villanueva R. A review of
Comperat E, Turman C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, common oral treatments for breast cancer: Improving patient safety in
Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, Kamat AM, nononcology settings. American Journal of Nursing. 2016;116(10):28-36.
Zhang L, Gong Y, Pu X, Hutchinson A, Burdett L, Wheeler WA, Karagas
MR, Johnson A, Schned A, Monawar Hosain GM, Schwenn M, Kogevinas Fischer-Cartlidge E, Romanoff S, Thom B, Walters CB. Comparing
M, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Andriole G self-injection teaching strategies for patients with breast cancer
Jr, Robert G 3rd, Black A, Diver WR, Gapstur SM, Weinstein S, Virtamo J, and their caregivers: A pilot study. Clinical Journal of Oncology
Haiman CA, Landi MT, Caporaso NE, Joseph F Jr, Vineis P, Wu X, Chanock Nursing. 2016;20(5):515-521.
SJ, Silverman DT, Prokunina-Olsson L, Rothman N. Identification of a
Fisher CG, Rhines LD, Bettegowda C, Germscheid NM, Laufer I,
novel susceptibility locus at 13q34 and refinement of the 20p12.2 region
Dea N, Bilsky MH, Verlaan JJ, Reynolds JJ, Sciubba DM, Williams
as a multi-signal locus associated with bladder cancer risk in individuals
R, Ailon T, Yamada YJ, Varga PP, Boriani S, Gokaslan ZL, Sahgal
of European ancestry. Human Molecular Genetics. 2016;25(6):1203-
A. Introduction to focus issue II in spine oncology: Evidence-based
1214. PMCID: PMC4817084
medicine recommendations for spine oncology. Spine. 2016;41(Suppl.
Filosso PL, Yao X, Ruffini E, Ahmad U, Antonicelli A, Huang J, 20):S159-S162.
Guerrera F, Venuta F, van Raemdonck D, Travis W, Lucchi M, Rimner
Fisicaro RA, Jost E, Shaw K, Brennan NP, Peck KK, Holodny A I. Cortical
A, Thomas P, Weder W, Rocco G, Detterbeck F, Korst R. Comparison
plasticity in the setting of brain tumors. Topics in Magnetic Resonance
of outcomes between neuroendocrine thymic tumours and other
subtypes of thymic carcinomas: A joint analysis of the European
Society of Thoracic Surgeons and the International Thymic Fizazi K, Chi KN, de Bono JS, Gomella LG, Miller K, Rathkopf DE, Ryan
Malignancy Interest Group. European Journal of Cardio-Thoracic CJ, Scher H I, Shore ND, De Porre P, Londhe A, McGowan T, Pelhivanov
Surgery. 2016;50(4):766-771. N, Charnas R, Todd MB, Montgomery B. Low incidence of corticosteroid-
associated adverse events on long-term exposure to low-dose prednisone
Fiorese CJ, Schulz AM, Lin YF, Rosin N, Pellegrino MW, Haynes
given with abiraterone acetate to patients with metastatic castration-
CM. The transcription factor ATF5 mediates a mammalian mitochondrial
resistant prostate cancer. European Urology. 2016;70(3):438-444.
UPR. Current Biology. 2016;26(15):2037-2043. PMCID: PMC4980197
Fizazi K, Flaig TW, Stöckle M, Scher H I, de Bono JS, Rathkopf DE, Ryan
Fischer BM, Siegel BA, Weber WA, von Bremen K, Beyer T, Kalemis
CJ, Kheoh T, Li J, Todd MB, Griffin TW, Molina A, Ohlmann CH. Does
A. PET/CT is a cost-effective tool against cancer: Synergy supersedes
Gleason score at initial diagnosis predict efficacy of abiraterone acetate
singularity. European Journal of Nuclear Medicine and Molecular
therapy in patients with metastatic castration-resistant prostate
cancer? An analysis of abiraterone acetate phase III trials. Annals of
Fischer C, Petriccione M, Donzelli M, Pottenger E. Improving care in Oncology. 2016;27(4):699-705.
88 OF 324
Journal Articles
Flavell RR, Truillet C, Regan MK, Ganguly T, Blecha JE, Kurhanewicz Foss F, Horwitz S, Pro B, Prince HM, Sokol L, Balser B, Wolfson J,
J, Vanbrocklin HF, Keshari KR, Chang CJ, Evans MJ, Wilson Coiffier B. Romidepsin for the treatment of relapsed/refractory
DM. Caged [(18)F]FDG glycosylamines for imaging acidic tumor peripheral T cell lymphoma: Prolonged stable disease provides clinical
microenvironments using positron emission tomography. Bioconjugate benefits for patients in the pivotal trial. Journal of Hematology &
Chemistry. 2016;27(1):170-178. PMCID: PMC4854293 Oncology. 2016;9(1):243. PMCID: PMC4785666
Fleming C, Rimner A, Cohen GN, Woo KM, Zhang Z, Rosenzweig Fossati N, Passoni NM, Moschini M, Gandaglia G, Larcher A, Freschi M,
KE, Alektiar KM, Zelefsky MJ, Bains MS, Wu AJ. High- and low-dose-rate Guazzoni G, Sjoberg DD, Vickers AJ, Montorsi F, Briganti A. Impact
intraoperative radiotherapy for thoracic malignancies resected with close or of stage migration and practice changes on high-risk prostate cancer:
positive margins. Brachytherapy. 2016;15(2):208-215. PMCID: PMC4789132 Results from patients treated with radical prostatectomy over the
last two decades. BJU International. 2016;117(5):740-747. PMCID:
Fleshner K, Assel M, Benfante N, Lee J, Vickers A, Fine S, Carlsson PMC5160041
S, Eastham J. Clinical findings and treatment outcomes in patients
with extraprostatic extension identified on prostate biopsy. Journal of Francis JH, Levin AM, Abramson DH. Update on ophthalmic oncology
Urology. 2016;196(3):703-708. PMCID: PMC5014705 2014: Retinoblastoma and uveal melanoma. Asia-Pacific Journal of
Ophthalmology. 2016;5(5):368-382.
Flory J, Farooki A. Diabetes management in cancer patients. Oncology
(Norwalk). 2016;30(6):565-568, 570. Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier
FL. Reply. Ophthalmology. 2016;123(2):e10-e11.
Flory JH, Wiesenthal AC, Thaler HT, Koranteng L, Moryl N. Methadone
use and the risk of hypoglycemia for inpatients with cancer pain. Journal Francis JH, Marr BP, Abramson DH. Classification of vitreous seeds
of Pain and Symptom Management. 2016;51(1):79-87.e1. in retinoblastoma correlations with patient, tumor, and treatment
characteristics. Ophthalmology. 2016;123(7):1601-1605. PMCID: PMC4921347
Fong CS, Mazo G, Das T, Goodman J, Kim M, O’Rourke BP,
Izquierdo D, Tsou MFB. 53BP1 and USP28 mediate p53-dependent Francis JH, Marr BP, Brodie SE, Gobin P, Dunkel IJ, Abramson
cell cycle arrest in response to centrosome loss and prolonged DH. Intravitreal melphalan as salvage therapy for refractory
mitosis. eLife. 2016;5:e16270. PMCID: PMC4946878 retinal and subretinal retinoblastoma. Retinal Cases and Brief
Reports. 2016;10(4):357-360. PMCID: PMC4917462
Fontenla DP, Ezzell GA. Point/counterpoint: Medical physicist assistants
are a bad idea. Medical Physics. 2016;43(1):1-3. Francis JH, Mondesire-Crump I, Marr BP, Brodie SE, Abramson
DH. Cytopathological evaluation of ocular surface and needle washings
Forlenza CJ, Boudreau JE, Zheng J, Le Luduec JB, Chamberlain following intravitreal melphalan injections for retinoblastoma. Journal of
E, Heller G, Cheung NK V, Hsu KC. KIR3DL1 allelic polymorphism Pediatric Ophthalmology & Strabismus. 2016;53(2):96-98.
and HLA-B epitopes modulate response to anti-GD2 monoclonal
antibody in patients with neuroblastoma. Journal of Clinical Francis JH, Wiesner T, Milman T, Won HH, Lin A, Lee V, Albert DM,
Oncology. 2016;34(21):2443-2451. PMCID: PMC4962735 Folberg R, Berger MF, Char DH, Marr B, Abramson DH. Investigation
of somatic GNAQ, GNA11, BAP1 and SF3B1 mutations in ophthalmic
89 OF 324
Journal Articles
melanocytomas. Ocular Oncology and Pathology. 2016;2(3):171- that may predict response to immune checkpoint inhibition. Current
177. PMCID: PMC4881266 Oncology Reports. 2016;18(4):1-7. PMCID: PMC5063308
Francis JH. Is surveillance of uveal melanoma just a screen?. JAMA Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the immune-
Ophthalmology. 2016;134(2):180-181. related adverse effects of immune checkpoint inhibitors: A review. JAMA
Oncology. 2016;2(10):1346-1353.
François P, Altan-Bonnet G. The case for absolute ligand discrimination:
Modeling information processing and decision by immune T cells. Journal Friedman CF, Wolchok JD. Patient-physician communication in the 21st
of Statistical Physics. 2016;162(5):1130-1152. century. Trends in Immunology. 2016;37(6):347-349.
Franklin RA, Li MO. Ontogeny of tumor-associated macrophages and Friedman DN, Chou JF, Oeffinger KC, Kleinerman RA, Ford JS, Sklar
its implication in cancer regulation. Trends in Cancer. 2016;2(1):20- CA, Li Y, McCabe MS, Robison LL, Marr BP, Abramson DH, Dunkel
34. PMCID: PMC4772875 IJ. Chronic medical conditions in adult survivors of retinoblastoma:
Results of the Retinoblastoma Survivor Study. Cancer. 2016;122(5):773-
Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz 781. PMCID: PMC4764449
L, Punt CJA, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio
E, Souglakos J, Falcone A, Chibaudel B, Heinemann V, Moen J, De Friedman MD, Lacouture M, Dang C. Dermatologic adverse events
Gramont A, Sargent DJ, Grothey A. Prognosis of patients with peritoneal associated with use of adjuvant lapatinib in combination with paclitaxel
metastatic colorectal cancer given systemic therapy: An analysis of and trastuzumab for HER2-positive breast cancer: A case series
individual patient data from prospective randomised trials from the analysis. Clinical Breast Cancer. 2016;16(3):E69-E74.
Analysis and Research in Cancers of the Digestive System (ARCAD)
database. Lancet Oncology. 2016;17(12):1709-1719. Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD,
Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick
Fridriksson JÖ, Folkvaljon Y, Nilsson P, Robinson D, Franck-Lissbrant A, Johnson EM, Ardeshir-Rouhani-fard S, Einhorn LH, Lipshultz SE,
I, Ehdaie B, Eastham JA, Widmark A, Karlsson CT, Stattin P. Long-term Dolan ME, Travis LB. Comprehensive audiometric analysis of hearing
adverse effects after curative radiotherapy and radical prostatectomy: impairment and tinnitus after cisplatin-based chemotherapy in survivors
Population-based nationwide register study. Scandinavian Journal of of adult-onset cancer. Journal of Clinical Oncology. 2016;34(23):2712-
Urology. 2016;50(5):338-345. PMCID: PMC5020330 2720. PMCID: PMC5019759
Friedland BA, Stoner M, Chau MM, Plagianos MG, Govender S, Morar Frogge MH, McCabe MS. Introduction. Seminars in Oncology
N, Altini L, Skoler-Karpoff S, Ahmed K, Ramjee G, Monedi C, Maguire Nursing. 2016;32(2):77-78.
R, Lähteenmäki P. Baseline predictors of high adherence to a coitally
dependent microbicide gel based on an objective marker of use: Findings Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook
from the Carraguard phase 3 trial. AIDS and Behavior. 2016;20(11):2565- AM, del Zoppo GJ, Kumar M, Peerschke EIB, Stiefel MF, Teitelbaum JS,
2577. PMCID: PMC5069326 Wartenberg KE, Zerfoss CL. Guideline for reversal of antithrombotics in
intracranial hemorrhage: Executive summary. A statement for healthcare
Friedman CF, Postow MA. Emerging tissue and blood-based biomarkers professionals from the Neurocritical Care Society and the Society of
90 OF 324
Journal Articles
Critical Care Medicine. Critical Care Medicine. 2016;44(12):2251-2257. of Biological Chemistry. 2016;291(12):6200-6217. PMCID: PMC4813546
Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook Fuller C, Cellura AP, Hibler BP, Burris K. Computer-assisted diagnosis of
AM, del Zoppo GJ, Kumar MA, Peerschke EIB, Stiefel MF, Teitelbaum JS, melanoma. Seminars in Cutaneous Medicine and Surgery. 2016;35(1):25-30.
Wartenberg KE, Zerfoss CL. Guideline for reversal of antithrombotics
in intracranial hemorrhage: A statement for healthcare professionals Fulmer CG, Hoda RS, Pirog EC, Park KJ, Holcomb K. Cytomorphology
from the Neurocritical Care Society and Society of Critical Care of gastric-type cervical adenocarcinoma on a ThinPrep
Medicine. Neurocritical Care. 2016;24(1):6-46. Pap test: Report of a p16-positive tumor case. Diagnostic
Cytopathology. 2016;44(8):710-713.
Frosina D, Jungbluth AA. A novel technique for the generation of
multitissue blocks using a carrier. Applied Immunohistochemistry & Fung EK, Cheal SM, Fareedy SB, Punzalan B, Beylergil V, Amir
Molecular Morphology. 2016;24(9):668-672. J, Chalasani S, Weber WA, Spratt DE, Veach DR, Bander NH, Larson
SM, Zanzonico PB, Osborne JR. Targeting of radiolabeled J591
Frost M, Kingham TP, Ferrada P, Bickler SW. Funding for global surgical antibody to PSMA-expressing tumors: Optimization of imaging and
programs. Success in Academic Surgery. 2016;:109-113. therapy based on non-linear compartmental modeling. EJNMMI
Research. 2016;6(1):7. PMCID: PMC4723373
Fu J, Zhang N, Chou JH, Dong HJ, Lin SF, Ulrich-Merzenich GS, Chou
TC. Drug combination in vivo using combination index method: Taxotere Fung TC, Bessman NJ, Hepworth MR, Kumar N, Shibata N, Kobuley D, Wang
and T607 against colon carcinoma HCT-116 xenograft tumor in nude K, Ziegler CGK, Goc J, Shima T, Umesaki Y, Sartor RB, Sullivan K V, Lawley
mice. Synergy. 2016;3(3):15-30. TD, Kunisawa J, Kiyono H, Sonnenberg GF. Lymphoid-tissue-resident
commensal bacteria promote members of the IL-10 cytokine family to
Fu T, Liu Y, Li K, Wan W, Pappou EP, Iacobuzio-Donahue establish mutualism. Immunity. 2016;44(3):634-646. PMCID: PMC4845739
CA, Kerner Z, Baylin SB, Wolfgang CL, Ahuja N. Tumors with
unmethylated MLH1 and the CpG island methylator phenotype Funt SA, Chapman PB. The role of neoadjuvant trials
are associated with a poor prognosis in stage II colorectal cancer in drug development for solid tumors. Clinical Cancer
patients. Oncotarget. 2016;7(52):86480-86489. Research. 2016;22(10):2323-2328.
Fu T, Pappou EP, Guzzetta AA, De Freitas Calmon M, Sun L, Herrera A, Funt SA, Feldman DR, Bosl GJ. The management of advanced germ
Li F, Wolfgang CL, Baylin SB, Iacobuzio-Donahue CA, Tong W, Ahuja cell tumors in 2016: The Memorial Sloan Kettering approach. Oncology
N. IGFBP-3 gene methylation in primary tumor predicts recurrence (Norwalk). 2016;30(7):653-664.
of stage II colorectal cancers. Annals of Surgery. 2016;263(2):337-
344. PMCID: PMC4648704 Fury MG, Xiao H, Sherman EJ, Baxi S, Smith-Marrone S, Schupak
K, Gewanter R, Gelblum D, Haque S, Schoder H, Shah JP, Katabi
Fu W, Sun J, Huang G, Liu JC, Kaufman A, Ryan RJH, Ramanathan N, Kurtzman R, Lipson B, Cox L, Lee NY, Pfister DG. Phase II trial of
SY, Venkatesh T, Singh B. Squamous cell carcinoma-related oncogene bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated
(SCCRO) family members regulate cell growth and proliferation through radiation therapy for patients with stage III/IVB head and neck squamous
their cooperative and antagonistic effects on cullin neddylation. Journal cell carcinoma. Head and Neck. 2016;38(Suppl. 1):E566-E570.
91 OF 324
Journal Articles
Fusco N, Colombo PE, Martelotto LG, De Filippo MR, Piscuoglio TCR downregulation. Nature Immunology. 2016;17(4):379-386. PMCID:
S, Ng CKY, Lim RS, Jacot W, Vincent-Salomon A, Reis-Filho PMC4803589
JS, Weigelt B. Resolving quandaries: Basaloid adenoid cystic
carcinoma or breast cylindroma? The role of massively parallel Gammoh N, Fraser J, Puente C, Syred HM, Kang H, Ozawa T,
sequencing. Histopathology. 2016;68(2):262-271. PMCID: PMC4637261 Lam D, Acosta JC, Finch AJ, Holland E, Jiang X. Suppression
of autophagy impedes glioblastoma development and induces
Fusco N, Geyer FC, De Filippo MR, Martelotto LG, Ng CKY, Piscuoglio senescence. Autophagy. 2016;12(9):1431-1439. PMCID: PMC5082770
S, Guerini-Rocco E, Schultheis AM, Fuhrmann L, Wang L, Jungbluth
AA, Burke KA, Lim RS, Vincent-Salomon A, Bamba M, Moritani S, Badve Gany F, Bari S, Gill P, Ramirez J, Ayash C, Loeb R, Aragones A, Leng
SS, Ichihara S, Ellis IO, Reis-Filho JS, Weigelt B. Genetic events in the J. Step on it! Workplace cardiovascular risk assessment of New
progression of adenoid cystic carcinoma of the breast to high-grade York City yellow taxi drivers. Journal of Immigrant and Minority
triple-negative breast cancer. Modern Pathology. 2016;29(11):1292- Health. 2016;18(1):118-134. PMCID: PMC4537410
1305. PMCID: PMC5083185
Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta
Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Landgren O, Greene EM, Litzow MR, Lee JW, Luger SM, Lazarus HM, Cripe LD, Tallman
MH. Brain tumors in patients with myotonic dystrophy: A population- MS. Extramedullary disease in adult acute myeloid leukemia is common
based study. European Journal of Neurology. 2016;23(3):542-547. but lacks independent significance: Analysis of patients in ECOG-
ACRIN Cancer Research Group trials, 1980-2008. Journal of Clinical
Gadhiya S, Madapa S, Kurtzman T, Alberts IL, Ramsey S, Pillarsetty Oncology. 2016;34(29):3544-3553. PMCID: PMC5074349
NK, Kalidindi T, Harding WW. Tetrahydroprotoberberine alkaloids
with dopamine and σ receptor affinity. Bioorganic & Medicinal Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk
Chemistry. 2016;24(9):2060-2071. PMCID: PMC4833520 D, Devlin S, Wang H, Zhang MJ, Weisdorf D, Douer D, Rowe JM, Polge
E, Esteve J, Nagler A, Mohty M, Tallman MS. Autologous transplant
Gajra A, Loh KP, Hurria A, Muss H, Maggiore R, Dale W, Klepin HD, remains the preferred therapy for relapsed APL in CR2. Bone Marrow
Magnuson A, Lichtman SM, Williams GR, Shahrokhni A, Mohile Transplantation. 2016;51(9):1180-1183. PMCID: PMC5014591
SG. Comprehensive geriatric assessment-guided therapy does improve
outcomes of older patients with advanced lung cancer. Journal of Clinical Gao D, Zhan Y, Di W, Moore AR, Sher JJ, Guan Y, Wang S, Zhang
Oncology. 2016;34(33):4047-4048. Z, Murphy DA, Sawyers CL, Chi P, Chen Y. ATmprss2-CreER(T2) knock-
in mouse model for cancer genetic studies on prostate and colon. PLoS
Galateau-Salle F, Churg A, Roggli V, Travis WD, on behalf of the ONE. 2016;11(8):e0161084. PMCID: PMC4990297
World Health Organization Committee for Tumors of the Pleura. The
2015 World Health Organization Classification of Tumors of the Gao H, Chakraborty G, Zhang Z, Akalay I, Gadiya M, Gao Y, Sinha S, Hu
Pleura: Advances since the 2004 Classification. Journal of Thoracic J, Jiang C, Akram M, Brogi E, Leitinger B, Giancotti F. Multi-organ site
Oncology. 2016;11(2):142-154. metastatic reactivation mediated by non-canonical discoidin domain
receptor 1 signaling. Cell. 2016;166(1):47-62. PMCID: PMC4980842
Gallegos AM, Xiong HZ, Leiner IM, Susac B, Glickman MS, Pamer
EG, van Heijst JWJ. Control of T cell antigen reactivity via programmed Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is
92 OF 324
Journal Articles
an autophagic cell death process. Cell Research. 2016;26(9):1021- Thornquist M, Le Marchand L, Potter J, Slattery ML, Zanke B, Baron JA,
1032. PMCID: PMC5034113 Caan BJ, Chanock SJ, Berndt S I, Stelling D, Fuchs CS, Hoffmeister M,
Butterbach K, Du M, James Gauderman W, Gunter MJ, Lemire M, Ogino
Gao P, Yang H, Rajashankar KR, Huang ZW, Patel DJ. Type V CRISPR- S, Lin J, Hayes RB, Haile RW, Schoen RE, Warnick GS, Jenkins MA,
Cas Cpf1 endonuclease employs a unique mechanism for crRNA- Thibodeau SN, Schumacher FR, Lindor NM, Kolonel LN, Hopper JL, Gong
mediated target DNA recognition. Cell Research. 2016;26(8):901- J, Seminara D, Pflugeisen BM, Ulrich CM, Qu C, Duggan D, Cotterchio
913. PMCID: PMC4973337 M, Campbell PT, Carlson CS, Newcomb PA, Giovannucci E, Hsu L, Chan
AT, Peters U, Chang-Claude J. CYP24A1 variant modifies the association
Gao SP, Chang Q, Mao N, Daly LA, Vogel R, Chan T, Liu SH, Bournazou between use of oestrogen plus progestogen therapy and colorectal
E, Schori E, Zhang H, Brewer MR, Pao W, Morris L, Ladanyi M, Arcila cancer risk. British Journal of Cancer. 2016;114(2):221-229. PMCID:
M, Manova-Todorova K, De Stanchina E, Norton L, Levine RL, Altan- PMC4815813
Bonnet G, Solit D, Zinda M, Huszar D, Lyden D, Bromberg JF. JAK2
inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to Gardenier JC, Hespe GE, Kataru RP, Savetsky IL, Torrisi JS, García
tyrosine kinase inhibitors. Science Signaling. 2016;9(421):ra33. PMCID: Nores GD, Dayan JJ, Chang D, Zampell J, Martínez-Corral I,
PMC4950506 Ortega S, Mehrara BJ. Diphtheria toxin-mediated ablation of
lymphatic endothelial cells results in progressive lymphedema. JCI
Garaulet DL, Sun K, Li W, Wen J, Panzarino AM, O’Neil JL, Insight. 2016;1(15):e84095. PMCID: PMC5033805
Robin Hiesinger P, Young MW, Lai EC. miR-124 regulates
diverse aspects of rhythmic behavior in Drosophila. Journal of Gardner EE, Rudin CM. Drug therapy: Preclinical oncology-reporting
Neuroscience. 2016;36(12):3414-3421. PMCID: PMC4804003 transparency needed. Nature Reviews Clinical Oncology. 2016;13(1):8-9.
Garcia B, Goodman KA, Cambridge L, Dunphy M, Wu AJ. Distribution of Garg V, Morgani S, Hadjantonakis AK. Capturing identity and fate
FDG-avid nodes in esophageal cancer: Implications for radiotherapy target ex vivo: Stem cells from the mouse blastocyst. Current Topics in
delineation. Radiation Oncology. 2016;11(1):156. PMCID: PMC5123237 Developmental Biology. 2016;120:361-400.
García Nores GD, Cuzzone DA, Albano NJ, Hespe GE, Kataru RP, Torrisi Garland SN, Gehrman P, Barg FK, Xie SX, Mao JJ. CHoosing Options for
JS, Gardenier JC, Savetsky IL, Aschen SZ, Nitti MD, Mehrara BJ. Obesity Insomnia in Cancer Effectively (CHOICE): Design of a patient centered
but not high-fat diet impairs lymphatic function. International Journal of comparative effectiveness trial of acupuncture and cognitive behavior
Obesity. 2016;40(10):1582-1590. PMCID: PMC5050064 therapy for insomnia. Contemporary Clinical Trials. 2016;47:349-355.
Garcia-Aguilar J, Glynne-Jones R, Schrag D. Multimodal rectal cancer Garner TP, Reyna DE, Priyadarshi A, Chen HC, Li S, Wu Y, Ganesan YT,
treatment: In some cases, less may be more. American Society of Clinical Malashkevich VN, Almo SS, Cheng EH, Gavathiotis E. An autoinhibited
Oncology educational book. American Society of Clinical Oncology. dimeric form of BAX regulates the BAX activation pathway. Molecular
Meeting. 2016;35:92-102. Cell. 2016;63(3):485-497. PMCID: PMC4975667
Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini
Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza
93 OF 324
Journal Articles
C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Milford D V, Saleem MA, Keng WT, Alexander S I, Valentini RP, Licht
Zaffaroni N, Daidone M, Sozzi G, Ferrari A. Anaplastic lymphoma C, Teh JC, Bogdanovic R, Koziell A, Bierzynska A, Soliman NA, Otto
kinase aberrations correlate with metastatic features in pediatric EA, Lifton RP, Holzman LB, Sibinga NES, Walz G, Tufro A, Hildebrandt
rhabdomyosarcoma. Oncotarget. 2016;7(37):58903-58914. F. FAT1 mutations cause a glomerulotubular nephropathy. Nature
Gauthier NP, Reznik E, Gao J, Sumer SO, Schultz N, Sander
C, Miller ML. MutationAligner: A resource of recurrent Geiger TL, Sun JC. Development and maturation of natural killer
mutation hotspots in protein domains in cancer. Nucleic Acids cells. Current Opinion in Immunology. 2016;39:82-89. PMCID:
Research. 2016;44(D1):D986-D991. PMCID: PMC4702822 PMC4801705
Gavrilov S, Lacy E. Symmetric BMPs on the developmental Gelblum DY, Thompson M, Wolden SL, Schupak KD, Berry SL, Lee
road. Developmental Cell. 2016;37(6):488-490. N. Neck spasms: A late sequela of head and neck irradiation. Oral
Oncology. 2016;57:e4-e5.
Gayvert KM, Dardenne E, Cheung C, Boland MR, Lorberbaum T, Wanjala
J, Chen Y, Rubin MA, Tatonetti NP, Rickman DS, Elemento O. A Gelhorn HL, Tong S, McQuarrie K, Vernon C, Hanlon J, Maclaine G,
computational drug repositioning approach for targeting oncogenic Lenderking W, Ye X, Speck RM, Lackman RD, Bukata S V, Healey JH,
transcription factors. Cell Reports. 2016;15(11):2348-2356. PMCID: Keedy VL, Anthony SP, Wagner AJ, Von Hoff DD, Singh AS, Becerra CR,
PMC4912004 Hsu HH, Lin PS, Tap WD. Patient-reported symptoms of tenosynovial
giant cell tumors. Clinical Therapeutics. 2016;38(4):778-793.
Gayvert KM, Madhukar NS, Elemento O. A data-driven approach
to predicting successes and failures of clinical trials. Cell Chemical Gemignani ML. Foreword: Trends in breast cancer treatment: Striving
Biology. 2016;23(10):1294-1301. PMCID: PMC5074862 to deliver optimal cancer treatment while avoiding morbidity. Clinical
Obstetrics and Gynecology. 2016;59(4):649-650.
Gebhart G, Flamen P, De Vries EGE, Jhaveri K, Wimana Z. Imaging
diagnostic and therapeutic targets: Human epidermal growth factor Genoff MC, Zaballa A, Gany F, Gonzalez J, Ramirez J, Jewell
receptor 2. Journal of Nuclear Medicine. 2016;57(Suppl. 1):81S-88S. ST, Diamond LC. Navigating language barriers: A systematic review
of patient navigators’ impact on cancer screening for limited English
Gedye C, Cardwell T, Dimopoulos N, Tan BS, Jackson H, Svobodová S, proficient patients. Journal of General Internal Medicine. 2016;31(4):426-
Anaka M, Behren A, Maher C, Hofmann O, Hide W, Caballero O, Davis 434. PMCID: PMC4803699
ID, Cebon J. Mycoplasma infection alters cancer stem cell properties in
vitro. Stem Cell Reviews and Reports. 2016;12(1):156-161. George S, Motzer RJ, Hammers HJ, Redman BG, Kuzel TM, Tykodi
SS, Plimack ER, Jiang J, Waxman IM, Rini B I. Safety and efficacy of
Gee HY, Sadowski CE, Aggarwal PK, Porath JD, Yakulov TA, Schueler nivolumab in patients with metastatic renal cell carcinoma treated
M, Lovric S, Ashraf S, Braun DA, Halbritter J, Fang H, Airik R, Vega- beyond progression: A subgroup analysis of a randomized clinical
Warner V, Jee Cho K, Chan TA, Morris LGT, Ffrench-Constant C, Allen trial. JAMA Oncology. 2016;2(9):1179-1186.
N, McNeill H, Büscher R, Kyrieleis H, Wallot M, Gaspert A, Kistler T,
94 OF 324
Journal Articles
Gerber PA, Buhren BA, Schrumpf H, Hevezi P, Bölke E, Sohn D, Jänicke angioedema. Immunological Reviews. 2016;274(1):281-289.
RU, Belum VR, Robert C, Lacouture ME, Homey B. Mechanisms
of skin aging induced by EGFR inhibitors. Supportive Care in Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V,
Cancer. 2016;24(10):4241-4248. Bacher U, Dahi P, De Lima M, D’Souza A, Fenske TS, Ganguly S, Kharfan-
Dabaja MA, Prestidge TD, Savani BN, Smith SM, Sureda AM, Waller EK,
Gershenwald JE, Halpern AC, Sondak VK. Melanoma prevention-avoiding Jaglowski S, Herrera AF, Armand P, Salit RB, Wagner-Johnston ND, Fuchs
indoor tanning and minimizing overexposure to the sun. JAMA - Journal E, Bolaños-Meade J, Hamadani M. Reduced-intensity transplantation for
of the American Medical Association. 2016;316(18):1913-1914. lymphomas using haploidentical related donors versus HLA-matched
sibling donors: A center for international blood and marrow transplant
Gertz MA, Landau H, Comenzo RL, Seldin D, Weiss B, Zonder J, Merlini research analysis. Journal of Clinical Oncology. 2016;34(26):3141-
G, Schönland S, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie SD, 3149. PMCID: PMC5012706
Liedtke M. First-in-human phase I/II study of NEOD001 in patients with
light chain amyloidosis and persistent organ dysfunction. Journal of Giacalone NJ, Wu J, Chen MH, Renshaw A, Loffredo M, Kantoff PW,
Clinical Oncology. 2016;34(10):1097-1103. D’Amico A V. Prostate-specific antigen failure and risk of death
within comorbidity subgroups among men with unfavorable-risk
Gertz MA, Landau HJ, Weiss BM. Organ response in patients prostate cancer treated in a randomized trial. Journal of Clinical
with AL amyloidosis treated with NEOD001, an amyloid- Oncology. 2016;34(31):3781-3786.
directed monoclonal antibody. American Journal of
Hematology. 2016;91(12):E506-E508. PMCID: PMC5132098 Gialleonardo VD, Wilson DM, Keshari KR. The potential of metabolic
imaging. Seminars in Nuclear Medicine. 2016;46(1):28-39. PMCID:
Getta BM, Woo KM, Devlin S, Park JH, Abdel-Wahab O, Saven A, PMC4686865
Rai K, Tallman MS. Treatment outcomes and secondary cancer
incidence in young patients with hairy cell leukaemia. British Journal of Gibbs DC, Orlow I, Bramson J I, Kanetsky PA, Luo L, Kricker A,
Haematology. 2016;175(3):402-409. Armstrong BA, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP,
Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ,
Gettinger S, Rizvi NA, Chow LQ, Borghaei H, Brahmer J, Ready N, Gerber Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE, on behalf of
DE, Shepherd FA, Antonia S, Goldman JW, Juergens RA, Laurie SA, the GEM Study Group. Association of interferon regulatory factor-4
Nathan FE, Shen Y, Harbison CT, Hellmann MD. Nivolumab monotherapy polymorphism rs12203592 with divergent melanoma pathways. JNCI:
for first-line treatment of advanced non-small-cell lung cancer. Journal of Journal of the National Cancer Institute. 2016;108(7):djw004. PMCID:
Clinical Oncology. 2016;34(25):2980-2987. PMC4948568
Geyer MB, Brentjens RJ. Review: Current clinical applications of chimeric Gilchrist ML, Ahn K, Li YM. Imaging and functional analysis of γ-secretase
antigen receptor (CAR) modified T cells. Cytotherapy. 2016;18(11):1393- and substrate in a proteolipobead system with an activity-based
1409. PMCID: PMC5067198 probe. Analytical Chemistry. 2016;88(2):1303-1311. PMCID: PMC4911041
Ghebrehiwet B, Kaplan AP, Joseph K, Peerschke EIB. The complement Giles AJ, Reid CM, De Wayne Evans J, Murgai M, Vicioso Y, Highfill SL,
and contact activation systems: Partnership in pathogenesis beyond Kasai M, Vahdat L, Mackall CL, Lyden D, Wexler L, Kaplan RN. Activation
95 OF 324
Journal Articles
of hematopoietic stem/progenitor cells promotes immunosuppression expression signature as an aid to the histologic classification of non-small
within the pre-metastatic niche. Cancer Research. 2016;76(6):1335- cell lung cancer. Clinical Cancer Research. 2016;22(19):4880-4889.
1347. PMCID: PMC4794356
Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW,
Gill M, González S. Enlightening the pink: Use of confocal microscopy in Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK. Locoregional
pink pesions. Dermatologic Clinics. 2016;34(4):443-458. recurrence after sentinel lymph node dissection with or without
axillary dissection in patients with sentinel lymph node metastases:
Gill RR, Naidich DP, Mitchell A, Ginsberg M, Erasmus J, Armato Long-term follow-up from the American College of Surgeons
SG III, Straus C, Katz S, Patios D, Richards WG, Rusch VW, Rice D, Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Annals of
Kindler HL, Vigneshwaran W, Friedberg J, De Perrot M, Giroux D, Surgery. 2016;264(3):413-420. PMCID: PMC5070540
Shemanski L. North American multicenter volumetric CT study for
clinical staging of malignant pleural mesothelioma: Feasibility and Givi B, Eskander A, Awad M I, Kong Q, Montero PH, Palmer FL, Xu W,
logistics of setting up a quantitative imaging study. Journal of Thoracic De Almeida JR, Lee N, O’Sullivan B, Irish JC, Gilbert RW, Ganly I, Patel
Oncology. 2016;11(8):1335-1344. PMCID: PMC5075991 SG, Goldstein DP, Morris LGT. Impact of elective neck dissection
on the outcome of oral squamous cell carcinomas arising in the
Gillaspie EA, Matsumoto JS, Morris NE, Downey RJ, Shen KR, Allen maxillary alveolus and hard palate. Head and Neck. 2016;38(Suppl.
MS, Blackmon SH. From 3-dimensional printing to 5-dimensional 1):E1688-E1694. PMCID: PMC4927080
printing: Enhancing thoracic surgical planning and resection of complex
tumors. Annals of Thoracic Surgery. 2016;101(5):1958-1962. PMCID: Glasgow SC, Morris AM, Baxter NN, Fleshman JW, Alavi KS, Luchtefeld MA,
PMC4997802 Monson JRT, Chang GJ, Temple LK. Development of The American Society
of Colon and Rectal Surgeons’ Rectal Cancer Surgery checklist. Diseases
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images are more than pictures, of the Colon and Rectum. 2016;59(7):601-606. PMCID: PMC4902168
they are data. Radiology. 2016;278(2):563-577. PMCID: PMC4734157
Glastonbury CM, Bhosale PR, Choyke PL, D’Orsi CJ, Erasmus JJ, Gill
Ginex PK, Hernandez M, Vrabel M. A clinical librarian-nursing partnership RR, Mukherji SK, Panicek DM, Schwartz LH, Subramaniam RM, Sullivan
to bridge clinical practice and research in an oncology setting. Oncology DC. Do radiologists have stage fright? Tumor staging and how we can
Nursing Forum. 2016;43(5):549-552. add value to the care of patients with cancer. Radiology. 2016;278(1):11-
12. PMCID: PMC4699490
Giralt S, Korngold R, Lazarus HM. Peer review in hematopoietic
cell transplantation: Are we doing our fair share?. Bone Marrow Glickman MS, Schluger N. Adding insult to injury: Exacerbating TB
Transplantation. 2016;51(9):1159-1162. risk with smoking. Cell Host & Microbe. 2016;19(4):432-433. PMCID:
PMC4990719
Giralt S. Allogeneic hematopoietic cell transplantation for
myelodysplastic syndromes: Where are we going with this?. Journal of Gluskin JS, Chegai F, Monti S, Squillaci E, Mannelli L. Hepatocellular
Oncology Practice. 2016;12(9):793-794. carcinoma and diffusion-weighted MRI: Detection and evaluation of
treatment response. Journal of Cancer. 2016;7(11):1565-1570. PMCID:
Girard L, Rodriguez-Canales J, Behrens C, Thompson DM, Botros IW, Tang PMC4964141
H, Xie Y, Rekhtman N, Travis WD, Wistuba I I, Minna JD, Gazdar AF. An
96 OF 324
Journal Articles
Godtman RA, Carlsson S, Holmberg E, Stranne J, Hugosson J. The for the Alliance for Clinical Trials in Oncology. Impact of neoadjuvant
effect of start and stop age at screening on the risk of being diagnosed therapy on eligibility for and frequency of breast conservation in stage
with prostate cancer. Journal of Urology. 2016;195(5):1390-1396. PMCID: II–III HER2-positive breast cancer: Surgical results of CALGB 40601
PMC4948858 (Alliance). Breast Cancer Research and Treatment. 2016;160(2):297-
304. PMCID: PMC5189982
Goh G, Walradt T, Makarov V, Blom A, Riaz N, Doumani R, Stafstrom
K, Moshiri A, Yelistratova L, Levinsohn J, Chan TA, Nghiem P, Gomez-Gelvez JC, Salama ME, Perkins SL, Leavitt M, Inamdar K
Lifton RP, Choi J. Mutational landscape of MCPyV-positive and V. Prognostic impact of tumor microenvironment in diffuse large B-cell
MCPyV-negative Merkel cell carcinomas with implications for lymphoma uniformly treated with R-CHOP chemotherapy. American
immunotherapy. Oncotarget. 2016;7(3):3403-3415. PMCID: Journal of Clinical Pathology. 2016;145(4):514-523.
PMC4823115
Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V, Larré S,
Goldberg AD, Tallman MS. Down for the count in acute myeloid Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Colombo R, Briganti A,
leukemia. Blood. 2016;128(18):2195-2197. Babjuk M, Soukup V, Malmström PU, Irani J, Malats N, Baniel J, Mano R,
Cai T, Cha EK, Ardelt P, Vakarakis J, Bartoletti R, Dalbagni G, Shariat SF,
Goldfarb SB, Kamer SA, Oppong BA, Eaton A, Patil S, Junqueira Xylinas E, Karnes RJ, Palou J. The impact of re-transurethral resection on
MJ, Olcese C, Kelvin JF, Gemignani ML. Fertility preservation clinical outcomes in a large multicentre cohort of patients with T1 high-
for the young breast cancer patient. Annals of Surgical grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin. BJU
Oncology. 2016;23(5):1530-1536. PMCID: PMC4880615 International. 2016;118(1):44-52.
Goldman DA, Panageas KS. Biases in estimation of overall survival in González F, Huangfu D. Mechanisms underlying the formation of induced
patients who underwent repeat resection of glioblastoma. Journal of pluripotent stem cells. Wiley Interdisciplinary Reviews: Developmental
Neurosurgery. 2016;125(2):519-521. Biology. 2016;5(1):39-65. PMCID: PMC4715477
Goldstein D, Rosenberg JE, Figlin RA, Townsend RR, McCann L, Gonzalez RS, Bagci P, Basturk O, Reid MD, Balci S, Knight JH, Kong
Carpenter C, Pandite L. Is change in blood pressure a biomarker of SY, Memis B, Jang KT, Ohike N, Tajiri T, Bandyopadhyay S, Krasinskas
pazopanib and sunitinib efficacy in advanced/metastatic renal cell AM, Kim GE, Cheng JD, Adsay N V. Intrapancreatic distal common bile
carcinoma?. European Journal of Cancer. 2016;53:96-104. duct carcinoma: Analysis, staging considerations, and comparison
with pancreatic ductal and ampullary adenocarcinomas. Modern
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt Pathology. 2016;29(11):1358-1369.
WEE, Nicholson AG, Groome P, Mitchell A, Bolejack V, International
Association for the Study of Lung Cancer Staging. The IASLC Lung Gonzalez-Aguirre AJ, Durack JC. Managing complications following
Cancer Staging Project: Proposals for revision of the TNM stage nephron-sparing procedures for renal masses. Techniques in Vascular and
groupings in the forthcoming (eighth) edition of the TNM Classification Interventional Radiology. 2016;19(3):194-202.
for Lung Cancer. Journal of Thoracic Oncology. 2016;11(1):39-51.
Good MJ, Hurley P, Woo KM, Szczepanek C, Stewart T, Robert N,
Golshan M, Cirrincione CT, Sikov WM, Carey LA, Berry DA, Overmoyer Lyss A, Gonen M, Lilenbaum R. Assessing clinical trial-associated
B, Henry NL, Somlo G, Port E, Burstein HJ, Hudis C, Winer E, Ollila DW, workload in community-based research programs using the ASCO
97 OF 324
Journal Articles
Clinical Trial Workload Assessment Tool. Journal of Oncology Gordon JN. Empowering oncology nurses to lead change through a
Practice. 2016;12(5):e536-e547. shared governance project. Oncology Nursing Forum. 2016;43(6):688-690.
Goodenberger ML, Thomas BC, Riegert-Johnson D, Boland CR, Plon Gordon M, Rodríguez VM, Shuk E, Schoenhammer M, Halpern AC,
SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK, Macrae Geller AC, Hay JL. Teen daughters and their mothers in conversation:
FA, Lynch HT, Weitzel JN, de la Chapelle A, Syngal S, Lynch P, Parry S, Identifying opportunities for enhancing awareness of risky tanning
Jenkins MA, Gallinger S, Holter S, Aronson M, Newcomb PA, Burnett T, behaviors. Journal of Adolescent Health. 2016;58(5):579-581. PMCID:
Le Marchand L, Pichurin P, Hampel H, Terdiman JP, Lu KH, Thibodeau PMC4933011
S, Lindor NM. PMS2 monoallelic mutation carriers: The known
unknown. Genetics in Medicine. 2016;18(1):13-19. PMCID: PMC4834863 Goss C, Avecilla ST, Garbaini J, Degtyaryova D, Lo D, Chang DYM,
Cushing M. Can the interval between antibody identifications be
Goodwin CR, Abu-Bonsrah N, Rhines LD, Verlaan JJ, Bilsky MH, Laufer I, increased for alloimmunized patients?. Transfusion. 2016;56(2):334-
Boriani S, Sciubba DM, Bettegowda C. Molecular markers and targeted 338. PMCID: PMC4984843
therapeutics in metastatic tumors of the spine: Changing the treatment
paradigms. Spine. 2016;41(Suppl. 20):S218-S223. Goss PE, Ingle JN, Pritchard K I, Robert NJ, Muss H, Gralow J,
Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff
Goodwin CR, Abu-Bonsrah N, Bilsky MH, Reynolds JJ, Rhines AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D,
LD, Laufer I, Disch AC, Bozsodi A, Patel SR, Gokaslan ZL, Sciubba Parulekar WR. Extending aromatase-inhibitor adjuvant therapy to 10
DM, Bettegowda C. Clinical decision making: Integrating advances in years. New England Journal of Medicine. 2016;375(3):209-219. PMCID:
the molecular understanding of spine tumors. Spine. 2016;41(Suppl. PMC5024713
20):S171-S177.
Gotlib J, Kluin-Nelemans HC, George T I, Akin C, Sotlar K, Hermine O,
Goodwin CR, Clarke MJ, Gokaslan ZL, Fisher C, Laufer I, Weber Awan FT, Hexner E, Mauro MJ, Sternberg DW, Villeneuve M, Labed AH,
MH, Sciubba DM. En bloc resection of solitary functional secreting Stanek EJ, Hartmann K, Horny HP, Valent P, Reiter A. Efficacy and safety
spinal metastasis. Global Spine Journal. 2016;6(3):277-283. PMCID: of midostaurin in advanced systemic mastocytosis. New England Journal
PMC4836935 of Medicine. 2016;374(26):2530-2541.
Goodwin CR, Yanamadala V, Ruiz-Valls A, Abu-Bonsrah N, Shankar G, Gounder MM, Zer A, Tap WD, Salah S, Dickson MA, Gupta
Sankey EW, Boone C, Clarke MJ, Bilsky M, Laufer I, Fisher C, Shin JH, AA, Keohan ML, Loong HH, D’Angelo SP, Baker S, Condy M,
Sciubba DM. A systematic review of metastatic hepatocellular carcinoma Nyquist-Schultz K, Tanner L, Erinjeri JP, Francis JH, Friedlander
to the spine. World Neurosurgery. 2016;91:510-517. S, Carlson R, Unger TJ, Saint-Martin JR, Rashal T, Ellis J, Kauffman
M, Shacham S, Schwartz GK, Abdul Razak AR. Phase IB study of
Gopal AK, Pro B, Connors JM, Younes A, Engert A, Shustov AR, Chi X, selinexor, a first-in-class inhibitor of nuclear export, in patients with
Larsen EK, Kennedy DA, Sievers EL. Response assessment in lymphoma: advanced refractory bone or soft tissue sarcoma. Journal of Clinical
Concordance between independent central review and local evaluation in Oncology. 2016;34(26):3166-3174.
a clinical trial setting. Clinical Trials. 2016;13(5):545-554.
98 OF 324
Journal Articles
Gracia-Cazaña T, González S, Gilaberte Y. Resistencias al tratamiento Frånlund M, Geterud K, Khatami A, Socratous A, Stranne J, Hellström
no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos M, Hugosson J. Role of magnetic resonance imaging in prostate cancer
tópicos. Actas Dermo-Sifiliográficas. 2016;107(9):730-739. screening: A pilot study within the Göteborg randomised screening
trial. European Urology. 2016;70(4):566-573. PMCID: PMC4958033
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A,
Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis Grewal RK, Ho A, Schöder H. Novel approaches to thyroid
CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, cancer treatment and response assessment. Seminars in Nuclear
Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Medicine. 2016;46(2):109-118. PMCID: PMC4761874
Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Invasive breast
cancer version 1.2016. Journal of the National Comprehensive Cancer Griffin M, Kosmisky DE, Templin MA, Huynh T, McCurdy LH 3rd, Pasquale
Network. 2016;14(3):324-354. TR, Martin KE. Antifungal use in immunocompetent, critically ill patients
with pneumonia does not improve clinical outcomes. Heart and Lung:
Graham MM, Weber WA. Evaluation of the efficacy of targeted imaging Journal of Acute and Critical Care. 2016;45(6):538-543.
agents. Journal of Nuclear Medicine. 2016;57(4):653-659. PMCID:
PMC4996268 Grimm J, Sahgal A, Soltys SG, Luxton G, Patel A, Herbert S, Xue J, Ma
L, Yorke E, Adler JR, Gibbs IC. Estimated risk level of unified stereotactic
Grant F, Brennan MF, Allen PJ, DeMatteo RP, Kingham TP, D’Angelica body radiation therapy dose tolerance limits for spinal cord. Seminars in
M, Fischer ME, Gonen M, Zhang H, Jarnagin WR. Prospective Radiation Oncology. 2016;26(2):165-171. PMCID: PMC4990135
randomized controlled trial of liberal vs restricted perioperative fluid
management in patients undergoing pancreatectomy. Annals of Grinnell SG, Ansonoff M, Marrone GF, Lu Z, Narayan A, Xu J, Rossi
Surgery. 2016;264(4):591-598. PMCID: PMC5017901 G, Majumdar S, Pan YX, Bassoni DL, Pintar J, Pasternak GW. Mediation
of buprenorphine analgesia by a combination of traditional and
Grassi R, Pinto A, Mannelli L, Marin D, Mazzei MA. New imaging truncated mu opioid receptor splice variants. Synapse. 2016;70(10):395-
in gastrointestinal tract. Gastroenterology Research and 407. PMCID: PMC4980214
Practice. 2016;2016:5785871. PMCID: PMC4757699
Grisham RN. Low-grade serous carcinoma of the ovary. Oncology
Greene K, Catona D, Elek E, Magsamen-Conrad K, Banerjee SC, Hecht (Norwalk). 2016;30(7):650-652.
ML. Improving prevention curricula: Lessons learned through formative
research on the youth message development curriculum. Journal of Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico
Health Communication. 2016;21(10):1071-1078. PMCID: PMC5059838 PB, Humm JL, Nehmeh SA. Feasibility of (18)F-fluoromisonidazole kinetic
modeling in head and neck cancer using shortened acquisition times. Journal
Grego Bessa J, Bloomekatz J, Castel P, Omelchenko of Nuclear Medicine. 2016;57(3):334-341. PMCID: PMC4977990
T, Baselga J, Anderson K V. The tumor suppressor PTEN and
the PDK1 kinase regulate formation of the columnar neural Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico
epithelium. eLife. 2016;5:e12034. PMCID: PMC4739759 PB, Humm JL, Nehmeh SA. Reproducibility of (18)F-fluoromisonidazole
intratumour distribution in non-small cell lung cancer. EJNMMI
Grenabo Bergdahl A, Wilderäng U, Aus G, Carlsson S, Damber JE, Research. 2016;6:79. PMCID: PMC5099292
99 OF 324
Journal Articles
Gronchi A, Guadagnolo BA, Erinjeri JP. Local ablative therapies to CA, Akram M, Fusco N, Ichihara S, Sakr RA, Yatabe Y, Vincent-Salomon
metastatic soft tissue sarcoma. American Society of Clinical Oncology A, Rakha EA, Ellis IO, Wen YH, Weigelt B, Schnitt SJ, Reis-Filho
Educational Book. 2016;36:e566-e575. JS. Microglandular adenosis associated with triple-negative breast cancer
is a neoplastic lesion of triple-negative phenotype harbouring TP53
Gross ND, Holsinger FC, Magnuson JS, Duvvuri U, Genden EM, Ghanem somatic mutations. Journal of Pathology. 2016;238(5):677-688. PMCID:
TAH, Yaremchuk KL, Goldenberg D, Miller MC, Moore EJ, Morris LGT, PMC4962789
Netterville J, Weinstein GS, Richmon J. Robotics in otolaryngology and
head and neck surgery: Recommendations for training and credentialing: Gugliemetti G, Sukhu R, Conca Baenas MA, Meeks J, Sjoberg
A report of the 2015 AHNS Education Committee, AAO-HNS Robotic DD, Eastham JA, Scardino PT, Touijer K. Number of metastatic
Task Force and AAO-HNS Sleep Disorders Committee. Head and lymph nodes as determinant of outcome after salvage radical
Neck. 2016;38:E151-E158. PMCID: PMC4927077 prostatectomy for radiation-recurrent prostate cancer. Actas Urológicas
Españolas. 2016;40(7):434-439.
Guacci A, Chetta M, Rizzo F, Marchese G, Filippo MRD, Giurato G, Nassa
G, Ravo M, Tarallo R, Rocco T, Operto FF, Weisz A, Coppola G. Phenytoin Guisado D I, Singh R, Minkowitz S, Zhou Z, Haque S, Peck KK, Young
neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene RJ, Tsiouris AJ, Souweidane MM, Thakur SB. A novel methodology for
mutations. Seizure. 2016;34:26-28. applying multivoxel mr spectroscopy to evaluate convection-enhanced
drug delivery in diffuse intrinsic pontine gliomas. American Journal of
Gucalp A, Iyengar NM, Hudis CA, Dannenberg AJ. Targeting obesity- Neuroradiology. 2016;37(7):1367-1373. PMCID: PMC4947015
related adipose tissue dysfunction to prevent cancer development
and progression. Seminars in Oncology. 2016;43(1):154-160. PMCID: Gulati N, Carvajal RD, Postow MA, Wolchok JD, Krueger JG. Definite
PMC4789163 regression of cutaneous melanoma metastases upon addition of topical
contact sensitizer diphencyprone to immune checkpoint inhibitor
Gucalp A, Traina TA. Targeting the androgen receptor in triple-negative treatment. Experimental Dermatology. 2016;25(7):553-554. PMCID:
breast cancer. Current Problems in Cancer. 2016;40(2-4):141-150. PMC4927368
Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli Gulati N, Garcet S, Fuentes-Duculan J, Gilleaudeau P, Sullivan-Whalen
F, Zeller M, Rochette L, Cottin Y, Vergely C. Obesity as a risk M, Li X, Suárez-Fariñas M, Coit DG, Krueger JG. Molecular profiling
factor for anthracyclines and trastuzumab cardiotoxicity in breast of immune activation associated with regression of melanoma
cancer: A systematic review and meta-analysis. Journal of Clinical metastases induced by diphencyprone. Journal of Investigative
Oncology. 2016;34(26):3157-3165. Dermatology. 2016;136(10):2101-2103.
Guerard EJ, Nightingale G, Bellizzi K, Burhenn P, Rosko A, Artz Gupta A, Long JB, Chen J, Gross CP, Feldman DR, Steingart RM. Risk of
AS, Korc-Grodzicki B, Canin B, Dale W, Ferrell B. Survivorship care for vascular toxicity with platinum based chemotherapy in elderly patients
older adults with cancer: U13 conference report. Journal of Geriatric with bladder cancer. Journal of Urology. 2016;195(1):33-40.
Gupta RK, Xie BH, Patton KT, Lisovsky M, Burks E, Behrman SW, Klimstra
Guerini-Rocco E, Piscuoglio S, Ng CKY, Geyer FC, De Filippo MR, Eberle D, Deshpande V. Follicular pancreatitis: A distinct form of chronic
100 OF 324
Journal Articles
pancreatitis—An additional mimic of pancreatic neoplasms. Human Gutiontov S, Leeman J, Lok B, Romesser P, Riaz N, Tsai CJ, Lee
Pathology. 2016;48:154-162. PMCID: PMC5023064 N, McBride S. Cervical nodal level V can safely be omitted in the
treatment of locally advanced oropharyngeal squamous cell carcinoma
Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, with definitive IMRT. Oral Oncology. 2016;58:27-31.
Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel
DE. Transforming growth factor-β is an upstream regulator of mammalian Guz N V, Patel SJ, Dokukin ME, Clarkson B, Sokolov I. AFM study
target of rapamycin complex 2-dependent bladder cancer cell migration shows prominent physical changes in elasticity and pericellular
and invasion. American Journal of Pathology. 2016;186(5):1351- layer in human acute leukemic cells due to inadequate cell-cell
1360. PMCID: PMC4861762 communication. Nanotechnology. 2016;27(49):494005. PMCID: PMC5221648
Gurion R, Mehta N, Migliacci JC, Zelenetz A, Moskowitz A, Lunning Guz N V, Patel SJ, Dokukin ME, Clarkson B, Sokolov I. Biophysical
M, Moskowitz C, Hamlin P, Horwitz S. Central nervous system differences between chronic myelogenous leukemic quiescent and
involvement in T-cell lymphoma: A single center experience. Acta proliferating stem/progenitor cells. Nanomedicine-Nanotechnology
Oncologica. 2016;55(5):561-566. Biology and Medicine. 2016;12(8):2429-2437. PMCID: PMC5116407
Guryanova OA, Lieu YK, Garrett-Bakelman FE, Spitzer B, Glass Haas RLM, Miah AB, LePechoux C, DeLaney TF, Baldini EH, Alektiar
JL, Shank K, Martinez AB V, Rivera SA, Durham BH, Rapaport F, Keller K, O’Sullivan B. Preoperative radiotherapy for extremity soft tissue
MD, Pandey S, Bastian L, Tovbin D, Weinstein AR, Teruya-Feldstein sarcoma; past, present and future perspectives on dose fractionation
J, Abdel-Wahab O, Santini V, Mason CE, Melnick AM, Mukherjee S, Levine regimens and combined modality strategies. Radiotherapy and
RL. Dnmt3a regulates myeloproliferation and liver-specific expansion Oncology. 2016;119(1):14-21.
of hematopoietic stem and progenitor cells. Leukemia. 2016;30(5):1133-
1142. PMCID: PMC4856586 Habous M, Farag M, Williamson B, Laban O, Mahmoud S, Abdelwahab O,
Elkhouly M, Kamil U, Binsaleh S, Tal R, Ralph D, Mulhall JP. Conservative
Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett- therapy is an effective option in patients with localized infection after
Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G, penile implant surgery. Journal of Sexual Medicine. 2016;13(6):972-976.
Rivera SA, Chramiec AG, Pronier E, Bastian L, Keller MD, Tovbin
D, Loizou E, Weinstein AR, Gonzalez AR, Lieu YK, Rowe JM, Pastore Haddad D, Socci N, Chen CH, Chen NG, Zhang Q, Carpenter SG, Mittra A,
F, McKenney AS, Krivtsov A V, Sperr WR, Cross JR, Mason CE, Tallman Szalay AA, Fong Y. Molecular network, pathway, and functional analysis
MS, Arcila ME, Abdel-Wahab O, Armstrong SA, Kubicek S, Staber of time-dependent gene changes associated with pancreatic cancer
PB, Gönen M, Paietta EM, Melnick AM, Nimer SD, Mukherjee S, Levine susceptibility to oncolytic vaccinia virotherapy. Molecular Therapy -
RL. DNMT3A mutations promote anthracycline resistance in acute Oncolytics. 2016;3:16008. PMCID: PMC4824563
myeloid leukemia via impaired nucleosome remodeling. Nature
Medicine. 2016;22(12):1488-1495. Hadjantonakis AK, Arias AM. Single-cell approaches: Pandora’s box of
developmental mechanisms. Developmental Cell. 2016;38(6):574-578.
Gutiontov S I, Shin EJ, Lok B, Lee NY, Cabanillas R. Intensity-
modulated radiotherapy for head and neck surgeons. Head and Hadoux J, Pacini F, Tuttle RM, Schlumberger M. Management of advanced
Neck. 2016;38(Suppl. 1):E2368-E2373. medullary thyroid cancer. Lancet Diabetes & Endocrinology. 2016;4(1):64-71.
101 OF 324
Journal Articles
Haeggstroem I, Beattie BJ, Schmidtlein CR. Dynamic PET simulator via Halpenny DF, Latson L, Mason D, Donnino R, Alpert J, Jacobs
tomographic emission projection for kinetic modeling and parametric JE. Intracardiac embolized prostate brachytherapy seeds:
image studies. Medical Physics. 2016;43(6):3104-3116. PMCID: Imaging features in patients undergoing electrocardiogram-gated
PMC4884183 cardiac computed tomography. Journal of Computer Assisted
Tomography. 2016;40(4):609-611.
Haka AS, Barbosa-Lorenzi VC, Lee HJ, Falcone DJ, Hudis CA,
Dannenberg AJ, Maxfield FR. Exocytosis of macrophage lysosomes leads Halpenny DF, Cunningham JD, Long NM, Sosa RE, Ginsberg MS. Patients
to digestion of apoptotic adipocytes and foam cell formation. Journal of with a previous history of malignancy undergoing lung cancer screening:
Lipid Research. 2016;57(6):980-992. PMCID: PMC4878183 Clinical characteristics and radiologic findings. Journal of Thoracic
Oncology. 2016;11(9):1447-1452.
Haka AS, Sue E, Zhang C, Bhardwaj P, Sterling J, Carpenter C, Leonard
M, Manzoor M, Walker J, Aleman JO, Gareau D, Holt PR, Breslow Halpern MT, McCabe MS, Burg MA. The cancer survivorship journey:
JL, Zhou XK, Giri D, Morrow M, Iyengar N, Barman I, Hudis CA, Models of care, disparities, barriers, and future directions. American
Dannenberg AJ. Noninvasive detection of inflammatory changes in Society of Clinical Oncology Educational Book. 2016;36:231-239.
white adipose tissue by label-free raman spectroscopy. Analytical
Chemistry. 2016;88(4):2140-2148. PMCID: PMC4799653 Halpern NA, Goldman DA, Tan KS, Pastores SM. Trends in critical
care beds and use among population groups and medicare and
Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo medicaid beneficiaries in the United States: 2000-2010. Critical Care
P, Winer AG, Mano R, Sankin A I, Motzer RJ, Voss MH, Offit K, Medicine. 2016;44(8):1490-1499.
Purdue M, Pomerantz M, Freedman M, Choueiri TK, Hsieh JJ,
Klein RJ. Validation and genomic interrogation of the MET variant Halpern NA. In between the intensive care unit and the ward. JAMA
rs11762213 as a predictor of adverse outcomes in clear cell renal cell Internal Medicine. 2016;176(10):1499-1500.
carcinoma. Cancer. 2016;122(3):402-410. PMCID: PMC4803437
Hamann J, Overholtzer M. Killing me softly: Microparticles target
Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna deformable cells. Cell Research. 2016;26(6):637-638. PMCID:
A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, PMC4897184
Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ. An
integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Hamilton JG, Lillie SE, Alden DL, Scherer L, Oser M, Rini C, Tanaka M,
Cell. 2016;29(1):104-116. PMCID: PMC4809063 Baleix J, Brewster M, Craddock Lee S, Goldstein MK, Jacobson RM,
Myers RE, Zikmund-Fisher BJ, Waters EA. What is a good medical
Halabi S, Kelly WK, Ma H, Zhou H, Solomon NC, Fizazi K, Tangen CM, decision? A research agenda guided by perspectives from multiple
Rosenthal M, Petrylak DP, Hussain M, Vogelzang NJ, Thompson IM, Chi stakeholders. Journal of Behavioral Medicine. 2016;40(1):52-68. PMCID:
KN, De Bono J, Armstrong AJ, Eisenberger MA, Fandi A, Li S, Araujo PMC5296255
JC, Logothetis CJ, Quinn D I, Morris MJ, Higano CS, Tannock IF, Small
EJ. Meta-analysis evaluating the impact of site of metastasis on overall Hamilton JG, Mays D, DeMarco T, Tercyak KP. Modeling the dyadic
survival in men with castration-resistant prostate cancer. Journal of effects of parenting, stress, and coping on parent–child communication
Clinical Oncology. 2016;34(14):1652-1659. PMCID: PMC4872320 in families tested for hereditary breast-ovarian cancer risk. Familial
Cancer. 2016;15(4):513-522. PMCID: PMC4982835
102 OF 324
Journal Articles
Hamilton JG, Shuk E, Arniella G, González CJ, Gold GS, Gany F, Robson Pelttari LM, Perkins B, Permuth-Wey J, Pike MC, Plisiecka-Halasa J, Poole
ME, Hay JL. Genetic testing awareness and attitudes among Latinos: EM, Risch HA, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB,
Exploring shared perceptions and gender-based differences. Public Rzepecka IK, Salvesen HB, Schernhammer E, Schmitt K, Schwaab I, Shu
Health Genomics. 2016;19(1):34-46. PMCID: PMC4706768 XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Tangen IL, Teo
SH, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, Tyrer J, van Altena
Hamlin PA. Obinutuzumab plus bendamustine in rituximab-refractory AM, Vergote I, Vierkant RA, Walsh C, Wang-Gohrke S, Wentzensen N,
indolent lymphoma. Lancet Oncology. 2016;17(8):1023-1025. Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang
H, Zheng W, Ziogas A, Gayther SA, Ramus SJ, Sellers TA, Schildkraut JM,
Hammer MJ, Eckardt P, Barton-Burke M. Informed consent: A clinical Phelan CM, Berchuck A, Chenevix-Trench G, Cunningham JM, Pharoah
trials perspective. Oncology Nursing Forum. 2016;43(6):694-696. PP, Ness RB, Odunsi K, Goode EL, Moysich KB. Assessment of variation in
immunosuppressive pathway genes reveals TGFBR2 to be associated with
Hammerling U. Retinol as electron carrier in redox signaling, a
risk of clear cell ovarian cancer. Oncotarget. 2016;7(43):69097-69110.
new frontier in vitamin A research. Hepatobiliary Surgery and
Nutrition. 2016;5(1):15-28. PMCID: PMC4739943 Han D, Lu X, Shih AH, Nie J, You Q, Xu MM, Melnick AM, Levine RL, He C. A
highly sensitive and robust method for genome-wide 5hmC profiling of rare
Hammerling U. Vitamin A as PKC co-factor and regulator of
cell populations. Molecular Cell. 2016;63(4):711-719. PMCID: PMC4992443
mitochondrial energetics. Sub-Cellular Biochemistry. 2016;81:201-230.
Hang L, Zhao X. The Rtt107 BRCT scaffold and its partner modification
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J,
enzymes collaborate to promote replication. Nucleus. 2016;7(4):346-
Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong
351. PMCID: PMC5038998
CC, Friel G, Davis W, Nesline M, Pearce CL, Kelemen LE, Goodman MT,
Bandera E V, Terry KL, Schoof N, Eng KH, Clay A, Singh PK, Joseph JM, Hansel DE, Reuter VE. Adrenal pathology in the adult: A
Aben KKH, Anton-Culver H, Antonenkova N, Baker H, Bean Y, Beckmann urological pathologist’s perspective. Advances in Anatomic
MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson Pathology. 2016;23(5):273-284.
A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW,
Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks Hansen A, Zhang J, Pritchard T, Melnic I. Letter to the editor: Author
E, Doherty JA, du Bois A, Dürst M, Easton D, Eccles D, Edwards RP, response. Current Medical Research and Opinion. 2016;32(9):1517.
Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG,
Glasspool R, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Hansen AR, Pritchard T, Melnic I, Zhang J. Physical activity, screen time,
Heitz F, Hildebrandt MAT, Hogdall C, Hogdall E, Hosono S, Iversen ES, and school absenteeism: Self-reports from NHANES 2005-2008. Current
Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney Medical Research and Opinion. 2016;32(4):651-659.
LA, Klapdor R, Kolomeyevskaya N, Krakstad C, Kjaer SK, Kruszka B,
Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele Hanson-Heath CA, Muller LM, Cunningham MF. Evaluating enhancements
S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, to a perioperative nurse liaison program. AORN Journal. 2016;103(4):414-
Lubinski J, Lundvall L, Massuger LFAG, Matsuo K, McGuire V, McLaughlin 420. PMCID: PMC5004248
JR, McNeish I, Menon U, Moes-Sosnowska J, Narod SA, Nedergaard L,
Nevanlinna H, Nickels S, Olson SH, Orlow I, Weber RP, Paul J, Pejovic T, Hantman AW, Kaltschmidt JA. Satb2 stations neurons along reflex
arcs. Neuron. 2016;91(4):711-713.
103 OF 324
Journal Articles
Harbi S, Wang R, Gregory M, Hanson N, Kobylarz K, Ryan K, Deng Y, Haseltine JM, Rimner A, Gelblum DY, Modh A, Rosenzweig KE, Jackson
Lopez P, Chiriboga L, Mignatti P. Infantile hemangioma originates from a A, Yorke ED, Wu AJ. Fatal complications after stereotactic body
dysregulated but not fully transformed multipotent stem cell. Scientific radiation therapy for central lung tumors abutting the proximal bronchial
Reports. 2016;6:35811. PMCID: PMC5081534 tree. Practical Radiation Oncology. 2016;6(2):e27-e33. PMCID: PMC4973477
Harding JJ, El Dika I, Abou-Alfa GK. Immunotherapy in hepatocellular Haser GC, Tuttle RM, Su HK, Alon EE, Bergman D, Bernet V, Brett E,
carcinoma: Primed to make a difference?. Cancer. 2016;122(3):367-377. Cobin R, Dewey EH, Doherty G, Dos Reis LL, Harris J, Klopper J, Lee
SL, Levine RA, Lepore SJ, Likhterov I, Lupo MA, Machac J, Mechanick
Harris B, Morjaria SM, Littmann ER, Geyer A I, Stover DE, Barker J I, Mehra S, Milas M, Orloff LA, Randolph G, Revenson TA, Roberts
JN, Giralt SA, Taur Y, Pamer EG. Gut microbiota predict pulmonary KJ, Ross DS, Rowe ME, Smallridge RC, Terris D, Tufano RP, Urken
infiltrates after allogeneic hematopoietic cell transplantation. American ML. Active surveillance for papillary thyroid microcarcinoma: New
Journal of Respiratory and Critical Care Medicine. 2016;194(4):450- challenges and opportunities for the health care system. Endocrine
463. PMCID: PMC5003327 Practice. 2016;22(5):602-611.
Hart SN, Maxwell KN, Thomas T, Ravichandran V, Wubberhorst B, Haser GC, Tuttle RM, Urken ML. Challenges of active surveillance
Klein RJ, Schrader K, Szabo C, Weitzel JN, Neuhausen SL, Nathanson protocols for low-risk papillary thyroid microcarcinoma in the United
K, Offit K, Couch FJ, Vijai J. Collaborative science in the next-generation States. Thyroid. 2016;26(7):989-990.
sequencing era: A viewpoint on how to combine exome sequencing data
across sites to identify novel disease susceptibility genes. Briefings in Hashimoto T, Krishnan R, Takeda T, Benfante N, Mulhall JP, Hricak
Bioinformatics. 2016;17(4):672-677. PMCID: PMC4945829 H, Eastham JA, Vargas HA. Prostate magnetic resonance imaging
findings in patients treated for testosterone deficiency while on active
Hartmann L, Drewe-Boß P, Wießner T, Wagner G, Geue S, Lee surveillance for low-risk prostate cancer. Urologic Oncology: Seminars
HC, Obermüller DM, Kahles A, Behr J, Sinz FH, Rätsch G, Wachter and Original Investigations. 2016;34(12):530.e9-530.e14.
A. Alternative splicing substantially diversifies the transcriptome during
early photomorphogenesis and correlates with the energy availability in Hatlen MA, Arora K, Vacic V, Grabowska EA, Liao W, Riley-Gillis B,
arabidopsis. Plant Cell. 2016;28(11):2715-2734. PMCID: PMC5155347 Oschwald DM, Wang L, Joergens JE, Shih AH, Rapaport F, Gu S, Voza F,
Asai T, Neel BG, Kharas MG, Gonen M, Levine RL, Nimer SD. Integrative
Hartnett J, Thom B, Kline N. Caregiver burden in end-stage ovarian genetic analysis of mouse and human AML identifies cooperating
cancer. Clinical Journal of Oncology Nursing. 2016;20(2):169-174. PMCID: disease alleles. Journal of Experimental Medicine. 2016;213(1):25-
PMC4996655 34. PMCID: PMC4710200
Hasan AN, Selvakumar A, Shabrova E, Liu XR, Afridi F, Heller Hatzoglou V, Karimi SK, Diamond EL, Lis E, Krol G, Holodny A I, Young
G, Riviere I, Sadelain M, Dupont B, O’Reilly RJ. Soluble and RJ. Nonenhancing leptomeningeal metastases: Imaging characteristics
membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate and potential causative factors. The Neurohospitalist. 2016;6(1):24-
proliferation of high-avidity central memory CD8(+) T cells for adoptive 28. PMCID: PMC4680901
immunotherapy of cancer and infections. Clinical and Experimental
104 OF 324
Journal Articles
Hatzoglou V, Omuro AM, Haque S, Khakoo Y, Ganly I, Oh JH, Shukla- Hay JL, Geller AC, Schoenhammer M, Gordon M, Bishop M, Shuk
Dave A, Fatovic R, Gaal J, Holodny A I. Second-opinion interpretations E, Oliveria S, Halpern AC. Tanning and beauty: Mother and teenage
of neuroimaging studies by oncologic neuroradiologists can help daughters in discussion. Journal of Health Psychology. 2016;21(7):1261-1270.
reduce errors in cancer care. Cancer. 2016;122(17):2708-2714. PMCID:
PMC4992439 Hay JL, Gold GS, Baser RE, Hricak H, Dauer LT. Prevalence and
correlates of worry about the health harms of medical imaging radiation
Hatzoglou V, Yang TJ, Omuro A, Gavrilovic I, Ulaner G, Rubel in the general population. Journal of Primary Care and Community
J, Schneider T, Woo KM, Zhang Z, Peck KK, Beal K, Young RJ. Health. 2016;7(4):219-225.
A prospective trial of dynamic contrast-enhanced MRI perfusion and
fluorine-18 FDG PET-CT in differentiating brain tumor progression from Hay JL, Ramos M, Li Y, Holland S, Brennessel D, Kemeny MM. Deliberative
radiation injury after cranial irradiation. Neuro-Oncology. 2016;18(6):873- and intuitive risk perceptions as predictors of colorectal cancer screening
880. PMCID: PMC4864262 over time. Journal of Behavioral Medicine. 2016;39(1):65-74. PMCID:
PMC4724274
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov
YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Hay JL, Zabor EC, Kumar J, Brennessel D, Kemeny MM, Lubetkin E
Sherman S I, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American I. Cancer beliefs and patient activation in a diverse, multilingual primary
Thyroid Association management guidelines for adult patients with care sample. Psycho-Oncology. 2016;25(9):1071-1078.
thyroid nodules and differentiated thyroid cancer: The American Thyroid
Association guidelines task force on thyroid nodules and differentiated Hayat S, Peters C, Shu N, Tsirigos KD, Elofsson A. Inclusion of dyad-
thyroid cancer. Thyroid. 2016;26(1):1-133. PMCID: PMC4739132 repeat pattern improves topology prediction of transmembrane β-barrel
proteins. Bioinformatics. 2016;32(10):1571-1573.
Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF,
Jackson RS, Moore EJ, Brandwein-Gensler M, Magnuson SJ, Carroll WR, Hayes SA, Pietanza MC, O’Driscoll D, Zheng J, Moskowitz CS, Kris
Jones TM, Wilkie MD, Lau A, Upile NS, Sheard J, Lancaster J, Tandon S, MG, Ginsberg MS. Comparison of CT volumetric measurement with
Robinson M, Husband D, Ganly I, Shah JP, Brizel DM, O’Sullivan B, Ridge RECIST response in patients with lung cancer. European Journal of
JA, Lydiatt WM. Pathology-based staging for HPV-positive squamous Radiology. 2016;85(3):524-533. PMCID: PMC4750046
carcinoma of the oropharynx. Oral Oncology. 2016;62:11-19.
Hayes-Jordan A, LaQuaglia MP, Modak S. Management of desmoplastic
Hawkins RB, Rosenberger LH, Swanson JC, Gangemi JJ, McGahren small round cell tumor. Seminars in Pediatric Surgery. 2016;25(5):299-304.
ED. Excision of an intrapericardial immature teratoma in a 26-
He J, Abdel-Wahab O, Nahas MK, Wang K, Rampal RK, Intlekofer
week premature neonate. Journal of Pediatric Surgery Case
AM, Patel J, Krivtsov A, Frampton GM, Young LE, Zhong S, Bailey
Reports. 2016;10:29-31. PMCID: PMC4920356
M, White JR, Roels S, Deffenbaugh J, Fichtenholtz A, Brennan T,
Hay JL, Brennessel D, Kemeny MM, Lubetkin E I. Examining intuitive Rosenzweig M, Pelak K, Knapp KM, Brennan KW, Donahue AL,
cancer risk perceptions in Haitian-Creole and Spanish-speaking Young G, Garcia L, Beckstrom ST, Zhao M, White E, Banning V, Buell
populations. Journal of Transcultural Nursing. 2016;27(4):368-375. J, Iwanik K, Ross JS, Morosini D, Younes A, Hanash AM, Paietta E,
Roberts K, Mullighan C, Dogan A, Armstrong SA, Mughal T, Vergilio
105 OF 324
Journal Articles
JA, Labrecque E, Erlich R, Vietz C, Yelensky R, Stephens PJ, Miller Analysis. 2016;22(2):263-279. PMCID: PMC4886856
VA, Van Den Brink MRM, Otto GA, Lipson D, Levine RL. Integrated
genomic DNA/RNA profiling of hematologic malignancies in the clinical Hellmann M, Rizvi N, Wolchok JD, Chan TA. Genomic profile,
setting. Blood. 2016;127(24):3004-3014. PMCID: PMC4968346 smoking, and response to anti-PD-1 therapy in non-small cell lung
carcinoma. Molecular & Cellular Oncology. 2016;3(1):e1048929. PMCID:
He Q, Kong L, Wang Y, Wang S, Chan TA, Holland E. Regularized quantile PMC4845184
regression under heterogeneous sparsity with application to quantitative
genetic traits. Computational Statistics and Data Analysis. 2016;95:222- Hellmann MD, Friedman CF, Wolchok JD. Combinatorial cancer
239. PMCID: PMC5267342 immunotherapies. Advances in Immunology. 2016;130:251-277.
He T, Kaplan S, Kamboj M, Tang YW. Laboratory diagnosis of Hellmann MD, Kris MG, Rudin CM. Medians and milestones in describing
central nervous system infection. Current Infectious Disease the path to cancer cures: Telling “tails”. JAMA Oncology. 2016;2(2):167-168.
Reports. 2016;18(11):35.
Hellmann MD, Li BT, Chaft JE, Kris MG. Chemotherapy remains
Healey JH. Editorial comment: 2014 Musculoskeletal Tumor an essential element of personalized care for persons with lung
Society. Clinical Orthopaedics and Related Research. 2016;474(3):640- cancers. Annals of Oncology. 2016;27(10):1829-1835. PMCID:
642. PMCID: PMC4746179 PMC5035786
Healey JH. Regorafenib: Efficacy in multiple refractory sarcoma Hellquist H, Skálová A, Barnes L, Cardesa A, Thompson LDR, Triantafyllou
types. Lancet Oncology. 2016;17(12):1633-1634. A, Williams MD, Devaney KO, Gnepp DR, Bishop JA, Wenig BM, Suárez C,
Rodrigo JP, Coca-Pelaz A, Strojan P, Shah JP, Hamoir M, Bradley PJ, Silver
Heaton TE, Davidoff AM. Surgical treatment of pulmonary metastases in CE, Slootweg PJ, Vander Poorten V, Teymoortash A, Medina JE, Robbins
pediatric solid tumors. Seminars in Pediatric Surgery. 2016;25(5):311-317. KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Eloy JA, Takes
RP, Rinaldo A, Ferlito A. Cervical lymph node metastasis in high-grade
Hechtman JF, Zehir A, Yaeger R, Wang L, Middha S, Zheng T, Hyman transformation of head and neck adenoid cystic carcinoma: A collective
DM, Solit D, Arcila ME, Borsu L, Shia J, Vakiani E, Saltz L, Ladanyi international review. Advances in Therapy. 2016;33(3):357-368. PMCID:
M. Identification of targetable kinase alterations in patients with colorectal PMC4833802
carcinoma that are preferentially associated with wild-type RAS/
RAF. Molecular Cancer Research. 2016;14(3):296-301. PMCID: PMC4972456 Henderson PW, Fernandez JG, Cemal Y, Mehrara BJ, Pusic
AL, McCarthy CM, Matros E, Cordeiro PG, Disa JJ. Successful salvage
Heeg S, Das KK, Reichert M, Bakir B, Takano S, Caspers J, Aiello NM, Wu of late anastomotic thrombosis after free tissue transfer. Journal of
K, Neesse A, Maitra A, Iacobuzio-Donahue CA, Hicks P, Rustgi AK. ETS- Reconstructive Microsurgery. 2016;32(4):316-323.
transcription factor ETV1 regulates stromal expansion and metastasis in
pancreatic cancer. Gastroenterology. 2016;151(3):540-553.e14. PMCID: Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang
PMC5002361 CT, Onel K, Friedman DN, Bhatia S, Strong LC, Stovall M, Kenney
LB, Barnea D, Lorenzi E, Hammond S, Leisenring WM, Robison
Heller G, Mo QX. Estimating the concordance probability in a LL, Armstrong GT, Diller LR, Oeffinger KC. Breast cancer risk in
survival analysis with a discrete number of risk groups. Lifetime Data childhood cancer survivors without a history of chest radiotherapy: A
106 OF 324
Journal Articles
report from the Childhood Cancer Survivor Study. Journal of Clinical Herold CJ, Lewin JS, Wibmer AG, Thrall JH, Krestin GP, Dixon AK,
Oncology. 2016;34(9):910-918. PMCID: PMC4871997 Schoenberg SO, Geckle RJ, Muellner A, Hricak H. Imaging in the
age of precision medicine: Summary of the proceedings of the 10th
Hendley AM, Wang YJ, Polireddy K, Alsina J, Ahmed I, Lafaro KJ, Zhang Biannual Symposium of the International Society for Strategic Studies in
H, Roy N, Savidge SG, Cao Y, Hebrok M, Maitra A, Reynolds AB, Goggins Radiology. Radiology. 2016;279(1):226-238.
M, Younes M, Iacobuzio-Donahue CA, Leach SD, Bailey JM. p120
catenin suppresses basal epithelial cell extrusion in invasive pancreatic Herr H, Donat SM. Commentary: Does asymptomatic bacteriuria
neoplasia. Cancer Research. 2016;76(11):3351-3363. PMCID: PMC4891257 reduce the risk of recurrence of non–muscle-invasive bladder
tumors?. Urology. 2016;98:1-3.
Hennessy S, Leonard C, Gagne JJ, Flory JH, Han X, Brensinger
CM, Bilker WB. Pharmacoepidemiologic methods for studying the Herr HW. Counterpoint: Is immediate radical cystectomy justified
health effects of drug-drug interactions. Clinical Pharmacology & when non-muscle-invasive bladder cancer first presents as
Therapeutics. 2016;99(1):92-100. PMCID: PMC4720556 high-grade T1 urothelial carcinoma on re-resection?. Oncology
(Norwalk). 2016;30(6):541, 543-544.
Henssen A, Althoff K, Odersky A, Beckers A, Koche R, Speleman F,
Schäfers S, Bell E, Nortmeyer M, Westermann F, De Preter K, Florin Herrera-Abreu MT, Palafox M, Asghar U, Rivas MA, Cutts RJ, Garcia-
A, Heukamp L, Spruessel A, Astrahanseff K, Lindner S, Sadowski N, Murillas I, Pearson A, Guzman M, Rodriguez O, Grueso J, Bellet M,
Schramm A, Astorgues-Xerri L, Riveiro ME, Eggert A, Cvitkovic E, Cortés J, Elliott R, Pancholi S, Baselga J, Dowsett M, Martin LA,
Schulte JH. Targeting MYCN-driven transcription by BET-bromodomain Turner NC, Serra V. Early adaptation and acquired resistance to
inhibition. Clinical Cancer Research. 2016;22(10):2470-2781. CDK4/6 inhibition in estrogen receptor-positive breast cancer. Cancer
Research. 2016;76(8):2301-2313.
Henssen AG, Jiang E, Zhuang J, Pinello L, Socci ND, Koche R, Gonen
M, Villasante CM, Armstrong SA, Bauer DE, Weng Z, Kentsis A. Forward Herrera-Almario G, Patane M, Sarkaria I, Strong VE. Initial report of near-
genetic screen of human transposase genomic rearrangements. BMC infrared fluorescence imaging as an intraoperative adjunct for lymph
Genomics. 2016;17(1):548. PMCID: PMC4973553 node harvesting during robot-assisted laparoscopic gastrectomy. Journal
of Surgical Oncology. 2016;113(7):768-770. PMCID: PMC4964277
Heritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa
S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clement C, Dijoud Herrera-Almario G, Strong VE. Minimally invasive gastric surgery. Annals
F, Rigau V, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Miron J, of Surgical Oncology. 2016;23(12):3792-3797. PMCID: PMC5201135
Jeziorski E, Plat G, Aladjidi N, Ferster A, Pacquement H, Galambrun C,
Brugieres L, Leverger G, Mansuy L, Paillard C, Deville A, Armari-Alla Herrinton LJ, Altschuler A, McMullen CK, Bulkley JE, Hornbrook MC, Sun
C, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, V, Wendel CS, Grant M, Baldwin CM, Demark-Wahnefried W, Temple LKF,
Pellier I, Millot F, Lescoeur B, Gandemer V, Bodemer C, Lacave R, Helias- Krouse RS. Conversations for providers caring for patients with rectal
Rodzewicz Z, Taly V, Geissmann F, Donadieu J. BRAF mutation correlates cancer: Comparison of long-term patient-centered outcomes for patients
with high-risk langerhans cell histiocytosis and increased resistance to with low rectal cancer facing ostomy or sphincter-sparing surgery. CA -
first-line therapy. Journal of Clinical Oncology. 2016;34(25):3023-3030. A Cancer Journal for Clinicians. 2016;66(5):387-397.
107 OF 324
Journal Articles
Herruzo E, Ontoso D, González-Arranz S, Cavero S, Lechuga A, San- Heung LJ, Hohl TM. DAP12 inhibits pulmonary immune responses to
Segundo PA. The Pch2 AAA+ ATPase promotes phosphorylation of Cryptococcus neoformans. Infection and Immunity. 2016;84(6):1879-
the Hop1 meiotic checkpoint adaptor in response to synaptonemal 1886. PMCID: PMC4907135
complex defects. Nucleic Acids Research. 2016;44(16):7722-7741.
PMCID: PMC5027488 Hibler BP, Qi Q, Rossi AM. Current state of imaging in
dermatology. Seminars in Cutaneous Medicine and Surgery. 2016;35(1):2-8.
Hertz DL, Owzar K, Lessans S, Wing C, Jiang C, Kelly WK, Patel J,
Halabi S, Furukawa Y, Wheeler HE, Sibley AB, Lassiter C, Weisman Hibler BP, Schwitzer J, Rossi AM. Assessing improvement of facial
L, Watson D, Krens SD, Mulkey F, Renn CL, Small EJ, Febbo PG, appearance and quality of life after minimally-invasive cosmetic
Shterev I, Kroetz DL, Friedman PN, Mahoney JF, Carducci MA, Kelley dermatology procedures using the FACE-Q scales. Journal of Drugs in
MJ, Nakamura Y, Kubo M, Dorsey SG, Dolan ME, Morris MJ, Ratain Dermatology. 2016;15(1):62-67. PMCID: PMC4980647
MJ, McLeod HL. Pharmacogenetic discovery in CALGB (Alliance)
90401 and mechanistic validation of a VAC14 polymorphism that Hibler BP, Sierra H, Cordova M, Phillips W, Rajadhyaksha M, Nehal
increases risk of docetaxel-induced neuropathy. Clinical Cancer KS, Rossi AM. Carbon dioxide laser ablation of basal cell carcinoma
Research. 2016;22(19):4890-4900. PMCID: PMC5050068 with visual guidance by reflectance confocal microscopy: A proof-of-
principle pilot study. British Journal of Dermatology. 2016;174(6):1359-
Herzlinger RE, Schleicher SM, Mullangi S. Health care delivery innovations 1364. PMCID: PMC4912952
that integrate care? Yes!: But integrating what?. JAMA - Journal of the
American Medical Association. 2016;315(11):1109-1110. Hicks AM, Chou J, Capanu M, Lowery MA, Yu KH, O’Reilly EM. Pancreas
adenocarcinoma: Ascites, clinical manifestations, and management
Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, implications. Clinical Colorectal Cancer. 2016;15(4):360-368. PMCID:
Danso MA, Jordan K, Somerfield MR, Kris MG. Antiemetics: American PMC5099112
Society of Clinical Oncology focused guideline update. Journal of Clinical
Oncology. 2016;34(4):381-386. Hicks MJ, Chiuchiolo MJ, Ballon D, Dyke JP, Aronowitz E, Funato K,
Tabar V, Havlicek D, Fan F, Sondhi D, Kaminsky SM, Crystal RG. Anti-
Hesketh PJ, Bohlke K, Kris MG. Antiemetics: American Society of epidermal growth factor receptor gene therapy for glioblastoma. PLoS
Clinical Oncology focused guideline update. Journal of Oncology ONE. 2016;11(10):e0162978. PMCID: PMC5053413
Practice. 2016;12(1):88-90.
Higgins MCSS, Hwang WT, Richard C, Chapman CH, Laporte A, Both S,
Hesketh PJ, Bohlke K, Kris MG. Reply to J. Jupp et al. Journal of Clinical Thomas CR Jr, Deville C. Underrepresentation of women and minorities in
Oncology. 2016;34(27):3353. the United States IR academic physician workforce. Journal of Vascular
and Interventional Radiology. 2016;27(12):1837-1844.e2.
Hespe GE, Kataru RP, Savetsky IL, García Nores GD, Torrisi JS, Nitti
MD, Gardenier JC, Zhou J, Yu JZ, Jones LW, Mehrara BJ. Exercise Hingorani P, Janeway K, Crompton BD, Kadoch C, Mackall CL, Khan
training improves obesity-related lymphatic dysfunction. Journal of J, Shern JF, Schiffman J, Mirabello L, Savage SA, Ladanyi M, Meltzer
Physiology. 2016;594(15):4267-4282. PMCID: PMC4967732 P, Bult CJ, Adamson PC, Lupo PJ, Mody R, DuBois SG, Parsons DW,
Khanna C, Lau C, Hawkins DS, Randall RL, Smith M, Sorensen PH,
108 OF 324
Journal Articles
Plon SE, Skapek SX, Lessnick S, Gorlick R, Reed DR. Current state of Hoang LN, Soslow RA. Small cell carcinoma of the ovary,
pediatric sarcoma biology and opportunities for future discovery: hypercalcemic type: Past, present, and future. AJSP: Reviews and
A report from the sarcoma translational research workshop. Cancer Reports. 2016;21(4):181-188.
Genetics. 2016;209(5):182-194.
Hobbs GS, Kaur N, Hilden P, Ponce D, Cho C, Castro-Malaspina
Hirschey R, Lipkus I, Jones L, Mantyh C, Sloane R, Demark-Wahnefried HR, Giralt S, Goldberg JD, Jakubowski AA, Papadopoulos EB, Sauter
W. Message framing and physical activity promotion in colorectal cancer C, Koehne G, Yahalom J, Devlin S, Barker JN, Perales MA. A novel
survivors. Oncology Nursing Forum. 2016;43(6):697-705. reduced intensity conditioning regimen for patients with high-
risk hematological malignancies undergoing allogeneic stem cell
Ho AL, Dunn L, Sherman EJ, Fury MG, Baxi SS, Chandramohan transplantation. Bone Marrow Transplantation. 2016;51(7):1010-1012.
R, Dogan S, Morris LGT, Cullen GD, Haque S, Sima CS, Ni A, Antonescu
CR, Katabi N, Pfister DG. A phase II study of axitinib (AG-013736) Hodak S, Tuttle RM, Maytal G, Nikiforov YE, Randolph G. Changing the
in patients with incurable adenoid cystic carcinoma. Annals of cancer diagnosis: The case of follicular variant of papillary thyroid cancer
Oncology. 2016;27(10):1902-1908. PMCID: PMC5035791 - Primum non nocere and NIFTP. Thyroid. 2016;26(7):869-871.
Ho AS, Zumsteg ZS, Meyer A, Riaz N, Rahmati R, Kraus DH, McCarthy Hodes RJ, Sierra F, Austad SN, Epel E, Neigh GN, Erlandson KM, Schafer
C, Wong RJ, Shah JP, Lee NY. Impact of flap reconstruction on MJ, LeBrasseur NK, Wiley C, Campisi J, Sehl ME, Scalia R, Eguchi S,
radiotoxicity after salvage surgery and reirradiation for recurrent head Kasinath BS, Halter JB, Cohen HJ, Demark-Wahnefried W, Ahles TA,
and neck cancer. Annals of Surgical Oncology. 2016;23(Suppl. 5):850- Barzilai N, Hurria A, Hunt PW. Disease drivers of aging. Annals of the New
857. PMCID: PMC5271365 York Academy of Sciences. 2016;1386(1):45-68.
Ho C, Kluk MJ. Molecular pathology: Predictive, prognostic, and Hodges TR, Ferguson SD, Caruso HG, Kohanbash G, Zhou SH, Cloughesy
diagnostic markers in lymphoid neoplasms. Surgical Pathology TF, Berger MS, Poste GH, Khasraw M, Ba SJ, Jiang T, Mikkelson T, Yung
Clinics. 2016;9(3):489-521. WKA, de Groot JF, Fine H, Cantley LC, Mellinghoff IK, Mitchell DA, Okada
H, Heimberger AB. Prioritization schema for immunotherapy clinical trials
Ho TC, Taggart J, Kharas MG. MUSASHI-2 duels in myelodysplastic in glioblastoma. OncoImmunology. 2016;5(6) PMCID: PMC4938323
syndromes. Cell Cycle. 2016;15(14):1799-1800. PMCID: PMC4968902
Hodi FS, Chesney J, Pavlick AC, Robert C, Grossmann KF, McDermott
Hoang LN, Lee YS, Karnezis AN, Tessier-Cloutier B, Almandani DF, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff
N, Coatham M, Gilks CB, Soslow RA, Stewart CJR, Köbel M, MS, Minor DR, Salama AK, Taylor MH, Ott PA, Horak C, Gagnier P, Jiang
Lee CH. Immunophenotypic features of dedifferentiated J, Wolchok JD. Combined nivolumab and ipilimumab versus ipilimumab
endometrial carcinoma – Insights from BRG1/INI1-deficient alone in patients with advanced melanoma: 2-year overall survival
tumours. Histopathology. 2016;69(4):560-569. outcomes in a multicentre, randomised, controlled, phase 2 trial. Lancet
Oncology. 2016;17(11):1558-1568.
Hoang LN, Park KJ, Soslow RA, Murali R. Squamous precursor
lesions of the vulva: Current classification and diagnostic Hodi FS, Hwu WJ, Kefford R, Weber JS, Daud A, Hamid O, Patnaik
challenges. Pathology. 2016;48(4):291-302. A, Ribas A, Robert C, Gangadhar TC, Joshua AM, Hersey P, Dronca
109 OF 324
Journal Articles
R, Joseph R, Hille D, Xue D, Li XN, Kang SP, Ebbinghaus S, Perrone S, Wilson LD, Choi J, Komaki R, Thomas CR Jr. Quantitative assessment
A, Wolchok JD. Evaluation of immune-related response criteria of target delineation variability for thymic cancers: Agreement
and RECIST v1.1 in patients with advanced melanoma treated with evaluation of a prospective segmentation challenge. Journal of Radiation
pembrolizumab. Journal of Clinical Oncology. 2016;34(13):1510- Oncology. 2016;5(1):55-61. PMCID: PMC4996619
1517. PMCID: PMC5070547
Holmgaard RB, Brachfeld A, Gasmi B, Jones DR, Mattar M, Doman T,
Hodi FS, Wolchok JD. Reply to M. Nishino. Journal of Clinical Murphy M, Schaer D, Wolchok JD, Merghoub T. Timing of CSF-1/CSF-
Oncology. 2016;34(28):3481. 1R signaling blockade is critical to improving responses to CTLA-4
based immunotherapy. OncoImmunology. 2016;5(7):e1151595. PMCID:
Hofer K, Li S, Abele F, Frindert J, Schlotthauer J, Grawenhoff J, Du JM, Patel PMC5006914
DJ, Jaschke A. Structure and function of the bacterial decapping enzyme
NudC. Nature Chemical Biology. 2016;12(9):730-734. PMCID: PMC5003112 Holmgaard RB, Zamarin D, Lesokhin A, Merghoub T, Wolchok
JD. Targeting myeloid-derived suppressor cells with colony
Hofheinz RD, Deplanque G, Komatsu Y, Kobayashi Y, Ocvirk J, Racca stimulating factor-1 receptor blockade can reverse immune resistance
P, Guenther S, Zhang J, Lacouture ME, Jatoi A. Recommendations for to immunotherapy in indoleamine 2,3-dioxygenase-expressing
the prophylacticmanagement of skin reactions induced by epidermal tumors. EBioMedicine. 2016;6:50-58. PMCID: PMC4856741
growth factor receptor inhibitors in patients with solid tumors. The
Oncologist. 2016;21(12):1483-1491. PMCID: PMC5153350 Holodny A I. “Am I about to lose my job?!”: A comment on “Computer-
extracted texture features to distinguish cerebral radiation necrosis
Hofmann JN, Birmann BM, Teras LR, Pfeiffer RM, Wang Y, Albanes D, from recurrent brain tumors on multiparametric MRI: A feasibility
Baris D, Colditz GA, De Roos AJ, Giles GG, Hosgood HD, Lan Q, Landgren study”. American Journal of Neuroradiology. 2016;37(12):2237-2238.
O, Liao LM, Rothman N, Weinstein SJ, Pollak MN, Neuhouser ML,
Purdue MP. Low levels of circulating adiponectin are associated with Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL,
multiple myeloma risk in overweight and obese individuals. Cancer Alavi M, Bagryanova L, Krotee PAL, Gardner BK, Behbahan IS, Horvath
Research. 2016;76(7):1935-1941. PMCID: PMC4878138 S, Chia D, Mellinghoff IK, Hurvitz SA, Dubinett SM, Critchlow SE,
Kurdistani SK, Goodglick L, Braas D, Graeber TG, Christofk HR. MCT1
Hofmann-Wellenhof R, Marghoob AA, Zalaudek I. Large acquired modulates cancer cell pyruvate export and growth of tumors that co-
nevus or dysplastic nevus: What’s in the name of a nevus?. JAMA express MCT1 and MCT4. Cell Reports. 2016;14(7):1590-1601. PMCID:
Dermatology. 2016;152(6):623-624. PMC4816454
Hogan MP, Osborne J, Ulaner GA. FDG-avid intrathecal inflammation Hoppe BS, Tsai H, Larson G, Laramore GE, Vargas C, Tseng YD, Dunn
following administration of intrathecal methotrexate. Clinical Nuclear M, McGee L, Cahlon O, Hartsell W. Proton therapy patterns-of-care
Medicine. 2016;41(12):995-997. and early outcomes for Hodgkin lymphoma: Results from the Proton
Collaborative Group Registry. Acta Oncologica. 2016;55(11):1378-1380.
Holland JC. Managing prostate cancer: A guide for living better - Book
review. Psycho-Oncology. 2016;25(4):480. Hortobagyi GN, Chen D, Piccart M, Rugo HS, Burris HA 3rd, Pritchard
K I, Campone M, Noguchi S, Perez AT, Deleu I, Shtivelband M, Masuda
Holliday E, Fuller CD, Kalpathy-Cramer J, Gomez D, Rimner A, Li Y, Senan N, Dakhil S, Anderson I, Robinson DM, He W, Garg A, McDonald ER 3rd,
110 OF 324
Journal Articles
Bitter H, Huang A, Taran T, Bachelot T, Lebrun F, Lebwohl D, Baselga SK, Russo P, Hricak H, Akin O. Use of DWI in the differentiation of renal
J. Correlative analysis of genetic alterations and everolimus benefit in cortical tumors. American Journal of Roentgenology. 2016;206(1):100-
hormone receptor-positive, human epidermal growth factor receptor 105. PMCID: PMC4826468
2-negative advanced breast cancer: Results from BOLERO-2. Journal of
Clinical Oncology. 2016;34(5):419-426. PMCID: PMC5070556 Hötker AM, Tarlinton L, Mazaheri Y, Woo KM, Gönen M, Saltz
LB, Goodman KA, Garcia-Aguilar J, Gollub MJ. Multiparametric
Horvat TZ, Adel NG, Dang TO, Momtaz P, Postow MA, Callahan MRI in the assessment of response of rectal cancer to neoadjuvant
MK, Carvajal RD, Dickson MA, D’Angelo SP, Woo KM, Panageas chemoradiotherapy: A comparison of morphological, volumetric and
KS, Wolchok JD, Chapman PB. Reply to A. Indini et al.. Journal of Clinical functional MRI parameters. European Radiology. 2016;26(12):4303-
Oncology. 2016;34(9):1018-1019. 4312. PMCID: PMC5203699
Horvat TZ, Pecoraro JJ, Daley RJ, Buie LW, King AC, Rampal Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis
RK, Tallman MS, Park JH, Douer D. The use of Erwinia asparaginase for JS. Pretargeted immuno-PET of pancreatic cancer: Overcoming circulating
adult patients with acute lymphoblastic leukemia after pegaspargase antigen and internalized antibody to reduce radiation doses. Journal of
intolerance. Leukemia Research. 2016;50:17-20. Nuclear Medicine. 2016;57(3):453-459. PMCID: PMC4852470
Horwitz SM, Zelenetz AD, Gordon L I, Wierda WG, Abramson JS, Advani Hourani A, Starr TD, Nelson CJ. For men with prostate cancer, can
RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher R I, Glenn MJ, exercise buffer the cognitive effects of hormone therapy?. Coping With
Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Kaminski Cancer. 2016;30(1):22.
MS, Kelsey CR, Kim YH, Krivacic S, La Casce AS, Lunning M, Nademanee
A, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol Howard MA, Sisco M, Yao K, Winchester DJ, Barrera E, Warner J,
L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H, Porcu Jaffe J, Hulick P, Kuchta K, Pusic AL, Sener SF. Patient satisfaction
P. NCCN Guidelines® insights: Non-Hodgkin’s lymphomas, version 3.2016: with nipple-sparing mastectomy: A prospective study of patient
Featured updates to the NCCN guidelines. Journal of the National reported outcomes using the BREAST-Q. Journal of Surgical
Comprehensive Cancer Network. 2016;14(9):1067-1079. Oncology. 2016;114(4):416-422.
Hötker AM, Karlo CA, Zheng J, Moskowitz CS, Russo P, Hricak H, Akin Hruby GW, Matsoukas K, Cimino JJ, Weng C. Facilitating biomedical
O. Clear cell renal cell carcinoma: Associations between CT features and researchers’ interrogation of electronic health record data: Ideas
patient survival. American Journal of Roentgenology. 2016;206(5):1023- from outside of biomedical informatics. Journal of Biomedical
1030. PMCID: PMC4983700 Informatics. 2016;60:376-384. PMCID: PMC4837021
Hötker AM, Mazaheri Y, Aras O, Zheng J, Moskowitz CS, Gondo Hrywna M, Jane Lewis M, Mukherjea A, Banerjee SC, Steinberg
T, Matsumoto K, Hricak H, Akin O. Assessment of prostate MB, Delnevo CD. Awareness and use of South Asian tobacco
cancer aggressiveness by use of the combination of quantitative products among South Asians in New Jersey. Journal of Community
DWI and dynamic contrast-enhanced MRI. American Journal of Health. 2016;41(6):1122-1129. PMCID: PMC5083141
Roentgenology. 2016;206(4):756-763.
Hsieh JJ, Cheng EH. The panoramic view of clear cell renal
Hotker AM, Mazaheri Y, Wibmer A, Zheng J, Moskowitz CS, Tickoo cell carcinoma metabolism: Values of integrated global cancer
111 OF 324
Journal Articles
metabolomics. Translational Andrology and Urology. 2016;5(6):984-986. EC, Kircher MF. High precision imaging of microscopic spread of
glioblastoma with a targeted ultrasensitive SERRS molecular imaging
Hu J, Wang XF. HIF-miR-215-KDM1B promotes glioma-initiating cell probe. Theranostics. 2016;6(8):1075-1084. PMCID: PMC4893636
adaptation to hypoxia. Cell Cycle. 2016;15(15):1939-1940. PMCID:
PMC4968960 Huang SC, Alaggio R, Sung YS, Chen CL, Zhang L, Kao YC, Agaram
NP, Wexler LH, Antonescu CR. Frequent HRAS mutations in
Hu J, Maybody M, Cao G, Wang X, Chen H, Zhu X, Yang R, Wang malignant ectomesenchymoma: Overlapping genetic abnormalities
X. Lipiodol retention pattern assessed by cone beam computed with embryonal rhabdomyosarcoma. American Journal of Surgical
tomography during conventional transarterial chemoembolization Pathology. 2016;40(7):876-885. PMCID: PMC4905780
of hepatocellular carcinoma: Accuracy and correlation with
response. Cancer Imaging. 2016;16:32. PMCID: PMC5048686 Huang SC, Ghossein RA, Bishop JA, Zhang L, Chen TC, Huang
HY, Antonescu CR. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal
Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss sarcoma with focal rhabdomyoblastic differentiation. American Journal
RH. The nephrologist’s tumor: Basic biology and management of Surgical Pathology. 2016;40(1):51-59. PMCID: PMC4679641
of renal cell carcinoma. Journal of the American Society of
Nephrology. 2016;27(8):2227-2237. PMCID: PMC4978061 Huang SC, Zhang L, Sung YS, Chen CL, Kao YC, Agaram NP, Antonescu
CR. Secondary EWSR1 gene abnormalities in SMARCB1-deficient
Hu YC, Grossberg M, Mageras G. Semiautomatic tumor segmentation tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting
with multimodal images in a conditional random field framework. Journal EWSR1 FISH results. Genes Chromosomes and Cancer. 2016;55(10):767-
of Medical Imaging. 2016;3(2):024503. PMCID: PMC4923672 776. PMCID: PMC5006943
Huang C, Niethammer P. Illuminating phagocyte biology: The view from Huang SC, Zhang L, Sung YS, Chen CL, Kao YC, Agaram NP, Singer
zebrafish. Developmental Cell. 2016;38(2):133-134. S, Tap WD, D’Angelo S, Antonescu CR. Recurrent CIC gene abnormalities
in angiosarcomas a molecular study of 120 cases with concurrent
Huang H, Deng Z, Vladimirova O, Wiedmer A, Lu F, Lieberman PM, Patel investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. American
DJ. Structural basis underlying viral hijacking of a histone chaperone Journal of Surgical Pathology. 2016;40(5):645-655. PMCID: PMC4833528
complex. Nature Communications. 2016;7:12707. PMCID: PMC5025803
Huang T, Alvarez AA, Pangeni RP, Horbinski CM, Lu S, Kim
Huang J. A new staging system for thymoma - Will it SH, James CD, Raizer JJ, Kessler JA, Brennan CW, Sulman EP,
improve outcomes?. Journal of Thoracic and Cardiovascular Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, Cheng SY. A
Surgery. 2016;151(1):20-22. regulatory circuit of miR-125b/miR-20b and Wnt signalling controls
glioblastoma phenotypes through FZD6-modulated pathways. Nature
Huang JJ, Gardenier JC, Hespe GE, García Nores GD, Kataru RP, Ly CL,
Martínez-Corral I, Ortega S, Mehrara BJ. Lymph node transplantation
decreases swelling and restores immune responses in a transgenic model Huang YT, Neofytos D, Foldi J, Kim SJ, Maloy M, Chung D, Castro-
of lymphedema. PLoS ONE. 2016;11(12):e0168259. PMCID: PMC5152898 Malaspina H, Giralt SA, Papadopoulos E, Perales MA, Jakubowski
AA, Papanicolaou GA. Cytomegalovirus infection after CD34(+)-selected
Huang R, Harmsen S, Samii JM, Karabeber H, Pitter KL, Holland
112 OF 324
Journal Articles
hematopoietic cell transplantation. Biology of Blood and Marrow Hurria A, Levit LA, Dale W, Mohile SG, Muss HB, Fehrenbacher L,
Transplantation. 2016;22(8):1480-1486. PMCID: PMC4949094 Magnuson A, Lichtman SM, Bruinooge SS, Soto-Perez-de-Celis E, Tew
WP, Postow MA, Cohen HJ. Reply to N. Lowy et al and to J. Dhanda et
Hübner J, Hoseini SS, Suerth JD, Hoffmann D, Maluski M, Herbst J, Maul al. Journal of Clinical Oncology. 2016;34(14):1708-1709.
H, Ghosh A, Eiz-Vesper B, Yuan Q, Ott M, Heuser M, Schambach A,
Sauer MG. Generation of genetically engineered precursor t-cells from Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A, Feng T,
human umbilical cord blood using an optimized alpharetroviral vector Smith D, Sun CL, De Glas N, Cohen HJ, Katheria V, Doan C, Zavala
platform. Molecular Therapy. 2016;24(7):1216-1226. PMCID: PMC5088766 L, Levi A, Akiba C, Tew WP. Validation of a prediction tool for
chemotherapy toxicity in older adults with cancer. Journal of Clinical
Hudis CA, Dickler M. Increasing precision in adjuvant therapy for breast Oncology. 2016;34(20):2366-2371.
cancer. New England Journal of Medicine. 2016;375(8):790-791.
Hurria A, Jones L, Muss HB. Cancer treatment as an accelerated aging
Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner process: Assessment, biomarkers, and interventions. American Society of
DM. Maintaining sexual health throughout gynecologic cancer Clinical Oncology Educational Book. 2016;36:e516-e522.
survivorship: A comprehensive review and clinical guide. Gynecologic
Oncology. 2016;140(2):359-368. PMCID: PMC4835814 Huse JT, Snuderl M, Jones DT, Brathwaite CD, Altman N, Lavi E,
Saffery R, Sexton-Oates A, Blumcke I, Capper D, Karajannis MA,
Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, Benayed R, Chavez L, Thomas C, Serrano J, Borsu L, Ladanyi
Cherny N, Glare P, Kaasa S, Bruera E. Referral criteria for outpatient M, Rosenblum MK. Polymorphous low-grade neuroepithelial
specialty palliative cancer care: An international consensus. Lancet tumor of the young (PLNTY): An epileptogenic neoplasm with
Oncology. 2016;17(12):e552-e559. oligodendroglioma-like components, aberrant CD34 expression,
and genetic alterations involving the MAP kinase pathway. Acta
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The Neuropathologica. 2016;133(3):417-429.
2016 WHO classification of tumours of the urinary system and male
genital organs—Part B: Prostate and bladder tumours. European Huse JT. Establishing a robust molecular taxonomy for diffuse gliomas of
Urology. 2016;70(1):106-119. adulthood. Surgical Pathology Clinics. 2016;9(3):379-390.
Hunt MA, Sonnick M, Pham H, Regmi R, Xiong JP, Morf D, Mageras Hussein YR, Broaddus R, Weigelt B, Levine DA, Soslow RA. The
GS, Zelefsky M, Zhang P. Simultaneous MV-kV imaging for intrafractional genomic heterogeneity of FIGO grade 3 endometrioid carcinoma
motion management during volumetric-modulated arc therapy impacts diagnostic accuracy and reproducibility. International Journal of
delivery. Journal of Applied Clinical Medical Physics . 2016;17(2):473- Gynecological Pathology. 2016;35(1):16-24. PMCID: PMC4934379
486. PMCID: PMC4831078
Hussein YR, Ducie JA, Arnold AG, Kauff ND, Vargas-Alvarez HA, Sala
Huq MS, Fraass BA, Dunscombe PB, Gibbons JP Jr, Ibbott GS, Mundt E, Levine DA, Soslow RA. Invasion patterns of metastatic extrauterine
AJ, Mutic S, Palta JR, Rath F, Thomadsen BR, Williamson JF, Yorke high-grade serous carcinoma with BRCA germline mutation and
ED. The report of Task Group 100 of the AAPM: Application of risk correlation with clinical outcomes. American Journal of Surgical
analysis methods to radiation therapy quality management. Medical Pathology. 2016;40(3):404-409. PMCID: PMC4970426
Physics. 2016;43(7):4209-4262. PMCID: PMC4985013
113 OF 324
Journal Articles
Hyde MK, Zajdlewicz L, Wootten AC, Nelson CJ, Lowe A, Dunn J, Iasonos A, O’Quigley J. Dose expansion cohorts in Phase I trials. Statistics
Chambers SK. Medical help-seeking for sexual concerns in prostate in Biopharmaceutical Research. 2016;8(2):161-170. PMCID: PMC4976787
cancer survivors. Sexual Medicine. 2016;4(1):e7-e17. PMCID: PMC4822483
Iasonos A, O’Quigley J. Integrating the escalation and dose expansion
Hylton HM, Scardino TG. Improving access to care: The physician/ studies into a unified Phase I clinical trial. Contemporary Clinical
physician assistant team: Development of a lymphoma-specific Trials. 2016;50:124-134. PMCID: PMC5266504
physician/physician assistant team at a comprehensive cancer
center. Physician Assistant Clinics. 2016;1(3):489-497. Iasonos A, Wages NA, Conaway MR, Cheung K, Yuan Y, O’Quigley
J. Dimension of model parameter space and operating characteristics in
Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, adaptive dose-finding studies. Statistics in Medicine. 2016;35(21):3760-
Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead 3775. PMCID: PMC4965325
GM, Marques HS, Esserman LJ, Schnall MD. Neoadjuvant chemotherapy
for breast cancer: Functional tumor volume by MR imaging predicts Iasonos A, Chapman PB, Satagopan JM. Quantifying treatment benefit
recurrencefree survival - Results from the ACRIN 6657/CALGB 150007 in molecular subgroups to assess a predictive biomarker. Clinical Cancer
I-SPY 1 TRIAL. Radiology. 2016;279(1):44-55. PMCID: PMC4819899 Research. 2016;22(9):2114-2120. PMCID: PMC4856220
Hyman DM, Eaton A, Ivy SP, Spriggs DR, Iasonos A. Measuring Iftimia N, Peterson G, Chang EW, Maguluri G, Fox W, Rajadhyaksha
toxicity in phase I clinical trials-letter — Letter. Clinical Cancer M. Combined reflectance confocal microscopy-optical coherence
Research. 2016;22(7):1828. tomography for delineation of basal cell carcinoma margins: An ex vivo
study. Journal of Biomedical Optics. 2016;21(1):016006. PMCID: PMC4719216
Hyman DM, Solit DB, Iasonos A. Reply to M.P. Decatris et al. Journal of
Clinical Oncology. 2016;34(8):887. Ignacio RAB, Lee JY, Rudek MA, Dittmer DP, Ambinder RF, Krown
SE, for the AIDS Malignancy Consortium (AMC)-059 Study Team. A
Iacconi C, Galman L, Zheng J, Sacchini V, Sutton EJ, Dershaw Phase 1b/Pharmacokinetic trial of PTC299, a novel posttranscriptional
D, Morris EA. Multicentric cancer detected at breast MR imaging and VEGF inhibitor, for AIDS-related Kaposi’s sarcoma: AIDS malignancy
not at mammography: Important or not?. Radiology. 2016;279(2):378- consortium trial 059. JAIDS: Journal of Acquired Immune Deficiency
384. PMCID: PMC5015863 Syndromes. 2016;72(1):52-57. PMCID: PMC4838493
Iacobucci I, Li Y, Roberts KG, Dobson SM, Kim JC, Payne-Turner D, Harvey Ilboudo A, Chouhan J, Mcneil BK, Osborne JR, Ogunwobi
RC, Valentine M, McCastlain K, Easton J, Yergeau D, Janke LJ, Shao Y, OO. PVT1 exon 9: A potential biomarker of aggressive prostate
Chen IML, Rusch M, Zandi S, Kornblau SM, Konopleva M, Jabbour E, cancer?. International Journal of Environmental Research and Public
Paietta EM, Rowe JM, Pui CH, Gastier-Foster J, Gu Z, Reshmi S, Loh ML, Health. 2016;13(1):12. PMCID: PMC4730403
Racevskis J, Tallman MS, Wiernik PH, Litzow MR, Willman CL, McPherson
JD, Downing JR, Zhang J, Dick JE, Hunger SP, Mullighan CG. Truncating Ilson DH. An update in the nonendoscopic treatment of gastric
erythropoietin receptor rearrangements in acute lymphoblastic cancer. Current Opinion in Gastroenterology. 2016;32(6):501-506.
leukemia. Cancer Cell. 2016;29(2):186-200. PMCID: PMC4750652
Ilson DH. Targeting the vascular endothelial growth factor pathway in gastric
cancer: A hit or a miss?. Journal of Clinical Oncology. 2016;34(13):1431-1432.
114 OF 324
Journal Articles
Imnadze M, Sjoberg DD, Vickers AJ. Adverse pathologic features Inoue S, Li WY, Tseng A, Beerman I, Elia AJ, Bendall SC, Lemonnier F,
at radical prostatectomy: Effect of preoperative risk on oncologic Kron KJ, Cescon DW, Hao Z, Lind EF, Takayama N, Planello AC, Shen
outcomes. European Urology. 2016;69(1):143-148. PMCID: PMC4618775 SY, Shih AH, Larsen DM, Li Q, Snow BE, Wakeham A, Haight J, Gorrini C,
Bassi C, Thu KL, Murakami K, Elford AR, Ueda T, Straley K, Yen KE, Melino
Inada M, Nichols RJ, Parsa JY, Homer CM, Benn RA, Hoxie RS, Madhani G, Cimmino L, Aifantis I, Levine RL, De Carvalho DD, Lupien M, Rossi DJ,
HD, Shuman S, Schwer B, Pleiss JA. Phospho-site mutants of the RNA Nolan GP, Cairns RA, Mak TW. Mutant IDH1 downregulates ATM and alters
Polymerase II C-terminal domain alter subtelomeric gene expression DNA repair and sensitivity to DNA damage independent of TET2. Cancer
and chromatin modification state in fission yeast. Nucleic Acids Cell. 2016;30(2):337-348. PMCID: PMC5022794
International Head and Neck Scientific Group. Cervical lymph node
Inagaki A, Roset R, Petrini JHJ. Functions of the MRE11 complex in the metastasis in adenoid cystic carcinoma of the sinonasal tract, nasopharynx,
development and maintenance of oocytes. Chromosoma. 2016;125(1):151- lacrimal glands and external auditory canal: A collective international
162. PMCID: PMC4734907 review. Journal of Laryngology and Otology. 2016;130(12):1093-1097.
Inda C, Bolaender A, Wang T, Gandu SR, Koren J 3rd. Stressing out Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK,
Hsp90 in neurotoxic proteinopathies. Current Topics in Medicinal Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA,
Chemistry. 2016;16(25):2829-2838. PMCID: PMC4995127 Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM,
Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles
Indelicato DJ, Merchant T, Laperriere N, Lassen Y, Vennarini S, Wolden S, GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes
Hartsell W, Pankuch M, Brandal P, Law CCK, Taylor R, Laskar S, Okcu MF, WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ,
Bouffet E, Mandeville H, Björk-Eriksson T, Nilsson K, Nyström H, Constine Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN,
LS, Story M, Timmermann B, Roberts K, Kortmann RD. Consensus report Whittemore AS, Sieh W. REVEL: An ensemble method for predicting
From the Stockholm Pediatric Proton Therapy Conference. International the pathogenicity of rare missense variants. American Journal of Human
Journal of Radiation Oncology, Biology, Physics. 2016;96(2):387-392. Genetics. 2016;99(4):877-885. PMCID: PMC5065685
Infante JR, Cassier PA, Gerecitano JF, Witteveen PO, Chugh R, Ribrag Iranmahboob A, Peck KK, Brennan NP, Karimi S, Fisicaro R, Hou
V, Chakraborty A, Matano A, Dobson JR, Crystal AS, Parasuraman B, Holodny A I. Vascular reactivity maps in patients with gliomas using
S, Shapiro G I. A phase I study of the cyclin-dependent kinase 4/6 breath-holding BOLD fMRI. Journal of Neuroimaging. 2016;26(2):232-
inhibitor ribociclib (LEE011) in patients with advanced solid tumors and 239. PMCID: PMC5087143
lymphomas. Clinical Cancer Research. 2016;22(23):5696-5705.
Isa F, Saito K, Huang YT, Schuetz A, Babady NE, Salvatore S, Pessin
Inoue D, Bradley RK, Abdel-Wahab O. Spliceosomal gene mutations M, Van Besien K, Perales MA, Giralt S, Sepkowitz K, Papanicolaou GA,
in myelodysplasia: Molecular links to clonal abnormalities of Soave R, Kamboj M. Implementation of molecular surveillance after a
hematopoiesis. Genes and Development. 2016;30(9):989-1001. PMCID: cluster of fatal toxoplasmosis at 2 neighboring transplant centers. Clinical
PMC4863743 Infectious Diseases. 2016;63(4):565-568. PMCID: PMC4967604
Inoue D, Abdel-Wahab O. Modeling SF3B1 mutations in cancer:
Advances, challenges, and opportunities. Cancer Cell. 2016;30(3):371-373.
115 OF 324
Journal Articles
Isaac KS, Hay JL, Lubetkin E I. Incorporating spirituality in primary screening and address health disparities. Cancer. 2016;122(2):269-
care. Journal of Religion and Health. 2016;55(3):1065-1077. PMCID: 277. PMCID: PMC4939480
PMC4814294
Iyengar NM, Zhou XK, Gucalp A, Morris PG, Howe LR, Giri DD, Morrow M,
Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast Wang H, Pollak M, Jones LW, Hudis CA, Dannenberg AJ. Systemic correlates
conservation surgery for cancer with 90-day reoperation rates in New of white adipose tissue inflammation in early-stage breast cancer. Clinical
York State. JAMA Surgery. 2016;151(7):648-655. Cancer Research. 2016;22(9):2283-2289. PMCID: PMC4854755
Isenberg-Grzeda E, Rahane S, DeRosa AP, Ellis J, Nicolson SE. Wernicke- Iyengar NM, Fornier MN, Sugarman SM, Theodoulou M, Troso-Sandoval
Korsakoff syndrome in patients with cancer: A systematic review. Lancet TA, D’Andrea GM, Drullinsky PR, Gajria D, Goldfarb SB, Comen EA, Lake
Oncology. 2016;17(4):E142-E148. DE, Modi S, Traina TA, Lacouture ME, Chen MF, Patil S, Baselga J, Norton
L, Hudis CA, Dang CT. A pilot study of dose-dense paclitaxel with
Isenberg-Grzeda E, Alici Y, Hatzoglou V, Nelson C, Breitbart trastuzumab and lapatinib for node-negative HER2-overexpressed breast
W. Nonalcoholic thiamine-related encephalopathy (Wernicke- cancer. Clinical Breast Cancer. 2016;16(2):87-94. PMCID: PMC4968930
Korsakoff Syndrome) among inpatients with cancer: A series of 18
cases. Psychosomatics. 2016;57(1):71-81. PMCID: PMC4979979 Iyengar NM, Ghossein RA, Morris LG, Zhou XK, Kochhar A, Morris
PG, Pfister DG, Patel SG, Boyle JO, Hudis CA, Dannenberg AJ. White
Ishida H, Saba R, Kokkinopoulos I, Hashimoto M, Yamaguchi adipose tissue inflammation and cancer-specific survival in patients with
O, Nowotschin S, Shiraishi M, Ruchaya P, Miller D, Harmer S, Poliandri A, squamous cell carcinoma of the oral tongue. Cancer. 2016;122(24):3794-
Kogaki S, Sakata Y, Dunkel L, Tinker A, Hadjantonakis AK, Sawa Y, Sasaki 3802. PMCID: PMC5138111
H, Ozono K, Suzuki K, Yashiro K. GFRA2 identifies cardiac progenitors
and mediates cardiomyocyte differentiation in a RET-independent Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer
signaling pathway. Cell Reports. 2016;16(4):1026-1038. PMCID: mechanisms: Tumor microenvironment and inflammation. Journal of
PMC4967477 Clinical Oncology. 2016;34(35):4270-4276.
Ito K, Turcotte R, Cui J, Zimmerman SE, Pinho S, Mizoguchi T, Jackson CC, Best L, Lorenzo L, Casanova JL, Wacker J, Bertz S, Agaimy
Arai F, Runnels JM, Alt C, Teruya-Feldstein J, Mar JC, Singh A, Harrer T. A multiplex kindred with Hennekam syndrome due to
R, Suda T, Lin CP, Frenette PS, Ito K. Self-renewal of a purified homozygosity for a CCBE1 mutation that does not prevent protein
Tie2+ hematopoietic stem cell population relies on mitochondrial expression. Journal of Clinical Immunology. 2016;36(1):19-27. PMCID:
clearance. Science. 2016;354(6316):1156-1160. PMCID: PMC5164878 PMC4984268
Ito S, Murphy CG, Doubrovina E, Jasin M, Moynahan ME. PARP inhibitors Jackson CC, Dickson MA, Sadjadi M, Gessain A, Abel L, Jouanguy
in clinical use induce genomic instability in normal human cells. PLoS E, Casanova JL. Kaposi sarcoma of childhood: Inborn or acquired
ONE. 2016;11(7):e0159341. PMCID: PMC4948780 immunodeficiency to oncogenic HHV-8. Pediatric Blood and
Cancer. 2016;63(3):392-397. PMCID: PMC4984265
Itzkowitz SH, Winawer SJ, Krauskopf M, Carlesimo M, Schnoll-Sussman
FH, Huang K, Weber TK, Jandorf L. New York Citywide Colon Cancer Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward. Nature
Control Coalition: A public health effort to increase colon cancer Reviews Clinical Oncology. 2016;13(6):370-383.
116 OF 324
Journal Articles
Jackson MA, Bellas N, Siegrist T, Haddock P, Staff I, Laudone V, Wagner inguinal lymphadenectomy: Report of a prospective multi-institutional
JR. Author reply. Urology. 2016;91:117-118. trial. Journal of the American College of Surgeons. 2016;222(3):253-
260. PMCID: PMC5012184
Jackson MA, Bellas N, Siegrist T, Haddock P, Staff I, Laudone V,
Wagner JR. Experienced open vs early robotic-assisted laparoscopic Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer
radical prostatectomy: A 10-year prospective and retrospective FL, Patel SG, Downey RJ, Strong VE, Russo P. Complete metastasectomy
comparison. Urology. 2016;91:111-116. for renal cell carcinoma: Comparison of five solid organ sites. Journal of
Surgical Oncology. 2016;114(3):375-379. PMCID: PMC5104341
Jacobsen PB, Rowland JH, Paskett ED, Leeuwen F V, Moskowitz C, Katta
S, Wollins D, Robison LL. Identification of key gaps in cancer survivorship James AW, Shurell E, Singh A, Dry SM, Eilber FC. Malignant
research: Findings from the American Society of Clinical Oncology peripheral nerve sheath tumor. Surgical Oncology Clinics of North
survey. Journal of Oncology Practice. 2016;12(3):190-193. America. 2016;25(4):789-802.
Jacquelot N, Enot DP, Flament C, Vimond N, Blattner C, Pitt JM, James TA, Coffman AR, Chagpar AB, Boughey JC, Klimberg VS, Morrow
Yamazaki T, Roberti MP, Daillère R, Vétizou M, Poirier-Colame V, M, Giuliano AE, Harlow SP. Troubleshooting sentinel lymph node biopsy in
Semeraro M, Caignard A, Slingluff CL, Sallusto F, Rusakiewicz S, breast cancer surgery. Annals of Surgical Oncology. 2016;23(11):3459-3466.
Weide B, Marabelle A, Kohrt H, Dalle S, Cavalcanti A, Kroemer G,
Di Giacomo AM, Maio M, Wong P, Yuan J, Wolchok J, Umansky V, Janjigian YY. Lapatinib in gastric cancer: What is the LOGiCal next
Eggermont A, Zitvogel L. Chemokine receptor patterns in lymphocytes step?. Journal of Clinical Oncology. 2016;34(5):401-403.
mirror metastatic spreading in melanoma. Journal of Clinical
Investigation. 2016;126(3):921-937. PMCID: PMC4767356 Jansen JFA, Parra C, Lu Y, Shukla-Dave A. Evaluation of head and neck
tumors with functional MR imaging. Magnetic Resonance Imaging Clinics
Jain M, Robinson BD, Aggarwal A, Shevchuk MM, Scherr DS, Mukherjee of North America. 2016;24(1):123-133. PMCID: PMC4663682
S. Multiphoton microscopy for rapid histopathological evaluation of
kidney tumours. BJU International. 2016;118(1):118-126. Jarow JP, Ahmed HU, Choyke PL, Taneja SS, Scardino PT. Partial gland
ablation for prostate cancer: Report of a Food and Drug Administration,
Jakacki R I, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum American Urological Association, and society of urologic oncology public
MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF. Phase workshop. Urology. 2016;88:8-13.
2 study of concurrent radiotherapy and temozolomide followed by
temozolomide and lomustine in the treatment of children with high- Jasin M, Haber JE. The democratization of gene editing: Insights from site-
grade glioma: A report of the Children’s Oncology Group ACNS0423 specific cleavage and double-strand break repair. DNA Repair. 2016;44:6-16.
study. Neuro-Oncology. 2016;18(10):1442-1450. PMCID: PMC5035517
Jasin M. Gene editing 20 years later. Genome Editing: The Next Step in
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Gene Therapy. 2016;895:1-14.
Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB,
Javier BM, Yaeger R, Wang L, Sanchez-Vega F, Zehir A, Middha
Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training high-
S, Sadowska J, Vakiani E, Shia J, Klimstra D, Ladanyi M, Iacobuzio-
volume melanoma surgeons to perform a novel minimally invasive
Donahue CA, Hechtman JF. Recurrent, truncating Sox9 mutations are
117 OF 324
Journal Articles
associated with sox9 overexpression, KRAS mutation, and TP53 wild type 90 inhibitors. Clinical Breast Cancer. 2016;16(4):276-283. PMCID:
status in colorectal carcinoma. Oncotarget. 2016;7(32):50875-50882. PMC5242238
Jawad Latif M, Jones DR. Adjuvant chemotherapy for a T3 additional Jhingran A, Kasahara S, Hohl TM. Flow cytometry of lung and
tumor nodule in the same lobe: Ready for prime time?. Journal of bronchoalveolar lavage fluid cells from mice challenged with Fluorescent
Thoracic Disease. 2016;8(12):E1709-E1710. PMCID: PMC5227218 Aspergillus Reporter (FLARE) conidia. Bio-protocol. 2016;6(18):e1927.
Jelinic P, Schlappe BA, Conlon N, Tseng J, Olvera N, Dao F, Mueller Ji C, Sharma I, Pratihar D, Hudson LL, Maura D, Guney T, Rahme LG,
JJ, Hussein Y, Soslow RA, Levine DA. Concomitant loss of SMARCA2 and Pesci EC, Coleman JP, Tan DS. Designed small-molecule inhibitors of
SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic the anthranilyl-CoA synthetase PqsA block quinolone biosynthesis
type. Modern Pathology. 2016;29(1):60-66. PMCID: PMC4697871 in Pseudomonas aeruginosa. ACS Chemical Biology. 2016;11(11):3061-
3067. PMCID: PMC5117135
Jena P V, Shamay Y, Shah J, Roxbury D, Paknejad N, Heller
DA. Photoluminescent carbon nanotubes interrogate the permeability of Jian J, Zhao S, Tian QY, Liu H, Zhao Y, Chen WC, Grunig G, Torres PA,
multicellular tumor spheroids. Carbon. 2016;97:99-109. PMCID: PMC4594636 Wang BC, Zeng B, Pastores G, Tang W, Sun Y, Grabowski GA, Kong
MX, Wang G, Chen Y, Liang F, Overkleeft HS, Saunders-Pullman R,
Jenq RR, van den Brink MRM. Antibiotic prophylaxis in allogeneic Chan GL, Liu CJ. Association between progranulin and Gaucher
stem cell transplantation — What is the correct choice?. Bone Marrow disease. EBioMedicine. 2016;11:127-137. PMCID: PMC5049935
Johns C, Seav SM, Dominick SA, Gorman JR, Li H, Natarajan L, Mao
Jensen BJ, Dalbagni G, Borre M, Love-Retinger N. Preoperative JJ, Su H I. Informing hot flash treatment decisions for breast cancer
nutritional status and the impact on radical cystectomy recovery: An survivors: A systematic review of randomized trials comparing active
international comparative study. Urologic Nursing. 2016;36(3):133-152. interventions. Breast Cancer Research and Treatment. 2016;156(3):415-
426. PMCID: PMC4838539
Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Zhao
WK, Marks AR, Schottinger JE, Ghai NR, Lee AT, Contreras R, Klabunde Johnson DB, Roszik J, Shoushtari AN, Eroglu Z, Balko JM, Higham
CN, Quesenberry CP, Levin TR, Mysliwiec PA. Fecal immunochemical test C, Puzanov I, Patel SP, Sosman JA, Woodman SE. Comparative
program performance over 4 rounds of annual screening: A retrospective analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in
cohort study. Annals of Internal Medicine. 2016;164(7):456-463. PMCID: melanoma and across the cancer spectrum. Pigment Cell & Melanoma
PMC4973858 Research. 2016;29(4):470-473.
Jeong J, Barker CA, Zaider M, Cohen GN. Impact of Johnson LR, Weizman OE, Rapp M, Way SS, Sun JC. Epitope-specific
source position on high-dose-rate skin surface applicator vaccination limits clonal expansion of heterologous naive T cells during
dosimetry. Brachytherapy. 2016;15(5):650-660. viral challenge. Cell Reports. 2016;17(3):636-644.
Jhaveri K, Chandarlapaty S, Iyengar N, Morris PG, Corben AD, Patil Johnson SF, Cruz C, Greifenberg AK, Dust S, Stover DG, Chi D, Primack
S, Akram M, Towers R, Sakr RA, King TA, Norton L, Rosen N, Hudis B, Cao S, Bernhardy AJ, Coulson R, Lazaro JB, Kochupurakkal B, Sun
C, Modi S. Biomarkers that predict sensitivity to heat shock protein
118 OF 324
Journal Articles
H, Unitt C, Moreau LA, Sarosiek KA, Scaltriti M, Juric D, Baselga J, develop second malignancies: A population-based cohort
Richardson AL, Rodig SJ, D’Andrea AD, Balmaña J, Johnson N, Geyer study. Haematologica. 2016;101(4):e145-e148. PMCID: PMC5004397
M, Serra V, Lim E, Shapiro G I. CDK12 inhibition reverses de novo and
acquired PARP inhibitor resistance in BRCA wild-type and mutated Joo JH, Wang B, Frankel E, Ge L, Xu L, Iyengar R, Li-Harms X, Wright
models of triple-negative breast cancer. Cell Reports. 2016;17(9):2367- C, Shaw T I, Lindsten T, Green DR, Peng J, Hendershot LM, Kilic F,
2381. PMCID: PMC5176643 Sze JY, Audhya A, Kundu M. The noncanonical role of ULK/ATG1 in
ER-to-Golgi trafficking is essential for cellular homeostasis. Molecular
Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Cell. 2016;62(4):491-506. PMCID: PMC4993601
Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD,
Chiang VL, Camidge DR, Contessa JN. Extended survival and prognostic Jordan E, Abou-Alfa GK, Lowery MA. Systemic therapy for biliary
factors for patients with ALK-rearranged non-small-cell lung cancer and cancers. Chinese Clinical Oncology. 2016;5(5):65.
brain metastasis. Journal of Clinical Oncology. 2016;34(2):123-129. PMCID:
PMC5070549 Jordan E, Braghiroli MIF, Lowery MA. The role of novel biologics in biliary
cancers. Minerva Gastroenterologica e Dietologica. 2016;62(4):325-339.
Jones DR. A career in translational research: The road not taken. Journal
of Thoracic and Cardiovascular Surgery. 2016;152(2):367-368. Jordan EJ, Basturk O, Leach SD, Klimstra DS, Allen PJ, Berger
MF, Askan G, Iacobuzio-Donahue CA, Yu KH, O’Reilly EM, Lowery
Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke MA. Clinical and molecular analysis of adenosquamous carcinoma of the
CH, Kwan ML, Quesenberry CP Jr, Scott J, Sternfeld B, Yu A, pancreas. Journal of the Pancreas. 2016;17(6):620-628.
Kushi LH, Caan BJ. Exercise and risk of cardiovascular events
in women with nonmetastatic breast cancer. Journal of Clinical Joseph DA, Meester RGS, Zauber AG, Manninen DL, Winges L, Dong
Oncology. 2016;34(23):2743-2749. PMCID: PMC5019746 FB, Peaker B, van Ballegooijen M. Colorectal cancer screening:
Estimated future colonoscopy need and current volume and
Jones LW, Kwan ML, Weltzien E, Chandarlapaty S, Sternfeld B, capacity. Cancer. 2016;122(16):2479-2486.
Sweeney C, Bernard PS, Castillo A, Habel LA, Kroenke CH, Langholz
BM, Queensberry CP Jr, Dang C, Weigelt B, Kushi LH, Caan BJ. Exercise Jour G, Oultache A, Sadowska J, Mitchell T, Healey J, Nafa
and prognosis on the basis of clinicopathologic and molecular features K, Hameed M. GNAS mutations in fibrous dysplasia: A comparative
in early-stage breast cancer: The LACE and pathways studies. Cancer study of standard sequencing and locked nucleic acid PCR
Research. 2016;76(18):5415-5422. PMCID: PMC5026589 sequencing on decalcified and nondecalcified formalin-fixed paraffin-
embedded tissues. Applied Immunohistochemistry & Molecular
Jones MJK, Jallepalli P V. Engineering and functional analysis of Morphology. 2016;24(9):660-667.
mitotic kinases through chemical genetics. Methods in Molecular
Biology. 2016;1413:349-363. Jover R, Bretthauer M, Dekker E, Holme O, Kaminski MF, Løberg
M, Zauber AG, Hernán MA, Lansdorp-Vogelaar I, Sunde A, McFadden
Jonsdottir G, Lund SH, Björkholm M, Turesson I, Wahlin A, E, Castells A, Regula J, Quintero E, Pellisé M, Senore C, Kalager
Mailankody S, Blimark C, Hultcrantz M, Porwit A, Landgren M, Dinis-Ribeiro M, Emilsson L, Ransohoff DF, Hoff G, Adami
O, Kristinsson SY. Survival in multiple myeloma patients who HO. Rationale and design of the European Polyp Surveillance (EPoS)
trials. Endoscopy. 2016;48(6):571-578.
119 OF 324
Journal Articles
Joyner AL. From cloning neural development genes to functional studies Unterhalt M, Weinstock DM, Weigert O. Clinicogenetic risk models
in mice, 30 years of advancements. Current Topics in Developmental predict early progression of follicular lymphoma after first-line
Biology. 2016;116:501-515. immunochemotherapy. Blood. 2016;128(8):1112-1120.
Julie DAR, Oh JH, Apte AP, Deasy JO, Tom A, Wu AJ, Goodman Kadota K, Sima CS, Arcila ME, Hedvat C, Kris MG, Jones DR, Adusumilli
KA. Predictors of acute toxicities during definitive chemoradiation using PS, Travis WD. KRAS mutation is a significant prognostic factor in
intensity-modulated radiotherapy for anal squamous cell carcinoma. Acta early-stage lung adenocarcinoma. American Journal of Surgical
Oncologica. 2016;55(2):208-216. PMCID: PMC4822488 Pathology. 2016;40(12):1579-1590. PMCID: PMC5106330
Julie DR, Goodman KA. Advances in the management of anal Kaffenberger SD, Barbieri CE. Molecular subtyping of prostate
cancer. Current Oncology Reports. 2016;18(3):20. cancer. Current Opinion in Urology. 2016;26(3):213-218. PMCID:
PMC4895200
Jung BC, Arevalo-Perez J, Lyo JK, Holodny A I, Karimi S, Young
RJ, Peck KK. Comparison of glioblastomas and brain metastases Kahles A, Ong CS, Zhong Y, Rätsch G. SplAdder: Identification,
using dynamic contrast-enhanced perfusion MRI. Journal of quantification and testing of alternative splicing events from RNA-Seq
Neuroimaging. 2016;26(2):240-246. PMCID: PMC4753138 data. Bioinformatics. 2016;32(12):1840-1847. PMCID: PMC4908322
Jung J, Lee JS, Dickson MA, Schwartz GK, Le Cesne A, Varga A, Kahn JM, Keegan THM, Tao L, Abrahão R, Bleyer A, Viny AD. Racial
Bahleda R, Wagner AJ, Choy E, De Jonge MJ, Light M, Rowley S, disparities in the survival of American children, adolescents, and young
Macé S, Watters J. TP53 mutations emerge with HDM2 inhibitor adults with acute lymphoblastic leukemia, acute myelogenous leukemia,
SAR405838 treatment in de-differentiated liposarcoma. Nature and Hodgkin lymphoma. Cancer. 2016;122(17):2723-2730. PMCID:
Communications. 2016;7:12609. PMCID: PMC5013668 PMC4992431
Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, Kajimura J, Kyoizumi S, Kubo Y, Misumi M, Yoshida K, Hayashi T, Imai K,
Crusoe E, Silva Dias ALM, Vij R, Fiala MA, Caers J, Rasche L, Nooka AK, Ohishi W, Nakachi K, Weng NP, Young LF, Shieh JH, Moore MA, van den
Lonial S, Vesole DH, Philip S, Gangatharan S, Druzd-Sitek A, Walewski Brink MRM, Kusunoki Y. Relationship between spontaneous γH2AX foci
J, Corso A, Cocito F, Vekemans MCM, Atilla E, Beksac M, Leleu X, Davila formation and progenitor functions in circulating hematopoietic stem
J, Badros A, Aneja E, Abildgaard N, Kastritis E, Fantl D, Schutz N, Pika and progenitor cells among atomic-bomb survivors. Mutation Research
T, Butrym A, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Usmani SZ, - Genetic Toxicology and Environmental Mutagenesis. 2016;802:59-
Nahi H, Chim CS, Shustik C, Madry K, Lentzsch S, Swiderska A, Helbig G, 65. PMCID: PMC5152679
Guzicka-Kazimierczak R, Lendvai N, Waage A, Andersen KT, Murakami H,
Zweegman S, Castillo JJ. Central nervous system involvement by multiple Kamboj M, Sheahan A, Sun J, Taur Y, Robilotti E, Babady E, Papanicolaou
myeloma: A multi-institutional retrospective study of 172 patients in daily G, Jakubowski A, Pamer E, Sepkowitz K. Transmission of Clostridium
clinical practice. American Journal of Hematology. 2016;91(6):575-580. difficile during hospitalization for allogeneic stem cell transplant. Infection
Control and Hospital Epidemiology. 2016;37(1):8-15. PMCID: PMC4896642
Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling
MH, Rosenwald A, Ott G, Klapper W, Zelenetz AD, Barr PM, Friedberg Kamel M, Terasaki Y, Adusumilli PS, Stiles BM. Plenary
JW, Ansell S, Sehn LH, Connors JM, Gascoyne RD, Hiddemann W, presentations and public citations from The American Association
120 OF 324
Journal Articles
for Thoracic Surgery. Journal of Thoracic and Cardiovascular NP, Zin A, Alaggio R, Antonescu CR. BCOR overexpression is a
Surgery. 2016;151(1):30-34. highly sensitive marker in round cell sarcomas with BCOR genetic
abnormalities. American Journal of Surgical Pathology. 2016;40(12):1670-
Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, Dogan 1678. PMCID: PMC5106294
A, Zou D, Luthra R, Weber DM, O’Malley DP, Jorgensen JL,
Khoury JD, Bueso-Ramos CE, Orlowski RZ, Medeiros LJ, Young Kaplan AL, Hu JC, Morgentaler A, Mulhall JP, Schulman CC, Montorsi
KH. Crystal-storing histiocytosis: A clinicopathological study of 13 F. Testosterone therapy in men with prostate cancer. European
cases. Histopathology. 2016;68(4):482-491. PMCID: PMC4704983 Urology. 2016;69(5):894-903. PMCID: PMC5000551
Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Kar SP, Beesley J, Al Olama AA, Michailidou K, Tyrer J, Kote-Jarai
Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP, Ganguly S, ZA, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS,
Hertzberg M, Klyuchnikov E, Lazarus HM, Olsson R, Perales MA, Rezvani Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, Gentry-Maharaj
A, Riches M, Saad A, Slavin S, Smith SM, Sureda A, Yared J, Ciurea S, A, Whittemore AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A,
Armand P, Salit R, Bolaños-Meade J, Hamadani M. Reduced-intensity Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A, Ziogas A,
transplantation for lymphomas using haploidentical related donors vs Ekici AB, Burwinkel B, Karlan BY, Nordestgaard BG, Blomqvist C, Phelan
HLA-matched unrelated donors. Blood. 2016;127(7):938-947. PMCID: C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Stegmaier C,
PMC4760094 Maier C, Ambrosone CB, Hogdall CK, Teerlink CC, Kang D, Tessier DC,
Schaid DJ, Stram DO, Cramer DW, Neal DE, Eccles D, Flesch-Janys D,
Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary Velez Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer
supplement use among US adults from 1999-2012. JAMA - Journal of the EJ, Bandera E V, Poole EM, Goode EL, Khusnutdinova E, Hogdall E, Song
American Medical Association. 2016;316(14):1464-1474. F, Bruinsma F, Heitz F, Modugno F, Hamdy FC, Wiklund F, Giles GG, Olsson
H, Wildiers H, Ulmer HU, Pandha H, Risch HA, Darabi H, Salvesen HB,
Kantor ED, Zhang X, Wu K, Signorello LB, Chan AT, Fuchs CS, Nevanlinna H, Gronberg H, Brenner H, Brauch H, Anton-Culver H, Song H,
Giovannucci EL. Use of glucosamine and chondroitin supplements in Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, Lubiński J, Stanford
relation to risk of colorectal cancer: Results from the Nurses’ Health JL, Benitez J, Doherty JA, Permuth JB, Chang-Claude J, Donovan JL,
Study and Health Professionals follow-up study. International Journal of Dennis J, Schildkraut JM, Schleutker J, Hopper JL, Kupryjanczyk J, Park
Cancer. 2016;139(9):1949-1957. PMCID: PMC4990485 JY, Figueroa J, Clements JA, Knight JA, Peto J, Cunningham JM, Pow-
Sang J, Batra J, Czene K, Lu KH, Herkommer K, Khaw KT, Matsuo K, Muir
Kao YC, Sung YS, Zhang L, Huang SC, Argani P, Chung CT, Graf NS,
K, Offitt K, Chen K, Moysich KB, Aittomaki K, Odunsi K, Kiemeney LA,
Wright DC, Kellie SJ, Agaram NP, Ludwig K, Zin A, Alaggio R, Antonescu
Massuger LFAG, Fitzgerald LM, Cook LS, Cannon-Albright L, Hooning
CR. Recurrent BCOR internal tandem duplication and YWHAE-
MJ, Pike MC, Bolla MK, Luedeke M, Teixeira MR, Goodman MT, Schmidt
NUTM2B fusions in soft tissue undifferentiated round cell sarcoma
MK, Riggan M, Aly M, Rossing MA, Beckmann MW, Moisse M, Sanderson
of infancy: Overlapping genetic features with clear cell sarcoma of
M, Southey MC, Jones M, Lush M, Hildebrandt MAT, Hou MF, Schoemaker
kidney. American Journal of Surgical Pathology. 2016;40(8):1009-
MJ, Garcia-Closas M, Bogdanova N, Rahman N, Le ND, Orr N, Wentzensen
1020. PMCID: PMC4942366
N, Pashayan N, Peterlongo P, Guenel P, Brennan P, Paulo P, Webb PM,
Kao YC, Sung YS, Zhang L, Jungbluth AA, Huang SC, Argani P, Agaram Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow
R, Kopperud RK, Schmutzler RK, Stephenson RA, Macinnis RJ, Hoover RN,
121 OF 324
Journal Articles
Winqvist R, Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell CH. Loss of switch/sucrose non-fermenting complex protein expression
SK, Tworoger SS, Maia S, Berndt S, Lee SC, Teo SH, Thibodeau SN, is associated with dedifferentiation in endometrial carcinomas. Modern
Bojesen SE, Gapstur SM, Kjar SK, Pejovic T, Tammela TLJ, Eeles A, Easton Pathology. 2016;29(3):302-314. PMCID: PMC4980656
D, Kote-Jarai ZS, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC,
Fitzgerald LM, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher Karoulia Z, Wu Y, Ahmed TA, Xin Q, Bollard J, Krepler C, Wu X, Zhang
F, Haiman CA, Schleutker J, Wahlfors T, Tammela TLJ, Nordestgaard BG, C, Bollag G, Herlyn M, Fagin JA, Lujambio A, Gavathiotis E, Poulikakos
Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan P I. An integrated model of RAF inhibitor action predicts inhibitor
N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier activity against oncogenic BRAF signaling. Cancer Cell. 2016;30(3):485-
C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokozorczyk 498. PMCID: PMC5021590
D, Kluzniak W, Cannon-Albright L, Brenner H, Dieffenbach AK, Arndt V,
Park JY, Sellers T, Lim HY, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle Karreci ES, Fan H, Uehara M, Mihali AB, Singh PK, Kurdi AT, Solhjou
A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Dork T, Z, Riella L V, Ghobrial I, Laragione T, Routray S, Assaker JP, Wang R,
Bruning T, Wahlfors T, Key TJ, Edwards TL, Menon U, Hamann U, Mitev V, Sukenick G, Shi L, Barrat FJ, Nathan CF, Lin G, Azzi J. Brief treatment
Kosma VM, Setiawan VW, Kristensen V, Arndt V, Vogel W, Zheng W, Sieh with a highly selective immunoproteasome inhibitor promotes
W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman ML, long-term cardiac allograft acceptance in mice. Proceedings
Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, of the National Academy of Sciences of the United States of
Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, Gayther America. 2016;113(52):E8425-E8432. PMCID: PMC5206568
SA, Easton DF, Chenevix-Trench G, Eeles R, Pharoah PDP, Lambrechts
Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter
D. Genome-wide meta-analyses of Breast, Ovarian, and Prostate Cancer
L, Womer RB, Meyers PA, Felgenhauer J, Marina N, DuBois
Association Studies identify multiple new susceptibility loci shared by at
SG. Identification of discrete prognostic groups in Ewing
least two cancer types. Cancer Discovery. 2016;6(9):1052-1067. PMCID:
sarcoma. Pediatric Blood and Cancer. 2016;63(1):47-53. PMCID:
PMC5010513
PMC5011751
Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B, Ettayebi
Karsten M, Stempel M, Radosa J, Patil S, King TA. Oncotype DX in
K, Papanicolaou GA, Jongwutiwes U, Perales MA, Shia J, Mercer
bilateral synchronous primary invasive breast cancer. Annals of Surgical
D, Finegold MJ, Vinjé J, Atmar RL, Estes MK. Detection of human
norovirus in intestinal biopsies from immunocompromised transplant
patients. Journal of General Virology. 2016;97(9):2291-2300. Karuturi M, Wong ML, Hsu T, Kimmick GG, Lichtman SM, Holmes HM,
Inouye SK, Dale W, Loh KP, Whitehead M I, Magnuson A, Hurria A,
Karlo CA, Kou L, Di Paolo PL, Kattan MW, Motzer RJ, Russo P, Tickoo
Janelsins MC, Mohile S. Understanding cognition in older patients
SK, Akin O, Hricak H. Renal cell carcinoma: A nomogram for the CT
with cancer. Journal of Geriatric Oncology. 2016;7(4):258-269. PMCID:
imaging-inclusive prediction of indolent, non-clear cell renal cortical
PMC4969091
tumours. European Journal of Cancer. 2016;59:57-64. PMCID: PMC4851871
Karuturi M, Younes A, Fayad L, Kwak L, Pro B, Shah J, Oki Y, Simien
Karnezis AN, Hoang LN, Coatham M, Ravn S, Almadani N, Tessier-
R, Liboon MJ, Hutto T, Feng L, Horowitz S, Nieto Y, Anderlini P,
Cloutier B, Irving J, Meng B, Li X, Chow C, McAlpine J, Kuo KT, Mao
Alousi A, Popat U, Medeiros LJ, Miranda R, Fanale M. Ifosfamide,
TL, Djordjevic B, Soslow RA, Huntsman DG, Gilks CB, Köbel M, Lee
122 OF 324
Journal Articles
carboplatin, etoposide with or without bortezomib in patients with Kaufman CK, Mosimann C, Fan ZP, Yang S, Thomas AJ, Ablain J, Tan JL,
relapsed/refractory Hodgkin lymphoma: Results of a randomized Fogley RD, van Rooijen E, Hagedorn EJ, Ciarlo C, White RM, Matos DA,
phase II trial. Leukemia and Lymphoma. 2016;57(2):445-447. PMCID: Puller AC, Santoriello C, Liao EC, Young RA, Zon L I. A zebrafish melanoma
PMC5215977 model reveals emergence of neural crest identity during melanoma
initiation. Science. 2016;351(6272):aad2197. PMCID: PMC4868069
Kasahara S, Jhingran A, Dhingra S, Salem A, Cramer RA, Hohl
TM. Role of granulocyte-macrophage colony-stimulating factor Kaufman DR, Sheehan B, Stetson P, Bhatt AR, Field A I, Patel C, Maisel
signaling in regulating neutrophil antifungal activity and the oxidative JM. Natural language processing-enabled and conventional data capture
burst during respiratory fungal challenge. Journal of Infectious methods for input to electronic health records: A comparative usability
Diseases. 2016;213(8):1289-1298. PMCID: PMC4799674 study. Jmir Medical Informatics. 2016;4(4):e35. PMCID: PMC5106560
Kash N, Massone C, Fink-Puches R, Cerroni L. Phenotypic variation Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D’Angelo SP,
in different lesions of mycosis fungoides biopsied within a short Shih KC, Lebbé C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH,
period of time from the same patient. American Journal of Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P. Avelumab
Dermatopathology. 2016;38(7):541-545. in patients with chemotherapy-refractory metastatic Merkel cell
carcinoma: A multicentre, single-group, open-label, phase 2 trial. Lancet
Kass EM, Lim PX, Helgadottir HR, Moynahan ME, Jasin Oncology. 2016;17(10):1374-1385.
M. Robust homology-directed repair within mouse mammary
tissue is not specifically affected by Brca2 mutation. Nature Kaye EA, Monette S, Srimathveeravalli G, Maybody M, Solomon
Communications. 2016;7:13241. PMCID: PMC5093336 SB, Gulati A. MRI-guided focused ultrasound ablation of lumbar medial
branch nerve: Feasibility and safety study in a swine model. International
Kass EM, Moynahan ME, Jasin M. When genome maintenance goes badly Journal of Hyperthermia. 2016;32(7):786-794. PMCID: PMC5206657
awry. Molecular Cell. 2016;62(5):777-787. PMCID: PMC4966655
Kazandjian D, Landgren O. A look backward and forward in the regulatory
Katsoulakis E, Riaz N, Hu M, Morris L, Sherman E, McBride S, Lee and treatment history of multiple myeloma: Approval of novel-novel
N. Hypopharyngeal squamous cell carcinoma: Three-dimensional agents, new drug development, and longer patient survival. Seminars in
or Intensity-modulated radiotherapy? A single institution’s Oncology. 2016;43(6):682-689. PMCID: PMC5282737
experience. Laryngoscope. 2016;126(3):620-626. PMCID: PMC4940128
Kazem S, Lauber C, van der Meijden E, Kooijman S, Kravchenko
Kattan MW, Hess KR, Amin MB, Lu Y, Moons KGM, Gershenwald JE, AA, the TrichSpin Network, Feltkamp MCW, Gorbalenya AE. Limited
Gimotty PA, Guinney JH, Halabi S, Lazar AJ, Mahar AL, Patel T, Sargent variation during circulation of a polyomavirus in the human population
DJ, Weiser MR, Compton C, members of the AJCC Precision Medicine involves the COCO-VA toggling site of Middle and Alternative
Core. American Joint Committee on Cancer acceptance criteria for T-antigen(s). Virology. 2016;487:129-140.
inclusion of risk models for individualized prognosis in the practice of
precision medicine. CA - A Cancer Journal for Clinicians. 2016;66(5):370- Kazi R, Moghaddam S, Chu P, Marghoob AA. Histologic
374. PMCID: PMC4955656 evidence of melanocytes isolated to the nail matrix. JAMA
Dermatology. 2016;152(5):573-575.
123 OF 324
Journal Articles
Keating D. Invited commentary on “Breast MR imaging for equivocal Kenific CM, Nogués L, Lyden D. Pre-metastatic niche formation has taken
mammographic findings”. Radiographics. 2016;36(4):956-958. its toll. Cancer Cell. 2016;30(2):189-191.
Keefe JR, Mao JJ, Soeller I, Li QS, Amsterdam JD. Short-term open-label Kent M, Penson DF, Albertsen PC, Goodman M, Hamilton AS, Stanford
chamomile (Matricaria chamomilla L.) therapy of moderate to severe JL, Stroup AM, Ehdaie B, Scardino PT, Vickers AJ. Successful external
generalized anxiety disorder. Phytomedicine. 2016;23(14):1699-1705. validation of a model to predict other cause mortality in localized
prostate cancer. BMC Medicine. 2016;14(1):25. PMCID: PMC4748497
Keinänen O, Li XG, Chenna NK, Lumen D, Ott J, Molthoff CFM, Sarparanta
M, Helariutta K, Vuorinen T, Windhorst AD, Airaksinen AJ. A new highly Kent MS, Mandrekar SJ, Landreneau R, Nichols F, DiPetrillo TA, Meyers
reactive and low lipophilicity fluorine-18 labeled tetrazine derivative for B, Heron DE, Jones DR, Tan AD, Starnes S, Putnam JB Jr, Fernando
pretargeted PET imaging. ACS Medicinal Chemistry Letters. 2016;7(1):62- HC. Impact of sublobar resection on pulmonary function: Long-term
66. PMCID: PMC4716598 results from American College of Surgeons Oncology Group Z4032
(Alliance). Annals of Thoracic Surgery. 2016;102(1):230-238. PMCID:
Kelly CM, Shahrokni A. Moving beyond Karnofsky and ECOG PMC4993049
Performance Status Assessments with new technologies. Journal of
Oncology. 2016;2016:6186543. PMCID: PMC4811104 Kent MS, Mandrekar SJ, Landreneau R, Nichols F, Foster NR, DiPetrillo
TA, Meyers B, Heron DE, Jones DR, Tan AD, Starnes S, Putnam JB Jr,
Kelly KJ, Wong J, Gönen M, Allen P, Brennan M, Coit D, Fong Fernando HC. A nomogram to predict recurrence and survival of high-
Y. Human trial of a genetically modified herpes simplex virus for rapid risk patients undergoing sublobar resection for lung cancer: An analysis
detection of positive peritoneal cytology in the staging of pancreatic of a multicenter prospective study (ACOSOG Z4032). Annals of Thoracic
cancer. EBioMedicine. 2016;7:94-99. PMCID: PMC4909379 Surgery. 2016;102(1):239-246. PMCID: PMC4993046
Kelvin JF, Thom B, Benedict C, Carter J, Corcoran S, Dickler MN, Goodman Keyes A, Mathias M, Boulad F, Lee YJ, Marchetti MA, Scaradavou
KA, Margolies A, Matasar MJ, Noy A, Goldfarb SB. Cancer and fertility A, Spitzer B, Papanicolaou GA, Wieczorek I, Busam KJ. Cutaneous
program improves patient satisfaction with information received. Journal involvement of disseminated adenovirus infection in an allogeneic stem
of Clinical Oncology. 2016;34(15):1780-1786. PMCID: PMC4966338 cell transplant recipient. British Journal of Dermatology. 2016;174(4):
885-888. PMCID: PMC4984257
Kelvin JF. Fertility preservation before cancer treatment:
Options, strategies, and resources. Clinical Journal of Oncology Khalil DN, Postow MA, Ibrahim N, Ludwig DL, Cosaert J, Kambhampati
Nursing. 2016;20(1):44-51. SRP, Tang S, Grebennik D, Kauh JSW, Lenz HJ, Flaherty KT, Hodi FS,
Lawrence DP, Wolchok JD. An open-label, dose-escalation phase I study
Kemeny NE, Chou JF, Boucher TM, Capanu M, DeMatteo RP, Jarnagin of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed
WR, Allen PJ, Fong Y, Cercek A, D’Angelica M I. Updated long-term or refractory melanoma. Clinical Cancer Research. 2016;22(21):5204-
survival for patients with metastatic colorectal cancer treated with 5210. PMCID: PMC5117650
liver resection followed by hepatic arterial infusion and systemic
chemotherapy. Journal of Surgical Oncology. 2016;113(5):477- Khalil DN, Segal NH. Modern immunotherapy for the treatment of advanced
484. PMCID: PMC5076474 gastrointestinal cancers. Oncology (Norwalk). 2016;30(1):85-90, 93.
124 OF 324
Journal Articles
Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of Khoury-Collado F, St. Clair C, Abu-Rustum NR. Sentinel
cancer treatment: Immunomodulation, CARs and combination lymph nodemapping in endometrial cancer: An update. The
immunotherapy. Nature Reviews Clinical Oncology. 2016;13(5):273-290. Oncologist. 2016;21(4):461-466. PMCID: PMC4828124
Khan SA, Morris M, Idrees K, Gimbel M I, Rosenberg S, Zeng Z, Li Khoushhal Z, Canner J, Schneider E, Stem M, Haut E, Mungo B, Lidor
F, Gan G, Shia J, LaQuaglia MP, Paty PB. Colorectal cancer in the A, Molena D. Influence of specialty training and trainee involvement
very young: A comparative study of tumor markers, pathology and on perioperative outcomes of esophagectomy. Annals of Thoracic
survival in early onset and adult onset patients. Journal of Pediatric Surgery. 2016;102(6):1829-1836.
Surgery. 2016;51(11):1812-1817. PMCID: PMC5312708
Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G,
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Bloomfield CD, Estey E, Burnett A, Cornelissen JJ, Scheinberg DA,
Anasetti C, Dreger P, Montserrat E, Perales MA, Alyea EP, Awan FT, Bouscary D, Linch DC. Acute myeloid leukaemia. Nature Reviews Disease
Ayala E, Barrientos JC, Brown JR, Castro JE, Furman RR, Gribben Primers. 2016;2:16010.
J, Hill BT, Mohty M, Moreno C, O’Brien S, Pavletic SZ, Pinilla-Ibarz J,
Reddy NM, Sorror M, Bredeson C, Carpenter P, Savani BN. Clinical Kiess AP, Agrawal N, Brierley JD, Duvvuri U, Ferris RL, Genden E, Wong
practice recommendations for use of allogeneic hematopoietic RJ, Tuttle RM, Lee NY, Randolph GW. External-beam radiotherapy for
cell transplantation in chronic lymphocytic leukemia on behalf differentiated thyroid cancer locoregional control: A statement of the
of the Guidelines Committee of the American Society for Blood American Head and Neck Society. Head and Neck. 2016;38(4):493-
and Marrow Transplantation. Biology of Blood and Marrow 498. PMCID: PMC4975923
Transplantation. 2016;22(12):2117-2125. PMCID: PMC5116249
Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SMH, Presley CJ,
Kheterpal M, Mehta-Shah N, Virmani P, Myskowski PL, Moskowitz Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won
A, Horwitz SM. Managing patients with cutaneous B-cell and T-cell E, Mustian KM. Designing exercise clinical trials for older adults with
lymphomas other than mycosis fungoides. Current Hematologic cancer: Recommendations from 2015 Cancer and Aging Research
Malignancy Reports. 2016;11(3):224-233. Group NCI U13 meeting. Journal of Geriatric Oncology. 2016;7(4):293-
304. PMCID: PMC4969104
Khosravan R, Motzer RJ, Fumagalli E, Rini B I. Population
pharmacokinetic/pharmacodynamic modeling of sunitinib Kilgoz HO, Bender G, Scandura JM, Viale A, Taneri B. KRAS and the
by dosing schedule in patients with advanced renal cell reality of personalized medicine in non-small cell lung cancer. Molecular
carcinoma or gastrointestinal stromal tumor. Clinical Medicine. 2016;22:380-387. PMCID: PMC5072415
Pharmacokinetics. 2016;55(10):1251-1269.
Kim DC, Bennett GL, Somberg M, Campbell N, Gaing B, Recht MP, Doshi
Khoury HJ, Goldberg SL, Mauro MJ, Stone RM, Deininger MW, Bradley- AM. A multidisciplinary approach to improving appropriate follow-up
Garelik MB, Mohamed H, Guilhot F. Cross-intolerance with dasatinib imaging of ovarian cysts: A quality improvement initiative. Journal of the
among imatinib-intolerant patients with chronic phase chronic myeloid American College of Radiology. 2016;13(5):535-541.
leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2016;16(6):341-349.e1.
125 OF 324
Journal Articles
Kim DW, Mehra R, Tan DSW, Felip E, Chow LQM, Camidge DR, imaging of brain tumours in the era of precision medicine. Nature
Vansteenkiste J, Sharma S, De Pas T, Riely GJ, Solomon BJ, Wolf J, Reviews Clinical Oncology. 2016;13(12):725-739. PMCID: PMC5115958
Thomas M, Schuler M, Liu G, Santoro A, Sutradhar S, Li SY, Szczudlo
T, Yovine A, Shaw AT. Activity and safety of ceritinib in patients with Kim S, Peterson SE, Jasin M, Keeney S. Mechanisms of germ line genome
ALK-rearranged non-small-cell lung cancer (ASCEND-1): Updated instability. Seminars in Cell and Developmental Biology. 2016;54:177-187.
results from the multicentre, open-label, phase 1 trial. Lancet
Oncology. 2016;17(4):452-463. PMCID: PMC5063047 Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I, Conrad M, Turker
MZ, Gao M, Jiang X, Monette S, Pauliah M, Gonen M, Zanzonico P, Quinn
Kim HT, Zhang MJ, Woolfrey AE, St. Martin A, Chen J, Saber W, Perales T, Wiesner U, Bradbury MS, Overholtzer M. Ultrasmall nanoparticles
MA, Armand P, Eapen M. Donor and recipient sex in allogeneic stem cell induce ferroptosis in nutrient-deprived cancer cells and suppress
transplantation: What really matters. Haematologica. 2016;101(10):1260- tumour growth. Nature Nanotechnology. 2016;11(11):977-985. PMCID:
1266. PMCID: PMC5046656 PMC5108575
Kim J, Medicherla CB, Ma CL, Feher A, Kukar N, Geevarghese A, Goyal Kimm SY, Tarin T V, Monette S, Srimathveeravalli G, Gerber D, Durack
P, Horn E, Devereux RB, Weinsaft JW. Association of right ventricular JC, Solomon SB, Scardino PT, Scherz A, Coleman J. Nonthermal
pressure and volume overload with non-ischemic septal fibrosis on cardiac ablation by using intravascular oxygen radical generation
magnetic resonance. PLoS ONE. 2016;11(1):e0147349. PMCID: PMC4723145 with WST11: Dynamic tissue effects and implications for focal
therapy. Radiology. 2016;281(1):109-118. PMCID: PMC5047127
Kim J, Mouw KW, Polak P, Braunstein LZ, Kamburov A, Tiao G,
Kwiatkowski DJ, Rosenberg JE, Van Allen EM, D’Andrea AD, Getz Kimmelman J, Heslop HE, Sugarman J, Studer L, Benvenisty N, Caulfield
G. Somatic ERCC2 mutations are associated with a distinct genomic T, Hyun I, Murry CE, Sipp D, Daley GQ. New ISSCR guidelines: Clinical
signature in urothelial tumors. Nature Genetics. 2016;48(6):600- translation of stem cell research. Lancet. 2016;387(10032):1979-1981.
606. PMCID: PMC4936490
King B, Boccalatte F, Moran-Crusio K, Wolf E, Wang JJ, Kayembe C,
Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Lazaris C, Yu XF, Aranda-Orgilles B, Lasorella A, Aifantis I. The ubiquitin
Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM, Population- ligase Huwe1 regulates the maintenance and lymphoid commitment
based Research Optimizing Screening through Personalized of hematopoietic stem cells. Nature Immunology. 2016;17(11):1312-
Regimens (PROSPR) consortium. Cancer models and real-world 1321. PMCID: PMC5117833
data: Better together. JNCI: Journal of the National Cancer
Institute. 2016;108(2):djv316. PMCID: PMC4907359 King MT, Nasser NJ, Mathur N, Cohen GN, Kollmeier MA, Yuen J, Vargas
HA, Pei X, Yamada Y, Zakian KL, Zaider M, Zelefsky MJ. Long-term
Kim M, O’Rourke BP, Soni RK, Jallepalli P V, Hendrickson RC, Tsou outcome of magnetic resonance spectroscopic image-directed dose
MFB. Promotion and suppression of centriole duplication are escalation for prostate brachytherapy. Brachytherapy. 2016;15(3):266-273.
catalytically coupled through PLK4 to ensure centriole homeostasis. Cell
Reports. 2016;16(5):1195-1203. PMCID: PMC4972634 King TA, Lyman JP, Gonen M, Voci A, De Brot M, Boafo C, Sing
AP, Hwang ES, Alvarado MD, Liu MC, Boughey JC, McGuire KP, Van
Kim MM, Parolia A, Dunphy MP, Venneti S. Non-invasive metabolic Poznak CH, Jacobs LK, Meszoely IM, Krontiras H, Babiera G V, Norton
L, Morrow M, Hudis CA. Prognostic impact of 21-gene Recurrence Score
126 OF 324
Journal Articles
in patients with stage IV breast cancer: TBCRC 013. Journal of Clinical chronic lymphocytic leukemia: A longitudinal single-center study. Annals
Oncology. 2016;34(20):2359-2365. PMCID: PMC4981976 of Hematology. 2016;95(6):871-879.
Kingham TP, Leung U, Kuk D, Gönen M, D’Angelica M I, Allen Klassen AF, Cano S, Pusic A. RHINO scale: A question about
PJ, DeMatteo RP, Laudone VP, Jarnagin WR, Fong Y. Robotic content validity. Plastic and Reconstructive Surgery-Global
liver resection: A case-matched comparison. World Journal of Open. 2016;4(8):e826. PMCID: PMC5010317
Klassen AF, Cano SJ, Alderman A, East C, Badia L, Baker SB,
Kirane A, Crago AM. The importance of surgical margins in retroperitoneal Robson S, Pusic AL. Self-report scales to measure expectations and
sarcoma. Journal of Surgical Oncology. 2016;113(3):270-276. appearance-related psychosocial distress in patients seeking cosmetic
treatments. Aesthetic Surgery Journal. 2016;36(9):1068-1078. PMCID:
Kirschbaum A, Teymoortash A, Suárez C, Shah JP, Silver CE, Nixon PMC5029370
I, Rinaldo A, Kowalski LP, Robbins KT, Ferlito A. Treatment of large
tracheal defects after resection: Laryngotracheal release and tracheal Klassen AF, Cano SJ, Alderman A, Soldin M, Thoma A, Robson S,
replacement. Auris Nasus Larynx. 2016;43(6):602-608. PMCID: Kaur M, Papas A, Van Laeken N, Taylor VH, Pusic AL. The BODY-Q:
PMC5152768 A patient-reported outcome instrument for weight loss and body
contouring treatments. Plastic and Reconstructive Surgery-Global
Kissane DW, Zaider T I, Li Y, Hichenberg S, Schuler T, Lederberg M, Open. 2016;4(4):e679. PMCID: PMC4859238
Lavelle L, Loeb R, Del Gaudio F. Randomized controlled trial of family
therapy in advanced cancer continued into bereavement. Journal of Klassen AF, Cano SJ, East CA, Baker SB, Badia L, Schwitzer JA, Pusic
Clinical Oncology. 2016;34(16):1921-1927. AL. Development and psychometric evaluation of the FACE-Q
scales for patients undergoing rhinoplasty. JAMA Facial Plastic
Kittler H, Marghoob AA, Argenziano G, Carrera C, Curiel- Surgery. 2016;18(1):27-35. PMCID: PMC4831065
Lewandrowski C, Hofmann-Wellenhof R, Malvehy J, Menzies S, Puig
S, Rabinovitz H, Stolz W, Saida T, Soyer HP, Siegel E, Stoecker W Klassen AF, Cano SJ, Pusic AL. FACE-Q satisfaction with appearance
V, Scope A, Tanaka M, Thomas L, Tschandl P, Zalaudek I, Halpern scores from close to 1000 facial aesthetic patients. Plastic and
A. Standardization of terminology in dermoscopy/dermatoscopy: Reconstructive Surgery. 2016;137(3):651e-652e. PMCID: PMC4819417
Results of the third consensus conference of the International
Society of Dermoscopy. Journal of the American Academy of Klassen AF, Cano SJ, Pusic AL. Use of FACE-Q to measure quality
Dermatology. 2016;74(6):1093-1106. of life following aesthetic facial treatments. JAMA Facial Plastic
Surgery. 2016;18(2):148-149.
Kiuru M, Jungbluth A, Kutzner H, Wiesner T, Busam KJ. Spitz
tumors: Comparison of histological features in relationship to Klassen AF, Cano SJ, Schwitzer JA, Baker SB, Carruthers A,
immunohistochemical staining for ALK and NTRK1. International Journal Carruthers J, Chapas A, Pusic AL. Development and psychometric
of Surgical Pathology. 2016;24(3):200-206. validation of the FACE-Q skin, lips, and facial rhytids appearance
scales and adverse effects checklists for cosmetic procedures. JAMA
Kjellander C, Björkholm M, Källman O, Giske CG, Weibull CE, Löve Dermatology. 2016;152(4):443-451. PMCID: PMC4833666
TJ, Landgren O, Kristinsson SY. Bloodstream infections in patients with
127 OF 324
Journal Articles
Klebanoff CA, Restifo NP. Customizing functionality and payload delivery Knutsson A, Hsiung S, Celik S, Rattik S, Mattisson IY, Wigren
for receptor-engineered T cells. Cell. 2016;167(2):304-306. M, Scher H I, Nilsson J, Hultgårdh-Nilsson A. Treatment with a GnRH
receptor agonist, but not the GnRH receptor antagonist degarelix,
Kleppe M, Levine RL. An unexpected chink in the transcriptional armor induces atherosclerotic plaque instability in ApoE-/- mice. Scientific
of plasmacytoid dendritic neoplasms. Cancer Cell. 2016;30(5):659-660. Reports. 2016;6:26220. PMCID: PMC4870555
Klevstig M, Ståhlman M, Lundqvist A, Scharin Täng M, Fogelstrand Ko JS, Prieto VG, Elson PJ, Vilain RE, Pulitzer MP, Scolyer RA, Reynolds
P, Adiels M, Andersson L, Kolesnick R, Jeppsson A, Borén J, Levin JP, Piliang MP, Ernstoff MS, Gastman BR, Billings SD. Histological pattern
MC. Targeting acid sphingomyelinase reduces cardiac ceramide of Merkel cell carcinoma sentinel lymph node metastasis improves
accumulation in the post-ischemic heart. Journal of Molecular and stratification of stage III patients. Modern Pathology. 2016;29(2):122-
Cellular Cardiology. 2016;93:69-72. PMCID: PMC5026316 130. PMCID: PMC5063050
Klimek VM, Tray NJ. Therapy-related myeloid neoplasms: What’s in a Kobel M, Meng B, Hoang LN, Almadani N, Li X, Soslow RA, Gilks CB, Lee
name?. Current Opinion in Hematology. 2016;23(2):161-166. CH. Molecular analysis of mixed endometrial carcinomas shows clonality
in most cases. American Journal of Surgical Pathology. 2016;40(2):166-
Klimstra DS, Adsay V. Acinar neoplasms of the pancreas - A summary of 25 180. PMCID: PMC5029122
years of research. Seminars in Diagnostic Pathology. 2016;33(5):307-318.
Kode A, Mosialou I, Manavalan SJ, Rathinam C V, Friedman RA, Teruya-
Klimstra DS. Pathologic classification of neuroendocrine Feldstein J, Bhagat G, Berman E, Kousteni S. FoxO1-dependent induction
neoplasms. Hematology/Oncology Clinics of North America. 2016;30(1):1-19. of acute myeloid leukemia by osteoblasts in mice. Leukemia. 2016;30(1):1-
13. PMCID: PMC4691220
Klimstra DS. Reassessing the grade of gastroenteropancreatic
neuroendocrine neoplasms. Endocrine. 2016;53(1):4-6. Koelsch BL, Sriram R, Keshari KR, Swisher CL, Van Criekinge M, Sukumar
S, Vigneron DB, Wang ZJ, Larson PEZ, Kurhanewicz J. Separation of
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Arozena
extra- and intracellular metabolites using hyperpolarized (13)C diffusion
AA, Adachi H, Adams CM, Adams PD, Adeli K, et al. Guidelines for
weighted MR. Journal of Magnetic Resonance. 2016;270:115-123.
the use and interpretation of assays for monitoring autophagy (3rd
edition). Autophagy. 2016;12(1):1-222. PMCID: PMC4835977 Koelwyn GJ, Lewis NC, Ellard SL, Jones LW, Gelinas JC, Douglass
Rolf J, Melzer B, Thomas SM, Douglas PS, Khouri MG, Eves
Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak
ND. Ventricular-arterial coupling in breast cancer patients after
C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM. Estimation
treatment with anthracycline-containing adjuvant chemotherapy. The
of benefits, burden, and harms of colorectal cancer screening strategies:
Modeling study for the US Preventive Services Task Force. JAMA -
Journal of the American Medical Association. 2016;315(23):2595-2609. Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox
BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L,
Knudsen ES, O’Reilly EM, Brody JR, Witkiewicz AK. Genetic diversity
Levy R, Lyerly HK, Maecker H, Marabelle A, Melenhorst J, Miller J, Melero
of pancreatic ductal adenocarcinoma and opportunities for precision
I, Odunsi K, Palucka K, Peoples G, Ribas A, Robins H, Robinson W,
medicine. Gastroenterology. 2016;150(1):48-63. PMCID: PMC5010785
128 OF 324
Journal Articles
Serafini T, Sondel P, Vivier E, Weber J, Wolchok J, Zitvogel L, Disis ML, Konstantinidis IT, Koerkamp BG, Do RKG, Gönen M, Fong Y, Allen
Cheever MA. Immunodynamics: A cancer immunotherapy trials network PJ, D’Angelica M I, Kingham TP, DeMatteo RP, Klimstra DS, Kemeny
review of immune monitoring in immuno-oncology clinical trials. Journal NE, Jarnagin WR. Unresectable intrahepatic cholangiocarcinoma:
for Immunotherapy of Cancer. 2016;4:15. PMCID: PMC4791805 Systemic plus hepatic arterial infusion chemotherapy is associated
with longer survival in comparison with systemic chemotherapy
Kohutek ZA, Weg ES, Pei X, Shi W, Zhang Z, Kollmeier MA, Zelefsky alone. Cancer. 2016;122(5):758-765. PMCID: PMC4764409
MJ. Long-term impact of androgen-deprivation therapy on
cardiovascular morbidity after radiotherapy for clinically localized Konstantinidis IT, Mastrodomenico P, Sofocleous CT, Brown
prostate cancer. Urology. 2016;87:146-152. KT, Getrajdman G I, Gönen M, Allen PJ, Kingham TP, DeMatteo
RP, Fong Y, Jarnagin WR, D’Angelica M I. Symptomatic perihepatic
Kole TP, Tong M, Wu B, Lei S, Obayomi-Davies O, Chen LN, Suy S, fluid collections after hepatic resection in the modern era. Journal of
Dritschilo A, Yorke E, Collins SP. Late urinary toxicity modeling after Gastrointestinal Surgery. 2016;20(4):748-756. PMCID: PMC4830382
stereotactic body radiotherapy (SBRT) in the definitive treatment of
localized prostate cancer. Acta Oncologica. 2016;55(1):52-58. PMCID: Koo DJ, Goring TN, Pinard KA, Egan BC. Malignant bowel obstruction in
PMC4986047 advanced cancer. Hospital Medicine Clinics. 2016;5(3):413-424.
Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin Koo DJ, Tonorezos ES, Kumar CB, Goring TN, Salvit C, Egan
JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman BC. Hospitalists caring for patients with advanced cancer: An
RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales experience-based guide. Journal of Hospital Medicine. 2016;11(4):292-
MA, Setterholm M, Woolfrey AE, Yu N, Eapen M. The effect of donor 296. PMCID: PMC4821746
characteristics on survival after unrelated donor transplantation for
hematologic malignancy. Blood. 2016;127(2):260-267. PMCID: PMC4713163 Korde N, Zhang Y, Loeliger K, Poon A, Simakova O, Zingone A, Costello
R, Childs R, Noel P, Silver S, Kwok M, Mo C, Young N, Landgren O,
Kollmeier MA. In reply to Ismaili. Practical Radiation Sloand E, Maric I. Monoclonal gammopathy-associated pure red cell
Oncology. 2016;6(5):e217-e218. aplasia. British Journal of Haematology. 2016;173(6):876-883.
Komanduri K V, Levine RL. Diagnosis and therapy of acute myeloid Korde N. Treatment of high-risk smoldering myeloma. Seminars in
leukemia in the era of molecular risk stratification. Annual Review of Oncology. 2016;43(6):695-696.
Medicine. 2016;67:59-72.
Korenstein D, Duan K, Diaz MJ, Ahn R, Keyhani S. Do health care
Komura K, Jeong SH, Hinohara K, Qu F, Wang X, Hiraki M, Azuma H, delivery system reforms improve value? The jury is still out. Medical
Lee GSM, Kantoff PW, Sweeney CJ. Resistance to docetaxel in prostate Care. 2016;54(1):55-66. PMCID: PMC4869989
cancer is associated with androgen receptor activation and loss of
KDM5D expression. Proceedings of the National Academy of Sciences Kossatz S, Brand C, Gutiontov S, Liu JTC, Lee NY, Gonen M, Weber
of the United States of America. 2016;113(22):6259-6264. PMCID: WA, Reiner T. Detection and delineation of oral cancer with a PARP1 targeted
PMC4896695 optical imaging agent. Scientific Reports. 2016;6:21371. PMCID: PMC4761964
129 OF 324
Journal Articles
Kossatz S, Weber WA, Reiner T. Optical imaging of PARP1 in in pediatrics. Journal of Child Neurology. 2016;31(12):1394-
response to radiation in oral squamous cell carcinoma. PLoS 1398. PMCID: PMC5028308
ONE. 2016;11(1):e0147752. PMCID: PMC4726809
Krebs S, Monti S, Seshan S, Fox J, Mannelli L. IgG4-related kidney disease
Kotini AG, De Stanchina E, Themeli M, Sadelain M, Papapetrou in a patient with history of breast cancer findings on (18)F-FDG PET/
EP. Escape mutations, ganciclovir resistance, and teratoma formation CT. Clinical Nuclear Medicine. 2016;41(8):e388-e389. PMCID: PMC4977093
in human iPSCs expressing an HSVtk suicide gene. Molecular Therapy -
Nucleic Acids. 2016;5:e284. PMCID: PMC4884789 Kridel R, Chan FC, Mottok A, Boyle M, Farinha P, Tan K, Meissner B,
Bashashati A, McPherson A, Roth A, Shumansky K, Yap D, Ben-Neriah
Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, De Alava S, Rosner J, Smith MA, Nielsen C, Giné E, Telenius A, Ennishi D, Mungall
E, Dirksen U, Van Der Ent W, Grohar P, Grünewald TGP, Helman L, A, Moore R, Morin RD, Johnson NA, Sehn LH, Tousseyn T, Dogan A, Connors
Houghton P, Iljin K, Korsching E, Ladanyi M, Lawlor E, Lessnick S, Ludwig JM, Scott DW, Steidl C, Marra MA, Gascoyne RD, Shah SP. Histological
J, Meltzer P, Metzler M, Mora J, Moriggl R, Nakamura T, Papamarkou transformation and progression in follicular lymphoma: A clonal evolution
T, Sarikas BR, Rédini F, Richter GHS, Rossig C, Schadler K, Schäfer study. PLoS Medicine. 2016;13(12):e1002197. PMCID: PMC5154502
BW, Scotlandi K, Sheffield NC, Shelat A, Snaar-Jagalska E, Sorensen
P, Stegmaier K, Stewart E, Sweet-Cordero A, Szuhai K, Tirado OM, Krishna S, Overholtzer M. Germ cells get by with a little cannibalistic help
Tirode F, Toretsky J, Tsafou K, Üren A, Zinovyev A, Delattre O. The from their friends. Developmental Cell. 2016;39(6):631-633.
second European interdisciplinary Ewing sarcoma research summit
- A joint effort to deconstructing the multiple layers of a complex Krishna S, Overholtzer M. Mechanisms and consequences of
disease. Oncotarget. 2016;7(8):8613-8624. PMCID: PMC4890991 entosis. Cellular and Molecular Life Sciences. 2016;73(11-12):2379-
2386. PMCID: PMC4889469
Kowalski CH, Beattie SR, Fuller KK, McGurk EA, Tang YW, Hohl
TM, Obar JJ, Cramer RA Jr. Heterogeneity among isolates reveals Krishna S, Palm W, Lee Y, Yang W, Bandyopadhyay U, Xu H,
that fitness in low oxygen correlates with Aspergillus fumigatus Florey O, Thompson CB, Overholtzer M. PlKfyve regulates vacuole
virulence. mBio. 2016;7(5):e01515-16. PMCID: PMC5040115 maturation and nutrient recovery following engulfment. Developmental
Cell. 2016;38(5):536-547. PMCID: PMC5046836
Koyama S, Akbay EA, Li YY, Aref AR, Skoulidis F, Herter-Sprie GS,
Buczkowski KA, Liu Y, Awad MM, Denning WL, Diao L, Wang J, Parra- Krop IE, Mayer IA, Ganju V, Dickler M, Johnston S, Morales SN, Yardley
Cuentas ER, Wistuba I I, Soucheray M, Thai T, Asahina H, Kitajima S, DA, Melichar B, Forero-Torres A, Lee SC, de Boer R, Petrakova K, Vallentin
Altabef A, Cavanaugh JD, Rhee K, Gao P, Zhang H, Fecci PE, Shimamura S, Perez EA, Piccart M, Ellis M, Winer E, Gendreau S, Derynck M, Lackner
T, Hellmann MD, Heymach J V, Hodi FS, Freeman GJ, Barbie DA, M, Levy G, Qiu JH, He J, Schmid P. Pictilisib for oestrogen receptor-
Dranoff G, Hammerman PS, Wong KK. STK11/LKB1 deficiency promotes positive, aromatase inhibitor-resistant, advanced or metastatic breast
neutrophil recruitment and proinflammatory cytokine production to cancer (FERGI): A randomised, double-blind, placebo-controlled, phase 2
suppress T-cell activity in the lung tumor microenvironment. Cancer trial. Lancet Oncology. 2016;17(6):811-821.
Krop IE, Modi S, LoRusso PM, Pegram M, Guardino E, Althaus B, Lu D,
Kramer K. Rare primary central nervous system tumors encountered Strasak A, Elias A. Phase 1b/2a study of trastuzumab emtansine (T-
130 OF 324
Journal Articles
DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast inhibits leukemogenic gene expression in NPM1 mutant leukemia. Cancer
cancer. Breast Cancer Research. 2016;18:34. PMCID: PMC4791863 Discovery. 2016;6(10):1166-1181.
Kruegel AC, Gassaway MM, Kapoor A, Váradi A, Majumdar S, Filizola M, Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz
Javitch JA, Sames D. Synthetic and receptor signaling explorations of P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD,
the mitragyna alkaloids: Mitragynine as an atypical molecular framework Carvajal RD, Postow MA. Prognosis of mucosal, uveal, acral, nonacral
for opioid receptor modulators. Journal of the American Chemical cutaneous, and unknown primary melanoma from the time of first
Society. 2016;138(21):6754-6764. PMCID: PMC5189718 metastasis. The Oncologist. 2016;21(7):848-854. PMCID: PMC4943393
Krzyzanowska A, Lippolis G, Helczynski L, Anand A, Peltola M, Pettersson Kulkarni AR, Mehrara BJ, Pusic AL, Cordeiro PG, Matros E, McCarthy
K, Lilja H, Bjartell A. Quantitative time-resolved fluorescence imaging CM, Disa JJ. Venous thrombosis in handsewn versus coupled
of androgen receptor and prostate-specific antigen in prostate tissue venous anastomoses in 857 consecutive breast free flaps. Journal of
sections. Journal of Histochemistry and Cytochemistry. 2016;64(5):311- Reconstructive Microsurgery. 2016;32(3):178-182. PMCID: PMC4787258
322. PMCID: PMC4851272
Kumar A, Burger IA, Zhang Z, Drill EN, Migliacci JC, Ng A, LaCasce
Ku GY, Kriplani A, Janjigian YY, Kelsen DP, Rusch VW, Bains A, Wall D, Witzig TE, Ristow K, Yahalom J, Moskowitz CH, Zelenetz
M, Chou J, Capanu M, Wu AJ, Goodman KA, Ilson DH. Change in AD. Definition of bulky disease in early stage Hodgkin lymphoma in
chemotherapy during concurrent radiation followed by surgery after computed tomography era: Prognostic significance of measurements
a suboptimal positron emission tomography response to induction in the coronal and transverse planes. Haematologica. 2016;101(10):1237-
chemotherapy improves outcomes for locally advanced esophageal 1243. PMCID: PMC5046653
adenocarcinoma. Cancer. 2016;122(13):2083-2090. PMCID: PMC4911302
Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu
Ku GY, Bains MS, Park DJ, Janjigian YY, Rusch VW, Rizk NP, Yoon A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton
SS, Millang B, Capanu M, Goodman KA, Ilson DH. Phase II study A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur
of bevacizumab and preoperative chemoradiation for esophageal GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock
adenocarcinoma. Journal of Gastrointestinal Oncology. 2016;7(6):828- CS, Straus DJ, Vander Els N, Verwys SL, Yang J, Younes A, Zelenetz
837. PMCID: PMC5177593 AD, Zhang Z, Moskowitz CH. Brentuximab vedotin and AVD followed
by involved-site radiotherapy in early stage, unfavorable risk Hodgkin
Kucine N, Viny AD, Rampal R, Berger M, Socci N, Viale A, lymphoma. Blood. 2016;128(11):1458-1464. PMCID: PMC5025897
Bussel JB, Levine RL, Rapaport F. Genetic analysis of five
children with essential thrombocytosis identified mutations Kumar A, Christensen R, Guo M, Chandris P, Duncan W, Wu Y, Santella
in cancer-associated genes with roles in transcriptional A, Moyle M, Winter PW, Colón-Ramos D, Bao Z, Shroff H. Using
regulation. Haematologica. 2016;101(6):e237-e239. PMCID: PMC5013957 stage-and slit-scanning to improve contrast and optical sectioning
in dual-view inverted light sheet microscopy (diSPIM). Biological
Kühn MWM, Song E, Feng Z, Sinha A, Chen CW, Deshpande AJ, Cusan Bulletin. 2016;231(1):26-39.
M, Farnoud N, Mupo A, Grove C, Koche R, Bradner JE, de Stanchina E,
Vassiliou GS, Hoshii T, Armstrong SA. Targeting chromatin regulators Kumar A, Coleman I, Morrissey C, Zhang XT, True LD, Gulati R, Etzioni
131 OF 324
Journal Articles
R, Bolouri H, Montgomery B, White T, Lucas JM, Brown LG, Dumpit RF, Kuntz KM, Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I. A
DeSarkar N, Higano C, Yu EY, Coleman R, Schultz N, Fang M, Lange restricted look at CRC screening: Not considering annual stool testing as
PH, Shendure J, Vessella RL, Nelson PS. Substantial interindividual and an option. American Journal of Managed Care. 2016;22(7):e270-e271.
limited intraindividual genomic diversity among tumors from men with
metastatic prostate cancer. Nature Medicine. 2016;22(4):369-378. PMCID: Kuo HC, Mehta KJ, Montgomery L, Shankar V, Yaparpalvi R, Hong L, Fox
PMC5045679 J, Tomé WA, Kalnicki S. Tumor bed variation during multi-lumen balloon-
based accelerated partial breast irradiation: Implication of surgical
Kumar A. The emerging role of checkpoint inhibitor therapy in Hodgkin clips. Acta Oncologica. 2016;55(4):526-529.
lymphoma. Oncology (Norwalk). 2016;30(10):921-922.
Kuo LC, Yorke ED, Dumane VA, Foster A, Zhang Z, Mechalakos JG, Wu
Kumar AJ, Gimotty PA, Gelfand J, Buck G, Rowe JM, Goldstone AH, AJ, Rosenzweig KE, Rimner A. Geometric dose prediction model for
Fielding A, Marks D I, Litzow M, Paietta E, Lazarus HM, Tallman MS, Luger hemithoracic intensity-modulated radiation therapy in mesothelioma
SM, Loren AW. Delays in postremission chemotherapy for Philadelphia patients with two intact lungs. Journal of Applied Clinical Medical Physics
chromosome negative acute lymphoblastic leukemia are associated . 2016;17(3):371-379.
with inferior outcomes in patients who undergo allogeneic transplant:
An analysis from ECOG 2993/MRC UK ALLXII. American Journal of Kurtz SL. Ethical considerations in oncology. Physician Assistant
Hematology. 2016;91(11):1107-1112. PMCID: PMC5073003 Clinics. 2016;1(3):511-522.
Kumar C, Remus D. Eukaryotic replication origins: Strength in Kusebauch U, Campbell DS, Deutsch EW, Chu CS, Spicer DA, Brusniak
flexibility. Nucleus. 2016;7(3):292-300. PMCID: PMC4991242 MY, Slagel J, Sun Z, Stevens J, Grimes B, Shteynberg D, Hoopmann MR,
Blattmann P, Ratushny A V, Rinner O, Picotti P, Carapito C, Huang CY,
Kumar H, Fojo T, Mailankody S. An appraisal of clinically Kapousouz M, Lam H, Tran T, Demir E, Aitchison JD, Sander C, Hood L,
meaningful outcomes guidelines for oncology clinical trials. JAMA Aebersold R, Moritz RL. Human SRMAtlas: A resource of targeted assays
Oncology. 2016;2(9):1238-1240. to quantify the complete human proteome. Cell. 2016;166(3):766-
778. PMCID: PMC5245710
Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P,
Munshi N, Lonial S, Bladé J, Mateos M V, Dimopoulos M, Kastritis E, Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Modak S, Kramer
Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, K, Roberts SS, Basu EM, Yataghene K, Cheung NK V. Lack of survival
Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, advantage with autologous stem-cell transplantation in high-risk
Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig neuroblastoma consolidated by anti-GD2 immunotherapy and
H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo isotretinoin. Oncotarget. 2016;7(4):4155-4166. PMCID: PMC4826196
A, Orfao A, Rajkumar S V, Miguel JS, Avet-Loiseau H. International
Myeloma Working Group consensus criteria for response and Kushwaha R, Jagadish N, Kustagi M, Mendiratta G, Seandel M, Soni R,
minimal residual disease assessment in multiple myeloma. Lancet Korkola JE, Thodima V, Califano A, Bosl GJ, Chaganti RSK. Mechanism
Oncology. 2016;17(8):e328-e346. and role of SOX2 repression in seminoma: Relevance to human germline
specification. Stem Cell Reports. 2016;6(5):772-783. PMCID: PMC4939754
132 OF 324
Journal Articles
Kwon AJ, Roshal M, DeSancho MT. Clinical adherence to thrombophilia Lakhman Y, D’Anastasi M, Miccò M, Scelzo C, Vargas HA, Nougaret
screening guidelines at a major tertiary care hospital. Journal of S, Sosa RE, Chi DS, Abu-Rustum NR, Hricak H, Sala E. Second-
Thrombosis and Haemostasis. 2016;14(5):982-986. opinion interpretations of gynecologic oncologic MRI examinations
by sub-specialized radiologists influence patient care. European
Kyi C, Postow MA. Immune checkpoint inhibitor combinations in solid Radiology. 2016;26(7):2089-2098.
tumors: Opportunities and challenges. Immunotherapy. 2016;8(7):821-837.
Lakhman Y, Katz SS, Goldman DA, Yakar D, Vargas HA, Sosa
Kyoizumi S, Kubo Y, Misumi M, Kajimura J, Yoshida K, Hayashi T, Imai RE, Miccò M, Soslow RA, Hricak H, Abu-Rustum NR, Sala E. Diagnostic
K, Ohishi W, Nakachi K, Young LF, Shieh JH, Moore MA, Van Den Brink performance of computed tomography for preoperative staging of
MRM, Kusunoki Y. Circulating hematopoietic stem and progenitor cells patients with non-endometrioid carcinomas of the uterine corpus. Annals
in aging atomic bomb survivors. Radiation Research. 2016;185(1):69- of Surgical Oncology. 2016;23(4):1271-1278. PMCID: PMC4910505
76. PMCID: PMC5015444
Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS,
Lacouture ME, Dréno B, Ascierto PA, Dummer R, Basset-Seguin N, Hill RC, Lakins JN, Schlaepfer DD, Mouw JK, LeBleu VS, Roy N, Novitskiy
Fife K, Ernst S, Licitra L, Neves R I, Peris K, Puig S, Sokolof J, Sekulic S V, Johansen JS, Poli V, Kalluri R, Iacobuzio-Donahue CA, Wood LD,
A, Hauschild A, Kunstfeld R. Characterization and management of Hebrok M, Hansen K, Moses HL, Weaver VM. Genotype tunes pancreatic
hedgehog pathway inhibitor-related adverse events in patients with ductal adenocarcinoma tissue tension to induce matricellular fibrosis
advanced basal cell carcinoma. The Oncologist. 2016;21(10):1218- and tumor progression. Nature Medicine. 2016;22(5):497-505. PMCID:
1229. PMCID: PMC5061532 PMC4860133
Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Lalor L, Busam K, Shah K. Prepubertal melanoma srising within
Doherty JP, Giri N, Nadanaciva S, O’Connell J, Sbar E, Piperdi B, a medium-sized congenital melanocytic nevus. Pediatric
Garon EB. A phase II study (ARCHER 1042) to evaluate prophylactic Dermatology. 2016;33(6):e372-e374.
treatment of dacomitinib-induced dermatologic and gastrointestinal
adverse events in advanced non-small-cell lung cancer. Annals of Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK,
Oncology. 2016;27(9):1712-1718. Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP,
Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC,
LaFave LM, Béguelin W, Koche R, Teater M, Spitzer B, Chramiec Warren GW. Research priorities, measures, and recommendations
A, Papalexi E, Keller MD, Hricik T, Konstantinoff K, Micol JB, Durham B,
Knutson SK, Campbell JE, Blum G, Shi X, Doud EH, Krivtsov A V, Chung for assessment of tobacco use in clinical cancer research. Clinical Cancer
YR, Khodos I, De Stanchina E, Ouerfelli O, Adusumilli PS, Thomas PM, Research. 2016;22(8):1907-1913. PMCID: PMC4861174
Kelleher NL, Luo M, Keilhack H, Abdel-Wahab O, Melnick A, Armstrong
SA, Levine RL. Reply to “Uveal melanoma cells are resistant to EZH2 Land SR, Warren GW, Crafts JL, Hatsukami DK, Ostroff JS, Willis GB,
inhibition regardless of BAP1 status”. Nature Medicine. 2016;22(6):578-579. Chollette VY, Mitchell SA, Folz JNM, Gulley JL, Szabo E, Brandon
TH, Duffy SA, Toll BA. Cognitive testing of tobacco use items for
LaFave LM, Levine RL. Targeting a regulator of protein homeostasis in administration to patients with cancer and cancer survivors in clinical
myeloproliferative neoplasms. Nature Medicine. 2016;22(1):20-21. research. Cancer. 2016;122(11):1728-1734.
133 OF 324
Journal Articles
Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan patterns on outcomes in patients with double-hit non-Hodgkin
S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger lymphoma. Cancer. 2016;122(4):559-564.
MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Genomic and
transcriptomic hallmarks of poorly differentiated and anaplastic thyroid Lang PY, Nanjangud GJ, Papkov MS, Shaw C, Hwang D, Parker JS,
cancers. Journal of Clinical Investigation. 2016;126(3):1052-1066. PMCID: Kabanov A V, Gershon TR. ATR maintains chromosomal integrity during
PMC4767360 postnatal cerebellar neurogenesis and is required for medulloblastoma
formation. Development. 2016;143(21):4038-4052. PMCID: PMC5117143
Landau H, Wood K, Chung DJ, Koehne G, Lendvai N, Hassoun
H, Lesokhin A, Hoover E, Zheng JT, Devlin SM, Giralt S. Fractionated Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight
stem cell infusions for patients with plasma cell myeloma undergoing JA, Bernstein L, Brooks J, Andersson M, Reiner AS, Liang X, Woods
autologous hematopoietic cell transplantation. Leukemia and M, Concannon PJ, WECARE Study Collaborative Group, Bernstein
Lymphoma. 2016;57(8):1781-1785. JL. Systemic therapy for breast cancer and risk of subsequent
contralateral breast cancer in the WECARE Study. Breast Cancer
Landgren O, Owen RG. Better therapy requires better response Research. 2016;18(1):65. PMCID: PMC4940926
evaluation: Paving the way for minimal residual disease testing for every
myeloma patient. Cytometry Part B - Clinical Cytometry. 2016;90(1):14-20. Lange J, Yamada S, Tischfield SE, Pan J, Kim S, Zhu X, Socci ND, Jasin
M, Keeney S. The landscape of mouse meiotic double-strand break
Landgren O, Rajkumar S V. New developments in diagnosis, prognosis, formation, processing, and repair. Cell. 2016;167(3):695-708.e16. PMCID:
and assessment of response in multiple myeloma. Clinical Cancer PMC5117687
Research. 2016;22(22):5428-5433.
Langevin HM, Keely P, Mao J, Hodge LM, Schleip R, Deng G, Hinz B,
Landgren O, Devlin S, Boulad M, Mailankody S. Role of MRD Swartz MA, De Valois BA, Zick S, Findley T. Connecting (t)issues: How
status in relation to clinical outcomes in newly diagnosed research in fascia biology can impact integrative oncology. Cancer
multiple myeloma patients: A meta-analysis. Bone Marrow Research. 2016;76(21):6159-6162.
Lantuejoul S, Rouquette I, Brambilla E, Travis WD. Nouvelle classification
Landgren O, Giralt S. MRD-driven treatment paradigm for newly OMS 2015 des adénocarcinomes pulmonaires et prénéoplasies. Annales
diagnosed transplant eligible multiple myeloma patients. Bone Marrow De Pathologie. 2016;36(1):5-14.
Larcher A, Meskawi M, Valdivieso R, Boehm K, Trudeau V, Tian
Landgren O. Combination therapy for fit (younger and older) newly Z, Fossati N, Dell’Oglio P, Lughezzani G, Buffi N, Sun M, Karakiewicz
diagnosed multiple myeloma patients: Data support carfilzomib, P. Comparison of renal function detriments after local tumor ablation
lenalidomide, and dexamethasone independent of cytogenetic risk or partial nephrectomy for renal cell carcinoma. World Journal of
status. Seminars in Oncology. 2016;43(6):703-706. Urology. 2016;34(3):383-389.
Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday Larcher A, Trudeau V, Sun M, Boehm K, Meskawi M, Tian Z, Fossati N,
R, Chavez JC, Song K, Zelenetz AD, Gandhi M, Shah N, Fenske TS, Jaso Dell’Oglio P, Capitanio U, Briganti A, Shariat SF, Montorsi F, Karakiewicz
J, Medeiros LJ, Yang DT, Nabhan C. Impact of oncogene rearrangement P I. Population-based assessment of cancer-specific mortality after local
134 OF 324
Journal Articles
tumour ablation or observation for kidney cancer: A competing risks CG. Predicting neurologic recovery after surgery in patients with
analysis. BJU International. 2016;118(4):541-546. deficits secondary to MESCC: Systematic review. Spine. 2016;41(Suppl.
20):S224-S230.
Larcher A, Fossati N, Tian Z, Boehm K, Meskawi M, Valdivieso R, Trudeau
V, Dell’Oglio P, Buffi N, Montorsi F, Guazzoni G, Sun M, Karakiewicz P Law C, Profes MS, Levesque M, Kaltschmidt JA, Verhage M, Kania
I. Prediction of complications following partial nephrectomy: Implications A. Normal molecular specification and neurodegenerative disease-
for ablative techniques candidates. European Urology. 2016;69(4):676-682. like death of spinal neurons lacking the SNARE-associated synaptic
protein Munc18-1. Journal of Neuroscience. 2016;36(2):561-576. PMCID:
Larsen BT, Mereuta OM, Dasari S, Fayyaz AU, Theis JD, Vrana JA, PMC4710775
Grogan M, Dogan A, Dispenzieri A, Edwards WD, Kurtin PJ, Maleszewski
JJ. Correlation of histomorphological pattern of cardiac amyloid Lawrence EM, Warren AY, Priest AN, Barrett T, Goldman DA, Gill AB,
deposition with amyloid type: A histological and proteomic analysis of Gnanapragasam VJ, Sala E, Gallagher FA. Evaluating prostate cancer
108 cases. Histopathology. 2016;68(5):648-656. using fractional tissue composition of radical prostatectomy specimens
and pre-operative diffusional kurtosis magnetic resonance imaging. PLoS
Larson SM. EXINI quantitative bone scan index: Expanded ONE. 2016;11(7):e0159652. PMCID: PMC4965080
utility for the planar radionuclide bone scan. Journal of Nuclear
Medicine. 2016;57(1):5-6. Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J,
Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis
Lastra RR, Park KJ, Schoolmeester JK. Invasive stratified mucin- IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Bandera E V, Barile M,
producing carcinoma and stratified mucin-producing intraepithelial Barkardottir RB, Barrowdale D, Beckmann MW, Benitez J, Berchuck
lesion (SMILE): 15 cases presenting a spectrum of cervical neoplasia with A, Bisogna M, Bjorge L, Blomqvist C, Blot W, Bogdanova N, Bojesen A,
description of a distinctive variant of invasive adenocarcinoma. American Bojesen SE, Bolla MK, Bonanni B, Børresen-Dale AL, Brauch H, Brennan
Journal of Surgical Pathology. 2016;40(2):262-269. P, Brenner H, Bruinsma F, Brunet J, Buhari SA, Burwinkel B, Butzow
R, Buys SS, Cai Q, Caldes T, Campbell I, Canniotto R, Chang-Claude J,
Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum Chiquette J, Choi JY, Claes KBM, GEMO Study Collaborators, Cook LS,
CD. Long-term renal outcomes after cisplatin treatment. Clinical Journal Cox A, Cramer DW, Cross SS, Cybulski C, Czene K, Daly MB, Damiola
of the American Society of Nephrology. 2016;11(7):1173-1179. PMCID: F, Dansonka-Mieszkowska A, Darabi H, Dennis J, Devilee P, Diez O,
PMC4934839 Doherty JA, Domchek SM, Dorfling CM, Dörk T, Dumont M, Ehrencrona
H, Ejlertsen B, Ellis S, EMBRACE, Engel C, Lee E, Evans DG, Fasching PA,
La-Touche S, Lemetre C, Lambros M, Stankiewicz E, Ng CKY, Weigelt
Feliubadalo L, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Foretova
B, Rajab R, Tinwell B, Corbishley C, Watkin N, Berney D, Reis-Filho
L, Fostira F, Foulkes WD, Fridley BL, Friedman E, Frost D, Gambino G,
JS. DNA copy number aberrations, and human papillomavirus status in
Ganz PA, Garber J, García-Closas M, Gentry-Maharaj A, Ghoussaini M,
penile carcinoma. Clinico-pathological correlations and potential driver
Giles GG, Glasspool R, Godwin AK, Goldberg MS, Goldgar DE, González-
genes. PLoS ONE. 2016;11(2):e0146740. PMCID: PMC4763861
Neira A, Goode EL, Goodman MT, Greene MH, Gronwald J, Guénel P,
Laufer I, Zuckerman SL, Bird JE, Bilsky MH, Lazáry Á, Quraishi Haiman CA, Hall P, Hallberg E, Hamann U, Hansen TVO, Harrington PA,
NA, Fehlings MG, Sciubba DM, Shin JH, Mesfin A, Sahgal A, Fisher Hartman M, Hassan N, Healey S, The Hereditary Breast and Ovarian
Cancer Research Group Netherlands (HEBON), Heitz F, Herzog J, Høgdall
135 OF 324
Journal Articles
E, Høgdall CK, Hogervorst FBL, Hollestelle A, Hopper JL, Hulick PJ, V, Noguchi T, Remenieras A, Coupier I, Pujol P, Sokolowska J, Bronner M,
Huzarski T, Imyanitov EN, KConFab Investigators, Australian Ovarian Delnatte C, Bézieau S, Mari V, Gauthier-Villars M, Buecher B, Rouleau E,
Cancer Study Group, Isaacs C, Ito H, Jakubowska A, Janavicius R, Jensen Golmard L, Moncoutier V, Belotti M, De Pauw A, Elan C, Fourme E, Birot
A, John EM, Johnson N, Kabisch M, Kang D, Kapuscinski M, Karlan BY, AM, Saule C, Laurent M, Houdayer C, Lesueur F, Mebirouk N, Coulet F,
Khan S, Kiemeney LA, Kjaer SK, Knight JA, Konstantopoulou I, Kosma Colas C, Soubrier F, Warcoin M, Prieur F, Lebrun M, Kientz C, Muller D,
VM, Kristensen V, Kupryjanczyk J, Kwong A, De La Hoya M, Laitman Y, Fricker JP, Toulas C, Guimbaud R, Gladieff L, Feillel V, Mortemousque
Lambrechts D, Le N, De Leeneer K, Lester J, Levine DA, Li J, Lindblom I, Bressac-De-Paillerets B, Caron O, Guillaud-Bataille M, Gregory H,
A, Long J, Lophatananon A, Loud JT, Lu K, Lubinski J, Mannermaa A, Miedzybrodzka Z, Morrison PJ, Donaldson A, Rogers MT, Kennedy MJ,
Manoukian S, Le Marchand L, Margolin S, Marme F, Massuger LFAG, Porteous ME, Brady A, Barwell J, Foo C, Lalloo F, Side LE, Eason J,
Matsuo K, Mazoyer S, McGuffog L, McLean C, McNeish I, Meindl A, Henderson A, Walker L, Cook J, Snape K, Murray A, McCann E, Rookus
Menon U, Mensenkamp AR, Milne RL, Montagna M, Moysich KB, Muir MA, Van Leeuwen FE, Van Der Kolk LE, Schmidt MK, Russell NS, De
K, Mulligan AM, Nathanson KL, Ness RB, Neuhausen SL, Nevanlinna H, Lange JL, Wijnands R, Collée JM, Hooning MJ, Seynaeve C, Van Deurzen
Nord S, Nussbaum RL, Odunsi K, Offit K, Olah E, Olopade O I, Olson CHM, Obdeijn IM, Van Asperen CJ, Tollenaar RAEM, Van Cronenburg
JE, Olswold C, O’Malley D, Orlow I, Orr N, Osorio A, Park SK, Pearce TCTEF, Kets CM, Ausems MGEM, Van Der Pol CC, Van Os TAM, Waisfisz
CL, Pejovic T, Peterlongo P, Pfeiler G, Phelan CM, Poole EM, Pylkäs K, Q, Meijers-Heijboer HEJ, Gómez-Garcia EB, Oosterwijk JC, Mourits MJ,
Radice P, Rantala J, Rashid MU, Rennert G, Rhenius V, Rhiem K, Risch De Bock GH, Vasen HF, Siesling S, Verloop J, Overbeek LIH, Fox S, Kirk J,
HA, Rodriguez G, Rossing MA, Rudolph A, Salvesen HB, Sangrajrang Lindeman G, Price M. Functional mechanisms underlying pleiotropic risk
S, Sawyer EJ, Schildkraut JM, Schmidt MK, Schmutzler RK, Sellers TA, alleles at the 19p13.1 breast - Ovarian cancer susceptibility locus. Nature
Seynaeve C, Shah M, Shen CY, Shu XO, Sieh W, Singer CF, Sinilnikova OM, Communications. 2016;7:12675. PMCID: PMC5023955
Slager S, Song H, Soucy P, Southey MC, Stenmark-Askmalm M, Stoppa-
Lyonnet D, Sutter C, Swerdlow A, Tchatchou S, Teixeira MR, Teo SH, Terry Layfield LJ, Baloch Z, Elsheikh T, Litzky L, Rektman N, Travis
KL, Terry MB, Thomassen M, Tibiletti MG, Tihomirova L, Tognazzo S, WD, Zakowski M, Zarka M, Geisinger K. Standardized terminology and
Toland AE, Tomlinson I, Torres D, Truong T, Tseng CC, Tung N, Tworoger nomenclature for respiratory cytology: The Papanicolaou Society of
SS, Vachon C, Van Den Ouweland AMW, Van Doorn HC, Van Rensburg EJ, Cytopathology guidelines. Diagnostic Cytopathology. 2016;44(5):399-409.
Van’t Veer LJ, Vanderstichele A, Vergote I, Vijai J, Wang Q, Wang-Gohrke
S, Weitzel JN, Wentzensen N, Whittemore AS, Wildiers H, Winqvist R, Layfield LJ, Roy-Chowdhuri S, Baloch Z, Ehya H, Geisinger K, Hsiao
Wu AH, Yannoukakos D, Yoon SY, Yu JC, Zheng W, Zheng Y, Khanna KK, SJ, Lin O, Lindeman N I, Roh M, Schmitt F, Sidiropoulos N, VanderLaan
Simard J, Monteiro AN, French JD, Couch FJ, Freedman ML, Easton DF, PA. Utilization of ancillary studies in the cytologic diagnosis of
Dunning AM, Pharoah PD, Edwards SL, Chenevix-Trench G, Antoniou respiratory lesions: The Papanicolaou Society of cytopathology
AC, Gayther SA, Bowtell D, DeFazio A, Webb P, Collonge-Rame MA, consensus recommendations for respiratory cytology. Diagnostic
Damette A, Barouk-Simonet E, Bonnet F, Bubien V, Sevenet N, Longy Cytopathology. 2016;44(12):1000-1009.
M, Berthet P, Vaur D, Castera L, Ferrer SF, Bignon YJ, Uhrhammer N,
Le Rolle AL, Chiu TK, Zeng Z, Shia J, Weiser MR, Paty PB, Chiu
Coron F, Faivre L, Baurand A, Jacquot C, Bertolone G, Lizard S, Leroux D,
VK. Oncogenic KRAS activates an embryonic stem cell-like program in
Dreyfus H, Rebischung C, Peysselon M, Peyrat JP, Fournier J, Révillion F,
human colon cancer initiation. Oncotarget. 2016;7(3):2159-2174. PMCID:
Adenis C, Vénat-Bouvet L, Léone M, Boutry-Kryza N, Calender A, Giraud
PMC4823026
S, Verny-Pierre C, Lasset C, Bonadona V, Barjhoux L, Sobol H, Bourdon
136 OF 324
Journal Articles
Le X, Antony R, Razavi P, Treacy DJ, Luo F, Ghandi M, Castel Lee AW, Bomkamp A, Bandera E V, Jensen A, Ramus SJ, Goodman
P, Scaltriti M, Baselga J, Garraway LA. Systematic functional MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph
characterization of resistance to PI3K inhibition in breast cancer. Cancer A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA,
Discovery. 2016;6(10):1134-1147. PMCID: PMC5050154 Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee
B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu
Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D’Angelica AH, Pike MC, Stram DO, Pearce CL, for the Ovarian Cancer Association
M I, Allen PJ, DeMatteo RP, Doyle MBM, Bathe OF, Greig PD, Wei Consortium. A splicing variant of TERT identified by GWAS interacts
A, Chapman WC, Dixon E, Jarnagin WR. Time-to-surgery and with menopausal estrogen therapy in risk of ovarian cancer. International
survival outcomes in resectable colorectal liver metastases: A Journal of Cancer. 2016;139(12):2646-2654.
multi-institutional evaluation. Journal of the American College of
Surgeons. 2016;222(5):766-779. PMCID: PMC4847545 Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J,
Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj
Leary A, Cowan R, Chi D, Kehoe S, Nankivell M. Primary surgery or A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing
neoadjuvant chemotherapy in advanced ovarian cancer: The debate MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A,
continues…. American Society of Clinical Oncology Educational Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ,
Book. 2016;36:153-162. Wu AH, Pike MC, Pearce CL, on behalf of the Ovarian Cancer Association
Consortium. Association between menopausal estrogen-only therapy
Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Papillary thyroid and ovarian carcinoma risk. Obstetrics and Gynecology. 2016;127(5):828-
microcarcinoma and active surveillance - Authors’ reply. Lancet Diabetes 836. PMCID: PMC4892111
& Endocrinology. 2016;4(12):976-977.
Lee AY, Agaram NP, Qin LX, Kuk D, Curtin C, Brennan MF, Singer
Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Papillary S. Optimal percent myxoid component to predict outcome in high-grade
thyroid microcarcinoma: Time to shift from surgery to active myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Annals of
surveillance?. Lancet Diabetes & Endocrinology. 2016;4(11):933-942. Surgical Oncology. 2016;23(3):818-825. PMCID: PMC4964786
Lederhandler M, Valins W, Zoghbi Z, Grossman ME. Leg ulcers in Lee CH, Hötker AM, Voss MH, Feldman DR, Woo KM, Patil S, Coskey
systemic lupus erythematosus associated with underlying dystrophic DT, Akin O, Hsieh JJ, Motzer RJ. Bevacizumab monotherapy as salvage
calcinosis and bone infarcts in the absence of antiphospholipid therapy for advanced clear cell renal cell carcinoma pretreated with
antibodies. JAAD Case Reports. 2016;2(2):164-167. PMCID: PMC4864114 targeted drugs. Clinical Genitourinary Cancer. 2016;14(1):56-62. PMCID:
PMC4965701
Leduc C, Zhang L, Öz B, Luo J, Fukuoka J, Antonescu CR, Travis
WD. Thoracic myoepithelial tumors: A pathologic and molecular study Lee CH, Motzer RJ. Immune checkpoint therapy in renal cell
of 8 cases with review of the literature. American Journal of Surgical carcinoma. The Cancer Journal. 2016;22(2):92-95.
Pathology. 2016;40(2):212-223. PMCID: PMC5006686
Lee DJ, Recabal P, Sjoberg DD, Thong A, Lee JK, Eastham JA, Scardino
Lee A, Huang P, Dematteo RP, Pollack SM. Immunotherapy for soft tissue PT, Vargas HA, Coleman J, Ehdaie B. Comparative effectiveness of
sarcoma: Tomorrow is only a day away. American Society of Clinical targeted prostate biopsy using magnetic resonance imaging ultrasound
Oncology Educational Book. 2016;36:281-290.
137 OF 324
Journal Articles
fusion software and visual targeting: A prospective study. Journal of carcinoma. International Journal of Radiation Oncology, Biology,
Urology. 2016;196(3):697-702. PMCID: PMC5014662 Physics. 2016;96(1):9-17. PMCID: PMC5035649
Lee EH, Klassen AF, Lawson JL, Cano SJ, Scott AM, Pusic Lee RE, Henricks WH, Sirintrapun SJ. Laboratory information systems
AL. Patient experiences and outcomes following facial skin in molecular diagnostics: Why molecular diagnostics data are
cancer surgery: A qualitative study. Australasian Journal of different. Advances in Anatomic Pathology. 2016;23(2):125-133.
Dermatology. 2016;57(3):e100-e104.
Lee SCW, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham
Lee EH. Patient expectations and performance measures in dermatologic BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor
surgery. Clinics in Dermatology. 2016;34(1):111-113. J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith
PG, Bradley RK, Abdel-Wahab O. Modulation of splicing catalysis for
Lee JY, Dhakal I, Casper C, Noy A, Palefsky JM, Haigentz M, Krown therapeutic targeting of leukemia with mutations in genes encoding
SE, Ambinder RF, Mitsuyasu RT. Risk of cancer among commercially spliceosomal proteins. Nature Medicine. 2016;22(6):672-678. PMCID:
insured HIV-infected adults on antiretroviral therapy. Journal of Cancer PMC4899191
Epidemiology. 2016;2016:2138259. PMCID: PMC5110893
Lee SCW, Abdel-Wahab O. Therapeutic targeting of splicing in
Lee KW, Bogenhagen DF. Scalable isolation of mammalian mitochondria cancer. Nature Medicine. 2016;22(9):976-986.
for nucleic acid and nucleoid analysis. Methods in Molecular
Biology. 2016;1351:67-79. Lee SG, Gangangari K, Kalidindi TM, Punzalan B, Larson SM, Pillarsetty
NVK. Copper-64 labeled liposomes for imaging bone marrow. Nuclear
Lee LH, Cavalcanti MS, Segal NH, Hechtman JF, Weiser MR, Smith Medicine and Biology. 2016;43(12):781-787. PMCID: PMC5118102
JJ, Garcia-Aguilar J, Sadot E, Ntiamoah P, Markowitz AJ, Shike
M, Stadler ZK, Vakiani E, Klimstra DS, Shia J. Patterns and prognostic Lee SW, Hosokawa K, Kim S, Jeong OC, Lilja H, Laurell T, Maeda
relevance of PD-1 and PD-L1 expression in colorectal carcinoma. Modern M. Porous silicon microarray for simultaneous fluorometric immunoassay
Pathology. 2016;29(11):1433-1442. PMCID: PMC5083129 of the biomarkers prostate-specific antigen and human glandular
kallikrein 2. Microchimica Acta. 2016;183(12):3321-3327.
Lee LH, Sadot E, Ivelja S, Vakiani E, Hechtman JF, Sevinsky CJ, Klimstra
DS, Ginty F, Shia J. ARID1A expression in early stage colorectal Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin
adenocarcinoma: An exploration of its prognostic significance. Human WR, Kluger MD. PET-avid hepatocellular adenomas: Incidental findings
Pathology. 2016;53:97-104. PMCID: PMC4994515 associated with HNF1-alpha mutated lesions. HPB. 2016;18(1):41-
48. PMCID: PMC4750225
Lee N, Schoder H, Beattie B, Lanning R, Riaz N, McBride S, Katabi
N, Li D, Yarusi B, Chan S, Mitrani L, Zhang Z, Pfister DG, Sherman E, Lee SY, Shia JR, Kingham TP, Jarnagin WR. Carcinosarcoma of the bile
Baxi S, Boyle J, Morris LGT, Ganly I, Wong R, Humm J. Strategy of duct: A case report and review of literature. Hepatobiliary Surgery and
using intratreatment hypoxia imaging to selectively and safely guide Nutrition. 2016;5(1):72-78. PMCID: PMC4739940
radiation dose de-escalation concurrent with chemotherapy for
locoregionally advanced human papillomavirus-related oropharyngeal Lee YJ, Huang YT, Kim SJ, Maloy M, Tamari R, Giralt SA, Papadopoulos
EB, Jakubowski AA, Papanicolaou GA. Adenovirus viremia in adult
138 OF 324
Journal Articles
CD34(+) selected hematopoietic cell transplant recipients: Low Lemke J, Sardariani E, Phipps JB, Patel N, Itri LM, Caravelli J, Viscusi
incidence and high clinical impact. Biology of Blood and Marrow ER. Fentanyl iontophoretic transdermal system (IONSYS®) can be
Transplantation. 2016;22(1):174-178. PMCID: PMC4706468 safely used in the hospital environment with X-rays, computerized
tomography and radiofrequency identification devices. Advances in
Leeman JE, Bilsky M, Laufer I, Folkert MR, Taunk NK, Osborne Therapy. 2016;33(9):1649-1659. PMCID: PMC5020125
JR, Arevalo-Perez J, Zatcky J, Alektiar KM, Yamada Y, Spratt
DE. Stereotactic body radiotherapy for metastatic spinal sarcoma: Lendvai N, Yee AJ, Tsakos I, Alexander A, Devlin SM, Hassoun
A detailed patterns-of-failure study. Journal of Neurosurgery: H, Korde N, Lesokhin AM, Landau H, Mailankody S, Koehne
Spine. 2016;25(1):52-58. G, Chung DJ, Landgren O, Raje NS, Giralt S. Phase IB study of
cabozantinib in patients with relapsed and/or refractory multiple
Leffler SR, Legué E, Aristizábal O, Joyner AL, Peskin CS, Turnbull DH. A myeloma. Blood. 2016;127(19):2355-2356. PMCID: PMC5003505
mathematical model of granule cell generation during mouse cerebellum
development. Bulletin of Mathematical Biology. 2016;78(5):859- Lesokhin AM, Ansell SM, Armand P, Scott EC, Halwani A, Gutierrez
878. PMCID: PMC4911999 M, Millenson MM, Cohen AD, Schuster SJ, Lebovic D, Dhodapkar M,
Avigan D, Chapuy B, Ligon AH, Freeman GJ, Rodig SJ, Cattry D,
Legué E, Gottshall JL, Jaumouillé E, Roselló-Díez A, Shi W, Barraza Zhu LL, Grosso JF, Garelik MBB, Shipp MA, Borrello I, Timmerman
LH, Washington S, Grant RL, Joyner AL. Differential timing of granule J. Nivolumab in patients with relapsed or refractory hematologic
cell production during cerebellum development underlies generation malignancy: Preliminary results of a phase Ib study. Journal of Clinical
of the foliation pattern. Neural Development. 2016;11:17. PMCID: Oncology. 2016;34(23):2698-2704. PMCID: PMC5019749
PMC5017010
Lespinats S, Pinker-Domenig K, Wengert G, Houben I, Lobbes M,
Leitao MM Jr. Sentinel lymph node mapping in patients with endometrial Stadlbauer A, Meyer-Bäse A, Meyer-Base AD, Dai L, Zheng Y, Chu
carcinoma: Less can be more. Current Obstetrics and Gynecology H. Proteomic data analysis of glioma cancer stem-cell lines based on
Reports. 2016;5(4):279-285. novel nonlinear dimensional data reduction techniques. Proceedings of
SPIE. 2016;9871:98710T-1-98710T-8.
Leitao MM, Narain WR, Boccamazzo D, Sioulas V, Cassella D, Ducie
JA, Eriksson AGZ, Sonoda Y, Chi DS, Brown CL, Levine DA, Jewell Leto K, Arancillo M, Becker EBE, Buffo A, Chiang C, Ding BJ, Dobyns
EL, Zivanovic O, Barakat RR, Abu-Rustum NR, Gardner GJ. Impact of WB, Dusart I, Haldipur P, Hatten ME, Hoshino M, Joyner AL, Kano M,
robotic platforms on surgical approach and costs in the management of Kilpatrick DL, Koibuchi N, Marino S, Martinez S, Millen KJ, Millner TO,
morbidly obese patients with newly diagnosed uterine cancer. Annals of Miyata T, Parmigiani E, Schilling K, Sekerkova G, Sillitoe R V, Sotelo
Surgical Oncology. 2016;23(7):2192-2198. PMCID: PMC4891264 C, Uesaka N, Wefers A, Wingate RJT, Hawkes R. Consensus paper:
Cerebellar development. Cerebellum. 2016;15(6):789-828. PMCID:
Lemetre C, Vieites B, Ng CKY, Piscuoglio S, Schultheis AM, Marchiò PMC4846577
C, Murali R, Lopez-García MA, Palacios JC, Jungbluth AA, Terracciano
LM, Reis-Filho JS, Weigelt B. RNASeq analysis reveals biological Leung MW, Goldfarb S, Dizon DS. Communication about sexuality
processes governing the clinical behaviour of endometrioid and in advanced illness aligns with a palliative care approach to patient-
serous endometrial cancers. European Journal of Cancer. 2016;64:149- centered care. Current Oncology Reports. 2016;18(2):11.
158. PMCID: PMC5099283
139 OF 324
Journal Articles
Leventhal DS, Gilmore DC, Berger JM, Nishi S, Lee V, Malchow S, Kline YW, Kreiswirth BN, Chen L, Du H. Complete sequences of mcr-1-
DE, Kline J, Vander Griend DJ, Huang H, Socci ND, Savage PA. Dendritic harboring plasmids from extended-spectrum-β-lactamase- and
cells coordinate the development and homeostasis of organ-specific carbapenemase-producing Enterobacteriaceae. Antimicrobial Agents
regulatory T cells. Immunity. 2016;44(4):847-859. PMCID: PMC4842258 and Chemotherapy. 2016;60(7):4351-4354. PMCID: PMC4914624
Levine DA, Karlan BY, Strauss JF 3rd. Evolving approaches in research Li BT, Barnes TA, Chan DL, Naidoo J, Lee A, Khasraw M, Marx GM, Kris
and care for ovarian cancers: A report from the national academies of MG, Clarke SJ, Drilon A, Rudin CM, Pavlakis N. The addition of anti-
sciences, engineering, and medicine. JAMA - Journal of the American angiogenic tyrosine kinase inhibitors to chemotherapy for patients with
Medical Association. 2016;315(18):1943-1944. advanced non-small-cell lung cancers: A meta-analysis of randomized
trials. Lung Cancer. 2016;102:21-27.
Levine R. Clinical perspective. Science Policy Reports. 2016;:131-136.
Li BT, Lou E, Hsu M, Yu HA, Naidoo J, Zauderer MG, Sima C, Johnson
Levis M, Guarneri A, Levra NG, Spratt DE, Bartoncini S, Munoz F, Trino ML, Daras M, Deangelis LM, Fleisher M, Kris MG, Azzoli CG. Serum
E, Botticella A, Arcadipane F, Ricardi U. Risk stratification system and biomarkers associated with clinical outcomes fail to predict brain
pattern of relapse in patients treated with adjuvant radiotherapy after metastases in patients with stage IV non-small cell lung cancers. PLoS
radical prostatectomy. Tumori. 2016;102(3):323-329. ONE. 2016;11(1):e0146063. PMCID: PMC4701719
Levy M, Smith T, Alvarez-Perez A, Back A, Baker JN, Beck AC, Block S, Li BT, Drilon A, Johnson ML, Hsu M, Sima CS, McGinn C, Sugita
Dalal S, Dans M, Fitch TR, Kapo J, Kutner JS, Kvale E, Misra S, Mitchell H, Kris MG, Azzoli CG. A prospective study of total plasma cell-free
W, Portman DG, Sauer TM, Spiegel D, Sutton L, Szmuilowicz E, Taylor DNA as a predictive biomarker for response to systemic therapy
RM, Temel J, Tickoo R, Urba SG, Weinstein E, Zachariah F, Bergman in patients with advanced non-small-cell lung cancers. Annals of
MA, Scavone JL. Palliative Care version 1.2016. Journal of the National Oncology. 2016;27(1):154-159. PMCID: PMC4684155
Li BT, Ross DS, Aisner DL, Chaft JE, Hsu M, Kako SL, Kris MG,
Lewis BB, Carter RA, Pamer EG. Bile acid sensitivity and in vivo Varella-Garcia M, Arcila ME. HER2 amplification and HER2 mutation
virulence of clinical Clostridium difficile isolates. Anaerobe. 2016;41:32- are distinct molecular targets in lung cancers. Journal of Thoracic
36. PMCID: PMC5050091 Oncology. 2016;11(3):414-419. PMCID: PMC4698879
Lewis DF, Chan MF. Technical Note: On GAFChromic EBT-XD film and the Li C, Evans T, Goll MG. Epigenetic regulation of hematopoietic stem cell
lateral response artifact. Medical Physics. 2016;43(2):643-649. PMCID: development. Methods in Cell Biology. 2016;135:431-448.
PMC4715006
Li D, O’Reilly EM. Adjuvant and neoadjuvant therapy for pancreatic
Leyva B, Persoskie A, Ottenbacher A, Hamilton JG, Allen JD, Kobrin cancer. Surgical Oncology Clinics of North America. 2016;25(2):311-326.
SC, Taplin SH. Do men receive information required for shared decision
making about PSA testing? Results from a national survey. Journal of Li G, Wei J, Huang H, Chen Q, Gaebler CP, Lin T, Yuan A, Rimner
Cancer Education. 2016;31(4):693-701. A, Mechalakos J. Characterization of optical-surface-imaging-based
spirometry for respiratory surrogating in radiotherapy. Medical
Li A, Yang Y, Miao M, Chavda KD, Mediavilla JR, Xie X, Feng P, Tang
140 OF 324
Journal Articles
physics. 2016;43(3):1348-1360. PMCID: PMC4769267 and genetic heterogeneity in acute myeloid leukemia. Nature
Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C, Conzen
SD, Whitman GJ, Sutton EJ, Net JM, Ganott M, Huang E, Morris Li S, Yang Z, Du X, Liu R, Wilkinson AW, Gozani O, Jacobsen
EA, Perou CM, Ji Y, Giger ML. MR imaging radiomics signatures SE, Patel DJ, Du J. Structural basis for the unique multivalent
for predicting the risk of breast cancer recurrence as given by readout of unmodified H3 tail by Arabidopsis ORC1b BAH-PHD
research versions of MammaPrint, oncotype DX, and PAM50 gene cassette. Structure. 2016;24(3):486-494. PMCID: PMC4775424
assays. Radiology. 2016;281(2):382-391. PMCID: PMC5069147
Li S, Yen L, Pastor WA, Johnston JB, Du J, Shew CJ, Liu W, Ho J,
Li K, Xiang X, Sun J, He HT, Wu J, Wang Y, Zhu C. Imaging spatiotemporal Stender B, Clark AT, Burlingame AL, Daxinger L, Patel DJ, Jacobsen
activities of ZAP-70 in live T cells using a FRET-based biosensor. Annals SE. Mouse MORC3 is a GHKL ATPase that localizes to H3K4me3 marked
of Biomedical Engineering. 2016;44(12):3510-3521. PMCID: PMC5114152 chromatin. Proceedings of the National Academy of Sciences of the
United States of America. 2016;113(35):E5108-E5116. PMCID: PMC5024608
Li M, Cole F, Patel DS, Misenko SM, Her J, Malhowski A, Alhamza A,
Zheng H, Baer R, Ludwig T, Jasin M, Nussenzweig A, Serrano L, Bunting Li S, Patel DJ. DROSHA and DICER: Slicers cut from the same cloth. Cell
SF. 53BP1 ablation rescues genomic instability in mice expressing ‘RING- Research. 2016;26(5):511-512. PMCID: PMC4856758
less’ BRCA1. EMBO Reports. 2016;17(11):1532-1541. PMCID: PMC5090706
Li X, Liang G, Du M, De Vivo I, Nan H. No association between
Li MMH, Bozzacco L, Hoffmann HH, Breton G, Loschko J, Xiao telomere length-related loci and number of cutaneous
JW, Monette S, Rice CM, MacDonald MR. Interferon regulatory factor 2 nevi. Oncotarget. 2016;7(50):82396-82399.
protects mice from lethal viral neuroinvasion. Journal of Experimental
Medicine. 2016;213(13):2931-2947. PMCID: PMC5154937 Li X, Wu R, Ventura A. The present and future of genome editing in
cancer research. Human Genetics. 2016;135(9):1083-1092.
Li MO, Rudensky AY. T cell receptor signalling in the control of
regulatory T cell differentiation and function. Nature Reviews Li Y, Root JC, Atkinson TM, Ahles TA. Examining the association between
Immunology. 2016;16(4):220-233. PMCID: PMC4968889 patient-reported symptoms of attention and memory dysfunction with
objective cognitive performance: A latent regression Rasch model
Li Q, Bagrodia A, Cha EK, Coleman JA. Prognostic genetic approach. Archives of Clinical Neuropsychology. 2016;31(4):365-
signatures in upper tract urothelial carcinoma. Current Urology 377. PMCID: PMC4876936
Reports. 2016;17(2):12. PMCID: PMC4823991
Liang LW, Perez AR, Cangemi NA, Young RJ, Makker V. Nonbacterial
Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapaport thrombotic endocarditis with embolic cerebral vascular accidents in
F, Patel J, Dillon R, Vijay P, Brown AL, Perl AE, Cannon J, Bullinger a patient with advanced, recurrent clear cell carcinoma of the ovary:
L, Luger S, Becker M, Lewis ID, To LB, Delwel R, Lowenberg B, A case report. Gynecologic Oncology Reports. 2016;16:25-27. PMCID:
Dohner H, Guzman ML, Hassane DC, Roboz GJ, Grimwade D, Valk PMC4899414
PJM, D’Andrea RJ, Carroll M, Park CY, Neuberg D, Levine R, Melnick
AM, Mason CE. Distinct evolution and dynamics of epigenetic Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum
N, Alektiar KM, Makker V. An assessment of prognostic factors, adjuvant
141 OF 324
Journal Articles
treatment, and outcomes of stage IA polyp-limited versus endometrium- guidelines. Laryngoscope. 2016;126(11):2640-2645.
limited type II endometrial carcinoma. International Journal of
Gynecological Cancer. 2016;26(3):497-504. PMCID: PMC4761284 Lim D, Murali R, Murray MP, Veras E, Park KJ, Soslow RA. Morphological
and immunohistochemical reevaluation of tumors initially diagnosed
Liapis V, Zinonos I, Labrinidis A, Hay S, Ponomarev V, Panagopoulos as ovarian endometrioid carcinoma with emphasis on high-grade
V, Zysk A, DeNichilo M, Ingman W, Atkins GJ, Findlay DM, Zannettino tumors. American Journal of Surgical Pathology. 2016;40(3):302-
ACW, Evdokiou A. Anticancer efficacy of the hypoxia-activated 312. PMCID: PMC4994535
prodrug evofosfamide (TH-302) in osteolytic breast cancer murine
models. Cancer Medicine. 2016;5(3):534-545. PMCID: PMC4799961 Lim F, O’Leary J. The will to live—and living well. American Nurse
Today. 2016;11(7):32-33.
Licht E, Markowitz AJ, Bains MS, Gerdes H, Ludwig E, Mendelsohn
RB, Rizk NP, Shah P, Strong VE, Schattner MA. Endoscopic management of Lim IIP, Goldman DA, Farber BA, Murphy JM, Abramson SJ, Basu
esophageal anastomotic leaks after surgery for malignant disease. Annals E, Roberts S, LaQuaglia MP, Price AP. Image-defined risk factors for
of Thoracic Surgery. 2016;101(1):301-304. PMCID: PMC4910386 nephrectomy in patients undergoing neuroblastoma resection. Journal of
Pediatric Surgery. 2016;51(6):975-980. PMCID: PMC4921302
Licht E, Schattner M. Reply. Annals of Thoracic Surgery. 2016;102(5):1763.
Lim MYT, Ng AWT, Chou Y, Lim TP, Simcox A, Tucker-Kellogg G,
Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff Okamura K. The Drosophila Dicer-1 partner Loquacious rnhances miRNA
AC, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. Effect processing from hairpins with unstable structures at the dicing site. Cell
of pretreatment renal function on treatment and clinical outcomes in Reports. 2016;15(8):1795-1808. PMCID: PMC4880499
the adjuvant treatment of older women with breast cancer: Alliance
A171201, an ancillary study of CALGB/CTSU 49907. Journal of Clinical Lin AL, Sum MW, Deangelis LM. Is there a role for early
Oncology. 2016;34(7):699-705. PMCID: PMC4872024 chemotherapy in the management of pituitary adenomas?. Neuro-
Lichtman SM, Reske T, Jacobs IA. Biosimilars and cancer treatment of
older patients. Journal of Geriatric Oncology. 2016;7(1 Suppl.):S1-S8. Lin C, Bradshaw T, Perk T, Harmon S, Eickhoff J, Jallow N, Choyke PL,
Dahut WL, Larson S, Humm JL, Perlman S, Apolo AB, Morris MJ, Liu
Lichtman SM. Geriatricizing oncology care: Older women with breast G, Jeraj R. Repeatability of quantitative 18F-NaF PET: A multicenter
cancer. Journal of Oncology Practice. 2016;12(2):135-136. study. Journal of Nuclear Medicine. 2016;57(12):1872-1879.
Ligibel JA, Winer E, Hudis CA, Barry WT. Response. JNCI: Journal of the Lin CC, Bruinooge SS, Kirkwood MK, Hershman DL, Jemal A, Guadagnolo
National Cancer Institute. 2016;108(1):djv334. BA, Yu JB, Hopkins S, Goldstein M, Bajorin D, Giordano SH, Kosty
M, Arnone A, Hanley A, Stevens S, Olsen C. Association between
Likhterov I, Tuttle RM, Haser GC, Su HK, Bergman D, Alon EE, Bernet geographic access to cancer care and receipt of radiation therapy for
V, Brett E, Cobin R, Dewey EH, Doherty G, Dos Reis LL, Klopper rectal cancer. International Journal of Radiation Oncology, Biology,
J, Lee SL, Lupo MA, Machac J, Mechanick J I, Milas M, Orloff L, Physics. 2016;94(4):719-728. PMCID: PMC5024783
Randolph G, Ross DS, Rowe ME, Smallridge R, Terris D, Tufano RP,
Urken ML. Improving the adoption of thyroid cancer clinical practice Lin Y, Chappell R, Gönen M, Lawson AB, Lee D, MacNab Y. A
142 OF 324
Journal Articles
systematic selection method for the development of cancer staging Lipska KJ, Flory JH, Hennessy S, Inzucchi SE. Citizen petition to the
systems. Statistical Methods in Medical Research. 2016;25(4):1438- US Food and Drug Administration to change prescribing guidelines:
1451. PMCID: PMC4250448 The metformin experience. Circulation. 2016;134(18):1405-1408. PMCID:
PMC5147418
Lin YF, Haynes CM. Metabolism and the UPRmt. Molecular
Cell. 2016;61(5):677-682. PMCID: PMC4779188 Lito P, Solomon M, Li LS, Hansen R, Rosen N. Allele-specific
inhibitors inactivate mutant KRAS G12C by a trapping
Lin YF, Schulz AM, Pellegrino MW, Lu Y, Shaham S, Haynes mechanism. Science. 2016;351(6273):604-608. PMCID: PMC4955282
CM. Maintenance and propagation of a deleterious
mitochondrial genome by the mitochondrial unfolded protein Litvak A, Pietanza MC. Bronchial and thymic carcinoid tumors. Hematology/
response. Nature. 2016;533(7603):416-419. PMCID: PMC4873342 Oncology Clinics of North America. 2016;30(1):83-102.
Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Shin BC, Vickers A, White Liu D, Khong PL, Gao Y, Mahmood U, Quinn B, St Germain J, Xu
AR. Acupuncture for the prevention of tension-type headache. Cochrane XG, Dauer LT. Radiation dosimetry of whole-body dual-tracer 18F-FDG
Database of Systematic Reviews. 2016;2016(4):CD007587. PMCID: and 11C-acetate PET/CT for hepatocellular carcinoma. Journal of Nuclear
PMC4955729 Medicine. 2016;57(6):907-912.
Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick Liu D, Plimack ER, Hoffman-Censits J, Garraway LA, Bellmunt J, Van
EA, Vickers A, White AR. Acupuncture for the prevention Allen E, Rosenberg JE. Clinical validation of chemotherapy response
of episodic migraine. Cochrane Database of Systematic biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma. JAMA
Reviews. 2016;2016(6):CD001218. PMCID: PMC4977344 Oncology. 2016;2(8):1094-1096.
Linscott JA, Kapilashrami K, Wang Z, Senevirathne C, Bothwell Liu F, Wang L, Perna F, Nimer SD. Beyond transcription factors: How
IR, Blum G, Luo M. Kinetic isotope effects reveal early transition oncogenic signalling reshapes the epigenetic landscape. Nature Reviews
state of protein lysine methyltransferase SET8. Proceedings Cancer. 2016;16(6):359-372.
of the National Academy of Sciences of the United States of
America. 2016;113(52):E8369-E8378. PMCID: PMC5206543 Liu F, Ng S, Huguet F, Yorke ED, Mageras GS, Goodman KA. Are
fiducial markers useful surrogates when using respiratory gating
Lipitz-Snyderman A, Weingart SN, Anderson C, Epstein AS, Killen to reduce motion of gastroesophageal junction tumors?. Acta
A, Classen D, Sima CS, Fortier E, Atoria CL, Pfister D. Detection Oncologica. 2016;55(8):1040-1046. PMCID: PMC5016835
of potentially avoidable harm in oncology from patient medical
records. Journal of Oncology Practice. 2016;12(2):e224-e230. Liu NW, Wren JD, Vertosick E, Lee JK, Power NE, Benfante
NE, Kimm SY, Bains MS, Sjoberg DD, Russo P, Coleman JA. The
Lipitz-Snyderman A, Sima CS, Atoria CL, Elkin EB, Anderson prognostic impact of a positive vascular margin on pT3 clear cell
C, Blinder V, Tsai CJ, Panageas KS, Bach PB. Physician-driven variation renal cell carcinoma. Journal of Urology. 2016;195(2):264-269. PMCID:
in nonrecommended services among older adults diagnosed with PMC4747821
cancer. JAMA Internal Medicine. 2016;176(10):1541-1548.
Liu X, Grogan TR, Hieronymus H, Hashimoto T, Mottahedeh J, Cheng D,
143 OF 324
Journal Articles
Zhang L, Huang K, Stoyanova T, Park JW, Shkhyan RO, Nowroozizadeh patients with cancer. Journal of Geriatric Oncology. 2016;7(4):270-
B, Rettig MB, Sawyers CL, Elashoff D, Horvath S, Huang J, Witte ON, 280. PMCID: PMC4969145
Goldstein AS. Low CD38 identifies progenitor-like inflammation-
associated luminal cells that can initiate human prostate cancer and Loibl S, Majewski I, Guarneri V, Nekljudova V, Holmes E, Bria E, Denkert
predict poor outcome. Cell Reports. 2016;17(10):2596-2606. C, Schem C, Sotiriou C, Loi S, Untch M, Conte P, Bernards R, Piccart
M, von Minckwitz G, Baselga J. PIK3CA mutations are associated
Liu Y, Amin EB, Mayo MW, Chudgar NP, Bucciarelli PR, Kadota with reduced pathological complete response rates in primary HER2-
K, Adusumilli PS, Jones DR. CK2α′ drives lung cancer metastasis positive breast cancer: Pooled analysis of 967 patients from five
by targeting BRMS1 nuclear export and degradation. Cancer prospective trials investigating lapatinib and trastuzumab. Annals of
Research. 2016;76(9):2675-2686. PMCID: PMC4873401 Oncology. 2016;27(8):1519-1525.
Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer Longo C, Ragazzi M, Rajadhyaksha M, Nehal K, Bennassar A, Pellacani G,
B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng Malvehy Guilera J. In vivo and ex vivo confocal microscopy for dermatologic
L, Wang Q, Niu T, Schultz N, Levine RL, Mills AA, Lowe SW. Deletions and Mohs surgeons. Dermatologic Clinics. 2016;34(4):497-504.
linked to TP53 loss drive cancer through p53-independent
mechanisms. Nature. 2016;531(7595):471-475. PMCID: PMC4836395 López F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall
WM, Haigentz M Jr, Strojan P, Pellitteri PK, Bradford CR, Shaha AR, Hunt
Llaguno SRA, Parada LF. Cell of origin of glioma: Biological and clinical JL, De Bree R, Takes RP, Rinaldo A, Ferlito A. Update on primary head
implications. British Journal of Cancer. 2016;115(12):1445-1450. PMCID: and neck mucosal melanoma. Head and Neck. 2016;38(1):147-155. PMCID:
PMC5155355 PMC4986507
Lockney NA, Friedman DN, Wexler LH, Sklar CA, Casey DL, Wolden Lopez F, Rodrigo JP, Silver CE, Haigentz M, Bishop JA, Strojan P,
SL. Late toxicities of intensity-modulated radiation therapy for head and Hartl DM, Bradley PJ, Mendenhall WM, Suarez C, Takes RP, Hamoir
neck rhabdomyosarcoma. Pediatric Blood and Cancer. 2016;63(9):1608- M, Robbins KT, Shaha AR, Werner JA, Rinaldo A, Ferlito A. Cervical
1614. PMCID: PMC4955714 lymph node metastases from remote primary tumor sites. Head and
Neck. 2016;38(Suppl. 1):E2374-E2385. PMCID: PMC4991634
Loder S, Agarwal S, Sorkin M, Breuler C, Li J, Peterson J, Gardenier
J, Hsieh HHS, Wang SC, Mehrara BJ, Levi B. Lymphatic contribution Lordick F, Janjigian YY. Clinical impact of tumour biology in the
to the cellular niche in heterotopic ossification. Annals of management of gastroesophageal cancer. Nature Reviews Clinical
Surgery. 2016;264(6):1174-1180. PMCID: PMC4947025 Oncology. 2016;13(6):348-360.
Loeb S, Lilja H, Vickers A. Beyond prostate-specific antigen: Utilizing Lorente D, Olmos D, Mateo J, Bianchini D, Seed G, Fleisher M, Danila DC,
novel strategies to screen men for prostate cancer. Current Opinion in Flohr P, Crespo M, Figueiredo I, Miranda S, Baeten K, Molina A, Kheoh
Urology. 2016;26(5):459-465. PMCID: PMC5035435 T, McCormack R, Terstappen LWMM, Scher H I, de Bono JS. Decline in
circulating tumor cell count and treatment outcome in advanced prostate
Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, Karuturi cancer. European Urology. 2016;70(6):985-992.
MS, Kimmick GG, Lichtman SM, Magnuson A, Whitehead M I, Wong
ML, Ahles TA. Chemotherapy-related cognitive impairment in older Loschko J, Schreiber HA, Rieke GJ, Esterházy D, Meredith MM,
144 OF 324
Journal Articles
Pedicord VA, Yao KH, Caballero S, Pamer EG, Mucida D, Nussenzweig Lu R, Wang P, Parton T, Zhou Y, Chrysovergis K, Rockowitz S, Chen
MC. Absence of MHC class II on cDCs results in microbial- WY, Abdel-Wahab O, Wade PA, Zheng D, Wang GG. Epigenetic
dependent intestinal inflammation. Journal of Experimental perturbations by Arg882-mutated DNMT3A potentiate aberrant stem
Medicine. 2016;213(4):517-534. PMCID: PMC4821651 cell gene-expression program and acute leukemia development. Cancer
Cell. 2016;30(1):92-107. PMCID: PMC4945461
Louie BE, Wilson JL, Kim S, Cerfolio RJ, Park BJ, Farivar AS, Vallières
E, Aye RW, Burfeind WR Jr, Block M I. Comparison of video-assisted Lu SX, Abdel-Wahab O. Genetic drivers of vulnerability and resistance
thoracoscopic surgery and robotic approaches for clinical stage I in relapsed acute lymphoblastic leukemia. Proceedings of the National
and stage II non-small cell lung cancer using The Society of Thoracic Academy of Sciences of the United States of America. 2016;113(40):11071-
Surgeons Database. Annals of Thoracic Surgery. 2016;102(3):917- 11073. PMCID: PMC5056046
924. PMCID: PMC5198574
Lu W, Chen W. Positron emission tomography/computerized tomography
Lowe MC, D’Angelica M I. Anatomy of hepatic resectional surgery. Surgical for tumor response assessment - A review of clinical practices and
Clinics of North America. 2016;96(2):183-195. PMCID: PMC4994882 radiomics studies. Translational Cancer Research. 2016;5(4):364-
370. PMCID: PMC5124903
Lowery JT, Ahnen DJ, Schroy PC III, Hampel H, Baxter N, Boland CR,
Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson Lu Y, Leslie CS. Learning to predict miRNA-mRNA interactions
N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, from AGO CLIP sequencing and CLASH data. PLoS Computational
Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith Biology. 2016;12(7):e1005026. PMCID: PMC4954643
R. Understanding the contribution of family history to colorectal
cancer risk and its clinical implications: A state-of-the-science Lucas AS, Ciccolini K. Nursing best practice referral algorithm for the
review. Cancer. 2016;122(17):2633-2645. early detection of mycosis fungoides. Journal of the Dermatology Nurses
Association. 2016;8(2):109-120.
Lown EA, Hijiya N, Zhang N, Srivastava DK, Leisenring WM, Nathan
PC, Castellino SM, Devine KA, Dilley K, Krull KR, Oeffinger KC, Luis TC, Luc S, Mizukami T, Boukarabila H, Thongjuea S, Woll PS, Azzoni
Hudson MM, Armstrong GT, Robison LL, Ness KK. Patterns and E, Giustacchini A, Lutteropp M, Bouriez-Jones T, Vaidya H, Mead AJ,
predictors of clustered risky health behaviors among adult survivors Atkinson D, Boiers C, Carrelha J, Macaulay IC, Patient R, Geissmann F,
of childhood cancer: A report from the Childhood Cancer Survivor Nerlov C, Sandberg R, de Bruijn Mftr, Blackburn CC, Godin I, Jacobsen
Study. Cancer. 2016;122(17):2747-2756. PMCID: PMC4992459 SEW. Initial seeding of the embryonic thymus by immune-restricted
lympho-myeloid progenitors. Nature Immunology. 2016;17(12):1424-
Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti 1435. PMCID: PMC5172420
S, Hameed M, Pawel BR, Wunder JS, Dickson BC, Lundgren SM, Jani
KS, De Jay N, Papillon-Cavanagh S, Andrulis IL, Sawyer SL, Grynspan D, Lujan-Barroso L, Zhang W, Olson SH, Gao YT, Yu H, Baghurst PA,
Turcotte RE, Nadaf J, Fahiminiyah S, Muir TW, Majewski J, Thompson Bracci PM, Bueno-De-Mesquita HB, Foretová L, Gallinger S, Holcatova
CB, Chi P, Garcia BA, Allis CD, Jabado N, Lewis PW. Histone H3K36 I, Janout V, Ji BT, Kurtz RC, La Vecchia C, Lagiou P, Li D, Miller AB,
mutations promote sarcomagenesis through altered histone methylation Serraino D, Zatonski W, Risch HA, Duell EJ. Menstrual and reproductive
landscape. Science. 2016;352(6287):844-849. PMCID: PMC4928577 factors, hormone use, and risk of pancreatic cancer: Analysis from
the International Pancreatic Cancer Case-Control Consortium
145 OF 324
Journal Articles
(PanC4). Pancreas. 2016;45(10):1401-1410. PMCID: PMC5065728 cancer cells via disrupting the DNA repair pathway. Toxicology
Research. 2016;5(3):859-870.
Luke MPS, LeVatte TL, Rutishauser U, Tremblay F, Clarke
DB. Polysialylated neural cell adhesion molecule protects against light- Lupoli TJ, Fay A, Adura C, Glickman MS, Nathan CF. Reconstitution
induced retinal degeneration. Investigative Ophthalmology and Visual of a mycobacterium tuberculosis proteostasis network highlights
Science. 2016;57(11):5066-5075. essential cofactor interactions with chaperone DnaK. Proceedings
of the National Academy of Sciences of the United States of
Lulla RR, Goldman S, Yamada T, Beattie CW, Bressler L, Pacini M, Pollack America. 2016;113(49):E7947-E7956. PMCID: PMC5150378
IF, Fisher PG, Packer RJ, Dunkel IJ, Dhall G, Wu S, Onar A, Boyett JM,
Fouladi M. Phase I trial of p28 (NSC745104), a non-HDM2-mediated Luskin MR, Gimotty PA, Smith C, Loren AW, Figueroa ME, Harrison J,
peptide inhibitor of p53 ubiquitination in pediatric patients with Sun Z, Tallman MS, Paietta EM, Litzow MR, Melnick AM, Levine RL,
recurrent or progressive central nervous system tumors: A Pediatric Fernandez HF, Luger SM, Carroll M, Master SR, Wertheim GBW. A
Brain Tumor Consortium Study. Neuro-Oncology. 2016;18(9):1319- clinical measure of DNA methylation predicts outcome in de novo acute
1325. PMCID: PMC4999001 myeloid leukemia. JCI Insight. 2016;1(9):e87323. PMCID: PMC4951094
Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma Luskin MR, Lee JW, Fernandez HF, Abdel-Wahab O, Bennett JM,
S, Reinhold W, Sander C, Pommier Y. rcellminer: Exploring Ketterling RP, Lazarus HM, Levine RL, Litzow MR, Paietta EM, Patel JP,
molecular profiles and drug response of the NCI-60 cell lines in Racevskis J, Rowe JM, Tallman MS, Sun Z, Luger SM. Benefit of high-
R. Bioinformatics. 2016;32(8):1272-1274. PMCID: PMC4907377 dose daunorubicin in AML induction extends across cytogenetic and
molecular groups. Blood. 2016;127(12):1551-1558. PMCID: PMC4807422
Luna A, Babur Ö, Aksoy BA, Demir E, Sander C. PaxtoolsR: Pathway
analysis in R using Pathway Commons. Bioinformatics. 2016;32(8):1262- Lv J, Qi X, Zhang D, Zheng Z, Chen Y, Guo Y, Wang S, Chen L,
1264. PMCID: PMC4824129 Kreiswirth BN, Tang YW, Chen Z, Hu L, Wang L, Yu F. First report
of complete sequence of a bla(NDM-13)-harboring plasmid from an
Lunning MA, Migliacci JC, Hilden P, Devlin SM, Castro-Malaspina Escherichia coli ST5138 clinical isolate. Frontiers in Cellular and Infection
H, Giralt S, Perales MA, Zelenetz AD, Moskowitz CH, Sauter CS. The Microbiology. 2016;6:130. PMCID: PMC5061728
potential benefit of allogeneic over autologous transplantation in
patients with very early relapsed and refractory follicular lymphoma Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-
with prior remission duration of <= 12 months. British Journal of Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel
Haematology. 2016;173(2):260-264. PMCID: PMC5051568 E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D,
Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz
Luo CT, Liao W, Dadi S, Toure A, Li MO. Graded Foxo1 activity in AJ, Bernstein I, De Haas N, Syngal S, Moeslein G. A proposed staging
T(reg) cells differentiates tumour immunity from spontaneous system and stage-specific interventions for familial adenomatous
autoimmunity. Nature. 2016;529(7587):532-536. PMCID: PMC4978705 polyposis. Gastrointestinal Endoscopy. 2016;84(1):115-125.e4.
Luo Y, Wang H, Zhao X, Dong C, Zhang F, Guo G, Guo G, Wang Ma W, Gilligan BM, Yuan J, Li T. Current status and perspectives
X, Powell SN, Feng Z. Valproic acid causes radiosensitivity of breast in translational biomarker research for PD-1/PD-L1 immune
146 OF 324
Journal Articles
checkpoint blockade therapy. Journal of Hematology & Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt S I, Birmann
Oncology. 2016;9:47. PMCID: PMC4884396 BM, Chanock SJ, Rothman N. Genetically predicted longer telomere length
is associated with increased risk of B-cell lymphoma subtypes. Human
Ma W, Goldberg J. TANGO1/cTAGE5 receptor as a polyvalent template Molecular Genetics. 2016;25(8):1663-1676. PMCID: PMC4854019
for assembly of large COPII coats. Proceedings of the National Academy
of Sciences of the United States of America. 2016;113(36):10061- MacHiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q,
10066. PMCID: PMC5018777 Hicks B, Dagnall C, Hautman C, Jacobs KB, Abnet CC, Aldrich MC, Amos
C, Amundadottir LT, Arslan AA, Beane-Freeman LE, Berndt S I, Black
Macadam SA, Zhong T, Weichman K, Papsdorf M, Lennox PA, Hazen A, Blot WJ, Bock CH, Bracci PM, Brinton LA, Bueno-De-Mesquita HB,
A, Matros E, Disa J, Mehrara B, Pusic AL. Quality of life and patient- Burdett L, Buring JE, Butler MA, Canzian F, Carreón T, Chaffee KG, Chang
reported outcomes in breast cancer survivors: A multicenter comparison IS, Chatterjee N, Chen C, Chen C, Chen K, Chung CC, Cook LS, Crous Bou
of four abdominally based autologous reconstruction methods. Plastic M, Cullen M, Davis FG, De Vivo I, Ding T, Doherty J, Duell EJ, Epstein CG,
and Reconstructive Surgery. 2016;137(3):758-771. PMCID: PMC5064829 Fan JH, Figueroa JD, Fraumeni JF, Friedenreich CM, Fuchs CS, Gallinger
S, Gao YT, Gapstur SM, Garcia-Closas M, Gaudet MM, Gaziano JM, Giles
Macaulay VM, Middleton MR, Eckhardt SG, Rudin CM, Juergens GG, Gillanders EM, Giovannucci EL, Goldin L, Goldstein AM, Haiman CA,
RA, Gedrich R, Gogov S, McCarthy S, Poondru S, Stephens AW, Hallmans G, Hankinson SE, Harris CC, Henriksson R, Holly EA, Hong YC,
Gadgeel SM. Phase I dose-escalation study of linsitinib (OSI-906) Hoover RN, Hsiung CA, Hu N, Hu W, Hunter DJ, Hutchinson A, Jenab M,
and erlotinib in patients with advanced solid tumors. Clinical Cancer Johansen C, Khaw KT, Kim HN, Kim YH, Kim YT, Klein AP, Klein R, Koh
Research. 2016;22(12):2897-2907. WP, Kolonel LN, Kooperberg C, Kraft P, Krogh V, Kurtz RC, Lacroix A, Lan
Q, Landi MT, Marchand LL, Li D, Liang X, Liao LM, Lin D, Liu J, Lissowska
Machiela MJ, Lan Q, Slager SL, Vermeulen RCH, Teras LR, Camp NJ, Cerhan
J, Lu L, Magliocco AM, Malats N, Matsuo K, McNeill LH, McWilliams RR,
JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquières
Melin BS, Mirabello L, Moore L, Olson SH, Orlow I, Park JY, Patinõ-Garcia
H, McKay J, Conde L, de Bakker PIW, Cox DG, Burdett L, Monnereau A,
A, Peplonska B, Peters U, Petersen GM, Pooler L, Prescott J, Prokunina-
Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J,
Olsson L, Purdue MP, Qiao YL, Rajaraman P, Real FX, Riboli E, Risch HA,
Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca
Rodriguez-Santiago B, Ruder AM, Savage SA, Schumacher F, Schwartz AG,
M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi
Schwartz KL, Seow A, Wendy Setiawan V, Severi G, Shen H, Sheng X, Shin
D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M,
MH, Shu XO, Silverman DT, Spitz MR, Stevens VL, Stolzenberg-Solomon
Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim
R, Stram D, Tang ZZ, Taylor PR, Teras LR, Tobias GS, Van Den Berg D,
H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA,
Visvanathan K, Wacholder S, Wang JC, Wang Z, Wentzensen N, Wheeler
Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker
W, White E, Wiencke JK, Wolpin BM, Wong MP, Wu C, Wu T, Wu X, Wu
N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines
YL, Wunder JS, Xia L, Yang HP, Yang PC, Yu K, Zanetti KA, Zeleniuch-
A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz
Jacquotte A, Zheng W, Zhou B, Ziegler RG, Perez-Jurado LA, Caporaso
A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey
NE, Rothman N, Tucker M, Dean MC, Yeager M, Chanock SJ. Female
MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing
chromosome X mosaicism is age-related and preferentially affects the
H, Tjønneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci
inactivated X chromosome. Nature Communications. 2016;7:11843. PMCID:
E, Kraft P, Huang J, Ma B, Ye Y, Chiu BCH, Liang L, Park JH, Chung CC,
PMC4909985
Weisenburger DD, Fraumeni JF Jr, Salles G, Glenn M, Cannon-Albright L,
147 OF 324
Journal Articles
MacInnis RJ, Pike MC, Hopper JL. Risk-reducing surgery in A paradigm shift. Archives of Pathology & Laboratory
hereditary breast and ovarian cancer. New England Journal of Medicine. 2016;140(8):791-798. PMCID: PMC5027875
Medicine. 2016;374(24):2403-2404.
Maguire A, Brogi E. Sentinel lymph nodes for breast carcinoma: An update
Maddalo D, Ventura A. Somatic engineering of oncogenic chromosomal on current practice. Histopathology. 2016;68(1):152-167. PMCID: PMC5027880
rearrangements: A perspective. Cancer Research. 2016;76(17):4918-
4923. PMCID: PMC5010508 Maher NG, Collgros H, Uribe P, Ch’ng S, Rajadhyaksha M, Guitera P. In
vivo confocal microscopy for the oral cavity: Current state of the field
Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC. Type I IFN and future potential. Oral Oncology. 2016;54:28-35.
promotes NK cell expansion during viral infection by protecting NK cells
against fratricide. Journal of Experimental Medicine. 2016;213(2):225- Mahner S, Trillsch F, Chi D, Harter P, Pfisterer J, Hilpert F, Burges A,
233. PMCID: PMC4749923 Weissenbacher T, du Bois A. Neoadjuvant chemotherapy in ovarian
cancer revisited. Annals of Oncology. 2016;27(Suppl. 1):i30-i32.
Madorsky-Feldman D, Sklair-Levy M, Perri T, Laitman Y, Paluch-Shimon
S, Schmutzler R, Rhiem K, Lester J, Karlan BY, Singer CF, Van Maerken Mailankody S, Prasad V. Implications of proposed medicare reforms to
T, Claes K, Brunet J, Izquierdo A, Teulé A, Lee JW, Kim SW, Arun B, counteract high cancer drug prices. JAMA - Journal of the American
Jakubowska A, Lubinski J, Tucker K, Poplawski NK, Varesco L, Bonelli Medical Association. 2016;316(3):271-272.
LA, Buys SS, Mitchell G, Tischkowitz M, Gerdes AM, Seynaeve C, Robson
M, Kwong A, Tung N, Tessa N, Domchek SM, Godwin AK, Rantala J, Mailankody S, Prasad V. Thinking systematically about the off-label use
Arver B, Friedman E. An international survey of surveillance schemes for of cancer drugs and combinations for patients who have exhausted
unaffected BRCA1 and BRCA2 mutation carriers. Breast Cancer Research proven therapies. The Oncologist. 2016;21(9):1031-1032. PMCID:
and Treatment. 2016;157(2):319-327. PMC5016075
Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca J I, Mailankody S, Landgren O. Monoclonal gammopathy of undetermined
Master VA, McKiernan JM, Libertino JA, Haferkamp A, on behalf of significance and Waldenström’s macroglobulinemia. Best Practice and
the International Renal Cell Carcinoma-Venous Thrombus Consortium, Research: Clinical Haematology. 2016;29(2):187-193.
Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T,
Makker V, Recio FO, Ma L, Matulonis UA, Lauchle JO, Parmar H,
Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner
Gilbert HN, Ware JA, Zhu R, Lu S, Huw LY, Wang Y, Koeppen H,
M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-
Spoerke JM, Lackner MR, Aghajanian CA. A multicenter, single-
Salamanca J I, Master VA, McKiernan JM, Montorsi F, Novara G, O’Malley
arm, open-label, phase 2 study of apitolisib (GDC-0980) for the
P, Pahernik S, Palou J, Moreno JLP, Pruthi RS, Faba OR, Russo P, Scherr
treatment of recurrent or persistent endometrial carcinoma (MAGGIE
DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso C V,
study). Cancer. 2016;122(22):3519-3528.
Vergho D, Wallen EM, Zigeuner R. Renal cell carcinoma with inferior vena
cava involvement: Prognostic effect of tumor thrombus consistency on Makohon-Moore A, Iacobuzio-Donahue CA. Pancreatic cancer biology
cancer specific survival. Journal of Surgical Oncology. 2016;114(6):764-768. and genetics from an evolutionary perspective. Nature Reviews
Cancer. 2016;16(9):553-565.
Maguire A, Brogi E. Sentinel lymph nodes for breast carcinoma:
148 OF 324
Journal Articles
Malandro N, Budhu S, Kuhn NF, Liu C, Murphy JT, Cortez C, Zhong A V, Heerdt AS, Morrow M. Age and receptor status do not indicate
H, Yang X, Rizzuto G, Altan-Bonnet G, Merghoub T, Wolchok JD. Clonal the need for axillary dissection in patients with sentinel lymph node
abundance of tumor-specific CD4(+) T cells potentiates efficacy and metastases. Annals of Surgical Oncology. 2016;23(11):3481-3486. PMCID:
alters susceptibility to exhaustion. Immunity. 2016;44(1):179-193. PMCID: PMC5070645
PMC4996670
Man N, Sun XJ, Tan Y, García-Cao M, Liu F, Cheng G, Hatlen M, Xu H,
Malbari F, Gershon TR, Garvin JH, Allen JC, Khakoo Y, Levy AS, Dunkel Shah R, Chastain N, Liu N, Huang G, Zhou Y, Sheng M, Song J, Yang
IJ. Psychiatric manifestations as initial presentation for pediatric CNS FC, Benezra R, Nimer SD, Wang L. Differential role of Id1 in MLL-AF9-
germ cell tumors, a case series. Child’s Nervous System. 2016;32(8):1359- driven leukemia based on cell of origin. Blood. 2016;127(19):2322-
Malchow S, Leventhal DS, Lee V, Nishi S, Socci ND, Savage PA. Aire Manasanch EE, Landgren O. Myeloma imaging: Time to move
enforces immune tolerance by directing autoreactive T cells into on!. Leukemia and Lymphoma. 2016;57(7):1499-1500.
the regulatory T cell lineage. Immunity. 2016;44(5):1102-1113. PMCID:
PMC4871732 Mancebo SE, Cordova M, Myskowski PL, Flores ES, Busam K, Jawed
S I, Skripnik A, Rajadhyaksha M, Querfeld C. Reflectance confocal
Malek E, de Lima M, Letterio JJ, Kim BG, Finke JH, Driscoll JJ, Giralt microscopy features of mycosis fungoides and Sézary syndrome:
SA. Myeloid-derived suppressor cells: The green light for myeloma Correlation with histopathologic and T-cell receptor rearrangement
immune escape. Blood Reviews. 2016;30(5):341-348. studies. Journal of Cutaneous Pathology. 2016;43(6):505-515.
Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, De Stanchina Manchado E, Weissmueller S, Morris JP, Chen CC, Wullenkord
E, Massagué J. Metastatic latency and immune evasion through R, Lujambio A, de Stanchina E, Poirier JT, Gainor JF, Corcoran RB,
autocrine inhibition of WNT. Cell. 2016;165(1):45-60. PMCID: Engelman JA, Rudin CM, Rosen N, Lowe SW. A combinatorial strategy
PMC4808520 for treating KRAS-mutant lung cancer. Nature. 2016;534(7609):647-
651. PMCID: PMC4939262
Mallela AN, Peck KK, Petrovich-Brennan NM, Zhang Z, Lou W, Holodny
A I. Altered resting-state functional connectivity in the hand motor Mandal R, Senbabaoglu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N,
network in glioma patients. Brain Connectivity. 2016;6(8):587-595. Lee KW, Ganly I, Hakimi AA, Chan TA, Morris LGT. The head and neck
cancer immune landscape and its immunotherapeutic implications. JCI
Mamtani A, Barrio A V, King TA, Van Zee KJ, Plitas G, Pilewskie M, El- Insight. 2016;1(17):e89829. PMCID: PMC5070962
Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS
3rd, Patil S, Morrow M. How often does neoadjuvant chemotherapy Mandal R, Chan TA. Personalized oncology meets immunology: The
avoid axillary dissection in patients with histologically confirmed path toward precision immunotherapy. Cancer Discovery. 2016;6(7):703-
nodal metastases? Results of a prospective study. Annals of Surgical 713. PMCID: PMC4930745
Mandal T, Shin S, Aluvila S, Chen HC, Grieve C, Choe JY, Cheng EH,
Mamtani A, Patil S, Van Zee KJ, Cody HS 3rd, Pilewskie M, Barrio Hustedt EJ, Oh KJ. Assembly of Bak homodimers into higher order
149 OF 324
Journal Articles
homooligomers in the mitochondrial apoptotic pore. Scientific stem cell transplantation. Journal of Consulting and Clinical
Reports. 2016;6:30763. PMCID: PMC4973285 Psychology. 2016;84(5):389-401.
Mandapathil M. Adenosine-mediated immunosuppression Manning AT, Sacchini VS. Conservative mastectomies for breast cancer
in patients with squamous cell carcinoma of the head and and risk-reducing surgery: The Memorial Sloan Kettering Cancer Center
neck. HNO. 2016;64(5):303-309. experience. Gland Surgery. 2016;5(1):55-62. PMCID: PMC4716859
Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon Mano R, Eastham J, Yossepowitch O. The very-high-risk prostate
TD, Whitley JA, Cai L, Ahles TA, Stern RA, Jacobsen PB, Small cancer: A contemporary update. Prostate Cancer and Prostatic
BJ, Pitcher BN, Dura-Fernandis E, Muss HB, Hurria A, Cohen HJ, Diseases. 2016;19(4):340-348.
Isaacs C. Long-term trajectories of self-reported cognitive function
in a cohort of older survivors of breast cancer: CALGB 369901 Mano R, Hakimi AA, Sankin A I, Sternberg IA, Chevinsky MS, Russo
(Alliance). Cancer. 2016;122(22):3555-3563. PMCID: PMC5113662 P. Surgical treatment of tumors involving kidneys with fusion anomalies:
A contemporary series. Urology. 2016;98:97-102. PMCID: PMC5125232
Mandelker D. Toward concurrent testing for somatic and germline variants
in cancer patients. Clinical Cancer Research. 2016;22(16):3987-3988. Mano R, Vertosick EA, Hakimi AA, Sternberg IA, Sjoberg
DD, Bernstein M, Dalbagni G, Coleman JA, Russo P. The effect of
Manderski MTB, Steinberg MB, Rahi KN, Banerjee SC, Delnevo delaying nephrectomy on oncologic outcomes in patients with renal
CD. Surveillance of tobacco use among South Asians in the US: tumors greater than 4 cm. Urologic Oncology: Seminars and Original
Are we underestimating prevalence?. Journal of Community Investigations. 2016;34(5):239.e1-239.e8. PMCID: PMC4834237
Health. 2016;41(6):1140-1145. PMCID: PMC5083167
Mansilla-Soto J, Riviere I, Boulad F, Sadelain M. Cell and gene therapy
Manley B, Hakimi AA. Editorial comment. Journal of for the beta-thalassemias: Advances and prospects. Human Gene
Urology. 2016;196(5):1370. Therapy. 2016;27(4):295-304. PMCID: PMC4994056
Manley B. A new castration-resistant prostate cancer entity?. Urology Mantha S, Moll S, Hilden P, Devlin S, Rose A. The patterns of
Times. 2016;44(2) anticoagulation control and the risk of stroke, bleeding and mortality
in patients with non-valvular atrial fibrillation: Comment. Journal of
Manley BJ, Hakimi AA. Molecular profiling of renal cell carcinoma: Thrombosis and Haemostasis. 2016;14(10):2083-2084.
Building a bridge toward clinical impact. Current Opinion in
Urology. 2016;26(5):383-387. PMCID: PMC5032025 Mantha S, Tallman MS, Soff GA. What’s new in the pathogenesis of the
coagulopathy in acute promyelocytic leukemia?. Current Opinion in
Manley BJ, Hsieh JJ. Sarcomatoid renal cell carcinoma: Genomic Hematology. 2016;23(2):121-126.
insights from sequencing of matched sarcomatous and carcinomatous
components. Translational Cancer Research. 2016;5(Suppl. 2):S160-S165. Mao H, Mao JJ, Guo M, Cheng K, Wei J, Shen X, Shen X. Effects of
infrared laser moxibustion on cancer-related fatigue: A randomized,
Manne S, Mee L, Bartell A, Sands S, Kashy DA. A randomized double-blind, placebo-controlled trial. Cancer. 2016;122(23):3667-
clinical trial of a parent-focused social-cognitive processing 3672. PMCID: PMC5132039
intervention for caregivers of children undergoing hematopoetic
150 OF 324
Journal Articles
Mao JJ, Dusek JA. Integrative medicine as standard care for pain Marino ML, Carrera C, Marchetti MA, Marghoob AA. Practice gaps
management: The need for rigorous research. Pain Medicine (United in dermatology: Melanocytic lesions and melanoma. Dermatologic
States). 2016;17(6):1181-1182. PMCID: PMC4894245 Clinics. 2016;34(3):353-362.
Mao JJ, Xie SX, Keefe JR, Soeller I, Li QS, Amsterdam JD. Long- Marino ML, Rogers T, Sierra Gil H, Rajadhyaksha M, Cordova
term chamomile (Matricaria chamomilla L.) treatment MA, Marghoob AA. Improving lesion localization when imaging
for generalized anxiety disorder: A randomized clinical with handheld reflectance confocal microscope. Skin Research and
trial. Phytomedicine. 2016;23(14):1735-1742. Technology. 2016;22(4):519-520.
Marchetti MA, Dusza SW, Halpern AC. A closer inspection of the number Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ,
needed to biopsy. JAMA Dermatology. 2016;152(8):952-953. Houssami N. The association of surgical margins and local recurrence
in women with ductal carcinoma in situ treated with breast-conserving
Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard therapy: A meta-analysis. Annals of Surgical Oncology. 2016;23(12):3811-
RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, 3821. PMCID: PMC5160992
Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG,
Winn DM, Khoury MJ. Population-based precision cancer screening: Markowitz JC, Meehan KB, Petkova E, Zhao Y, Van Meter PE, Neria
A symposium on evidence, epidemiology, and next steps. Cancer Y, Pessin H, Nazia Y. Treatment preferences of psychotherapy patients
Epidemiology Biomarkers and Prevention. 2016;25(11):1449- with chronic PTSD. Journal of Clinical Psychiatry. 2016;77(3):363-370.
1455. PMCID: PMC5165650
Markowitz SD, Nock NL, Schmit SL, Stadler ZK, Joseph V, Zhang L, Willis
Mardis ER, Ladanyi M. Cancer genomics: Large-scale projects translate JE, Scacheri P, Veigl M, Adams MD, Raskin L, Sullivan JF, Stratton K, Shia
into therapeutic advances. PLoS Medicine. 2016;13(12):e1002209. PMCID: J, Ellis N, Rennert HS, Manschreck C, Li L, Offit K, Elston RC, Rennert
PMC5189932 G, Gruber SB. A germline variant on chromosome 4q31.1 associates
with susceptibility to developing colon cancer metastasis. PLoS
Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, ONE. 2016;11(1):e0146435. PMCID: PMC4709047
Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB,
Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt Marr B, Reinherz B, Belinsky I, Saffra NA. Pseudo uveal melanoma
MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, caused by optic disk drusen with juxtapapillary choroidal neovascular
Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, membrane. Retinal Cases and Brief Reports. 2016;10(2):168-170. PMCID:
Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PMC5317008
PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai
Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens Marraffini LA, Hay A, Grinstein S, Patel DJ, Chen L, Cisse II. Breaking
MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS. Comparison down walls. Cell. 2016;167(4):880-881.
of MAPIE versus MAP in patients with a poor response to preoperative
chemotherapy for newly diagnosed high-grade osteosarcoma Marron TU, Hanna MG, Ramanathan L, Chari A. Validation and utility of
(EURAMOS-1): An open-label, international, randomised controlled the free light chain assay in pleural effusions of patients with multiple
trial. Lancet Oncology. 2016;17(10):1396-1408. PMCID: PMC5052459 myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2016;16(7):e113-e117.
151 OF 324
Journal Articles
Marrone GF, Grinnell SG, Lu Z, Rossi GC, Le Rouzic V, Xu J, Majumdar Zabala-Letona A, Arruabarrena-Aristorena A, Zúñiga-García P, Caro-
S, Pan YX, Pasternak GW. Truncated mu opioid GPCR variant Maldonado A, Valcárcel-Jiménez L, Sánchez-Mosquera P, Varela-Rey
involvement in opioid-dependent and opioid-independent pain M, Martínez-Chantar ML, Anguita J, Ibrahim YH, Scaltriti M, Lawrie
modulatory systems within the CNS. Proceedings of the National CH, Aransay AM, Iovanna JL, Baselga J, Caldas C, Barrio R, Serra
Academy of Sciences of the United States of America. 2016;113(13):3663- V, Dm Vivanco M, Matheu A, Gomis RR, Carracedo A. Stratification
3668. PMCID: PMC4822618 and therapeutic potential of PML in metastatic breast cancer. Nature
Marrone GF, Lu Z, Rossi G, Narayan A, Hunkele A, Marx S, Xu J, Pintar
J, Majumdar S, Pan YX, Pasternak GW. Tetrapeptide endomorphin Marusyk A, Tabassum DP, Janiszewska M, Place AE, Trinh A, Rozhok
analogs require both full length and truncated splice variants of A I, Pyne S, Guerriero JL, Shu S, Ekram M, Ishkin A, Cahill DP, Nikolsky
the mu opioid receptor gene Oprm1 for analgesia. ACS Chemical Y, Chan TA, Rimawi MF, Hilsenbeck S, Schiff R, Osborne KC, Letai A,
Neuroscience. 2016;7(12):1717-1727. PMCID: PMC5177531 Polyak K. Spatial proximity to fibroblasts impacts molecular features
and therapeutic sensitivity of breast cancer cells influencing clinical
Marshall RH, Avila EK, Solomon SB, Erinjeri JP, Maybody M. Feasibility outcomes. Cancer Research. 2016;76(22):6495-6506.
of intraoperative nerve monitoring in preventing thermal damage to the
“nerve at risk” during image-guided ablation of tumors. CardioVascular Mass E, Ballesteros I, Farlik M, Halbritter F, Günther P, Crozet
and Interventional Radiology. 2016;39(6):875-884. L, Jacome-Galarza CE, Händler K, Klughammer J, Kobayashi Y,
Gomez-Perdiguero E, Schultze JL, Beyer M, Bock C, Geissmann
Martens A, Wistuba-Hamprecht K, Foppen MG, Yuan J, Postow F. Specification of tissue-resident macrophages during
MA, Wong P, Romano E, Khammari A, Dreno B, Capone M, Ascierto PA, organogenesis. Science. 2016;353(6304):aaf4238. PMCID: PMC5066309
Di Giacomo AM, Maio M, Schilling B, Sucker A, Schadendorf D, Hassel JC,
Eigentler TK, Martus P, Wolchok JD, Blank C, Pawelec G, Garbe C, Weide Massagué J, Obenauf AC. Metastatic colonization by circulating tumour
B. Baseline peripheral blood biomarkers associated with clinical outcome cells. Nature. 2016;529(7586):298-306. PMCID: PMC5029466
of advanced melanoma patients treated with ipilimumab. Clinical Cancer
Research. 2016;22(12):2908-2918. Massard C, Gordon MS, Sharma S, Rafii S, Wainberg ZA, Luke J, Curiel
TJ, Colon-Otero G, Hamid O, Sanborn RE, O’Donnell PH, Drakaki A,
Martens A, Wistuba-Hamprecht K, Yuan J, Postow MA, Wong P, Capone Tan W, Kurland JF, Rebelatto MC, Jin X, Blake-Haskins JA, Gupta
M, Madonna G, Khammari A, Schilling B, Sucker A, Schadendorf D, A, Segal NH. Safety and efficacy of durvalumab (MEDI4736), an
Martus P, Dreno B, Ascierto PA, Wolchok JD, Pawelec G, Garbe C, anti-programmed cell death ligand-1 immune checkpoint inhibitor, in
Weide B. Increases in absolute lymphocytes and circulating CD4(+) patients with advanced urothelial bladder cancer. Journal of Clinical
and CD8(+) T cells are associated with positive clinical outcome Oncology. 2016;34(26):3119-3125.
of melanoma patients treated with ipilimumab. Clinical Cancer
Research. 2016;22(19):4848-4858. Massimino KP, Jochelson MS, Burgan IE, Stempel M, Morrow M. How
beneficial is follow-up mammography in elderly breast cancer
Martín-Martín N, Piva M, Urosevic J, Aldaz P, Sutherland JD, Fernández- survivors?. Annals of Surgical Oncology. 2016;23(11):3518-3523. PMCID:
Ruiz S, Arreal L, Torrano V, Cortazar AR, Planet E, Guiu M, Radosevic- PMC5070646
Robin N, Garcia S, Macías I, Salvador F, Domenici G, Rueda OM,
152 OF 324
Journal Articles
Mateos M V, Landgren O. MGUS and smoldering multiple myeloma: Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee
Diagnosis and epidemiology. Cancer Treatment and Research. 2016;169:3-12. KJ, Pusic A, King TA, Cody HS 3rd, Pilewskie M, Cordeiro P, Sclafani
L, Plitas G, Gemignani ML, Disa J, El-Tamer M, Morrow M. Skin
Mathewson ND, Jenq R, Mathew A V, Koenigsknecht M, Hanash A, Toubai flap necrosis after mastectomy with reconstruction: A prospective
T, Oravecz-Wilson K, Wu SR, Sun YP, Rossi C, Fujiwara H, Byun J, Shono study. Annals of Surgical Oncology. 2016;23(1):257-264. PMCID:
Y, Lindemans C, Calafiore M, Schmidt TC, Honda K, Young VB, Pennathur PMC4697877
S, van den Brink M, Reddy P. Gut microbiome-derived metabolites
modulate intestinal epithelial cell damage and mitigate graft-versus-host Matsuki E, Younes A. Checkpoint inhibitors and other immune therapies
disease. Nature Immunology. 2016;17(5):505-513. PMCID: PMC4836986 for Hodgkin and non-Hodgkin lymphoma. Current Treatment Options in
Oncology. 2016;17(6):31.
Mathias MD, Ambati SR, Chou AJ, Slotkin EK, Wexler LH, Meyers
PA, Magnan H. A single-center experience with undifferentiated Mattes MD, Zhou Y, Berry SL, Barker CA. Dosimetric comparison of axilla
embryonal sarcoma of the liver. Pediatric Blood and and groin radiotherapy techniques for high-risk and locally advanced
Cancer. 2016;63(12):2246-2248. PMCID: PMC5073002 skin cancer. Radiation Oncology Journal. 2016;34(2):145-155. PMCID:
PMC4938352
Mathias MD, Chou AJ, Meyers P, Shukla N, Hameed M, Agaram N, Wang
L, Berger MF, Walsh M, Kentsis A. Osteosarcoma with apparent Ewing Matulewicz RS, Oberlin DT, Sheinfeld J, Meeks JJ. The
sarcoma gene rearrangement. Journal of Pediatric Hematology/ evolving management of patients with clinical stage I
Oncology. 2016;38(5):e166-e168. PMCID: PMC4928585 seminoma. Urology. 2016;98:113-119.
Matoso A, Chen YB, Rao V, Wang L, Cheng L, Epstein J I. Atypical Mauer C, Spencer S, Dungan J, Hurley K. Exploration of male attitudes
renal cysts a morphologic, immunohistochemical, and molecular on partnerships and sexuality with female BRCA1/2 mutation
study. American Journal of Surgical Pathology. 2016;40(2):202-211. carriers. Journal of Genetic Counseling. 2016;25(2):290-297.
Matros E, Stranix JT. Long-term operative outcomes of preoperative Maughan WP, Shuman S. Distinct contributions of enzymic functional
computed tomography-guided virtual surgical planning for groups to the 2’,3’-cyclic phosphodiesterase, 3’-phosphate guanylylation,
osteocutaneous free flap mandible reconstruction. Plastic and and 3’-ppG/5’-OH ligation steps of the Escherichia coli RtcB nucleic acid
Reconstructive Surgery. 2016;138(4):774e-775e. splicing pathway. Journal of Bacteriology. 2016;198(8):1294-1304. PMCID:
PMC4859591
Matros E, Albornoz CR, Cohen WA. The impact of travel distance
on breast reconstruction in the United States - Reply. Plastic and Mauguen A, Begg CB. Using the lorenz curve to characterize
Reconstructive Surgery. 2016;138(2):367e-368e. risk predictiveness and etiologic heterogeneity. Epidemiology.
2016;27(4):531-537.
Matsen C, Villegas K, Eaton A, Stempel M, Manning A, Cody HS
3rd, Morrow M, Heerdt A. Late axillary recurrence after negative Mauro MJ. Chronic myeloid leukemia: Is it dusk or dawn?. Best Practice
sentinel lymph node biopsy is uncommon. Annals of Surgical and Research: Clinical Haematology. 2016;29(3):249-251.
153 OF 324
Journal Articles
Maus M V, Plotkin J, Jakka G, Stewart-Jones G, Rivière I, Merghoub T, Cell Biology. 2016;26(3):227-237. PMCID: PMC4955613
Wolchok J, Renner C, Sadelain M. An MHC-restricted antibody-based
chimeric antigen receptor requires TCR-like affinity to maintain antigen Mazgaj R, Gerson R, Khakoo Y, Petriccione M, Haque S, Haddad
specificity. Molecular Therapy - Oncolytics. 2016;3:16023. F. Command hallucinations to harm self in a child with recurrent right
temporal astrocytoma: A case report. Psycho-Oncology. 2016;25(8):994-996.
Maxwell KN, Domchek SM, Nathanson KL, Robson ME. Population
frequency of germline BRCA1/2 mutations. Journal of Clinical Mazo G, Soplop N, Wang WJ, Uryu K, Tsou MFB. Spatial control
Oncology. 2016;34(34):4183-4185. of primary ciliogenesis by subdistal appendages alters sensation-
associated properties of cilia. Developmental Cell. 2016;39(4):424-
Maxwell KN, Hart SN, Vijai J, Schrader KA, Slavin TP, Thomas T, 437. PMCID: PMC5125554
Wubbenhorst B, Ravichandran V, Moore RM, Hu C, Guidugli L, Wenz B,
Domchek SM, Robson ME, Szabo C, Neuhausen SL, Weitzel JN, Offit K, Mazzulli JR, Zunke F, Isacson O, Studer L, Krainc D. α-Synuclein-induced
Couch FJ, Nathanson KL. Evaluation of ACMG-guideline-based variant lysosomal dysfunction occurs through disruptions in protein trafficking
classification of cancer susceptibility and non-cancer-associated genes in human midbrain synucleinopathy models. Proceedings of the National
in families affected by breast cancer. American Journal of Human Academy of Sciences of the United States of America. 2016;113(7):1931-
Genetics. 2016;98(5):801-817. PMCID: PMC4863474 1936. PMCID: PMC4763774
Maybody M, Grewal RK, Healey JH, Antonescu CR, Fanchon L, Hwang McArthur HL, Diab A, Page DB, Yuan J, Solomon SB, Sacchini
S, Carrasquillo JA, Kirov A, Farooki A. Ga-68 DOTATOC PET/CT-guided V, Comstock C, Durack JC, Maybody M, Sung J, Ginsberg A, Wong
biopsy and cryoablation with autoradiography of biopsy specimen P, Barlas A, Dong Z, Zhao C, Blum B, Patil S, Neville D, Comen
for treatment of tumor-induced osteomalacia. CardioVascular and EA, Morris EA, Kotin A, Brogi E, Wen YH, Morrow M, Lacouture ME,
Interventional Radiology. 2016;39(9):1352-1357. Sharma P, Allison JP, Hudis CA, Wolchok JD, Norton L. A pilot study of
preoperative single-dose ipilimumab and/or cryoablation in women with
Mayo CS, Deasy JO, Chera BS, Freymann J, Kirby JS, Hardenberg early-stage breast cancer with comprehensive immune profiling. Clinical
PH. How can we effect culture change toward data-driven Cancer Research. 2016;22(23):5729-5737. PMCID: PMC5161031
medicine?. International Journal of Radiation Oncology, Biology,
Physics. 2016;95(3):916-921. McArthur HL. Checkpoint inhibitors in breast cancer: Hype or promise?
[interview]. Clinical Advances in Hematology & Oncology. 2016;14(6):392-395.
Mayor M, Yang N, Sterman D, Jones DR, Adusumilli PS. Immunotherapy
for non-small cell lung cancer: Current concepts and clinical McCarrier KP, Atkinson TM, DeBusk KPA, Liepa AM, Scanlon M, Coons SJ,
trials. European Journal of Cardio-Thoracic Surgery. 2016;49(5):1324- on behalf of the Patient-Reported Outcome Consortium Non–Small Cell
1333. PMCID: PMC4851162 Lung Cancer Working Group. Qualitative development and content validity
of the Non-Small Cell lung Cancer Symptom Assessment Questionnaire
Mayor M, Zeltsman M, McGee E, Adusumilli PS. A regional approach for (NSCLC-SAQ), a patient-reported outcome instrument. Clinical
CAR T-cell therapy for mesothelioma: From mouse models to clinical Therapeutics. 2016;38(4):794-810. PMCID: PMC4851890
trial. Immunotherapy. 2016;8(5):491-494.
McCartan D, Gemignani ML. Current management of the axilla. Clinical
Mayr C. Evolution and biological roles of alternative 3’UTRs. Trends in Obstetrics and Gynecology. 2016;59(4):743-755. PMCID: PMC5117457
154 OF 324
Journal Articles
McCartan D, Stempel M, Eaton A, Morrow M, Pilewskie M. Impact of McFarland DC, Andreotti C, Harris K, Mandeli J, Tiersten
body mass index on clinical axillary nodal assessment in breast cancer A, Holland J. Early childhood adversity and its associations
patients. Annals of Surgical Oncology. 2016;23(10):3324-3329. PMCID: with anxiety, depression, and distress in women with breast
PMC5070647 cancer. Psychosomatics. 2016;57(2):174-184. PMCID: PMC5023013
McCarthy CM. Discussion: The impact of radiation therapy, lymph node McFarland DC, Holland JC. The management of psychological
dissection, and hormonal therapy on outcomes of tissue expander- issues in oncology. Clinical Advances in Hematology &
implant exchange in prosthetic breast reconstruction. Plastic and Oncology. 2016;14(12):999-1009.
Reconstructive Surgery. 2016;137(1):10-11.
McFarland DC, Shen MJ, Harris K, Mandeli J, Tiersten A, Holland
McCormick B. The mastectomy myth. Lancet Oncology. 2016;17(8):1035-1037. J. Would women with breast cancer prefer to receive an antidepressant
for anxiety or depression from their oncologist?. Journal of Oncology
McFadden DG, Politi K, Bhutkar A, Chen FK, Song X, Pirun M, Santiago Practice. 2016;12(2):172-174, e197-e206.
PM, Kim-Kiselak C, Platt JT, Lee E, Hodges E, Rosebrock AP, Bronson
RT, Socci ND, Hannon GJ, Jacks T, Varmus H. Mutational landscape of McGranahan N, Furness AJS, Rosenthal R, Ramskov S, Lyngaa
EGFR-, MYC-, and Kras-driven genetically engineered mouse models of R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT,
lung adenocarcinoma. Proceedings of the National Academy of Sciences Watkins TBK, Shafi S, Murugaesu N, Mitter R, Akarca AU, Linares J,
of the United States of America. 2016;113(42):E6409-E6417. PMCID: Marafioti T, Henry JY, Van Allen EM, Miao D, Schilling B, Schadendorf
PMC5081629 D, Garraway LA, Makarov V, Rizvi NA, Snyder A, Hellmann
MD, Merghoub T, Wolchok JD, Shukla SA, Wu CJ, Peggs KS, Chan
McFarland D, Lahijani S, Holland J. Managing depression in patients with TA, Hadrup SR, Quezada SA, Swanton C. Clonal neoantigens elicit
cancer. Oncology (Norwalk). 2016;30(7):665-671. T cell immunoreactivity and sensitivity to immune checkpoint
blockade. Science. 2016;351(6280):1463-1469. PMCID: PMC4984254
McFarland DC, Naikan J, Rozenblit M, Mandeli J, Bleiweiss I, Tiersten
A. Changes in pathological complete response rates after neoadjuvant McIntosh CA, Bialer PA. Developmental milestones. Journal of Gay and
chemotherapy for breast carcinoma over five years. Journal of Lesbian Mental Health. 2016;20(3):193-194.
Oncology. 2016;2016:4324863. PMCID: PMC4921638
McIntosh CA, Bialer PA. The promise of PrEP. Journal of Gay and Lesbian
McFarland DC, Polizzi H, Mascarenhas J, Kremyanskaya M, Holland Mental Health. 2016;20(1):1-3.
J, Hoffman R. Psychological symptoms among patients with BCR-
ABL-negative myeloproliferative neoplasms. Journal of the National McKay RR, De Velasco G, Werner L, Bellmunt J, Harshman L, Sweeney
Comprehensive Cancer Network. 2016;14(12):1563-1570. C, Rosenberg JE, Hirsch M, Signoretti S, Van Allen EM, Walsh M,
Vaishampayan U, McDermott DF, Choueiri TK. A phase 1 study of
McFarland DC, Shen MJ, Holcombe RF. Predictors of patient satisfaction buparlisib and bevacizumab in patients with metastatic renal cell
with inpatient hospital pain management across the United States: A carcinoma progressing on vascular endothelial growth factor-targeted
national study. Journal of Hospital Medicine. 2016;11(7):498-501. therapies. Cancer. 2016;122(15):2389-2398.
155 OF 324
Journal Articles
McKay RR, Lin X, Albiges L, Fay AP, Kaymakcalan MD, Mickey SS, McNeel DG, Bander NH, Beer TM, Drake CG, Fong L, Harrelson S, Kantoff
Ghoroghchian PP, Bhatt RS, Kaffenberger SD, Simantov R, Choueiri TK, PW, Madan RA, Oh WK, Peace DJ, Petrylak DP, Porterfield H, Sartor
Heng DYC. Statins and survival outcomes in patients with metastatic O, Shore ND, Slovin SF, Stein MN, Vieweg J, Gulley JL. The Society for
renal cell carcinoma. European Journal of Cancer. 2016;52:155-162. Immunotherapy of Cancer consensus statement on immunotherapy for
the treatment of prostate carcinoma. Journal for Immunotherapy of
McKay RR, Werner L, Fiorillo M, Nakabayashi M, Kantoff PW, Taplin Cancer. 2016;4(1):92. PMCID: PMC5170901
ME. Predictors of duration of abiraterone acetate in men with
castration-resistant prostate cancer. Prostate Cancer and Prostatic McWilliams JP, Shah RP, Quirk M, White SB, Dybul SL, Ahrar J, Steele JR,
Diseases. 2016;19(4):398-405. Kwan SW, Handel J, Winokur RS, Gilliland CA, Durack JC. Standardized
reporting in IR: A prospective multi-institutional pilot study. Journal of
McKay RR, Zurita AJ, Werner L, Bruce JY, Carducci MA, Stein MN, Heath Vascular and Interventional Radiology. 2016;27(12):1779-1785.
E I, Hussain A, Tran HT, Sweeney CJ, Ross RW, Kantoff PW, Slovin
SF, Taplin ME. A randomized phase II trial of short-course androgen Mead E, Halpern NA. Interventions to decrease albumin utilization:
deprivation therapy with or without bevacizumab for patients with Identifying what works. Critical Care Medicine. 2016;44(7):1428-1429.
recurrent prostate cancer after definitive local therapy. Journal of Clinical
Oncology. 2016;34(16):1913-1920. Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q,
Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper
McKenney PT, Ling L, Wang G, Mane S, Pamer EG. Complete JL, Southey MC, Tesoriero A, James PA, Bruinsma F, Campbell IG,
genome sequence of Enterococcus faecium ATCC 700221. Genome Broeks A, Schmidt MK, Hogervorst FBL, Beckman MW, Fasching PA,
Announcements. 2016;4(3):e00386-16. PMCID: PMC4888979 Fletcher O, Johnson N, Sawyer EJ, Riboli E, Banerjee S, Menon U,
Tomlinson I, Burwinkel B, Hamann U, Marme F, Rudolph A, Janavicius
McKiernan J, Thom B. Human papillomavirus-related oropharyngeal R, Tihomirova L, Tung N, Garber J, Cramer D, Terry KL, Poole EM,
cancer: A review of nursing considerations. American Journal of Tworoger SS, Dorfling CM, Van Rensburg EJ, Godwin AK, Guénel P,
Nursing. 2016;116(8):34-43. Truong T, Stoppa-Lyonnet D, Damiola F, Mazoyer S, Sinilnikova OM,
Isaacs C, Maugard C, Bojesen SE, Flyger H, Gerdes AM, Hansen TVO,
McLoughlin K, Schluter J, Rakoff-Nahoum S, Smith AL, Foster Jensen A, Kjaer SK, Hogdall C, Hogdall E, Pedersen IS, Thomassen
KR. Host selection of microbiota via differential adhesion. Cell Host & M, Benitez J, González-Neira A, Osorio A, Hoya MDL, Segura PP,
Microbe. 2016;19(4):550-559. Diez O, Lazaro C, Brunet J, Anton-Culver H, Eunjung L, John EM,
Neuhausen SL, Ding YC, Castillo D, Weitzel JN, Ganz PA, Nussbaum
McMillen T, Kamboj M, Babady NE. Comparison of multilocus sequence
RL, Chan SB, Karlan BY, Lester J, Wu A, Gayther S, Ramus SJ, Sieh W,
typing and the Xpert C. difficile/Epi assay for identification of Clostridium
Whittermore AS, Monteiro ANA, Phelan CM, Terry MB, Piedmonte M,
difficile 027/NAP1/BI. Journal of Clinical Microbiology. 2016;54(3):775-
Offit K, Robson M, Levine D, Moysich KB, Cannioto R, Olson SH, Daly
778. PMCID: PMC4767941
MB, Nathanson KL, Domchek SM, Lu KH, Liang D, Hildebrant MAT,
McNamara WF, Wang LY, Palmer FL, Nixon IJ, Shah JP, Patel SG, Ganly Ness R, Modugno F, Pearce L, Goodman MT, Thompson PJ, Brenner
I. Pattern of neck recurrence after lateral neck dissection for cervical H, Butterbach K, Meindl A, Hahnen E, Wappenschmidt B, Brauch H,
metastases in papillary thyroid cancer. Surgery. 2016;159(6):1565- Brüning T, Blomqvist C, Khan S, Nevanlinna H, Pelttari LM, Aittomäki
1571. PMCID: PMC5138026 K, Butzow R, Bogdanova N V, Dörk T, Lindblom A, Margolin S, Rantala
156 OF 324
Journal Articles
J, Kosma VM, Mannermaa A, Lambrechts D, Neven P, Claes KBM, Van Mehta N, O’Connell K, Giambrone GP, Baqai A, Diwan S. Efficacy
Maerken T, Chang-Claude J, Flesch-Janys D, Heitz F, Varon-Mateeva of methylnaltrexone for the treatment of opiod-induced
R, Peterlongo P, Radice P, Viel A, Barile M, Peissel B, Manoukian S, constipation: A meta-analysis and systematic review. Postgraduate
Montagna M, Oliani C, Peixoto A, Teixeira MR, Collavoli A, Hallberg E, Medicine. 2016;128(3):282-289.
Olson JE, Goode EL, Hart SN, Shimelis H, Cunningham JM, Giles GG,
Milne RL, Healey S, Tucker K, Haiman CA, Henderson BE, Goldberg MS, Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester
Tischkowitz M, Simard J, Soucy P, Eccles DM, Le N, Borresen-Dale AL, R, Laiyemo AO, Fedewa S, Goodman M, Fletcher RH, Levin TR,
Kristensen V, Salvesen HB, Bjorge L, Bandera E V, Risch H, Zheng W, Corley DA, Doubeni CA. Race/ethnicity and adoption of a population
Beeghly-Fadiel A, Cai H, Pylkäs K, Tollenaar RAEM, Ouweland AMWVD, health management approach to colorectal cancer screening in a
Andrulis IL, Knight JA, Narod S, Devilee P, Winqvist R, Figueroa J, community-based healthcare system. Journal of General Internal
Greene MH, Mai PL, Loud JT, García-Closas M, Schoemaker MJ, Czene Medicine. 2016;31(11):1323-1330. PMCID: PMC5071288
K, Darabi H, McNeish I, Siddiquil N, Glasspool R, Kwong A, Park SK,
Teo SH, Yoon SY, Matsuo K, Hosono S, Woo YL, Gao YT, Foretova L, Mehta-Shah N, Horwitz SM. Lenalidomide in adult T-cell leukemia/
Singer CF, Rappaport-Feurhauser C, Friedman E, Laitman Y, Rennert lymphoma. Journal of Clinical Oncology. 2016;34(34):4066-4067.
G, Imyanitov EN, Hulick PJ, Olopade O I, Senter L, Olah E, Doherty
Melisko ME, Narus JB. Sexual function in cancer survivors: Updates to the
JA, Schildkraut J, Koppert LB, Kiemeney LA, Massuger LFAG, Cook
NCCN guidelines for survivorship. Journal of the National Comprehensive
LS, Pejovic T, Li J, Borg A, Öfverholm A, Rossing MA, Wentzensen N,
Cancer Network. 2016;14(5S):685-689.
Henriksson K, Cox A, Cross SS, Pasini BJ, Shah M, Kabisch M, Torres D,
Jakubowska A, Lubinski J, Gronwald J, Agnarsson BA, Kupryjanczyk Mende M, Fletcher E V, Belluardo JL, Pierce JP, Bommareddy
J, Moes-Sosnowska J, Fostira F, Konstantopoulou I, Slager S, Jones M, PK, Weinrich JA, Kabir ZD, Schierberl KC, Pagiazitis JG, Mendelsohn
Antoniou AC, Berchuck A, Swerdlow A, Chenevix-Trench G, Dunning A I, Francesconi A, Edwards RH, Milner TA, Rajadhyaksha AM,
AM, Pharoah PDP, Hall P, Easton DF, Couch FJ, Spurdle AB, Goldgar van Roessel PJ, Mentis GZ, Kaltschmidt JA. Sensory-derived
DE. BRCA2 polymorphic stop codon K3326X and the risk of breast, glutamate regulates presynaptic inhibitory terminals in mouse spinal
prostate, and ovarian cancers. JNCI: Journal of the National Cancer cord. Neuron. 2016;90(6):1189-1202. PMCID: PMC4912012
Institute. 2016;108(2):djv315. PMCID: PMC4907358
Menezes S, Melandri D, Anselmi G, Perchet T, Loschko J, Dubrot J, Patel
Meester RGS, Zauber AG, Doubeni CA, Jensen CD, Quinn VP, Helfand M, R, Gautier EL, Hugues S, Longhi MP, Henry JY, Quezada SA, Lauvau G,
Dominitz JA, Levin TR, Corley DA, Lansdorp-Vogelaar I. Consequences Lennon-Duménil AM, Gutiérrez-Martínez E, Bessis A, Gomez-Perdiguero
of increasing time to colonoscopy examination after positive result from E, Jacome-Galarza CE, Garner H, Geissmann F, Golub R, Nussenzweig
fecal colorectal cancer screening test. Clinical Gastroenterology and MC, Guermonprez P. The heterogeneity of Ly6C(hi) monocytes controls
Hepatology. 2016;14(10):1445-1451.e8. PMCID: PMC5028249 their differentiation into iNOS(+) macrophages or monocyte-derived
dendritic cells. Immunity. 2016;45(6):1205-1218. PMCID: PMC5196026
Mehta N, Bucior I, Bujanover S, Shah R, Gulati A. Relationship between
pain relief, reduction in pain-associated sleep interference, and overall Menge TD, Hibler BP, Cordova MA, Nehal KS, Rossi AM. Concordance of
impression of improvement in patients with postherpetic neuralgia handheld reflectance confocal microscopy (RCM) with histopathology
treated with extended-release gabapentin. Health and Quality of Life in the diagnosis of lentigo maligna (LM): A prospective study. Journal of
Outcomes. 2016;14:54. PMCID: PMC4818513 the American Academy of Dermatology. 2016;74(6):1114-1120.
157 OF 324
Journal Articles
Merchant MS, Wright M, Baird K, Wexler LH, Rodriguez-Galindo C, following adjuvant trastuzumab and the importance of distant disease-
Bernstein D, Delbrook C, Lodish M, Bishop R, Wolchok JD, Streicher free interval: The HERA trial experience. Breast Cancer Research and
H, Mackall CL. Phase I clinical trial of ipilimumab in pediatric patients Treatment. 2016;155(1):127-132. PMCID: PMC4947530
with advanced solid tumors. Clinical Cancer Research. 2016;22(6):1364-
1370. PMCID: PMC5027962 Meyer JP, Adumeau P, Lewis JS, Zeglis BM. Click chemistry
and radiochemistry: The first 10 years. Bioconjugate
Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Chemistry. 2016;27(12):2791-2807. PMCID: PMC5193009
Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas
MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Meyer JP, Edwards KJ, Kozlowski P, Backer M V, Backer JM, Lewis
Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, JS. Selective imaging of VEGFR-1 and VEGFR-2 using (89)
Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long G V, McArthur Zr-labeled single-chain VEGF mutants. Journal of Nuclear
G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Medicine. 2016;57(11):1811-1816.
Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein
S, Turnham T, Ronai ZA. The state of melanoma: Challenges and Meyer JP, Houghton JL, Kozlowski P, Abdel-Atti D, Reiner T, Pillarsetty
opportunities. Pigment Cell & Melanoma Research. 2016;29(4):404-416. NVK, Scholz WW, Zeglis BM, Lewis JS. (18)F-based pretargeted PET
imaging based on bioorthogonal Diels-Alder click chemistry. Bioconjugate
Merluzzi T V, Philip EJ, Yang M, Heitzmann CA. Matching of received Chemistry. 2016;27(2):298-301. PMCID: PMC4759614
social support with need for support in adjusting to cancer and cancer
survivorship. Psycho-Oncology. 2016;25(6):684-690. PMCID: PMC4960824 Meyer SE, Qin T, Muench DE, Masuda K, Venkatasubramanian M, Orr E,
Suarez L, Gore SD, Delwel R, Paietta E, Tallman MS, Fernandez H, Melnick
Merrill AL, Esserman L, Morrow M. Ductal carcinoma in situ. New England A, Le Beau MM, Kogan S, Salomonis N, Figueroa ME, Grimes HL. DNMT3A
Journal of Medicine. 2016;374(4):390-392. haploinsufficiency transforms FLT3(ITD) myeloproliferative disease into a
rapid, spontaneous, and fully penetrant acute myeloid leukemia. Cancer
Mertens F, Antonescu CR, Mitelman F. Gene fusions in soft tissue tumors: Discovery. 2016;6(5):501-515. PMCID: PMC4861898
Recurrent and overlapping pathogenetic themes. Genes Chromosomes
and Cancer. 2016;55(4):291-310. PMCID: PMC5012284 Meyers PA. Glucarpidase for the treatment of methotrexate-induced
renal dysfunction and delayed methotrexate excretion. Pediatric Blood
Mesa R, Jamieson C, Bhatia R, Deininger MW, Gerds AT, Gojo I, Gotlib J, and Cancer. 2016;63(2):364.
Gundabolu K, Hobbs G, Klisovic RB, Kropf P, Mohan SR, Oh S, Padron
E, Podoltsev N, Pollyea DA, Rampal R, Rein LAM, Scott B, Snyder DS, Michaud L, Touijer KA. Mise au point sur l’imagerie moléculaire dans le
Stein BL, Verstovsek S, Wadleigh M, Wang ES, Bergman MA, Gregory KM, cancer de la prostate. Progrès en Urologie. 2016;26(11-12):619-627.
Sundar H. Myeloproliferative neoplasms, version 2.2017: Clinical practice
guidelines in oncology. Journal of the National Comprehensive Cancer Micol JB, Abdel-Wahab O. The role of additional sex combs-
Network. 2016;14(12):1572-1611. like proteins in cancer. Cold Spring Harbor Perspectives in
Medicine. 2016;6(10):a026526. PMCID: PMC5046687
Metzger-Filho O, de Azambuja E, Procter M, Krieguer M, Smith I, Baselga
J, Cameron D, Untch M, Jackisch C, Bell R, Gianni L, Goldhirsch A, Miga M I, Sun K, Chen I, Clements LW, Pheiffer TS, Simpson AL,
Piccart M, Gelber RD, HREA Study Team. Trastuzumab re-treatment Thompson RC. Clinical evaluation of a model-updated image-
158 OF 324
Journal Articles
guidance approach to brain shift compensation: Experience in 16 Mishori R, Hannaford A, Mujawar I, Ferdowsian H, Kureshi S. “Their stories
cases. International Journal of Computer Assisted Radiology and have changed my life”: Clinicians’ reflections on their experience with and
Surgery. 2016;11(8):1467-1474. PMCID: PMC4834281 their motivation to conduct asylum evaluations. Journal of Immigrant and
Minority Health. 2016;18(1):210-218.
Milazzo-Kiedaisch CA, Itano J, Dutta PR. Role of gabapentin in managing
mucositis pain in patients undergoing radiation therapy to the head and Mitchell E, Klein SL, Argyropoulos K V, Sharma A, Chan RB, Toth JG,
neck. Clinical Journal of Oncology Nursing. 2016;20(6):623-628. Barboza L, Bavley C, Bortolozzi A, Chen Q, Liu B, Ingenito J, Mark
W, Dudakov J, Gross S, Di Paolo G, Artigas F, Van Den Brink M, Toth
Miles LA, Garippa RJ, Poirier JT. Design, execution, and analysis of pooled M. Behavioural traits propagate across generations via segregated
in vitro CRISPR/Cas9 screens. FEBS Journal. 2016;283(17):3170-3180. iterative-somatic and gametic epigenetic mechanisms. Nature
Miletta NR, Kim S, Lezanski-Gujda A, Rossi AM, Marquart JD. Improving
health-related quality of life in wounded warriors: The promising Mizrachi A, Cotrim AP, Katabi N, Mitchell JB, Verheij M, Haimovitz-
benefits of laser hair removal to the residual limb-prosthetic Friedman A. Radiation-induced microvascular injury as a
interface. Dermatologic Surgery. 2016;42(10):1182-1187. mechanism of salivary gland hypofunction and potential target for
radioprotectors. Radiation Research. 2016;186(2):189-195. PMCID:
Millard NE, De Braganca KC. Medulloblastoma. Journal of Child PMC5134326
Neurology. 2016;31(12):1341-1353. PMCID: PMC4995146
Mizrachi A, Shaha AR. In response to: Pay attention to EBSLN in
Miller BF, Sánchez-Vega F, Elnitski L. The emergence of pan-cancer CIMP and anatomical classification of the superior pole in thyroid surgery. Journal
its elusive interpretation. Biomolecules. 2016;6(4):45. PMCID: PMC5197955 of Surgical Oncology. 2016;114(3):394.
Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016
Rao C V, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim WHO classification of tumours of the urinary system and male genital
AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo organs—Part A: Renal, penile, and testicular tumours. European
JAS. Pancreatic Cancer Chemoprevention Translational Workshop: Urology. 2016;70(1):93-105.
Meeting report. Pancreas. 2016;45(8):1080-1091. PMCID: PMC4988336
Modak S, Santopolo S, Chu B, Basu E. Is extended sedation necessary for
Miloushev VZ, Keshari KR, Holodny A I. Hyperpolarization MRI preclinical young children receiving high-dose 131I-MIBG therapy?. Pediatric Blood
models and potential applications in neuroradiology. Topics in Magnetic and Cancer. 2016;63(10):1867.
Resonance Imaging. 2016;25(1):31-37. PMCID: PMC4968075
Modak S, Zanzonico P, Carrasquillo JA, Kushner BH, Kramer K, Cheung NK
Milowsky M I, Galsky MD, Morris MJ, Crona DJ, George DJ, Dreicer V, Larson SM, Pandit-Taskar N. Arsenic trioxide as a radiation sensitizer for
R, Tse K, Petruck J, Webb IJ, Bander NH, Nanus DM, Scher H I. Phase 1/2 (131)I-metaiodobenzylguanidine therapy: Results of a phase II study. Journal
multiple ascending dose trial of the prostate-specific membrane antigen- of Nuclear Medicine. 2016;57(2):231-237. PMCID: PMC4976822
targeted antibody drug conjugate MLN2704 in metastatic castration-
resistant prostate cancer. Urologic Oncology: Seminars and Original Modh A, Rimner A, Allen PK, Greenfield B, Marom EM, Rice D, Huang
Investigations. 2016;34(12):530.e15-530.e21.
159 OF 324
Journal Articles
J, Rosenzweig KE, Komaki R, Gomez DR. Treatment modalities and Mandolfino M, Santoro D, Mondello S, Aloisi C, Altavilla G, Benvenga
outcomes in patients with advanced invasive thymoma or thymic S. Thyroid hormone autoantibodies: Are they a better marker to detect
carcinoma: A retrospective multicenter study. American Journal of early thyroid damage in patients with hematologic cancers receiving
Clinical Oncology: Cancer Clinical Trials. 2016;39(2):120-125. PMCID: tyrosine kinase inhibitor or immunoregulatory drug treatments?. Current
PMC5007217 Oncology. 2016;23(3):e165-e170. PMCID: PMC4900836
Mohanty SK, Kim SA, DeLair DF, Bose S, Laury AR, Chopra S, Mertens Mondello P, Pitini V, Barresi V, Brea EJ, di Mirto C, Arrigo C, Cuzzocrea
RB, Dhall D. Comparison of metastatic neuroendocrine neoplasms to the S, Mian M. Extranodal diffuse large B-cell lymphoma with monoclonal
breast and primary invasive mammary carcinomas with neuroendocrine gammopathy: An aggressive and primary refractory disease responding
differentiation. Modern Pathology. 2016;29(8):788-798. to an immunomodulatory agent. Experimental Hematology and
Oncology. 2016;5:1. PMCID: PMC4702294
Mohler JL, Armstrong AJ, Bahnson RR, D’Amico A V, Davis BJ, Eastham
JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane Mondello P, Steiner N, Willenbacher W, Arrigo C, Cuzzocrea S, Pitini
CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, V, Mian M. 90Y-ibritumomab-tiuxetan consolidation therapy for
Pow-Sang JM, Raben D, Richey S, Roach M, Rosenfeld S, Schaeffer E, advanced-stage mantle cell lymphoma after first-line autologous stem
Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead cell transplantation: Is it time for a step forward?. Clinical Lymphoma,
DA, Freedman-Cass DA. Prostate cancer, version 1.2016. Journal of the Myeloma and Leukemia. 2016;16(2):82-88.
National Comprehensive Cancer Network. 2016;14(1):19-30.
Mondello P, Steiner N, Willenbacher W, Ferrero S, Ghione P, Marabese
Molina-Ruiz AM, Busam KJ. Primary cutaneous Ewing sarcoma with A, Pitini V, Cuzzocrea S, Mian M. Lenalidomide in relapsed or refractory
Ewsr1-Erg fusion. Journal of Cutaneous Pathology. 2016;43(9):729-734. diffuse large B-cell lymphoma: Is it a valid treatment option?. The
Momesso DP, Vaisman F, Yang SP, Bulzico DA, Corbo R, Vaisman
M, Tuttle RM. Dynamic risk stratification in patients with differentiated Mondello P, Steiner N, Willenbacher W, Wasle I, Zaja F, Zambello R,
thyroid cancer treated without radioactive iodine. Journal of Clinical Visentin A, Mauro E, Ferrero S, Ghione P, Pitini V, Cuzzocrea S, Mian
Endocrinology and Metabolism. 2016;101(7):2692-2700. M. Bendamustine plus rituximab versus R-CHOP as first-line treatment
for patients with indolent non-Hodgkin’s lymphoma: evidence from a
Momtaz P, Pentsova E, Abdel-Wahab O, Diamond E, Hyman multicenter, retrospective study. Annals of Hematology. 2016;95(7):1107-1114.
D, Merghoub T, You D, Gasmi B, Viale A, Chapman PB. Quantification
of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) Monian P, Jiang X. The cellular apoptosis susceptibility protein (CAS)
in cerebrospinal fluid of patients with BRAFV600 mutated promotes tumor necrosis factor-related apoptosis-inducing ligand
malignancies. Oncotarget. 2016;7(51):85430-85436. (TRAIL)-induced apoptosis and cell proliferation. Journal of Biological
Chemistry. 2016;291(5):2379-2388. PMCID: PMC4732220
Mondello P, Cuzzocrea S, Navarra M, Mian M. 90 Y-ibritumomab
tiuxetan: A nearly forgotten opportunity. Oncotarget. 2016;7(7):7597- Monk BJ, Sill MW, Walker JL, Darus CJ, Sutton G, Tewari KS, Martin LP,
7609. PMCID: PMC4884941 Schilder JM, Coleman RL, Balkissoon J, Aghajanian C. Randomized
phase II evaluation of bevacizumab versus bevacizumab plus
Mondello P, Mian M, Pitini V, Cuzzocrea S, Sindoni A, Galletti M, fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: An
160 OF 324
Journal Articles
NRG Oncology/Gynecologic Oncology Group Study. Journal of Clinical Moraes FY, Taunk NK, Marta GN, Suh JH, Yamada Y. The rationale for
Oncology. 2016;34(19):2279-2286. PMCID: PMC4962710 targeted therapies and stereotactic radiosurgery in the treatment
of brain metastases. The Oncologist. 2016;21(2):244-251. PMCID:
Montazeri Z, Theodoratou E, Nyiraneza C, Timofeeva M, Chen W, Svinti PMC4746085
V, Sivakumaran S, Gresham G, Cubitt L, Carvajal-Carmona L, Bertagnolli
MM, Zauber AG, Tomlinson I, Farrington SM, Dunlop MG, Campbell Moreland A, Novogrodsky E, Brody L, Durack J, Erinjeri J, Getrajdman
H, Little J. Systematic meta-analyses and field synopsis of genetic G, Solomon S, Yarmohammadi H, Maybody M. Pneumothorax
association studies in colorectal adenomas. International Journal of with prolonged chest tube requirement after CT-guided
Epidemiology. 2016;45(1):186-205. percutaneous lung biopsy: Incidence and risk factors. European
Radiology. 2016;26(10):3483-3491.
Monteleone M, Teng H. Intravenous dexmedetomidine as
an ‘adjuvant’ to the infant spinal anesthetic. Paediatric Morello A, Sadelain M, Adusumilli PS. Mesothelin-targeted CARs:
Anaesthesia. 2016;26(12):1214-1215. Driving T cells to solid tumors. Cancer Discovery. 2016;6(2):133-
146. PMCID: PMC4744527
Monticelli LA, Buck MD, Flamar AL, Saenz SA, Wojno EDT, Yudanin
NA, Osborne LC, Hepworth MR, Tran S V, Rodewald HR, Shah H, Cross Morency E, Leitao MM Jr, Soslow RA. Low-stage high-grade serous
JR, Diamond JM, Cantu E, Christie JD, Pearce EL, Artis D. Arginase 1 ovarian carcinomas: Support for an extraovarian origin. International
is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling Journal of Gynecological Pathology. 2016;35(3):222-229.
type 2 inflammation. Nature Immunology. 2016;17(6):656-665. PMCID:
PMC4873382 Morgado-Palacin I, Day A, Murga M, Lafarga V, Anton ME, Tubbs A,
Chen HT, Ergan A, Anderson R, Bhandoola A, Pike KG, Barlaam B,
Montorsi F, Oelke M, Henneges C, Brock G, Salonia A, d’Anzeo G, Cadogan E, Wang X, Pierce AJ, Hubbard C, Armstrong SA, Nussenzweig
Rossi A, Mulhall JP, Büttner H. Exploratory decision-tree modeling of A, Fernandez-Capetillo O. Targeting the kinase activities of ATR and
data from the randomized REACTT trial of tadalafil versus placebo to ATM exhibits antitumoral activity in mouse models of MLL-rearranged
predict recovery of erectile function after bilateral nerve-sparing radical AML. Science Signaling. 2016;9(445):ra91. PMCID: PMC5066844
prostatectomy. European Urology. 2016;70(3):529-537.
Morgan DJ, Dhruva SS, Wright SM, Korenstein D. 2016 update
Montrose DC, Zhou XK, McNally EM, Sue E, Yantiss RK, Gross SS, Leve on medical overuse: A systematic review. JAMA Internal
ND, Karoly ED, Suen CS, Ling L, Benezra R, Pamer EG, Dannenberg Medicine. 2016;176(11):1687-1692.
AJ. Celecoxib alters the intestinal microbiota and metabolome
in association with reducing polyp burden. Cancer Prevention Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht
Research. 2016;9(9):721-731. PMCID: PMC5010963 K, Chen LM, Copeland L, Crispens MA, De Rosa M, Dorigo O, Gershenson
DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L,
Moore AR, Ceraudo E, Sher J, Guan Y, Shoushtari AN, Chang MT, Matulonis UA, O’Malley DM, Penson RT, Percac-Lima S, Pineda M, Plaxe
Zhang JQ, Walczak EG, Kazmi MA, Taylor BS, Huber T, Chi P, Sakmar SC, Powell MA, Ratner E, Remmenga SW, Rose PG, Sabbatini P, Santoso
TP, Chen Y. Recurrent activating mutations of G-protein-coupled JT, Werner TL, Burns J, Hughes M. Ovarian cancer, version 1.2016: Clinical
receptor CYSLTR2 in uveal melanoma. Nature Genetics. 2016;48(6):675- Practice Guidelines in Oncology. Journal of the National Comprehensive
680. PMCID: PMC5032652 Cancer Network. 2016;14(9):1134-1163.
161 OF 324
Journal Articles
Morgenstern PF, Connors S, Reiner AS, Greenfield JP. Image guidance Morris MJ, Rathkopf DE, Novotny W, Gibbons JA, Peterson AC, Khondker
for placement of Ommaya reservoirs: Comparison of fluoroscopy Z, Ouatas T, Scher H I, Fleming MT. Phase Ib study of enzalutamide in
and frameless stereotactic navigation in 145 patients. World combination with docetaxel in men with metastatic castration-resistant
Neurosurgery. 2016;93:154-158. prostate cancer. Clinical Cancer Research. 2016;22(15):3774-3781.
Morgenstern PF, Shah K, Dunkel IJ, Reiner AS, Khakoo Y, Rosenblum Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M,
MK, Gutin P. Meningioma after radiotherapy for malignancy. Journal of Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ,
Clinical Neuroscience. 2016;30:93-97. Wapnir I, Moran MS. Society of Surgical Oncology - American Society
for Radiation Oncology - American Society of Clinical Oncology
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial consensus guideline on margins for breast-conserving surgery with
cancer. Lancet. 2016;387(10023):1094-1108. whole-breast irradiation in ductal carcinoma in situ. Practical Radiation
Morjaria S, Epstein DJ, Romero FA, Taur Y, Seo SK, Papanicolaou
GA, Hatzoglou V, Rosenblum M, Perales MA, Scordo M, Kaltsas Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M,
A. Toxoplasma encephalitis in atypical hosts at an academic cancer Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ,
center. Open Forum Infectious Diseases. 2016;3(2):ofw070. PMCID: Wapnir I, Moran MS. Society of Surgical Oncology-American Society
PMC4834739 for Radiation Oncology-American Society of Clinical Oncology
consensus guideline on margins for breast-conserving surgery with
Moroz E, Albrecht RA, Aden B, Beeder AB, Yuan J, García-Sastre A, whole-breast irradiation in ductal carcinoma in situ. Journal of Clinical
Edlin BR, Salvatore M. Active opioid use does not attenuate the humoral Oncology. 2016;34(33):4040-4046.
responses to inactivated influenza vaccine. Vaccine. 2016;34(11):1363-
1369. PMCID: PMC4780674 Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M,
Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ,
Morris LGT, Riaz N, Desrichard A, Senbabaoglu Y, Ari Hakimi Wapnir I, Moran MS. Society of Surgical Oncology–American Society
A, Makarov V, Reis-Filho JS, Chan TA. Pan-cancer analysis for Radiation Oncology–American Society of Clinical Oncology
of intratumor heterogeneity as a prognostic determinant of consensus guideline on margins for breast-conserving surgery with
survival. Oncotarget. 2016;7(9):10051-10063. PMCID: PMC4891103 whole-breast irradiation in ductal carcinoma in situ. Annals of Surgical
Morris LGT, Tuttle RM, Davies L. Changing trends in the incidence of
thyroid cancer in the United States. JAMA Otolaryngology - Head and Morrow M, Van Zee KJ. Margins in DCIS: Does residual disease provide an
Neck Surgery. 2016;142(7):709-711. PMCID: PMC4956490 answer?. Annals of Surgical Oncology. 2016;23(11):3423-3425.
Morris LGT, Wong RJ, Tuttle RM. Ethical considerations when counseling Morrow M. Ductal carcinoma in situ: How much treatment is enough, how
patients with thyroid cancer about surgery vs observation. JAMA much is too much?. Journal of Oncology Practice. 2016;12(4):312-313.
Otolaryngology - Head and Neck Surgery. 2016;142(4):406-407. PMCID:
PMC4924474 Morrow M. Parsing pathologic complete response in patients
receiving neoadjuvant chemotherapy for breast cancer. JAMA
Oncology. 2016;2(4):516-517.
162 OF 324
Journal Articles
Morrow M. Recommend lumpectomy with or without radiation. New Motzer RJ, Hutson TE, Ren M, Dutcus C, Larkin J. Independent
England Journal of Medicine. 2016;374(4):391-392. assessment of lenvatinib plus everolimus in patients with metastatic renal
cell carcinoma. Lancet Oncology. 2016;17(1):e4-e5.
Moryl N, Tamasdan C, Tarcatu D, Thaler HT, Correa D, Steingart R, Payne
R, Obbens E. A phase I study of D-methadone in patients with chronic Motzer RJ. Perspective: What next for treatment?. Nature. 2016;537(7620
pain. Journal of Opioid Management. 2016;12(1):47-55. Suppl.):S111.
Moskowitz AJ. Bleomycin for older patients: Less is Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V,
more. Blood. 2016;127(18):2167-2168. Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ Jr, Garces
Y I, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus
Moskowitz AJ. Lenalidomide in adult T-cell leukaemia-lymphoma. Lancet R, Choy H. Quality of life analysis of a radiation dose-escalation study
Haematology. 2016;3(3):e100-e101. of patients with non-small-cell lung cancer: A secondary analysis of the
Radiation Therapy Oncology Group 0617 randomized clinical trial. JAMA
Moskowitz CH. Consolidation therapy after autologous stem cell Oncology. 2016;2(3):359-367. PMCID: PMC4786463
transplant in relapsed/refractory Hodgkin lymphoma [interview]. Clinical
Advances in Hematology & Oncology. 2016;14(9):662-664. Mueller JJ, Holzapfel M, Han CH, Santos K, Gunderson C, Moore K,
Erickson B, Leath CA, Diaz E, Walsh C, Wethington SL, Dejbakhsh
Mosso L, Martínez A, Rojas MP, Latorre G, Margozzini P, Lyng T, Carvajal SZ, Barakat RR, Gardner GJ, Hyman DM, Soslow RA, Leitao MM. Staging
J, Campusano C, Arteaga E, Boucai L. Early pregnancy thyroid hormone lymphadenectomy in patients with clear cell carcinoma of the
reference ranges in Chilean women: The influence of body mass ovary. International Journal of Gynecological Cancer. 2016;26(1):120-
index. Clinical Endocrinology. 2016;85(6):942-948. 124. PMCID: PMC4891809
Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Mueller JJ, Kelly A, Zhou Q, Iasonos A, Long Roche K, Sonoda
Stovall M, Meacham LR, Green DM, Weathers R, Ginsberg JP, Robison Y, O’Cearbhaill RE, Zivanovic O, Chi DS, Gardner GJ. Intraperitoneal
LL, Sklar CA. Endocrine abnormalities in aging survivors of childhood chemotherapy after interval debulking surgery for advanced-stage
cancer: A report from the Childhood Cancer Survivor Study. Journal of ovarian cancer: Feasibility and outcomes at a comprehensive cancer
Clinical Oncology. 2016;34(27):3240-3247. PMCID: PMC5024546 center. Gynecologic Oncology. 2016;143(3):496-503.
Motzer RJ, Alyasova A, Ye D, Karpenko A, Li H, Alekseev B, Xie L, Kurteva Mueller JJ, Zhou QC, Iasonos A, O’Cearbhaill RE, Alvi FA, El Haraki
G, Kowalyszyn R, Karyakin O, Neron Y, Cosgriff T, Collins L, Brechenmacher A, Eriksson AGZ, Gardner GJ, Sonoda Y, Levine DA, Aghajanian
T, Lin C, Morgan L, Yang L. Phase II trial of second-line everolimus in C, Chi DS, Abu-Rustum NR, Zivanovic O. Neoadjuvant chemotherapy
patients with metastatic renal cell carcinoma (RECORD-4). Annals of and primary debulking surgery utilization for advanced-stage
Oncology. 2016;27(3):441-448. PMCID: PMC5006123 ovarian cancer at a comprehensive cancer center. Gynecologic
Motzer RJ, Escudier B, Choueiri TK. Treatment of advanced renal-
cell carcinoma - The authors reply. New England Journal of Mughal T I, Abdel-Wahab O, Rampal R, Mesa R, Koschmieder S, Levine
Medicine. 2016;374(9):889-890. R, Hehlmann R, Saglio G, Barbui T, Van Etten RA. Contemporary insights
163 OF 324
Journal Articles
into the pathogenesis and treatment of chronic myeloproliferative Practice. 2016;70(12):1012-1018.
neoplasms. Leukemia and Lymphoma. 2016;57(7):1517-1526.
Mullane SA, Werner L, Guancial EA, Lis RT, Stack EC, Loda M, Kantoff
Mukaihara K, Suehara Y, Kohsaka S, Kubota D, Toda-Ishii M, Akaike PW, Choueiri TK, Rosenberg J, Bellmunt J. Expression levels of
K, Fujimura T, Kobayashi E, Yao T, Ladanyi M, Kaneko K, Saito DNA damage repair proteins are associated with overall survival in
T. Expression of F-actin-capping protein subunit beta, CAPZB, is platinum-treated advanced urothelial carcinoma. Clinical Genitourinary
associated with cell growth and motility in epithelioid sarcoma. BMC Cancer. 2016;14(4):352-359.
Cancer. 2016;16(1):206. PMCID: PMC4787035
Mullane SA, Werner L, Rosenberg J, Signoretti S, Callea M, Choueiri TK,
Mukaihara K, Suehara Y, Kohsaka S, Akaike K, Tanabe Y, Kubota D, Ishii Freeman GJ, Bellmunt J. Correlation of APOBEC mRNA expression with
M, Fujimura T, Kazuno S, Okubo T, Takagi T, Yao T, Kaneko K, Saito overall survival and pd-l1 expression in urothelial carcinoma. Scientific
T. Protein expression profiling of giant cell tumors of bone treated with Reports. 2016;6:27702. PMCID: PMC4901342
denosumab. PLoS ONE. 2016;11(2):e0148401. PMCID: PMC4749282
Munden RF, Ginsberg MS. Reply to “Improved postoperative mortality
Mukamana D, Karonkano GR, Rosa W. Advancing perioperative nursing rates after thoracic surgery for lung cancer” [CLM-D-16-00187]. Clinical
in Rwanda through global partnerships and collaboration. AORN Imaging. 2016;40(4):828-829.
Journal. 2016;104(6):583-587.
Mundy LR, Miller HC, Klassen AF, Cano SJ, Pusic AL. Patient-
Mukhopadhyay S, Frias MA, Chatterjee A, Yellen P, Foster reported outcome instruments for surgical and traumatic scars: A
DA. The enigma of rapamycin dosage. Molecular Cancer systematic review of their development, content, and psychometric
Therapeutics. 2016;15(3):347-353. PMCID: PMC4783198 validation. Aesthetic Plastic Surgery. 2016;40(5):792-800.
Mulhall JP, Brock G, Oelke M, Fode M, Probst KA, Henneges C, d’Anzeo Mungo B, Hooker CM, Ho JSY, Yang SC, Battafarano RJ, Brock M V, Molena
G, Rossi A, Büttner H. Effects of tadalafil once-daily or on-demand vs D. Robotic versus thoracoscopic resection for lung cancer: Early results
placebo on return to baseline erectile function after bilateral nerve- of a new robotic program. Journal of Laparoendoscopic and Advanced
sparing radical prostatectomy: Results from a randomized controlled trial Surgical Techniques. 2016;26(4):243-248. PMCID: PMC4994050
(REACTT). Journal of Sexual Medicine. 2016;13(4):679-683.
Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, Marques
Mulhall JP, Brock GB, Glina S, Baygani S, Donatucci CF, Maggi RJ. Gonadotropin-releasing hormone agonists for ovarian function
M. Impact of baseline total testosterone level on successful treatment preservation in premenopausal women undergoing chemotherapy for
of sexual dysfunction in men taking once-daily tadalafil 5 mg for lower early-stage breast cancer: A systematic review and meta-analysis. JAMA
urinary tract symptoms and benign prostatic hyperplasia: An integrated Oncology. 2016;2(1):65-73. PMCID: PMC5003018
analysis of three randomized controlled trials. Journal of Sexual
Medicine. 2016;13(5):843-851. Muraki T, Reid MD, Basturk O, Jang KT, Bedolla G, Bagci P, Mittal P, Memis
B, Katabi N, Bandyopadhyay S, Sarmiento JM, Krasinskas A, Klimstra
Mulhall JP, Luo X, Zou KH, Stecher V, Galaznik A. Relationship between DS, Adsay V. Undifferentiated carcinoma with osteoclastic giant cells of
age and erectile dysfunction diagnosis or treatment using real- the pancreas: Clinicopathologic analysis of 38 cases highlights a more
world observational data in the USA. International Journal of Clinical protracted clinical course than currently appreciated. American Journal
164 OF 324
Journal Articles
of Surgical Pathology. 2016;40(9):1203-1216. PMCID: PMC4987218 JE, Ari Hakimi A, Bernstein ML, Dalbagni G, Coleman JA, Furberg
H. Second primary malignancies in renal cortical neoplasms: An
Murn J, Teplova M, Zarnack K, Shi Y, Patel DJ. Recognition of distinct updated evaluation from a single institution. World Journal of
RNA motifs by the clustered CCCH zinc fingers of neuronal protein Urology. 2016;34(12):1667-1672. PMCID: PMC5075261
Unkempt. Nature Structural & Molecular Biology. 2016;23(1):16-
23. PMCID: PMC4703518 Murray M. Pathologic high-risk lesions, diagnosis and
management. Clinical Obstetrics and Gynecology. 2016;59(4):727-
Murphy CG, Dickler MN. Endocrine resistance in hormone-responsive 732. PMCID: PMC5079293
breast cancer: Mechanisms and therapeutic strategies. Endocrine-Related
Cancer. 2016;23(8):R337-R352. Mussetti A, Kernan NA, Prockop SE, Scaradavou A, Lehrman
R, Ruggiero JM, Curran K, Kobos R, O’Reilly R, Boulad F. Allogeneic
Murphy JM, Lim IIP, Farber BA, Heaton TE, Basu EM, Roberts SS, Modak hematopoietic stem cell transplantation for nonmalignant
S, Kushner BH, LaQuaglia MP. Salvage rates after progression of hematologic disorders using chemotherapy-only cytoreductive
high-risk neuroblastoma with a soft tissue mass. Journal of Pediatric regimens and T-cell-depleted grafts from human leukocyte antigen-
Surgery. 2016;51(2):285-288. PMCID: PMC4769938 matched or - mismatched donors. Pediatric Hematology and
Oncology. 2016;33(6):347-358.
Murray K. Bladder cancer tests: What factors impact results?. Urology
Times. 2016;44(2) Myers AP, Filiaci VL, Zhang Y, Pearl M, Behbakht K, Makker V, Hanjani
P, Zweizig S, Burke JJ 2nd, Downey G, Leslie KK, Van Hummelen P,
Murray KM, Parker W, Stephany H, Redger K, Mirza M, Lopez-Corona Birrer MJ, Fleming GF. Tumor mutational analysis of GOG 248, a phase
E, Holzbeierlein JM, Lee EK. Venous thromboembolism after radical II study of temsirolimus or temsirolimus and alternating megestrol
cystectomy: Experience with screening ultrasonography. Arab Journal of acetate and tamoxifen for advanced endometrial cancer (EC): An
Urology. 2016;14(1):37-43. PMCID: PMC4767786 NRG Oncology/Gynecologic Oncology Group study. Gynecologic
Murray KS, Winter AG, Corradi RB, LaRosa S, Jebiwott S, Somma
A, Takaki H, Srimathveeravalli G, Lepherd M, Monette S, Kim K, Myers JE, Xia Q, Torian L V, Irvine M, Harriman G, Sepkowitz KA, Shepard
Scherz A, Coleman JA. Treatment effects of WST11 vascular targeted CW. CD4 count monitoring frequency and risk of CD4 count dropping
photodynamic therapy for urothelial cell carcinoma in swine. Journal of below 200 cells per cubic millimeter among stable HIV-infected patients
Urology. 2016;196(1):236-243. PMCID: PMC4914469 in New York City, 2007-2013. JAIDS: Journal of Acquired Immune
Deficiency Syndromes. 2016;71(3):e73-e78. PMCID: PMC4770377
Murray KS, Ehdaie B, Musser J, Mashni J, Srimathveeravalli G, Durack
JC, Solomon SB, Coleman JA. Pilot study to assess safety and clinical Nabhan C, Zhou X, Day BM, Dawson K, Zelenetz AD, Friedberg JW,
outcomes of irreversible electroporation for partial gland ablation Cerhan JR, Link BK, Flowers CR. Disease, treatment, and outcome
in men with prostate cancer. Journal of Urology. 2016;196(3):883- differences between men and women with follicular lymphoma in the
889. PMCID: PMC5102502 United States. American Journal of Hematology. 2016;91(8):770-775.
Murray KS, Zabor EC, Spaliviero M, Russo P, Bazzi WM, Musser Nadal R, Amin A, Geynisman DM, Voss MH, Weinstock M, Doyle J, Zhang
165 OF 324
Journal Articles
Z, Viudez A, Plimack ER, McDermott DF, Motzer R, Rini B, Hammers MG, Riely GJ, Lito P, Iqbal A, Veach S, Smith-Marrone S, Sarkaria IS,
HJ. Safety and clinical activity of vascular endothelial growth factor Krug LM, Rudin CM, Travis WD, Rekhtman N, Pietanza MC. Large cell
receptor (VEGFR)-tyrosine kinase inhibitors after programmed cell neuroendocrine carcinoma of the lung: Clinico-pathologic features,
death 1 inhibitor treatment in patients with metastatic clear cell renal cell treatment, and outcomes. Clinical Lung Cancer. 2016;17(5):e121-e129.
carcinoma. Annals of Oncology. 2016;27(7):1304-1311.
Naing A, Papadopoulos KP, Autio KA, Ott PA, Patel MR, Wong DJ,
Nadkarni GN, Simoes PK, Patel A, Patel S, Yacoub R, Konstantinidis Falchook GS, Pant S, Whiteside M, Rasco DR, Mumm JB, Chan IH, Bendell
I, Kamat S, Annapureddy N, Parikh CR, Coca SG. National trends JC, Bauer TM, Colen RR, Hong DS, Van Vlasselaer P, Tannir NM, Oft M,
of acute kidney injury requiring dialysis in decompensated Infante JR. Safety, antitumor activity, and immune activation of pegylated
cirrhosis hospitalizations in the United States. Hepatology recombinant human interleukin-10 (AM0010) in patients with advanced
International. 2016;10(3):525-531. solid tumors. Journal of Clinical Oncology. 2016;34(29):3562-3569.
Nafa K, Hameed M, Arcila ME. Locked nucleic acid probes (LNA) for Nair JS, Schwartz GK. MLN-8237: A dual inhibitor of aurora A and B
enhanced detection of low-level, clinically significant mutations. Methods in soft tissue sarcomas. Oncotarget. 2016;7(11):12893-12903. PMCID:
in Molecular Biology. 2016;1392:71-82. PMC4914329
Nagarajah J, Le M, Knauf JA, Ferrandino G, Montero-Conde C, Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES,
Pillarsetty N, Bolaender A, Irwin C, Krishnamoorthy GP, Saqcena Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt
M, Larson SM, Ho AL, Seshan V, Ishii N, Carrasco N, Rosen N, Weber SJ, King TA. Incidence of adjacent synchronous invasive carcinoma
WA, Fagin JA. Sustained ERK inhibition maximizes responses of and/or ductal carcinoma in-situ in patients with lobular neoplasia on
Braf(V600E) thyroid cancers to radioiodine. Journal of Clinical core biopsy: Results from a prospective multi-Institutional registry
Investigation. 2016;126(11):4119-4124. PMCID: PMC5096947 (TBCRC 020). Annals of Surgical Oncology. 2016;23(3):722-728. PMCID:
PMC4984674
Naidoo J, Schindler K, Querfeld C, Busam K, Cunningham J, Page
DB, Postow MA, Weinstein A, Lucas AS, Ciccolini KT, Quigley Namuduri M, Brentjens RJ. Medical management of side effects related
EA, Lesokhin AM, Paik PK, Chaft JE, Segal NH, D’Angelo SP, Dickson to CAR T cell therapy in hematologic malignancies. Expert Review of
MA, Wolchok JD, Lacouture ME. Autoimmune bullous skin disorders Hematology. 2016;9(6):511-513.
with immune checkpoint inhibitors targeting PD-1 and PD-L1. Cancer
Immunology Research. 2016;4(5):383-390. PMCID: PMC5241697 Narus JB. Men, cancer, and sexual health. Coping With
Cancer. 2016;30(2):36.
Naidoo J, Drilon A. KRAS-mutant lung cancers in the era of targeted
therapy. Advances in Experimental Medicine and Biology. 2016;893:155-178. Nasser NJ, Cohen GN, Dauer LT, Zelefsky MJ. Radiation safety of
receptive anal intercourse with prostate cancer patients treated with low-
Naidoo J, Li BT, Schindler K, Page DB. What does the future dose-rate brachytherapy. Brachytherapy. 2016;15(4):420-425.
hold for immunotherapy in cancer?. Annals of Translational
Medicine. 2016;4(9):177. PMCID: PMC4876278 Natrajan R, Weigelt B. Risk stratification and intrinsic subtype
classification of breast cancer: A multiparameter test to rule them
Naidoo J, Santos-Zabala ML, Iyriboz T, Woo KM, Sima CS, Fiore JJ, Kris all?. JNCI: Journal of the National Cancer Institute. 2016;108(9):djw118.
166 OF 324
Journal Articles
Navarrete-Dechent C, Bajaj S, Marchetti MA, Rabinovitz H, Dusza for motor deficits with a combined hybrid MRI-PET and navigated
SW, Marghoob AA. Association of shiny white blotches and strands transcranial magnetic stimulation approach. American Journal of
with nonpigmented basal cell carcinoma evaluation of an additional Neuroradiology. 2016;37(2):266-273.
dermoscopic diagnostic criterion. JAMA Dermatology. 2016;152(5):546-
552. PMCID: PMC5037958 Neuschmelting V, Lockau H, Ntziachristos V, Grimm J, Kircher
MF. Lymph node micrometastases and in-transit metastases from
Navarro SL, Kantor ED, Song X, Milne GL, Lampe JW, Kratz melanoma: In vivo detection with multispectral optoacoustic imaging in
M, White E. Factors associated with multiple biomarkers of a mouse model. Radiology. 2016;280(1):137-150. PMCID: PMC4942996
systemic inflammation. Cancer Epidemiology Biomarkers and
Prevention. 2016;25(3):521-531. PMCID: PMC4779684 Ng AK, Dabaja BS, Hoppe RT, Illidge T, Yahalom J. Re-examining the role
of radiation therapy for diffuse large B-cell lymphoma in the modern
Neal D, Lilja H. Circulating tumor cell count as an indicator era. Journal of Clinical Oncology. 2016;34(13):1443-1447.
of treatment benefit in advanced prostate cancer. European
Urology. 2016;70(6):993-994. Ng SY, Colborn KL, Cambridge L, Hajj C, Yang TJ, Wu AJ, Goodman
KA. Acute toxicity with intensity modulated radiotherapy versus
Neil EC, Hanmantgad S, Khakoo Y. Neurological complications 3-dimensional conformal radiotherapy during preoperative
of pediatric cancer. Journal of Child Neurology. 2016;31(12):1412- chemoradiation for locally advanced rectal cancer. Radiotherapy and
1420. PMCID: PMC4927408 Oncology. 2016;121(2):252-257.
Nelson CJ, Schofield E. The seduction of P values. Journal of Sexual Ngu S, Lebron-Zapata L, Pomeranz C, Katz S, Gerst S, Zheng
Medicine. 2016;13(12):1828-1829. J, Moskowitz C, Do RKG. Inter-observer agreement on the assessment
of relative liver lesion signal intensity on hepatobiliary phase imaging
Nelson CJ, Starr TD, Macchia RJ, Hyacinthe L, Friedman S, Roth with gadoxetate (Gd-EOB-DTPA). Abdominal Radiology. 2016;41(1):50-
AJ. Assessing anxiety in Black men with prostate cancer: Further 55. PMCID: PMC4740974
data on the reliability and validity of the Memorial Anxiety Scale for
Prostate Cancer (MAX-PC). Supportive Care in Cancer. 2016;24(7):2905- Nguyen A, Loo JM, Mital R, Weinberg EM, Man FY, Zeng Z, Paty
2911. PMCID: PMC4879077 PB, Saltz L, Janjigian YY, De Stanchina E, Tavazoie SF. PKLR promotes
colorectal cancer liver colonization through induction of glutathione
Neuschmelting V, Burton NC, Lockau H, Urich A, Harmsen S, synthesis. Journal of Clinical Investigation. 2016;126(2):681-694. PMCID:
Ntziachristos V, Kircher MF. Performance of a multispectral optoacoustic PMC4731165
tomography (MSOT) system equipped with 2D vs. 3D handheld probes
for potential clinical translation. Photoacoustics. 2016;4(1):1-10. PMCID: Nguyen DP, Hakimi AA, Vertosick EA, Russo P. Reply to Williamson
PMC4811917 S.R. What is the malignant potential of clear cell papillary renal cell
carcinoma? Urol Oncol 2016; 34: 420. Urologic Oncology: Seminars and
Neuschmelting V, Weiss Lucas C, Stoffels G, Oros-Peusquens AM, Lockau Original Investigations. 2016;34(12):581-582.
H, Shah NJ, Langen KJ, Goldbrunner R, Grefkes C. Multimodal imaging
in malignant brain tumors: Enhancing the preoperative risk evaluation
167 OF 324
Journal Articles
Nguyen DP, Touijer KA. Re: Oncologic surveillance after surgical PM, Tischler AS, Tuttle M, Wall KB, LiVolsi VA, Randolph GW, Ghossein
resection for renal cell carcinoma: A novel risk-based approach. European RA. Nomenclature revision for encapsulated follicular variant of papillary
Urology. 2016;69(5):962. thyroid carcinoma: A paradigm shift to reduce overtreatment of indolent
tumors. JAMA Oncology. 2016;2(8):1023-1029.
Nguyen DP, Vertosick EA, Corradi RB, Vilaseca A, Benfante NE, Touijer
KA, Sjoberg DD, Russo P. Histological subtype of renal cell carcinoma Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X,
significantly affects survival in the era of partial nephrectomy. Urologic Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS,
Oncology: Seminars and Original Investigations. 2016;34(6):259.e1-259. Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød
e8. PMCID: PMC5133368 A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt
C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GKJ,
Nguyen DP, Vilaseca A, Vertosick EA, Corradi RB, Touijer KA, Benfante Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee
NE, Sjoberg DD, Russo P. Histologic subtype impacts cancer-specific JY, Li Y, McLaren S, Menzies A, Mustonen V, O’Meara S, Pauporté I,
survival in patients with sarcomatoid-variant renal cell carcinoma treated Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González
surgically. World Journal of Urology. 2016;34(4):539-544. PMCID: FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L,
PMC4962689 Stefansson OA, Teague J, Tommasi S, Treilleux I, Van Den Eynden GG,
Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Veer L V, Tutt A,
Nguyen VN, Wang B, Shi C. A sensitivity dosimetry study of the Knappskog S, Tan BKT, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A,
setup uncertainties during machine commissioning and annual Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE,
QA. International Journal of Medical Physics, Clinical Engineering and Thompson AM, Birney E, Stunnenberg HG, Van De Vijver MJ, Martens
Radiation Oncology. 2016;5(4):329-347. JWM, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton
MR. Landscape of somatic mutations in 560 breast cancer whole-
Nicholson MR, Van Horn GT, Tang YW, Vinjé J, Payne DC, Edwards KM,
genome sequences. Nature. 2016;534(7605):47-54. PMCID: PMC4910866
Chappell JD. Using multiplex molecular testing to determine the etiology
of acute gastroenteritis in children. Journal of Pediatrics. 2016;176:50- Nishijima TF, Suzuki M, Muss HB. A comparison of toxicity profiles
56. PMCID: PMC5215462 between the lower and standard dose capecitabine in breast cancer:
A systematic review and meta-analysis. Breast Cancer Research and
Niethammer P. Neutrophil mechanotransduction: A GEF to sense
Treatment. 2016;156(2):227-236. PMCID: PMC4988831
fluid shear stress. Journal of Cell Biology. 2016;215(1):13-14. PMCID:
PMC5057290 Nitti MD, Hespe GE, Kataru RP, García Nores GD, Savetsky IL, Torrisi
JS, Gardenier JC, Dannenberg AJ, Mehrara BJ. Obesity-induced
Niethammer P. The early wound signals. Current Opinion in Genetics and
lymphatic dysfunction is reversible with weight loss. Journal of
Development. 2016;40:17-22. PMCID: PMC5278878
Physiology. 2016;594(23):7073-7087. PMCID: PMC5134379
Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LDR,
Nixon IJ, Simo R, Newbold K, Rinaldo A, Suarez C, Kowalski LP, Silver
Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA,
C, Shah JP, Ferlito A. Management of invasive differentiated thyroid
Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd R V,
cancer. Thyroid. 2016;26(9):1156-1166. PMCID: PMC5118958
Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow
168 OF 324
Journal Articles
Nixon IJ, Suárez C, Simo R, Sanabria A, Angelos P, Rinaldo A, Rodrigo JP, Nougaret S, Ragucci M, Bach AM, Carollo G, Mannelli L. Incidental
Kowalski LP, Hartl DM, Hinni ML, Shah JP, Ferlito A. The impact of family detection of femoral pseudoaneurysm at 18F-FDG PET/CT. Clinical
history on non-medullary thyroid cancer. European Journal of Surgical Nuclear Medicine. 2016;41(1):e68-e69. PMCID: PMC4976445
Nougaret S, Lakhman Y, Reinhold C, Addley HC, Fujii S, Delhom E,
Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel Guiu B, Sala E. The wheel of the mesentery: Imaging spectrum of
SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. Defining a valid primary and secondary mesenteric neoplasms - How can radiologists
age cutoff in staging of well-differentiated thyroid cancer. Annals of help plan treatment?. Radiographics. 2016;36(2):412-413. PMCID:
Surgical Oncology. 2016;23(2):410-415. PMCID: PMC4959904 PMC4901984
Nixon IJ, Wang LY, Ganly I, Patel SG, Morris LG, Migliacci JC, Tuttle Nougaret S, Mannelli L, Pierredon MA, Schembri V, Guiu B. Cystic
RM, Shah JP, Shaha AR. Outcomes for patients with papillary thyroid pancreatic lesions: From increased diagnosis rate to new
cancer who do not undergo prophylactic central neck dissection. British dilemmas. Diagnostic and Interventional Imaging. 2016;97(12):1275-1285.
Journal of Surgery. 2016;103(3):218-225. PMCID: PMC4976488
Nougaret S, Vargas HA, Lakhman Y, Sudre R, Do RKG, Bibeau F, Azria
Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss D, Assenat E, Molinari N, Pierredon MA, Rouanet P, Guiu B. Intravoxel
A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, incoherent motion-derived histogram metrics for assessment of response
Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer after combined chemotherapy and radiation therapy in rectal cancer:
FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak Initial experience and comparison between single-section and volumetric
KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. An analyses1. Radiology. 2016;280(2):446-454. PMCID: PMC4976464
international multi-institutional validation of age 55 years as a cutoff for
risk stratification in the AJCC/UICC staging system for well-differentiated Nowak AK, Chansky K, Rice DC, Pass H I, Kindler HL, Shemanski L, Billé
thyroid cancer. Thyroid. 2016;26(3):373-380. PMCID: PMC4790212 A, Rintoul RC, Batirel HF, Thomas CF, Friedberg J, Cedres S, De Perrot
M, Rusch VW. The IASLC Mesothelioma Staging Project: Proposals
Nocetti N, Whitehouse I. Nucleosome repositioning underlies dynamic for revisions of the T descriptors in the forthcoming eighth edition of
gene expression. Genes and Development. 2016;30(6):660-672. PMCID: the TNM classification for pleural mesothelioma. Journal of Thoracic
PMC4803052 Oncology. 2016;11(12):2089-2099.
Nolan C, De Angelis LM. The confused oncologic patient: A rational Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R,
clinical approach. Current Opinion in Neurology. 2016;29(6):789-796. Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R,
Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W,
Nölling J, Rapireddy S, Amburg J I, Crawford EM, Prakash RA, Rabson Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A
AR, Tang YW, Singer A. Duplex DNA-invading γ-modified peptide nucleic 10 year retrospective by the AIDS Malignancy Consortium. Leukemia and
acids enable rapid identification of bloodstream infections in whole Lymphoma. 2016;57(7):1731-1734. PMCID: PMC4899288
blood. mBio. 2016;7(2):e00345-16. PMCID: PMC4850259
Ntziachristos P, Abdel-Wahab O, Aifantis I. Emerging concepts of
Nonaillada J. The role of occupational and physical therapy in geriatric epigenetic dysregulation in hematological malignancies. Nature
oncology. The ASCO Post. 2016;7(9):102-103. Immunology. 2016;17(9):1016-1024. PMCID: PMC5134743
169 OF 324
Journal Articles
Nuciforo P, Thyparambil S, Aura C, Garrido-Castro A, Vilaro M, Peg Oehlke O, Mix M, Graf E, Schimek-Jasch T, Nestle U, Götz I, Schneider-
V, Jimenez J, Vicario R, Cecchi F, Hoos W, Burrows J, Hembrough T, Fuchs S, Weyerbrock A, Mader I, Baumert BG, Short SC, Meyer
Ferreres JC, Perez-Garcia J, Arribas J, Cortes J, Scaltriti M. High HER2 PT, Weber WA, Grosu AL. Amino-acid PET versus MRI guided re-
protein levels correlate with increased survival in breast cancer patients irradiation in patients with recurrent glioblastoma multiforme (GLIAA)
treated with anti-HER2 therapy. Molecular Oncology. 2016;10(1):138- - Protocol of a randomized phase II trial (NOA 10/ARO 2013-1). BMC
147. PMCID: PMC4968773 Cancer. 2016;16:769. PMCID: PMC5052714
O’Cearbhaill RE, Ragupathi G, Zhu J, Wan Q, Mironov S, Yang Oellrich A, Collier N, Groza T, Rebholz-Schuhmann D, Shah N,
G, Spassova MK, Iasonos A, Kravetz S, Ouerfelli O, Spriggs Bodenreider O, Boland MR, Georgiev I, Liu H, Livingston K, Luna A, Mallon
DR, Danishefsky SJ, Sabbatini PJ. A phase I study of unimolecular AM, Manda P, Robinson PN, Rustici G, Simon M, Wang L, Winnenburg
pentavalent (Globo-H-GM2-sTn-TF-Tn) immunization of patients R, Dumontier M. The digital revolution in phenotyping. Briefings in
with epithelial ovarian, fallopian tube, or peritoneal cancer in first Bioinformatics. 2016;17(5):819-830. PMCID: PMC5036847
remission. Cancers. 2016;8(4):46. PMCID: PMC4846855
Offit K. The future of clinical cancer genomics. Seminars in
Obar JJ, Hohl TM, Cramer RA. New advances in invasive aspergillosis Oncology. 2016;43(5):615-622. PMCID: PMC5225752
immunobiology leading the way towards personalized therapeutic
approaches. Cytokine. 2016;84:63-73. PMCID: PMC4904826 Ofran Y, Tallman MS, Rowe JM. How I treat acute myeloid leukemia
presenting with preexisting comorbidities. Blood. 2016;128(4):488-496.
Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V,
Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling Ogino K, Obase Y, Ito T, Fujimura M, Eguchi E, Kubo M, Nagaoka K,
A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli Nakamura H. Relationship between serum arginase I and L-arginine or
G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman exhaled nitric oxide in asthma. Free Radical Research. 2016;50(11):1165-1172.
A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM. A Delphic
consensus assessment: Imaging and biomarkers in gastroenteropancreatic Oh JH, Deasy JO. A literature mining-based approach for identification
neuroendocrine tumor disease management. Endocrine of cellular pathways associated with chemoresistance in cancer. Briefings
Connections. 2016;5(5):174-187. PMCID: PMC5045519 in Bioinformatics. 2016;17(3):468-478.
O’Donnell PH, Alanee S, Stratton KL, Garcia-Grossman IR, Cao Oh JH, Thor M, Olsson C, Skokic V, Jörnsten R, Alsadius D,
H, Ostrovnaya I, Plimack ER, Manschreck C, Ganshert C, Smith Pettersson N, Steineck G, Deasy JO. A factor analysis approach for
ND, Steinberg GD, Vijai J, Offit K, Stadler WM, Bajorin DF. Clinical clustering patient reported outcomes. Methods of Information in
evaluation of cisplatin sensitivity of germline polymorphisms in Medicine. 2016;55(5):431-439.
neoadjuvant chemotherapy for urothelial cancer. Clinical Genitourinary
Oikonomou EK, Repanas T I, Papanastasiou C, Kokkinidis DG, Miligkos
Cancer. 2016;14(6):511-517. PMCID: PMC5018246
M, Feher A, Gupta D, Kampaktsis PN. The effect of in-hospital acquired
Oeffinger KC, Fontham ETH, Wender RC. Clinical breast examination thrombocytopenia on the outcome of patients with acute coronary
and breast cancer screening guideline — In reply. JAMA - Journal of the syndromes: A systematic review and meta-analysis. Thrombosis
American Medical Association. 2016;315(13):1404. Research. 2016;147:64-71.
170 OF 324
Journal Articles
Okada T, Lee AY, Qin LX, Agaram N, Mimae T, Shen Y, O’Connor O’Reilly EM. Early detection and treatment opportunities in pancreatic
R, López-Lago MA, Craig A, Miller ML, Agius P, Molinelli E, Socci adenocarcinoma. Journal of Oncology Practice. 2016;12(1):31-32.
ND, Crago AM, Shima F, Sander C, Singer S. Integrin-α10 dependency
identifies RAC and RICTOR as therapeutic targets in high-grade O’Reilly RJ, Prockop S, Hasan AN, Koehne G, Doubrovina E. Virus-
myxofibrosarcoma. Cancer Discovery. 2016;6(10):1148-1165. PMCID: specific T-cell banks for ‘off the shelf’ adoptive therapy of refractory
PMC5050162 infections. Bone Marrow Transplantation. 2016;51(9):1163-1172.
Oktay Y, Ülgen E, Can Ö, Akyerli CB, Yüksel Ş, Erdemgil Y, Durasl IM, Orlow I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S,
Henegariu O I, Nanni EP, Selevsek N, Grossmann J, Erson-Omay EZ, Bai Armstrong BK, Kricker A, Marrett LD, Rosso S, Zanetti R, Gruber SB,
H, Gupta M, Lee W, Turcan Ş, Özplnar A, Huse JT, Sav MA, Flanagan Anton-Culver H, Gallagher RP, Dwyer T, Busam K, Begg CB, Berwick
A, Günel M, Sezerman OU, Yaklcler MC, Pamir MN, Özduman K. IDH- M, the GEM Study Group. Vitamin D receptor polymorphisms and
mutant glioma specific association of rs55705857 located at 8q24.21 survival in patients with cutaneous melanoma: A population-based
involves MYC deregulation. Scientific Reports. 2016;6:27569. PMCID: study. Carcinogenesis. 2016;37(1):30-38. PMCID: PMC4715233
PMC4901315
Orom H, Biddle C, Underwood W 3rd, Nelson CJ, Homish DL. What is
Olejniczak SH, La Rocca G, Radler MR, Egan SM, Xiang Q, Garippa a “good” treatment decision? Decisional control, knowledge, treatment
R, Thompson CB. Coordinated regulation of cap-dependent translation decision making, and quality of life in men with clinically localized prostate
and microrna function by convergent signaling pathways. Molecular and cancer. Medical Decision Making. 2016;36(6):714-725. PMCID: PMC4930707
Cellular Biology. 2016;36(18):2360-2373. PMCID: PMC5007797
O’Rourke KP, Dow LE, Lowe SW. Immunofluorescent staining of mouse
Olson SH, Xu Y, Herzog K, Saldia A, Defilippis EM, Li P, Allen PJ, O’Reilly intestinal stem cells. Bio-protocol. 2016;6(4):e1732. PMCID: PMC4996654
EM, Kurtz RC. Weight loss, diabetes, fatigue, and depression preceding
pancreatic cancer. Pancreas. 2016;45(7):986-991. PMCID: PMC4912937 O’Rourke KP, Ackermann S, Dow LE, Lowe SW. Isolation,
culture, and maintenance of mouse intestinal stem cells. Bio-
Onaitis M, Park B. Teaching robotic surgery: Making progress. Journal of protocol. 2016;6(4):e1733. PMCID: PMC4996657
Thoracic and Cardiovascular Surgery. 2016;152(4):950-951.
Ortiz M V, Meier ER, Hsieh MM. Identification and clinical characterization
O’Neill CB, Atoria CL, O’Reilly EM, Henman MC, Bach PB, Elkin of children with benign ethnic neutropenia. Journal of Pediatric
EB. Hospitalizations in older adults with advanced cancer: The role of Hematology/Oncology. 2016;38(3):E140-E143.
chemotherapy. Journal of Oncology Practice. 2016;12(2):151-152, e138-e148.
Ortiz M V, Dunkel IJ. Retinoblastoma. Journal of Child
Ong LT, Dunphy M, Foster A, Woo KM, Zhang Z, Perez CA, Pietanza Neurology. 2016;31(2):227-236.
CM, Rosenzweig KE, Gelblum DY, Rimner A, Wu AJ. Prognostic value
of preradiotherapy (18)F-FDG PET/CT volumetrics in limited-stage Ortiz M V, Kobos R, Walsh M, Slotkin EK, Roberts S, Berger MF, Hameed
small-cell lung cancer. Clinical Lung Cancer. 2016;17(3):184-188. PMCID: M, Solit D, Ladanyi M, Shukla N, Kentsis A. Integrating genomics
PMC4740253 onto clinical pediatric oncology using the molecular tumor board
at the Memorial Sloan Kettering Cancer Center. Pediatric Blood and
Cancer. 2016;63(8):1368-1374.
171 OF 324
Journal Articles
Osborne JR. Guest editorial. Seminars in Nuclear Medicine. 2016;46(1):3-4. Arver B, Ashworth A, Consortium of Modifiers of BRCA1 and BRCA2,
Baglietto L, Balleine R, Bandera E V, Barrowdale D, Bean YT, Beckmann
Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DS, Henschke C L, Beckmann MW, Benitez J, Berger A, Berger R, Beuselinck B, Bisogna
I. Readiness of lung cancer screening sites to deliver smoking cessation M, Bjorge L, Blomqvist C, Bogdanova N V, Bojesen A, Bojesen SE, Bolla
treatment: Current practices, organizational priority, and perceived MK, Bonanni B, Brand JS, Brauch H, Breast Cancer Family Register,
barriers. Nicotine & Tobacco Research. 2016;18(5):1067-1075. Brenner H, Brinton L, Brooks-Wilson A, Bruinsma F, Brunet J, Brüning T,
Budzilowska A, Bunker CH, Burwinkel B, Butzow R, Australian Ovarian
Ostroff JS, Goffin JR, Khuri FR, Warren GW. Perspective on the Cancer Study Group, Buys SS, Caligo MA, Campbell I, Carter J, Chang-
National Comprehensive Cancer Network’s Clinical Practice Guidelines Claude J, Chanock SJ, Claes KBM, Collée JM, Cook LS, Couch FJ, Cox A,
for Smoking Cessation. Journal of Oncology Practice. 2016;12(1):55- Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F,
58. PMCID: PMC4979976 Dansonka-Mieszkowska A, Darabi H, De La Hoya M, Defazio A, Dennis
J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM,
O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, Lee
Dörk T, Silva IDS, Du Bois A, Dumont M, Dunning AM, Duran M, Easton
N, Riaz N, Pei X, Koyfman SA, Adelstein D, Burkey BB, Friborg J,
DF, Eccles D, Edwards RP, Ehrencrona H, Ejlertsen B, Ekici AB, Ellis SD,
Kristensen CA, Gothelf AB, Hoebers F, Kremer B, Speel EJ, Bowles DW,
EMBRACE, Engel C, Eriksson M, Fasching PA, Feliubadalo L, Figueroa
Raben D, Karam SD, Yu E, Xu W. Development and validation of a staging
J, Flesch-Janys D, Fletcher O, Fontaine A, Fortuzzi S, Fostira F, Fridley
system for HPV-related oropharyngeal cancer by the International
BL, Friebel T, Friedman E, Friel G, Frost D, Garber J, García-Closas M,
Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): A
Gayther SA, GEMO Study Collaborators, GENICA Network, Gentry-
multicentre cohort study. Lancet Oncology. 2016;17(4):440-451.
Maharaj A, Gerdes AM, Giles GG, Glasspool R, Glendon G, Godwin AK,
O’Sullivan TE, Geary CD, Weizman OE, Geiger TL, Rapp M, Dorn GW Goodman MT, Gore M, Greene MH, Grip M, Gronwald J, Gschwantler
2nd, Overholtzer M, Sun JC. Atg5 is essential for the development and Kaulich D, Guénel P, Guzman SR, Haeberle L, Haiman CA, Hall P,
survival of innate lymphocytes. Cell Reports. 2016;15(9):1910-1919. PMCID: Halverson SL, Hamann U, Hansen TVO, Harter P, Hartikainen JM, Healey
PMC4889506 S, HEBON, Hein A, Heitz F, Henderson BE, Herzog J, T Hildebrandt
MA, Høgdall CK, Høgdall E, Hogervorst FBL, Hopper JL, Humphreys
O’Sullivan TE, Rapp M, Fan X, Weizman OE, Bhardwaj P, Adams K, Huzarski T, Imyanitov EN, Isaacs C, Jakubowska A, Janavicius R,
NM, Walzer T, Dannenberg AJ, Sun JC. Adipose-resident group Jaworska K, Jensen A, Jensen UB, Johnson N, Jukkola-Vuorinen
1 innate lymphoid cells promote obesity-associated insulin A, Kabisch M, Karlan BY, Kataja V, Kauff N, KConFab Investigators,
resistance. Immunity. 2016;45(2):428-441. PMCID: PMC5004886 Kelemen LE, Kerin MJ, Kiemeney LA, Kjaer SK, Knight JA, Knol-Bout JP,
Konstantopoulou I, Kosma VM, Krakstad C, Kristensen V, Kuchenbaecker
Otsu K, Ono M, Fuchs TJ, Baldwin I, Kubota T. Autonomous terrain KB, Kupryjanczyk J, Laitman Y, Lambrechts D, Lambrechts S, Larson
classification with co-and self-training approach. IEEE Robotics and MC, Lasa A, Laurent-Puig P, Lazaro C, Le ND, Le Marchand L, Leminen
Automation Letters. 2016;1(2):814-819. A, Lester J, Levine DA, Li J, Liang D, Lindblom A, Lindor N, Lissowska
J, Long J, Lu KH, Lubinski J, Lundvall L, Lurie G, Mai PL, Mannermaa A,
Ovarian Cancer Association Consortium, Breast Cancer Association Margolin S, Mariette F, Marme F, Martens JWM, Massuger LFAG, Maugard
Consortium, Hollestelle A, Van Der Baan FH, Berchuck A, Johnatty SE, C, Mazoyer S, McGuffog L, McGuire V, McLean C, McNeish I, Meindl A,
Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver Menegaux F, Menéndez P, Menkiszak J, Menon U, Mensenkamp AR, Miller
H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, Arnold N, Arun BK, N, Milne RL, Modugno F, Montagna M, Moysich KB, Müller H, Mulligan
172 OF 324
Journal Articles
AM, Muranen TA, Narod SA, Nathanson KL, Ness RB, Neuhausen SL, head and neck spindle cell and sclerosing rhabdomyosarcoma. Oral
Nevanlinna H, Neven P, Nielsen FC, Nielsen SF, Nordestgaard BøG, Oncology. 2016;58:e6-e11.
Nussbaum RL, Odunsi K, Offit K, Olah E, Olopade O I, Olson JE, Olson
SH, Oosterwijk JC, Orlow I, Orr N, Orsulic S, Osorio A, Ottini L, Paul Owosho AA, Pedreira Ramalho LM, Rosenberg H I, Yom SK, Drill
J, Pearce CL, Pedersen IS, Peissel B, Pejovic T, Pelttari LM, Perkins J, E, Riedel E, Tsai CJ, Lee NY, Huryn JM, Estilo CL. Objective assessment
Permuth-Wey J, Peterlongo P, Peto J, Phelan CM, Phillips KA, Piedmonte of trismus in oral and oropharyngeal cancer patients treated with
M, Pike MC, Platte R, Plisiecka-Halasa J, Poole EM, Poppe B, Pylkäs intensity-modulated radiation therapy (IMRT). Journal of Cranio-
K, Radice P, Ramus SJ, Rebbeck TR, Reed MWR, Rennert G, Risch Maxillofacial Surgery. 2016;44(9):1408-1413. PMCID: PMC5279066
HA, Robson M, Rodriguez GC, Romero A, Rossing MA, Rothstein JH,
Rudolph A, Runnebaum I, Salani R, Salvesen HB, Sawyer EJ, Schildkraut Owosho AA, Blanchard A, Levi L, Kadempour A, Rosenberg H, Yom
JM, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, SK, Farooki A, Fornier M, Huryn JM, Estilo CL. Osteonecrosis of the
Schrauder MG, Schumacher F, Schwaab I, Scuvera G, Sellers TA, Severi jaw in patients treated with denosumab for metastatic tumors to the
G, Seynaeve CM, Shah M, Shrubsole M, Siddiqui N, Sieh W, Simard J, bone: A series of thirteen patients. Journal of Cranio-Maxillofacial
Singer CF, Sinilnikova OM, Smeets D, Sohn C, Soller M, Song H, Soucy Surgery. 2016;44(3):265-270. PMCID: PMC4784099
P, Southey MC, Stegmaier C, Stoppa-Lyonnet D, Sucheston L, Swerdlow
Owosho AA, Brady P, Wolden SL, Wexler LH, Antonescu CR, Huryn
A, Tangen IL, Tea MK, Teixeira MR, Terry KL, Terry MB, Thomassen M,
JM, Estilo CL. Long-term effect of chemotherapy–intensity-modulated
Thompson PJ, Tihomirova L, Tischkowitz M, Toland AE, Tollenaar RAEM,
radiation therapy (chemo-IMRT) on dentofacial development in head
Tomlinson I, Torres D, Truong T, Tsimiklis H, Tung N, Tworoger SS, Tyrer
and neck rhabdomyosarcoma patients. Pediatric Hematology and
JP, Vachon CM, Van ‘t Veer LJ, Van Altena AM, Van Asperen CJ, Van Den
Berg D, Van Den Ouweland AMW, Van Doorn HC, Van Nieuwenhuysen
E, Van Rensburg EJ, Vergote I, Verhoef S, Vierkant RA, Vijai J, Owosho AA, Estilo CL, Huryn JM, Yom SK. Pentoxifylline and tocopherol
Vitonis AF, Von Wachenfeldt A, Walsh C, Wang Q, Wang-Gohrke S, in the management of cancer patients with medication-related
Wappenschmidt B, Weischer M, Weitzel JN, Weltens C, Wentzensen osteonecrosis of the jaw: An observational retrospective study of
N, Whittemore AS, Wilkens LR, Winqvist R, Wu AH, Wu X, Yang HP, initial case series. Oral Surgery, Oral Medicine, Oral Pathology and Oral
Zaffaroni D, Pilar Zamora M, Zheng W, Ziogas A, Chenevix-Trench G, Radiology. 2016;122(4):455-459.
Pharoah PDP, Rookus MA, Hooning MJ, Goode EL. No clinical utility
of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Owosho AA, Huang SC, Chen S, Kashikar S, Estilo CL, Wolden
Oncology. 2016;141(2):386-401. PMCID: PMC4630206 SL, Wexler LH, Huryn JM, Antonescu CR. A clinicopathologic study of
head and neck rhabdomyosarcomas showing FOXO1 fusion-positive
Owonikoko TK, Hussain A, Stadler WM, Smith DC, Kluger H, Molina alveolar and MYOD1-mutant sclerosing are associated with unfavorable
AM, Gulati P, Shah A, Ahlers CM, Cardarelli PM, Cohen LJ. First-in- outcome. Oral Oncology. 2016;61:89-97. PMCID: PMC5097864
human multicenter phase i study of BMS-936561 (MDX-1203), an
antibody-drug conjugate targeting CD70. Cancer Chemotherapy and Owosho AA, Ko E, Rosenberg H I, Yom SK, Antonescu CR, Huryn
Pharmacology. 2016;77(1):155-162. JM, Estilo CL. Primary Ewing family of tumors of the jaw has a better
prognosis compared to tumors of extragnathic sites. Journal of Oral and
Owosho AA, Chen SJ, Kashikar S, Zhang L, Chen CL, Wexler LH, Estilo Maxillofacial Surgery. 2016;74(5):973-981. PMCID: PMC4850111
CL, Huryn JM, Antonescu CR. Clinical and molecular heterogeneity of
173 OF 324
Journal Articles
Owosho AA, Randazzo J, Rosen EB, Estilo CL, Huryn JM, Chi TILs in breast cancer after immunotherapy. Cancer Immunology
P, Yom SK. Squamous cell carcinoma associated with chronic graft Research. 2016;4(10):835-844. PMCID: PMC5064839
versus host disease-like/lichen planus-like lesion of the oral cavity
in a patient managed for metastatic melanoma with a PD-1 inhibitor Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron
pembrolizumab. Oral Oncology. 2016;63:e1-e3. M, Constine LS, Cooper A, Glare P, Keefe F, Koyyalagunta L, Levy
M, Miaskowski C, Otis-Green S, Sloan P, Bruera E. Management of
Owosho AA, Xu B, Kadempour A, Yom SK, Randazzo J, Ghossein chronic pain in survivors of adult cancers: American Society of
RA, Huryn JM, Estilo CL. Metastatic solid tumors to the jaw and oral Clinical Oncology clinical practice guideline. Journal of Clinical
soft tissue: A retrospective clinical analysis of 44 patients from a single Oncology. 2016;34(27):3325-3345.
institution. Journal of Cranio-Maxillofacial Surgery. 2016;44(8):1047-
1053. PMCID: PMC5279458 Paik PK, Rudin CM. Missing the mark in FGFR1-amplified squamous cell
cancer of the lung. Cancer. 2016;122(19):2938-2940.
Owosho AA, Yom SK, Han Z, Sine K, Lee NY, Huryn JM, Estilo
CL. Comparison of mean radiation dose and dosimetric distribution to Paik PK, Shen R, Won H, Rekhtman N, Wang L, Sima CS, Arora A, Seshan
tooth-bearing regions of the mandible associated with proton beam V, Ladanyi M, Berger MF, Kris MG. Next-generation sequencing of
radiation therapy and intensity-modulated radiation therapy for ipsilateral stage IV squamous cell lung cancers reveals an association of PI3K
head and neck tumor. Oral Surgery, Oral Medicine, Oral Pathology and aberrations and evidence of clonal heterogeneity in patients with brain
Oral Radiology. 2016;122(5):566-571. PMCID: PMC5279063 metastases. Cancer Discovery. 2016;5(6):610-621. PMCID: PMC4643059
Oxnard GR, Wilcox KH, Gonen M, Polotsky M, Hirsch BR, Schwartz Paik PK. Something old, something new, something borrowed, something
LH. Response rate as a regulatory end point in single-arm studies of fused: Novel EGFR rearrangements in lung adenocarcinomas. Cancer
advanced solid tumors. JAMA Oncology. 2016;2(6):772-779. Discovery. 2016;6(6):574-575. PMCID: PMC4894533
Ozkaya N, Grogg KL, Dogan A. Seroma-associated anaplastic large- Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P,
cell lymphoma arising on the background of subcutaneous calcinosis: DeAngelo DJ, Gotlib J, Tanner Hagelstrom R, Hobbs G, Jagasia M,
Beyond breast implants. Histopathology. 2016;69(5):890-892. Kantarjian HM, Kropf P, Metheny L, Moore JO, Ontiveros E, Purev E,
Quiery A, Reddy VVB, Rose MG, Shah NP, Douglas Smith B, Snyder DS,
Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sweet KL, Tibes R, Yang DT, Gregory K, Sundar H, Deininger M, Radich
Sanford EM, Ali SM, Miller VA, Mossé YP, Granger MP, Weiss B, Maris JP. NCCN Guidelines® Insights: Chronic myeloid leukemia, version 1.2017:
JM, Modak S. Enrichment of targetable mutations in the relapsed Featured updates to the NCCN Guidelines. Journal of the National
neuroblastoma genome. PLoS Genetics. 2016;12(12):e1006501. PMCID: Comprehensive Cancer Network. 2016;14(12):1505-1512.
PMC5172533
Palma G, Monti S, D’Avino V, Conson M, Liuzzi R, Pressello MC, Donato
Page DB, Yuan J, Redmond D, Wen YH, Durack JC, Emerson R, Solomon V, Deasy JO, Quarantelli M, Pacelli R, Cella L. A voxel-based approach
S, Dong Z, Wong P, Comstock C, Diab A, Sung J, Maybody M, Morris to explore local dose differences associated with radiation-induced
E, Brogi E, Morrow M, Sacchini V, Elemento O, Robins H, Patil S, lung damage. International Journal of Radiation Oncology, Biology,
Allison JP, Wolchok JD, Hudis C, Norton L, McArthur HL. Deep Physics. 2016;96(1):127-133.
sequencing of T-cell receptor DNA as a biomarker of clonally expanded
174 OF 324
Journal Articles
Palmer J, McCune JS, Perales MA, Marks D, Bubalo J, Mohty M, Wingard in patients with metastatic prostate cancer: Pharmacokinetics,
JR, Paci A, Hassan M, Bredeson C, Pidala J, Shah N, Shaughnessy P, biodistribution, dosimetry, and lesion uptake. Journal of Nuclear
Majhail N, Schriber J, Savani BN, Carpenter PA. Personalizing busulfan- Medicine. 2016;57(12):1858-1864.
based conditioning: Considerations from the American Society for Blood
and Marrow Transplantation Practice Guidelines Committee. Biology of Pandit-Taskar N, Veach DR, Fox JJ, Scher H I, Morris MJ, Larson
Blood and Marrow Transplantation. 2016;22(11):1915-1925. SM. Evaluation of castration-resistant prostate cancer with androgen
receptor-axis imaging. Journal of Nuclear Medicine. 2016;57(Suppl.
Palomba ML. Learning from Waldenstrom Macroglobulinemia. Best 3):73S-78S.
Practice and Research: Clinical Haematology. 2016;29(2):135.
Panicek DM, Hricak H. How sure are you, doctor? A standardized lexicon
Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic- to describe the radiologists level of certainty. American Journal of
resistant pathogens. Science. 2016;352(6285):535-538. PMCID: Roentgenology. 2016;207(1):2-3.
PMC4984266
Papaemmanuil E, Döhner H, Campbell PJ. Genomic classification in
Pan E, Supko JG, Kaley TJ, Butowski NA, Cloughesy T, Jung J, Desideri acute myeloid leukemia - The authors reply. New England Journal of
S, Grossman S, Ye X, Park DM. Phase I study of RO4929097 with Medicine. 2016;375(9):900-901.
bevacizumab in patients with recurrent malignant glioma. Journal of
Neuro-Oncology. 2016;130(3):571-579. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik V I, Paschka P,
Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P,
Pan JJ, Ng WT, Zong JF, Chan LLK, O’Sullivan B, Lin SJ, Sze HCK, Chen Martincorena I, Ganly P, Mudie L, McLaren S, O’Meara S, Raine K, Jones
YB, Choi HCW, Guo QJ, Kan WK, Xiao YP, Wei X, Le QT, Glastonbury DR, Teague JW, Butler AP, Greaves MF, Ganser A, Döhner K, Schlenk RF,
CM, Colevas AD, Weber RS, Shah JP, Lee AWM. Proposal for the 8th Döhner H, Campbell PJ. Genomic classification and prognosis in acute
edition of the AJCC/UICC staging system for nasopharyngeal cancer in myeloid leukemia. New England Journal of Medicine. 2016;374(23):2209-
the era of intensity-modulated radiotherapy. Cancer. 2016;122(4):546- 2221. PMCID: PMC4979995
558. PMCID: PMC4968037
Papamichael D, Renfro LA, Matthaiou C, Yothers G, Saltz L, Guthrie KA,
Pan JJ, Ng WT, Zong JF, Lee SWM, Choi HCW, Chan LLK, Lin SJ, Van Cutsem E, Schmoll HJ, Labianca R, André T, O’Connell M, Alberts
Guo QJ, Sze HCK, Chen YB, Xiao YP, Kan WK, O’Sullivan B, Xu W, SR, Haller DG, Kountourakis P, Sargent DJ, the Adjuvant Colon Cancer
Le QT, Glastonbury CM, Colevas AD, Weber RS, Lydiatt W, Shah JP, Endpoints (ACCENT) Group. Validity of Adjuvant! Online in older patients
Lee AWM. Prognostic nomogram for refining the prognostication with stage III colon cancer based on 2967 patients from the ACCENT
of the proposed 8th edition of the AJCC/UICC staging system database. Journal of Geriatric Oncology. 2016;7(6):422-429. PMCID:
for nasopharyngeal cancer in the era of intensity-modulated PMC5159186
radiotherapy. Cancer. 2016;122(21):3307-3315.
Parashar K, Pandit-Taskar N. Foot and ankle hepatocellular carcinoma
Pandit-Taskar N, O’Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo metastasis. Clinical Nuclear Medicine. 2016;41(1):69-71.
JA, Heller G, Martinez DF, Cheal SM, Lewis JS, Fleisher M, Keppler
JS, Reiter RE, Wu AM, Weber WA, Scher H I, Larson SM, Morris Pareja F, Corben AD, Brennan SB, Murray MP, Bowser ZL,
MJ. First-in-human imaging with 89Zr-Df-IAB2M Anti-PSMA minibody Jakate K, Sebastiano C, Morrow M, Morris EA, Brogi E. Breast
175 OF 324
Journal Articles
intraductal papillomas without atypia in radiologic-pathologic Park CY. Context matters in MLL-AF9-driven
concordant core-needle biopsies: Rate of upgrade to carcinoma at leukemias. Blood. 2016;127(19):2268-2269. PMCID: PMC4865586
excision. Cancer. 2016;122(18):2819-2827. PMCID: PMC5014573
Park D, Ozkaya N, Hariharan A. Novel insights into the early
Paresi CJ, Liu Q, Li YM. Benzimidazole covalent probes and the gastric histopathogenesis of immunodeficiency-associated Burkitt
H+/K+-ATPase as a model system for protein labeling in a copper- lymphoma: A case report of Burkitt microlymphoma arising within HIV
free setting. Molecular BioSystems. 2016;12(6):1772-1780. PMCID: lymphadenitis. Histopathology. 2016;69(3):516-521.
PMC4879604
Park ER, Ostroff JS, Perez GK, Hyland KA, Rigotti NA, Borderud S,
Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Association of Regan S, Muzikansky A, Friedman ER, Levy DE, Holland S, Eusebio
intensity-modulated radiation therapy on overall survival for patients with J, Peterson L, Rabin J, Miller-Sobel J, Gonzalez I, Malloy L, O’Brien M, de
Hodgkin lymphoma. Radiotherapy and Oncology. 2016;118(1):52-59. León-Sanchez S, Whitlock CW. Integrating tobacco treatment into
cancer care: Study protocol for a randomized controlled comparative
Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Early- effectiveness trial. Contemporary Clinical Trials. 2016;50:54-65. PMCID:
stage nodular lymphocyte-predominant Hodgkin lymphoma: PMC5035625
The impact of radiotherapy on overall survival. Leukemia and
Lymphoma. 2016;57(2):320-327. Park JH, Geyer MB, Brentjens RJ. CD19-targeted CAR T-cell therapeutics
for hematologic malignancies: Interpreting clinical outcomes to
Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Impact of delays date. Blood. 2016;127(26):3312-3320. PMCID: PMC4929923
in definitive treatment on overall survival: A National Cancer
Database study of patients with Hodgkin lymphoma. Leukemia and Park S, Kim SJ, Yu D, Peña-Llopis S, Gao J, Park JS, Chen B, Norris
Lymphoma. 2016;57(5):1074-1082. J, Wang X, Chen M, Kim M, Yong J, Wardak Z, Choe K, Story M, Starr
T, Cheong JH, Hwang TH. An integrative somatic mutation analysis
Park BJ, Snider JM, Bates NR, Cassivi SD, Jett GK, Sonett JR, to identify pathways linked with survival outcomes across 19 cancer
Toloza EM. Prospective evaluation of biodegradable polymeric types. Bioinformatics. 2016;32(11):1643-1651. PMCID: PMC4892411
sealant for intraoperative air leaks. Journal of Cardiothoracic
Surgery. 2016;11(1):168. PMCID: PMC5154021 Parker PA, Banerjee SC, Matasar MJ, Bylund CL, Franco K, Li Y, Levin TT,
Jacobsen PB, Astrow AB, Leventhal H, Horwitz S, Kissane DW. Protocol
Park BJ, Yang HX, Woo KM, Sima CS. Minimally invasive (robotic assisted for a cluster randomised trial of a communication skills intervention
thoracic surgery and video-assisted thoracic surgery) lobectomy for for physicians to facilitate survivorship transition in patients with
the treatment of locally advanced non-small cell lung cancer. Journal of lymphoma. BMJ Open. 2016;6(6):e011581. PMCID: PMC4932279
Thoracic Disease. 2016;8(Suppl. 4):S406-S413. PMCID: PMC4856844
Parrado C, Mascaraque M, Gilaberte Y, Juarranz A, Gonzalez
Park BY, Grisham RN, den Hollander B, Thapi D, Berman T, de Stanchina S. Fernblock (Polypodium leucotomos extract): Molecular mechanisms
E, Zhou Q, Iyer G, Aghajanian C, Spriggs DR. Tumor inhibition and pleiotropic effects in light-related skin conditions, photoaging
by enzalutamide in a xenograft model of ovarian cancer. Cancer and skin cancers, a review. International Journal of Molecular
Investigation. 2016;34(10):517-520. Sciences. 2016;17(7):1026. PMCID: PMC4964402
176 OF 324
Journal Articles
Parton DL, Grinaway PB, Hanson SM, Beauchamp KA, Chodera Pastores SM, Oropello JM, Halpern NA, Kvetan V. Daytime intensivist
JD. Ensembler: Enabling high-throughput molecular physician staffing and mortality. Critical Care Medicine. 2016;44(5):e316-e317.
simulations at the superfamily scale. PLoS Computational
Biology. 2016;12(6):e1004728. PMCID: PMC4918922 Pastores SM. Burnout syndrome in ICU caregivers: Time to
extinguish!. Chest. 2016;150(1):1-2.
Pasqualetti F, Panichi M, Sainato A, Matteucci F, Galli L, Cocuzza P,
Ferrazza P, Coraggio G, Pasqualetti G, Derosa L, Sollini M, Mannelli Paszkiewicz PJ, Fräßle SP, Srivastava S, Sommermeyer D, Hudecek M,
L, Ortori S, Monzani F, Ricci S, Greco C, Fabrini MG, Erba PA. [F- Drexler I, Sadelain M, Liu L, Jensen MC, Riddell SR, Busch DH. Targeted
18]Choline PET/CT and stereotactic body radiotherapy on antibody-mediated depletion of murine CD19 CAR T cells permanently
treatment decision making of oligometastatic prostate cancer reverses B cell aplasia. Journal of Clinical Investigation. 2016;126(11):4262-
patients: Preliminary results. Radiation Oncology. 2016;11:9. PMCID: 4272. PMCID: PMC5096899
PMC4722628
Patel AB, Solomon AR, Mauro MJ, Ehst BD. Unique cutaneous reaction
Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, to second- and third-generation tyrosine kinase inhibitors for chronic
Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, myeloid leukemia. Dermatology. 2016;232(1):122-125.
Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble
RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks Patel DJ. A structural perspective on readout of epigenetic histone
D I, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher and DNA methylation marks. Cold Spring Harbor Perspectives in
MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten Biology. 2016;8(3):a018754. PMCID: PMC4772102
HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS,
Patel DN, Wakeam E, Genoff M, Mujawar I, Ashley SW, Diamond
Batiwalla M, Weisdorf DJ. Hematopoietic cell transplantation outcomes
LC. Preoperative consent for patients with limited English
in monosomal karyotype myeloid malignancies. Biology of Blood and
proficiency. Journal of Surgical Research. 2016;200(2):514-522. PMCID:
Marrow Transplantation. 2016;22(2):248-257. PMCID: PMC4716890
PMC4691361
Pass H, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, Asamura H,
Patel MR, Kozuch SD, Cultrara CN, Yadav R, Huang S, Samuni U, Koren
Waller D, Edwards J, Weder W, Hoffmann H, Van Meerbeeck JP, Nowak
J 3rd, Chiosis G, Sabatino D. RNAi screening of the glucose-regulated
A, Rusch VW. The IASLC Mesothelioma Staging Project: Improving
chaperones in cancer with self-assembled siRNA nanostructures. Nano
staging of a rare disease through international participation. Journal of
Letters. 2016;16(10):6099-6108.
Thoracic Oncology. 2016;11(12):2082-2088.
Patel S V, Roxburgh CS, Vakiani E, Shia J, Smith JJ, Temple LK, Paty
Pastore F, Levine RL. Epigenetic regulators and their impact on therapy
P, Garcia-Aguilar J, Nash G, Guillem J, Wu A, Reyngold M, Weiser
in acute myeloid leukemia. Haematologica. 2016;101(3):269-278. PMCID:
MR. Distance to the anal verge is associated with pathologic
PMC4815718
complete response to neoadjuvant therapy in locally advanced rectal
Pastores SM, Esquinas AM. Long-term survival and quality of life in critically cancer. Journal of Surgical Oncology. 2016;114(5):637-641.
ill cancer patients: What to expect?. Critical Care Medicine. 2016;44(11):e1150.
177 OF 324
Journal Articles
Patel SJ, Darie CC, Clarkson BD. Exosome mediated growth effect on Pednekar L, Valentino A, Ji Y, Tumma N, Valentino C, Kadoor A, Hosszu
the non-growing pre-B acute lymphoblastic leukemia cells at low starting KK, Ramadass M, Kew RR, Kishore U, Peerschke EIB, Ghebrehiwet
cell density. American Journal of Translational Research. 2016;8(9):3614- B. Identification of the gC1qR sites for the HIV-1 viral envelope protein
3629. PMCID: PMC5040663 gp41 and the HCV core protein: Implications in viral-specific pathogenesis
and therapy. Molecular Immunology. 2016;74:18-26. PMCID: PMC4987126
Patel SJ, Su D, Darie CC, Clarkson BD. Defective quorum sensing of acute
lymphoblastic leukemic cells: Evidence of collective behavior of leukemic Pedoto A, Desiderio DP, Amar D, Downey RJ. Hemodynamic
populations as semi-autonomous aberrant ecosystems. American Journal instability following airway spray cryotherapy. Anesthesia and
of Cancer Research. 2016;6(6):1177-1230. PMCID: PMC4937729 Analgesia. 2016;123(5):1302-1306. PMCID: PMC5117828
Patsalides A, Leng LZ, Kimball D, Marcus J, Knopman J, Laufer I, Bilsky Peerschke EIB, Panicker S, Bussel J. Classical complement pathway
M, Gobin YP. Preoperative catheter spinal angiography and embolization activation in immune thrombocytopenia purpura: Inhibition by a
of cervical spinal tumors: Outcomes from a single center. Interventional novel C1s inhibitor. British Journal of Haematology. 2016;173(6):942-
Neuroradiology. 2016;22(4):457-465. PMCID: PMC4984386 945. PMCID: PMC4973859
Patsalides A, Yamada Y, Bilsky M, Lis E, Laufer I, Gobin YP. Spinal Pehrson C, Banerjee SC, Manna R, Shen MJ, Hammonds S, Coyle
intraarterial chemotherapy: Interim results of a Phase I clinical N, Krueger CA, Maloney E, Zaider T, Bylund CL. Responding
trial. Journal of Neurosurgery. 2016;24(2):217-222. empathically to patients: Development, implementation, and evaluation
of a communication skills training module for oncology nurses. Patient
Patwardhan PP, Ivy KS, Musi E, de Stanchina E, Schwartz GK. Significant Education and Counseling. 2016;99(4):610-616. PMCID: PMC4962546
blockade of multiple receptor tyrosine kinases by MGCD516
(Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute
activity in preclinical models of sarcoma. Oncotarget. 2016;7(4):4093- gastrointestinal GVHD. Blood. 2016;128(20):2395-2402. PMCID: PMC5114486
4109. PMCID: PMC4826192
Peled JU, Jenq RR, Holler E, van den Brink MRM. Role of gut flora after
Pavlova NN, Thompson CB. The emerging hallmarks of cancer bone marrow transplantation. Nature Microbiology. 2016;1:16036. PMCID:
metabolism. Cell Metabolism. 2016;23(1):27-47. PMCID: PMC4715268 PMC5027134
Pearson AD, Federico SM, Aerts I, Hargrave DR, DuBois SG, Iannone R, Pelossof R, Chow O, Garcia-Aguilar J. Reply to Cristobal and co-
Geschwindt RD, Wang R, Haluska FG, Trippett TM, Geoerger B. A phase authors’ comment, deregulation of miR-92a in locally advanced rectal
1 study of oral ridaforolimus in pediatric patients with advanced solid cancer. Genes Chromosomes and Cancer. 2016;55(7):613.
tumors. Oncotarget. 2016;7(51):84736-84747.
Pelossof R, Chow OS, Fairchild L, Smith JJ, Setty M, Chen CT, Chen
Pednekar L, Pathan AA, Paudyal B, Tsolaki AG, Kaur A, Abozaid SM, Z, Egawa F, Avila K, Leslie CS, Garcia-Aguilar J. Integrated genomic
Kouser L, Khan HA, Peerschke E I, Shamji MH, Stenbeck G, Ghebrehiwet profiling identifies microRNA-92a regulation of IQGAP2 in locally
B, Kishore U. Analysis of the interaction between globular head advanced rectal cancer. Genes Chromosomes and Cancer. 2016;55(4):311-
modules of human C1q and its candidate receptor gC1qR. Frontiers in 321. PMCID: PMC4755360
Immunology. 2016;7:567. PMCID: PMC5153404
178 OF 324
Journal Articles
Pelto DJ, Sadler GR, Njoku O, Rodriguez MC, Villagra C, Malcarne VL, Perales MA. Timing is everything: Combining post-transplantation
Riley NE, Behar A I, Jandorf L. Adaptation of a cancer clinical trials adoptive cell therapy and tumor vaccines. Biology of Blood and Marrow
education program for African American and Latina/o community Transplantation. 2016;22(12):2113-2114.
members. Health Education and Behavior. 2016;43(4):381-388. PMCID:
PMC5154612 Perdiguero EG, Geissmann F. The development and maintenance of
resident macrophages. Nature Immunology. 2016;17(1):2-8. PMCID:
Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic PMC4950995
glycolysis promotes T helper 1 cell differentiation through an epigenetic
mechanism. Science. 2016;354(6311):481-484. Perez DL, Vago DR, Pan H, Root J, Tuescher O, Fuchs BH, Leung L,
Epstein J, Cain NM, Clarkin JF, Lenzenweger MF, Kernberg OF, Levy KN,
Pennicooke B, Laufer I, Sahgal A, Varga PP, Gokaslan Silbersweig DA, Stern E. Frontolimbic neural circuit changes in emotional
ZL, Bilsky MH, Yamada YJ. Safety and local control of radiation processing and inhibitory control associated with clinical improvement
therapy for chordoma of the spine and sacrum: A systematic following transference-focused psychotherapy in borderline personality
review. Spine. 2016;41(Suppl. 20):S186-S192. disorder. Psychiatry and Clinical Neurosciences. 2016;70(1):51-61. PMCID:
PMC4718821
Pentsova E I, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro
A, Lin X, Fleisher M, Grommes C, Panageas KS, Meng F, Selcuklu Perez GIP, Gao Z, Jourdain R, Ramirez J, Gany F, Clavaud C, Demaude
SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M, DeAngelis J, Breton L, Blaser MJ. Body site is a more determinant factor than
LM, Viale A, Mellinghoff IK, Berger MF. Evaluating cancer of the central human population diversity in the healthy skin microbiome. PLoS
nervous system through next-generation sequencing of cerebrospinal ONE. 2016;11(4):e0151990. PMCID: PMC4835103
fluid. Journal of Clinical Oncology. 2016;34(20):2404-2415. PMCID:
PMC4981784 Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen
L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S,
Perales MA, Drake EK, Pemmaraju N, Wood WA. Social media and Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM,
the adolescent and young adult (AYA) patient with cancer. Current Stroes ESG, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster
Hematologic Malignancy Reports. 2016;11(6):449-455. PMCID: V, Kjær A, Fisher EA, Fayad ZA, Mulder WJM. In vivo PET imaging
PMC4990505 of HDL in multiple atherosclerosis models. JACC: Cardiovascular
Imaging. 2016;9(8):950-961.
Perales MA, Sauter CS, Armand P. Fast cars and no brakes:
Autologous stem cell transplantation as a platform for Pérez-Medina C, Abdel-Atti D, Tang J, Zhao Y, Fayad ZA, Lewis JS,
novel immunotherapies. Biology of Blood and Marrow Mulder WJM, Reiner T. Nanoreporter PET predicts the efficacy of anti-
Transplantation. 2016;22(1):17-22. PMCID: PMC4706480 cancer nanotherapy. Nature Communications. 2016;7:11838. PMCID:
PMC4915130
Perales MA, Sauter CS, Armand P. Reprint of: Fast cars and
no brakes: Autologous stem cell transplantation as a platform Pergolotti M, Williams GR, Campbell C, Munoz LA, Muss
for novel immunotherapies. Biology of Blood and Marrow HB. Occupational therapy for adults with cancer: Why it matters. The
Transplantation. 2016;22(3 Suppl.):S9-S14. Oncologist. 2016;21(3):314-319. PMCID: PMC4786355
179 OF 324
Journal Articles
Perl G, Nordheimer S, Lando S, Benedict C, Brenner B, Perry S, Using a Delphi survey of stakeholders. JAMA Surgery. 2016;151(10):930-
Shmoisman G, Purim O, Amit L, Stemmer SM, Ben-Aharon I. Young 936. PMCID: PMC5216456
patients and gastrointestinal (GI) tract malignancies - Are we addressing
the unmet needs?. BMC Cancer. 2016;16(1):630. PMCID: PMC4983017 Phillips KA, Regan MM, Ribi K, Francis PA, Puglisi F, Bellet M, Spazzapan
S, Karlsson P, Budman DR, Zaman K, Abdi EA, Domchek SM, Feng Y, Price
Permuth JB, Reid B, Earp M, Chen YA, Monteiro ANA, Chen Z, Chenevix- KN, Coates AS, Gelber RD, Maruff P, Boyle F, Forbes JF, Ahles T, Fleming
Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele GF, Bernhard J, for the Co-SOFT investigators. Adjuvant ovarian function
A, Van Niewenhuyse E, Vergote I, Rossing MA, Doherty JA, Chang- suppression and cognitive function in women with breast cancer. British
Claude J, Moysich K, Odunsi K, Goodman MT, Shvetsov YB, Wilkens LR, Journal of Cancer. 2016;114(9):956-964. PMCID: PMC4984913
Thompson PJ, Dörk T, Bogdanova N, Butzow R, Nevanlinna H, Pelttari
L, Leminen A, Modugno F, Edwards RP, Ness RB, Kelley J, Heitz F, Philp LK, Day TK, Butler MS, Laven-Law G, Jindal S, Hickey TE, Scher H
Karlan B, Lester J, Kjaer SK, Jensen A, Giles G, Hildebrandt M, Liang I, Butler LM, Tilley WD. Small glutamine-rich tetratricopeptide repeat-
D, Lu KH, Wu X, Levine DA, Bisogna M, Berchuck A, Cramer DW, Terry containing protein alpha (SGTA) ablation limits offspring viability and
KL, Tworoger SS, Poole EM, Bandera E V, Fridley B, Cunningham J, growth in mice. Scientific Reports. 2016;6:28950. PMCID: PMC4928056
Winham SJ, Olson SH, Orlow I, Bjorge L, Kiemeney LA, Massuger L,
Pejovic T, Moffitt M, Le N, Cook LS, Brooks-Wilson A, Kelemen LE, Phukan R, Herzog T, Boland PJ, Healey J, Rose P, Sim FH, Yazsemski M,
Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Yang Hess K, Osler P, DeLaney TF, Chen YL, Hornicek F, Schwab J. How does
H, Hogdall E, Hogdall C, Lundvall L, Pharoah PD, Song H, Campbell I, the level of sacral resection for primary malignant bone tumors affect
Eccles D, McNeish I, Whittemore A, McGuire V, Sieh W, Rothstein J, physical and mental health, pain, mobility, incontinence, and sexual
Phelan CM, Risch H, Narod S, McLaughlin J, Anton-Culver H, Ziogas A, function?. Clinical Orthopaedics and Related Research. 2016;474(3):687-
Menon U, Gayther S, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, 696. PMCID: PMC4746195
Kupryjanczyk J, Dansonka-Mieszkowska A, Schildkraut JM, Cheng JQ,
Piccart-Gebhart M, Holmes E, Baselga J, de Azambuja E, Dueck AC,
Goode EL, Sellers TA. Inherited variants affecting RNA editing may
Viale G, Zujewski JA, Goldhirsch A, Armour A, Pritchard K I, McCullough
contribute to ovarian cancer susceptibility: Results from a large-scale
AE, Dolci S, McFadden E, Holmes AP, Tonghua L, Eidtmann H, Dinh P, Di
collaboration. Oncotarget. 2016;7(45):72381-72394.
Cosimo S, Harbeck N, Tjulandin S, Im YH, Huang CS, Diéras V, Hillman
Perna F, Sadelain M. Myeloid leukemia switch as immune escape from DW, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez
CD19 chimeric antigen receptor (CAR) therapy. Translational Cancer H, Suter T, Gelber RD, Perez EA. Adjuvant lapatinib and trastuzumab
Research. 2016;5(Suppl. 2):S221-S225. for early human epidermal growth factor receptor 2-positive breast
cancer: Results From the randomized phase III Adjuvant Lapatinib
Peterson EB, Ostroff JS, DuHamel KN, D’Agostino TA, Hernandez M, and/or Trastuzumab Treatment Optimization trial. Journal of Clinical
Canzona MR, Bylund CL. Impact of provider-patient communication Oncology. 2016;34(10):1034-1042. PMCID: PMC4872016
on cancer screening adherence: A systematic review. Preventive
Medicine. 2016;93:96-105. Pietanza MC, Hellmann MD, Fiore JJ, Smith-Marrone S, Basch EM,
Schwartz LH, Ginsberg MS, Shouery M, Newman SK, Shaw M, Rogak LJ,
Pezold ML, Pusic AL, Cohen WA, Hollenberg JP, Butt Z, Flum DR, Temple Lash AE, Hilden P, Kris MG. Phase II study of a non-platinum-containing
LK. Defining a research agenda for patient-reported outcomes in surgery: doublet of paclitaxel and pemetrexed with bevacizumab as initial
180 OF 324
Journal Articles
therapy for patients with advanced lung adenocarcinomas. Journal of Pilewskie M, Olcese C, Patil S, Van Zee KJ. Women with low-risk
Thoracic Oncology. 2016;11(6):890-899. PMCID: PMC4877255 DCIS eligible for the LORIS trial after complete surgical excision:
How low is their risk after standard therapy?. Annals of Surgical
Pietanza MC, Litvak AM, Varghese AM, Krug LM, Fleisher M, Teitcher Oncology. 2016;23(13):4253-4261. PMCID: PMC5167359
JB, Holodny A I, Sima CS, Woo KM, Ng KK, Won HH, Berger MF, Kris
MG, Rudin CM. A phase I trial of the Hedgehog inhibitor, sonidegib Pilewskie M, Stempel M, Rosenfeld H, Eaton A, Van Zee KJ, Morrow
(LDE225), in combination with etoposide and cisplatin for the M. Do LORIS trial eligibility criteria identify a ductal carcinoma in situ
initial treatment of extensive stage small cell lung cancer. Lung patient population at low risk of upgrade to invasive carcinoma?. Annals
Cancer. 2016;99:23-30. of Surgical Oncology. 2016;23(11):3487-3493. PMCID: PMC5070657
Pietanza MC. Using a population-based analysis to determine the Pinciroli P, Won H, Iyer G, Canevari S, Colecchia M, Giannatempo P,
management and treatment of early-stage small-cell lung cancer. Journal Raggi D, Pierotti MA, De Braud FG, Solit DB, Rosenberg JE, Berger
of Clinical Oncology. 2016;34(10):1027-1029. MF, Necchi A. Molecular signature of response to pazopanib
salvage therapy for urothelial carcinoma. Clinical Genitourinary
Pietzak EJ, Eastham JA. Neoadjuvant treatment of high-risk, clinically Cancer. 2016;14(1):e81-e90. PMCID: PMC5003615
localized prostate cancer prior to radical prostatectomy. Current Urology
Reports. 2016;17(5):37. Pinker K, Marino MA, Dr. Meyer-Baese A, Helbich TH. Multiparametrische
und molekulare Bildgebung von Brusttumoren mit MRT und
Pilewskie M, Karsten M, Radosa J, Eaton A, King TA. Is sentinel lymph PETMRT. Radiologe. 2016;56(7):612-621.
node biopsy indicated at completion mastectomy for ductal carcinoma
in situ?. Annals of Surgical Oncology. 2016;23(7):2229-2234. PMCID: Pinker K, Riedl CC, Ong L, Jochelson M, Ulaner GA, McArthur H, Dickler
PMC4943570 M, Gönen M, Weber WA. The impact that number of analyzed metastatic
breast cancer lesions has on response assessment by (18)F-FDG PET/CT
Pilewskie M, Jochelson M, Gooch JC, Patil S, Stempel M, Morrow M. Is using PERCIST. Journal of Nuclear Medicine. 2016;57(7):1102-1104.
preoperative axillary imaging beneficial in identifying clinically node-
negative patients requiring axillary lymph node dissection?. Journal Pirazzoli V, Ayeni D, Meador CB, Sanganahalli BG, Hyder F, De Stanchina
of the American College of Surgeons. 2016;222(2):138-145. PMCID: E, Goldberg SB, Pao W, Politi K. Afatinib plus cetuximab delays
PMC4729648 resistance compared to single-agent erlotinib or afatinib in mouse
models of TKI-naïve EGFR L858R-Induced lung adenocarcinoma. Clinical
Pilewskie M, Mautner SK, Stempel M, Eaton A, Morrow M. Does a positive Cancer Research. 2016;22(2):426-435. PMCID: PMC4715986
axillary lymph node needle biopsy result predict the need for an axillary
lymph node dissection in clinically node-negative breast cancer patients Pisapia DJ, Rosenblum MK, Lavi E. CD1a reactivity in non-
in the ACOSOG Z0011 era?. Annals of Surgical Oncology. 2016;23(4):1123- neoplastic adenohypophysis. American Journal of Surgical
1128. PMCID: PMC4775411 Pathology. 2016;40(6):812-817.
Pilewskie M, Morrow M. Reply to “Implications of abnormal preoperative Piscuoglio S, Burke KA, Ng CKY, Papanastasiou AD, Geyer FC, Macedo
axillary imaging in the post Z011 era”. Gland Surgery. 2016;5(4):453- GS, Martelotto LG, De Bruijn I, De Filippo MR, Schultheis AM, Ioris
454. PMCID: PMC4971349 RA, Levine DA, Soslow RA, Rubin BP, Reis-Filho JS, Weigelt
181 OF 324
Journal Articles
B. Uterine adenosarcomas are mesenchymal neoplasms. Journal of Plaza MJ, Morris EA, Thakur SB. Diffusion tensor imaging in the normal
Pathology. 2016;238(3):381-388. PMCID: PMC4986517 breast: Influences of fibroglandular tissue composition and background
parenchymal enhancement. Clinical Imaging. 2016;40(3):506-511. PMCID:
Piscuoglio S, Fusco N, Ng CKY, Martelotto LG, da Cruz Paula A, Katabi PMC4853756
N, Rubin BP, Skálová A, Weinreb I, Weigelt B, Reis JS. Lack of PRKD2
and PRKD3 kinase domain somatic mutations in PRKD1 wild-type Plitas G, Konopacki C, Wu K, Bos PD, Morrow M, Putintseva E V, Chudakov
classic polymorphous low-grade adenocarcinomas of the salivary DM, Rudensky AY. Regulatory T cells exhibit distinct features in human
gland. Histopathology. 2016;68(7):1055-1062. breast cancer. Immunity. 2016;45(5):1122-1134. PMCID: PMC5134901
Piscuoglio S, Ng CKY, Murray M, Burke KA, Edelweiss M, Geyer Plitas G, Rudensky AY. Regulatory T cells: Differentiation and
FC, Macedo GS, Inagaki A, Papanastasiou AD, Martelotto LG, Marchio function. Cancer Immunology Research. 2016;4(9):721-725. PMCID:
C, Lim RS, Ioris RA, Nahar PK, de Bruijn I, Smyth L, Akram M, Ross PMC5026325
D, Petrini JH, Norton L, Solit DB, Baselga J, Brogi E, Ladanyi M, Weigelt
B, Reis-Filho JS. Massively parallel sequencing of phyllodes tumours Plusa B, Hadjantonakis AK. Mammalian development: Mechanics drives
of the breast reveals actionable mutations, and TERT promoter cell differentiation. Nature. 2016;536(7616):281-282.
hotspot mutations and TERT gene amplification as likely drivers
of progression. Journal of Pathology. 2016;238(4):508-518. PMCID: Podlasek CA, Mulhall J, Davies K, Wingard CJ, Hannan JL, Bivalacqua
PMC4962788 TJ, Musicki B, Khera M, González-Cadavid NF, Burnett AL II. Translational
perspective on the role of testosterone in sexual function and
Piscuoglio S, Ng CKY, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer dysfunction. Journal of Sexual Medicine. 2016;13(8):1183-1198.
FC, Bidard FC, Berman S, Fusco N, Sakr RA, Eberle CA, De Mattos-
Arruda L, Macedo GS, Akram M, Baslan T, Hicks JB, King TA, Brogi Porta C, Gore ME, Rini B I, Escudier B, Hariharan S, Charles LP, Yang L,
E, Norton L, Weigelt B, Hudis CA, Reis-Filho JS. The genomic landscape Deannuntis L, Motzer RJ. Long-term safety of sunitinib in metastatic
of male breast cancers. Clinical Cancer Research. 2016;22(16):4045- renal cell carcinoma. European Urology. 2016;69(2):345-351. PMCID:
4056. PMCID: PMC4987160 PMC5032140
Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Poruk KE, Valero V 3rd, Saunders T, Blackford AL, Griffin JF, Poling J,
Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker Hruban RH, Anders RA, Herman J, Zheng L, Rasheed ZA, Laheru DA,
CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Ahuja N, Weiss MJ, Cameron JL, Goggins M, Iacobuzio-Donahue CA,
Holland EC, Hambardzumyan D. Corticosteroids compromise survival in Wood LD, Wolfgang CL. Circulating tumor cell phenotype predicts
glioblastoma. Brain. 2016;139(5):1458-1471. PMCID: PMC5006251 recurrence and survival in pancreatic adenocarcinoma. Annals of
Planchard D, Kim TM, Mazieres J, Quoix E, Riely G, Barlesi F, Souquet PJ,
Smit EF, Groen HJM, Kelly RJ, Cho BC, Socinski MA, Pandite L, Nase C, Postema AW, De Reijke TM, Ukimura O, Van den Bos W, Azzouzi
Ma B, D’Amelio A Jr, Mookerjee B, Curtis CM Jr, Johnson BE. Dabrafenib AR, Barret E, Baumunk D, Blana A, Bossi A, Brausi M, Coleman JA,
in patients with BRAF(V600E)-positive advanced non-small-cell lung Crouzet S, Dominguez-Escrig J, Eggener S, Ganzer R, Ghai S, Gill IS,
cancer: A single-arm, multicentre, open-label, phase 2 trial. Lancet Gupta RT, Henkel TO, Hohenfellner M, Jones JS, Kahmann F, Kastner C,
Oncology. 2016;17(5):642-650. PMCID: PMC5006181 Köhrmann KU, Kovacs G, Miano R, van Moorselaar RJ, Mottet N, Osorio
182 OF 324
Journal Articles
L, Pieters BR, Polascik TJ, Rastinehad AR, Salomon G, Sanchez-Salas Poyet C, Wettstein MS, Lundon DJ, Bhindi B, Kulkarni GS, Saba K, Sulser
R, Schostak M, Sentker L, Tay KJ, Varkarakis IM, Villers A, Walz J, De la T, Vickers AJ, Hermanns T. External evaluation of a novel prostate cancer
Rosette JJ. Standardization of definitions in focal therapy of prostate risk calculator (ProstateCheck) based on data from the Swiss arm of the
cancer: Report from a Delphi consensus project. World Journal of ERSPC. Journal of Urology. 2016;196(5):1402-1407.
Urology. 2016;34(10):1373-1382. PMCID: PMC5026990
Præstegaard C, Kjaer SK, Nielsen TSS, Jensen SM, Webb PM, on behalf of
Poullis C, Shabbir M, Eardley I, Mulhall J, Minhas S. Clostridium the Australian Ovarian Cancer Study Group, Nagle CM, Høgdall E, Risch
histolyticum collagenase – Is this a revolutionary medical treatment for HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F,
Peyronie’s disease?. BJU International. 2016;118(2):186-189. Moysich K, Ness RB, Edwards RP, Goode EL, Winham SJ, Fridley BL,
Cramer DW, Terry KL, Schildkraut JM, Berchuck A, Bandera E V, Paddock
Poulos MG, Ramalingam P, Gutkin MC, Kleppe M, Ginsberg M, Crowley L, Kiemeney LA, Massuger LF, Wentzensen N, Pharoah P, Song H,
MJP, Elemento O, Levine RL, Rafii S, Kitajewski J, Greenblatt MB, Shim JH, Whittemore AS, McGuire V, Sieh W, Rothstein J, Anton-Culver H, Ziogas
Butler JM. Endothelial-specific inhibition of NF-κB enhances functional A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce
haematopoiesis. Nature Communications. 2016;7:13829. PMCID: CL, Pike MC, Lee AW, Chang-Claude J, Jensen A, on behalf of the Ovarian
PMC5187502 Cancer Association Consortium. The association between socioeconomic
status and tumour stage at diagnosis of ovarian cancer: A pooled
Poulsen L, Klassen A, Jhanwar S, Pusic A, Roessler KK, Rose M, Sorensen analysis of 18 case-control studies. Cancer Epidemiology. 2016;41:71-
JA. Patient expectations of bariatric and body contouring surgery. Plastic 79. PMCID: PMC4993452
and Reconstructive Surgery-Global Open. 2016;4(4):e694. PMCID:
PMC4859253 Prasad S, Cambridge L, Huguet F, Chou JF, Zhang Z, Wu AJ, O’Reilly
EM, Allen PJ, Goodman KA. Intensity modulated radiation therapy
Pourkarimi E, Bellush JM, Whitehouse I. Spatiotemporal coupling and reduces gastrointestinal toxicity in locally advanced pancreas
decoupling of gene transcription with DNA replication origins during cancer. Practical Radiation Oncology. 2016;6(2):78-85. PMCID:
embryogenesis in C. elegans. eLife. 2016;5:e21728. PMCID: PMC5222557 PMC4782151
Powell EA, Babady E. Antimicrobial resistance-could less really be Prasad V, Mailankody S. The UK Cancer Drugs Fund experiment and the
more?. Clinical Chemistry. 2016;62(11):1544. US cancer drug cost problem: Bearing the cost of cancer drugs until it is
unbearable. Mayo Clinic Proceedings. 2016;91(6):707-712.
Powell SN. BRCA1 loses the ring but lords over resistance. Journal of
Clinical Investigation. 2016;126(8):2802-2804. PMCID: PMC4966308 Pratt EC, Shaffer TM, Grimm J. Nanoparticles and radiotracers: Advances
toward radionanomedicine. Wiley Interdisciplinary Reviews: Nanomedicine
Powles T, Lackner MR, Oudard S, Escudier B, Ralph C, Brown JE,
and Nanobiotechnology. 2016;8(6):872-890. PMCID: PMC5035177
Hawkins RE, Castellano D, Rini B I, Staehler MD, Ravaud A, Lin W,
O’Keeffe B, Wang Y, Lu S, Spoerke JM, Huw LY, Byrtek M, Zhu R, Ware Praveen A, Friedman DN, Sklar C, Oeffinger K, Castiel M, Kearney
JA, Motzer RJ. Randomized open-label phase II trial of apitolisib (GDC- J, Singh B, Prockop SE, Kernan NA, Scaradavou A, Kobos R, Curran
0980), a novel inhibitor of the PI3K/mammalian target of rapamycin K, Ruggiero J, Zakak N, O’Reilly RJ, Boulad F. Late effects in
pathway, versus everolimus in patients with metastatic renal cell patients with Fanconi anemia following allogeneic hematopoietic
carcinoma. Journal of Clinical Oncology. 2016;34(14):1660-1668.
183 OF 324
Journal Articles
stem cell transplantation from alternative donors. Bone Marrow Price EW, Edwards KJ, Carnazza KE, Carlin SD, Zeglis BM, Adam MJ,
Transplantation. 2016;51(7):938-944. PMCID: PMC4968886 Orvig C, Lewis JS. A comparative evaluation of the chelators H4octapa
and CHX-A″-DTPA with the therapeutic radiometal 90Y. Nuclear Medicine
Prazak K, Gahres J. Ovarian cancer: Practice essentials. Physician and Biology. 2016;43(9):566-576. PMCID: PMC4992617
Assistant Clinics. 2016;1(3):479-487.
Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi
Prendergast L, Müller S, Liu Y, Huang H, Dingli F, Loew D, Vassias P, Antonescu CR. Loss of H3K27me3 expression is a highly sensitive
I, Patel DJ, Sullivan KF, Almouzni G. The CENP-T/-W complex marker for sporadic and radiation-induced MPNST. American Journal of
is a binding partner of the histone chaperone FACT. Genes and Surgical Pathology. 2016;40(4):479-489. PMCID: PMC4882106
Development. 2016;30(11):1313-1326. PMCID: PMC4911930
Prigerson HG, Vaughan SC, Lichtenthal WG. The hidden dangers
Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won of a cancer diagnosis. BMJ: British Medical Journal (International
E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Edition). 2016;354:i4446. PMCID: PMC5007352
Demark-Wahnefried W. Gaps in nutritional research among older adults
with cancer. Journal of Geriatric Oncology. 2016;7(4):281-292. PMCID: Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran
PMC4969118 H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA,
Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko
Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey
LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger
Barr PM, Fanale MA, Knopp M V, Noy A, Hsi ED, Cook JR, Lechowicz MJ, M, Zhang L, Zehir A, Vijai J, Scher H I, Sawyers C, Schultz N, Kantoff
Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher R I, Friedberg PW, Solit D, Robson M, Van Allen EM, Offit K, De Bono J, Nelson
JW. US intergroup trial of response-adapted therapy for stage III PS. Inherited DNA-repair gene mutations in men with metastatic
to IV Hodgkin lymphoma using early interim fluorodeoxyglucose- prostate cancer. New England Journal of Medicine. 2016;375(5):443-
positron emission tomography imaging: Southwest Oncology Group 453. PMCID: PMC4986616
S0816. Journal of Clinical Oncology. 2016;34(17):2020-2027. PMCID:
PMC4966513 Pritchard CC, Offit K, Nelson PS. The authors reply: DNA-Repair gene
mutations in metastatic prostate cancer. New England Journal of
Preston MA, Batista JL, Wilson KM, Carlsson S V, Gerke T, Sjoberg Medicine. 2016;375(18):1804-1805.
DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ,
Mucci LA. Baseline prostate-specific antigen levels in midlife predict Pritchett W, Kinsley K. Benefits and risks of fosaprepitant in patients
lethal prostate cancer. Journal of Clinical Oncology. 2016;34(23):2705- receiving emetogenic regimens. Clinical Journal of Oncology
2711. PMCID: PMC5019757 Nursing. 2016;20(5):555-556.
Price DL, Li P, Chen CH, Wong D, Yu Z, Chen NG, Yu YA, Szalay AA, Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, David
Cappello J, Fong Y, Wong RJ. Silk-elastin-like protein polymer matrix DS, Early DS, Erwin D, Ford JM, Giardiello FM, Grady W, Halverson
for intraoperative delivery of an oncolytic vaccinia virus. Head and AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW,
Neck. 2016;38(2):237-246. PMCID: PMC4975925 Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Regenbogen SE, Samadder
NJ, Shike M, Steinbach G, Weinberg D, Dwyer M, Darlow S. Genetic/
184 OF 324
Journal Articles
familial high-risk assessment: Colorectal version 1.2016: Clinical practice mediate renal carcinoma metastasis. International Journal of
guidelines in oncology. Journal of the National Comprehensive Cancer Cancer. 2016;139(12):2791-2801.
Network. 2016;14(8):1010-1030.
Qi S, Yahalom J, Hsu M, Chelius M, Lunning M, Moskowitz A, Horwitz
Prudova A, Gocheva V, auf dem Keller U, Eckhard U, Olson OC, Akkari L, S. Encouraging experience in the treatment of nasal type extra-
Butler GS, Fortelny N, Lange PF, Mark JC, Joyce JA, Overall CM. TAILS nodal NK/T-cell lymphoma in a non-Asian population. Leukemia and
N-terminomics and proteomics show protein degradation dominates Lymphoma. 2016;57(11):2575-2583.
over proteolytic processing by cathepsins in pancreatic tumors. Cell
Reports. 2016;16(6):1762-1773. Qian XL, Wen HY, Yang YL, Gu F, Guo XJ, Liu FF, Zhang L, Zhang XM,
Fu L. Assessment of dual-probe Her-2 fluorescent in situ hybridization
Puente C, Hendrickson RC, Jiang X. Nutrient-regulated phosphorylation in breast cancer by the 2013 ASCO/CAP guidelines produces more
of ATG13 inhibits starvation-induced autophagy. Journal of Biological equivocal results than that by the 2007 ASCO/CAP guidelines. Breast
Chemistry. 2016;291(11):6026-6035. PMCID: PMC4786734 Cancer Research and Treatment. 2016;159(1):31-39.
Pugalenthi A, Protic M, Gonen M, Kingham TP, D’Angelica M I, DeMatteo Qin LX, Tuschl T, Singer S. Empirical insights into the stochasticity
RP, Fong Y, Jarnagin WR, Allen PJ. Postoperative complications of small RNA sequencing. Scientific Reports. 2016;6:24061. PMCID:
and overall survival after pancreaticoduodenectomy for pancreatic PMC4823707
ductal adenocarcinoma. Journal of Surgical Oncology. 2016;113(2):188-
193. PMCID: PMC4830358 Qin LX, Huang HC, Begg CB. Cautionary note on using cross-
validation for molecular classification. Journal of Clinical
Pun SC, Plodkowski A, Matasar MJ, Lakhman Y, Halpenny Oncology. 2016;34(32):3931-3938.
DF, Gupta D, Moskowitz C, Kim J, Steingart R, Weinsaft JW. Pattern
and prognostic implications of cardiac metastases among Qin LX, Levine DA. Study design and data analysis considerations for
patients with advanced systemic cancer assessed with cardiac the discovery of prognostic molecular biomarkers: A case study of
magnetic eesonance imaging. Journal of the American Heart progression free survival in advanced serous ovarian cancer. BMC Medical
Association. 2016;5(5):e003368. PMCID: PMC4889201 Genomics. 2016;9:27. PMCID: PMC4901402
Qadan M, Garden OJ, Corvera CU, Visser BC. Management of Qu J, Yu H, Li F, Zhang C, Trad A, Brooks C, Zhang B, Gong T, Guo Z,
postoperative hepatic failure. Journal of the American College of Li Y, Ragupathi G, Lou Y, Hwu P, Huang W, Zhou D. Molecular basis of
Surgeons. 2016;222(2):195-208. antibody binding to mucin glycopeptides in lung cancer. International
Journal of Oncology. 2016;48(2):587-594. PMCID: PMC4725460
Qadan M, Kingham TP. Technical aspects of gallbladder cancer
surgery. Surgical Clinics of North America. 2016;96(2):229-245. PMCID: Quail DF, Bowman RL, Akkari L, Quick ML, Schuhmacher
PMC4907326 AJ, Huse JT, Holland EC, Sutton JC, Joyce JA. The tumor
microenvironment underlies acquired resistance to CSF-1R inhibition in
Qazi H, Shi ZD, Song JW, Cancel LM, Huang PG, Zeng Y, gliomas. Science. 2016;352(6288):aad3018.
Roberge S, Munn LL, Tarbell JM. Heparan sulfate proteoglycans
185 OF 324
Journal Articles
Quinn B, Dauer Z, Pandit-Taskar N, Schoder H, Dauer LT. Radiation potential: Proposals to improve their recognition and clinical
dosimetry of 18F-FDG PET/CT: Incorporating exam-specific parameters management. Histopathology. 2016;68(1):45-56. PMCID: PMC4987288
in dose estimates. BMC Medical Imaging. 2016;16:41. PMCID: PMC4912712
Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito
Rabellino A, Melegari M, Tompkins VS, Chen W, Van Ness BG, Teruya- T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, Pascher
Feldstein J, Conacci-Sorrell M, Janz S, Scaglioni PP. PIAS1 A. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine
promotes lymphomagenesis through MYC upregulation. Cell Neoplasms. Neuroendocrinology. 2016;103(2):139-143.
Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW,
Rafiei P, Walser EM, Duncan JR, Rana H, Ross JR, Kerlan RK Jr, Jones DTW, Luu B, Cavalli FMG, Aldape K, Remke M, Mynarek M,
Gross KA, Balter S, Bartal G, Abi-Jaoudeh N, Stecker MS, Cohen AM, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J,
Dixon RG, Thornton RH, Nikolic B, for the Society of Interventional Eisenstat DD, Fulton D, van Landeghem FKH, Santi M, van Veelen MLC,
Radiology Health and Safety Committee. Society of Interventional Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DPC, Oba-Shinjo SM,
Radiology IR pre-procedure patient dafety checklist by the Safety Marie SKN, Carlotti CG, Lee JY, Rao AAN, Giannini C, Faria CC, Nunes S,
and Health Committee. Journal of Vascular and Interventional Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L,
Radiology. 2016;27(5):695-699. Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian
RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB,
Rageth CJ, O’Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR,
Lepori D, Kampmann G, Mundinger A, Baege A, Decker T, Hosch S, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach
Tausch C, Delaloye JF, Morris E, Varga Z. First International Consensus A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff
Conference on lesions of uncertain malignant potential in the breast K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA,
(B3 lesions). Breast Cancer Research and Treatment. 2016;159(2):203- Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar
213. PMCID: PMC5012144 A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K,
Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins H I,
Rahmim A, Schmidtlein CR, Jackson A, Sheikhbahaei S, Marcus Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE,
C, Ashrafinia S, Soltani M, Subramaniam RM. A novel metric for Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS,
quantification of homogeneous and heterogeneous tumors in PET Korshunov A, Ellison DW, Taylor MD. Therapeutic impact of cytoreductive
for enhanced clinical outcome prediction. Physics in Medicine and surgery and irradiation of posterior fossa ependymoma in the
Biology. 2016;61(1):227-242. PMCID: PMC4887091 molecular era: A retrospective multicohort analysis. Journal of Clinical
Raj N, Reidy-Lagunes D. Systemic therapies for advanced pancreatic
neuroendocrine tumors. Hematology/Oncology Clinics of North Ramkumar N, Omelchenko T, Silva-Gagliardi NF, McGlade CJ,
America. 2016;30(1):119-133. PMCID: PMC5046222 Wijnholds J, Anderson K V. Crumbs2 promotes cell ingression during
the epithelial-to-mesenchymal transition at gastrulation. Nature Cell
Rakha EA, Badve S, Eusebi V, Reis-Filho JS, Fox SB, Dabbs DJ,
Biology. 2016;18(12):1281-1291. PMCID: PMC5268168
Decker T, Hodi Z, Ichihara S, Lee AH, Palacios J, Richardson AL,
Vincent-Salomon A, Schmitt FC, Tan PH, Tse GM, Ellis IO. Breast Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, Tang J, Castillo J, Fayad
lesions of uncertain malignant nature and limited metastatic
186 OF 324
Journal Articles
ZA, Mulder WJM. Conformational changes in high-density lipoprotein DA, Iacobuzio-Donahue CA, Wolfgang CL, Koong A, Herman JM. Patient-
nanoparticles induced by high payloads of paramagnetic lipids. ACS reported outcomes of a multicenter phase 2 study investigating
Omega. 2016;1(3):470-475. PMCID: PMC5046173 gemcitabine and stereotactic body radiation therapy in locally advanced
pancreatic cancer. Practical Radiation Oncology. 2016;6(6):417-424.
Ramos-Espiritu L, Diaz A, Nardin C, Saviola AJ, Shaw F, Plitt
T, Yang X, Wolchok J, Pirog EC, Desman G, Sboner A, Zhang T, Rao SD, Saleh ZH, Setton J, Tam M, McBride SM, Riaz N, Deasy
Xiang J, Merghoub T, Levin LR, Buck J, Zippin JH. The metabolic/ JO, Lee NY. Dose-volume factors correlating with trismus
pH sensor soluble adenylyl cyclase is a tumor suppressor following chemoradiation for head and neck cancer. Acta
protein. Oncotarget. 2016;7(29):45597-45607. PMCID: PMC5216745 Oncologica. 2016;55(1):99-104. PMCID: PMC4784420
Rampal R, Figueroa ME. Wilms tumor 1 mutations in the pathogenesis of acute Raoof S, Bondalapati P, Vydyula R, Ryu JH, Gupta N, Raoof S, Galvin J,
myeloid leukemia. Haematologica. 2016;101(6):672-679. PMCID: PMC5013955 Rosen MJ, Lynch D, Travis W, Mehta S, Lazzaro R, Naidich D. Cystic lung
diseases: Algorithmic approach. Chest. 2016;150(4):945-965.
Ramsey SD, Nademanee A, Masszi T, Holowiecki J, Abidi M, Chen
A, Stiff P, Viviani S, Sweetenham JW, Radford J, Zhu Y, Bonthapally Raparia K, Aisner DL, Allen TC, Beasley MB, Borczuk A, Cagle PT,
V, Thomas E, Richhariya A, Hunder NN, Walewski J, Moskowitz Capelozzi V, Dacic S, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson
CH. Quality of life results from a phase 3 study of brentuximab M, Rekhtman N, Roden AC, Roy-Chowdhuri S, Sholl L, Smith ML,
vedotin consolidation following autologous haematopoietic stem cell Thunnissen E, Tsao MS, Yatabe Y. Transbronchial lung cryobiopsy for
transplant for persons with Hodgkin lymphoma. British Journal of interstitial lung disease diagnosis: A perspective from members of the
Haematology. 2016;175(5):860-867. Pulmonary Pathology Society. Archives of Pathology & Laboratory
Medicine. 2016;140(11):1281-1284.
Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka
L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M. A positive family Rapisuwon S, Busam KJ, Parks K, Chapman PB, Lee E, Atkins
history as a risk factor for prostate cancer in a population-based study MB. Discordance between Cobas BRAF V600 testing and VE1
with organised prostate-specific antigen screening: Results of the Swiss immunohistochemistry in a melanoma patient with bone marrow
European Randomised Study of Screening for Prostate Cancer (ERSPC, metastases. American Journal of Dermatopathology. 2016;38(9):687-689.
Aarau). BJU International. 2016;117(4):576-583. PMCID: PMC4955666
Rashidi A, Walter RB, Tallman MS, Appelbaum FR, DiPersio JF. Maintenance
Randhawa M, Wang S, Leyden JJ, Cula GO, Pagnoni A, Southall MD. Daily use therapy in acute myeloid leukemia: An evidence-based review of randomized
of a facial broad spectrum sunscreen over one-year significantly improves trials. Blood. 2016;128(6):763-773. PMCID: PMC4982451
clinical evaluation of photoaging. Dermatologic Surgery. 2016;42(12):1354-1361.
Ratner L, Rauch D, Abel H, Caruso B, Noy A, Barta SK, Parekh S, Ramos
Ranganath R, Shaha MA, Xu B, Migliacci J, Ghossein R, Shaha AR. de JC, Ambinder R, Phillips A, Harding J, Baydoun HH, Cheng X, Jacobson
Quervain’s thyroiditis: A review of experience with surgery. American S. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir
Journal of Otolaryngology. 2016;37(6):534-537. for human T-cell leukemia virus-associated adult T-cell leukemia
lymphoma. Blood Cancer Journal. 2016;6:e408. PMCID: PMC4817103
Rao AD, Sugar EA, Chang DT, Goodman KA, Hacker-Prietz A, Rosati LM,
Columbo L, O’Reilly E, Fisher GA, Zheng L, Pai JS, Griffith ME, Laheru Ratta R, Zappasodi R, Raggi D, Grassi P, Verzoni E, Necchi A, Di
187 OF 324
Journal Articles
Nicola M, Salvioni R, de Braud F, Procopio G. Immunotherapy Jakubowska A, Janavicius R, Jaworska-Bieniek K, John EM, Karlan BY,
advances in uro-genital malignancies. Critical Reviews in Oncology Kaufman B, KConFab investigators, Kwong A, Laitman Y, Lasset C, Lazaro
Hematology. 2016;105:52-64. C, Lester J, Loman N, Lubinski J, Manoukian S, Mitchell G, Montagna M,
Neuhausen SL, Nevanlinna H, Niederacher D, Nussbaum RL, Offit K, Olah
Ravaud A, Motzer RJ, Pandha HS, George DJ, Pantuck AJ, Patel A, E, Olopade O I, Park SK, Piedmonte M, Radice P, Rappaport-Fuerhauser
Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre C, Rookus MA, Seynaeve C, Simard J, Singer CF, Soucy P, Southey M,
B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Martini JF, Stoppa-Lyonnet D, Sukiennicki G, Szabo C I, Tancredi M, Teixeira MR, Teo
Ramaswamy K, Casey M, Staehler M, Patard JJ. Adjuvant sunitinib in SH, Terry MB, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE,
high-risk renal-cell carcinoma after nephrectomy. New England Journal Toloczko-Grabarek A, Tung N, van Rensburg EJ, Villano D, Wang-Gohrke
of Medicine. 2016;375(23):2246-2254. S, Wappenschmidt B, Weitzel JN, Zidan J, Zorn KK, McGuffog L, Easton
D, Chenevix-Trench G, Antoniou AC, Ramus SJ. Inheritance of deleterious
Raymond DP, Seder CW, Wright CD, Magee MJ, Kosinski AS, Cassivi mutations at both BRCA1 and BRCA2 in an international sample of
SD, Grogan EL, Blackmon SH, Allen MS, Park BJ, Burfeind WR, Chang 32,295 women. Breast Cancer Research. 2016;18:112. PMCID: PMC5106833
AC, DeCamp MM, Wormuth DW, Fernandez FG, Kozower BD. Predictors
of major morbidity or mortality after resection for esophageal cancer: Rebeiz K, Shamseddine A, Hachem R, Brown K, Mukherji D, Faraj
A Society of Thoracic Surgeons General Thoracic Surgery Database W, Abou-Alfa GK, Nasr LA, Haydar AA. Pancreatic neuroendocrine tumor
risk adjustment model. Annals of Thoracic Surgery. 2016;102(1):207- with aneurysms of the gastroduodenal artery: A case report. Clinical
214. PMCID: PMC5016796 Imaging. 2016;40(2):228-231. PMCID: PMC4989911
Razdan SN, Patel V, Jewell S, McCarthy CM. Quality of life among Recabal P, Assel M, Musser JE, Caras RJ, Sjoberg DD, Coleman
patients after bilateral prophylactic mastectomy: A systematic review of JA, Mulhall JP, Parra RO, Scardino PT, Touijer K, Eastham JA, Laudone
patient-reported outcomes. Quality of Life Research. 2016;25(6):1409- VP. Erectile function recovery after radical prostatectomy in men with
1421. PMCID: PMC4867133 high risk features. Journal of Urology. 2016;196(2):507-512. PMCID:
PMC4969139
Razdan SN, Cordeiro PG, Albornoz CR, Ro T, Cohen WA, Mehrara
BJ, McCarthy CM, Disa JJ, Pusic AL, Matros E. Cost-effectiveness analysis Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham
of breast reconstruction options in the setting of postmastectomy JA, Vargas HA, Coleman J, Ehdaie B. The efficacy of multiparametric
radiotherapy using the BREAST-Q. Plastic and Reconstructive magnetic resonance imaging and magnetic resonance imaging targeted
Surgery. 2016;137(3):510e-517e. PMCID: PMC4986994 biopsy in risk classification for patients with prostate cancer on active
surveillance. Journal of Urology. 2016;196(2):374-380.
Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou
P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Recabal P. Editorial comment. Journal of Urology. 2016;196(2):365-366.
Borg A, Buys SS, Caldes T, Carter J, Chiquette J, Claes KBM, Couch FJ,
Cybulski C, Daly MB, de la Hoya M, Diez O, Domchek SM, Nathanson Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho
KL, Durda K, Ellis S, Evans DG, Foretova L, Friedman E, Frost D, Ganz AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE,
PA, Garber J, Glendon G, Godwin AK, Greene MH, Gronwald J, Hahnen Sledge GW Jr, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge
E, Hallberg E, Hamann U, Hansen TVO, HEBON, Imyanitov EN, Isaacs C, SB. Postmastectomy radiotherapy: An American Society of Clinical
188 OF 324
Journal Articles
Oncology, American Society for Radiation Oncology, and Society of stand out and fit in: A report from the American Society of Preventive
Surgical Oncology Focused Guideline Update. Practical Radiation Oncology Junior Members Interest Group. Cancer Epidemiology
Oncology. 2016;6(6):e219-e234. Biomarkers and Prevention. 2016;25(1):224-225. PMCID: PMC4991884
Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho Reid MD, Stallworth CR, Lewis MM, Akkas G, Memis B, Basturk O,
AY, Hudis CA, Hwang ES, Kirshner JJ, Morrow M, Salerno KE, Adsay V. Cytopathologic diagnosis of oncocytic type intraductal
Sledge GW Jr, Solin LJ, Spears PA, Whelan TJ, Somerfield MR, Edge papillary mucinous neoplasm: Criteria and clinical implications of
SB. Postmastectomy radiotherapy: An American Society of Clinical accurate diagnosis. Cancer Cytopathology. 2016;124(2):122-134. PMCID:
Oncology, American Society for Radiation Oncology, and Society PMC4982396
of Surgical Oncology focused guideline update. Journal of Clinical
Oncology. 2016;34(36):4431-4442. Reiss SN, Buie LW, Adel N, Goldman DA, Devlin SM, Douer
D. Hypoalbuminemia is significantly associated with increased clearance
Reck M, Luft A, Szczesna A, Havel L, Kim SW, Akerley W, Pietanza MC, time of high dose methotrexate in patients being treated for lymphoma
Wu YL, Zielinski C, Thomas M, Felip E, Gold K, Horn L, Aerts J, Nakagawa or leukemia. Annals of Hematology. 2016;95(12):2009-2015.
K, Lorigan P, Pieters A, Sanchez TK, Fairchild J, Spigel D. Phase III
randomized trial of ipilimumab plus etoposide and platinum versus Rekhtman N, Roy-Chowdhuri S. Cytology specimens: A goldmine
placebo plus etoposide and platinum in extensive-stage small-cell lung for molecular testing. Archives of Pathology & Laboratory
cancer. Journal of Clinical Oncology. 2016;34(31):3740-3748. Medicine. 2016;140(11):1189-1190.
Reddy KC, Dunbar TL, Nargund AM, Haynes CM, Troemel ER. The Rekhtman N, Pietanza MC, Hellmann MD, Naidoo J, Arora A, Won
C. elegans CCAAT-enhancer-binding protein gamma is required for H, Halpenny DF, Wang H, Tian SK, Litvak AM, Paik PK, Drilon
surveillance immunity. Cell Reports. 2016;14(7):1581-1589. PMCID: AE, Socci N, Poirier JT, Shen R, Berger MF, Moreira AL, Travis
PMC4767654 WD, Rudin CM, Ladanyi M. Next-generation sequencing of pulmonary
large cell neuroendocrine carcinoma reveals small cell carcinoma-
Redelsperger IM, Taldone T, Riedel ER, Lepherd ML, Lipman NS, Wolf like and non-small cell carcinoma-like subsets. Clinical Cancer
FR. Stability of doxycycline in feed and water and minimal effective Research. 2016;22(14):3618-3629. PMCID: PMC4995776
doses in tetracycline-inducible systems. Journal of the American
Association for Laboratory Animal Science. 2016;55(4):467-474. PMCID: Rekhtman N. Molecular assessment of multiple pulmonary carcinomas:
PMC4943619 An evolving area. Journal of Thoracic Oncology. 2016;11(4):e54.
Reed GA, Schiller GJ, Kambhampati S, Tallman MS, Douer D, Minden Remus BS, Schwer B, Shuman S. Characterization of the tRNA
MD, Yee KW, Gupta V, Brandwein J, Jitkova Y, Gronda M, Hurren R, ligases of pathogenic fungi Aspergillus fumigatus and Coccidioides
Shamas-Din A, Schuh AC, Schimmer AD. A Phase 1 study of intravenous immitis. RNA. 2016;22(10):1500-1509. PMCID: PMC5029449
infusions of tigecycline in patients with acute myeloid leukemia. Cancer
Medicine. 2016;5(11):3031-3040. PMCID: PMC5119957 Ren A, Vusurovic N, Gebetsberger J, Gao P, Juen M, Kreutz C, Micura
R, Patel DJ. Pistol ribozyme adopts a pseudoknot fold facilitating site-
Reeves KW, Tehranifar P, Crane TE, Ko LK, Cameron C, Hamilton JG, specific in-line cleavage. Nature Chemical Biology. 2016;12(9):702-
Lavigne JA, Reiter PL, Thomson CA. Job talks and interviews: How to 708. PMCID: PMC4990474
189 OF 324
Journal Articles
Renfro LA, Loupakis F, Adams RA, Seymour MT, Heinemann V, Schmoll Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua
HJ, Douillard JY, Hurwitz H, Fuchs CS, Diaz-Rubio E, Porschen R, AM, Patnaik A, Hwu WJ, Weber JS, Gangadhar TC, Hersey P, Dronca R,
Tournigand C, Chibaudel B, Falcone A, Tebbutt NC, Punt CJA, Hecht Joseph RW, Zarour H, Chmielowski B, Lawrence DP, Algazi A, Rizvi NA,
JR, Bokemeyer C, Van Cutsem E, Goldberg RM, Saltz LB, De Gramont Hoffner B, Mateus C, Gergich K, Lindia JA, Giannotti M, Li XN, Ebbinghaus
A, Sargent DJ, Lenz HJ. Body mass index is prognostic in metastatic S, Kang SP, Robert C. Association of pembrolizumab with tumor
colorectal cancer: Pooled analysis of patients from first-line clinical trials response and survival among patients with advanced melanoma. JAMA -
in the ARCAD database. Journal of Clinical Oncology. 2016;34(2):144- Journal of the American Medical Association. 2016;315(15):1600-1609.
150. PMCID: PMC5070548
Rice D, Chansky K, Nowak A, Pass H, Kindler H, Shemanski L, Opitz I,
Resh MD. Fatty acylation of proteins: The long and the short of Call S, Hasegawa S, Kernstine K, Atinkaya C, Rea F, Nafteux P, Rusch
it. Progress in Lipid Research. 2016;63:120-131. PMCID: PMC4975971 VW, on behalf of the Mesothelioma Domain of the IASLC Staging
and Prognostic Factors Committee advisory boards and participating
Restifo NP, Smyth MJ, Snyder A. Acquired resistance to immunotherapy institutions. The IASLC Mesothelioma Staging Project: Proposals for
and future challenges. Nature Reviews Cancer. 2016;16(2):121-126. revisions of the N descriptors in the forthcoming eighth edition of
the TNM classification for pleural mesothelioma. Journal of Thoracic
Reyes SA, King TA, Fei K, Franco R, Bickell NA. Factors affecting Oncology. 2016;11(12):2100-2111.
the completion of adjuvant chemotherapy in early-stage breast
cancer. Annals of Surgical Oncology. 2016;23(5):1537-1542. Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TEMR,
Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW,
Reznik E, Miller ML, Şenbabaoğlu Y, Riaz N, Sarungbam J, Tickoo Wijnhoven BPL, Chen KN, Davies AR, D’Journo XB, Kesler KA, Luketich
SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, Sander JD, Ferguson MK, Räsänen J V, van Hillegersberg R, Fang W, Durand
C. Mitochondrial DNA copy number variation across human L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R,
cancers. eLife. 2016;5:e10769. PMCID: PMC4775221 Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau
A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH. Worldwide
Riaz N, Havel JJ, Kendall SM, Makarov V, Walsh LA, Desrichard
Esophageal Cancer Collaboration: Clinical staging data. Diseases of the
A, Weinhold N, Chan TA. Recurrent SERPINB3 and SERPINB4 mutations
Esophagus. 2016;29(7):707-714.
in patients who respond to anti-CTLA4 immunotherapy. Nature
Genetics. 2016;48(11):1327-1329. Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven
BPL, Chen KL, Davies AR, D’Journo XB, Kesler KA, Luketich JD, Ferguson
Riaz N, Morris L, Havel JJ, Makarov V, Desrichard A, Chan TA. The role of
MK, Räsänen J V, van Hillegersberg R, Fang W, Durand L, Cecconello I,
neoantigens in response to immune checkpoint blockade. International
Allum WH, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS,
Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE,
Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Schipper PH, Lerut TEMR, Orringer MB, Ishwaran H, Apperson-Hansen
Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N. Concurrent C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal
chemoradiotherapy with cisplatin versus cetuximab for squamous cell Cancer Collaboration: Pathologic staging data. Diseases of the
carcinoma of the head and neck. American Journal of Clinical Oncology: Esophagus. 2016;29(7):724-733.
Cancer Clinical Trials. 2016;39(1):27-31. PMCID: PMC4978947
190 OF 324
Journal Articles
Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S,
Apperson-Hansen C, for the Worldwide Esophageal Cancer Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G,
Collaboration Investigators. Recommendations for clinical staging Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin
(cTNM) of cancer of the esophagus and esophagogastric junction JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D’Agostino
for the 8th edition AJCC/UICC staging manuals. Diseases of the RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M,
Esophagus. 2016;29(8):913-919. Nejadnik B, Hannah AL, Soiffer RJ. Phase 3 trial of defibrotide for
the treatment of severe veno-occlusive disease and multi-organ
Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson- failure. Blood. 2016;127(13):1656-1665. PMCID: PMC4817309
Hansen C, Blackstone EH, for the Worldwide Esophageal Cancer
Collaboration Investigators. Recommendations for pathologic staging Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks
(pTNM) of cancer of the esophagus and esophagogastric junction D I, Martino R, Maziarz RT, Papanicolaou GA, Wingard JR, Young JAH,
for the 8th edition AJCC/UICC staging manuals. Diseases of the Bennett CL. Risk factors and impact of non-Aspergillus mold infections
Esophagus. 2016;29(8):897-905. following allogeneic HCT: A CIBMTR infection and immune reconstitution
analysis. Bone Marrow Transplantation. 2016;51(2):277-282. PMCID:
Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, PMC4740251
Blackstone EH, for the Worldwide Esophageal Cancer Collaboration
Investigators. Recommendations for neoadjuvant pathologic staging Riely GJ. Counterpoints: Should EGFR tyrosine kinase inhibitors be used
(ypTNM) of cancer of the esophagus and esophagogastric junction in non-small cell lung cancer in the absence of EGFR mutations?—No,
for the 8th edition AJCC/UICC staging manuals. Diseases of the EGFR TKIs should be reserved for patients with EGFR mutations. Clinical
Esophagus. 2016;29(8):906-912. PMCID: PMC5137813 Advances in Hematology & Oncology. 2016;14(1):41, 44-45.
Rice TW, Lerut TEMR, Orringer MB, Chen LQ, Hofstetter WL, Smithers Rimner A, Simone CB 2nd, Zauderer MG, Cengel KA, Rusch
BM, Rusch VW, van Lanschot J, Chen KN, Davies AR, D’Journo XB, VW. Hemithoracic radiotherapy for mesothelioma: Lack of benefit or lack
Kesler KA, Luketich JD, Ferguson MK, Räsänen J V, van Hillegersberg R, of statistical power?. Lancet Oncology. 2016;17(2):e43-e44.
Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin
SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Rimner A, Yao X, Huang J, Antonicelli A, Ahmad U, Korst RJ, Detterbeck
Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Apperson-Hansen F, Gomez DR. Postoperative radiation therapy is associated with
C, DiPaola LM, Semple ME, Blackstone EH. Worldwide Esophageal longer overall survival in completely resected stage II and III thymoma-
Cancer Collaboration: Neoadjuvant pathologic staging data. Diseases of an analysis of the international thymic malignancies interest group
the Esophagus. 2016;29(7):715-723. retrospective database. Journal of Thoracic Oncology. 2016;11(10):1785-
1792. PMCID: PMC5257334
Richardson L, Brite J, Del Castillo M, Childers T, Sheahan A, Huang
YT, Dougherty E, Babady NE, Sepkowitz K, Kamboj M. Comparison of Rimner A, Zauderer MG, Gomez DR, Adusumilli PS, Parhar PK, Wu
respiratory virus shedding by conventional and molecular testing methods AJ, Woo KM, Shen R, Ginsberg MS, Yorke ED, Rice DC, Tsao
in patients with haematological malignancy. Clinical Microbiology and AS, Rosenzweig KE, Rusch VW, Krug LM. Phase II study of hemithoracic
Infection. 2016;22(4):380.e1-380.e7. PMCID: PMC4994888 intensity-modulated pleural radiation therapy (IMPRINT) as part
of lung-sparing multimodality therapy in patients with malignant
191 OF 324
Journal Articles
pleural mesothelioma. Journal of Clinical Oncology. 2016;34(23):2761- treatment of advanced non-small-cell lung cancer. Journal of Clinical
2768. PMCID: PMC5019761 Oncology. 2016;34(25):2969-2979.
Rini B I, McDermott DF, Hammers H, Bro W, Bukowski RM, Faba B, Faba Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano
J, Figlin RA, Hutson T, Jonasch E, Joseph RW, Leibovich BC, Olencki T, JF, Kipps TJ, Anderson MA, Brown JR, Gressick L, Wong S, Dunbar
Pantuck AJ, Quinn D I, Seery V, Voss MH, Wood CG, Wood LS, Atkins M, Zhu M, Desai MB, Cerri E, Enschede SH, Humerickhouse RA,
MB. Society for Immunotherapy of Cancer consensus statement on Wierda WG, Seymour JF. Targeting BCL2 with venetoclax in
immunotherapy for the treatment of renal cell carcinoma. Journal for relapsed chronic lymphocytic leukemia. New England Journal of
Immunotherapy of Cancer. 2016;4:81. PMCID: PMC5109802 Medicine. 2016;374(4):311-322.
Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones Robertson NL, Hricak H, Sonoda Y, Sosa RE, Benz M, Lyons G, Abu-
DR, Adusumilli PS, Huang J, Finley DJ, Rusch VW, Rizk NP. Pretreatment Rustum NR, Sala E, Vargas HA. The impact of FDG-PET/CT in the
dysphagia in esophageal cancer patients may eliminate the need management of patients with vulvar and vaginal cancer. Gynecologic
for staging by endoscopic ultrasonography. Annals of Thoracic Oncology. 2016;140(3):420-424. PMCID: PMC4988238
Robin TP, Gan GN, Tam M, Westerly D, Riaz N, Karam SD, Lee N, Raben
Ripley RT, Suzuki K, Tan KS, Adusumilli PS, Huang J, Park BJ, Downey D. Safety of contralateral submandibular gland sparing in locally
RJ, Rizk NP, Rusch VW, Bains M, Jones DR. Postinduction positron advanced oropharyngeal cancers: A multicenter review. Head and
emission tomography assessment of N2 nodes is not associated Neck. 2016;38(4):506-511.
with ypN2 disease or overall survival in stage IIIA non-small cell lung
cancer. Journal of Thoracic and Cardiovascular Surgery. 2016;151(4):969- Robinson JK, Halpern AC. Cost-effective melanoma screening. JAMA
979.e3. PMCID: PMC4801676 Dermatology. 2016;152(1):19-21. PMCID: PMC4862863
Ritenour CWM, Seidel KD, Leisenring W, Mertens AC, Wasilewski-Masker Robles A I, Olsen KS, Tsui DWY, Georgoulias V, Creaney J, Dobra K,
K, Shnorhavorian M, Sklar CA, Whitton JA, Stovall M, Constine LS, Vyberg M, Minato N, Anders RA, Børresen-Dale AL, Zhou J, Sætrom
Armstrong GT, Robison LL, Meacham LR. Erectile dysfunction in male P, Nielsen BS, Kirschner MB, Krokan HE, Papadimitrakopoulou V,
survivors of childhood cancer - A report from the childhood cancer Tsamardinos I, Røe OD. Excerpts from the 1st international NTNU
survivor study. Journal of Sexual Medicine. 2016;13(6):945-954. PMCID: symposium on current and future clinical biomarkers of cancer: Innovation
PMC4879056 and implementation, June 16th and 17th 2016, Trondheim, Norway. Journal
of Translational Medicine. 2016;14(1):295. PMCID: PMC5069785
Rizvi NA, Chan TA. Immunotherapy and oncogenic pathways: The PTEN
connection. Cancer Discovery. 2016;6(2):128-129. PMCID: PMC4746001 Rocco G, Nason K, Brunelli A, Varela G, Waddell T, Jones DR. Management
of stage IIIA (N2) non-small cell lung cancer: A transatlantic
Rizvi NA, Hellmann MD, Brahmer JR, Juergens RA, Borghaei H, perspective. Annals of Thoracic Surgery. 2016;101(4):1247-1250.
Gettinger S, Chow LQ, Gerber DE, Laurie SA, Goldman JW, Shepherd
FA, Chen AC, Shen Y, Nathan FE, Harbison CT, Antonia S. Nivolumab in Rocco G, Nason K, Brunelli A, Varela G, Waddell T, Jones
combination with platinum-based doublet chemotherapy for first-line DR. Management of stage IIIA (N2) non-small cell lung cancer: A
192 OF 324
Journal Articles
transatlantic perspective. Journal of Thoracic and Cardiovascular DG, Cosulich S, Klinowska T, Rosen N, Shokat KM. Overcoming
Surgery. 2016;151(5):1235-1238. mTOR resistance mutations with a new-generation mTOR
inhibitor. Nature. 2016;534(7606):272-276. PMCID: PMC4902179
Rocco G, Nason K, Brunelli A, Varela G, Waddell T, Jones
DR. Management of stage IIIA (N2) non-small-cell lung cancer: A Rogers T, Marino ML, Dusza SW, Bajaj S, Usatine RP, Marchetti
transatlantic perspective. European Journal of Cardio-Thoracic MA, Marghoob AA. A clinical aid for detecting skin cancer: The triage
Surgery. 2016;49(4):1025-1027. PMCID: PMC4794446 amalgamated dermoscopic algorithm (TADA). Journal of the American
Board of Family Medicine. 2016;29(6):694-701.
Rocha PP, Raviram R, Fu Y, Kim J, Luo VM, Aljoufi A, Swanzey E,
Pasquarella A, Balestrini A, Miraldi ER, Bonneau R, Petrini J, Schotta Rogers T, Marino ML, Raciti P, Jain M, Busam KJ, Marchetti
G, Skok JA. A damage-independent role for 53BP1 that impacts break MA, Marghoob AA. Biologically distinct subsets of nevi. Giornale Italiano
order and Igh architecture during class switch recombination. Cell di Dermatologia e Venereologia. 2016;151(4):365-384.
Roma AA, Mistretta TA, De Vivar AD, Park KJ, Alvarado-Cabrero I, Rasty
Roche KL, Angarita AM, Cristello A, Lippitt M, Haider AH, Bowie J G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R,
V, Fader AN, Tergas A I. “Little big things”: A qualitative study of Barbuto D, Rutgers JKL, Silva EG. New pattern-based personalized
ovarian cancer survivors and their experiences with the health care risk stratification system for endocervical adenocarcinoma with
system. Journal of Oncology Practice. 2016;12(12):e974-e980. important clinical implications and surgical outcome. Gynecologic
Oncology. 2016;141(1):36-42.
Rodina A, Wang T, Yan P, Gomes ED, Dunphy MPS, Pillarsetty N, Koren
J 3rd, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh Roman BR, Goldenberg D, Givi B, The Education Committee of American
M, Corben A, Riolo M, Beattie B, Pressl C, Peter R I, Xu C, Trondl Head and Neck Society (AHNS). AHNS Series — Do you know your
R, Patel HJ, Shimizu F, Bolaender A, Yang C, Panchal P, Farooq guidelines? Guideline recommended follow-up and surveillance of head
MF, Kishinevsky S, Modi S, Lin O, Chu F, Patil S, Erdjument-Bromage and neck cancer survivors. Head and Neck. 2016;38(2):168-174.
H, Zanzonico P, Hudis C, Studer L, Roboz GJ, Cesarman E, Cerchietti
L, Levine R, Melnick A, Larson SM, Lewis JS, Guzman ML, Chiosis G. The Romanienko PJ, Giacalone J, Ingenito J, Wang YJ, Isaka M, Johnson
epichaperome is an integrated chaperome network that facilitates T, You Y, Mark WH. A vector with a single promoter for in vitro
tumour survival. Nature. 2016;538(7625):397-401. PMCID: PMC5283383 transcription and mammalian cell expression of CRISPR gRNAs. PLoS
ONE. 2016;11(2):e0148362. PMCID: PMC4744079
Rodriguez ES. Considerations for the doctor of nursing practice
degree. Oncology Nursing Forum. 2016;43(1):26-29. Romero-Otero J, García-Gómez B, Duarte-Ojeda JM, Rodríguez-Antolín
A, Vilaseca A, Carlsson S V, Touijer KA. Active surveillance for prostate
Rodríguez VM, Corona R, Bodurtha JN, Quillin JM. Family ties: The role of cancer. International Journal of Urology. 2016;23(3):211-218. PMCID:
family context in family health history communication about cancer. Journal PMC4966658
of Health Communication. 2016;21(3):346-355. PMCID: PMC4852547
Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, Sine
Rodrik-Outmezguine VS, Okaniwa M, Yao Z, Novotny CJ, McWhirter KM, Tang S, Sherman EJ, Wong R, Lee NY. Proton beam radiation
C, Banaji A, Won H, Wong W, Berger M, De Stanchina E, Barratt therapy results in significantly reduced toxicity compared with intensity-
193 OF 324
Journal Articles
modulated radiation therapy for head and neck tumors that require PJ, D’Angelica M I, DeMatteo RP, Fong Y, Kingham TP, Kowdley K
ipsilateral radiation. Radiotherapy and Oncology. 2016;118(2):286- V, Jarnagin WR, Rocha FG. The role of biliary carcinoembryonic antigen-
292. PMCID: PMC4980117 related cellular adhesion molecule 6 (CEACAM6) a sa biomarker in
cholangiocarcinoma. PLoS ONE. 2016;11(3):e0150195. PMCID: PMC4790932
Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, Deselm C, Fox JL,
Mah D, Garg MK, Han-Chih Chang J, Lee NY. Proton beam reirradiation Rosenberg JE, Hoffman-Censits J, Powles T, van der Heijden MS, Balar A
for recurrent head and neck cancer: Multi-institutional report on V, Necchi A, Dawson N, O’Donnell PH, Balmanoukian A, Loriot Y, Srinivas
feasibility and early outcomes. International Journal of Radiation S, Retz MM, Grivas P, Joseph RW, Galsky MD, Fleming MT, Petrylak DP,
Oncology, Biology, Physics. 2016;95(1):386-395. PMCID: PMC4997784 Perez-Gracia JL, Burris HA, Castellano D, Canil C, Bellmunt J, Bajorin
D, Nickles D, Bourgon R, Frampton GM, Cui N, Mariathasan S, Abidoye
Rooper LM, Huang SC, Antonescu CR, Westra WH, Bishop O, Fine GD, Dreicer R. Atezolizumab in patients with locally advanced
JA. Biphenotypic sinonasal sarcoma: An expanded immunoprofile and metastatic urothelial carcinoma who have progressed following
including consistent nuclear β-catenin positivity and absence of SOX10 treatment with platinum-based chemotherapy: A single-arm, multicentre,
expression. Human Pathology. 2016;55:44-50. PMCID: PMC4981530 phase 2 trial. Lancet. 2016;387(10031):1909-1920.
Root JC, Andreotti C, Tsu L, Ellmore TM, Ahles TA. Learning and Rosenberger LH, Mamtani A, Fuzesi S, Stempel M, Eaton A, Morrow
memory performance in breast cancer survivors 2 to 6 years post- M, Gemignani ML. Early adoption of the SSO-ASTRO consensus
treatment: The role of encoding versus forgetting. Journal of Cancer guidelines on margins for breast-conserving surgery with whole-breast
Survivorship. 2016;10(3):593-599. PMCID: PMC4864094 irradiation in stage I and II invasive breast cancer: Initial experience
from Memorial Sloan Kettering Cancer Center. Annals of Surgical
Roper N, Korenstein D. Industry collaboration and primary guest Oncology. 2016;23(10):3239-3246. PMCID: PMC5070650
authorship of high-impact clinical trials. Journal of General Internal
Medicine. 2016;31(1):12. PMCID: PMC4700019 Rosenfeld JA, Reeves D, Brugler MR, Narechania A, Simon S, Durrett
R, Foox J, Shianna K, Schatz MC, Gandara J, Afshinnekoo E, Lam
Rosa W. Vulnerability & mental health challenges: Three case studies ET, Hastie AR, Chan S, Cao H, Saghbini M, Kentsis A, Planet PJ,
form local to global. Beginnings. 2016;36(6):16-22. Kholodovych V, Tessler M, Baker R, DeSalle R, Sorkin LN, Kolokotronis
SO, Siddall ME, Amato G, Mason CE. Genome assembly and
Rosa-Rosa JM, Leskela S, Cristobal-Lana E, Santon A, Lopez-Garcia MA,
geospatial phylogenomics of the bed bug Cimex lectularius. Nature
Munoz G, Perez-Mies B, Biscuola M, Prat J, Esther OE, Soslow RA, Matias-
Guiu X, Palacios J. Molecular genetic heterogeneity in undifferentiated
endometrial carcinomas. Modern Pathology. 2016;29(11):1390-1398. Rosenkrantz AB, Friedman K, Chandarana H, Melsaether A, Moy L, Ding
YS, Jhaveri K, Beltran L, Jain R. Current status of hybrid PET/MRI in
Rosati CM, Koniaris LG, Molena D, Blitzer D, Su KW, Tahboub M, Vardas
oncologic imaging. American Journal of Roentgenology. 2016;206(1):162-
PN, Girardi LN, Gaudino M. Characteristics of cardiothoracic surgeons
172. PMCID: PMC4915069
practicing at the top-ranked US institutions. Journal of Thoracic
Disease. 2016;8(11):3232-3244. PMCID: PMC5179456 Rosenthal R, McGranahan N, Herrero J, Taylor BS, Swanton
C. deconstructSigs: Delineating mutational processes in single tumors
Rose JB, Correa-Gallego C, Li Y, Nelson J, Alseidi A, Helton WS, Allen
194 OF 324
Journal Articles
distinguishes DNA repair deficiencies and patterns of carcinoma progenitor cells vary temporally and spatially. Developmental
evolution. Genome Biology. 2016;17:31. PMCID: PMC4762164 Biology. 2016;409(1):261-271. PMCID: PMC4827254
Rosner MH, Edeani A, Yanagita M, Glezerman IG, Leung N, for the Roy DM, Walsh LA, Desrichard A, Huse JT, Wu W, Gao J, Bose P, Lee
American Society of Nephrology Onco-Nephrology Forum. Paraprotein- W, Chan TA. Integrated genomics for pinpointing survival loci within
related kidney disease: Diagnosing and treating monoclonal arm-level somatic copy number alterations. Cancer Cell. 2016;29(5):737-
gammopathy of renal significance. Clinical Journal of the American 750. PMCID: PMC4864611
Society of Nephrology. 2016;11(12):2280-2287. PMCID: PMC5142062
Roy-Chowdhuri S, Aisner DL, Allen TC, Beasley MB, Borczuk A, Cagle
Rossi A, Marghoob A. Are patients capable and comfortable PT, Capelozzi V, Dacic S, da Cunha Santos G, Hariri LP, Kerr KM,
using mobile teledermoscopy?. British Journal of Lantuejoul S, Mino-Kenudson M, Moreira A, Raparia K, Rekhtman N,
Dermatology. 2016;175(6):1146. PMCID: PMC5180364 Sholl L, Thunnissen E, Tsao MS, Vivero M, Yatabe Y. Biomarker testing in
lung carcinoma cytology specimens: A perspective from members of
Rossi AM. Introduction. Seminars in Cutaneous Medicine and the Pulmonary Pathology Society. Archives of Pathology & Laboratory
Surgery. 2016;35(1):1. Medicine. 2016;140(11):1267-1272.
Rossi AM. Introduction. Seminars in Cutaneous Medicine and Royston DJ, Gao Q, Nguyen N, Maslak P, Dogan A, Roshal M. Single-
Surgery. 2016;35(1):1. tube 10-fluorochrome analysis for efficient flow cytometric evaluation of
minimal residual disease in plasma cell myeloma. American Journal of
Rossi AM. Tips and tools for melanoma diagnosis. Cutis. 2016;97(6):394. Clinical Pathology. 2016;146(1):41-49.
Rossi EL, de Angel RE, Bowers LW, Khatib SA, Smith LA, Van Buren E, Rubin LR, Roberts K. Prophylactic mastectomy: Insights from women
Bhardwaj P, Giri D, Estecio MR, Troester MA, Hair BY, Kirk EL, Gong T, who chose to reduce their risk. Psycho-Oncology. 2016;25(6):747-748.
Shen J, Dannenberg AJ, Hursting SD. Obesity-associated alterations
in inflammation, epigenetics, and mammary tumor growth persist Rubio-Tapia A, Ludvigsson JF, Choung RS, Brantner TL, Rajkumar S
in formerly obese mice. Cancer Prevention Research. 2016;9(5):339- V, Landgren O, Murray JA. Increased mortality among men aged 50
348. PMCID: PMC4854773 years old or above with elevated IgA anti-transglutaminase antibodies:
NHANES III. BMC Gastroenterology. 2016;16(1):136. PMCID: PMC5093944
Rössing RM, Jentzen W, Nagarajah J, Bockisch A, Görges
R. Serum thyroglobulin doubling time in progressive thyroid Rudin CM, Giaccone G, Ismalla N. Treatment of small-cell lung
cancer. Thyroid. 2016;26(12):1712-1718. cancer: American Society of Clinical Oncology endorsement of the
american college of chest physicians guideline. Journal of Oncology
Roxbury D, Jena P V, Shamay Y, Horoszko CP, Heller DA. Cell membrane Practice. 2016;12(1):83-87.
proteins modulate the carbon nanotube optical bandgap via surface
charge accumulation. ACS Nano. 2016;10(1):499-506. PMCID: PMC4975035 Rugo HS, Hortobagyi GN, Yao J, Pavel M, Ravaud A, Franz D, Ringeisen
F, Gallo J, Rouyrre N, Anak O, Motzer R. Meta-analysis of stomatitis
Roy D, Michaelson D, Hochman T, Santella A, Bao Z, Goldberg JD, in clinical studies of everolimus: Incidence and relationship with
Hubbard EJA. Cell cycle features of C. elegans germline stem/
195 OF 324
Journal Articles
efficacy. Annals of Oncology. 2016;27(3):519-525. PMCID: PMC4769991 Russell J, Tian J, Kinuya S, Shen B, Li XF. Molecular
imaging for personalized medicine. Biomed Research
Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN, International. 2016;2016:5170159. PMCID: PMC5019926
Fallowfield L, Fowble B, Ingle JN, Jahanzeb M, Johnston SRD, Korde
LA, Khatcheressian JL, Mehta RS, Muss HB, Burstein HJ. Endocrine Russo P. Delayed systemic treatment in metastatic renal-cell
therapy for hormone receptor-positive metastatic breast cancer: carcinoma. Lancet Oncology. 2016;17(9):1187-1189.
American Society of Clinical Oncology Guideline. Journal of Clinical
Oncology. 2016;34(25):3069-3103. Russo P. Editorial comment. Urology. 2016;93:129.
Runyan CM, Sharma V, Staffenberg DA, Levine JP, Brecht Rustenburg AS, Dancer J, Lin B, Feng JA, Ortwine DF, Mobley
LE, Wexler LH, Hirsch DL. Jaw in a day: State of the art in maxillary DL, Chodera JD. Measuring experimental cyclohexane-water distribution
reconstruction. Journal of Craniofacial Surgery. 2016;27(8):2101-2104. coefficients for the SAMPL5 challenge. Journal of Computer-Aided
Molecular Design. 2016;30(11):945-958. PMCID: PMC5209288
Rusch VW, Chansky K, Kindler HL, Nowak AK, Pass H I, Rice DC,
Shemanski L, Galateau-Sallé F, McCaughan BC, Nakano T, Ruffini E, Rutgers JKL, Roma AA, Park KJ, Zaino RJ, Johnson A, Alvarado I, Daya
Van Meerbeeck JP, Yoshimura M, on behalf of the IASLC Staging and D, Rasty G, Longacre TA, Ronnettl BM, Silvan EG. Pattern classification
Prognostic Factors Committee advisory boards and participating of endocervical adenocarcinoma: Reproducibility and review of
institutions. The IASLC Mesothelioma Staging Project: Proposals criteria. Modern Pathology. 2016;29(9):1083-1094.
for the M descriptors and for revision of the TNM stage groupings
in the forthcoming (eighth) edition of the TNM classification for Rutter CM, Knudsen AB, Marsh TL, Doria-Rose VP, Johnson E, Pabiniak
mesothelioma. Journal of Thoracic Oncology. 2016;11(12):2112-2119. C, Kuntz KM, Van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar
I. Validation of models used to inform colorectal cancer screening
Rusch VW, Gill R, Mitchell A, Naidich D, Rice DC, Pass H I, Kindler HL, guidelines. Medical Decision Making. 2016;36(5):604-614. PMCID:
De Perrot M, Friedberg J, on behalf of the Malignant Mesothelioma PMC5009464
Volumetric CT Study Group. A multicenter study of volumetric computed
tomography for staging malignant pleural mesothelioma. Annals of Sabari JK, Chaft JE. Have adjuvant tyrosine kinase inhibitors lost
Thoracic Surgery. 2016;102(4):1059-1066. PMCID: PMC5031145 their shine?. Annals of Translational Medicine. 2016;4(15):285. PMCID:
PMC4980379
Rusch VW, Rimner A, Adusumilli PS. SMART or simply bold?. Journal of
Thoracic and Cardiovascular Surgery. 2016;151(2):476-477. Sabath DE, Bender MA, Sankaran VG, Vamos E, Kentsis A, Yi HS,
Greisman HA. Characterization of deletions of the HBA and HBB loci
Rusch VW. Perioperative pharmacotherapy for lung resection: by array comparative genomic hybridization. Journal of Molecular
“Going for the gold’’?. Journal of Thoracic and Cardiovascular Diagnostics. 2016;18(1):92-99. PMCID: PMC4715224
Surgery. 2016;151(1):18-19.
Sabra MM, Ghossein R, Tuttle RM. Time course and predictors of structural
Rusch VW. Stage III non-small cell lung cancer. Seminars in Respiratory disease progression in pulmonary metastases arising from follicular cell-
and Critical Care Medicine. 2016;37(5):727-735. derived thyroid cancer. Thyroid. 2016;26(4):518-524. PMCID: PMC5076482
196 OF 324
Journal Articles
Saddawi-Konefka R, Seelige R, Gross ETE, Levy E, Searles SC, day. Advances and concepts in cervical cancer trials: A road map for the
Washington A Jr, Santosa EK, Liu B, O’Sullivan TE, Harismendy O, Bui future. International Journal of Gynecological Cancer. 2016;26(1):199-
JD. Nrf2 induces IL-17D to mediate tumor and virus surveillance. Cell 207. PMCID: PMC4831060
Sahin IH, Geyer A I, Kelly DW, O’Reilly EM. Gemcitabine-related
Sadelain M. Chimeric antigen receptors: Driving immunology towards pneumonitis in pancreas adenocarcinoma - An infrequent event:
synthetic biology. Current Opinion in Immunology. 2016;41:68-76. Elucidation of risk factors and management implications. Clinical
Colorectal Cancer. 2016;15(1):24-31. PMCID: PMC4981480
Sadelain M. Tales of antigen evasion from CAR therapy. Cancer
Immunology Research. 2016;4(6):473-473. Sahin IH, Iacobuzio-Donahue CA, O’Reilly EM. Molecular signature of
pancreatic adenocarcinoma: An insight from genotype to phenotype
Sadot E, Lee SY, Sofocleous CT, Solomon SB, Gönen M, Kingham and challenges for targeted therapy. Expert Opinion on Therapeutic
TP, Allen PJ, DeMatteo RP, Jarnagin WR, Hudis CA, D’Angelica Targets. 2016;20(3):341-359. PMCID: PMC4985526
M I. Hepatic resection or ablation for isolated breast cancer liver
metastasis: A case-control study with comparison to medically treated Sahin IH, Lowery MA, Stadler ZK, Salo-Mullen E, Iacobuzio-Donahue
patients. Annals of Surgery. 2016;264(1):147-154. PMCID: PMC4818209 CA, Kelsen DP, O’Reilly EM. Genomic instability in pancreatic
adenocarcinoma: A new step towards precision medicine and novel
Sadot E, Reidy-Lagunes DL, Tang LH, Do RKG, Gonen M, D’Angelica therapeutic approaches. Expert Review of Gastroenterology and
M I, DeMatteo RP, Kingham TP, Koerkamp BG, Untch BR, Brennan Hepatology. 2016;10(8):893-905. PMCID: PMC4988832
MF, Jarnagin WR, Allen PJ. Observation versus resection for small
asymptomatic pancreatic neuroendocrine tumors: A matched Saiz N, Kang M, Schrode N, Lou X, Hadjantonakis AK. Quantitative
case-control study. Annals of Surgical Oncology. 2016;23(4):1361- analysis of protein expression to study lineage specification
1370. PMCID: PMC4798427 in mouse preimplantation embryos. Journal of Visualized
Experiments. 2016;2016(108):e53654. PMCID: PMC4828170
Safdar N, Abbo LM, Knobloch MJ, Seo SK. Research methods in
healthcare epidemiology: Survey and qualitative research. Infection Saiz N, Williams KM, Seshan VE, Hadjantonakis AK. Asynchronous
Control and Hospital Epidemiology. 2016;37(11):1272-1277. fate decisions by single cells collectively ensure consistent
lineage composition in the mouse blastocyst. Nature
Sag AA, Brody LA, Maybody M, Erinjeri JP, Wang X, Wimmer T, Silk Communications. 2016;7:13463.
M, Petre EN, Solomon SB. Acute and delayed bleeding requiring
embolization after image-guided liver biopsy in patients with Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-
cancer. Clinical Imaging. 2016;40(3):535-540. Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas
G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V. Pancreatic
Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, ductal adenocarcinoma is spread to the peripancreatic soft tissue in the
McCormack M, Plante M, Casado A, Reuss A, Chávez-Blanco A, Kitchener majority of resected cases, rendering the AJCC T-stage protocol (7th
H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll edition) inapplicable and insignificant: A size-based staging system (pT1:
C, Abu-Rustum NR, Lecuru F, Small W, On behalf of the participants ≤2, pT2: >2–≤4, pT3: >4 cm) is more valid and clinically relevant. Annals of
of the Gynecologic Cancer InterGroup Cervix Cancer brainstorming Surgical Oncology. 2016;23(6):2010-2018.
197 OF 324
Journal Articles
Sakr RA, Schizas M, Scarpa Carniello J V, Ng CKY, Piscuoglio S, Giri Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt S
D, Andrade VP, de Brot M, Lim RS, Towers R, Weigelt B, Reis-Filho I, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello
JS, King TA. Targeted capture massively parallel sequencing analysis L, Savage SA, Taylor PR, De Vivo I, McGlynn KA, Purdue MP, Rajaraman
of LCIS and invasive lobular cancer: Repertoire of somatic genetic P, Adami HO, Ahlbom A, Albanes D, Amary MF, An SJ, Andersson U,
alterations and clonal relationships. Molecular Oncology. 2016;10(2):360- Andriole G Jr, Andrulis IL, Angelucci E, Ansell SM, Arici C, Armstrong
370. PMCID: PMC4989916 BK, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Becker
N, Benavente Y, Benhamou S, Berg C, Van Den Berg D, Bernstein L,
Salama AKS, Postow MA, Salama JK. Irradiation and immunotherapy: Bertrand KA, Birmann BM, Black A, Boeing H, Boffetta P, Boutron-
From concept to the clinic. Cancer. 2016;122(11):1659-1671. Ruault MC, Bracci PM, Brinton L, Brooks-Wilson AR, Bueno-De-Mesquita
HB, Burdett L, Buring J, Butler MA, Cai Q, Cancel-Tassin G, Canzian F,
Saleh Z, Thor M, Apte AP, Sharp G, Tang X, Veeraraghavan H, Muren Carrato A, Carreon T, Carta A, Chan JKC, Chang ET, Chang GC, Chang
L, Deasy J. A multiple-image-based method to evaluate the performance IS, Chang J, Chang-Claude J, Chen CJ, Chen CY, Chen C, Chen CH,
of deformable image registration in the pelvis. Physics in Medicine and Chen C, Chen H, Chen K, Chen KY, Chen KC, Chen Y, Chen YH, Chen YS,
Biology. 2016;61(16):6172-6180. PMCID: PMC5063075 Chen YM, Chien LH, Chirlaque MD, Choi JE, Choi YY, Chow WH, Chung
CC, Clavel J, Clavel-Chapelon F, Cocco P, Colt JS, Comperat E, Conde
Salem D, Stetler-Stevenson M, Yuan C, Landgren O. Myeloma
L, Connors JM, Conti D, Cortessis VK, Cotterchio M, Cozen W, Crouch
minimal residual disease testing in the United States:
S, Crous-Bou M, Cussenot O, Davis FG, Ding T, Diver WR, Dorronsoro
Evidence of improved standardization. American Journal of
M, Dossus L, Duell EJ, Ennas MG, Erickson RL, Feychting M, Flanagan
Hematology. 2016;91(12):E502-E503. PMCID: PMC5118175
AM, Foretova L, Fraumeni JF Jr, Freedman ND, Freeman LEB, Fuchs C,
Saltz LB. Bevacizumab in colorectal cancer: It should have Gago-Dominguez M, Gallinger S, Gao YT, Gapstur SM, Garcia-Closas M,
worked. Lancet Oncology. 2016;17(11):1469-1470. García-Closas R, Gascoyne RD, Gastier-Foster J, Gaudet MM, Gaziano
JM, Giffen C, Giles GG, Giovannucci E, Glimelius B, Goggins M, Gokgoz
Saltz LB. Genetic screening in all young patients with colorectal N, Goldstein AM, Gorlick R, Gross M, Grubb R III, Gu J, Guan P, Gunter
cancer?. Journal of Clinical Oncology. 2016;34(13):1560. M, Guo H, Habermann TM, Haiman CA, Halai D, Hallmans G, Hassan
M, Hattinger C, He Q, He X, Helzlsouer K, Henderson B, Henriksson R,
Saltz LB. Perspectives on cost and value in cancer care. JAMA Hjalgrim H, Hoffman-Bolton J, Hohensee C, Holford TR, Holly EA, Hong
Oncology. 2016;2(1):19-21. YC, Hoover RN, Horn-Ross PL, Hosain GMM, Hosgood HD III, Hsiao CF, Hu
N, Hu W, Hu Z, Huang MS, Huerta JM, Hung JY, Hutchinson A, Inskip PD,
Saltz LB. The value of considering cost, and the cost of not considering Jackson RD, Jacobs EJ, Jenab M, Jeon HS, Ji BT, Jin G, Jin L, Johansen
value. Journal of Clinical Oncology. 2016;34(7):659-660. C, Johnson A, Jung YJ, Kaaks R, Kamineni A, Kane E, Kang CH, Karagas
MR, Kelly RS, Khaw KT, Kim C, Kim HN, Kim JH, Kim JS, Kim YH, Kim YT,
Saltz LB. Value in colorectal cancer treatment: Where it is lacking, and Kim YC, Kitahara CM, Klein AP, Klein RJ, Kogevinas M, Kohno T, Kolonel
why. The Cancer Journal. 2016;22(3):232-235. LN, Kooperberg C, Kricker A, Krogh V, Kunitoh H, Kurtz RC, Kweon SS, La
Croix A, Lawrence C, Lecanda F, Lee VHF, Li D, Li H, Li J, Li YJ, Li Y, Liao
Salz T, Baxi S. Moving survivorship care plans forward: Focus on care
LM, Liebow M, Lightfoot T, Lim WY, Lin CC, Lin D, Lindstrom S, Linet MS,
coordination. Cancer Medicine. 2016;5(7):1717-1722. PMCID: PMC4944899
Link BK, Liu C, Liu J, Liu L, Ljungberg B, Lloreta J, Di Lollo S, Lu D, Lund
198 OF 324
Journal Articles
E, Malats N, Mannisto S, Marchand LL, Marina N, Masala G, Mastrangelo Sanfilippo P, Smibert P, Duan H, Lai EC. Neural specificity of the RNA-
G, Matsuo K, Maynadie M, McKay J, McKean-Cowdin R, Melbye M, Melin binding protein elav is achieved by post-transcriptional repression in
BS, Michaud DS, Mitsudomi T, Monnereau A, Montalvan R, Moore LE, non-neural tissues. Development. 2016;143(23):4474-4485. PMCID:
Mortensen LM, Nieters A, North KE, Novak AJ, Oberg AL, Offit K, Oh PMC5201049
IJ, Olson SH, Palli D, Pao W, Park IK, Park JY, Park KH, Patiño-Garcia A,
Pavanello S, Peeters PHM, Perng RP, Peters U, Petersen GM, Picci P, Pike Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP, Cha
MC, Porru S, Prescott J, Prokunina-Olsson L, Qian B, Qiao YL, Rais M, EK, Yee A, Friedman FM, Sjoberg DD, Ehdaie B, Coleman J. Impact
Riboli E, Riby J, Risch HA, Rizzato C, Rodabough R, Roman E, Roupret M, of ureteroscopy before nephroureterectomy for upper tract urothelial
Ruder AM, De Sanjose S, Scelo G, Schned A, Schumacher F, Schwartz K, carcinoma on oncologic outcomes. Urology. 2016;94:148-153. PMCID:
Schwenn M, Scotlandi K, Seow A, Serra C, Serra M, Sesso HD, Setiawan PMC5114126
VW, Severi G, Severson RK, Shanafelt TD, Shen H, Shen W, Shin MH,
Shiraishi K, Shu XO, Siddiq A, Sierrasesúmaga L, Sihoe ADL, Skibola CF, Sansone P, Ceccarelli C, Berishaj M, Chang Q, Rajasekhar VK, Perna
Smith A, Smith MT, Southey MC, Spinelli JJ, Staines A, Stampfer M, Stern F, Bowman RL, Vidone M, Daly L, Nnoli J, Santini D, Taffurelli M,
MC, Stevens VL, Stolzenberg-Solomon RS, Su J, Su WC, Sund M, Sung Shih NNC, Feldman M, Mao JJ, Colameco C, Chen J, DeMichele
JS, Sung SW, Tan W, Tang W, Tardón A, Thomas D, Thompson CA, Tinker A, Fabbri N, Healey JH, Cricca M, Gasparre G, Lyden D, Bonafé
LF, Tirabosco R, Tjønneland A, Travis RC, Trichopoulos D, Tsai FY, Tsai M, Bromberg J. Self-renewal of CD133hi cells by IL6/Notch3 signalling
YH, Tucker M, Turner J, Vajdic CM, Vermeulen RCH, Villano DJ, Vineis P, regulates endocrine resistance in metastatic breast cancer. Nature
Virtamo J, Visvanathan K, Wactawski-Wende J, Wang C, Wang CL, Wang Communications. 2016;7:10442. PMCID: PMC4748123
JC, Wang J, Wei F, Weiderpass E, Weiner GJ, Weinstein S, Wentzensen
Santella A, Kovacevic I, Herndon LA, Hall DH, Du Z, Bao Z. Digital
N, White E, Witzig TE, Wolpin BM, Wong MP, Wu C, Wu G, Wu J, Wu T,
development: A database of cell lineage differentiation in C. elegans
Wu W, Wu X, Wu YL, Wunder JS, Xiang YB, Xu J, Xu P, Yang PC, Yang
with lineage phenotypes, cell-specific gene functions and a multiscale
TY, Ye Y, Yin Z, Yokota J, Yoon H I, Yu CJ, Yu H, Yu K, Yuan JM, Zelenetz
model. Nucleic Acids Research. 2016;44(D1):D781-D785. PMCID:
A, Zeleniuch-Jacquotte A, Zhang XC, Zhang Y, Zhao X, Zhao Z, Zheng H,
PMC4702815
Zheng T, Zheng W, Zhou B, Zhu M, Zucca M, Boca SM, Cerhan JR, Ferri
GM, Hartge P, Hsiung CA, Magnani C, Miligi L, Morton LM, Smedby KE, Santosa KB, Chen X, Qi J, Ballard TNS, Kim HM, Hamill JB, Bensenhaver
Teras LR, Vijai J, Wang SS, Brennan P, Caporaso NE, Hunter DJ, Kraft P, JM, Pusic AL, Wilkins EG. Postmastectomy radiation therapy and
Rothman N, Silverman DT, Slager SL, Chanock SJ, Chatterjee N. Analysis two-stage implant-based breast reconstruction: Is there a better time
of heritability and shared heritability based on genome-wide association to irradiate?. Plastic and Reconstructive Surgery. 2016;138(4):761-
studies for thirteen cancer types. JNCI: Journal of the National Cancer 769. PMCID: PMC5117482
Institute. 2016;107(12):djv279. PMCID: PMC4806328
Santosa KB, Qi J, Kim HM, Hamill JB, Pusic AL, Wilkins EG. Effect of
Samstein RM, Carvajal RD, Postow MA, Callahan MK, Shoushtari patient age on outcomes in breast reconstruction: Results from a
AN, Patel SG, Lee NY, Barker CA. Localized sinonasal mucosal multicenter prospective study. Journal of the American College of
melanoma: Outcomes and associations with stage, radiotherapy, Surgeons. 2016;223(6):745-754. PMCID: PMC5124383
and positron emission tomography response. Head and
Neck. 2016;38(9):1310-1317. Saracino RM, Rosenfeld B, Nelson CJ. Towards a new conceptualization of
199 OF 324
Journal Articles
depression in older adult cancer patients: A review of the literature. Aging resistant Enterobacteriaceae in neutropenic patients with hematologic
and Mental Health. 2016;20(12):1230-1242. PMCID: PMC4925309 malignancies. Journal of Infection. 2016;73(4):336-345. PMCID:
PMC5026910
Saramago P, Woods B, Weatherly H, Manca A, Sculpher M, Khan
K, Vickers AJ, MacPherson H. Methods for network meta-analysis Saumoy M, Jesudian AB, Aden B, Serur D, Sundararajan S, Sivananthan
of continuous outcomes using individual patient data: A case G, Gambarin-Gelwan M. High prevalence of colon adenomas in end-stage
study in acupuncture for chronic pain. BMC Medical Research kidney disease patients on hemodialysis undergoing renal transplant
Methodology. 2016;16:131. PMCID: PMC5053345 evaluation. Clinical Transplantation. 2016;30(3):256-262.
Saredi G, Huang H, Hammond CM, Alabert C, Bekker-Jensen S, Saxe GN, Statnikov A, Fenyo D, Ren J, Li Z, Prasad M, Wall D, Bergman N,
Forne I, Reveron-Gomez N, Foster BM, Mlejnkova L, Bartke T, Cejka Briggs EC, Aliferis C. A complex systems approach to causal discovery in
P, Mailand N, Imhof A, Patel DJ, Groth A. H4K20me0 marks post- psychiatry. PLoS ONE. 2016;11(3):e0151174. PMCID: PMC4814084
replicative chromatin and recruits the TONSL-MMS22L DNA repair
complex. Nature. 2016;534(7609):714-718. PMCID: PMC4939875 Scaltriti M, Elkabets M, Baselga J. Molecular pathways: AXL, a
membrane receptor mediator of resistance to therapy. Clinical Cancer
Sarkaria IS, Rizk NP, Grosser R, Goldman D, Finley DJ, Ghanie Research. 2016;22(6):1313-1317. PMCID: PMC4957976
A, Sima CS, Bains MS, Adusumilli PS, Rusch VW, Jones DR. Attaining
proficiency in robotic-assisted minimally invasive esophagectomy Scharpf J, Tuttle M, Wong R, Ridge D, Smith R, Hartl D, Levine R,
while maximizing safety during procedure development. Innovations: Randolph G. Comprehensive management of recurrent thyroid cancer:
Technology and Techniques in Cardiothoracic and Vascular An American Head and Neck Society consensus statement. Head and
Surgery. 2016;11(4):268-273. Neck. 2016;38(12):1862-1869.
Sarungbam J, Agaram N, Hwang S, Lu C, Wang L, Healey J, Hameed Scher H I, Lu D, Schreiber NA, Louw J, Graf RP, Vargas HA, Johnson
M. Symplastic/pseudoanaplastic giant cell tumor of the bone. Skeletal A, Jendrisak A, Bambury R, Danila D, McLaughlin B, Wahl J, Greene
Radiology. 2016;45(7):929-935. PMCID: PMC4996350 SB, Heller G, Marrinucci D, Fleisher M, Dittamore R. Association of AR-
V7 on circulating tumor cells as a treatment-specific biomarker with
Satagopan JM, Sen A, Zhou Q, Lan Q, Rothman N, Langseth H, Engel outcomes and survival in castration-resistant prostate cancer. JAMA
LS. Bayes and empirical Bayes methods for reduced rank regression Oncology. 2016;2(11):1441-1449. PMCID: PMC5206761
models in matched case-control studies. Biometrics. 2016;72(2):584-
595. PMCID: PMC4870158 Scher H I, Heller G, Molina A, Kheoh T, De Bono JS. Reply to A. Addeo
and A. Bahl. Journal of Clinical Oncology. 2016;34(4):387-388.
Satasivam P, Poon BY, Ehdaie B, Vickers AJ, Eastham JA. Can
confirmatory biopsy be omitted in patients with prostate cancer Scher H I, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K,
favorable diagnostic features on active surveillance?. Journal of Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, De Bono JS,
Urology. 2016;195(1):74-79. PMCID: PMC4840176 Dreicer R, George DJ, Heath E I, Hussain M, Kelly WK, Liu G, Logothetis
C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor O, Small
Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, Chen L, EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz
Kreiswirth BN, Walsh TJ, Seo SK. Bacteremia due to carbapenem- LH, Halabi S, Kantoff PW, Armstrong AJ. Trial design and objectives for
200 OF 324
Journal Articles
castration-resistant prostate cancer: Updated recommendations from access to high-quality cancer care. JAMA Oncology. 2016;2(4):427-428.
the prostate cancer clinical trials working group 3. Journal of Clinical
Oncology. 2016;34(12):1402-1418. PMCID: PMC4872347 Schleicher SM, Wood NM, Lee S, Feeley TW. How the Affordable Care
Act has affected cancer care in the United States: Has value for cancer
Scher H I. Defining new standards of care for men with prostate patients improved?. Oncology (Norwalk). 2016;30(5):468-471-474.
cancer. Lancet. 2016;387(10024):1135-1137.
Schlottmann F, Molena D. Anastomotic leak: An early complication
Schiavone MB, Bielen MS, Gardner GJ, Zivanovic O, Jewell with potentially long-term consequences. Journal of Thoracic
EL, Sonoda Y, Barakat RR, Chi DS, Abu-Rustum NR, Leitao MM Disease. 2016;8(10):E1219-E1220. PMCID: PMC5107498
Jr. Herniation formation in women undergoing robotically assisted
laparoscopy or laparotomy for endometrial cancer. Gynecologic Schluter J, Schoech AP, Foster KR, Mitri S. The evolution of quorum
Oncology. 2016;140(3):383-386. PMCID: PMC4767533 sensing as a mechanism to infer kinship. PLoS Computational
Biology. 2016;12(4):e1004848. PMCID: PMC4847791
Schiavone MB, Broach V, Shoushtari AN, Carvajal RD, Alektiar
K, Kollmeier MA, Abu-Rustum NR, Leitao MM Jr. Combined Schmidt MK, Hogervorst F, Van Hien R, Cornelissen S, Broeks A, Adank
immunotherapy and radiation for treatment of mucosal melanomas MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, Van Den Ouweland
of the lower genital tract. Gynecologic Oncology Reports. 2016;16:42- A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou
46. PMCID: PMC4899413 AC, Arndt V, Bermisheva M, Bogdanova N V, Bolla MK, Brauch H, Brenner
H, Brüning T, Burwinkel B, Chang-Claude J, Chenevix-Trench G, Couch
Schiavone MB, Zivanovic O, Zhou Q, Leitao MM Jr, Levine DA, Soslow FJ, Cox A, Cross SS, Czene K, Dunning AM, Fasching PA, Figueroa J,
RA, Alektiar KM, Makker V, Iasonos A, Abu-Rustum NR. Survival of Fletcher O, Flyger H, Galle E, García-Closas M, Giles GG, Haeberle L,
patients with uterine carcinosarcoma undergoing sentinel lymph node Hall P, Hillemanns P, Hopper JL, Jakubowska A, John EM, Jones M,
mapping. Annals of Surgical Oncology. 2016;23(1):196-202. PMCID: Khusnutdinova E, Knight JA, Kosma VM, Kristensen V, Lee A, Lindblom
PMC4836610 A, Lubinski J, Mannermaa A, Margolin S, Meindl A, Milne RL, Muranen TA,
Newcomb PA, Offit K, Park-Simon TW, Peto J, Pharoah PDP, Robson M,
Schietinger A, Philip M, Krisnawan VE, Chiu EY, Delrow JJ, Basom Rudolph A, Sawyer EJ, Schmutzler RK, Seynaeve C, Soens J, Southey
RS, Lauer P, Brockstedt DG, Knoblaugh SE, Hämmerling GJ, Schell MC, Spurdle AB, Surowy H, Swerdlow A, Tollenaar RAEM, Tomlinson I,
TD, Garbi N, Greenberg PD. Tumor-specific T cell dysfunction is a Trentham-Dietz A, Vachon C, Wang Q, Whittemore AS, Ziogas A, Van
dynamic antigen-driven differentiation program initiated early during Der Kolk L, Nevanlinna H, Dörk T, Bojesen S, Easton DF. Age- and tumor
tumorigenesis. Immunity. 2016;45(2):389-401. PMCID: PMC5119632 subtype- Specific breast cancer risk estimates for CHEK2∗1100delC
carriers. Journal of Clinical Oncology. 2016;34(23):2750-2760. PMCID:
Schlappe BA, Mueller JJ, Zivanovic O, Gardner GJ, Roche KL, Sonoda PMC5019754
Y, Chi DS, O’Cearbhaill RE. Cited rationale for variance in the use of primary
intraperitoneal chemotherapy following optimal cytoreduction for stage Schmitt AM, Chang HY. Long noncoding RNAs in cancer
III ovarian carcinoma at a high intraperitoneal chemotherapy utilization pathways. Cancer Cell. 2016;29(4):452-463. PMCID: PMC4831138
center. Gynecologic Oncology. 2016;142(1):13-18. PMCID: PMC4917455
Schmitt AM, Garcia JT, Hung T, Flynn RA, Shen Y, Qu K, Payumo AY,
Schleicher SM, Mullangi S, Feeley TW. Effects of narrow networks on Peres-da-Silva A, Broz DK, Baum R, Guo SL, Chen JK, Attardi LD,
201 OF 324
Journal Articles
Chang HY. An inducible long noncoding RNA amplifies DNA damage Schoolmeester JK, Stamatakos MD, Moyer AM, Park KJ, Fairbairn M,
signaling. Nature Genetics. 2016;48(11):1370-1376. PMCID: PMC5083181 Fader AN. Pleomorphic liposarcoma arising in a lipoleiomyosarcoma
of the uterus: Report of a case with genetic profiling by a next
Schneeberger VE, Allaj V, Gardner EE, Poirier JT, Rudin generation sequencing panel. International Journal of Gynecological
CM. Quantitation of murine stroma and selective purification of the Pathology. 2016;35(4):321-326.
human tumor component of patient-derived xenografts for genomic
analysis. PLoS ONE. 2016;11(9):e0160587. PMCID: PMC5017757 Schrader KA, Cheng DT, Joseph V, Prasad M, Walsh M, Zehir A, Ni
A, Thomas T, Benayed R, Ashraf A, Lincoln A, Arcila M, Stadler Z, Solit
Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, D, Hyman D, Zhang L, Klimstra D, Ladanyi M, Offit K, Berger M, Robson
Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey M. Germline variants in targeted tumor sequencing using matched
T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, normal DNA. JAMA Oncology. 2016;2(1):104-111.
Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL. Updating
the American Society of Clinical Oncology Value Framework: Revisions Schrader KA, Stratton KL, Murali R, Laitman Y, Cavallone L, Offit L, Wen
and reflections in response to comments received. Journal of Clinical YH, Thomas T, Shah S, Rau-Murthy R, Manschreck C, Salo-Mullen
Oncology. 2016;34(24):2925-2934. E, Otegbeye E, Corines M, Zhang L, Norton L, Hudis C, Klein RJ, Kauff
ND, Robson M, Stadler ZK, Haber DA, Lipkin SM, Friedman E, Foulkes
Schnitt SJ, Morrow M. False breast margins: Human factors — In WD, Altshuler D, Vijai J, Offit K. Genome sequencing of multiple
reply. Archives of Pathology & Laboratory Medicine. 2016;140(2):116. primary tumors reveals a novel PALB2 variant. Journal of Clinical
Oncology. 2016;34(8):e61-e67.
Schödel J, Grampp S, Maher ER, Moch H, Ratcliffe PJ, Russo P, Mole
DR. Hypoxia, hypoxia-inducible transcription factors, and renal Schram AM, Iasonos A, Hyman DM. Picking the right patient for human
cancer. European Urology. 2016;69(4):646-657. PMCID: PMC5012644 epidermal growth factor receptor 3 - Targeted therapy in platinum-resistant
ovarian cancer. Journal of Clinical Oncology. 2016;34(36):4312-4314.
Schöder H, Moskowitz C. Metabolic tumor volume in lymphoma: Hype or
hope?. Journal of Clinical Oncology. 2016;34(30):3591-3594. Schultheis AM, Martelotto LG, De Filippo MR, Piscuoglio S, Ng
CKY, Hussein YR, Reis JS, Soslow RA, Weigelt B. TP53 mutational spectrum
Schoder H, Zelenetz AD, Hamlin P, Gavane S, Horwitz S, Matasar in endometrioid and serous endometrial cancers. International Journal of
M, Moskowitz A, Noy A, Palomba L, Portlock C, Straus D, Grewal Gynecological Pathology. 2016;35(4):289-300. PMCID: PMC5087968
R, Migliacci JC, Larson SM, Moskowitz CH. Prospective study of
3′-deoxy-3′-(18)F-fluorothymidine PET for early interim response Schultheis AM, Ng CKY, De Filippo MR, Piscuoglio S, Macedo GS,
assessment in advanced-stage B-cell lymphoma. Journal of Nuclear Gatius S, Perez Mies B, Soslow RA, Lim RS, Viale A, Huberman KH,
Medicine. 2016;57(5):728-734. PMCID: PMC4854760 Palacios JC, Reis-Filho JS, Matias-Guiu X, Weigelt B. Massively parallel
sequencing-based clonality analysis of synchronous endometrioid
Schofield RC, Ramanathan L V, Murata K, Fleisher M, Pessin MS, Carlow endometrial and ovarian carcinomas. JNCI: Journal of the National
DC. Development of an assay for methotrexate and its metabolites Cancer Institute. 2016;108(6):djv427. PMCID: PMC4909128
7-hydroxy methotrexate and DAMPA in serum by LC-MS/MS. Methods in
Molecular Biology. 2016;1383:213-222. Schumacher B, Mishra NK, Dusza SW, Halpern AC, Stoecker W
V. Computer-aided classification of melanocytic lesions using
202 OF 324
Journal Articles
dermoscopic images: Low reported accuracy for reader study Schwei RJ, Del Pozo S, Agger-Gupta N, Alvarado-Little W, Bagchi A,
on melanomas with low melanoma in situ to invasive melanoma Chen AH, Diamond L, Gany F, Wong D, Jacobs EA. Changes in research
ratio - To the editor . Journal of the American Academy of on language barriers in health care since 2003: A cross-sectional review
Dermatology. 2016;75(3):e119-e120. study. International Journal of Nursing Studies. 2016;54:36-44. PMCID:
PMC4943579
Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ,
Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Schwer B, Khalid F, Shuman S. Mechanistic insights into the
Bernstein ML, Lipshultz SE. Intensified chemotherapy with dexrazoxane manganese-dependent phosphodiesterase activity of yeast
cardioprotection in newly diagnosed nonmetastatic osteosarcoma: Dbr1 with bis-pnitrophenylphosphate and branched RNA
A report from the Children’s Oncology Group. Pediatric Blood and substrates. RNA. 2016;22(12):1819-1827. PMCID: PMC5113202
Cancer. 2016;63(1):54-61. PMCID: PMC4779061
Schwer B, Kruchten J, Shuman S. Structure-function analysis and genetic
Schwartz GK, Dickson MA, LoRusso PM, Sausville EA, Maekawa Y, interactions of the SmG, SmE, and SmF subunits of the yeast Sm protein
Watanabe Y, Kashima N, Nakashima D, Akinaga S. Preclinical and first-in- ring. RNA. 2016;22(9):1320-1328. PMCID: PMC4986888
human phase I studies of KW-2450, an oral tyrosine kinase inhibitor with
insulin-like growth factor receptor-1/insulin receptor selectivity. Cancer Sciubba DM, Goodwin CR, Yurter A, Ju D, Gokaslan ZL, Fisher C, Rhines
Science. 2016;107(4):499-506. PMCID: PMC4832855 LD, Fehlings MG, Fourney DR, Mendel E, Laufer I, Bettegowda C, Patel
SR, Rampersaud YR, Sahgal A, Reynolds J, Chou D, Weber MH, Clarke
Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S, MJ. A systematic review of clinical outcomes and prognostic factors for
Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, patients undergoing surgery for spinal metastases secondary to breast
Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L. RECIST 1.1— cancer. Global Spine Journal. 2016;6(5):482-496. PMCID: PMC4947406
Update and clarification: From the RECIST committee. European Journal
of Cancer. 2016;62:132-137. Scope A, Selinger L, Oliviero M, Farnetani F, Moscarella E, Longo C,
Rabinovitz HS, Pellacani G. Precise longitudinal tracking of microscopic
Schwartz LH, Seymour L, Litière S, Ford R, Gwyther S, Mandrekar structures in melanocytic nevi using reflectance confocal microscopy: A
S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, feasibility study. JAMA Dermatology. 2016;152(3):299-304.
Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, De
Vries E. RECIST 1.1 - Standardisation and disease-specific adaptations: Scope A, Marchetti MA, Marghoob AA, Dusza SW, Geller AC, Satagopan
Perspectives from the RECIST Working Group. European Journal of JM, Weinstock MA, Berwick M, Halpern AC. The study of nevi in children:
Cancer. 2016;62:138-145. Principles learned and implications for melanoma diagnosis. Journal of
the American Academy of Dermatology. 2016;75(4):813-823. PMCID:
Schwartz RM, Yip R, Olkin I, Sikavi D, Taioli E, Henschke C, for PMC5030195
the International Early Lung Cancer Action Program (I-ELCAP)
investigators. Impact of surgery for stage IA non-small cell lung Scope A, Marchetti MA. An evolving approach to the detection of
cancer on patient quality of life. Journal of Community and Supportive melanoma and other skin cancers using in vivo reflectance confocal
Oncology. 2016;14(1):37-44. microscopy. JAMA Dermatology. 2016;152(10):1085-1087.
203 OF 324
Journal Articles
Scott JM, Adams SC, Koelwyn GJ, Jones LW. Cardiovascular late effects IS, MSKCC VTE Task Force. Preoperative chemoprophylaxis is
and exercise treatment in breast cancer: Current evidence and future safe in major oncology operations and effective at preventing
directions. Canadian Journal of Cardiology. 2016;32(7):881-890. venous thromboembolism. Journal of the American College of
Surgeons. 2016;222(2):129-137. PMCID: PMC4729628
Scott JM, Armenian S, Giralt S, Moslehi J, Wang T, Jones
LW. Cardiovascular disease following hematopoietic stem cell Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de
transplantation: Pathogenesis, detection, and the cardioprotective role of Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A, Weinhold N, Lee
aerobic training. Critical Reviews in Oncology Hematology. 2016;98:222- W, Manley BJ, Khalil DN, Kaffenberger SD, Chen Y, Danilova L, Voss
234. PMCID: PMC5003053 MH, Coleman JA, Russo P, Reuter VE, Chan TA, Cheng EH, Scheinberg
DA, Li MO, Choueiri TK, Hsieh JJ, Sander C, Hakimi AA. Tumor immune
Seed TM, Xiao S, Manley N, Nikolich-Zugich J, Pugh J, Van Den Brink M, microenvironment characterization in clear cell renal cell carcinoma
Hirabayashi Y, Yasutomo K, Iwama A, Koyasu S, Shterev I, Sempowski identifies prognostic and immunotherapeutically relevant messenger
G, Macchiarini F, Nakachi K, Kunugi KC, Hammer CG, Dewerd LA. An RNA signatures. Genome Biology. 2016;17(1):231. PMCID: PMC5114739
interlaboratory comparison of dosimetry for a multi-institutional
radiobiological research project: Observations, problems, solutions and Şenbabaoğlu Y, Sümer SO, Sánchez-Vega F, Bemis D, Ciriello
lessons learned. International Journal of Radiation Biology. 2016;92(2):59- G, Schultz N, Sander C. A multi-method approach for proteomic
70. PMCID: PMC4976771 network inference in 11 human cancers. PLoS Computational
Biology. 2016;12(2):e1004765. PMCID: PMC4771175
Seftel MD, Neuberg D, Zhang MJ, Wang HL, Ballen KK, Bergeron J,
Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus Seo SK, Lo K, Abbo LM. Current state of antimicrobial stewardship at
HM, Nishihori T, Paulson K, Saber W, Sallan SE, Soiffer R, Tallman MS, solid organ and hematopoietic cell transplant centers in the United
Woolfrey AE, DeAngelo DJ, Weisdorf DJ, Acute Leukemia Committee States. Infection Control and Hospital Epidemiology. 2016;37(10):1195-1200.
of the CIBMTR, Dana Farber ALL Consortium. Pediatric-inspired
therapy compared to allografting for Philadelphia chromosome- Sepe R, Piscuoglio S, Quintavalle C, Perrina V, Quagliata L, Formisano U,
negative adult ALL in first complete remission. American Journal of Terracciano LM, Fusco A, Pallante P. HMGA1 overexpression is associated
Hematology. 2016;91(3):322-329. PMCID: PMC4764423 with a particular subset of human breast carcinomas. Journal of Clinical
Pathology. 2016;69(2):117-121.
Segal NH, Gada P, Senzer N, Gargano MA, Patchen ML, Saltz LB. A phase
II efficacy and safety, open-label, multicenter study of imprime PGG Setiawan VW, Pandol SJ, Porcel J, Wilkens LR, Le Marchand L, Pike
injection in combination with cetuximab in patients with stage IV KRAS- MC, Monroe KR. Prospective study of alcohol drinking, smoking,
mutant colorectal cancer. Clinical Colorectal Cancer. 2016;15(3):222-227. and pancreatitis the multiethnic cohort. Pancreas. 2016;45(6):819-
825. PMCID: PMC4905778
Seidman AD. When to combine endocrine therapy with a new agent for
hormone receptor-positive metastatic breast cancer in postmenopausal Setton J, Han J, Kannarunimit D, Wuu YR, Rosenberg SA, Deselm
women. Oncology (Norwalk). 2016;30(3):224, 226, 228. C, Wolden SL, Tsai CJ, McBride SM, Riaz N, Lee NY. Long-term
patterns of relapse and survival following definitive intensity-modulated
Selby L V, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones radiotherapy for non-endemic nasopharyngeal carcinoma. Oral
DR, Scardino PT, Soff GA, Fabbri N, Sepkowitz K, Strong VE, Sarkaria Oncology. 2016;53:67-73. PMCID: PMC4975930
204 OF 324
Journal Articles
Sevransky JE, Chai ZJ, Cotsonis GA, Cobb JP, Pastores SM. Survey of following allogeneic hematopoietic cell transplantation. Biology of Blood
annual staffing workloads for adult critical care physicians working in the and Marrow Transplantation. 2016;22(4):705-709. PMCID: PMC4801764
United States. Annals of the American Thoracic Society. 2016;13(5):751-
753. PMCID: PMC5018891 Shaffer BC, Tallman M, Malone AK, Reshef R, Litzow M, Liesveld J, Wiernik
PH, Ahn KW, Hu ZH, Saber W, Nishihori T, Kharfan-Dabaja MA, Valcárcel
Shabrova E, Hoyos B, Vinogradov V, Kim YK, Wassef L, Leitges M, D, Grunwald MR, Fasan O, Copelan E, Wood WA, Rizzieri DA, Bacher U,
Quadro L, Hammerling U. Retinol as a cofactor for PKC delta-mediated Hamilton B, Gerds A, Kalaycio M, Sobecks R, William B, Saad A, Costa
impairment of insulin sensitivity in a mouse model of diet-induced LJ, Cutler C, Alyea E, Warlick E, Ustun C, Wirk BM, Sabloff M, Daly
obesity. FASEB Journal. 2016;30(3):1339-1355. PMCID: PMC4750423 A, Marks D, Gale RP, Olsson R, Miller AM, Kamble R, Cortes J, Popat
U, Kindwall-Keller TL, Cahn JY, Savani BN, Vij R, Maziarz R, Pavletic
Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, Gonen S. Scoring system prognostic of outcome in patients undergoing
M, Ziv E, Boas FE, Sofocleous CT. Metabolic tumor volume and total allogeneic hematopoietic cell transplantation for myelodysplastic
lesion glycolysis on FDG-PET/CT can predict overall survival after syndrome. Journal of Clinical Oncology. 2016;34(16):1864-1871. PMCID:
90Y radioembolization of colorectal liver metastases: A comparison PMC4966345
with SUVmax, SUVpeak, and RECIST 1.0. European Journal of
Radiology. 2016;85(6):1224-1231. Shaffer TM, Drain CM, Grimm J. Optical imaging of ionizing radiation
from clinical sources. Journal of Nuclear Medicine. 2016;57(11):1661-
Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago 1666. PMCID: PMC5093029
W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D’Angelica M
I, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT. Percutaneous Shaffer TM, Harmsen S, Khwaja E, Kircher MF, Drain CM, Grimm
radiofrequency ablation of colorectal cancer liver metastases: J. Stable radiolabeling of sulfur-functionalized silica nanoparticles with
Factors affecting outcomes-a 10-year experience at a single copper-64. Nano Letters. 2016;16(9):5601-5604. PMCID: PMC5066563
center. Radiology. 2016;278(2):601-611. PMCID: PMC4734163
Shah AA, Ohori NP, Yip L, Coyne C, Antonescu CR, Seethala
Shady W, Sotirchos VS, Do RK, Pandit-Taskar N, Carrasquillo RR. Epithelioid hemangioendothelioma: A rare primary thyroid tumor
JA, Gonen M, Sofocleous CT. Surrogate imaging biomarkers of with confirmation of WWTR1 and CAMTA1 rearrangements. Endocrine
response of colorectal liver metastases after salvage radioembolization Pathology. 2016;27(2):147-152.
using (90)Y-loaded resin microspheres. American Journal of
Roentgenology. 2016;207(3):661-670. Shah GL, Winn A, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum
R, Cohen JT, Miller KB, Comenzo R, Parsons SK. Cost implications
Shaffer BC, Hsu KC. How important is NK alloreactivity and KIR in of comorbidity for autologous stem cell transplantation in elderly
allogeneic transplantation?. Best Practice and Research: Clinical patients with multiple myeloma using SEER-Medicare. Bone Marrow
Haematology. 2016;29(4):351-358. Research. 2016;2016:3645623. PMCID: PMC5088316
Shaffer BC, Le Luduec JB, Forlenza C, Jakubowski AA, Perales Shah GL, Giralt SA. Recommend upfront consolidation with high-
MA, Young JW, Hsu KC. Phase II study of haploidentical natural killer cell dose melphalan and autologous stem cell support. Seminars in
infusion for treatment of relapsed or persistent myeloid malignancies Oncology. 2016;43(6):707-708.
205 OF 324
Journal Articles
Shah GL, Moskowitz CH. Role of positron emission tomography in Shahrokni A, Wu AJ, Carter J, Lichtman SM. Long-term toxicity of cancer
diffuse large B-cell lymphoma. Hematology/Oncology Clinics of North treatment in older patients. Clinics in Geriatric Medicine. 2016;32(1):63-
America. 2016;30(6):1215-1228. 80. PMCID: PMC4839483
Shah GL, Yahalom J, Matasar MJ, Verwys SL, Goldman DA, Bantilan Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller
KS, Zhang Z, McCall SJ, Moskowitz AJ, Moskowitz CH. Risk factors AC, Halpern AC. Melanoma thickness and survival trends in the
predicting outcomes for primary refractory Hodgkin lymphoma United States, 1989 to 2009. JNCI: Journal of the National Cancer
patients treated with salvage chemotherapy and autologous stem cell Institute. 2016;108(1):djv294. PMCID: PMC4857148
transplantation. British Journal of Haematology. 2016;175(3):440-447.
Shamay Y, Elkabets M, Li H, Shah J, Brook S, Wang F, Adler K, Baut
Shah MK. The immunocompromised traveler. Oncology E, Scaltriti M, Jena P V, Gardner EE, Poirier JT, Rudin CM, Baselga
(Norwalk). 2016;30(2):142-146, 159. J, Haimovitz-Friedman A, Heller DA. P-selectin is a nanotherapeutic
delivery target in the tumor microenvironment. Science Translational
Shah N, Shi Q, Williams LA, Mendoza TR, Wang XS, Reuben JM, Medicine. 2016;8(345):345ra87. PMCID: PMC5064151
Dougherty PM, Bashir Q, Qazilbash MH, Champlin RE, Cleeland
CS, Giralt SA. Higher stem cell dose infusion after intensive Shanavas M, Popat U, Michaelis LC, Fauble V, McLornan D, Klisovic R,
chemotherapy does not improve symptom burden in older patients Mascarenhas J, Tamari R, Arcasoy MO, Davies J, Gergis U, Ukaegbu OC,
with multiple myeloma and amyloidosis. Biology of Blood and Marrow Kamble RT, Storring JM, Majhail NS, Romee R, Verstovsek S, Pagliuca A, Vasu
Transplantation. 2016;22(2):226-231. PMCID: PMC4716870 S, Ernst B, Atenafu EG, Hanif A, Champlin R, Hari P, Gupta V. Outcomes of
allogeneic hematopoietic cell transplantation in patients with myelofibrosis
Shah PD, Patil S, Dickler MN, Offit K, Hudis CA, Robson ME. Twenty- with prior exposure to Janus kinase 1/2 inhibitors. Biology of Blood and
one-gene recurrence score assay in BRCA-associated versus Marrow Transplantation. 2016;22(3):432-440. PMCID: PMC5030817
sporadic breast cancers: Differences based on germline mutation
status. Cancer. 2016;122(8):1178-1184. Sharma P, Callahan MK, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai RN,
Ott PA, de Braud F, Morse M, Le DT, Jaeger D, Chan E, Harbison C, Lin
Shaha AR. Editorial: Laryngeal evaluation for thyroid surgery: Back to the CS, Tschaika M, Azrilevich A, Rosenberg JE. Nivolumab monotherapy
basics. Surgery. 2016;159(1):65-66. PMCID: PMC4988387 in recurrent metastatic urothelial carcinoma (CheckMate 032): A
multicentre, open-label, two-stage, multi-arm, phase 1/2 trial. Lancet
Shaha AR. Revisiting the gastric pull up for pharyngoesophageal Oncology. 2016;17(11):1590-1598.
reconstruction: A systematic review and meta-analysis of mortality and
morbidity. Journal of Surgical Oncology. 2016;114(8):915-916. Sharma S, Bekelman J, Lin A, Lukens JN, Roman BR, Mitra N, Swisher-
McClure S. Clinical impact of prolonged diagnosis to treatment
Shaha AR. Right paraesophageal lymph node metastasis. European interval (DTI) among patients with oropharyngeal squamous cell
Journal of Surgical Oncology. 2016;42(1):79-80. PMCID: PMC4988395 carcinoma. Oral Oncology. 2016;56:17-24. PMCID: PMC4968047
Shaha AR. Transforming head and neck surgeon into thyroid expert: Sharma SK, Nemieboka B, Sala E, Lewis JS, Zeglis BM. Molecular
The 2016 Hayes Martin lecture. JAMA Otolaryngology - Head and Neck imaging of ovarian cancer. Journal of Nuclear Medicine. 2016;57(6):827-
Surgery. 2016;142(12):1233-1236. 833. PMCID: PMC5047520
206 OF 324
Journal Articles
Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala editor, “Lung cancer stigma and patient-provider communication: A
E, Zeglis BM, Lewis JS. Preclinical (89)Zr immuno-PET of high-grade complex association”. Supportive Care in Cancer. 2016;24(8):3271-3272.
serous ovarian cancer and lymph node metastasis. Journal of Nuclear
Medicine. 2016;57(5):771-776. PMCID: PMC4959443 Shen MJ, Prigerson HG, Paulk E, Trevino KM, Penedo FJ, Tergas A
I, Epstein AS, Neugut A I, Maciejewski PK. Impact of end-of-life
Shaw AT, Gandhi L, Gadgeel S, Riely GJ, Cetnar J, West H, Camidge DR, discussions on the reduction of Latino/non-Latino disparities in do-not-
Socinski MA, Chiappori A, Mekhail T, Chao BH, Borghaei H, Gold KA, resuscitate order completion. Cancer. 2016;122(11):1749-1756. PMCID:
Zeaiter A, Bordogna W, Balas B, Puig O, Henschel V, Ou SH I. Alectinib PMC5021070
in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-
group, multicentre, phase 2 trial. Lancet Oncology. 2016;17(2):234- Shen R, Seshan VE. FACETS: Allele-specific copy number and clonal
242. PMCID: PMC4752892 heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic
Acids Research. 2016;44(16):e131. PMCID: PMC5027494
Shaw K, Brennan N, Woo K, Zhang Z, Young R, Peck K, Holodny
A. Infiltration of the basal ganglia by brain tumors is associated with Shi H, Yamamoto S, Sheng M, Bai J, Zhang P, Chen R, Chen S, Shi
the development of co-dominant language function on fMRI. Brain and L, Abdel-Wahab O, Xu M, Zhou Y, Yang FC. ASXL1 plays an important role
Language. 2016;155-156:44-48. PMCID: PMC4868667 in erythropoiesis. Scientific Reports. 2016;6:28789. PMCID: PMC4926121
She QB, Gruvberger-Saal SK, Maurer M, Chen Y, Jumppanen M, Su Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB,
T, Dendy M, Lau YK I, Memeo L, Horlings HM, van de Vijver MJ, Isola Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang
J, Hibshoosh H, Rosen N, Parsons R, Saal LH. Integrated molecular M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S,
pathway analysis informs a synergistic combination therapy targeting Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper
PTEN/PI3K and EGFR pathways for basal-like breast cancer. BMC MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J. Smoking
Cancer. 2016;16(1):587. PMCID: PMC4971667 Cessation, Version 1.2016 Clinical Practice Guidelines in Oncology. Journal
of the National Comprehensive Cancer Network. 2016;14(11):1430-1468.
Sheffer CE, Payne T, Ostroff JS, Jolicoeur D, Steinberg M, Czabafy
S, Foulds J, Bars M, Wassum K, Perry B. Increasing the quality and Shih KK, Hajj C, Kollmeier M, Frey MK, Sonoda Y, Abu-Rustum
availability of evidence-based treatment for tobacco dependence NR, Alektiar KM. Impact of postoperative intensity-modulated radiation
through unified certification of tobacco treatment specialists. Journal of therapy (IMRT) on the rate of bowel obstruction in gynecologic
Smoking Cessation. 2016;11(4):229-235. malignancy. Gynecologic Oncology. 2016;143(1):18-21. PMCID: PMC5031532
Sheinfeld J, Becerra MF, Feldman DR. Are some cases of somatic type Shimizu K, Nuida K, Rätsch G. Efficient privacy-preserving string search
malignancy potentially avoidable?. Journal of Urology. 2016;196(1):11-13. and an application in genomics. Bioinformatics. 2016;32(11):1652-
1661. PMCID: PMC4892414
Shen MJ, Hamann HA, Thomas AJ, Ostroff JS. Association between
patient-provider communication and lung cancer stigma. Supportive Shin JA, El-Jawahri A, Parkes A, Schleicher SM, Knight HP, Temel
Care in Cancer. 2016;24(5):2093-2099. PMCID: PMC4805469 JS. Quality of life, mood, and prognostic understanding in patients with
metastatic breast cancer. Journal of Palliative Medicine. 2016;19(8):863-
Shen MJ, Hamann HA, Thomas AJ, Ostroff JS. Response to letter to the 869. PMCID: PMC4982956
207 OF 324
Journal Articles
Shiono M, Huang K, Downey RJ, Consul N, Villanueva N, Beck K, cell transplantation in human patients and mice. Science Translational
Fenn K, Dietz D, Yamaguchi T, Kato S, Divgi C, Kalinsky K, Wei Y, Medicine. 2016;8(339):339ra71. PMCID: PMC4991773
Zhang Y, Borczuk AC, Inoue A, Halmos B, Acharyya S. An analysis
of the relationship between metastases and cachexia in lung cancer Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai
patients. Cancer Medicine. 2016;5(9):2641-2648. PMCID: PMC5055184 JJ, Smith OM, Levy ER, Kreines FM, Ziegler CGK, Scallion M I, Doubrovin
M, Heller G, Younes A, O’Reilly RJ, Van Den Brink MRM, Zakrzewski
Shirole NH, Pal D, Kastenhuber ER, Senturk S, Boroda J, Pisterzi P, Miller JL. Characterization of a c-Rel inhibitor that mediates anticancer
M, Munoz G, Anderluh M, Ladanyi M, Lowe SW, Sordella R. TP53 exon-6 properties in hematologic malignancies by blocking NF-κB-controlled
truncating mutations produce separation of function isoforms with pro- oxidative stress responses. Cancer Research. 2016;76(2):377-389. PMCID:
tumorigenic functions. eLife. 2016;5:e17929. PMCID: PMC5092050 PMC4715937
Shkedy Y, Alkan U, Roman BR, Hilly O, Feinmesser R, Bachar G, Mizrachi Shoushtari AN, Carvajal RD. Treatment of uveal melanoma. Cancer
A. Role of perioperative antibiotic treatment in parotid gland surgery. Head Treatment and Research. 2016;167:281-293.
and Neck. 2016;38(Suppl. 1):E1876-E1880. PMCID: PMC4990133
Shoushtari AN, Landa J, Kuk D, Sanchez A, Lala B, Schmidt
Sholl LM, Aisner DL, Allen TC, Beasley MB, Borczuk AC, Cagle PT, N, Okoli C, Chi P, Dickson MA, Gounder MM, Keohan
Capelozzi V, Dacic S, Hariri L, Kerr KM, Lantuejoul S, Mino-Kenudson M, ML, Crago AM, Tap WD, D’Angelo SP. Overall survival and
Raparia K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao MS, Yatabe response to systemic therapy in metastatic extrauterine
Y, for the members of the Pulmonary Pathology Society. Programmed leiomyosarcoma. Sarcoma. 2016;2016:3547497. PMCID: PMC4903146
death ligand-1 immunohistochemistry—A new challenge for pathologists: A
perspective from members of the Pulmonary Pathology Society. Archives Shoushtari AN, Munhoz RR, Kuk D, Ott PA, Johnson DB, Tsai KK,
of Pathology & Laboratory Medicine. 2016;140(4):341-344. Rapisuwon S, Eroglu Z, Sullivan RJ, Luke JJ, Gangadhar TC, Salama
AKS, Clark V, Burias C, Puzanov I, Atkins MB, Algazi AP, Ribas
Sholl LM, Aisner DL, Allen TC, Beasley MB, Cagle PT, Capelozzi VL, A, Wolchok JD, Postow MA. The efficacy of anti-PD-1 agents in acral
Dacic S, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson M, Raparia and mucosal melanoma. Cancer. 2016;122(21):3354-3362. PMCID:
K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao M, Vivero M, PMC5134420
Yatabe Y. Liquid biopsy in lung cancer: A perspective from members of
the pulmonary pathology society. Archives of Pathology & Laboratory Shoushtari AN, Ong LT, Schoder H, Singh-Kandah S, Abbate KT, Postow
Medicine. 2016;140(8):825-829. MA, Callahan MK, Wolchok J, Chapman PB, Panageas KS, Schwartz
GK, Carvajal RD. A phase 2 trial of everolimus and pasireotide long-
Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai acting release in patients with metastatic uveal melanoma. Melanoma
JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay H Research. 2016;26(3):272-277.
V, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calafiore M, Poeck H, Caballero
S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy Shrestha L, Young JC. Function and chemotypes of human Hsp70
GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer chaperones. Current Topics in Medicinal Chemistry. 2016;16(25):2812-2828.
EG, Van Den Brink MRM, Jenq RR. Increased GVHD-related mortality
with broad-spectrum antibiotic use after allogeneic hematopoietic stem Shrestha L, Bolaender A, Patel HJ, Taldone T. Heat shock protein
(HSP) drug discovery and development: Targeting heat shock proteins
208 OF 324
Journal Articles
in disease. Current Topics in Medicinal Chemistry. 2016;16(25):2753- ME. Dermatological adverse events with taxane chemotherapy. European
2764. PMCID: PMC4995156 Journal of Dermatology. 2016;26(5):427-443.
Shrestha L, Patel HJ, Chiosis G. Chemical tools to investigate Sierra H, Damanpour S, Hibler B, Nehal K, Rossi A, Rajadhyaksha
mechanisms associated with HSP90 and HSP70 in disease. Cell Chemical M. Confocal imaging of carbon dioxide laser-ablated basal cell
Biology. 2016;23(1):158-172. PMCID: PMC4779498 carcinomas: An ex-vivo study on the uptake of contrast agent and
ablation parameters. Lasers in Surgery and Medicine. 2016;48(2):133-
Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, 139. PMCID: PMC4769922
Nathanson KL, Konner JA, Arnold AG, Bogomolniy F, Dao F, Olvera N,
Bancroft EK, Goldfrank DJ, Stadler ZK, Robson ME, Brown CL, Leitao Sierra H, Cordova M, Nehal K, Rossi A, Chen CSJ, Rajadhyaksha
MM Jr, Abu-Rustum NR, Aghajanian CA, Blum JL, Neuhausen SL, M. Laser ablation of basal cell carcinomas guided by
Garber JE, Daly MB, Isaacs C, Eeles RA, Ganz PA, Barakat RR, Offit K, confocal microscopy. Photonic Therapeutics and Diagnostics
Domchek SM, Rebbeck TR, Kauff ND. Uterine cancer after risk-reducing XII. 2016;9689:96890R-1-96890R-5.
salpingo-oophorectomy without hysterectomy in women with BRCA
mutations. JAMA Oncology. 2016;2(11):1434-1440. Sigel C, Cavalcanti MS, Daniel T, Vakiani E, Shia J, Sigel
K. Clinicopathologic features of colorectal carcinoma in HIV-
Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes positive patients. Cancer Epidemiology Biomarkers and
J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi Prevention. 2016;25(7):1098-1104. PMCID: PMC4942127
J, Munita JM, Hasbun R, Arias CA. Influence of minimum inhibitory
concentration in clinical outcomes of Enterococcus faecium bacteremia Sigel C, Reidy-Lagunes D, Lin O, Basturk O, Aggarwal G, Klimstra
treated with daptomycin: Is it time to change the breakpoint?. Clinical DS, Tang L. Cytological features contributing to the misclassification of
Infectious Diseases. 2016;62(12):1514-1520. PMCID: PMC4885651 pancreatic neuroendocrine tumors. Journal of the American Society of
Cytopathology. 2016;5(5):266-276.
Shukla N, Somwar R, Smith RS, Ambati S, Munoz S, Merchant M, D’Arcy
P, Wang X, Kobos R, Antczak C, Bhinder B, Shum D, Radu C, Yang Silberhumer GR, Paty PB, Denton B, Guillem J, Gonen M, Araujo RLC,
G, Taylor BS, Ng CKY, Weigelt B, Khodos I, De Stanchina E, Reis-Filho Nash GM, Temple LK, Allen PJ, DeMatteo RP, Weiser MR, Wong WD,
JS, Ouerfelli O, Linder S, Djaballah H, Ladanyi M. Proteasome addiction Jarnagin WR, D’Angelica M I, Fong Y. Long-term oncologic outcomes
defined in Ewing sarcoma is effectively targeted by a novel class of 19S for simultaneous resection of synchronous metastatic liver and primary
proteasome inhibitors. Cancer Research. 2016;76(15):4525-4534. colorectal cancer. Surgery. 2016;160(1):67-73. PMCID: PMC4911703
Shukla-Dave A, Castillo-Martin M, Chen M, Lobo J, Gladoun N, Collazo- Silva MD, Genoff M, Zaballa A, Jewell S, Stabler S, Gany FM, Diamond
Lorduy A, Khan FM, Ponomarev V, Yi Z, Zhang W, Pandolfi PP, Hricak LC. Interpreting at the end of life: A systematic review of the impact
H, Cordon-Cardo C. Ornithine decarboxylase is sufficient for prostate of interpreters on the delivery of palliative care services to cancer
tumorigenesis via androgen receptor signaling. American Journal of patients with limited english proficiency. Journal of Pain and Symptom
Pathology. 2016;186(12):3131-3145. PMCID: PMC5225291 Management. 2016;51(3):569-580. PMCID: PMC4955824
Sibaud V, Leboeuf NR, Roche H, Belum VR, Gladieff L, Deslandres Silva S, Altmannova V, Eckert-Boulet N, Kolesar P, Gallina I, Hang
M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture L, Chung I, Arneric M, Zhao X, Buron LD, Mortensen UH, Krejci L, Lisby
209 OF 324
Journal Articles
M. SUMOylation of Rad52-Rad59 synergistically change the outcome of Simpson AL, Kingham TP. Current evidence in image-guided liver
mitotic recombination. DNA Repair. 2016;42:11-25. PMCID: PMC5051639 surgery. Journal of Gastrointestinal Surgery. 2016;20(6):1265-
1269. PMCID: PMC4970568
Silvay G, Zafirova Z, Desiderio D, Valauri D, Castillo J. Serious problem
of oral health and dental evaluation before surgery. Bratislava Medical Singh R, Zhou Z, Tisnado J, Haque S, Peck KK, Young RJ, Tsiouris
Journal—Bratislavske Lekarske Listy. 2016;117(3):185-187. AJ, Thakur SB, Souweidane MM. A novel magnetic resonance
imaging segmentation technique for determining diffuse
Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan intrinsic pontine glioma tumor volume. Journal of Neurosurgery-
BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Pediatrics. 2016;18(5):565-572.
Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade O I,
Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Singh R, Ryan C, Chohan MO, Tisnado J, Hadjigeorgiou GF, Bilsky
Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon MH. Intracranial meningioma with vertebral or intraspinal
G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport- metastasis: report of 2 cases and review of the literature. Journal of
Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs Neurosurgery. 2016;25(6):775-781.
L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ,
Hallberg E, Ruddy KJ, Sharma P, Kim SW, kConFab Investigators, Sinha J, Cao Z, Dai J, Tang H, Partyka K, Hostetter G, Simeone
Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson DM, Feng Z, Allen PJ, Brand RE, Haab BB. A gastric glycoform of
OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, MUC5AC is a biomarker of mucinous cysts of the pancreas. PLoS
Balmaña J, Diez O, Ivady G, Papp J, Olah E, Kwong A, Hereditary Breast ONE. 2016;11(12):e0167070. PMCID: PMC5167232
and Ovarian Cancer Research Group Netherlands (HEBON), Nevanlinna
H, Aittomäki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Sinha S, Leach SD. New insights in the development of pancreatic
Claes KBM, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux cancer. Current Opinion in Gastroenterology. 2016;32(5):394-400.
L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D,
Sirintrapun SJ, Artz DR. Health information systems. Clinics in
Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand
Laboratory Medicine. 2016;36(1):133-152.
D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L, Platte R,
Eeles R, Ellis S, EMBRACE, Hamann U, Garber J, Fostira F, Fountzilas Sirintrapun SJ, Zehir A, Syed A, Gao J, Schultz N, Cheng
G, Pasini B, Giannini G, Rizzolo P, Russo A, Cortesi L, Papi L, Varesco DT. Translational bioinformatics and clinical research (biomedical)
L, Palli D, Zanna I, Savarese A, Radice P, Manoukian S, Peissel B, Barile informatics. Clinics in Laboratory Medicine. 2016;36(1):153-181.
M, Bonanni B, Viel A, Pensotti V, Tommasi S, Peterlongo P, Weitzel
JN, Osorio A, Benitez J, McGuffog L, Healey S, Gerdes AM, Ejlertsen Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen
B, Hansen TVO, Steele L, Ding YC, Tung N, Janavicius R, Goldgar DE, AH. Reproductive risk factors in relation to molecular subtypes of breast
Buys SS, Daly MB, Bane A, Terry MB, John EM, Southey M, Easton cancer: Results from the Nurses’ Health Studies. International Journal of
DF, Chenevix-Trench G, Antoniou AC, Ottini L. Male breast cancer Cancer. 2016;138(10):2346-2356. PMCID: PMC5245093
in BRCA1 and BRCA2 mutation carriers: Pathology data from the
Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, Liao
Research. 2016;18(1):15. PMCID: PMC4746828 RG, Andre F, Banks I, Barrett JC, Caldas C, Camargo AA, Fitzgerald
RC, Mao M, Mattison JE, Pao W, Sellers WR, Sullivan P, Teh BT, Ward
210 OF 324
Journal Articles
RL, Zenklusen JC, Sawyers CL, Voest EE. Facilitating a culture of Chari A, Jagannath S, Koehne G. CD34-selected allogeneic
responsible and effective sharing of cancer genome data. Nature hematopoietic stem cell transplantation for patients with relapsed,
Medicine. 2016;22(5):464-471. PMCID: PMC4995884 high-risk multiple myeloma. Biology of Blood and Marrow
Sjöblom L, Saramäki O, Annala M, Leinonen K, Nättinen J, Tolonen T,
Wahlfors T, Nykter M, Bova GS, Schleutker J, Tammela TLJ, Lilja H, Smith JD, Lowery MA, Fell D, Gallagher DJ, Nash GM, Kemeny NE. Young
Visakorpi T. Microseminoprotein-beta expression in different stages of patients with synchronous colorectal liver metastases. Journal of Surgical
prostate cancer. PLoS ONE. 2016;11(3):e0150241. PMCID: PMC4777373 Oncology. 2016;113(5):473-476. PMCID: PMC5125512
Slovin SF. Biomarkers for immunotherapy in genitourinary Smith MR, Antonarakis ES, Ryan CJ, Berry WR, Shore ND, Liu G,
malignancies. Urologic Oncology: Seminars and Original Alumkal JJ, Higano CS, Chow Maneval E, Bandekar R, de Boer CJ, Yu
Investigations. 2016;34(4):205-213. MK, Rathkopf DE. Phase 2 study of the safety and antitumor activity
of apalutamide (ARN-509), a potent androgen receptor antagonist,
Slovin SF. Immunotherapy for genitourinary malignancies in in the high-risk nonmetastatic castration-resistant prostate cancer
the here and now!. Urologic Oncology: Seminars and Original cohort. European Urology. 2016;70(6):963-970.
Investigations. 2016;34(4):169-170.
Smith P, Ho CK, Takagi Y, Djaballah H, Shuman S. Nanomolar inhibitors
Slovin SF. Immunotherapy for prostate cancer: Is prostate an immune of Trypanosoma brucei RNA triphosphatase. mBio. 2016;7(1):e00058-
responsive tumor?. Current Opinion in Urology. 2016;26(6):529-534. 16. PMCID: PMC4791841
Slovin SF. Immunotherapy in metastatic prostate cancer. Indian Journal Smith SC, Trpkov K, Chen YB, Mehra R, Sirohi D, Ohe C, Cani AK,
of Urology. 2016;32(4):271-276. PMCID: PMC5054656 Hovelson DH, Omata K, McHugh JB, Jochum W, Colecchia M, Amin M,
Divatia MK, Hes O, Menon S, Werneck Da Cunha I, Tripodi S, Brimo F,
Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van Gill AJ, Osunkoya AO, Magi-Galluzzi C, Sibony M, Williamson SR, Nesi G,
Der Smissen WJC, Vlugt-Daane MVD, Van Galen A, Nik-Zainal S, Staaf Picken MM, Maclean F, Agaimy A, Cheng L, Epstein J I, Reuter VE, Tickoo
J, Brinkman AB, Van De Vijver MJ, Richardson AL, Fatima A, Berentsen SK, Tomlins SA, Amin MB. Tubulocystic carcinoma of the kidney with
K, Butler A, Martin S, Davies HR, Debets R, Gelder MEM V, Van Deurzen poorly differentiated foci: A frequent morphologic pattern of fumarate
CHM, Macgrogan G, Van Den Eynden GGGM, Purdie C, Thompson AM, hydratase-deficient renal cell carcinoma. American Journal of Surgical
Caldas C, Span PN, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Pathology. 2016;40(11):1457-1472.
Ringnér M, Tommasi S, Eyford J, Broeks A, Vincent-Salomon A, Futreal
PA, Knappskog S, King T, Thomas G, Viari A, Langerød A, Børresen- Smyth LM, Iyengar NM, Chen MF, Popper SM, Patil S, Wasserheit-
Dale AL, Birney E, Stunnenberg HG, Stratton M, Foekens JA, Martens Lieblich C, Argolo DF, Singh JC, Chandarlapaty S, Sugarman
JWM. Breast cancer genome and transcriptome integration implicates SM, Comen EA, Drullinsky PR, Traina TA, Troso-Sandoval T, Baselga
specific mutational signatures with immune cell infiltration. Nature J, Norton L, Hudis CA, Dang CT. Weekly paclitaxel with trastuzumab
Communications. 2016;7:12910. PMCID: PMC5052682 and pertuzumab in patients with HER2-overexpressing metastatic
breast cancer: Overall survival and updated progression-free
Smith E, Devlin SM, Kosuri S, Orlando E, Landau H, Lesokhin survival results from a phase II study. Breast Cancer Research and
AM, Chung DJ, Hassoun H, Lendvai N, Landgren O, Giralt S,
211 OF 324
Journal Articles
Treatment. 2016;158(1):91-97. PMCID: PMC5017157 A, di Lorenzo G, Bellmunt J. Improved 5-factor prognostic classification
of patients receiving salvage systemic therapy for advanced urothelial
Snyder A, Wolchok JD. Successful treatment of a patient with carcinoma. Journal of Urology. 2016;195(2):277-282. PMCID: PMC5025874
glioblastoma and a germline POLE mutation: Where next?. Cancer
Discovery. 2016;6(11):1210-1211. PMCID: PMC5109825 Soo I, Gerdes H, Markowitz AJ, Mendelsohn RB, Ludwig E, Shah
P, Schattner MA. Palliation of malignant gastric outlet obstruction
So WKW, Chan RJ, Truant T, Trevatt P, Bialous SA, Barton-Burke with simultaneous endoscopic insertion of afferent and efferent jejunal
M. Global perspectives on cancer health disparities: Impact, utility, limb enteral stents in patients with recurrent malignancy. Surgical
and implications for cancer nursing. Asia-Pacific Journal of Oncology Endoscopy. 2016;30(2):521-525. PMCID: PMC5027626
Nursing. 2016;3(4):316-323. PMCID: PMC5214864
Sood A, Miller AM, Brogi E, Sui Y, Armenia J, McDonough E, Santamaria-
Sohal DPS, Mangu PB, Khorana AA, Shah MA, Philip PA, O’Reilly EM, Pang A, Carlin S, Stamper A, Campos C, Pang Z, Li Q, Port E, Graeber
Uronis HE, Ramanathan RK, Crane CH, Engebretson A, Ruggiero JT, TG, Schultz N, Ginty F, Larson SM, Mellinghoff IK. Multiplexed
Copur MS, Lau M, Urba S, Laheru D. Metastatic pancreatic cancer: immunofluorescence delineates proteomic cancer cell states associated
American Society of Clinical Oncology clinical practice guideline. Journal with metabolism. JCI Insight. 2016;1(6):e87030. PMCID: PMC4863708
of Clinical Oncology. 2016;34(23):2784-2796. PMCID: PMC5019760
Soslow RA. Practical issues related to uterine pathology:
Soler A, Figueiredo AM, Castel P, Martin L, Monelli E, Angulo- Staging, frozen section, artifacts, and Lynch syndrome. Modern
Urarte A, Milà-Guasch M, Viñals F, Baselga J, Casanovas O, Pathology. 2016;29(Suppl. 1):S59-S77. PMCID: PMC4821462
Graupera M. Therapeutic benefit of selective inhibition of p110α
PI3-kinase in pancreatic neuroendocrine tumors. Clinical Cancer Sotirchos VS, Petrovic LM, Gönen M, Klimstra DS, Do RKG, Petre
Research. 2016;22(23):5805-5817. EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago
W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-
Soliman F, Hwang S, Landa J, Lefkowitz RA, Panicek DM. Infiltrative Todorova KO, Sofocleous CT. Colorectal cancer liver metastases: Biopsy
pattern of carcinomatosis in extremity muscles on MRI. Clinical of the ablation zone and margins can be used to predict oncologic
Imaging. 2016;40(3):451-455. PMCID: PMC4853653 outcome. Radiology. 2016;280(3):949-959. PMCID: PMC5006720
Solit DB, Kantoff PW. To put that into context. Oncology Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz
(Norwalk). 2016;30(5):381. M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T,
Nevanlinna H, Hopper JL, Dörk T, Claes KBM, Reis-Filho J, Teo ZL, Radice
Solomon SB, Cornelis F. Interventional molecular imaging. Journal of P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt
Nuclear Medicine. 2016;57(4):493-496. MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ,
Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, dos-Santos-
Soni RK, Tsou MFB. A cell-free system for real-time analyses of centriole
Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ,
disengagement and centriole-to-centrosome conversion. Methods in
Miller N, Marme F, Burwinkel B, Yang R, Guénel P, Truong T, Menegaux F,
Molecular Biology. 2016;1413:197-206. PMCID: PMC5039041
Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez
Sonpavde G, Pond GR, Rosenberg JE, Bajorin DF, Choueiri TK, Necchi JIA, Menéndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA,
212 OF 324
Journal Articles
Brenner H, Arndt V, Stegmaier C, Brauch H, Brüning T, Ko YD, Muranen TA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R,
Aittomäki K, Blomqvist C, Bogdanova N V, Antonenkova NN, Lindblom A, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten
Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN,
AB, kConFab Investigations, Australian Ovarian Cancer Study Group, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen
Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce
A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa
C, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Kristensen J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PDP, Song H, Winship I,
V, Alnæs GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Chenevix-Trench G, Giles GG, Tavtigian S V, Easton DF, Milne RL. PALB2,
Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip CHEK2 and ATM rare variants and cancer risk: Data from COGS. Journal of
M, Kauppila S, Devilee P, Tollenaar RAEM, Seynaeve C, Hollestelle A, Medical Genetics. 2016;53(12):800-811. PMCID: PMC5200636
Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H,
Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens Spaliviero M, Harmsen S, Huang R, Wall MA, Andreou C, Eastham
JWM, Collée JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, JA, Touijer KA, Scardino PT, Kircher MF. Detection of lymph node
Cox A, Reed MWR, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres metastases with SERRS nanoparticles. Molecular Imaging and
D, Ulmer HU, Rüdiger T, Jakubowska A, Lubinski J, Jaworska K, Durda Biology. 2016;18(5):677-685. PMCID: PMC5010961
K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A,
Ashworth A, Orr N, Jones M, González-Neira A, Pita G, Alonso MR, álvarez Spaliviero M, Poon BY, Karlo CA, Guglielmetti GB, Di Paolo PL, Beluco
N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy Corradi R, Martin-Malburet AG, Campos-Juanatey F, Escudero-Fontano
P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, E, Sjoberg DD, Russo P, Coleman JA, Akin O, Touijer KA. An Arterial Based
Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford Complexity (ABC) scoring system to assess the morbidity profile of partial
JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski nephrectomy. European Urology. 2016;69(1):72-79. PMCID: PMC4826765
C, Cannon-Albright L, Butterbach K, Park J, Kaneva R, Batra J, Teixeira MR,
Spans L, Fletcher CDM, Antonescu CR, Rouquette A, Coindre JM, Sciot
Kote-Jarai Z, Al Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A,
R, Debiec-Rychter M. Recurrent MALAT1–GLI1 oncogenic fusion and
Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs
GLI1 up-regulation define a subset of plexiform fibromyxoma. Journal of
S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K,
Pathology. 2016;239(3):335-343.
Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman
MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Specht K, Zhang L, Sung YS, Nucci M, Dry S, Vaiyapuri S, Richter
Edwards RP, Ness RB, Moysich KB, Bois A, Heitz F, Harter P, Kommoss GHS, Fletcher CDM, Antonescu CR. Novel BCOR-MAML3 and
S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Høgdall E, Peissel B, ZC3H7B-BCOR gene fusions in undifferentiated small blue round cell
Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham sarcomas. American Journal of Surgical Pathology. 2016;40(4):433-
JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MAT, 442. PMCID: PMC4792719
Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR,
Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer Spencer CN, Lopez G, Cohen L, Urbauer DL, Hallman DM,
M, Tworoger SS, Bandera E V, Orlow I, Olson SH, Bjorge L, Salvesen HB, Fisch MJ, Parker PA. Nurse and patient characteristics
van Altena AM, Aben KKH, Kiemeney LA, Massuger LFAG, Pejovic T, Bean predict communication about complementary and alternative
Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Górski B, Gronwald medicine. Cancer. 2016;122(10):1552-1559.
J, Menkiszak J, Høgdall CK, Lundvall L, Nedergaard L, Engelholm SA,
213 OF 324
Journal Articles
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley of metastatic castration-resistant prostate cancer therapy in clinical
R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak practice: Implication of pre-treatment spinal epidural disease. Prostate
KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Cancer and Prostatic Diseases. 2016;19(3):271-276.
Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP. The
effect of gene alterations and tyrosine kinase inhibition on survival Spratt DE, Wu AJ, Adeseye V, Din SU, Shaikh F, Woo KM, Zhang
and cause of death in patients with adenocarcinoma of the lung and Z, Foster A, Rosenzweig KE, Gewanter R, Huang J, Rimner A. Recurrence
brain metastases. International Journal of Radiation Oncology, Biology, patterns and second primary lung cancers after stereotactic body
Physics. 2016;96(2):406-413. radiation therapy for early-stage non-small-cell lung cancer: Implications
for surveillance. Clinical Lung Cancer. 2016;17(3):177-183.e2. PMCID:
Spitzer B, Perales MA, Kernan NA, Prockop SE, Zabor EC, Webb PMC4887418
N, Castro-Malaspina H, Papadopoulos EB, Young JW, Scaradavou
A, Kobos R, Giralt SA, O’Reilly RJ, Boulad F. Second allogeneic stem Spriggs DR, Longo DL. PARP inhibitors in ovarian cancer treatment. New
cell transplantation for acute leukemia using a chemotherapy- Only England Journal of Medicine. 2016;375(22):2197-2198.
cytoreduction with clofarabine, melphalan, and thiotepa. Biology of Blood
and Marrow Transplantation. 2016;22(8):1449-1454. PMCID: PMC4989237 Spring L, Bardia A, Modi S. Targeting the cyclin d-cyclin-dependent
kinase (CDK) 4/6-retinoblastoma pathway with selective cdk 4/6
Spratt DE, Beadle BM, Zumsteg ZS, Rivera A, Skinner HD, Osborne inhibitors in hormone receptor-positive breast cancer: Rationale, current
JR, Garden AS, Lee NY. The influence of diabetes mellitus and status, and future directions. Discovery Medicine. 2016;21(113):65-74.
metformin on distant metastases in oropharyngeal cancer: A
multicenter study. International Journal of Radiation Oncology, Biology, Srimathveeravalli G, Cornelis F, Mashni J, Takaki H, Durack JC, Solomon
Physics. 2016;94(3):523-531. PMCID: PMC4993040 SB, Coleman JA. Comparison of ablation defect on MR imaging with
computer simulation estimated treatment zone following irreversible
Spratt DE, Chan T, Waldron L, Speers C, Feng FY, Ogunwobi electroporation of patient prostate. SpringerPlus. 2016;5:219 . PMCID:
OO, Osborne JR. Racial/ethnic disparities in genomic sequencing. JAMA PMC4771651
St. Clair CM, Eriksson AGZ, Ducie JA, Jewell EL, Alektiar KM, Hensley
Spratt DE, Zaki B I, Franc BL, Hartford AC, Osborne JR. ACR ML, Soslow RA, Abu-Rustum NR, Leitao MM. Low-volume lymph
Practice Parameter for the performance of therapy with unsealed node metastasis discovered during sentinel lymph node mapping for
radiopharmaceutical sources. Clinical Nuclear Medicine. 2016;41(2):106-117. endometrial carcinoma. Annals of Surgical Oncology. 2016;23(5):1653-
1659. PMCID: PMC4835811
Spratt DE, Arevalo-Perez J, Leeman JE, Gerber NK, Folkert M, Taunk
NK, Alektiar KM, Karimi S, Lyo JK, Tap WD, Bilsky MH, Laufer I, Yamada Stadler ZK, Battaglin F, Middha S, Hechtman JF, Tran C, Cercek
Y, Osborne JR. Early magnetic resonance imaging biomarkers to predict A, Yaeger R, Segal NH, Varghese AM, Reidy-Lagunes DL, Kemeny
local control after high dose stereotactic body radiotherapy for patients NE, Salo-Mullen EE, Ashraf A, Weiser MR, Garcia-Aguilar J, Robson
with sarcoma spine metastases. Spine Journal. 2016;16(3):291-298. ME, Offit K, Arcila ME, Berger MF, Shia J, Solit DB, Saltz LB. Reliable
detection of mismatch repair deficiency in colorectal cancers using
Spratt DE, Osborne JR, Zumsteg ZS, Rebeiz K, Leeman J, Rivera mutational load in next-generation sequencing panels. Journal of Clinical
A, Morris MJ, Zelefsky MJ. Radium-223 outcomes after multiple lines Oncology. 2016;34(18):2141-2147. PMCID: PMC4962706
214 OF 324
Journal Articles
Stahl M, Xu ML, Steensma DP, Rampal R, Much M, Zeidan AM. Clinical Cancer. 2016;115(2):178-187. PMCID: PMC4947700
response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic
leukemia. Annals of Hematology. 2016;95(7):1197-1200. Stepney R, Lichtman SM, Danesi R. Drug-drug interactions in older
patients with cancer: A report from the 15th Conference of the
Stamatiades EG, Tremblay ME, Bohm M, Crozet L, Bisht K, Kao D, Coelho International Society of Geriatric Oncology, Prague, Czech Republic,
C, Fan X, Yewdell WT, Davidson A, Heeger PS, Diebold S, Nimmerjahn November 2015. Ecancermedicalscience. 2016;10:611. PMCID: PMC4720490
F, Geissmann F. Immune monitoring of trans-endothelial transport
by kidney-resident macrophages. Cell. 2016;166(4):991-1003. PMCID: Sternberg IA, Vela I, Scardino PT. Molecular profiles of prostate cancer:
PMC4983224 To treat or not to treat. Annual Review of Medicine. 2016;67:119-135.
Stanzione M, Baumann M, Papanikos F, Dereli I, Lange J, Ramlal A, Steuer CE, Behera M, Berry L, Kim S, Rossi M, Sica G, Owonikoko TK,
Trankner D, Shibuya H, de Massy B, Watanabe Y, Jasin M, Keeney Johnson BE, Kris MG, Bunn PA, Khuri FR, Garon EB, Ramalingam
S, Toth A. Meiotic DNA break formation requires the unsynapsed SS. Role of race in oncogenic driver prevalence and outcomes in
chromosome axis-binding protein IHO1 (CCDC36) in mice. Nature Cell lung adenocarcinoma: Results from the Lung Cancer Mutation
Biology. 2016;18(11):1208-1220. PMCID: PMC5089853 Consortium. Cancer. 2016;122(5):766-772. PMCID: PMC5038591
Steering Committee of the Blood and Marrow Transplant Clinical Stewart BT, Groen RS, Kamara TB, Kwon S, Kingham TP, Kushner
Trials Network. The Blood and Marrow Transplant Clinical Trials AL. Rectal bleeding and endoscopy need in Sierra Leone: Results of a
Network: An effective infrastructure for addressing important issues nationwide, cluster-randomized, community-based survey. International
in hematopoietic cell transplantation. Biology of Blood and Marrow Journal of Colorectal Disease. 2016;31(4):939-941.
Stoecker W V, Rader RK, Rabinovitz HS, Oliviero M, Calcara DA,
Stein EM, Tallman MS. Emerging therapeutic drugs for Malters JM, Drugge RJ, Bernard ML, Perry LA, Marghoob AA. Patient
AML. Blood. 2016;127(1):71-78. PMCID: PMC4915807 concern as a predictor of cutaneous malignancy. British Journal of
Dermatology. 2016;174(1):222-224. PMCID: PMC4724244
Stein EM. Molecular pathways: IDH2 mutations—Co-opting
cellular metabolism for malignant transformation. Clinical Cancer Stolnicu S, Molnar C, Barsan I, Boros M, Nogales FF, Soslow RA. The
Research. 2016;22(1):16-19. PMCID: PMC5050039 impact on survival of an extensive sex cord-like component in mullerian
adenosarcomas: A study comprising 6 cases. International Journal of
Steinbeck JA, Jaiswal MK, Calder EL, Kishinevsky S, Weishaupt A, Toyka Gynecological Pathology. 2016;35(2):147-152. PMCID: PMC4970425
K V, Goldstein PA, Studer L. Functional connectivity under optogenetic
control allows modeling of human neuromuscular disease. Cell Stem Stone JB, DeAngelis LM. Cancer-treatment-induced neurotoxicity
Cell. 2016;18(1):134-143. PMCID: PMC4707991 - Focus on newer treatments. Nature Reviews Clinical
Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaløy S, Thorsen L,
Arbo I, Jones LW, Aakhus S, Lund MB, Kiserud CE. Cardiorespiratory Stone JB, DeAngelis LM. Correction regarding data on
fitness in long-term lymphoma survivors after high-dose chemotherapy blinatumomab-associated seizures - Reply. Nature Reviews Clinical
with autologous stem cell transplantation. British Journal of Oncology. 2016;13(10):p650.
215 OF 324
Journal Articles
Stout NL, Silver JK, Raj VS, Rowland J, Gerber L, Cheville A, Ness KK, KO, Thompson LDR, Hamoir M, Slootweg PJ, Vander Poorten V, Williams
Radomski M, Nitkin R, Stubblefield MD, Morris GS, Acevedo A, Brandon MD, Wenig BM, Skálová A, Ferlito A. Cervical lymph node metastasis in
Z, Braveman B, Cunningham S, Gilchrist L, Jones L, Padgett L, Wolf T, adenoid cystic carcinoma of oral cavity and oropharynx: A collective
Winters-Stone K, Campbell G, Hendricks J, Perkin K, Chan L. Toward international review. Auris Nasus Larynx. 2016;43(5):477-484. PMCID:
a national initiative in cancer rehabilitation: Recommendations from PMC5193158
a subject matter expert group. Archives of Physical Medicine and
Rehabilitation. 2016;97(11):2006-2015. Subramanian M, Pearce G, Guldu OK, Tekin V, Miaskowski A, Aras
O, Unak P. A pilot study into the use of FDG-mNP as an alternative
Stoykow C, Erbes T, Maecke HR, Bulla S, Bartholomä M, Mayer S, Drendel approach in neuroblastoma cell hyperthermia. IEEE Transactions on
V, Bronsert P, Werner M, Gitsch G, Weber WA, Stickeler E, Meyer Nanobioscience. 2016;15(6):517-525.
PT. Gastrin-releasing peptide receptor imaging in breast cancer using the
receptor antagonist (68)Ga-RM2 and PET. Theranostics. 2016;6(10):1641- Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-
1650. PMCID: PMC4955063 Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy
T, Hohla F, Allen P, Taieb J, Hong TS, Shridhar R, Chau I, van Eijck
Stratton KL, Alanee S, Glogowski EA, Schrader KA, Rau-Murthy CH, Koerkamp BG. FOLFIRINOX for locally advanced pancreatic
R, Klein R, Russo P, Coleman J, Offit K. Outcome of genetic evaluation cancer: A systematic review and patient-level meta-analysis. Lancet
of patients with kidney cancer referred for suspected hereditary Oncology. 2016;17(6):801-810.
cancer syndromes. Urologic Oncology: Seminars and Original
Investigations. 2016;34(5):238.e1-238.e7. PMCID: PMC4996267 Sultan KT, Han Z, Zhang XJ, Xianyu A, Li Z, Huang K, Shi SH. Clonally related
GABAergic interneurons do not randomly disperse but frequently form local
Straus DJ, Cahlon O. Radiation therapy for Hodgkin lymphoma clusters in the forebrain. Neuron. 2016;92(1):31-44. PMCID: PMC5066572
— Can it be administered more safely if necessary?. JAMA
Oncology. 2016;2(2):169-170. Sun J, Mc Millen T, Babady NE, Kamboj M. Role of coinfecting strains in
recurrent Clostridium difficile Infection. Infection Control and Hospital
Streich FC, Lima CD. Capturing a substrate in an activated RING E3/E2- Epidemiology. 2016;37(12):1481-1484.
SUMO complex. Nature. 2016;536(7616):304-308. PMCID: PMC5019495
Sun JC. Transcriptional control of NK cells. Current Topics in Microbiology
Su HK, Wenig BM, Haser GC, Rowe ME, Asa SL, Baloch Z, Du and Immunology. 2016;395:1-36.
E, Faquin WC, Fellegara G, Giordano T, Ghossein R, Livolsi VA,
Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Sun Y, Ma Y, Lin P, Tang YW, Yang L, Shen Y, Zhang R, Liu L, Cheng J,
Turk AT, Urken ML. Inter-observer variation in the pathologic Shao J, Qi T, Tang Y, Cai R, Guan L, Luo B, Sun M, Li B, Pei Z, Lu H. Fecal
identification of minimal extrathyroidal extension in papillary thyroid bacterial microbiome diversity in chronic HIV-infected patients in
carcinoma. Thyroid. 2016;26(4):512-517. China. Emerging Microbes & Infections. 2016;5:e31. PMCID: PMC4855070
Suárez C, Barnes L, Silver CE, Rodrigo JP, Shah JP, Triantafyllou A, Sundararajan S, Kumar A, Korde N, Agarwal A. Smoldering multiple
Rinaldo A, Cardesa A, Pitman KT, Kowalski LP, Robbins KT, Hellquist H, myeloma: Emerging concepts and therapeutics. Current Hematologic
Medina JE, de Bree R, Takes RP, Coca-Pelaz A, Bradley PJ, Gnepp DR, Malignancy Reports. 2016;11(2):102-110.
Teymoortash A, Strojan P, Mendenhall WM, Eloy JA, Bishop JA, Devaney
216 OF 324
Journal Articles
Sundaresan TK, Sequist L V, Heymach J V, Riely GJ, Jänne PA, Koch Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JKC, Sander B, Ott
WH, Sullivan JP, Fox DB, Maher R, Muzikansky A, Webb A, Tran HT, G, Xerri L, Quintanilla-Martinez L, Campo E. The many faces of small B
Giri U, Fleisher M, Yu HA, Wei W, Johnson BE, Barber TA, Walsh cell lymphomas with plasmacytic differentiation and the contribution
JR, Engelman JA, Stott SL, Kapur R, Maheswaran S, Toner M, Haber of MYD88 testing. Virchows Archiv. 2016;468(3):259-275. PMCID:
DA. Detection of T790M, the acquired resistance EGFR mutation, by PMC5002945
tumor biopsy versus noninvasive blood-based analyses. Clinical Cancer
Research. 2016;22(5):1103-1110. PMCID: PMC4775471 Swetter SM, Geller AC, Halpern AC. What the USPSTF “insufficient” skin
cancer screening recommendation means for primary care clinicians and
Sung JS, Stamler S, Brooks J, Kaplan J, Huang T, Dershaw DD, Lee dermatologists. JAMA Dermatology. 2016;152(9):973-975.
CH, Morris EA, Comstock CE. Breast cancers detected at screening MR
imaging and mammography in patients at high risk: Method of detection Swisher-McClure S, Yin L, Rosen M, Batra S, Berman AT, Both
reflects tumor histopathologic results. Radiology. 2016;280(3):716- S, Vapiwala N. Prospective MRI-based imaging study to assess
722. PMCID: PMC5006733 feasibility of proton therapy for post-prostatectomy radiation. Acta
Oncologica. 2016;55(7):828-833.
Sutton EJ, Dashevsky BZ, Oh JH, Veeraraghavan H, Apte AP, Thakur
SB, Morris EA, Deasy JO. Breast cancer molecular subtype classifier Tabbara M, Duque JC, Martinez L, Escobar LA, Wu W, Pan Y, Fernandez
that incorporates MRI features. Journal of Magnetic Resonance N, Velazquez OC, Jaimes EA, Salman LH, Vazquez-Padron R I. Pre-
Imaging. 2016;44(1):122-129. existing and postoperative intimal hyperplasia and arteriovenous fistula
outcomes. American Journal of Kidney Diseases. 2016;68(3):455-
Svensson LG, Gillinov AM, Weisel RD, Keshavjee S, Bacha EA, Moon 464. PMCID: PMC5002252
MR, Cameron DE, Sugarbaker DJ, Adams DH, Gaynor JW, Coselli
JS, Del Nido PJ, Jones D, Sundt TM, Cohn LH, Pomar JL, Lytle BW, Taggart J, Ho TC, Amin E, Xu H, Barlowe TS, Perez AR, Durham
Schaff H V. The American Association for Thoracic Surgery Consensus BH, Tivnan P, Okabe R, Chow A, Vu L, Park SM, Prieto C, Famulare
Guidelines: Reasons and purpose. Journal of Thoracic and Cardiovascular C, Patel M, Lengner CJ, Verma A, Roboz G, Guzman M, Klimek
Surgery. 2016;151(4):935-939.e1. VM, Abdel-Wahab O, Leslie C, Nimer SD, Kharas MG. MSI2 is required
for maintaining activated myelodysplastic syndrome stem cells. Nature
Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, Chandarlapaty S, de Communications. 2016;7:10739. PMCID: PMC4764878
Koning L, Dive C, Feunteun J, Leung SY, Marais R, Mardis ER, McGranahan
N, Middleton G, Quezada SA, Rodón J, Rosenfeld N, Sotiriou C, André Tahover E, Bar Shalom R, Bogot N, Kelsen D, Gabizon A. MEK inhibitor
F. Consensus on precision medicine for metastatic cancers: A report from treatment is effective in a patient with metastatic carcinoma of the
the MAP conference. Annals of Oncology. 2016;27(8):1443-1448. ampulla of Vater with BRAF and NRAS mutations shown by next-
generation sequencing. Anti-Cancer Drugs. 2016;27(6):569-572.
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R,
Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 Tai W, Guzman ML, Chiosis G. The epichaperome: The power of many as
revision of the World Health Organization classification of lymphoid the power of one. Oncoscience. 2016;3(9-10):266-267.
neoplasms. Blood. 2016;127(20):2375-2390. PMCID: PMC4874220
217 OF 324
Journal Articles
Taich P, Requejo F, Asprea M, Sgroi M, Gobin P, Abramson DH, Tam AL, Lim HJ, Wistuba I I, Tamrazi A, Kuo MD, Ziv E, Wong S,
Chantada G, Schaiquevich P. Topotecan delivery to the optic nerve after Shih AJ, Webster RJ 3rd, Fischer GS, Nagrath S, Davis SE, White
ophthalmic artery chemosurgery. PLoS ONE. 2016;11(3):e0151343. PMCID: SB, Ahrar K. Image-guided biopsy in the era of personalized cancer
PMC4784825 care: Proceedings from the Society of Interventional Radiology
research consensus panel. Journal of Vascular and Interventional
Tai-Seale M, Hatfield LA, Wilson CJ, Stults CD, McGuire TG, Diamond LC, Radiology. 2016;27(1):8-19. PMCID: PMC5056791
Frankel RM, MacLean L, Stone A, Lafata JE. Periodic health examinations
and missed opportunities among patients likely needing mental health Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo
care. American Journal of Managed Care. 2016;22(10):e350-e357. JP, Dabbs DJ, Ellis IO, Eusebi V, Farshid G, Fox SB, Ichihara S,
Lakhani SR, Rakha EA, Reis-Filho JS, Richardson AL, Sahin A,
Takahashi Y, Eguchi T, Bains S, Adusumilli PS. Significance of IASLC/ Schmitt FC, Schnitt SJ, Siziopikou KP, Soares FA, Tse GM, Vincent-
ATS/ERS classification for early-stage lung adenocarcinoma patients in Salomon A, Tan PH. Phyllodes tumours of the breast: A consensus
predicting benefit from adjuvant chemotherapy. Annals of Translational review. Histopathology. 2016;68(1):5-21. PMCID: PMC5027876
Medicine. 2016;4(4):66. PMCID: PMC4779772
Tan JL, Fogley RD, Flynn RA, Ablain J, Yang S, Saint-André V, Fan ZP, Do
Takaki H, Imai N, Thomas CT, Srimathveeravalli G, Covey BT, Laga AC, Fujinaga K, Santoriello C, Greer CB, Kim YJ, Clohessy JG,
AM, Getrajdman G I, Brown KT, Solomon SB, Erinjeri JP. Peripheral Bothmer A, Pandell N, Avagyan S, Brogie JE, van Rooijen E, Hagedorn
blood regulatory T-cell and type 1 helper T-cell population decrease EJ, Shyh-Chang N, White RM, Price DH, Pandolfi PP, Peterlin BM, Zhou Y,
after hepatic artery embolization. Journal of Vascular and Interventional Kim TH, Asara JM, Chang HY, Young RA, Zon L I. Stress from nucleotide
Radiology. 2016;27(10):1561-1568. PMCID: PMC5039109 depletion activates the transcriptional regulator HEXIM1 to suppress
melanoma. Molecular Cell. 2016;62(1):34-46. PMCID: PMC4836061
Taldone T, Zatorska D, Ochiana SO, Smith-Jones P, Koziorowski
J, Dunphy MP, Zanzonico P, Bolaender A, Lewis JS, Larson Tan MCB, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin
SM, Chiosis G, Pillarsetty NVK. Radiosynthesis of the iodine-124 LX, Moraco N, Crago AM, Singer S. Histology-based classification
labeled Hsp90 inhibitor PU-H71. Journal of Labelled Compounds and predicts pattern of recurrence and improves risk stratification in
Radiopharmaceuticals. 2016;59(3):129-132. PMCID: PMC4779400 primary retroperitoneal sarcoma. Annals of Surgery. 2016;263(3):593-
600. PMCID: PMC4619189
Talhouk A, Hoang LN, McConechy MK, Nakonechny Q, Leo J, Cheng A,
Leung S, Yang W, Lum A, Köbel M, Lee CH, Soslow RA, Huntsman DG, Tan SF, Liu X, Fox TE, Barth BM, Sharma A, Turner SD, Awwad A,
Gilks CB, McAlpine JN. Molecular classification of endometrial carcinoma Dewey A, Doi K, Spitzer B, Shah M V, Morad SAF, Desai D, Amin
on diagnostic specimens is highly concordant with final hysterectomy: S, Zhu J, Liao J, Yun J, Kester M, Claxton DF, Wang HG, Cabot
Earlier prognostic information to guide treatment. Gynecologic MC, Schuchman EH, Levine RL, Feith DJ, Loughran TP Jr. Acid
Oncology. 2016;143(1):46-53. ceramidase is upregulated in AML and represents a novel therapeutic
target. Oncotarget. 2016;7(50):83208-83222.
Tallman MS. Editorial introduction. Current Opinion in
Hematology. 2016;23(2):v. Tan X, Liu WA, Zhang XJ, Shi W, Ren SQ, Li Z, Brown KN, Shi
SH. Vascular influence on ventral telencephalic progenitors and
218 OF 324
Journal Articles
neocortical interneuron production. Developmental Cell. 2016;36(6):624- Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao
638. PMCID: PMC4806403 Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D, Duivenvoorden R,
Calcagno C, Storm G, Tsimikas S, Moore KJ, Swirski FK, Nahrendorf M,
Tanas MR, Ma S, Jadaan FO, Ng CKY, Weigelt B, Reis-Filho JS, Fisher EA, Pérez-Medina C, Fayad ZA, Reiner T, Mulder WJM. Immune
Rubin BP. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion cell screening of a nanoparticle library improves atherosclerosis
oncoprotein. Oncogene. 2016;35(7):929-938. PMCID: PMC4983459 therapy. Proceedings of the National Academy of Sciences of the United
States of America. 2016;113(44):E6731-E6740. PMCID: PMC5098679
Taneja SS, Bennett J, Coleman J, Grubb R, Andriole G, Reiter RE, Marks L,
Azzouzi AR, Emberton M. Final results of a phase I/II multicenter trial of Tang LH, Basturk O, Sue JJ, Klimstra DS. A practical approach to the
WST11 vascular targeted photodynamic therapy for hemi-ablation of the classification of WHO grade 3 (G3) well-differentiated neuroendocrine
prostate in men with unilateral low risk prostate cancer performed in the tumor (WD-NET) and poorly differentiated neuroendocrine
United States. Journal of Urology. 2016;196(4):1096-1104. carcinoma (PD-NEC) of the pancreas. American Journal of Surgical
Pathology. 2016;40(9):1192-1202. PMCID: PMC4988129
Tanenbaum DG, Hall WA, Mittal P, Nickleach DC, Mikell JL, Colbert
LE, Moreno CC, Squires MH, Fisher SB, Yu DS, Kooby DA, Maithel SK, Tang LH, Untch BR, Reidy DL, O’Reilly E, Dhall D, Jih L, Basturk O, Allen
Landry JC. Cholangiocarcinoma size on magnetic resonance imaging PJ, Klimstra DS. Well-differentiated neuroendocrine tumors with a
versus pathologic specimen: Implications for radiation treatment morphologically apparent high-grade component: A pathway distinct
planning. Practical Radiation Oncology. 2016;6(3):201-206. from poorly differentiated neuroendocrine carcinomas. Clinical Cancer
Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim
S, Dwivedi B, Kowalski J, Landry JC, Yu DS. TNFRSF10C copy number Tang SJ, Vilmann AS, Saftoiu A, Wang W, Streba CT, Fink PP, Griswold
variation is associated with metastatic colorectal cancer. Journal of M, Wu R, Dietrich CF, Jenssen C, Hocke M, Kantowski M, Pohl J, Fockens
Gastrointestinal Oncology. 2016;7(3):306-314. PMCID: PMC4880759 P, Annema JT, van der Heijden EHFM, Havre RF, Pham KDC, Kunda
R, Deprez PH, Mariana J, Vazquez-Sequeiros E, Larghi A, Buscarini E,
Tang G, Moussot C, Morf D, Seppi E, Amols H. Low-dose 2.5 MV cone- Fusaroli P, Lahav M, Puri R, Garg PK, Sharma M, Maluf-Filho F, Sahai A,
beam computed tomography with thick CsI flat-panel imager. Journal of Brugge WR, Lee LS, Aslanian HR, Wang AY, Shami VM, Markowitz A,
Applied Clinical Medical Physics . 2016;17(4):235-245. Siddiqui AA, Mishra G, Scheiman JM, Isenberg G, Siddiqui UD, Shah RJ,
Buxbaum J, Watson RR, Willingham FF, Bhutani MS, Levy MJ, Harris C,
Tang H, Chen Y, Liu X, Wang S, Lv Y, Wu D, Wang Q, Luo M, Deng
Wallace MB, Nolsøe CP, Lorentzen T, Bang N, Sørensen SM, Gilja OH,
H. Downregulation of HSP60 disrupts mitochondrial proteostasis
D’Onofrio M, Piscaglia F, Gritzmann N, Radzina M, Sparchez ZA, Sidhu PS,
to promote tumorigenesis and progression in clear cell renal cell
Freeman S, McCowan TC, de Araujo CR Jr, Patel A, Ali MA, Campbell G,
carcinoma. Oncotarget. 2016;7(25):38822-38834. PMCID: PMC5122432
Chen E, Vilmann P. EUS needle identification comparison and evaluation
Tang H, Li J, Liu X, Wang G, Luo M, Deng H. Down-regulation of HSP60 study (with videos). Gastrointestinal Endoscopy. 2016;84(3):424-433.e2.
suppresses the proliferation of glioblastoma cells via the ROS/AMPK/
Tang YW, Gonsalves S, Sun JY, Stiles J, Gilhuley KA, Mikhlina
mTOR pathway. Scientific Reports. 2016;6:28388. PMCID: PMC4914999
A, Dunbar SA, Babady NE, Zhang H. Clinical evaluation of the
219 OF 324
Journal Articles
Luminex NxTAG Respiratory Pathogen Panel. Journal of Clinical enhancer remodeling to senescence immune surveillance. Cancer
Microbiology. 2016;54(7):1912-1914. PMCID: PMC4922127 Discovery. 2016;6(6):612-629. PMCID: PMC4893996
Tantillo G, Peck KK, Arevalo-Perez J, Lyo JK, Chou JF, Young Taunk NK, Moraes FY, Escorcia FE, Mendez LC, Beal K, Marta GN. External
RJ, Brennan NP, Holodny A I. Corpus callosum diffusion and language beam re-irradiation, combination chemoradiotherapy, and particle therapy
lateralization in patients with brain tumors: A DTI and fMRI study. Journal for the treatment of recurrent glioblastoma. Expert Review of Anticancer
of Neuroimaging. 2016;26(2):224-231. PMCID: PMC4753142 Therapy. 2016;16(3):347-358. PMCID: PMC4998049
Taouli B, Beer AJ, Chenevert T, Collins D, Lehman C, Matos C, Padhani AR, Taunk NK, Kushner B, Ibanez K, Wolden SL. Short-interval retreatment
Rosenkrantz AB, Shukla-Dave A, Sigmund E, Tanenbaum L, Thoeny H, with stereotactic body radiotherapy (SBRT) for pediatric neuroblastoma
Thomassin-Naggara I, Barbieri S, Corcuera-Solano I, Orton M, Partridge resulting in severe myositis. Pediatric Blood and Cancer. 2016;63(4):731-
SC, Koh DM. Diffusion-weighted imaging outside the brain: Consensus 733. PMCID: PMC5029085
statement from an ISMRM-sponsored workshop. Journal of Magnetic
Resonance Imaging. 2016;44(3):521-540. PMCID: PMC4983499 Taur Y, Pamer EG. Microbiome mediation of infections in the cancer
setting. Genome Medicine. 2016;8(1):40. PMCID: PMC4835935
Tap WD, Jones RL, Van Tine BA, Chmielowski B, Elias AD, Adkins D,
Agulnik M, Cooney MM, Livingston MB, Pennock G, Hameed MR, Shah Taur Y. Intestinal microbiome changes and stem cell transplantation:
GD, Qin A, Shahir A, Cronier DM, Ilaria R Jr, Conti I, Cosaert J, Schwartz Lessons learned. Virulence. 2016;7(8):930-938.
GK. Olaratumab and doxorubicin versus doxorubicin alone for treatment
of soft-tissue sarcoma: An open-label phase 1b and randomised phase 2 Taylor D, Brady JE, Li G, Sonty N, Saroyan JM. Characterization
trial. Lancet. 2016;388(10043):488-497. of pain in patients with Barth syndrome. Children’s Health
Care. 2016;45(2):192-203.
Tarasova VD, Tuttle RM. A risk-adapted approach to follow-up
in differentiated thyroid cancer. Rambam Maimonides Medical Taylor NJ, Thomas NE, Anton-Culver H, Armstrong BK, Begg CB, Busam
Journal. 2016;7(1) PMCID: PMC4737510 KJ, Cust AE, Dwyer T, From L, Gallagher RP, Gruber SB, Nishri DE, Orlow
I, Rosso S, Venn AJ, Zanetti R, Berwick M, Kanetsky PA, on behalf of
Taromi S, Kayser G, Catusse J, von Elverfeldt D, Reichardt W, Braun the GEM Study Group. Nevus count associations with pigmentary
F, Weber WA, Zeiser R, Burger M. CXCR4 antagonists suppress small cell phenotype, histopathological melanoma characteristics and survival
lung cancer progression. Oncotarget. 2016;7(51):85185-85195. from melanoma. International Journal of Cancer. 2016;139(6):1217-
1222. PMCID: PMC4939099
Taromi S, Kayser G, von Elverfeldt D, Reichardt W, Braun F, Weber
WA, Zeiser R, Burger M. An orthotopic mouse model of small cell lung Teckie S, Lok BH, Rao S, Gutiontov S I, Yamada Y, Berry SL, Zelefsky
cancer reflects the clinical course in patients. Clinical and Experimental MJ, Lee NY. High-dose hypofractionated radiotherapy is effective and
Metastasis. 2016;33(7):651-660. safe for tumors in the head-and-neck. Oral Oncology. 2016;60:74-80.
Tasdemir N, Banito A, Roe JS, Alonso-Curbelo D, Camiolo Tee SS, DiGialleonardo V, Eskandari R, Jeong S, Granlund KL, Miloushev
M, Tschaharganeh DF, Huang CH, Aksoy O, Bolden JE, Chen V, Poot AJ, Truong S, Alvarez JA, Aldeborgh HN, Keshari KR. Sampling
CC, Fennell M, Thapar V, Chicas A, Vakoc CR, Lowe SW. BRD4 connects hyperpolarized molecules utilizing a 1 Tesla permanent magnetic
220 OF 324
Journal Articles
field. Scientific Reports. 2016;6:32846. PMCID: PMC5011774 Thong AE, Petruzella S, Orlow I, Zabor EC, Ehdaie B, Ostroff
JS, Bochner BH, Furberg Barnes H. Accuracy of self-reported smoking
Teijido O, Ganesan YT, Llanos R, Peton A, Urtecho JB, Soprani A, exposure among bladder cancer patients undergoing surveillance
Villamayor A, Antonsson B, Manon S, Dejean L. A sandwich ELISA for at a tertiary referral center. European Urology Focus. 2016;2(4):441-
the conformation-specific quantification of the activated form of human 444. PMCID: PMC5289752
Bax. Analytical Biochemistry. 2016;497:90-94.
Thor M, Olsson C, Oh JH, Petersen SE, Alsadius D, Bentzen L, Pettersson
Teo MY, Morris MJ. Prostate-specific membrane antigen-directed N, Muren LP, Hoyer M, Steineck G, Deasy JO. Urinary bladder dose-
therapy for metastatic castration-resistant prostate cancer. The Cancer response relationships for patient-reported genitourinary morbidity
Journal. 2016;22(5):347-352. domains following prostate cancer radiotherapy. Radiotherapy and
Oncology. 2016;119(1):117-122.
Terrier JE, Nelson CJ. Psychological aspects of Peyronie’s
disease. Translational Andrology and Urology. 2016;5(3):290- Thorek DLJ, Watson PA, Lee SG, Ku AT, Bournazos S, Braun K, Kim K,
295. PMCID: PMC4893509 Sjostrom K, Doran MG, Lamminmaki U, Santos E, Veach D, Turkekul
M, Casey E, Lewis JS, Abou DS, Van Voss MRH, Scardino PT, Strand SE,
Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Alpaugh ML, Scher H I, Lilja H, Larson SM, Ulmert D. Internalization of
Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio secreted antigen-targeted antibodies by the neonatal Fc receptor for
PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank precision imaging of the androgen receptor axis. Science Translational
SJ. Defining the value framework for prostate brachytherapy using Medicine. 2016;8(367):367ra167.
patient-centered outcome metrics and time-driven activity-based
costing. Brachytherapy. 2016;15(3):274-282. Thornton RH, Covey AM. Urinary drainage procedures in
interventional radiology. Techniques in Vascular and Interventional
Theilen TM, Chou AJ, Klimstra DS, Laquaglia MP. Esophageal Radiology. 2016;19(3):170-181.
adenocarcinoma and squamous cell carcinoma in children and adolescents:
Report of 3 cases and comprehensive literature review. Journal of Pediatric Tian SK, Killian JK, Rekhtman N, Benayed R, Middha S, Ladanyi M, Lin
Surgery Case Reports. 2016;5:23-29. PMCID: PMC4819333 O, Arcila ME. Optimizing workflows and processing of cytologic samples
for comprehensive analysis by next-generation sequencing: Memorial
Themelil M, Sadelain M. Combinatorial antigen targeting: Ideal Sloan Kettering Cancer Center experience. Archives of Pathology &
T-cell sensing and anti-tumor response. Trends in Molecular Laboratory Medicine. 2016;140(11):1200-1205.
Tisnado J, Young R, Peck KK, Haque S. Conventional and advanced
Thomas S, Hussein Y, Bandyopadhyay S, Cote M, Hassan O, Abdulfatah imaging of diffuse intrinsic pontine glioma. Journal of Child
E, Alosh B, Guan H, Soslow RA, Ali-Fehmi R. Interobserver variability in Neurology. 2016;31(12):1386-1393.
the diagnosis of uterine high-grade endometrioid carcinoma. Archives of
Pathology & Laboratory Medicine. 2016;140(8):836-843. Tofighi M, Yorulmaz O, Kose K, Yildirim DC, Çetin-Atalay R, Çetin
AE. Phase and TV based convex sets for blind deconvolution of
Thompson CB. Into thin air: How we sense and respond to microscopic images. IEEE Journal on Selected Topics in Signal
hypoxia. Cell. 2016;167(1):9-11. Processing. 2016;10(1):81-91.
221 OF 324
Journal Articles
Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo- Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz
Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, SM, Inghirami G, Intlekoffer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson
Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martín- CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N,
Martín N, David Sutherland J, Sanchez-Mosquera P, Bozal-Basterra L, Kornblau SM, Kung AL, Kupper TS, LaBoeuf N, LaCasce AS, Lees E,
Zabala-Letona A, Arruabarrena-Aristorena A, Berenguer A, Embade Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide
N, Ugalde-Olano A, Lacasa-Viscasillas I, Loizaga-Iriarte A, Unda-Urzaiz OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE,
M, Schultz N, Aransay AM, Sanz-Moreno V, Barrio R, Velasco G, Pinton P, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM,
Cordon-Cardo C, Locasale JW, Gomis RR, Carracedo A. The metabolic Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M,
co-regulator PGC1α suppresses prostate cancer metastasis. Nature Cell Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A,
Biology. 2016;18(6):645-656. PMCID: PMC4884178 Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD,
Weinstock DM. The public repository of xenografts enables discovery
Torrisi JS, Hespe GE, Cuzzone DA, Savetsky IL, Nitti MD, Gardenier and randomized phase II-like trials in mice. Cancer Cell. 2016;29(4):574-
JC, Nores GDG, Jowhar D, Kataru RP, Mehrara BJ. Inhibition of 586. PMCID: PMC5177991
inflammation and iNOS improves lymphatic function in obesity. Scientific
Reports. 2016;6:19817. PMCID: PMC4726274 Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder
DB, Goo JM, MacMahon H, Naidich D, Nicholson AG, Powell CA, Prokop
Toska E, Baselga J. Pharmacology in the era of targeted therapies: M, Rami-Porta R, Rusch V, Van Schil P, Yatabe Y, on behalf of the
The case of PI3K inhibitors. Clinical Cancer Research. 2016;22(9):2099- International Association for the Study of Lung Cancer Staging and
2101. PMCID: PMC4946572 Prognostic Factors Committee and Advisory Board Members. The
IASLC lung cancer staging project: Proposals for coding T categories
Touijer KA, Eastham JA. The sentinel lymph node concept and for subsolid nodules and assessment of tumor size in part-solid tumors
novel approaches in detecting lymph node metastasis in prostate in the forthcoming eighth edition of the TNM classification of lung
cancer. European Urology. 2016;70(5):738-739. cancer. Journal of Thoracic Oncology. 2016;11(8):1204-1223.
Touijer KA. Reply to Gianluca Giannarini, Alessandro Crestani, Andrea Travis WD, Brambilla E, Geisinger KR. Histological grading in lung
Porzionato, Veronica Macchi, and Vincenzo Ficarra’s letter to the editor cancer: One system for all or separate systems for each histological
re: Massimiliano Spaliviero, Bing Ying Poon, Christoph A. Karlo, et al. An type?. European Respiratory Journal. 2016;47(3):720-723.
arterial based complexity (ABC) scoring system to assess the morbidity
profile of partial nephrectomy. Eur Urol 2016; 69: 72-9. European Travis WD, Brambilla E, Nicholson AG. Testing for neuroendocrine
Urology. 2016;69(3):E55-E56. immunohistochemical markers should not be performed in poorly
differentiated NSCCS in the absence of neuroendocrine morphologic
Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, features according to the 2015 WHO Classification. Journal of Thoracic
DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero Oncology. 2016;11(2):e26-e27.
J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK,
Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo Triantafyllou A, Williams MD, Angelos P, Shah JP, Westra WH, Hunt
DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher JL, Devaney KO, Rinaldo A, Slootweg PJ, Gnepp DR, Silver C, Ferlito
DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, A. Incidental findings of thyroid tissue in cervical lymph nodes: Old
222 OF 324
Journal Articles
controversy not yet resolved?. European Archives of Oto-Rhino- Associated factors and postoperative outcomes. Gynecologic
Laryngology. 2016;273(10):2867-2875. Oncology. 2016;142(2):217-224. PMCID: PMC4961543
Trock BJ, Fedor H, Gurel B, Jenkins RB, Knudsen BS, Fine SW, Said Tseng TY, Ostroff JS, Campo A, Gerard M, Kirchner T, Rotrosen J,
JW, Carter HB, Lotan TL, De Marzo AM. PTEN loss and chromosome 8 Shelley D. A randomized trial comparing the effect of nicotine versus
alterations in Gleason grade 3 prostate cancer cores predicts the presence placebo electronic cigarettes on smoking reduction among young adult
of un-sampled grade 4 tumor: Implications for active surveillance. Modern smokers. Nicotine & Tobacco Research. 2016;18(10):1937-1943. PMCID:
Pathology. 2016;29(7):764-771. PMCID: PMC4925272 PMC5016841
Trost LW, Mulhall JP. Challenges in testosterone measurement, Tsui DWY, Berger MF. Profiling non-small cell lung cancer: From
data interpretation, and methodological appraisal of interventional tumor to blood. Clinical Cancer Research. 2016;22(4):790-792. PMCID:
trials. Journal of Sexual Medicine. 2016;13(7):1029-1046. PMC4852855
Trudeau V, Larcher A, Sun M, Boehm K, Dell’Oglio P, Meskawi M, Sosa Tsuruta Y, Rogers LQ, Krontiras H, Grizzle WE, Frugé AD, Oster RA,
J, Tian Z, Fossati N, Briganti A, Karakiewicz P I. Sociodemographic Umphrey HR, Jones LW, Azrad M, Demark-Wahnefried W. Exploring
disparities in the nonoperative management of small renal effects of presurgical weight loss among women with stage 0-II breast
masses. Clinical Genitourinary Cancer. 2016;14(2):e177-e182. cancer: Protocol for a randomised controlled feasibility trial. BMJ
Open. 2016;6(9):e012320. PMCID: PMC5030610
Tsao AS, Scagliotti G V, Bunn PA Jr, Carbone DP, Warren GW, Bai C,
De Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli Tufano RP, Shindo M, Shaha AR. New recommendations for extent
PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam of thyroidectomy and active surveillance for the treatment of
SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ou SH I, differentiated thyroid cancer. JAMA Otolaryngology - Head and Neck
Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Surgery. 2016;142(7):625-626.
Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW,
Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass H I. Scientific advances Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I,
in lung cancer 2015. Journal of Thoracic Oncology. 2016;11(5):613-638. Furberg HF, Rosenberg JE, Bajorin DF. The high incidence of
vascular thromboembolic events in patients with metastatic or
Tschaharganeh DF, Bosbach B, Lowe SW. Coordinated tumor unresectable urothelial cancer treated with platinum chemotherapy
suppression by chromosome 8p. Cancer Cell. 2016;29(5):617-619. PMCID: agents. Cancer. 2016;122(5):712-721. PMCID: PMC4990408
PMC5120649
Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber
Tschaharganeh DF, Lowe SW, Garippa RJ, Livshits G. Using CRISPR/ JE, Offit K, Robson ME. Counselling framework for moderate-
Cas to study gene function and model disease in vivo. FEBS penetrance cancer-susceptibility mutations. Nature Reviews Clinical
Journal. 2016;283(17):3194-3203. PMCID: PMC5120361 Oncology. 2016;13(9):581-588.
Tseng JH, Suidan RS, Zivanovic O, Gardner GJ, Sonoda Y, Levine Turpen PB, Hockberger PE, Meyn SM, Nicklin C, Tabarini D, Auger
DA, Abu-Rustum NR, Tew WP, Chi DS, Long Roche K. Diverting JA. Metrics for success: Strategies for enabling core facility
ileostomy during primary debulking surgery for ovarian cancer: performance and assessing outcomes. Journal of Biomolecular
223 OF 324
Journal Articles
Techniques. 2016;27(1):25-39. PMCID: PMC4736753 Ulaner GA, Hyman DM, Ross DS, Corben A, Chandarlapaty S, Goldfarb
S, McArthur H, Erinjeri JP, Solomon SB, Kolb H, Lyashchenko SK, Lewis
Tuttle RM, Brose MS. Best use of the tyrosine kinase inhibitors in JS, Carrasquillo JA. Detection of HER2-positive metastases in patients
progressive differentiated thyroid cancer: Discussion. Clinical Advances with HER2-negative primary breast cancer using 89Zr-trastuzumab
in Hematology & Oncology. 2016;14(5 Suppl. 9):12-13. PET/CT. Journal of Nuclear Medicine. 2016;57(10):1523-1528. PMCID:
PMC5050126
Tuttle RM. Initial treatment of progressive differentiated thyroid
cancer. Clinical Advances in Hematology & Oncology. 2016;14(5 Suppl. 9):3-6. Ulaner GA, Riedl CC, Dickler MN, Jhaveri K, Pandit-Taskar N, Weber
W. Molecular imaging of biomarkers in breast cancer. Journal of Nuclear
Tyagi N, Riaz N, Hunt M, Wengler K, Hatzoglou V, Young R, Mechalakos Medicine. 2016;57(Suppl. 1):53S-59S. PMCID: PMC4979972
J, Lee N. Weekly response assessment of involved lymph nodes to
radiotherapy using diffusion-weighted MRI in oropharynx squamous cell Ulaner GA, Samstein R, Cahlon O, Weber WA, Rimner A. Unilateral
carcinoma. Medical Physics. 2016;43(1):137-147. suppression of brown fat on FDG PET/CT in horner syndrome. Clinical
Nuclear Medicine. 2016;41(10):797-798.
Tzatha E, DeAngelis LM. Chemotherapy-induced peripheral
neuropathy. Oncology (Norwalk). 2016;30(3):240, 243-244. Unciuleac MC, Smith PC, Shuman S. Crystal structure and biochemical
characterization of a Mycobacterium smegmatis AAA-type
Ubel PA, Bach PB. Copay assistance for expensive drugs: A helping hand nucleoside triphosphatase phosphohydrolase (Msm0858). Journal of
that raises costs. Annals of Internal Medicine. 2016;165(12):878-879. Bacteriology. 2016;198(10):1521-1533. PMCID: PMC4859601
Udoh I. Understanding venous thromboembolism in patients with Urbanski MM, Kingsbury L, Moussouros D, Kassim I, Mehjabeen
cancer. Journal for Nurse Practitioners. 2016;12(1):53-59. S, Paknejad N, Melendez-Vasquez C V. Myelinating glia
differentiation is regulated by extracellular matrix elasticity. Scientific
Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS
Reports. 2016;6:33751. PMCID: PMC5028715
3rd. Reoperative sentinel lymph node biopsy is feasible for locally
recurrent breast cancer, but is it worthwhile?. Annals of Surgical Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-
Oncology. 2016;23(3):744-748. PMCID: PMC4753801 Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton L,
Cunningham JM, DeFazio A, Doherty JA, Edwards RP, Gayther SA,
Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig
Gentry-Maharaj A, Goodman MT, Høgdall E, Jensen A, Johnatty SE,
K, Jochelson MS, Gönen M. (18)F-FDG-PET/CT for systemic staging of
Kiemeney LA, Kjaer SK, Larson MC, Lurie G, Massuger L, Menon
newly diagnosed triple-negative breast cancer. European Journal of
U, Modugno F, Moysich KB, Ness RB, Pike MC, Ramus SJ, Rossing
Nuclear Medicine and Molecular Imaging. 2016;43(11):1937-1944.
MA, Rothstein J, Song H, Thompson PJ, Van Den Berg DJ, Vierkant
Ulaner GA, Goldman DA, Gönen M, Pham H, Castillo R, Lyashchenko RA, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wilkens LR,
SK, Lewis JS, Dang C. Initial results of a prospective clinical trial of (18) Wu AH, Yang H, Pearce CL, Schildkraut JM, Pharoah P, Goode EL,
F-fluciclovine PET/CT in newly diagnosed invasive ductal and invasive Fridley BL, on behalf of the Cancer Association Consortium, the
lobular breast cancers. Journal of Nuclear Medicine. 2016;57(9):1350-1356. Australian Cancer Study. Assessment of multifactor gene-environment
interactions and ovarian cancer risk: Cndidate genes, obesity, and
224 OF 324
Journal Articles
hormone-related risk factors. Cancer Epidemiology Biomarkers and ion channel. Proceedings of the National Academy of Sciences of
Prevention. 2016;25(5):780-790. PMCID: PMC4873330 the United States of America. 2016;113(47):E7399-E7408. PMCID:
PMC5127342
Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R,
Kluin-Nelemans HC, Verstovsek S, Gajewski J, Perales MA, George T, Valente K, Blackham AU, Levine E, Russell G, Votanopoulos K I, Stewart
Shore T, Sperr W, Saber W, Kota V, Yavuz AS, Pullarkat V, Rogosheske JH, Shen P, Geisinger KR, Sirintrapun SJ. A histomorphologic grading
J, Hogan W, Van Besien K, Hagglund H, Damaj G, Arock M, Horny system that predicts overall survival in diffuse malignant peritoneal
HP, Metcalfe DD, Deeg HJ, Devine S, Weisdorf D, Akin C, Valent mesothelioma with epithelioid subtype. American Journal of Surgical
P. Consensus opinion on allogeneic hematopoietic cell transplantation Pathology. 2016;40(9):1243-1248. PMCID: PMC5029445
in advanced systemic mastocytosis. Biology of Blood and Marrow
Transplantation. 2016;22(8):1348-1356. Valleix S, Verona G, Jourde-Chiche N, Nédelec B, Mangione PP, Bridoux
F, Mangé A, Dogan A, Goujon JM, Lhomme M, Dauteuille C, Chabert
Vachha BA, Ginat DT, Mallur P, Cunnane M, Moonis G. “Finding a M, Porcari R, Waudby CA, Relini A, Talmud PJ, Kovrov O, Olivecrona
voice”: Imaging features after phonosurgical procedures for vocal fold G, Stoppini M, Christodoulou J, Hawkins PN, Grateau G, Delpech M,
paralysis. American Journal of Neuroradiology. 2016;37(9):1574-1580. Kontush A, Gillmore JD, Kalopissis AD, Bellotti V. D25V apolipoprotein
C-III variant causes dominant hereditary systemic amyloidosis
Vadaparampil ST, Gwede CK, Meade C, Kelvin J, Reich RR, Reinecke J, and confers cardiovascular protective lipoprotein profile. Nature
Bowman M, Sehovic I, Quinn GP, ENRICH RESEARCH GROUP. ENRICH: Communications. 2016;7:10353. PMCID: PMC4735822
A promising oncology nurse training program to implement ASCO
clinical practice guidelines on fertility for AYA cancer patients. Patient van de Nes J, Gessi M, Sucker A, Möller I, Stiller M, Horn S, Scholz SL,
Education and Counseling. 2016;99(11):1907-1910. PMCID: PMC5069115 Pischler C, Stadtler N, Schilling B, Zimmer L, Hillen U, Scolyer RA,
Buckland ME, Lauriola L, Pietsch T, Waha A, Schadendorf D, Murali
Vadaparampil ST, Kelvin J, Murphy D, Bowman M, Sehovic I, Quinn R, Griewank KG. Targeted next generation sequencing reveals unique
GP. Fertility and fertility preservation: Scripts to support oncology nurses mutation profile of primary melanocytic tumors of the central nervous
in discussions with adolescent and young adult patients. Journal of system. Journal of Neuro-Oncology. 2016;127(3):435-444.
Clinical Outcomes Management. 2016;23(2):73-78.
van de Nes J, Wrede K, Ringelstein A, Stiller M, Horn S, Sucker A, Möller I,
Vadde R, Pastores SM. Management of acute respiratory failure in Scholz SL, Murali R, Gessi M, Schadendorf D, Griewank KG. Diagnosing a
patients with hematological malignancy. Journal of Intensive Care primary leptomeningeal melanoma by gene mutation signature. Journal
Medicine. 2016;31(10):627-641. of Investigative Dermatology. 2016;136(7):1526-1528.
Vadrevu SK, Sharma S, Chintala N, Patel J, Karbowniczek M, Van Den Neste E, Schmitz N, Mounier N, Gill D, Linch D, Trneny M,
Markiewski M. Studying the role of alveolar macrophages Milpied N, Radford J, Ketterer N, Shpilberg O, Dührsen U, Ma D, Brière
in breast cancer metastasis. Journal of Visualized J, Thieblemont C, Salles G, Moskowitz CH, Glass B, Gisselbrecht
Experiments. 2016;2016(112):e54306. PMCID: PMC4993250 C. Outcome of patients with relapsed diffuse large B-cell lymphoma who
fail second-line salvage regimens in the International CORAL study. Bone
Vaisey G, Miller AN, Long SB. Distinct regions that control ion Marrow Transplantation. 2016;51(1):51-57.
selectivity and calcium-dependent activation in the bestrophin
225 OF 324
Journal Articles
Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der Bruggen Van Zee KJ, Barrio A V, Tchou J. Treatment and long-term risks
W, Mohan HK, Gnanasegaran G, Delgado-Bolton R, Weber WA, Beheshti M, for patients with a diagnosis of ductal carcinoma in situ. JAMA
Langsteger W, Giammarile F, Mottaghy FM, Paycha F. The EANM practice Oncology. 2016;2(3):397-398. PMCID: PMC4937997
guidelines for bone scintigraphy. European Journal of Nuclear Medicine
and Molecular Imaging. 2016;43(9):1723-1738. PMCID: PMC4932135 Vander Walde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn
P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AKP, Gross C,
van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch H I, O’Donovan M, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC,
Fitzgerald RC, van Krieken H, Carneiro F. Histopathological, molecular, Mrozek E, O’Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA,
and genetic profile of hereditary diffuse gastric cancer: Current Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H,
knowledge and challenges for the future. Advances in Experimental Hurria A. NCCN Guidelines® insights: Older adult oncology, version
Medicine and Biology. 2016;908:371-391. 2.2016: Featured updates to the NCCN Guidelines. Journal of the National
van der Veeken J, Gonzalez AJ, Cho H, Arvey A, Hemmers
S, Leslie CS, Rudensky AY. Memory of inflammation in regulatory T Vandross A, Prasad V, Mailankody S. ASCO Plenary Sessions: Impact,
cells. Cell. 2016;166(4):977-990. PMCID: PMC4996371 legacy, future. Seminars in Oncology. 2016;43(3):321-326.
Van Dorp W, Mulder RL, Kremer LCM, Hudson MM, Van Den Heuvel- Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IM, Kurman
Eibrink MM, Van Den Berg MH, Levine JM, Van Dulmen-Den Broeder E, RJ. Molecular alterations of TP53 are a defining feature of ovarian high-
Di Iorgi N, Albanese A, Armenian SH, Bhatia S, Constine LS, Corrias A, grade serous carcinoma: A rereview of cases lacking TP53 mutations
Deans R, Dirksen U, Gracia CR, Hjorth L, Kroon L, Lambalk CB, Landier in The Cancer Genome Atlas Ovarian Study. International Journal of
W, Levitt G, Leiper A, Meacham L, Mussa A, Neggers SJ, Oeffinger KC, Gynecological Pathology. 2016;35(1):48-55. PMCID: PMC4696053
Revelli A, Van Santen HM, Skinner R, Toogood A, Wallace WH, Haupt
R. Recommendations for premature ovarian insufficiency surveillance Váradi A, Marrone GF, Palmer TC, Narayan A, Szabó MR, Le Rouzic
for female survivors of childhood, adolescent, and young adult cancer: V, Grinnell SG, Subrath JJ, Warner E, Kalra S, Hunkele A, Pagirsky J,
A report from the International Late Effects of Childhood Cancer Eans SO, Medina JM, Xu J, Pan YX, Borics A, Pasternak GW, McLaughlin
Guideline Harmonization Group in collaboration with the PanCareSurFup JP, Majumdar S. Mitragynine/corynantheidine pseudoindoxyls as opioid
consortium. Journal of Clinical Oncology. 2016;34(28):3440-3450. analgesics with mu agonism and delta antagonism, which do not recruit
β-arrestin-2. Journal of Medicinal Chemistry. 2016;59(18):8381-8397.
van Galen P, Viny AD, Ram O, Ryan RJH, Cotton MJ, Donohue L,
Sievers C, Drier Y, Liau BB, Gillespie SM, Carroll KM, Cross MB, Levine Váradi A, Palmer TC, Dardashti RN, Majumdar S. Isocyanide-
RL, Bernstein BE. A multiplexed system for quantitative comparisons based multicomponent reactions for the synthesis of
of chromatin landscapes. Molecular Cell. 2016;61(1):170-180. PMCID: heterocycles. Molecules. 2016;21(1):19. PMCID: PMC4782750
PMC4707994
Vardhana S, Younes A. The immune microenvironment
van Klaveren D, Gönen M, Steyerberg EW, Vergouwe Y. A new in hodgkin lymphoma: T cells, B cells, and immune
concordance measure for risk prediction models in external validation checkpoints. Haematologica. 2016;101(7):794-802. PMCID: PMC5004458
settings. Statistics in Medicine. 2016;35(23):4136-4152.
Vargas HA, Hötker AM, Goldman DA, Moskowitz CS, Gondo
226 OF 324
Journal Articles
T, Matsumoto K, Ehdaie B, Woo S, Fine SW, Reuter VE, Sala E, Hricak Veronesi G, Novellis P, Park B. Quality of life after video-assisted surgery
H. Updated prostate imaging reporting and data system (PIRADS for lung cancer - Reply. Lancet Oncology. 2016;17(8):e316-e317.
v2) recommendations for the detection of clinically significant
prostate cancer using multiparametric MRI: Critical evaluation Verrill C, Cerundolo L, McKee C, White M, Kartsonaki C, Fryer E, Morris
using whole-mount pathology as standard of reference. European E, Brewster S, Ratnayaka I, Marsden L, Lilja H, Muschel R, Lu X, Hamdy
Radiology. 2016;26(6):1606-1612. PMCID: PMC4803633 F, Bryant RJ. Altered expression of epithelial-to-mesenchymal transition
proteins in extraprostatic prostate cancer. Oncotarget. 2016;7(2):1107-
Vargas HA, Martin-Malburet AG, Takeda T, Corradi RB, Eastham 1119. PMCID: PMC4811447
J, Wibmer A, Sala E, Zelefsky MJ, Weber WA, Hricak H. Localizing
sites of disease in patients with rising serum prostate-specific antigen Verstovsek S, Manshouri T, Pilling D, Bueso-Ramos CE, Newberry KJ,
up to 1 ng/ml following prostatectomy: How much information Prijic S, Knez L, Bozinovic K, Harris DM, Spaeth EL, Post SM, Multani
can conventional imaging provide?. Urologic Oncology: Seminars AS, Rampal RK, Ahn J, Levine RL, Creighton CJ, Kantarjian HM,
and Original Investigations. 2016;34(11):482.e5-482.e10. PMCID: Estrov Z. Role of neoplastic monocyte-derived fibrocytes in primary
PMC5097681 myelofibrosis. Journal of Experimental Medicine. 2016;213(9):1723-
1740. PMCID: PMC4995084
Varghese AM, Lowery MA, Yu KH, O’Reilly EM. Current
management and future directions in metastatic pancreatic Veselis R, Kelhoffer E, Mehta M, Root JC, Robinson F, Mason KP. Propofol
adenocarcinoma. Cancer. 2016;122(24):3765-3775. sedation in children: Sleep trumps amnesia. Sleep Medicine. 2016;27-28:115-120.
Veit JA, Heine D, Thierauf J, Lennerz J, Shetty S, Schuler PJ, Whiteside Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches
T, Beutner D, Meyer M, Grünewald I, Ritter G, Gnjatic S, Sikora AG, to the evaluation of prediction models, molecular markers, and
Hoffmann TK, Laban S. Expression and clinical significance of MAGE and diagnostic tests. BMJ: British Medical Journal (International
NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head Edition). 2016;352:i6. PMCID: PMC4724785
and neck. Head and Neck. 2016;38(7):1008-1016.
Vickers AJ, Eastham JA, Scardino PT, Lilja H. Author
Vélez R, Turesson I, Landgren O, Kristinsson SY, Cuzick J. Incidence of reply. Urology. 2016;91:17-18.
multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: The
impact of differences in case ascertainment on observed incidence Vickers AJ, Eastham JA, Scardino PT, Lilja H. Reply to re: The Memorial
trends. BMJ Open. 2016;6(1):e009584. PMCID: PMC4735168 Sloan Kettering Cancer Center recommendations for prostate cancer
screening. Urology. 2016;95:224.
Ventura A. NORAD: Defender of the genome. Trends in
Genetics. 2016;32(7):390-392. Vickers AJ, Eastham JA, Scardino PT, Lilja H. The Memorial Sloan
Kettering Cancer Center recommendations for prostate cancer
Vera E, Bosco N, Studer L. Generating late-onset human iPSC-based screening. Urology. 2016;91:12-17. PMCID: PMC4842100
disease models by inducing neuronal age-related phenotypes through
telomerase manipulation. Cell Reports. 2016;17(4):1184-1192. PMCID: Vickers AJ, Vertosick EA. An empirical study of race times in
PMC5089807 recreational endurance runners. BMC Sports Science Medicine and
227 OF 324
Journal Articles
Rehabilitation. 2016;8:26. PMCID: PMC5000509 FJ, Offit K, Pharoah PDP, Chenevix-Trench G, Antoniou AC. Fine-scale
mapping at 9p22.2 identifies candidate causal variants that modify
Vickers AJ. Does prostate-specific antigen screening do more good than ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS
harm? Depends on how you do it. JAMA Oncology. 2016;2(7):899-900. ONE. 2016;11(7):e0158801. PMCID: PMC4963094
Vickers AJ. Incorporating clinical considerations into statistical analyses Vijai J, Topka S, Villano D, Ravichandran V, Maxwell KN, Maria
of markers: A quiet revolution in how we think about data. Clinical A, Thomas T, Gaddam P, Lincoln A, Kazzaz S, Wenz B, Carmi S,
Chemistry. 2016;62(5):671-672. Schrader KA, Hart SN, Lipkin SM, Neuhausen SL, Walsh MF, Zhang L,
Lejbkowicz F, Rennert H, Stadler ZK, Robson M, Weitzel JN, Domchek
Vickers AJ. Sharing raw data from clinical trials: What progress since we S, Daly MJ, Couch FJ, Nathanson KL, Norton L, Rennert G, Offit K. A
first asked “Whose data set is it anyway?”. Trials. 2016;17(1):227. PMCID: recurrent ERCC3 truncating mutation confers moderate risk for breast
PMC4855346 cancer. Cancer Discovery. 2016;6(11):1267-1275.
Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Vilhelmsson Timmermand O, Larsson E, Ulmert D, Tran TA, Strand
Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen SE. Radioimmunotherapy of prostate cancer targeting human kallikrein-
A, Bonanni B, Brewer C, Caldes T, Caligo MA, Campbell I, Chan SB, Claes related peptidase 2. EJNMMI Research. 2016;6:27. PMCID: PMC4797400
KBM, Cohn DE, Cook J, Daly MB, Damiola F, Davidson R, de Pauw A,
Delnatte C, Diez O, Domchek SM, Dumont M, Durda K, Dworniczak B, Villasante A, Marturano-Kruik A, Ambati SR, Liu Z, Godier-Furnemont
Easton DF, Eccles D, Ardnor CE, Eeles R, Ejlertsen B, Ellis S, Evans DG, A, Parsa H, Lee BW, Moore MAS, Vunjak-Novakovic G. Recapitulating
Feliubadalo L, Fostira F, Foulkes WD, Friedman E, Frost D, Gaddam the size and cargo of tumor exosomes in a tissue-engineered
P, Ganz PA, Garber J, Garcia-Barberan V, Gauthier-Villars M, Gehrig model. Theranostics. 2016;6(8):1119-1130. PMCID: PMC4893640
A, Gerdes AM, Giraud S, Godwin AK, Goldgar DE, Hake CR, Hansen
TVO, Healey S, Hodgson S, Hogervorst FBL, Houdayer C, Hulick PJ, Viny AD, Levine RL. Roads diverge - A Robert Frost view of leukemia
Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jacobs L, Jakubowska A, development. New England Journal of Medicine. 2016;374(23):2282-2284.
Janavicius R, Jaworska-Bieniek K, Jensen UB, John EM, Vijai J, Karlan
BY, Kast K, Khan S, Kwong A, Laitman Y, Lester J, Lesueur F, Liljegren Virmani P, Jawed S, Myskowski PL, Horwitz S, Skripnik Lucas
A, Lubinski J, Mai PL, Manoukian S, Mazoyer S, Meindl A, Mensenkamp A, Moskowitz A, Pulitzer M, Zain J, Rosen ST, Querfeld C. Long-term
AR, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, follow-up and management of small and medium-sized CD4+ T cell
Niederacher D, Olah E, Olopade O I, Ong KR, Osorio A, Park SK, lymphoma and CD8+ lymphoid proliferations of acral sites: A multicenter
Paulsson-Karlsson Y, Pedersen IS, Peissel B, Peterlongo P, Pfeiler G, experience. International Journal of Dermatology. 2016;55(11):1248-
Phelan CM, Piedmonte M, Poppe B, Pujana MA, Radice P, Rennert G, 1254. PMCID: PMC5053827
Rodriguez GC, Rookus MA, Ross EA, Schmutzler RK, Simard J, Singer
CF, Slavin TP, Soucy P, Southey M, Steinemann D, Stoppa-Lyonnet D, Virmani P, Myskowski PL, Pulitzer M. Unusual variants of mycosis
Sukiennicki G, Sutter C, Szabo C I, Tea MK, Teixeira MR, Teo SH, Terry fungoides. Diagnostic Histopathology. 2016;22(4):142-151.
MB, Thomassen M, Tibiletti MG, Tihomirova L, Tognazzo S, van Rensburg
Virudachalam S, Gruver RS, Gerdes M, Power TJ, Magge SN, Shults
EJ, Varesco L, Varon-Mateeva R, Vratimos A, Weitzel JN, McGuffog L,
J, Faerber JA, Kalra GK, Bishop-Gilyard CT, Suh AW, Berkowitz R
Kirk J, Toland AE, Hamann U, Lindor N, Ramus SJ, Greene MH, Couch
I, Fiks AG. Mothers’ and clinicians’ priorities for obesity prevention
228 OF 324
Journal Articles
among black, high-risk infants. American Journal of Preventive bevacizumab in advanced non-clear cell renal cell carcinoma. Journal of
Medicine. 2016;51(1):46-53. Clinical Oncology. 2016;34(32):3846-3853.
Vogel RM, Erez A, Altan-Bonnet G. Dichotomy of cellular inhibition Voss MH, Hsieh JJ. Therapeutic guide for mTOuRing through
by small-molecule inhibitors revealed by single-cell analysis. Nature the braided kidney cancer genomic river. Clinical Cancer
Communications. 2016;7:12428. PMCID: PMC5056434 Research. 2016;22(10):2320-2322.
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad Vriend LEM, Prakash R, Chen CC, Vanoli F, Cavallo F, Zhang
EU, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Koon Y, Jasin M, Krawczyk PM. Distinct genetic control of homologous
H, Mayerson J, McCarter M, McGarry S V, Meyer C, O’Donnell RJ, recombination repair of Cas9-induced double-strand breaks, nicks and
Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Schuetze paired nicks. Nucleic Acids Research. 2016;44(11):5204-5217. PMCID:
S, Schupak KD, Schwartz HS, Tap WD, Wayne JD, Bergman MA, PMC4914091
Scavone J. Soft Tissue Sarcoma, Version 2.2016 Clinical Practice
Guidelines in Oncology. Journal of the National Comprehensive Cancer Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla
Network. 2016;14(6):758-786. M, Lamb C, Casey KR, Patel S, Silvestri GA, Feller-Kopman
DJ. Technical aspects of endobronchial ultrasound-guided
Von Stackelberg A, Locatelli F, Zugmaier G, Handgretinger R, Trippett transbronchial needle aspiration CHEST guideline and expert panel
TM, Rizzari C, Bader P, O’Brien MM, Brethon B, Bhojwani D, Schlegel report. Chest. 2016;149(3):816-835.
PG, Borkhardt A, Rheingold SR, Cooper TM, Zwaan CM, Barnette
P, Messina C, Michel G, Dubois SG, Hu K, Zhu M, Whitlock JA, Gore Waingankar N, Bratslavsky G, Jimenez C, Russo P, Kutikov
L. Phase I/Phase II study of blinatumomab in pediatric patients with A. Pheochromocytoma in urologic practice. European Urology
relapsed/refractory acute lymphoblastic leukemia. Journal of Clinical Focus. 2016;1(3):231-240. PMCID: PMC5222610
Oncology. 2016;34(36):4381-4389.
Wainwright SR, Barha CK, Hamson DK, Epp JR, Chow C, Lieblich
von Tresckow B, Moskowitz CH. Treatment of relapsed and refractory SE, Rutishauser U, Galea LAM. Enzymatic depletion of the polysialic
Hodgkin lymphoma. Seminars in Hematology. 2016;53(3):180-185. acid moiety associated with the neural cell adhesion molecule inhibits
antidepressant efficacy. Neuropsychopharmacology. 2016;41(6):1670-
Voss MH, Chen D, Marker M, Hakimi AA, Lee CH, Hsieh JJ, Knox JJ, Voi 1680. PMCID: PMC4832030
M, Motzer RJ. Circulating biomarkers and outcome from a randomised
phase II trial of sunitinib vs everolimus for patients with metastatic renal Walkowicz WE, Fernández-Tejada A, George C, Corzana F, Jiménez-
cell carcinoma. British Journal of Cancer. 2016;114(6):642-649. PMCID: Barbero J, Ragupathi G, Tan DS, Gin DY. Quillaja saponin variants with
PMC4800293 central glycosidic linkage modifications exhibit distinct conformations
and adjuvant activities. Chemical Science. 2016;7(3):2371-2380. PMCID:
Voss MH, Molina AM, Chen YB, Woo KM, Chaim JL, Coskey PMC4800320
DT, Redzematovic A, Wang P, Lee W, Selcuklu SD, Lee CH, Berger
MF, Tickoo SK, Reuter VE, Patil S, Hsieh JJ, Motzer RJ, Feldman Wallner PE, Shrieve DC, Kachnic LA, Wilson LD, Hahn S, Alektiar KM,
DR. Phase II trial and correlative genomic analysis of everolimus plus Laszakovits D, Guiberteau MJ. American Board of Radiology maintenance of
229 OF 324
Journal Articles
certification program: Evolution to better serve stakeholders. International chromatin regulatory genes in chordoma. Genes Chromosomes and
Journal of Radiation Oncology, Biology, Physics. 2016;94(1):16-18. Cancer. 2016;55(7):591-600. PMCID: PMC5031498
Walsh MF, Nathanson KL, Couch FJ, Offit K. Genomic biomarkers Wang LY, Ganly I. Nodal metastases in thyroid cancer: Prognostic
for breast cancer risk. Advances in Experimental Medicine and implications and management. Future Oncology. 2016;12(7):981-
Biology. 2016;882:1-32. PMCID: PMC5016023 994. PMCID: PMC4992997
Wan B, Hang LE, Zhao X. Multi-BRCT scaffolds use distinct strategies to Wang LY, Nixon IJ, Patel SG, Palmer FL, Tuttle RM, Shaha A, Shah
support genome maintenance. Cell Cycle. 2016;15(19):2561-2570. PMCID: JP, Ganly I. Operative management of locally advanced, differentiated
PMC5053572 thyroid cancer. Surgery (United States). 2016;160(3):738-746. PMCID:
PMC5126966
Wang D, Narula N, Azzopardi S, Smith RS, Nasar A, Altorki NK,
Mittal V, Somwar R, Stiles BM, Du YCN. Expression of the receptor Wang LY, Palmer FL, Migliacci JC, Nixon IJ, Shaha AR, Shah
for hyaluronic acid mediated motility (RHAMM) is associated JP, Tuttle RM, Patel SG, Ganly I. Role of RAI in the management
with poor prognosis and metastasis in non-small cell lung of incidental N1a disease in papillary thyroid cancer. Clinical
carcinoma. Oncotarget. 2016;7(26):39957-39969. PMCID: PMC5129984 Endocrinology. 2016;84(2):292-295. PMCID: PMC4959964
Wang ES, Jabbour EJ, Douer D. Novel approaches for the interim Wang LY, Roman BR, Palmer FL, Tuttle RM, Shaha AR, Shah
management of relapsed/refractory acute lymphocytic leukemia: JP, Patel SG, Ganly I. Effectiveness of routine ultrasonographic
A case-study compendium. Clinical Advances in Hematology & surveillance of patients with low-risk papillary carcinoma of the
Oncology. 2016;14(3 Suppl. 4):7-23. thyroid. Surgery. 2016;159(5):1390-1395. PMCID: PMC4991630
Wang G, De Kruijff RM, Abou D, Ramos N, Mendes E, Franken LE, Wang SC, Parekh JR, Porembka MR, Nathan H, D’Angelica M
Wolterbeek HT, Denkova AG. Pharmacokinetics of polymersomes I, DeMatteo RP, Fong Y, Kingham TP, Jarnagin WR, Allen PJ. A pilot
composed of poly(Butadiene-Ethylene Oxide); Healthy versus tumor- study evaluating serum MMP7 as a preoperative prognostic marker for
bearing mice. Journal of Biomedical Nanotechnology. 2016;12(2):320-328. pancreatic ductal adenocarcinoma patients. Journal of Gastrointestinal
Wang G, Hauver J, Thomas Z, Darst SA, Pertsinidis A. Single-molecule
real-time 3D imaging of the transcription cycle by modulation Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit
interferometry. Cell. 2016;167(7):1839-1852.e21. DG. Pretreatment neutrophil to lymphocyte ratio independently predicts
disease-specific sur vival in resectable gastroesophageal junction
Wang H, Feng M, Jackson A, Ten Haken RK, Lawrence TS, Cao Y. Local and gastric adenocarcinoma. Annals of Surgery. 2016;263(2):292-
and global function model of the liver. International Journal of Radiation 297. PMCID: PMC4905761
Oncology, Biology, Physics. 2016;94(1):181-188. PMCID: PMC4692182
Wang SQ, Virmani P, Lim HW. Consumer acceptability and compliance:
Wang L, Zehir A, Nafa K, Zhou N, Berger MF, Casanova J, Sadowska The next frontier in sunscreen innovation. Photodermatology
J, Lu C, Allis CD, Gounder M, Chandhanayingyong C, Ladanyi Photoimmunology and Photomedicine. 2016;32(1):55-56.
M, Boland PJ, Hameed M. Genomic aberrations frequently alter
230 OF 324
Journal Articles
Wang W, Tang Y, Wang Y, Tascau L, Balcerek J, Tong W, Levine RL, Welch C, Wang Z, Seow WJ, Shiraishi K, Hsiung CA, Matsuo K, Liu J, Chen K, Yamji
Tall AR, Wang N. LNK/SH2B3 loss of function promotes atherosclerosis and T, Yang Y, Chang IS, Wu C, Hong YC, Burdett L, Wyatt K, Chung CC, Li
thrombosis. Circulation Research. 2016;119(6):e91-e103. PMCID: PMC5016083 SA, Yeager M, Hutchinson A, Hu W, Caporaso N, Landi MT, Chatterjee
N, Song M, Fraumeni JF Jr, Kohno T, Yokota J, Kunitoh H, Ashikawa K,
Wang X, Sun CL, Quiñones-Lombraña A, Singh P, Landier W, Hageman Momozawa Y, Daigo Y, Mitsudomi T, Yatabe Y, Hida T, Hu Z, Dai J, Ma H,
L, Mather M, Rotter J I, Taylor KD, Chen YD I, Armenian SH, Winick N, Jin G, Song B, Wang Z, Cheng S, Yin Z, Li X, Ren Y, Guan P, Chang J, Tan
Ginsberg JP, Neglia JP, Oeffinger KC, Castellino SM, Dreyer ZE, Hudson W, Chen CJ, Chang GC, Tsai YH, Su WC, Chen KY, Huang MS, Chen YM,
MM, Robison LL, Blanco JG, Bhatia S. CELF4 variant and anthracycline- Zheng H, Li H, Cui P, Guo H, Xu P, Liu L, Iwasaki M, Shimazu T, Tsugane S,
related cardiomyopathy: A Children’s Oncology Group genome-wide Zhu J, Jiang G, Fei K, Park JY, Kim YH, Sung JS, Park KH, Kim YT, Jung
association study. Journal of Clinical Oncology. 2016;34(8):863- YJ, Kang CH, Park IK, Kim HN, Jeon HS, Choi JE, Choi YY, Kim JH, Oh IJ,
870. PMCID: PMC5070560 Kim YC, Sung SW, Kim JS, Yoon H I, Kweon SS, Shin MH, Seow A, Chen
Y, Lim WY, Liu J, Wong MP, Lee VHF, Bassig BA, Tucker M, Berndt S I,
Wang X, Chen CW, Armstrong SA. The role of DOT1L in the Chow WH, Ji BT, Wang J, Xu J, Sihoe ADL, Ho JCM, Chan JKC, Wang JC,
maintenance of leukemia gene expression. Current Opinion in Genetics Lu D, Zhao X, Zhao Z, Wu J, Chen H, Jin L, Wei F, Wu G, An SJ, Zhang
and Development. 2016;36:68-72. XC, Su J, Wu YL, Gao YT, Xiang YB, He X, Li J, Zheng W, Shu XO, Cai
Q, Klein R, Pao W, Lawrence C, Hosgood HD 3rd, Hsiao CF, Chien LH,
Wang X, Rivière I. Clinical manufacturing of CAR T cells: Foundation of a
Chen YH, Chen CH, Wang WC, Chen CY, Wang CL, Yu CJ, Chen HL, Su
promising therapy. Molecular Therapy - Oncolytics. 2016;3:16015. PMCID:
YC, Tsai FY, Chen YS, Li YJ, Yang TY, Lin CC, Yang PC, Wu T, Lin D, Zhou
PMC4909095
B, Yu J, Shen H, Kubo M, Chanock SJ, Rothman N, Lan Q. Meta-analysis
Wang Y, Kang S, Khan A, Ruttner G, Leigh SY, Murray M, Abeytunge of genome-wide association studies identifies multiple lung cancer
S, Peterson G, Rajadhyaksha M, Dintzis S, Javid S, Liu JTC. Quantitative susceptibility loci in never-smoking Asian women. Human Molecular
molecular phenotyping with topically applied SERS nanoparticles Genetics. 2016;25(3):620-629. PMCID: PMC4731021
for intraoperative guidance of breast cancer lumpectomy. Scientific
Waqar SN, Bonomi PD, Govindan R, Hirsch FR, Riely GJ,
Papadimitrakopoulou V, Kazandjian D, Khozin S, Larkins E, Dickson
Wang Y, Li Z, Hu G, Hao S, Deng X, Huang M, Ren M, Jiang X, Kanegaye DJ, Malik S, Horn L, Ferris A, Shaw AT, Jänne PA, Mok TSK, Herbst
JT, Ha KS, Lee J, Li X, Jiang X, Yu Y, Tremoulet AH, Burns JC, Whitin R, Keegan P, Pazdur R, Blumenthal GM. Clinician perspectives on
JC, Shin AY, Sylvester KG, McElhinney DB, Cohen HJ, Ling XB, Pediatric current issues in lung cancer drug development. Journal of Thoracic
Emergency Medicine Kawasaki Disease Research Group. Unique Oncology. 2016;11(9):1387-1396. PMCID: PMC5131641
molecular patterns uncovered in kawasaki disease patients with elevated
Warner EL, Nam GE, Zhang YY, McFadden M, Wright J, Spraker-Perlman
serum gamma glutamyl transferase levels: Implications for intravenous
H, Kinney AY, Oeffinger KC, Kirchhoff AC. Health behaviors, quality
immunoglobulin responsiveness. PLoS ONE. 2016;11(12):e0167434. PMCID:
of life, and psychosocial health among survivors of adolescent and
PMC5176264
young adult cancers. Journal of Cancer Survivorship. 2016;10(2):280-
Wang Z, Ramsey BJ, Wang D, Wong K, Li H, Wang E, Bao Z. An observation- 290. PMCID: PMC5030099
driven agent-based modeling and analysis framework for C. elegans
Warner SG, Haddad D, Au J, Carson JS, O’Leary MP, Lewis C, Monette
embryogenesis. PLoS ONE. 2016;11(11):e0166551. PMCID: PMC5113041
231 OF 324
Journal Articles
S, Fong Y. Oncolytic herpes simplex virus kills stem-like tumor-initiating RNA structures in vitro and in vivo with selective 2’-hydroxyl
colon cancer cells. Molecular Therapy - Oncolytics. 2016;3:16013. PMCID: acylation analyzed by primer extension sequencing (SHAPE-
PMC4909096 Seq). Methods. 2016;103:34-48. PMCID: PMC4921265
Warren GW, Ostroff JS, Goffin JR. Lung cancer screening, cancer Watts JM, Dumitriu B, Hilden P, Kishtagari A, Rapaport F, Chen
treatment, and addressing the continuum of health risks caused C, Ahn J, Devlin SM, Stein EM, Rampal R, Levine RL, Young N, Tallman
by tobacco. American Society of Clinical Oncology Educational MS. Telomere length and associations with somatic mutations and clinical
Book. 2016;36:223-229. outcomes in acute myeloid leukemia. Leukemia Research. 2016;49:62-65.
Warrier T, Kapilashrami K, Argyrou A, Ioerger TR, Little D, Murphye Watts JM, Wang X V, Swords RT, Paietta E, Douer D, Lugar SM,
KC, Nandakumar M, Park S, Gold B, Mi J, Zhang T, Meiler E, Rees M, Fernandez HF, Rowe JM, Lazarus HM, Tallman MS, Litzow MR. Very late
Somersan-Karakaya S, Francisco EPD, Martinez-Hoyos M, Burns- relapse of AML after allogeneic hematopoietic cell transplantation is
Huang K, Roberts J, Ling Y, Rhee KY, Mendoza-Losana A, Luo often extramedullary. Bone Marrow Transplantation. 2016;51(7):1013-1015.
M, Nathan CF. N-methylation of a bactericidal compound as a
resistance mechanism in Mycobacterium tuberculosis. Proceedings Weber JS, Postow M, Lao CD, Schadendorf D. Management of adverse
of the National Academy of Sciences of the United States of events following treatment with anti-programmed death-1 agents. The
America. 2016;113(31):E4523-E4530. PMCID: PMC4978242 Oncologist. 2016;21(10):1230-1240. PMCID: PMC5061539
Waters EA, Kiviniemi MT, Orom H, Hay JL. “I don’t know” my cancer Weber WA, Morris MJ. Molecular imaging and targeted radionuclide
risk: Implications for health behavior engagement. Annals of Behavioral therapy of prostate cancer. Journal of Nuclear Medicine. 2016;57(Suppl.
Medicine. 2016;50(5):784-788. PMCID: PMC5010525 3):3S-5S.
Waters EA, Wheeler C, Hamilton JG. How are information seeking, Wee B, Pietras A, Ozawa T, Bazzoli E, Podlaha O, Antczak C, Westermark
scanning, and processing related to beliefs about the roles of B, Nelander S, Uhrbom L, Forsberg-Nilsson K, Djaballah H, Michor
genetics and behavior in cancer causation?. Journal of Health F, Holland EC. ABCG2 regulates self-renewal and stem cell marker
Communication. 2016;21:6-15. PMCID: PMC5079642 expression but not tumorigenicity or radiation resistance of glioma
cells. Scientific Reports. 2016;6 PMCID: PMC4960591
Watson KS, Blok AC, Buscemi J, Molina Y, Fitzgibbon M, Simon MA,
Williams L, Matthews K, Studts JL, Lillie SE, Ostroff JS, Carter-Harris L, Wehrenberg-Klee E, Turker NS, Heidari P, Larimer B, Juric
Winn RA. Society of Behavioral Medicine supports implementation of D, Baselga J, Scaltriti M, Mahmood U. Differential receptor tyrosine
high quality lung cancer screening in high-risk populations. Translational kinase PET Imaging for therapeutic guidance. Journal of Nuclear
Behavioral Medicine. 2016;6(4):669-671. PMCID: PMC5110503 Medicine. 2016;57(9):1413-1419.
Watters KE, Strobel EJ, Yu AM, Lis JT, Lucks JB. Cotranscriptional folding Wei CH, Scott AM, Price AN, Miller HC, Klassen AF, Jhanwar SM, Mehrara
of a riboswitch at nucleotide resolution. Nature Structural & Molecular BJ, Disa JJ, McCarthy C, Matros E, Cordeiro PG, Sacchini V, Pusic
Biology. 2016;23(12):1124-1131. AL. Psychosocial and sexual well-being following nipple-sparing mastectomy
and reconstruction. Breast Journal. 2016;22(1):10-17. PMCID: PMC4843778
Watters KE, Yu AM, Strobel EJ, Settle AH, Lucks JB. Characterizing
232 OF 324
Journal Articles
Wei L, Zhao X. A new MCM modification cycle regulates DNA replication approaches to optimize molecular therapies. Science Translational
initiation. Nature Structural & Molecular Biology. 2016;23(3):209- Medicine. 2016;8(355):355ps16.
216. PMCID: PMC4823995
Wengert GJ, Helbich TH, Woitek R, Kapetas P, Clauser P, Baltzer
Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, PA, Vogl WD, Weber M, Meyer-Baese A, Pinker K. Inter- and intra-
Simeone E, Mangana J, Schilling B, Di Giacomo AM, Brenner N, Kähler observer agreement of BI-RADS-based subjective visual estimation
K, Heinzerling L, Gutzmer R, Bender A, Gebhardt C, Romano E, Meier of amount of fibroglandular breast tissue with magnetic resonance
F, Martus P, Maio M, Blank C, Schadendorf D, Dummer R, Ascierto PA, imaging: Comparison to automated quantitative assessment. European
Hospers G, Garbe C, Wolchok JD. Baseline biomarkers for outcome Radiology. 2016;26(11):3917-3922. PMCID: PMC5052327
of melanoma patients treated with pembrolizumab. Clinical Cancer
Research. 2016;22(22):5487-5496. Werneck Krauss Silva V, Askan G, Daniel TD, Lowery M, Klimstra
DS, Abou-Alfa GK, Shia J. Biliary carcinomas: Pathology and the role of
Weinsaft JW, Kim J, Medicherla CB, Ma CL, Codella NCF, Kukar N, DNA mismatch repair deficiency. Chinese Clinical Oncology. 2016;5(5):62.
Alaref S, Kim RJ, Devereux RB. Echocardiographic algorithm for
post-myocardial infarction LV thrombus: A gatekeeper for thrombus Westblade LF, van Belkum A, Grundhoff A, Weinstock GM, Pamer
evaluation by delayed enhancement CMR. JACC: Cardiovascular EG, Pallen MJ, Dunne WM Jr. Role of clinicogenomics in infectious
Imaging. 2016;9(5):505-515. PMCID: PMC5104336 disease diagnostics and public health microbiology. Journal of Clinical
Microbiology. 2016;54(7):1686-1693. PMCID: PMC4922100
Weiser MR. Rectal cancer: Time for precision medicine?. Annals of
Surgical Oncology. 2016;23(1):12-15. Westhoff CL, Eisenberger A, Tang R, Cremers S, Grossman L V, Pike
MC. Clotting factor changes during the first cycle of oral contraceptive
Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, use. Contraception. 2016;93(1):70-76. PMCID: PMC5004596
Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D,
Jude K, Guerston H, Barkal A, Trapani F, George J, Poirier JT, Gardner Wexler AG, Bao Y, Whitney JC, Bobay LM, Xavier JB, Schofield WB, Barry
EE, Miles LA, de Stanchina E, Lofgren SM, Vogel H, Winslow MM, Dive NA, Russell AB, Tran BQ, Goo YA, Goodlett DR, Ochman H, Mougous
C, Thomas RK, Rudin CM, van de Rijn M, Majeti R, Garcia KC, Weissman JD, Goodman AL, Isberg RR. Human symbionts inject and neutralize
IL, Sage J. CD47-blocking immunotherapies stimulate macrophage- antibacterial toxins to persist in the gut. Proceedings of the National
mediated destruction of small-cell lung cancer. Journal of Clinical Academy of Sciences of the United States of America. 2016;113(13):3639-
Investigation. 2016;126(7):2610-2620. PMCID: PMC4922696 3644. PMCID: PMC4822603
Weisman PS, Ng CK, Brogi E, Eisenberg RE, Won HH, Piscuoglio S, De Wexler LH. Metastatic rhabdomyosarcoma: Still room for
Filippo MR, Ioris R, Akram M, Norton L, Weigelt B, Berger MF, Reis improvement. Journal of Clinical Oncology. 2016;34(2):105-106.
JS, Wen HY. Genetic alterations of triple negative breast cancer by
targeted next-generation sequencing and correlation with tumor White J, Winter K, Kuske RR, Bolton JS, Arthur DW, Scroggins T,
morphology. Modern Pathology. 2016;29(5):476-488. PMCID: PMC4848211 Rabinovitch RA, Kelly T, Toonkel LM, Vicini FA, McCormick B. Long-term
cancer outcomes from study NRG oncology/RTOG 9517: A phase 2 study
Weissleder R, Schwaiger MC, Gambhir SS, Hricak H. Imaging of accelerated partial breast irradiation with multicatheter brachytherapy
233 OF 324
Journal Articles
after lumpectomy for early-stage breast cancer. International Journal neoplasms. JAMA Dermatology. 2016;152(3):260-261.
of Radiation Oncology, Biology, Physics. 2016;95(5):1460-1465. PMCID:
PMC5088493 Wiggers JK, Koerkamp BG, Cieslak KP, Doussot A, van Klaveren D, Allen
PJ, Besselink MG, Busch OR, D’Angelica M I, DeMatteo RP, Gouma
White KAM, Luo L, Thompson TA, Torres S, Hu CAA, Thomas NE, Lilyquist DJ, Kingham TP, van Gulik TM, Jarnagin WR. Postoperative mortality
J, Anton-Culver H, Gruber SB, From L, Busam KJ, Orlow I, Kanetsky PA, after liver resection for perihilar cholangiocarcinoma: Development
Marrett LD, Gallagher RP, Sacchetto L, Rosso S, Dwyer T, Cust AE, Begg of a risk score and importance of biliary drainage of the future liver
CB, Berwick M, The GEM Study Group. Variants in autophagy-related remnant. Journal of the American College of Surgeons. 2016;223(2):321-
genes and clinical characteristics in melanoma: A population-based 331.e1. PMCID: PMC4961586
study. Cancer Medicine. 2016;5(11):3336-3345. PMCID: PMC5119988
Wilbur MB, Birrer MJ, Spriggs DR. Chemotherapy-induced nausea and
White RM. Genomic approaches to zebrafish cancer. Advances in vomiting. New England Journal of Medicine. 2016;375(2):177-179.
Experimental Medicine and Biology. 2016;916:125-145.
Wild AT, Herman JM, Dholakia AS, Moningi S, Lu Y, Rosati LM, Hacker-
Wibmer AG, Burger IA, Sala E, Hricak H, Weber WA, Vargas HA. Molecular Prietz A, Assadi RK, Saeed AM, Pawlik TM, Jaffee EM, Laheru DA, Tran
imaging of prostate cancer. Radiographics. 2016;36(1):142-161. PT, Weiss MJ, Wolfgang CL, Ford E, Grossman SA, Ye X, Ellsworth
SG. Lymphocyte-sparing effect of stereotactic body radiation therapy
Wibmer AG, Sala E, Hricak H, Vargas HA. The expanding in patients with unresectable pancreatic cancer. International Journal
landscape of diffusion-weighted MRI in prostate cancer. Abdominal of Radiation Oncology, Biology, Physics. 2016;94(3):571-579. PMCID:
Radiology. 2016;41(5):854-861. PMC4847529
Widmar M, Keskin M, Beltran P, Nash GM, Guillem JG, Temple LK, Paty William WN Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EEW,
PB, Weiser MR, Garcia-Aguilar J. Incisional hernias after laparoscopic and Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM,
robotic right colectomy. Hernia. 2016;20(5):723-728. PMCID: PMC5025379 Vigneswaran N, Shinn N, Heymach J V, Wistuba I I, Tang X, Kim
ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar
Wiener L, Viola A, Kearney J, Mullins LL, Sherman-Bien S, Zadeh A, Lippman SM. Erlotinib and the risk of oral cancer: The Erlotinib
S, Farkas-Patenaude A, Pao M, Lone Parent Study Group. Impact Prevention of Oral Cancer (EPOC) randomized clinical trial. JAMA
of caregiving for a child with cancer on parental health behaviors, Oncology. 2016;2(2):209-216. PMCID: PMC4771491
relationship quality, and spiritual faith: Do lone parents fare
worse?. Journal of Pediatric Oncology Nursing. 2016;33(5):378- Williams R, White P, Nieto J, Vieira D, Francois F, Hamilton F. Colorectal
386. PMCID: PMC5066587 cancer in African Americans: An update. Clinical and Translational
Gastroenterology. 2016;7:e185. PMCID: PMC4977418
Wiesner T, Kutzner H, Cerroni L, Mihm MC Jr, Busam
KJ, Murali R. Genomic aberrations in spitzoid melanocytic Williams RM, Jaimes EA, Heller DA. Nanomedicines for kidney
tumours and their implications for diagnosis, prognosis and diseases. Kidney International. 2016;90(4):740-745. PMCID:
therapy. Pathology. 2016;48(2):113-131. PMCID: PMC4817351 PMC5064150
Wiesner T. Genomic rearrangements in unusual and atypical melanocytic Wimmer T, Srimathveeravalli G, Silk M, Monette S, Gutta N, Maybody
234 OF 324
Journal Articles
M, Erinjeri JP, Coleman JA, Solomon SB, Sofocleous CT. Feasibility Winter J, Winter M, Krohn T, Heinzel A, Behrendt FF, Tuttle RM, Mottaghy
of a modified biopsy needle for irreversible electroporation ablation FM, Verburg FA. Patients with high-risk differentiated thyroid cancer
and periprocedural tissue sampling. Technology in Cancer Research & have a lower I-131 ablation success rate than low-risk ones in spite of a
Treatment. 2016;15(6):749-758. high ablation activity. Clinical Endocrinology. 2016;85(6):926-931.
Winawer SJ, Fischer SE, Levin B. Evidence-based, reality-driven Winter JM, Jiang W, Basturk O, Mino-Kenudson M, Ven Fong Z, Tan WP,
colorectal cancer screening guidelines - The critical relationship of Lavu H, Vollmer CM, Furth EE, Haviland D, Klimstra DS, Jarnagin WR,
adherence to effectiveness. JAMA - Journal of the American Medical Lillemoe KD, Yeo CJ, Castillo CFD, Allen PJ. Recurrence and survival after
Association. 2016;315(19):2065-2066. resection of small intraductal papillary mucinous neoplasm-associated
carcinomas (≤ 20-mm invasive component): A multi-institutional
Winer AG, Motzer RJ, Hakimi AA. Prognostic biomarkers for response analysis. Annals of Surgery. 2016;263(4):793-801. PMCID: PMC4957241
to vascular endothelial growth factor-targeted therapy for renal
cell carcinoma. Urologic Clinics of North America. 2016;43(1):95- Wiser I, Scope A, Azriel D, Zloczower E, Carmel NN, Shalom A. Head and
104. PMCID: PMC4864362 neck cutaneous squamous cell carcinoma clinicopathological risk factors
according to age and gender: A population-based study. Israel Medical
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton- Association Journal. 2016;18(5):275-278.
Culver H, Bandera E V, Cramer D, Doherty JA, Goodman MT, Gronwald
J, Karlan BY, Kjaer SK, Levine DA, Menon U, Ness RB, Pearce CL, Pejovic Wistuba-Hamprecht K, Martens A, Haehnel K, Geukes Foppen M, Yuan
T, Rossing MA, Wentzensen N, Bean YT, Bisogna M, Brinton LA, Carney J, Postow MA, Wong P, Romano E, Khammari A, Dreno B, Capone M,
ME, Cunningham JM, Cybulski C, deFazio A, Dicks EM, Edwards RP, Ascierto PA, Demuth I, Steinhagen-Thiessen E, Larbi A, Schilling B,
Gayther SA, Gentry-Maharaj A, Gore M, Iversen ES, Jensen A, Johnatty Schadendorf D, Wolchok JD, Blank CU, Pawelec G, Garbe C, Weide
SE, Lester J, Lin HY, Lissowska J, Lubinski J, Menkiszak J, Modugno F, B. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with
Moysich KB, Orlow I, Pike MC, Ramus SJ, Song H, Terry KL, Thompson overall survival of melanoma patients treated with ipilimumab. European
PJ, Tyrer JP, van den Berg DJ, Vierkant RA, Vitonis AF, Walsh C, Journal of Cancer. 2016;64:116-126. PMCID: PMC5201188
Wilkens LR, Wu AH, Yang H, Ziogas A, Berchuck A, Chenevix-Trench
G, on behalf of Australian Ovarian Cancer Study Group, Schildkraut Witjes JA, Dalbagni G, Karnes RJ, Shariat S, Joniau S, Palou J, Serretta
JM, Permuth-Wey J, Phelan CM, Pharoah PDP, Fridley BL, Sellers TA, V, Larré S, di Stasi S, Colombo R, Babjuk M, Malmström PU, Malats N,
Goode EL. Investigation of exomic variants associated with overall Irani J, Baniel J, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Spahn
survival in ovarian cancer. Cancer Epidemiology Biomarkers and M, Pisano F, Gontero P, Sylvester R. The efficacy of BCG TICE and
Prevention. 2016;25(3):446-454. PMCID: PMC4779669 BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-
invasive bladder cancer. Urologic Oncology: Seminars and Original
Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers Investigations. 2016;34(11):484.e19-484.e25.
CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML,
Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes Witkiewicz AK, Balaji U, Eslinger C, McMillan E, Conway W, Posner B,
A, Constine LS. ACR Appropriateness Criteria® recurrent Hodgkin Mills GB, O’Reilly EM, Knudsen ES. Integrated patient-derived models
lymphoma. Oncology (Norwalk). 2016;30(12):1099-1108. delineate individualized therapeutic vulnerabilities of pancreatic
cancer. Cell Reports. 2016;16(7):2017-2031. PMCID: PMC5287055
235 OF 324
Journal Articles
Witkowski L, Goudie C, Ramos P, Boshari T, Brunet JS, Karnezis AN, Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen
Longy M, Knost JA, Saloustros E, McCluggage WG, Stewart CJR, M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG. Influence of
Hendricks WPD, Cunliffe H, Huntsman DG, Pautier P, Levine DA, Trent extracapsular nodal spread extent on prognosis of oral squamous
JM, Berchuck A, Hasselblatt M, Foulkes WD. The influence of clinical and cell carcinoma. Head and Neck. 2016;38(Suppl. 1):E1192-E1199. PMCID:
genetic factors on patient outcome in small cell carcinoma of the ovary, PMC4996672
hypercalcemic type. Gynecologic Oncology. 2016;141(3):454-460.
Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman
Wojciechowska S, van Rooijen E, Ceol C, Patton EE, White RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham
RM. Generation and analysis of zebrafish melanoma models. Methods in J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson M I. Neoadjuvant
Cell Biology. 2016;134:531-549. chemotherapy for newly diagnosed, advanced ovarian cancer: Society
of Gynecologic Oncology and American Society of Clinical Oncology
Wolach O, Itchaki G, Bar-Natan M, Yeshurun M, Ram R, Herscovici C, Clinical Practice Guideline. Gynecologic Oncology. 2016;143(1):3-15.
Shpilberg O, Douer D, Tallman MS, Raanani P. High-dose cytarabine
as salvage therapy for relapsed or refractory acute myeloid Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA,
leukemia-is more better or more of the same?. Hematological Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye
Oncology. 2016;34(1):28-35. AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson M
I. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian
Won E, Shah MA, Schöder H, Strong VE, Coit DG, Brennan cancer: Society of Gynecologic Oncology and American Society
MF, Kelsen DP, Janjigian YY, Tang LH, Capanu M, Rizk NP, Allen of Clinical Oncology Clinical Practice Guideline. Journal of Clinical
PJ, Bains MS, Ilson DH. Use of positron emission tomography Oncology. 2016;34(28):3460-3473.
scan response to guide treatment change for locally advanced
gastric cancer: The Memorial Sloan Kettering Cancer Center Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman
experience. Journal of Gastrointestinal Oncology. 2016;7(4):506- RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham
514. PMCID: PMC4963363 J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson M I. Neoadjuvant
chemotherapy for newly diagnosed, advanced ovarian cancer:
Wong E, Cohen T, Romi E, Levin M, Peleg Y, Arad U, Yaron A, Milla Society of gynecologic oncology and American society of clinical
ME, Sagi I. Harnessing the natural inhibitory domain to control oncology clinical practice guideline. Obstetrical and Gynecological
TNFα Converting Enzyme (TACE) activity in vivo. Scientific Survey. 2016;71(12):717-718.
Wu GC, Cheung NK V, Georgiou G, Marcotte EM, Ippolito GC. Temporal
Wong MH, Chan DL, Lee A, Li BT, Lumba S, Clarke SJ, Samra J, Pavlakis stability and molecular persistence of the bone marrow plasma cell antibody
N. Systematic review and meta-analysis on the role of chemotherapy repertoire. Nature Communications. 2016;7:13838. PMCID: PMC5187582
in advanced and metastatic neuroendocrine tumor (NET). PLoS
ONE. 2016;11(6):e0158140. PMCID: PMC4928873 Wu H, Zheng W, Eram MS, Vhuiyan M, Dong A, Zeng H, He H,
Brown P, Frankel A, Vedadi M, Luo M, Min J. Structural basis of
Woolthuis CM, Park CY. Hematopoietic stem/progenitor cell arginine asymmetrical dimethylation by PRMT6. Biochemical
commitment to the megakaryocyte lineage. Blood. 2016;127(10):1242- Journal. 2016;473(19):3049-3063. PMCID: PMC5280038
1248. PMCID: PMC5003506
236 OF 324
Journal Articles
Wu K, Chong RA, Yu Q, Bai J, Spratt DE, Ching K, Lee C, Miao H, Tappin A retrospective study of 69 patients. American Journal of Surgical
I, Hurwitz J, Zheng N, Shaw GS, Sun Y, Felsenfeld DP, Sanchez Pathology. 2016;40(11):1526-1537. PMCID: PMC5069130
R, Zheng JN, Pan ZQ. Suramin inhibits cullin-RING E3 ubiquitin
ligases. Proceedings of the National Academy of Sciences of the United Xu B, Ghossein R, Lane J, Lin O, Katabi N. The utility of p16
States of America. 2016;113(14):E2011-E2018. PMCID: PMC4833235 immunostaining in fine needle aspiration in p16-positive head and neck
squamous cell carcinoma. Human Pathology. 2016;54:193-200.
Wu SP, Pfeiffer RM, Ahn IE, Mailankody S, Sonneveld P, Duin M V,
Munshi NC, Walker BA, Morgan G, Landgren O. Impact of genes highly Xu B, Ghossein R. Genomic landscape of poorly differentiated and
correlated with MMSET myeloma on the survival of non-MMSET myeloma anaplastic thyroid carcinoma. Endocrine Pathology. 2016;27(3):205-212.
patients. Clinical Cancer Research. 2016;22(16):4039-4044.
Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, Ganly
Xavier JB. Sociomicrobiology and pathogenic bacteria. Microbiology I, Ghossein R. Clinicopathologic features of fatal non-anaplastic follicular
Spectrum. 2016;4(3):VMBF-0019-2015-0003-2015. PMCID: cell- Derived thyroid carcinomas. Thyroid. 2016;26(11):1588-1597. PMCID:
PMC4920084 PMC5105347
Xia D, Langan DA, Solomon SB, Zhang Z, Chen B, Lai H, Sidky EY, Pan Xu B, Wang L, Borsu L, Ghossein R, Katabi N, Ganly I, Dogan S. A
X. Optimization-based image reconstruction with artifact reduction proportion of primary squamous cell carcinomas of the parotid gland
in C-arm CBCT. Physics in Medicine and Biology. 2016;61(20):7300- harbour high-risk human papillomavirus. Histopathology. 2016;69(6):921-
Xie W, Drouin S, Nakabayashi M, Pomerantz M, Lee GSM, Kantoff Xu H, Guo H, Cheung IY, Cheung NK V. Antitumor efficacy of anti-
PW, Sharifi N. A genetic variation of SOD2 does not determine GD2 IgG1 Is enhanced by Fc glyco-engineering. Cancer Immunology
duration of response to androgen deprivation therapy for prostate Research. 2016;4(7):631-638. PMCID: PMC4948116
cancer. Prostate. 2016;76(14):1338-1341.
Xu H, Valerio DG, Eisold ME, Sinha A, Koche RP, Hu W, Chen CW, Chu
Xiong H, Keith JW, Samilo DW, Carter RA, Leiner IM, Pamer EG. Innate SH, Brien GL, Park CY, Hsieh JJ, Ernst P, Armstrong SA. NUP98
lymphocyte/Ly6C(hi) monocyte crosstalk promotes Klebsiella fusion proteins interact with the NSL and MLL1 complexes to drive
pneumoniae clearance. Cell. 2016;165(3):679-689. PMCID: PMC4842125 leukemogenesis. Cancer Cell. 2016;30(6):863-878.
Xu B, Naughton D, Busam K, Pulitzer M. ERG is a useful Xu J, Li PX, Wu J, Gao YJ, Yin MX, Lin Y, Yang M, Chen DP, Sun HP, Liu
immunohistochemical marker to distinguish leukemia cutis from ZB, Gu XC, Huang HL, Fu LL, Hu HM, He LL, Wu WQ, Fei ZL, Ji HB,
nonneoplastic leukocytic infiltrates in the skin. American Journal of Zhang L, Mei CL. Involvement of the Hippo pathway in regeneration
Dermatopathology. 2016;38(9):672-677. PMCID: PMC5026187 and fibrogenesis after ischaemic acute kidney injury: YAP is the key
effector. Clinical Science. 2016;130(5):349-363. PMCID: PMC4727597
Xu B, Aneja A, Ghossein R, Katabi N. Predictors of outcome in the
phenotypic spectrum of polymorphous low-grade adenocarcinoma Xu J, Pham CG, Albanese SK, Dong Y, Oyama T, Lee CH, Rodrik-
(PLGA) and cribriform adenocarcinoma of salivary gland (CASG): Outmezguine V, Yao Z, Han S, Chen D, Parton DL, Chodera JD, Rosen
237 OF 324
Journal Articles
N, Cheng EH, Hsieh JJ. Mechanistically distinct cancer-associated mTOR Piris MA, Medeiros JL, Young KH. p63 expression confers significantly
activation clusters predict sensitivity to rapamycin. Journal of Clinical better survival outcomes in high-risk diffuse large B-cell lymphoma
Investigation. 2016;126(9):3526-3540. PMCID: PMC5004947 and demonstrates p53-like and p53-independent tumor suppressor
function. Aging. 2016;8(2):345-365. PMCID: PMC4789587
Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, Liu X, Kanan
S, Castillo JJ, Tai YT, Zehnder JL, Brown JR, Carrasco RD, Advani R, Yacoub R, Kaji D, Patel SN, Simoes PK, Busayavalasa D, Nadkarni GN,
Sabile JM, Argyropoulos K, Palomba ML, Morra E, Trojani A, Greco A, He JC, Coca SG, Uribarri J. Association between probiotic and yogurt
Tedeschi A, Varettoni M, Arcaini L, Munshi NM, Anderson KC, Treon consumption and kidney disease: Insights from NHANES. Nutrition
SP. Clonal architecture of CXCR4 WHIM-like mutations in Waldenstrom Journal. 2016;15(1):10. PMCID: PMC4728789
Macroglobulinaemia. British Journal of Haematology. 2016;172(5):735-744.
Yadav T, Whitehouse I. Replication-coupled nucleosome assembly and
Xu R, Shimizu F, Hovinga K, Beal K, Karimi S, Droms L, Peck KK, Gutin positioning by ATP-dependent chromatin-remodeling enzymes. Cell
P, Iorgulescu JB, Kaley T, DeAngelis L, Pentsova E, Nolan C, Grommes Reports. 2016;15(4):715-723. PMCID: PMC5063657
C, Chan T, Bobrow D, Hormigo A, Cross JR, Wu N, Takebe N, Panageas
K, Ivy P, Supko JG, Tabar V, Omuro A. Molecular and clinical effects of Yaeger R, Shah MA, Miller VA, Kelsen JR, Wang K, Heins ZJ, Ross
notch inhibition in glioma patients: A phase 0/I trial. Clinical Cancer JS, He Y, Sanford E, Yantiss RK, Balasubramanian S, Stephens
Research. 2016;22(19):4786-4796. PMCID: PMC5050072 PJ, Schultz N, Oren M, Tang L, Kelsen D. Genomic alterations
observed in colitis-associated cancers are distinct from those found in
Xue X, Papusha A, Choi K, Bonner JN, Kumar S, Niu H, Kaur H, Zheng sporadic colorectal cancers and vary by type of inflammatory bowel
XF, Donnianni RA, Lu L, Lichten M, Zhao X, Ira G, Sung P. Differential disease. Gastroenterology. 2016;151(2):278-287.e6.
regulation of the anti-crossover and replication fork regression activities
of Mph1 by Mte1. Genes and Development. 2016;30(6):687-699. PMCID: Yafi FA, Jenkins L, Albersen M, Corona G, Isidori A, Goldfarb S, Maggi M,
PMC4803054 Nelson CJ, Parish S, Salonia A, Tan R, Mulhall JP, Hellstrom WJG. Erectile
dysfunction. Nature Reviews Disease Primers. 2016;2:16003. PMCID:
Xu-Monette ZY, Deng Q, Manyam GC, Tzankov A, Li L, Xia Y, Wang XX, Zou PMC5027992
D, Visco C, Dybkær K, Li J, Zhang L, Liang H, Montes-Moreno S, Chiu A, Orazi
A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, Van Krieken JH, Huh J, Yahanda AT, Lafaro KJ, Spolverato G, Pawlik TM. A systematic review of
Ponzoni M, Ferreri AJM, Parsons BM, Møller MB, Wang SA, Miranda RN, Piris the factors that patients use to choose their surgeon. World Journal of
MA, Winter JN, Medeiros LJ, Li Y, Young KH. Clinical and biologic significance Surgery. 2016;40(1):45-55.
of MYC genetic mutations in de novo diffuse large B-cell lymphoma. Clinical
Cancer Research. 2016;22(14):3593-3605. PMCID: PMC4947447 Yalon M, Tuval-Kochen L, Castel D, Moshe I, Mazal I, Cohen O, Avivi
C, Rosenblatt K, Aviel-Ronen S, Schiby G, Yahalom J, Amariglio N,
Xu-Monette ZY, Zhang S, Li X, Manyam GC, Wang X, Xia Y, Visco C, Pfeffer R, Lawrence Y, Toren A, Rechavi G, Paglin S. Overcoming
Tzankov A, Zhang L, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, resistance of cancer cells to PARP-1 inhibitors with three different drug
Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, van Krieken JH, Huh combinations. PLoS ONE. 2016;11(5):e0155711. PMCID: PMC4873128
J, Ponzoni M, Ferreri AJM, Zhao X, Møller MB, Parsons BM, Winter JN,
238 OF 324
Journal Articles
Yan D, Wang HW, Bowman RL, Joyce JA. STAT3 and STAT6 signaling Yang TJ, Wu AJ. Cranial irradiation in patients with EGFR-mutant non-
pathways synergize to promote cathepsin secretion from macrophages small cell lung cancer brain metastases. Translational Lung Cancer
via IRE1α activation. Cell Reports. 2016;16(11):2914-2927. Research. 2016;5(1):134-137. PMCID: PMC4758984
Yang C, Arnold AG, Trottier M, Sonoda Y, Abu-Rustum NR, Zivanovic Yannuzzi NA, Francis JH, Abramson DH. Incidence of orbital
O, Robson ME, Stadler ZK, Walsh MF, Hyman DM, Offit K, Zhang recurrence after enucleation or ophthalmic artery chemosurgery
L. Characterization of a novel germline PALB2 duplication in a for advanced intraocular retinoblastoma - Reply. JAMA
hereditary breast and ovarian cancer family. Breast Cancer Research and Ophthalmology. 2016;134(1):114-115.
Treatment. 2016;160(3):447-456.
Yarmohammadi H, Brody LA, Erinjeri JP, Covey AM, Boas FE, Ziv
Yang H, Gao P, Rajashankar KR, Patel DJ. PAM-dependent E, Maybody M, Gonzalez-Aguirre AJ, Brown KT, Sheinfeld
target DNA recognition and cleavage by C2c1 CRISPR-Cas J, Getrajdman G I. Therapeutic application of percutaneous
endonuclease. Cell. 2016;167(7):1814-1828.e12. PMCID: PMC5278635 peritoneovenous (Denver) shunt in treating chylous ascites
in cancer patients. Journal of Vascular and Interventional
Yang J, Qian S, Cai X, Lu W, Hu C, Sun X, Yang Y, Yu Q, Gao SP, Radiology. 2016;27(5):665-673. PMCID: PMC5060070
Cao P. Chikusetsusaponin IVa butyl ester (CS-IVa-Be), a novel IL6R
antagonist, inhibits IL6/STAT3 signaling pathway and induces cancer cell Yarmohammadi H, Covey AM. Percutaneous biliary interventions and
apoptosis. Molecular Cancer Therapeutics. 2016;15(6):1190-1200. complications in malignant bile duct obstruction. Chinese Clinical
Oncology. 2016;5(5):68.
Yang J, Tang G, Zhang P, Hunt M, Lim SB, LoSasso T, Mageras G. Dose
calculation for hypofractionated volumetric-modulated arc therapy: Ye H, Adane B, Khan N, Minhajuddin M, Gasparetto M, Stevens B, Pei
Approximating continuous arc delivery and tongue-and-groove S, Balys M, Ashton JM, Klemm DJ, Woolthuis CM, Stranahan AW, Park
modeling. Journal of Applied Clinical Medical Physics . 2016;17(2):3- CY, Jordan CT. Leukemic stem cells evade chemotherapy by metabolic
13. PMCID: PMC4831077 adaptation to an adipose tissue niche. Cell Stem Cell. 2016;19(1):23-
37. PMCID: PMC4938766
Yang JC, Terezakis SA, Dunkel IJ, Gilheeney SW, Wolden SL. Intensity-
modulated radiation therapy with dose painting: A brain-sparing Ye J, Cai X, Yang J, Sun X, Hu C, Xia J, Shen J, Su K, Yan H, Xu Y,
technique for intracranial germ cell tumors. Pediatric Blood and Zhang Y, Zhang S, Yang L, Zhi H, Gao SP, Yu Q, Hu J, Cao P. Bacillus
Cancer. 2016;63(4):646-651. as a potential diagnostic marker for yellow tongue coating. Scientific
Yang R, Piperdi S, Zhang Y, Zhu W, Neophytou N, Hoang BH,
Mason G, Geller D, Dorfman H, Meyers PA, Healey JH, Phinney DG, Ye Q, Xu-Monette ZY, Tzankov A, Deng L, Wang X, Manyam GC,
Gorlick R. Transcriptional profiling identifies the signaling axes Visco C, Montes-Moreno S, Zhang L, Dybkær K, Chiu A, Orazi A, Zu
of IGF and transforming growth factor-beta as involved in the Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J,
pathogenesis of osteosarcoma. Clinical Orthopaedics and Related Ponzoni M, Ferreri AJM, Parsons BM, Møller MB, Piris MA, Winter JN,
Research. 2016;474(1):178-189. PMCID: PMC4686509 Medeiros LJ, Hu S, Young KH. Prognostic impact of concurrent MYC and
BCL6 rearrangements and expression in de novo diffuse large B-cell
lymphoma. Oncotarget. 2016;7(3):2401-2416. PMCID: PMC4823044
239 OF 324
Journal Articles
Yeh JM, Hanmer J, Ward ZJ, Leisenring WM, Armstrong GT, Yoon C, Chang KK, Lee JH, Tap WD, Hart CP, Simon MC, Yoon
Hudson MM, Stovall M, Robison LL, Oeffinger KC, Diller L. Chronic SS. Multimodal targeting of tumor vasculature and cancer stem-like
conditions and utility-based health-related quality of life in adult cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-
childhood cancer survivors. JNCI: Journal of the National Cancer activated chemotherapy. Oncotarget. 2016;7(28):42844-42858.
Institute. 2016;108(9):djw046.
Yoon C, Cho SJ, Aksoy BA, Park DJ, Schultz N, Ryeom SW, Yoon
Yeh YC, Kadota K, Nitadori J I, Sima CS, Rizk NP, Jones DR, Travis SS. Chemotherapy resistance in diffuse-type gastric adenocarcinoma is
WD, Adusumilli PS. International Association for the Study of Lung mediated by RhoA activation in cancer stem-like cells. Clinical Cancer
Cancer/American Thoracic Society/European Respiratory Society Research. 2016;22(4):971-983. PMCID: PMC4823002
classification predicts occult lymph node metastasis in clinically
mediastinal node-negative lung adenocarcinoma. European Journal of Yoon J, Leyva Castillo JM, Wang G, Galand C, Oyoshi MK, Kumar L,
Cardio-Thoracic Surgery. 2016;49(1):e9-e15. PMCID: PMC4678972 Hoff S, He R, Chervonsky A, Oppenheim JJ, Kuchroo VK, van den Brink
MRM, Malefyt RDW, Tessier PA, Fuhlbrigge R, Rosenstiel P, Terhorst
Yeku O, Slovin SF. Immune therapy for prostate cancer. The Cancer C, Murphy G, Geha RS. IL-23 induced in keratinocytes by endogenous
Journal. 2016;22(5):334-341. PMCID: PMC5117426 TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin
immunization. Journal of Experimental Medicine. 2016;213(10):2147-
Yeku O, Slovin SF. Radium-223 and concomitant therapies: Prospects 2166. PMCID: PMC5032726
and prudence. Translational Andrology and Urology. 2016;5(6):968-970.
Yorke E, Xiong Y, Han Q, Zhang P, Mageras G, Lovelock M, Pham
Yeku OO, Brentjens RJ. Armored CAR T-cells: Utilizing cytokines H, Xiong JP, Goodman KA. Kilovoltage imaging of implanted
and pro-inflammatory ligands to enhance CAR T-cell anti-tumour fiducials to monitor intrafraction motion with abdominal compression
efficacy. Biochemical Society Transactions. 2016;44(2):412-418. during stereotactic body radiation therapy for gastrointestinal
tumors. International Journal of Radiation Oncology, Biology,
Yélamos O, Nehal KS. Integrating clinical information, dermoscopy and Physics. 2016;95(3):1042-1049.
reflectance confocal microscopy to improve the diagnostic accuracy
and confidence of amelanotic and lightly pigmented melanomas. British Yoshimi A, Abdel-Wahab O. Defining risk in MDS over
Journal of Dermatology. 2016;175(6):1147-1148. time. Blood. 2016;128(7):885-886.
Yelskaya Z, Bacares R, Salo-Mullen E, Somar J, Lehrich DA, Fasaye Younes A, Ansell SM. Novel agents in the treatment of Hodgkin
GA, Coit DG, Tang LH, Stadler ZK, Zhang L. CDH1 missense variant lymphoma: Biological basis and clinical results. Seminars in
c. 1679C>G (p. T560R) completely disrupts normal splicing through Hematology. 2016;53(3):186-189.
creation of a novel 5 ‘ splice site. PLoS ONE. 2016;11(11):e0165654.
Younes A, Berdeja JG, Patel MR, Flinn I, Gerecitano JF, Neelapu SS, Kelly
Yin C, Glaser AK, Leigh SY, Chen Y, Wei L, Pillai PCS, Rosenberg KR, Copeland AR, Akins A, Clancy MS, Gong L, Wang J, Ma A, Viner JL,
MC, Abeytunge S, Peterson G, Glazowski C, Sanai N, Mandella Oki Y. Safety, tolerability, and preliminary activity of CUDC-907, a first-
MJ, Rajadhyaksha M, Liu JTC. Miniature in vivo MEMS-based line-scanned in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed
dual-axis confocal microscope for point-of-care pathology. Biomedical or refractory lymphoma or multiple myeloma: An open-label, dose-
Optics Express. 2016;7(2):251-263. PMCID: PMC4771446 escalation, phase 1 trial. Lancet Oncology. 2016;17(5):622-631.
240 OF 324
Journal Articles
Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell trastuzumab and pertuzumab in patients with HER2-positive metastatic
S, Armand P, Fanale M, Ratanatharathorn V, Kuruvilla J, Cohen JB, breast cancer. The Oncologist. 2016;21(4):418-424. PMCID: PMC4828117
Collins G, Savage KJ, Trneny M, Kato K, Farsaci B, Parker SM, Rodig S,
Roemer MGM, Ligon AH, Engert A. Nivolumab for classical Hodgkin’s Yu AF, Raikhelkar J, Zabor EC, Tonorezos ES, Moskowitz CS, Adsuar
lymphoma after failure of both autologous stem-cell transplantation and R, Mara E, Huie K, Oeffinger KC, Steingart RM, Liu JE. Two-
brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 dimensional speckle tracking echocardiography detects subclinical
trial. Lancet Oncology. 2016;17(9):1283-1294. left ventricular systolic dysfunction among adult survivors of
childhood, adolescent, and young adult cancer. Biomed Research
Younes A. Promising novel agents for aggressive B-cell International. 2016;2016:9363951. PMCID: PMC4749762
lymphoma. Hematology/Oncology Clinics of North
America. 2016;30(6):1229-1237. Yu CJ, Yang Q, Chen YH, Wang DM, Levine R, Crispino J, Wen Q, Huang
Z. Tyrosine 625 plays a key role and cooperates with tyrosine 630 in MPL
Younes A. Targeting programmed death 1/programmed death W515L-induced signaling and myeloproliferative neoplasms. Cell and
ligand 1 in lymphoma: A game changer. Journal of Oncology Bioscience. 2016;6(1):34. PMCID: PMC4877759
Practice. 2016;12(2):107-108.
Yu H, Qu F, Shan B, Huang B, Jia W, Chen C, Li A, Miao M, Zhang
Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig X, Bao C, Xu Y, Chavda KD, Tang YW, Kreiswirth BN, Du H, Chen
R, Bossuyt PMM, De Silva M, Guittet L, Halloran SP, Haug U, Hoff L. Detection of the mcr-1 colistin resistance gene in carbapenem-resistant
G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O’Morain CA, Parry S, Enterobacteriaceae from different hospitals in China. Antimicrobial
Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJC, Agents and Chemotherapy. 2016;60(8):5033-5035. PMCID: PMC4958199
Sung JJY, Winawer SJ. Recommendations for a step-wise comparative
approach to the evaluation of new screening tests for colorectal Yu KH, Levine DA, Zhang H, Chan DW, Zhang Z, Snyder M. Predicting
cancer. Cancer. 2016;122(6):826-839. PMCID: PMC5066737 ovarian cancer patients’ clinical response to platinum-based
Young RJ, Francis JH, Abramson DH. Aicardi chemotherapy by their tumor proteomic signatures. Journal of Proteome
syndrome. Ophthalmology. 2016;123(8):1645. Research. 2016;15(8):2455-2465.
Yousefi M, Li N, Nakauka-Ddamba A, Wang S, Davidow K, Schoenberger Yu Q, Fang D, Swerdlow RH, Yu H, Chen JX, Yan SS. Antioxidants
J, Yu Z, Jensen ST, Kharas MG, Lengner CJ. Msi RNA-binding proteins rescue mitochondrial transport in differentiated Alzheimer’s
control reserve intestinal stem cell quiescence. Journal of Cell disease trans-mitochondrial cybrid cells. Journal of Alzheimer’s
Biology. 2016;215(3):401-413. PMCID: PMC5100293 Disease. 2016;54(2):679-690.
Yu AF, Ky B. Roadmap for biomarkers of cancer therapy Yu SJ, Jiang R, Mazzu YZ, Wei CB, Sun ZL, Zhang YZ, Zhou LD, Zhang
cardiotoxicity. Heart. 2016;102(6):425-430. PMCID: PMC4769926 QH. Epigallocatechin-3-gallate prevents triptolide-induced hepatic
injury by restoring the Th17/T(reg) balance in mice. American Journal of
Yu AF, Manrique C, Pun S, Liu JE, Mara E, Fleisher M, Patil S, Jones Chinese Medicine. 2016;44(6):1221-1236.
LW, Steingart RM, Hudis CA, Dang CT. Cardiac safety of paclitaxel plus
241 OF 324
Journal Articles
Yu X, Li Y, Chen Q, Su C, Zhang Z, Yang C, Hu Z, Hou J, Zhou J, Gong BRAF(V600E)-mutated metastatic melanoma patients treated with
L, Jiang X, Zheng C, He S. Herpes simplex virus 1 (HSV-1) and HSV- vemurafenib. Clinical Cancer Research. 2016;22(6):1341-1347.
2 mediate species-specific modulations of programmed necrosis
through the viral ribonucleotide reductase large subunit R1. Journal of Zadinsky JK, Barton-Burke M. Conducting research with limited
Virology. 2016;90(2):1088-1095. PMCID: PMC4702709 resources. Journal of Health and Human Experience. 2016;2(1):94-104.
Yuan A, Wei J, Gaebler CP, Huang H, Olek D, Li G. A novel respiratory Zaider T I, Banerjee SC, Manna R, Coyle N, Pehrson C, Hammonds
motion perturbation model adaptable to patient breathing S, Krueger CA, Bylund CL. Responding to challenging interactions with
irregularities. International Journal of Radiation Oncology, Biology, families: A training module for inpatient oncology nurses. Families,
Physics. 2016;96(5):1087-1096. PMCID: PMC5118064 Systems and Health. 2016;34(3):204-212. PMCID: PMC5213594
Yuan H, Paskov I, Paskov H, González AJ, Leslie CS. Multitask Zakian KL, Hatfield W, Aras O, Cao K, Yakar D, Goldman DA, Moskowitz
learning improves prediction of cancer drug sensitivity. Scientific CS, Shukla-Dave A, Tehrani YM, Fine S, Eastham J, Hricak H. Prostate
Reports. 2016;6:31619. PMCID: PMC4994023 MRSI predicts outcome in radical prostatectomy patients. Magnetic
Resonance Imaging. 2016;34(5):674-681. PMCID: PMC4860021
Yuan J, Hegde PS, Clynes R, Foukas PG, Harari A, Kleen TO, Kvistborg
P, Maccalli C, Maecker HT, Page DB, Robins H, Song W, Stack EC, Wang Zakowski MF, Rekhtman N, Auger M, Booth CN, Crothers
E, Whiteside TL, Zhao Y, Zwierzina H, Butterfield LH, Fox BA. Novel B, Ghofrani M, Khalbuss W, Laucirica R, Moriarty AT, Laura
technologies and emerging biomarkers for personalized cancer Tabatabai Z, Barkan GA. Morphologic accuracy in differentiating
immunotherapy. Journal for Immunotherapy of Cancer. 2016;4:3. PMCID: primary lung adenocarcinoma from squamous cell carcinoma
PMC4717548 in cytology specimens. Archives of Pathology & Laboratory
Medicine. 2016;140(10):1116-1120.
Yuan J, Wang E, Fox BA. Immune monitoring technology primer:
Protein microarray (‘seromics’). Journal for Immunotherapy of Zakowski MF. Cytology nomenclature and 2015 World
Cancer. 2016;4:2. PMCID: PMC4717589 Health Organization classification of lung cancer. Cancer
Cytopathology. 2016;124(2):81-88.
Yun T, Yu K, Yan SS, Cui Y, Wang Z, Ren H, Chen S, Li L, Liu X, Fang
M, Jiang X. Acetylation of p53 protein at lysine 120 up-regulates Apaf-1 Zamarin D, Jazaeri AA. Leveraging immunotherapy for the treatment
protein and sensitizes the mitochondrial apoptotic pathway. Journal of of gynecologic cancers in the era of precision medicine. Gynecologic
Biological Chemistry. 2016;291(14):7386-7395. PMCID: PMC4817170 Oncology. 2016;141(1):86-94. PMCID: PMC5007873
Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P. Factors Zanzonico P, Dauer L, Strauss HW. Radiobiology in cardiovascular
associated with recovery of renal function following radical nephrectomy imaging. JACC: Cardiovascular Imaging. 2016;9(12):1446-1461.
for kidney neoplasms. Clinical Journal of the American Society of
Nephrology. 2016;11(1):101-107. PMCID: PMC4702228 Zanzonico PB. The neglected side of the coin: Quantitative benefit-
risk analyses in medical imaging. Health Physics. 2016;110(3):301-
Zabor EC, Heller G, Schwartz LH, Chapman PB. Correlating surrogate 304. PMCID: PMC5056790
endpoints with overall survival at the individual patient level in
242 OF 324
Journal Articles
Zappasodi R, Merghoub T. Interfering with Helios-induced regulatory Zelenetz AD, Gordon L I, Wierda WG, Abramson JS, Advani RH,
T cell stability as a strategy for cancer immunotherapy. Translational Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher R I, Glenn MJ,
Cancer Research. 2016;5:S1116-S1118. Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz
SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M,
Zarbo A, Ouerfelli O, Klang M, Lacouture ME. Increased airport Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts
scrutiny by the transportation security administration of a patient- K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M,
passenger carrying ammonium lactate-containing moisturizer. JAMA Sundar H. Diffuse large B-cell lymphoma version 1.2016. Journal of the
Dermatology. 2016;152(9):1054-1055. National Comprehensive Cancer Network. 2016;14(2):196-231.
Zarghouni M, Charles HW, Maldonado TS, Deipolyi AR. Catheter-directed Zeltner N, Fattahi F, Dubois NC, Saurat N, Lafaille F, Shang L, Zimmer
interventions for pulmonary embolism. Cardiovascular Diagnosis and B, Tchieu J, Soliman MA, Lee G, Casanova JL, Studer L. Capturing
Therapy. 2016;6(6):651-661. PMCID: PMC5220195 the biology of disease severity in a PSC-based model of familial
dysautonomia. Nature Medicine. 2016;22(12):1421-1427.
Zarnegar S, Giulino-Roth L. Reducing radiation exposure in children
with febrile neutropenia: Can pulmonary MRI replace CT?. Leukemia and Zeltsman M, Mayor M, Jones DR, Adusumilli PS. Surgical immune
Lymphoma. 2016;57(1):4-5. interventions for solid malignancies. American Journal of
Surgery. 2016;212(4):682-690.e5. PMCID: PMC5089080
Zauderer MG. A new standard for malignant pleural
mesothelioma. Lancet. 2016;387(10026):1352-1354. Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K,
Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang
Zaydfudim VM, Vachharajani N, Klintmalm GB, Jarnagin WR, Hemming AW, Q, Dennis J, Agata S, Ahmed S, Aittomäki K, Andrulis IL, Anton-Culver
Majella Doyle MB, Cavaness KM, Chapman WC, Nagorney DM. Liver resection H, Antonenkova NN, Arason A, Arndt V, Arun BK, Arver B, Bacot F,
and transplantation for patients with hepatocellular carcinoma beyond Milan Barrowdale D, Baynes C, Beeghly-Fadiel A, Benitez J, Bermisheva M,
criteria. Annals of Surgery. 2016;264(4):650-658. PMCID: PMC5279918 Blomqvist C, Blot WJ, Bogdanova N V, Bojesen SE, Bonanni B, Borresen-
Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Broeks A, Brüning
Zelefsky MJ, Kollmeier MA, Gorshein E, Pei X, Torres M, McBride
T, Burwinkel B, Buys SS, Cai Q, Caldes T, Campbell I, Carpenter J,
S, Happersett L, Cohen GN, Yamada Y. Hip-related toxicity after prostate
Chang-Claude J, Choi JY, Claes KBM, Clarke C, Cox A, Cross SS, Czene
radiotherapy: Treatment related or coincidental?. Radiotherapy and
K, Daly MB, de la Hoya M, De Leeneer K, Devilee P, Diez O, Domchek
Oncology. 2016;121(1):109-112.
SM, Doody M, Dorfling CM, Dörk T, dos-Santos-Silva I, Dumont M, Dwek
Zelefsky MJ, Poon BY, Eastham J, Vickers A, Pei X, Scardino M, Dworniczak B, Egan K, Eilber U, Einbeigi Z, Ejlertsen B, Ellis S, Frost
PT. Longitudinal assessment of quality of life after surgery, conformal D, Lalloo F, on behalf of EMBRACE, Fasching PA, Figueroa J, Flyger H,
brachytherapy, and intensity-modulated radiation therapy for prostate Friedlander M, Friedman E, Gambino G, Gao YT, Garber J, García-Closas
cancer. Radiotherapy and Oncology. 2016;118(1):85-91. PMCID: M, Gehrig A, Damiola F, Lesueur F, Mazoyer S, Stoppa-Lyonnet D, on
PMC4848377 behalf of GEMO Study Collaborators, Giles GG, Godwin AK, Goldgar DE,
González-Neira A, Greene MH, Guénel P, Haeberle L, Haiman CA, Hallberg
Zelenetz AD, Becker PS. The role of biosimilars. Journal of the National E, Hamann U, Hansen TVO, Hart S, Hartikainen JM, Hartman M, Hassan N,
Comprehensive Cancer Network. 2016;14(5S):626-629. Healey S, Hogervorst FBL, Verhoef S, on behalf of HEBON, Hendricks CB,
243 OF 324
Journal Articles
Hillemanns P, Hollestelle A, Hulick PJ, Hunter DJ, Imyanitov EN, Isaacs C, of progressive chronic lymphocytic leukemia in older patients: A trial of
Ito H, Jakubowska A, Janavicius R, Jaworska-Bieniek K, Jensen UB, John the ECOG-ACRIN cancer research group (E1908). American Journal of
EM, Joly Beauparlant C, Jones M, Kabisch M, Kang D, Karlan BY, Kauppila Hematology. 2016;91(3):308-312. PMCID: PMC4806550
S, Kerin MJ, Khan S, Khusnutdinova E, Knight JA, Konstantopoulou I,
Kraft P, Kwong A, Laitman Y, Lambrechts D, Lazaro C, Le Marchand L, Zergoun AA, Zebboudj A, Sellam SL, Kariche N, Djennaoui D, Ouraghi
Lee CN, Lee MH, Lester J, Li J, Liljegren A, Lindblom A, Lophatananon S, Kerboua E, Amir-Tidadini ZC, Chilla D, Asselah F, Touil-Boukoffa
A, Lubinski J, Mai PL, Mannermaa A, Manoukian S, Margolin S, Marme C, Merghoub T, Bourouba M. IL-6/NOS2 inflammatory signals regulate
F, Matsuo K, McGuffog L, Meindl A, Menegaux F, Montagna M, Muir K, MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal
Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H, Newcomb PA, carcinoma patients. Tumor Biology. 2016;37(3):3505-3514.
Nord S, Nussbaum RL, Offit K, Olah E, Olopade O I, Olswold C, Osorio
A, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Peeters S, Peissel B, Zhang JH, McCastlain K, Yoshihara H, Xu BS, Chang YC, Churchman
Peterlongo P, Peto J, Pfeiler G, Phelan CM, Presneau N, Radice P, Rahman ML, Wul G, Li YJ, Wei L, Iacobucci I, Liu Y, Qu CX, Wen J, Edmonsonl M,
N, Ramus SJ, Rashid MU, Rennert G, Rhiem K, Rudolph A, Salani R, Payne-Turner D, Kaufmann KB, Takayanagi S, Wienholds E, Waanders E,
Sangrajrang S, Sawyer EJ, Schmidt MK, Schmutzler RK, Schoemaker MJ, Ntziachristos P, Bakogianni S, Wang JJ, Aifantis I, Roberts KG, Ma J, Song
Schürmann P, Seynaeve C, Shen CY, Shrubsole MJ, Shu XO, Sigurdson GC, Easton J, Mulder HL, Chen X, Newman S, Ma XT, Rusch M, Gupta P,
A, Singer CF, Slager S, Soucy P, Southey M, Steinemann D, Swerdlow Boggs K, Vadodaria B, Dalton J, Liu YL, Valentine ML, Ding L, Lu C, Fulton
A, Szabo C I, Tchatchou S, Teixeira MR, Teo SH, Terry MB, Tessier DC, RS, Fulton L, Tabib Y, Ochoa K, Devidas M, Pei DQ, Cheng C, Yang J,
Teulé A, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE, Tung Evans WE, Relling M V, Pui CH, Jeha S, Harvey RC, Chen IML, Willman CL,
N, Turnbull C, van den Ouweland AMW, van Rensburg EJ, ven den Berg Marcucci G, Bloomfield CD, Kohlschmidt J, Mrozek K, Paietta E, Tallman
D, Vijai J, Wang-Gohrke S, Weitzel JN, Whittemore AS, Winqvist R, MS, Stock W, Foster MC, Racevskis J, Rowe JM, Luger S, Kornblau SM,
Wong TY, Wu AH, Yannoukakos D, Yu JC, Pharoah PDP, Hall P, Chenevix- Shurtleff SA, Raimondi SC, Mardis ER, Wilson RK, Dick JE, Hunger SP,
Trench G, on behalf of KConFab, AOCS Investigators, Dunning AM, Loh ML, Downing JR, Mullighan CG. Deregulation of DUX4 and ERG
Simard J, Couch FJ, Antoniou AC, Easton DF, Zheng W. Identification in acute lymphoblastic leukemia. Nature Genetics. 2016;48(12):1481-
of independent association signals and putative functional variants for 1489. PMCID: PMC5144107
breast cancer risk through fine-scale mapping of the 12p11 locus. Breast
Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci
Cancer Research. 2016;18(1):64. PMCID: PMC4962376
E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci
Zeng H, Cohen S, Guy C, Shrestha S, Neale G, Brown SA, Cloer C, Kishton PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman
RJ, Gao X, Youngblood B, Do M, Li MO, Locasale JW, Rathmell JC, Chi PJ, Kamineni A, Kolonel LN, Kulke MH, Malats N, Olson SH, Sesso HD,
H. mTORC1 and mTORC2 kinase signaling and glucose metabolism Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G,
drive follicular helper T cell differentiation. Immunity. 2016;45(3):540- Brais L, Bas Bueno-de-Mesquita H, Basso D, Berndt S I, Boutron-Ruault
554. PMCID: PMC5050556 MC, Bijlsma MF, Brenner H, Burdette L, Campa D, Caporaso NE, Capurso
G, Cavestro GM, Cotterchio M, Costello E, Elena J, Boggi U, Michael
Zent CS, Wang X V, Ketterling RP, Hanson CA, Libby EN, Barrientos JC, Gaziano J, Gazouli M, Giovannucci EL, Goggins M, Gross M, Haiman
Call TG, Chang JE, Liu JJ, Calvo AR, Lazarus HM, Rowe JM, Luger SM, CA, Hassan M, Helzlsouer KJ, Hu N, Hunter DJ, Iskierka-Jazdzewska E,
Litzow MR, Tallman MS. A phase II randomized trial comparing standard Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V,
and low dose rituximab combined with alemtuzumab as initial treatment Kupcinskas J, Kurtz RC, Landi MT, Landi S, Marchand LL, Mambrini A,
244 OF 324
Journal Articles
Mannisto S, Milne RL, Neale RE, Oberg AL, Panico S, Patel A V, Peeters L, Zhou Y, Chen S, Mohammad KS, Guise TA, Abdel-Wahab O, Xu M,
PHM, Peters U, Pezzilli R, Porta M, Purdue M, Ramón Quiros J, Riboli E, Wang QF, Yang FC. Loss of Asxl1 alters self-renewal and cell fate of
Rothman N, Scarpa A, Scelo G, Shu XO, Silverman DT, Soucek P, Strobel bone marrow stromal cell, leading to Bohring-Opitz-like syndrome in
O, Sund M, Malecka-Panas E, Taylor PR, Tavano F, Travis RC, Thornquist mice. Stem Cell Reports. 2016;6(6):914-925. PMCID: PMC4911496
M, Tjønneland A, Tobias GS, Trichopoulos D, Vashist Y, Vodicka P,
Wactawski-Wende J, Wentzensen N, Yu H, Yu K, Zeleniuch-Jacquotte A, Zhang P, Happersett L, Ravindranath B, Zelefsky M, Mageras G, Hunt
Kooperberg C, Risch HA, Jacobs EJ, Li D, Fuchs C, Hoover R, Hartge P, M. Optimizing fiducial visibility on periodically acquired megavoltage
Chanock SJ, Petersen GM, Stolzenberg-Solomon RS, Wolpin BM, Kraft and kilovoltage image pairs during prostate volumetric modulated arc
P, Klein AP, Canzian F, Amundadottir LT. Three new pancreatic cancer therapy. Medical Physics. 2016;43(5):2024-2029. PMCID: PMC4826385
susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and
8q24.21. Oncotarget. 2016;7(41):66328-66343. Zhang Q, Du Y, Jing L, Liang X, Li Y, Li X, Dai Z, Tian J. Infra red
dye and endostar loaded poly lactic acid nano particles as a novel
Zhang M, Xu-Monette ZY, Li L, Manyam GC, Visco C, Tzankov A, Wang J, theranostic nanomedicine for breast cancer. Journal of Biomedical
Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards Nanotechnology. 2016;12(3):491-502.
KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJM,
Møller MB, Parsons BM, Winter JN, Piris MA, Medeiros LJ, Pham L V, Zhang X, Rao A, Sette P, Deibert C, Pomerantz A, Kim WJ, Kohanbash
Young KH. RelA NF-kB subunit activation as a therapeutic target in G, Chang Y, Park Y, Engh J, Choi J, Chan T, Okada H, Lotze M, Grandi
diffuse large B-cell lymphoma. Aging. 2016;8(12):3321-3340. PMCID: P, Amankulor N. IDH mutant gliomas escape natural killer cell immune
PMC5270671 surveillance by downregulation of NKG2D ligand expression. Neuro-
Zhang M, Gulotta B, Thomas A, Kaley T, Karimi S, Gavrilovic I, Woo
KM, Zhang Z, Arevalo-Perez J, Holodny A I, Rosenblum M, Young Zhang X, Sullivan E, Scimeca M, Wu X, Li YM, Sisodia SS. Evidence
RJ. Large-volume low apparent diffusion coefficient lesions predict That the “lid” domain of nicastrin is not essential for regulating
poor survival in bevacizumab-treated glioblastoma patients. Neuro- γ-secretase activity. Journal of Biological Chemistry. 2016;291(13):6748-
Oncology. 2016;18(5):735-743. PMCID: PMC4827045 6753. PMCID: PMC4807262
Zhang M, Lin O. Molecular testing of thyroid nodules: A review of Zhao J, Yorke ED, Li L, Kavanagh BD, Li XA, Das S, Miften M, Rimner
current available tests for fine-needle aspiration specimens. Archives of A, Campbell J, Xue J, Jackson A, Grimm J, Milano MT, Spring Kong
Pathology & Laboratory Medicine. 2016;140(12):1338-1344. FM. Simple factors associated with radiation-induced lung toxicity after
stereotactic body radiation therapy of the thorax: A pooled analysis
Zhang N, Fu JN, Chou TC. Synergistic combination of microtubule of 88 studies. International Journal of Radiation Oncology, Biology,
targeting anticancer fludelone with cytoprotective panaxytriol derived Physics. 2016;95(5):1357-1366.
from panax ginseng against MX-1 cells in vitro: Experimental design and
data analysis using the combination index method. American Journal of Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray
Cancer Research. 2016;6(1):97-104. PMCID: PMC4759401 BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G,
Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann
Zhang P, Xing C, Rhodes SD, He Y, Deng K, Li Z, He F, Zhu C, Nguyen J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M,
245 OF 324
Journal Articles
Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso Zhovmer A, Qu XH. Proximal disruptor aided ligation (ProDAL) of kilobase-
MCB V, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, long RNAs. RNA Biology. 2016;13(7):613-621. PMCID: PMC4962814
Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, The Cancer
Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak Zhu F, Dai C, Fu Y, Loo JFC, Xia D, Gao SP, Ma Z, Chen Z. Physalin
RGW. Comprehensive pan-genomic characterization of adrenocortical A exerts anti-tumor activity in non-small cell lung cancer cell lines
carcinoma. Cancer Cell. 2016;29(5):723-736. PMCID: PMC4864952 by suppressing JAK/STAT3 signaling. Oncotarget. 2016;7(8):9462-
9476. PMCID: PMC4891052
Zhong Q, Rüschoff JH, Guo T, Gabrani M, Schüffler PJ, Rechsteiner M,
Liu Y, Fuchs TJ, Rupp NJ, Fankhauser C, Buhmann JM, Perner S, Poyet Zhu LM, Tang L, Qiao XW, Wolin E, Nissen NN, Dhall D, Chen J,
C, Blattner M, Soldini D, Moch H, Rubin MA, Noske A, Rüschoff J, Haffner Shen L, Chi Y, Yuan YZ, Ben QW, Lv B, Zhou YR, Bai CM, Chen
MC, Jochum W, Wild PJ. Image-based computational quantification and J, Song YL, Song TT, Lu CM, Yu R, Chen YJ. Differences and
visualization of genetic alterations and tumour heterogeneity. Scientific similarities in the clinicopathological features of pancreatic
Reports. 2016;6:24146. PMCID: PMC4823793 neuroendocrine tumors in China and the United States: A multicenter
study. Medicine. 2016;95(7):e2836. PMCID: PMC4998644
Zhong X, Dong Z, Dong H, Li J, Peng Z, Deng L, Zhu X, Sun Y, Lu X,
Shen F, Su X, Zhang L, Gu Y, Zheng H. Prevalence and prognostic role Zhu N, Chen M, Eng R, DeJong J, Sinha AU, Rahnamay NF, Koche R, Al-
of BRCA1/2 variants in unselected Chinese breast cancer patients. PLoS Shahrour F, Minehart JC, Chen CW, Deshpande AJ, Xu H, Chu SH, Ebert
ONE. 2016;11(6):e0156789. PMCID: PMC4892623 BL, Roeder RG, Armstrong SA. MLL-AF9-and HOXA9-mediated acute
myeloid leukemia stem cell self-renewal requires JMJD1C. Journal of
Zhou ES, Bober SL, Nekhlyudov L, Hu JC, Kantoff PW, Recklitis Clinical Investigation. 2016;126(3):997-1011. PMCID: PMC4767347
CJ. Physical and emotional health information needs and preferences
of long-term prostate cancer survivors. Patient Education and Zhu Z, Li Q V, Lee K, Rosen BP, González F, Soh CL, Huangfu D. Genome
Counseling. 2016;99(12):2049-2054. editing of lineage determinants in human pluripotent stem cells reveals
mechanisms of pancreatic development and diabetes. Cell Stem
Zhou F, Moreira AL. Lung carcinoma predictive biomarker testing by Cell. 2016;18(6):755-768. PMCID: PMC4892994
immunoperoxidase stains in cytology and small biopsy specimens:
Advantages and limitations. Archives of Pathology & Laboratory Zimel MN, Farfalli GL, Zindman AM, Riedel ER, Morris CD, Boland
Medicine. 2016;140(12):1331-1337. PJ, Healey JH. Revision distal femoral arthroplasty with the Compress®
prosthesis has a low rate of mechanical failure at 10 years. Clinical
Zhou Z, Rademaker AW, Gordon L I, LaCasce AS, Crosby-Thompson Orthopaedics and Related Research. 2016;474(2):528-536. PMCID:
A, Vanderplas A, Abel GA, Rodriguez MA, Nademanee A, Kaminski PMC4709327
MS, Czuczman MS, Millenson MM, Zelenetz AD, Niland J, Friedberg
JW, Winter JN. High body mass index in elderly patients with DLBCL Zimmer B, Piao J, Ramnarine K, Tomishima MJ, Tabar V, Studer
treated with rituximab-containing therapy compensates for negative L. Derivation of diverse hormone-releasing pituitary cells from human
impact of male sex. Journal of the National Comprehensive Cancer pluripotent stem cells. Stem Cell Reports. 2016;6(6):858-872. PMCID:
Network. 2016;14(10):1274-1281. PMC4912387
246 OF 324
Journal Articles
Zinder JC, Wasmuth E V, Lima CD. Nuclear RNA exosome at 3.1 Å reveals Zumsteg ZS, Cook-Wiens G, Yoshida E, Shiao SL, Lee NY, Mita A, Jeon C,
substrate specificities, RNA paths, and allosteric inhibition of Rrp44/ Goodman MT, Ho AS. Incidence of oropharyngeal cancer among elderly
Dis3. Molecular Cell. 2016;64(4):734-745. PMCID: PMC5115963 patients in the United States. JAMA Oncology. 2016;2(12):1617-1623.
Ziv E, Durack JC, Solomon SB. The importance of biopsy in the era of Zumsteg ZS, Morse N, Krigsfeld G, Gupta G, Higginson DS, Lee
molecular medicine. The Cancer Journal. 2016;22(6):418-422. NY, Morris L, Ganly I, Shiao SL, Powell SN, Chung CH, Scaltriti
M, Baselga J. Taselisib (GDC-0032), a potent β-sparing small
Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 molecule inhibitor of PI3K, radiosensitizes head and neck squamous
pathway blockade for cancer therapy: Mechanisms, response carcinomas containing activating PIK3CA alterations. Clinical Cancer
biomarkers, and combinations. Science Translational Research. 2016;22(8):2009-2019. PMCID: PMC4870591
Medicine. 2016;8(328):328rv4. PMCID: PMC4859220
Zuckerman SL, Laufer I, Sahgal A, Yamada YJ, Schmidt MH, Chou D,

Shin JH, Kumar N, Sciubba DM. When less is more: The indications
for MIS techniques and separation surgery in metastatic spine
disease. Spine. 2016;41(Suppl. 20):S246-S253.
247 OF 324
Title
Conference
Papers (206)
248 OF 324
Conference Papers
Arias FX, Sierra H, Arzuaga E. Classification performance of a Hoffmann S, Lobbes M, Houben I, Pinker-Domenig K, Wengert G,
block-compressive sensing algorithm for hyperspectral data Burgeth B, Meyer-Bäse U, Lemaitre G, Meyer-Baese A. Computer-
processing. Proceedings of SPIE. 2016;9840:984005. aided diagnosis of diagnostically challenging lesions in breast
MRI: A comparison between a radiomics and a feature-selective
Arias FX, Sierra H, Rajadhyaksha M, Arzuaga E. Compressive sensing approach. Proceedings of SPIE. 2016;9871:98710H.
in reflectance confocal microscopy of skin images: A preliminary
comparative study. Proceedings of SPIE. 2016;9713:97130Z. Hyland SL, Karaletsos T, Rätsch G. A generative model of words and
relationships from multiple sources. 30th AAAI Conference on Artificial
Bozkurt A, Kose K, Fox CA, Dy J, Brooks DH, Rajadhyaksha M. An Intelligence, AAAI 2016. 2016;:2622-2629.
unsupervised machine learning method for delineating stratum
corneum in reflectance confocal microscopy stacks of human skin in Jain M, Rajadhyaksha M, Nehal K. Implementation of fluorescence
vivo. Proceedings of SPIE. 2016;9689:96890Z. confocal mosaicing microscopy by «early adopter» Mohs surgeons: A
review of recent progress. Proceedings of SPIE. 2016;9703:97030P.
Chakraborty J, Langdon-Embry L, Escalon JG, Allen PJ, Lowery
MA, O’Reilly EM, Do RKG, Simpson AL. Texture analysis for survival Julca MAM, Rivera I, Mercado JS, Sierra H, Perales-Pérez
prediction of pancreatic ductal adenocarcinoma patients with O. Induced structural defects in Ti-doped ZnO and its two-photon-
neoadjuvant chemotherapy. Proceedings of SPIE. 2016;9784:9784 1W. excitation. Proceedings of SPIE. 2016;9722:9722 1E.
Codella N, Moradi M, Matasar M, Sveda-Mahmood T, Smith Kircher MF. Ultra-high sensitivity imaging of cancer using SERRS
JR. Lymphoma diagnosis in histopathology using a multi-stage visual nanoparticles. Proceedings of SPIE. 2016;9836:98361L.
learning approach. Proceedings of SPIE. 2016;9791:97910H.
Kose K, Alessi-Fox C, Gill M, Dy JG, Brooks DH, Rajadhyaksha M. A
Demyanov S, Chakravorty R, Abedini M, Halpern A, Garnavi machine learning method for identifying morphological patterns in
R. Classification of dermoscopy patterns using deep convolutional reflectance confocal microscopy mosaics of melanocytic skin lesions in-
neural networks. International Symposium on Biomedical Imaging. vivo. Proceedings of SPIE. 2016;9689:968908.
Proceedings. 2016;:364-368.
Li X, Singanamalli A, Shanbhag D, Hötker AM, Aras O, Akin O,
Dickensheets DL, Kreitinger S, Peterson G, Heger M, Rajadhyaksha Bhagalia R. Improved noninvasive prostate cancer assessment using
M. Dermoscopy-guided reflectance confocal microscopy of skin multiparametric magnetic resonance imaging. International Symposium
using high-NA objective lens with integrated wide-field color on Biomedical Imaging. Proceedings. 2016;:1199-1203.
camera. Proceedings of SPIE. 2016;9689:96890U.
Nehal KS, Rajadhyaksha M, Sierra H. Latest advances in
Fehr D, Schmidtlein CR, Hwang S, Deasy JO, Veeraraghavan confocal microscopy of skin cancers toward guiding patient
H. Automatic detection and tracking of longitudinal changes of multiple care: A Mohs surgeon’s review and perspective (Conference
bone metastases from dual energy CT. International Symposium on Presentation). Proceedings of SPIE. 2016;9689:968907.
Biomedical Imaging. Proceedings. 2016;:168-171.
249 OF 324
Conference Papers
Nishikawa RM, Comstock CE, Linver MN, Newstead GM, Sandhir Schmidtlein CR, Turner JN, Thompson MO, Mandal KC, Häggström
V, Schmidt RA. Agreement between radiologists’ interpretations I, Zhang J, Humm JL, Feiglin DH, Krol A. Performance modeling
of screening mammograms. Lecture Notes in Computer of a wearable brain PET (BET) camera. Proceedings of
Science. 2016;9699:3-10. SPIE. 2016;9788:978806.
Obcemea C. Potential clinical impact of laser-accelerated beams Selby L V, Rifkin MB, Yoon SS, Ariyan CE, Strong VE. Decreased
in cancer ion therapy. Nuclear Instruments and Methods in Physics length of stay and earlier oral feeding associated with standardized
Research, Section A: Accelerators, Spectrometers, Detectors and postoperative clinical care for total gastrectomies at a cancer
Associated Equipment. 2016;829:149-152. center. Surgery (United States). 2016;160(3):607-612. PMCID:
PMC4975674
Peterson G, Zanoni DK, Migliacci J, Cordova M, Rajadhyaksha M, Patel
S. Progress in reflectance confocal microscopy for imaging oral tissues in Sierra H, Qi Q, Jiang A, Taskar N, Rossi A, Rajadhyaksha M. Fluorescein
vivo. Proceedings of SPIE. 2016;9689:96891X. as a contrast agent for confocal intra-operative imaging of basal
cell carcinomas: A preliminary ex vivo study. Proceedings of
Poupore AK, Stem M, Molena D, Lidor AO. Incidence, reasons, and SPIE. 2016;9703:97030N.
risk factors for readmission after surgery for benign distal esophageal
disease. Surgery. 2016;160(3):599-606. Vanloo G, Wong K, Ng C, Ramsey B, Bao Z, Osborne K, Wang D. Using
high performance computing to model cellular embryogenesis. ACM
Rabidas R, Midya A, Chakraborty J, Arif W. A study of different International Conference Proceeding Series. 2016;:a12.
texture features based on local operator for benign-malignant mass
classification. Procedia Computer Science. 2016;93:389-395.
Rojas-Cordova A, Baghaei-Lakeh A, Zhang H, Wernz C, Rahmandad H,

Slonim AD, Caroline A. Improving technology investment decisions at
hospitals through system dynamics and decision analysis. Proceedings
of the Annual Hawaii International Conference on System
Sciences. 2016;2016:1517-1526.
250 OF 324
Title
Meeting
Abstracts
(891)
251 OF 324
Meeting Abstracts
Abida W, Brennan R, Armenia J, Curtis KR, Gopalan A, Arcila ME, Danila Adams NM, Rapp M, Sun JCY. The transcription factor IRF8 regulates
DC, Rathkopf DE, Morris MJ, Slovin SF, Solit DB, Hyman DM, Durack natural killer cell development and response to cytomegalovirus
JC, Solomon SB, Reuter VE, Taylor BS, Berger MF, Schultz N, Scher H infection. Journal of Immunology. 2016;196(1 Suppl.)
I. Genomic characterization of primary and metastatic prostate cancer
(PC) using a targeted next-generation sequencing assay. Journal of Adsay V, Roa JC, Basturk O, Torres J, Mucientes F, Del Pozo M, Villaseca
Clinical Oncology. 2016;34(2 Suppl.) MA, Aguayo G, Bellolio ER, Araya JC, Endo B, Lee K, Jang KT, Jang JY,
Ohike N, Shimizu M, Hirabayashi K, Terris B, Zamboni G, Reid M, Xue Y,
Abou-Alfa GK, Niedzwieski D, Knox JJ, Kaubisch A, Posey J, Tan Bedolla G, Quigley B, Krasinskas A, Akkas G, Memis B, Klimstra D, Hruban
BR, Kavan P, Goel R, Murray JJ, Bekaii-Saab TS, Tam VC, Rajdev L, RH, Zhu B, Van Dyke AL, Koshiol J. Epithelial atypia in the gallbladder:
Kelley RK, Siegel A, Balletti J, Harding JJ, Schwartz LH, Goldberg RM, Diagnosis and classification in an international consensus study. Modern
Bertagnolli MM, Venook AP. Phase III randomized study of sorafenib plus Pathology. 2016;29(Suppl. 2):438A-439A.
doxorubicin versus sorafenib in patients with advanced hepatocellular
carcinoma (HCC): CALGB 80802 (Alliance). Journal of Clinical Adsay V, Roa JC, Basturk O, Torres J, Mucientes F, Del Pozo M, Villaseca
Oncology. 2016;34(4 Suppl.) MA, Aguayo G, Bellolio ER, Araya JC, Endo I, Lee K, Jang KT, Jang JY,
Ohike N, Shimizu M, Hirabayashi K, Terris B, Zamboni G, Reid M, Xue
Abou-Alfa GK, Yoon JH, Modiano M, Ryoo BY, Yau T, Freilich B, Knox Y, Bedolla G, Quigley B, Krasinskas A, Akkas G, Memis B, Klimstra D,
J, Ly M, Ahmed H, Gahir S, Niforos D, Kowalski M, Kelley RK. An open- Hruban RH, Zhu B, Van Dyke AL, Koshiol J. Epithelial atypia in the
label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in gallbladder: Diagnosis and classification in an international consensus
subjects with advanced hepatocellular carcinoma. European Journal of study. Laboratory Investigation. 2016;96(Suppl. 1):438A-439A.
Cancer. 2016;69(Suppl. 1):S22.
Agaram NP, Zhang L, Sung YS, Chen CL, Chung C, Fletcher
Abraham-Kaba A, Stopol C. Survivorship continuum: Implications C, Antonescu C. NTRK1 associated gene fusions in pediatric fibroblastic/
for patient-centered programming. Journal of Psychosocial myofibroblastic neoplasms: A molecular study of 58 cases. Laboratory
Oncology. 2016;34(1-2):125-127. Investigation. 2016;96(Suppl. 1):12A.
Abt MC, Lewis BB, Ling LL, Carter RA, Susac B, Pamer EG. Cooperative Agaram NP, Zhang L, Sung YS, Chen CL, Chung C, Fletcher
defense against acute Clostridium difficile infection is mediated C, Antonescu C. NTRK1 associated gene fusions in pediatric fibroblastic/
by two innate lymphoid cell subsets. Cancer Immunology myofibroblastic neoplasms: A molecular study of 58 cases. Modern
Research. 2016;4(Suppl.) Pathology. 2016;29(Suppl. 2):12A.
Abu Zaid M I, Fung C, Williams A, Sesso HD, Kerns SL, Feldman DR, Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan
Hamilton RJ, Vaughn DJ, Beard C, Liu H, Fossa SD, Einhorn LH, Travis LB, EJ, Gao SP, Ramirez R, Cha EK, Desai N, Zabor EC, Ostrovnaya
The Platinum Study Group. Cardiovascular disease (CVD) risk factors I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Viale A, Arcila ME, Dalbagni
and health behaviors following cisplatin-based chemotherapy (CHEM): A G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor
multi-institutional study of testicular cancer survivors (TCS). Journal of BS, Solit DB. Comprehensive molecular analysis of plasmacytoid variant
Clinical Oncology. 2016;34(3 Suppl.) urothelial carcinoma. Laboratory Investigation. 2016;96(Suppl. 1):214A.
252 OF 324
Meeting Abstracts
Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan Anand A, Morris MJ, Larson SM, Ohlsson M, Joseffson A, Helgstrand
EJ, Gao SP, Ramirez R, Cha EK, Desai N, Zabor EC, Ostrovnaya JT, Edenbrandt L, Oturai PS, Roeder MA, Bjartell A. Automated bone
I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Viale A, Arcila ME, Dalbagni scan index as a quantitative imaging biomarker indicative of efficacy
G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor to enzalutamide in patients with metastatic castrate resistant prostate
BS, Solit DB. Comprehensive molecular analysis of plasmacytoid variant cancer (mCRPC). Journal of Clinical Oncology. 2016;34(2 Suppl.)
urothelial carcinoma. Modern Pathology. 2016;29(Suppl. 2):214A.
Anderlini P, Saliba R, Ledesma C, Plair T, Alousi A, Hosing C, Khouri
Alatise O I, Komolafe AO, Famurewa OC, Katung A I, Ariyibi OO, I, Nieto Y, Popat U, Shpall E, Fanale M, Oki Y, Neelapu S, Younes A,
Egberoungbe AA, Olatoke SA, Agodirin OS, Olaofe OO, Kolawole Champlin R. Gemcitabine, fludarabine, and melphalan for reduced-
OA, Eaton A, Kingham TP. Colorectal cancer patient outcomes in Nigeria: intensity conditioning (RIC) and allogeneic stem cell transplantation
Results from the African Colorectal Cancer Group. Journal of Clinical (allo-SCT) for relapsed/refractory Hodgkin lymphoma in the brentuximab
Oncology. 2016;34(4 Suppl.) vedotin era. Bone Marrow Transplantation. 2016;51(Suppl. 1):S70-S71.
Albanese S, Xu J, Hsieh J, Chodera JD. Simulating mTOR hyperactivating Anderson ES, Postow MA, Young R, Chan TA, Yamada Y, Beal K. Initial
mutations to understand functionally significant structural report on safety and lesion response of melanoma brain metastases
rearrangements. Biophysical Journal. 2016;110(3 Suppl. 1):207A. after stereotactic radiosurgery or hypofractionated radiation therapy in
patients receiving concurrent pembrolizumab. International Journal of
Alex D, Wang L, Jour G, Middha S, Chandramohan R, Healey J, Nafa Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E132.
K, Hameed M. Primary adult skeletal osteosarcoma: A clinicopathological
and molecular study. Laboratory Investigation. 2016;96(Suppl. 1):12A. Anderson MA, Roberts AW, Seymour JF, Gerecitano JF, Kahl BS, Kipps
TJ, Pagel JM, Puvvada SD, Wierda WG, Gressick L, Zhu M, Dunbar M,
Alex D, Wang L, Jour G, Middha S, Chandramohan R, Healey J, Nafa Chyla B, Verdugo M, Kim SY, Davids MS. Safety, efficacy and immune
K, Hameed M. Primary adult skeletal osteosarcoma: A clinicopathological effects of venetoclax 400 mg daily in patients (pts) with relapsed chronic
and molecular study. Modern Pathology. 2016;29(Suppl. 2):12A. lymphocytic leukemia (CLL). Haematologica. 2016;101(Suppl.):228.
Alexander K, Nonaillada J, Gangai N, Korc-Grodzicki B. Educational Andronico J, Thomas L, Lochner C, Hughes C, Cruz R, Moore
initiative to promote knowledge of geriatric syndromes in minority older J. Walk a mile in another’s shoes: Improving collaboration and
communities. Gerontologist. 2016;56(Suppl. 3):235. communication across infusion units through a charge nurse exchange
program. Oncology Nursing Forum. 2016;43(2):32.
Alonso M, Najera L, Carrasco E, Salazar N, Gonzalez S, Gilaberte
Y, Cuezva J, Rojo F, Juarranz A. Altered expression of metabolic Antonia S, Rizvi N, Brahmer J, Ou SH, Khleif SN, Hwu WJ, Gutierrez M,
markers in cutaneous melanoma cells. Journal of Investigative Schoffski P, Hamid O, Weiss J, Lutzky J, Maio M, Nemunaitis J, Jaeger
Dermatology. 2016;136(5 Suppl. 1):S110. D, Balmanoukian A, Rebelatto MC, Steele KE, Jin XP, Robbins PB,
Blake-Haskins JA, Segal NH. Safety and clinical activity of durvalumab
Amodio A. Oncology social workers as cultural ambassadors: Addressing (MEDI4736), an anti-programmed cell death ligand-1 (PD-L1) antibody, in
health disparities affecting migrants and the underserved. Journal of patients with non-small cell lung cancer (NSCLC). Cancer Immunology
Psychosocial Oncology. 2016;34(1-2):160-162. Research. 2016;4(Suppl.)
253 OF 324
Meeting Abstracts
Aradottir K, Lund SH, Landgren O, Bjorkholm M, Turesson I, Askan G, Klimstra D, Adsay V, Allen P, Memis B, Sigel C, Basturk
Kristinsson SY. Impact of family history on risk of progression O. “Oncocytic-type” of intraductal papillary mucinous neoplasm (IPMN):
of MGUS to multiple myeloma: A population-based An analysis of 25 cases. Modern Pathology. 2016;29(Suppl. 2):439A.
study. Haematologica. 2016;101(Suppl.):521-522.
Assal A, Jakubowski AA, Maloy M, Zheng JT, Devlin SM, Avecilla
Arai S, Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, S, Barker JN, Castro-Malaspina H, Dahi P, Gyurkocza B, Meagher
Antin JH, Lehmann L, Liang W, Hume R, Hannah AL, Nejadnik B, Soiffer R, Perales MA, Shaffer B, Tamari R, Young JW, Giralt SA, Papadopoulos
RJ. Efficacy and safety of defibrotide in a subset analysis of late-onset EB. The role of post-remission chemotherapy before T-cell
hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/ depleted allogeneic stem cell transplant for acute myeloid leukemia
SOS) patients from an ongoing, expanded-access program. Biology of in first complete remission. Biology of Blood and Marrow
Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S303. Transplantation. 2016;22(3 Suppl. 1):S197-S198.
Argolo D, Friedman M, Smyth L, Iyengar N, Singh J, Patil S, Norton Aufhauser D, Sadot E, Murken D, Eddinger K, Goldberg D, Furth E, Abt
L, Baselga J, Hudis C, Dang C. Activity of HP-based therapies as P, DeMatteo R, Levine M. Occult multifocal hepatocellular carcinoma in
third and later lines for the treatment of HER2-positive metastatic surgical patients. American Journal of Transplantation. 2016;16(Suppl.
breast cancer: A retrospective study from a single institution. Cancer 3):464.
Research. 2016;76(4 Suppl.)
Autio KA, Garcia JA, Alva AS, Hart LL, Milowsky M I, Posadas EM, Ryan
Argolo D, Friedman M, Smyth L, Iyengar N, Singh J, Patil S, Norton CJ, Summa JM, Youssoufian H, Scher H I, Dreicer R. A phase 2 study
L, Baselga J, Hudis C, Dang C. Activity of HP-based therapies as of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered
third and later lines for the treatment of HER2-positive metastatic to patients with chemotherapy-naive metastatic castration-resistant
breast cancer: A retrospective study from a single institution. Cancer prostate cancer (mCRPC). Journal of Clinical Oncology. 2016;34(2 Suppl.)
Avila AM, Barba P, Cho C, Devlin S, Ceberio I, Ponce D, Maloy
Armstrong AJ, Saad F, Shore ND, Fizazi K, Phung D, Dmuchowski M, Perales MA. Sirolimus, tacrolimus and low-dose methotrexate as
CF, Hirmand M, Forer D, Scher H I, De Bono JS. Surrogacy analysis GVHD prophylaxis is safe and associated with promising results in
of prostate-specific antigen (PSA) decline for improved overall patients receiving reduced-toxicity allogeneic hematopoietic cell
survival (OS) with enzalutamide (ENZ) in AFFIRM. Journal of Clinical transplantation. Bone Marrow Transplantation. 2016;51(Suppl. 1):S167.
Oncology. 2016;34(2 Suppl.)
Awan MJ, Zakem SJ, Ward MC, Machtay M, Riaz N, Caudell JJ, Dunlap
Arun G, Diermeier S, Akerman M, Chang KC, Wilkinson JE, Hearn S, NE, Isrow D, Dault J, Higgins KA, Beitler JJ, Siddiqui F, Trotti A, Lee
Kim Y, MacLeod AR, Krainer AR, Norton L, Brogi E, Egeblad M, Spector N, Koyfman S, Heron DE, Yao M. Reirradiation outcomes after upfront
DL. Differentiation of mammary tumors and reduction in metastasis upon larynx preservation or total laryngectomy: A multi-institutional
Malat1 LncRNA loss. Cancer Research. 2016;76(6 Suppl.) analysis. International Journal of Radiation Oncology, Biology,
Physics. 2016;96(2 Suppl.):E376.
Askan G, Klimstra D, Adsay V, Allen P, Memis B, Sigel C, Basturk
O. “Oncocytic-type” of intraductal papillary mucinous neoplasm (IPMN): Badiyan SN, Hartsell WF, Cahlon O, Giap H, Prabhu K, Feigenberg SJ,
An analysis of 25 cases. Laboratory Investigation. 2016;96(Suppl. 1):439A. Chuong MD, Mohindra P, Mehta MP, Vargas C, Hoppe BS, Simone CB
254 OF 324
Meeting Abstracts
2nd. Clinical outcomes of patients with stage II-III non-small cell lung Barba P, Burns LJ, Juckett MB, Komanduri K V, Litzow MR, Lee SJ, Devlin
cancer (NSCLC) treated with proton beam therapy (PBT) on the Proton SM, Costa LJ, Khan SP, Klein AK, Krishnan A, Malone AK, Moravec CG,
Collaborative Group (PCG) prospective registry trial. International Journal Mir M, Selby GB, Vivek R, Cochran M, Stricherz M, Westmoreland M,
of Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E434-E435. Tierney DK, Wood WA, Perales MA. Success of an International Learning
Healthcare System in hematopoietic cell transplantation: The American
Bagrodia A, Kaffenberger SD, Lee B, Lee W, Cha EK, Sfakianos J, Gao Society of Blood and Marrow Transplantation clinical case forum. Biology
SP, Zabor EC, Ostrovnaya I, Eng J, Berger MF, Bajorin DF, Schultz of Blood and Marrow Transplantation. 2016;22(3):S266-S267.
N, Sheinfeld J, Bosl GJ, Al-Ahmadie H, Solit DB, Feldman DR. Actionable
targets in patients with cisplatin-resistant advanced germ cell Barba P, Martino R, Zhou Q, Cho C, Castro-Malaspina H, Devlin S,
tumors. Journal of Clinical Oncology. 2016;34(2 Suppl.) Esquirol A, Giralt S, Jakubowski A, Lopez-Corral L, Papadopoulos E,
Pinana JL, Fox ML, Valcarcel D, Solano C, Caballero D, Sierra J, Perales
Baker KS, Ambrose K, Arvey SR, Casillas JN, Ganz PA, Jacobs LA, McCabe MA. Myeloablative conditioning and CD34+ selection results in higher
MS, Overholser L, Partridge AH, Rajotte EJ, Risendal BC, Rosenstein D, chronic-GVHD free/relapse free-survival compared to reduced-
Syrjala K. Financial and work related impact of cancer in young adult (YA) intensity conditioning and unmodified graft in patients with AML and
survivors. Journal of Clinical Oncology. 2016;34(3 Suppl.) MDS > 50 years receiving HLA-matched allogeneic HCT. Bone Marrow
Transplantation. 2016;51(Suppl. 1):S436-S437.
Balar A V, Iyer G, Milowsky M I, Huang WC, Woods M, Donat SM, Herr
HW, Dalbagni G, Bochner BH, Ostrovnaya I, Al-Ahmadie H, Rose Barba P, Ratan R, Ceberio I, Hilden P, Maloy M, Barker JN, Castro-
TL, Riches JC, Kania BE, Regazzi AM, McCoy AS, Delbeau D, Rosenberg Malaspina H, Jakubowski AA, Koehne G, Papadopoulos E, Ponce
JE, Bajorin DF. Multicenter prospective phase II trial of neoadjuvant DM, Sauter CS, van den Brink MRM, Young JW, Avecilla S, Meagher
(neo) dose dense gemcitabine and cisplatin (DD-GC) in patients R, Devlin SM, O’Reilly RJ, Giralt SA, Perales MA. The hematopoietic
(pts) with muscle-invasive bladder cancer (MIBC). Journal of Clinical cell transplantation comorbidity index (HCT-CI) predicts outcomes in
Oncology. 2016;34(2 Suppl.) patients with acute myeloid leukemia and myelodysplastic syndromes
receiving CD34+ selected grafts for allogeneic hematopoietic cell
Balko JM, Hicks M, Berger MF, Solit DB, Bouvier N, Sanders ME, Estrada transplantation. Biology of Blood and Marrow Transplantation. 2016;22(3
M V, Won H, Cantley LC, Mayer IA, Arteaga CL. Genomic alterations Suppl. 1):S304-S305.
indicative of a luminal A subtype associate with clinical benefit to
buparlisib and letrozole in endocrine-resistant ER+/HER2- metastatic Barba P, Rosillo C, Huang YT, Avila AM, Montoro J, Malloy
breast cancer. Cancer Research. 2016;76(4 Suppl.) M, Papanicolaou G, Perales MA. Sequential systematic anti-mold
prophylaxis with micafungin and voriconazole results in very
Barba P, Burns L, Litzow M, Juckett M, Komanduri K, Lee S, Devlin S, low incidence of invasive mold infections in patients undergoing
Costa L, Khan S, Klein A, Krishnan A, Malone A, Moravec C, Mir M, Selby allogeneic hematopoietic cell transplantation. Bone Marrow
G, Vivek R, Cochran M, Stricherz M, Westmoreland M, Tierney DK, Perales Transplantation. 2016;51(Suppl. 1):S33-S34.
MA, Wood WA. Success of an international learning healthcare system
in hematopoietic cell transplantation: The American Society of Blood Barba P, Hilden P, Devlin S, Maloy M, Barker J, Castro-Malaspina
and Marrow Transplantation Clinical Case Forum. Bone Marrow H, Jakubowski A, Koehne G, Papadopoulos E, Sauter C, van den Brink
Transplantation. 2016;51(Suppl. 1):S553. M, Young J, Avecilla S, Meagher R, Giralt S, Perales MA, Ponce D. CD34+
255 OF 324
Meeting Abstracts
selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell Barlesi F, Steins M, Horn L, Ready N, Felip E, Borghaei H, Spigel DR,
transplantation is associated with low incidence of acute and chronic Arrieta O, Antonia S, Fayette J, Rizvi N, Crino L, Reck M, Eberhardt WE,
graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free Hellman M, Geese WJ, Li A, Healey D, Brahmer J, Paz-Ares L. Long-term
survival. Bone Marrow Transplantation. 2016;51(Suppl. 1):S379. outcomes with nivolumab vesrsus docetaxel in patients with advanced
NSCLC: CheckMate 017 and CheckMate 057 2-year update. Asia-Pacific
Barba P, Hilden P, Devlin SM, Maloy M, Ciolino C, Dierov D, Herman Journal of Clinical Oncology. 2016;12(Suppl. 5):115-116.
D, Mosesso K, Nieves J, Barker JN, Castro-Malaspina H, Jakubowski
AA, Koehne G, Papadopoulos E, Sauter CS, van den Brink MRM, Young Barnea D, Tonorezos ES, Moskowitz CS, Chou JF, Elkin EB, Sklar
JW, Giralt SA, Perales MA, Ponce DM. CD34+ selected ex-vivo T-cell CA, Wong RJ, Li D, Tuttle RM, Korenstein D, Wolden SL, Oeffinger
depleted (TCD) grafts for allogeneic hematopoietic cell transplantation KC. Neck radiation, thyroid cancer, and avoiding harm. Journal of Clinical
(Allo-HSCT) is associated with low incidence of acute and chronic Oncology. 2016;34(3 Suppl.)
graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-
free survival. Biology of Blood and Marrow Transplantation. 2016;22(3 Barnes C, McMillan S, Cohen A. Knowledge, attitudes, and behaviors
Suppl. 1):S389. of nurse practitioners concerning advanced care planning for oncology
patients. Oncology Nursing Forum. 2016;43(2):90.
Barba P, Ratan R, Ceberio I, Hilden P, Devlin S, Maloy M, Barker
J, Castro-Malaspina H, Jakubowski A, Koehne G, Papadopoulos Barrio A, Mamtani A, Stempel M, Eaton A, Edelweiss M, Morrow M. How
E, Ponce D, Sauter C, van den Brink MR, Young J, O’Reilly RJ, Giralt often is treatment effect identified in axillary nodes with a pathologic
S, Perales MA. The hematopoietic cell transplantation comorbidity complete response after neoadjuvant chemotherapy?. Annals of Surgical
index (HCT-CI) predicts outcomes in patients with acute myeloid Oncology. 2016;23(1 Suppl.):S16.
leukemia and myelodysplastic syndromes receiving CD34+ selected
grafts for allogeneic hematopoietic cell transplantation. Bone Marrow Barrio A, Mamtani A, Stempel M, Eaton A, Morrow M. Is routine
Transplantation. 2016;51(Suppl. 1):S37-S38. axillary imaging necessary in clinically node-negative patients
undergoing neoadjuvant chemotherapy?. Annals of Surgical
Bardia A, Diamond JR, Mayer IA, Starodub AN, Moroose RL, Isakoff Oncology. 2016;23(Suppl. 3):38-39.
SJ, Ocean AJ, Guarino MJ, Berlin JD, Messersmith WA, Thomas SS,
O’Shaughnessy JA, Kalinsky K, Maurer M, Chang JC, Forero A, Traina Baselga J, Cortés J, De Laurentiis M, Diéras V, Harbeck N, Hsu J, Jin H,
T, Gucalp A, Wilhelm F, Wegener WA, Maliakal P, Sharkey RM, Schimmoller F, Wilson TR, Im YH, Jacot W, Krop IE, Verma S. SANDPIPER:
Goldenberg DM, Vahdat LT. Safety and efficacy of anti-Trop-2 antibody Phase III study of the PI3-kinase inhibitor taselisib (GDC-0032) plus
drug conjugate, sacituzumab govitecan (IMMU-132), in heavily pretreated fulvestrant in patients with estrogen receptor-positive, HER2-negative
patients with TNBC. Cancer Research. 2016;76(4 Suppl.) locally advanced or metastatic breast cancer enriched for patients with
PIK3CA-mutant tumors. Cancer Research. 2016;76(4 Suppl.)
Bardia A, Modi S, Oliveira M, Campone M, Ma B, Dirix L, Weise A, Nardi
L, Zhang V, Bhansali SG, Hewes B, Chavez-MacGregor M. Triplet therapy Baselga J, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Jagiello-
with ribociclib, everolimus, and exemestane in women with HR+/HER2- Gruszfeld A, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De
advanced breast cancer. Cancer Research. 2016;76(4 Suppl.) Laurentiis M, Arteaga CL, Jiang Z, Jonat W, Hachemi S, Le Mouhaër
S, Di Tomaso E, Urban P, Massacesi C, Campone M. PIK3CA status in
circulating tumor DNA (ctDNA) predicts efficacy of buparlisib (BUP)
256 OF 324
Meeting Abstracts
plus fulvestrant (FULV) in postmenopausal women with endocrine- Bavi P, Yang Q, Roehrl MH. Nuclear maspin expression is an independent
resistant HR+/HER2- advanced breast cancer (BC): First results from the prognostic marker in microsatellite stable stage II colorectal
randomized, phase Ill BELLE-2 trial. Cancer Research. 2016;76(4 Suppl.) carcinoma. Laboratory Investigation. 2016;96(Suppl. 1):162A.
Battiato K, Patterson J, Sanchez L, McKenzie C, McCormick M, Dowling Bavi P, Yang Q, Roehrl MH. Nuclear maspin expression is an independent
M. Remember to wear your PPE: Safe handling of antineoplastic prognostic marker in microsatellite stable stage II colorectal
agents on a hematology oncology unit. Oncology Nursing carcinoma. Modern Pathology. 2016;29(Suppl. 2):162A.
Forum. 2016;43(2):35-36.
Baxi SS, Yeahia R, Korenstein D. The evidence base in support of breast
Bavi P, Kiehl R, Adeyi O, Mete O, Avila-Casado C, Sharifzad H, cancer surveillance guidelines: Flying without a net?. Journal of Clinical
Joshua A, Butany J, Roehrl MH. Immune-related adverse events Oncology. 2016;34(3 Suppl.)
(irAEs) following CTLA-4 and PD-1/PD-L1 blockade in advanced
melanoma: A comprehensive rapid autopsy study. Laboratory Bayliss J, Mukherjee P, Lu C, Jain SU, Martinez D, Margol AS,
Investigation. 2016;96(Suppl. 1):4A. Pekmezci M, Chung C, McEachin RC, Cieslik M, Garcia BA, Tamrazi
B, La Rocca G, Santi M, Lewis PW, Melnik A, Allis CD, Thompson
Bavi P, Kiehl R, Adeyi O, Mete O, Avila-Casado C, Sharifzad H, Joshua A, CB, Chinnaiyan AM, Judkins AR, Venneti S. Lowered H3K27me3 and
Butany J, Roehrl MH. Immune-related adverse events (irAEs) following DNA hypomethylation define poorly prognostic pediatric posterior
CTLA-4 and PD-1/PD-L1 blockade in advanced melanoma: A comprehensive fossa ependymomas. Journal of Neuropathology and Experimental
rapid autopsy study. Modern Pathology. 2016;29(Suppl. 2):4A. Neurology. 2016;75(6):592.
Bavi P, Sharifzad H, Butany J, Joshua A, Roehrl MH. Our Rapid Research Becerra M, Sanchez-Vega F, Reznik E, Kashan M, Mendonca
Autopsy Program: A solid platform for next generation clinical SJ, Manley B, Ghanaat M, Khan N, Coleman J, Russo P, Hsieh J, Hakimi
trials. Laboratory Investigation. 2016;96(Suppl. 1):4A. AA. Characterization of genomic alterations associated with metastatic
tropism in a cohort of patients with renal cell carcinoma. BJU
Bavi P, Sharifzad H, Butany J, Joshua A, Roehrl MH. Our Rapid Research International. 2016;118(Suppl. 5):6.
Autopsy Program: A solid platform for next generation clinical
trials. Modern Pathology. 2016;29(Suppl. 2):4A. Bekele S, Patterson E, Kelly S, Featherstone C, Giralt SA, Perales
MA, Robilotti E, Jenq R, Ponce DM. Stool PCR for Clostridium
Bavi P, Sharifzad H, Yang Q, Oldfield L, Joshua A, Butany J, Roehrl difficile Toxin B is frequently detected at the first stool assay in the
MH. Unique insights into cardiac metastases and tumor biology immediate peri-transplant period in allogeneic hematopoietic stem
from a cancer center’s rapid research autopsy program. Laboratory cell transplant (HSCT) recipients. Biology of Blood and Marrow
Investigation. 2016;96(Suppl. 1):81A. Transplantation. 2016;22(3 Suppl. 1):S427-S428.
Bavi P, Sharifzad H, Yang Q, Oldfield L, Joshua A, Butany J, Roehrl Ben-Aharon I, Elkabets M, Pelossof R, Yu KH, Allen PJ, Iacobuzio-
MH. Unique insights into cardiac metastases and tumor biology Donahue CA, Leach SD, Lowery MA, Goodman KA, O’Reilly EM. Genomic
from a cancer center’s rapid research autopsy program. Modern landscape of pancreatic adenocarcinoma: Does age matter?. Journal of
Pathology. 2016;29(Suppl. 2):81A. Clinical Oncology. 2016;34(4 Suppl.)
257 OF 324
Meeting Abstracts
Bergareche A, Bednarz MJ, Sánchez E, Krebs CE, Ruiz-Martinez J, Bidard FC, Peeters D, Fehm T, Nole F, Gisbert-Criado R, Mavroudis D,
De la Riva P, Makarov V, Gorostidi A, Jurkat-Rott K, Marti-Masso JF, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga
Paisán-Ruiz C. SCN4A pore mutation pathogenetically contributes to P, Manso L, Zamarchi R, de Lascoiti AF, de Mattos-Arruda L, Ignatiadis
autosomal dominant essential tremor and may increase susceptibility to M, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki
epilepsy. Biophysical Journal. 2016;110(3 Suppl. 1):112A. E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C,
Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L,
Berney D, Fisher G, North B, Moller H, Scardino P, Cuzick J, Beltran Solomayer E, Zorzino L, Reis JS, Squifflet P, Pantel K, Belie N, Sleijfers S,
L. Validation of reporting percentage high grade prostate cancer in 988 Pierga JY, Michiels S. Circulating tumor cells count-based nomograms to
conservatively treated patients with long term outcome. Laboratory predict survival of metastatic breast cancer patients: Results from the
Investigation. 2016;96(Suppl. 1):217A. European pooled analysis. Cancer Research. 2016;76(4 Suppl.)
Berney D, Fisher G, North B, Moller H, Scardino P, Cuzick J, Beltran Biel K, Bowker M, Semler R, Amaya B, McCoy A, O’Sullivan M. “Can you
L. Validation of reporting percentage high grade prostate cancer in help me send this email”? A computer orientation project. Oncology
988 conservatively treated patients with long term outcome. Modern Nursing Forum. 2016;43(2):100.
Pathology. 2016;29(Suppl. 2):217A.
Bierings M, Bonfim C, Aljurf M, Mehta P, de la Tour RP, Knol C, Sucak
Bhagavath A, Geyer A. Carfilzomib pulmonary toxicity. Chest. 2016;150(4 G, Othman TB, Socie G, Thomson K, McQuaker G, Esquirol A, Zecca
Suppl.):492A. M, Boulad F, Kroger N, Michallet M, Risitano A, Ehninger G, Porcher R,
Dufour C. HCT outcome in adult patients with Fanconi anemia. Bone
Bhagavath A, Geyer A. Immune reconstitution syndrome following Marrow Transplantation. 2016;51(Suppl. 1):S108-S109.
neutrophil recovery after chemotherapy. Chest. 2016;150(4 Suppl.):1055A.
Bisogna M, Dao F, Olvera N, Bacares R, Zhang L, Levine DA. BRCA1
Bhatt V, Lin A, Beyer K, Proli AJ, Yoo Y, Lauer E, Giralt SA, Ponce promoter hypermethylation loss in recurrent high-grade serous
DM, Barker JN. Analysis of cyclosporine-a (CSA) levels supports new carcinoma. Clinical Cancer Research. 2016;22(2 Suppl.)
dosing guidelines in adult double unit cord blood transplant (dCBT)
recipients to optimize immunosuppression early post-transplant. Biology Blay JY, Tap W, Jones R, Chmielowski B, Elias A, Adkins D, Van Tine B,
of Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S473-S474. Agulnik M, Cooney M, Livingston M, Pennock G, Qin A, Shahir A, Ilaria
R, Schwartz G. Évaluation de l’efficacité de Doxorubicine ± Olaratumab
Bhatt V, Palazzo M, Kilroy K, Hilden P, Devlin SM, Maloy M, Barker dans les STM. Bulletin du Cancer. 2016;103(6 Suppl.):S118.
JN, Castro-Malaspina H, Chung DJ, Dahi P, Hsu KC, Hanash
AM, Jakubowski AA, Jenq R, Koehne G, Landau H, Papadopoulos Borsu L, Mullaney K, Benayed R, Chi P, Busam K, Paik P, Drilon
E, Perales MA, Sauter CS, Tamari R, van den Brink MRM, Young A, Ladanyi M. Detection of ALK alternative transcription initiation and
JW, Giralt SA, Ponce DM. Low dose unfractionated heparin (UFH) MET exon 14 skipping using nanoString digital nCounter technology in a
prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal clinical setting. Journal of Molecular Diagnostics. 2016;18(6):1011.
obstruction syndrome (SOS) after myeloablative adult allogeneic
hematopoietic stem cell transplantation (HSCT). Biology of Blood and Borthakur G, Tallman M, Ofran Y, Foran J, Uy G, DiPersio J, Nagler A,
Marrow Transplantation. 2016;22(3 Suppl. 1):S287-S288. Rowe J, Showel M, Altman J, Peled A, Abraham M, Pereg Y, Vainstein A,
Oberkovitz G, Lustig T, Aharon A, Bueso-Ramos C, Cortes J, Andreeff
258 OF 324
Meeting Abstracts
M. Final phase IIa study results evaluating the CXCR4 antagonist BL- Braso-Maristany F, Filosto S, Catchpole S, Marlow R, Quist J, Domenech
8040 in combination with cytarabine (Ara-C) for the treatment of EF, Plumb DA, Zakka L, Gazinska P, Liccardi G, Meier P, Gris-Oliver A,
relapsed/refractory AML patients. Clinical Lymphoma, Myeloma and Cheang MCU, Rosell AP, Shafat M, Noel E, Patel N, McEachern K, Scaltriti
Leukemia. 2016;16(Suppl. 2):S28. M, Castel P, Noor F, Buus R, Mathew S, Watkins J, Serra V, Marra P,
Grigoriadis A, Tutt AN. PIM1 kinase regulates cell death, tumour growth
Borthakur G, Tallman MS, Ofran Y, Foran J, Uy GL, DiPersio JF, Nagler and chemotherapy resistance revealing a novel target in triple-negative
A, Rowe JM, Showel MM, Altman JK, Peled A, Abraham M, Pereg Y, breast cancer. Breast Cancer Research and Treatment. 2016;159(1):179-180.
Vainstein A, Oberkovitz G, Aharon A, Bueso-Ramos C, Cortes JE,
Andreeff M. Clinical response in relapsed/refractory AML patients Braza M, Lameijer M, Perez-Medina C, Reiner T, Nahrendorf M,
correlates with leukemic blast mobilization and differentiation induced Fayad Z, Duivenvoorden R, Ochando J, Mulder W. Rapamycin
by BL-8040, a potent CXCR4 antagonist; results of a phase IIA nanotherapy delays heart transplant rejection. American Journal of
study. Haematologica. 2016;101(Suppl.):43. Transplantation. 2016;16(Suppl. 3):391-392.
Bose R, Abida W, Iaquinta P, Karthaus W, Armenia J, Wongvipat Breitbart W. Meaning-centered psychotherapy for cancer
J, Doran M, Hieronymus H, Philip W, Liang YP, Schultz N, Sawyers patients. Journal of Psychosocial Oncology. 2016;34(1-2):85.
CL. Investigation of a frequently mutated transcriptional repressor in
prostate cancer, in particular its role in modulating androgen signaling Brennan R, Walsh M, Wu H, Wu J, Billups C, Spunt S. Influence of
and its effects on TMPRSS2-ERG dependent tumor maintenance. Journal time to detection (TTD) on clinical outcomes in paediatric testicular
of Clinical Oncology. 2016;34(2 Suppl.) tumors. Pediatric Blood and Cancer. 2016;63(Suppl. 3):S30.
Boudreau J, Liu XR, Zhao Z, Zhang A, Shultz LD, Greiner DL, Dupont Brentjens RJ. Moving CAR T cell therapy forward: CARs and armored
B, Hsu KC. Human natural killer cell education is dynamically CARs. Clinical Cancer Research. 2016;22(1 Suppl.)
controlled by environmental and cell-intrinsic HLA. Journal of
Immunology. 2016;196(1 Suppl.) Bugov D, Raoof N, Pastores S, Halpern N. Air in the brain seven years
after cervical spine surgery. Chest. 2016;150(4 Suppl.):236A.
Bowers L, Estilo C, Yom SH, Lehrman N, Huryn J. Pentoxifylline with
vitamin E and laser therapy for MRONJ. Oral Surgery, Oral Medicine, Oral Buonocore D, Roshal M, McCash S I, Lin O. Cerebrospinal fluid specimen
Pathology and Oral Radiology. 2016;122(4):e113-e114. evaluation in patients with hematopoietic neoplasms: The need for an
integrated approach. Laboratory Investigation. 2016;96(Suppl. 1):491A.
Braghiroli M, Nash GM, Morris M, Hechtman JF, Vakiani E, Berger
MF, Solit DB, Saltz L, Cercek A. Genomic profiling and efficacy of Buonocore D, Roshal M, McCash S I, Lin O. Cerebrospinal fluid specimen
anti-EGFR therapy in appendiceal adenocarcinoma. Journal of Clinical evaluation in patients with hematopoietic neoplasms: The need for an
Oncology. 2016;34(4 Suppl.) integrated approach. Modern Pathology. 2016;29(Suppl. 2):491A.
Brant JM, McLeod K, Keller L, Summers J, Timmons T, Gallagher Buonocore D, Scott SN, Bouvier N, Berger MF, Lin O. Sex and genetic
N. Breakthrough cancer pain (BTCP): Putting evidence into alterations in high grade urothelial carcinoma on urine cytologic
practice. Oncology Nursing Forum. 2016;43(2):23. specimens. Laboratory Investigation. 2016;96(Suppl. 1):93A.
259 OF 324
Meeting Abstracts
Buonocore D, Scott SN, Bouvier N, Berger MF, Lin O. Sex and genetic Durno C, Kruger J, Cabric V, Zhukova N, Ramaswamy V, Farah R, Afzal S,
alterations in high grade urothelial carcinoma on urine cytologic Yalon M, Rechavi G, Walsh MF, Constantini S, Dvir R, Elhasid R, Sullivan
specimens. Modern Pathology. 2016;29(Suppl. 2):93A. M, Hansford JR, Dodgshun A, Klauber-Demore N, Peterson L, Patel
S, Lindhorst S, Atkinson J, Laframboise R, Cohen Z, Dirks P, Taylor M,
Burns J, Ramrup N, James S, Rodrigue D. “Flu on the Go” an effective Malkin D, Albrecht S, Dudley R, Jabado N, Hawkins C, Shlien A, Tabori
process to increase flu vaccination compliance: Implications for nursing U. Hypermutation and neoantigen formation predict response to immune
leadership. Oncology Nursing Forum. 2016;43(2):106. checkpoint inhibition in childhood biallelic mismatch repair deficient
glioblastoma. Neuro-Oncology. 2016;18(Suppl. 3):iii59-iii60.
Byun DJ, Happersett L, Zhang P, Pei X, McBride S, Kollmeier M, Zelefsky
MJ. Variation in interfractional bladder volume during hypofractionated Carlo M. Genomic alterations and outcomes with targeted
radiation therapy for prostate cancer. International Journal of Radiation therapy in patients with clear cell renal cell carcinoma. BJU
Oncology, Biology, Physics. 2016;96(2 Suppl.):E614. International. 2016;118(Suppl. 5):13.
Cabot J, Coppola M, Ganetsky M, Gupta N, Goldstein J, Voigt L, Pastores Carson SS, Cox CE, Wallenstein S, Hanson L, Danis M, Tulsky JA, Chai
S, Halpern N, Kaafarani H, Shah K, Lee J. Comparison of long-term E, Nelson J. A multicenter randomized controlled trial of palliative care-
functional outcomes following treatment with and without 4-factor led informational/emotional support meetings for family decision makers
prothrombin complex concentrate for warfarin-associated intracranial of patients with chronic critical illness. American Journal of Respiratory
hemorrhage. Chest. 2016;150(4 Suppl.):284A. and Critical Care Medicine. 2016;193
Cabot J, Shirzadi C, Voigt L, Pastores S, Halpern N. Recurrent Carter J, Seidel B, Stabile C, Baser R, Eaton A, Goldfarb S, Goldfrank
ventricular dysrhythmias following placement of a peripherally inserted D. Program evaluation of a female sexual medicine and women’s health
central catheter using intracavitary ECG guidance. Chest. 2016;150(4 program. Cancer Research. 2016;76(4 Suppl.)
Suppl.):252A.
Carter J, Seidel B, Stabile C, Dickler M, Goldfrank D, Baser R, Goldfarb
Cadoo K, Kaufman PA, Hudis C, Chang C, Berrak E, Song J, Seidman S. Feasibility of a non-hormonal vaginal moisturizer in postmenopausal
AD, Traina TA. Phase 2 study of dose-dense doxorubicin and cancer survivors. Cancer Research. 2016;76(4 Suppl.)
cyclophosphamide followed by eribulin mesylate with or without
prophylactic growth factor for adjuvant treatment of early-stage breast Case-Eads S, Travis LB, Fung C, Sesso HD, Feldman DR, Vaughn DJ,
cancer. Cancer Research. 2016;76(4 Suppl.) Hamilton RJ, Johnson E, Peterson DR, Fossa SD, Einhorn LH, Beard
C. Psychotropic and stimulant medication (PSM) use among testicular
Cairns J, Ingle J, Dudenkov T, Kalari K, Buzdar A, Kubo M, Robson cancer survivors (TCS): A multi-institutional clinical study of 680 patients
M, Ellis M, Goss P, Shepherd L, Weinshilboum R, Wang L. Aromatase given cisplatin-based chemotherapy (CHEM) (NCI 1R01 CA157823-
inhibitor-induced hormone level change associated with CSMD1 SNP and 02). Journal of Clinical Oncology. 2016;34(3 Suppl.)
androstenedione-dependent variation in aromatase expression. Clinical
Pharmacology & Therapeutics. 2016;99(Suppl. 1):S84-S85. Casey DL, Kushner BH, Cheung NK V, Modak S, LaQuaglia
M, Wolden SL. Local control with 21-Gy radiation therapy for high-risk
Campbell B, Bouffet E, Larouche V, Mason G, Reddy A, Osborn M, neuroblastoma. International Journal of Radiation Oncology, Biology,
Magimairan V, Merico D, de Borja R, Chung B, Galati M, Aronson M, Physics. 2016;96(2 Suppl.):S229.
260 OF 324
Meeting Abstracts
Castillo C, McDonough M. The advocacy role of the case manager for Cavalcanti MS, Sigel K, Shia JR, Daniel T, Vakiani E, Sigel
bone marrow transplant patients throughout the care continuum. Biology C. Histopathologic features of colorectal carcinoma in patients with HIV
of Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S444. infection. Laboratory Investigation. 2016;96(Suppl. 1):197A.
Castillo C, McDonough M. The advocacy role of the case manager Cavalcanti MS, Sigel K, Shia JR, Daniel T, Vakiani E, Sigel
for bone marrow transplant patients throughout the care C. Histopathologic features of colorectal carcinoma in patients with HIV
continuum. Oncology Nursing Forum. 2016;43(2):29. infection. Modern Pathology. 2016;29(Suppl. 2):197A.
Castillo JJ, Glezerman IG, Boklage SH, Lamerato LE, Chiodo JA, Cavalcanti MS, Sigel K, Shia JR, Daniel T, Vakiani E, Sigel
Tidwell BA, Schulman KL. Incidence and prognostic importance of C. Mismatch repair protein deficiency is not present at a higher
hyponatremia in a cohort of patients with breast cancer. Cancer rate in HIV-infected patients with colorectal carcinoma. Laboratory
Research. 2016;76(4 Suppl.) Investigation. 2016;96(Suppl. 1):197A-198A.
Castrovieio-Bermejo M, Cruz C, Guerra S, Llop-Guevara A, Gutierrez- Cavalcanti MS, Sigel K, Shia JR, Daniel T, Vakiani E, Sigel C. Mismatch repair
Enriquez S, Bruna A, Rubio IT, Oakin A, Nuciforo P, Diez O, Arribas J, protein deficiency is not present at a higher rate in HIV-infected patients
Judde JG, Caldas C, Baselga J, Cortes J, Balmana J, Saura C, O’Connor with colorectal carcinoma. Modern Pathology. 2016;29(Suppl. 2):197A-198A.
MJ, Cairo S, Serra V. Lack of RAD51 foci formation enables the
identification of PARP inhibitor sensitive breast tumors. European Journal Cavalcanti MS, Lee LH, Vakiani E, Hechtman JF, Klimstra D, Shia
of Cancer. 2016;69(Suppl. 1):S122-S123. JR. Mismatch repair-deficient neuroendocrine carcinomas of the lower GI
tract. Laboratory Investigation. 2016;96(Suppl. 1):198A.
Casuscelli J, Wang P, Redzematovic A, Lee W, Seshan VE, Shen R, Donin
N, Chen Y, Cheville JC, Pantuck AJ, Thompson RH, Coleman JA, Russo Cavalcanti MS, Lee LH, Vakiani E, Hechtman JF, Klimstra D, Shia
P, Reuter VE, Tickoo S, Hakimi AA, Hsieh J. Understanding the genomic JR. Mismatch repair-deficient neuroendocrine carcinomas of the lower GI
underpinnings of metastatic chromophobe renal cell carcinoma. Journal tract. Modern Pathology. 2016;29(Suppl. 2):198A.
of Clinical Oncology. 2016;34(2 Suppl.)
Cavnar MJ, Turcotte S, Katz SC, D’Angelica M, Kingham PT, Allen
Casuscelli J, Winer AG, Reznik E, Xu J, Manley B, Chouhan J, Reuter P, Jarnagin WR, DeMatteo RP. Tumor-associated macrophage
VE, Tickoo S, Russo P, Coleman JA, Hsieh J, Hakimi AA. Single- infiltration in colorectal cancer liver metastases is associated with better
institutional analysis of patients with clear-cell papillary renal cell outcome. Annals of Surgical Oncology. 2016;23(1 Suppl.):S114.
carcinoma. Journal of Clinical Oncology. 2016;34(2 Suppl.)
Cavuoto M, McTague-Allen P. Extra extra read all about it - Connecting
Caudell JJ, Ward MC, Koyfman S, Riaz N, Dunlap NE, Isrow D, Zakem nursing staff via an electronic newsletter. Oncology Nursing
SJ, Awan MJ, Vargo J, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay Forum. 2016;43(2):57.
M, Trotti A, Siddiqui F, Lee N. Multi-institution analysis of intensity
modulated radiation therapy-based reirradiation for head and neck Chadwick D, Roehrl MH. Pathology review of research biopsies
cancer: Improved risk-benefit profile in the modern era. International highlights inter- and intra-tumor variability: Towards improving quality
Journal of Radiation Oncology, Biology, Physics. 2016;96(2 and utility for next generation biospecimen research. Laboratory
Suppl.):S115-S116. Investigation. 2016;96(Suppl. 1):491A-492A.
261 OF 324
Meeting Abstracts
Chadwick D, Roehrl MH. Pathology review of research biopsies Chase D, Huang H, Ramondetta L, Monk B, Penson R, Gil K, Landrum
highlights inter- and intra-tumor variability: Towards improving L, Leitao M, Oaknin A, Huh W, Pulaski H, Katina R, Guntupalli S,
wuality and utility for next-generation biospecimen research. Modern Richardson D, Salani R, Ali S, Tewari K. Patient-reported outcomes and
Pathology. 2016;29(Suppl. 2):491A-492A. toxicity at discontinuation of therapy in advanced or persistent cervical
cancer: An analysis of GOG protocol 240. International Journal of
Chandarlapaty S, Sung P, Chen D, He W, Samoila A, You D, Bhatt T, Gynecological Cancer. 2016;26(Suppl. 3):40-41.
Patel P, Voi M, Gnant M, Hortobagyi G, Baselga J, Moynahan ME. cfDNA
analysis from BOLERO-2 plasma samples identifies a high rate of ESR1 Cheli S, Baider L, Goldzweig G, Andritsch E, Gany F. Mediterrean
mutations: Exploratory analysis for prognostic and predictive correlation bridges and drifts: The European migrant crisis and the role of psycho-
of mutations reveals different efficacy outcomes of endocrine therapy- oncology. Psycho-Oncology. 2016;25(Suppl. 3):90-91.
based regimens. Cancer Research. 2016;76(4 Suppl.)
Chellapandian D, Zhang R, Jeng M, van den Bos C, Lopez VSM,
Chang JHC, Romesser PB, Scher ED, Cahlon O, Hug EB, Sine Lehmberg K, Sieni E, Wang Y, Nakano T, Williams J, Fustino N,
K, DeSelm CJ, Mah D, Lee N. Proton beam reirradiation for recurrent Astigarraga I, Dunkel I, An Q, Cheng C, Weitzman S, Sung LL, Nichols
head and neck cancer: Multi-institutional report on feasibility and KE. Hemophagocytic lymphohistiocytosis in langerhans cell histiocytosis:
early outcomes. International Journal of Radiation Oncology, Biology, A multicenter retrospective descriptional study. Pediatric Blood and
Physics. 2016;94(4):865. Cancer. 2016;63(Suppl. 2):S38-S39.
Chang KK, Cho S, Yoon C, Lee JH, Park DJ, Yoon S. Increased RhoA Chemaitilly W, Li Z, Krasin M, Wilson C, Green D, Klosky J, Barnes N, Clark
activity predicts worse overall survival in patients undergoing surgical K, Frenandez-Pineda I, Metzger M, Ching-Hon P, Kirsten N, Kumar SD,
resection for diffuse-type gastric adenocarcinoma. Annals of Surgical Robison L, Hudson M, Sklar C, Yasui Y. Primary ovarian insufficiency in
Oncology. 2016;23(1 Suppl.):S156. childhood cancer survivors: A report from the St Jude Lifetime Cohort
(SJLIFE). Hormone Research in Paediatrics. 2016;86(Suppl. 1):256-257.
Chao HH, Berman AT, Mick R, Ciunci C, Gabriel PE, Lin H, Both S, Langer
C, Lelionis K, Rengan R, Prabhu K, Hartsell WF, Simone CB, Plastaras Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H,
JP. Central volume target overlap and esophageal dose predict for Sze D, Salem R, Metz D, Soulen MC. Embolotherapy for neuroendocrine
toxicity in a prospective study of reirradiation for non-small cell lung tumor liver metastases: Prognostic factors for hepatic progression-free
carcinoma using proton therapy. International Journal of Radiation survival and overall survival. Pancreas. 2016;45(3):473.
Oncology, Biology, Physics. 2016;96(2 Suppl.):S172.
Chen S, Deniz K, Sung YS, Zhang L, Dry SM, Antonescu C. Ewing
Chapman PB, Sznol M, Lao CD, Gonzalez R, Daniels GA, Thompson sarcoma (ES) with ERG gene rearrangements: A molecular study
JA, Kudchadkar RR, Sharfman WH, Atkins MB, Pavlick AC, Infante focusing on the prevalence of FUS-ERG and common pitfalls in detecting
JR, Kim KB, Weber JS, Nair S, Cowey L, Lipson EJ, Lee S, Avila A, EWSR1-ERG fusions by FISH. Laboratory Investigation. 2016;96(Suppl.
Hodi S. Safety data from an expanded access program (EAP) of 1):15A-16A.
nivolumab (NIVO) in combination with ipilimumab (IPI) in patients
with advanced melanoma (MEL). Asia-Pacific Journal of Clinical Chen S, Deniz K, Sung YS, Zhang L, Dry SM, Antonescu C. Ewing
Oncology. 2016;12(Suppl. 5):119. sarcoma (ES) with ERG gene rearrangements: A molecular
study focusing on the prevalence of FUS-ERG and common
262 OF 324
Meeting Abstracts
pitfalls in detecting EWSR1-ERG fusions by FISH. Modern MA. Long-term prognosis of one-year survivors of CD34-selected
Pathology. 2016;29(Suppl. 2):15A-16A. allogeneic hematopoietic stem cell transplantation: A landmark
analysis. Bone Marrow Transplantation. 2016;51(Suppl. 1):S97.
Chen YB, Perales MA, Li SL, Konkel S, Loiselle C, Efebera YA, Devine SM,
Ei-Jawahri A, McAfee SL, Soiffer RJ, Ritz J, Cutler CS. Phase I multicenter Cho C, Hsu M, Avecilla S, Barba P, Barker JN, Castro-Malaspina
trial of brentuximab vedotin for steroid refractory acute graft-vs.-host H, Devlin SM, Giralt SA, Jakubowski AA, Koehne G, Meagher R, O’Reilly
disease (GVHD). Biology of Blood and Marrow Transplantation. 2016;22(3 RJ, Papadopoulos E, Ponce DM, van den Brink MRM, Young JW, Perales
Suppl. 1):S391. MA. Long-term prognosis among 1-year survivors of ex vivo T-cell
depleted allogeneic hematopoietic stem cell transplantation: A landmark
Cherkassky L, Morello A, Villena-Vargas J, Sadelain M, Adusumilli analysis. Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl.
P. Enhancing CAR T-cell efficacy and functional persistence in solid 1):S84-S85.
tumors. Annals of Surgical Oncology. 2016;23(1 Suppl.):S40.
Choo K, Wallace MH, Grant-Navarro P, Feustel J. Nursing workflow: An
Chiappinelli KB, Strissel PL, Desrichard A, Li HL, Henke C, Akman B, integral component to medical research. Biology of Blood and Marrow
Hein A, Rote NS, Cope LM, Snyder A, Makarov V, Budhu S, Wolchok J, Transplantation. 2016;22(3 Suppl. 1):S444-S445.
Zahnow CA, Merghoub T, Chan TA, Strick R, Baylin SB. Inhibiting DNA
methylation causes an interferon response in cancer via dsRNA including Choueiri TK, Rini B I, Cosgriff T, Miyake H, Vogelzang NJ, Kannourakis
endogenous retroviruses. Cancer Research. 2016;76(2 Suppl.) G, Mariani M, Chiruzzi C, Albiges L, Haanen JB, Larkin J, Atkins MB,
Schmidinger M, Magazzù D, Di Pietro A, Motzer RJ. JAVELIN renal 101:
Chiles KA, Nelson CJ, Berookhim B, Mulhall JP. Characterizing Peyronie’s A phase 3 study of avelumab in combination with axitinib vs sunitinib
Disease and its response to intralesional verapamil in men developing as first-line treatment for patients with advanced renal cell carcinoma
Peyronie’s Disease after radical prostatectomy. Journal of Sexual (aRCC). BJU International. 2016;118(Suppl. 5):29-30.
Medicine. 2016;13(5 Suppl.):S57.
Chow OS, Kuk D, Keskin M, Smith JJ, Ordonez N, Pelossof R, Chen
Chin C, Santos N. Managing the complexities of patients with C, Chen Z, Avila K, Nash G, Temple LK, Weiser M, Guillem JG, Paty
substance use disorders through stem cell transplant: Psychoeducation PB, Berger M, Patil S, Garcia-Aguilar J. KRAS mutation in locally
and social work interventions. Biology of Blood and Marrow advanced rectal cancer is independently associated with a lower rate of
Transplantation. 2016;22(3 Suppl. 1):S184. pathologic complete response following neoadjuvant therapy. Annals of
Surgical Oncology. 2016;23(1 Suppl.):S18.
Cho C, Eaton A, Barker JN, Castro-Malaspina H, Devlin SM, Moskowitz
A, Sauter CS, Moskowitz CH, Perales MA. Functional imaging predicts Chowell D, Krishna S, Snyder A, Vladimir M, Chan TA, Anderson KS. A
progression-free survival after allogeneic hematopoietic stem cell predictive model to identify immunogenic neoepitopes in patients
transplantation (HCT) in relapsed/refractory Hodgkin lymphoma. Biology with melanoma treated with CTLA-4 blockade. Cancer Immunology
of Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S218-S219. Research. 2016;4(Suppl.)
Cho C, Hsu M, Avecilla S, Barba P, Barker J, Castro-Malaspina Ciccolini K. Cream principles: Nursing role in the management of
H, Devlin S, Giralt S, Jakubowski A, Koehne G, Meagher R, O’Reilly dermatologic adverse events to anticancer therapy. Oncology Nursing
R, Papadopoulos E, Ponce D, van den Brink M, Young J, Perales Forum. 2016;43(2):121.
263 OF 324
Meeting Abstracts
Ciccolini K. Oncodermatologic adverse events (DAE): Driving Cornejo KM, Paner GP, Tomaszewicz K, Meng XL, Mehta V, Sirintrapun
nursing practice with cream principles. Cancer Nursing. 2016;39(6 SJ, Barkan G, Cosar EF, Hutchinson L. Mutational profile using next
Suppl.):S44-S45. generation sequencing may aid in distinguishing urachal adenocarcinoma
from bladder adenocarcinoma. Modern Pathology. 2016;29(Suppl.
Cimbak N, Barker CA. Short-course radiation therapy for Merkel 2):223A.
cell carcinoma: Relative effectiveness in a “radiosensitive”
tumor. International Journal of Radiation Oncology, Biology, Cosgriff T, Yang L, Alyasova A, Ye D, Karpenko A, Alekseev B,
Physics. 2016;96(2 Suppl.):S160. Kowalyszyn R, Karyakin O, Neron Y, Collins LT, Brechenmacher T, Lin C,
Morgan L, Motzer R. RECORD-4 multicenter phase 2 trial of second-
Clark AL, Pozotrigo M, Mathew S, Liu D, Prockop SE, Ruggiero line everolimus (EVE) in patients with metastatic renal cell carcinoma
JM, Torok-Castanza J, Zakak N, Boulad F. Retrospective evaluation (mRCC): Anti-VEGF cohort subanalysis. BJU International. 2016;118(Suppl.
of palivizumab efficacy and safety for RSV prophylaxis in pediatric 5):18-19.
hematopoietic stem cell transplant patients: A single center
experience. Biology of Blood and Marrow Transplantation. 2016;22(3 Cosgriff T, Yang L, Alyasova A, Ye D, Karpenko A, Alekseev B,
Suppl. 1):S161. Kowalyszyn R, Karyakin O, Neron Y, Collins LT, Brechenmacher T, Lin C,
Morgan L, Motzer R. RECORD-4 multicenter phase 2 trial of second-
Classen C, Drozd A, O’Meara Y, Roelfsema L, Barbera L, Carter J, Brotto line everolimus (EVE) in patients with metastatic renal cell carcinoma
L, Robinson J, Ferguson S. GyneGals: An online support group for (mRCC): Anti-VEGF cohort subanalysis. BJU International. 2016;118(Suppl.
women who are sexually distressed following treatment for gynecologic 5):23-24.
cancer. Psycho-Oncology. 2016;25(Suppl. 3):133.
Cosgriff T, Yang L, Alyasova A, Ye D, Karpenko A, Li H, Alekseev B, Xie LP,
Collin M, Milne P, Bigley V, Neel A, Haniffa M, Durham B, Diamond Kowalyszyn RD, Karyakin O, Neron Y V, Collins L, Brechenmacher T, Lin C,
E, Abdel-Wahab O. The hematopoietic origin of adult Morgan L, Motzer RJ. RECORD-4 phase 2 trial of second-line everolimus
histiocytosis. Pediatric Blood and Cancer. 2016;63(Suppl. 2):S15-S16. (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC):
Final OS analysis. Journal of Clinical Oncology. 2016;34(2 Suppl.)
Connell LC, Chou JF, Boucher TM, Capanu M, Kemeny NE. Relevance of
CEA and LDH in relation to KRAS status in patients with unresectable Cosgriff T, Yang L, Alyasova A, Ye D, Karpenko A, Li H, Alekseev B, Xie
colorectal liver metastases. Journal of Clinical Oncology. 2016;34(4 LP, Kowalyszyn RD, Karyakin O, Neron Y V, Collins L, Brechenmacher
Suppl.) T, Lin CJ, Morgan L, Motzer RJ. RECORD-4 multicenter phase II trial of
second-line everolimus (EVE) in patients (pts) with metastatic renal cell
Conti L, Fitzmaurice D, Borg K. Enhancing patient education for carcinoma (mRCC): Anti-VEGF cohort subanalysis. Journal of Clinical
drainage catheters. Oncology Nursing Forum. 2016;43(2):97. Oncology. 2016;34(2 Suppl.)
Cooper R, Cohen N, Schofield E, Starr T, Nelson C, Jandorf L, Duhamel Coukos G, Brady MF, Lankes HA, Aghajanian C, Gottardo R, Swisher EM,
K. Assessing screening disparities for CRC by race across states. Cancer Kandalaft L, Foukas PG, Rizack T, Leach J, Salani R, Higgins R, Hanjani
Epidemiology Biomarkers and Prevention. 2016;25(3) P, Morgan M, Edwards R, Bryan JK, Manjarrez KL, Mannel RS, Hershberg
RM, Monk BJ. GOG-3003: Identifying biomarkers predictive of immune
264 OF 324
Meeting Abstracts
and clinical response in a phase 2 RCT of chemo-immunotherapy Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo CT, Oh SA, Toure
in recurrent ovarian cancer. International Journal of Gynecological A, Pritykin Y, Huse M, Leslie CS, Li MO. Cancer immunosurveillance by
Cancer. 2016;26(Suppl. 3):26-27. tissue-resident innate lymphoid cells and innate-like T cells. European
Journal of Immunology. 2016;46(Suppl. 1):498.
Coutre S, Barrientos J, Brown J, De Vos S, Furman R, Keating M,
O’Brien S, Pagel J, Sharman J, Zelenetz A, Newcomb T, Cho Y, Dai P, Wang W, Li T, Serna-Tamayo C, Shuman S, Chen Z, Deng
Aguilar C, Dreiling L. Safety of idelalisib in B-cell malignancies: L. Inhibition of the cytosolic DNA sensor cyclic GMP-AMP
Integrated analysis of eight clinical trials. British Journal of synthase by poxviral virulence factor E3. Journal of Investigative
Haematology. 2016;173(Suppl. ):97-98. Dermatology. 2016;136(5 Suppl. 1):S81.
Cracchiolo J, Baxi SS, Ganly I, Patel SG, Cohen MA, Roman Dai PH, Wang WY, Serna-Tamayo C, Zamarin D, Shuman S, Merghoub
BR. Increasing primary surgical treatment of T1 and T2 oropharyngeal T, Wolchok JD, Deng L. Heat-inactivated modified vaccinia virus ankara
squamous cell carcinoma and the treatment selection learning curve: induces type I IFN and antitumor immunity via the cytosolic DNA-sensing
National Cancer Data Base. International Journal of Radiation Oncology, pathway. Cancer Immunology Research. 2016;4(Suppl.)
Biology, Physics. 2016;94(4):872.
Dalvi N, Kleinerman R, Huse J, Abramson D, Dunkel I. Low grade
Cronin PA, Olcese C, Patil S, Morrow M, Van Zee KJ. Age and recurrence astrocytoma: A rare second tumor in retinoblastoma survivors. Neuro-
risk in 2,996 women with DCIS treated with breast-conserving surgery Oncology. 2016;18(Suppl. 3):iii86.
(BCS). Annals of Surgical Oncology. 2016;23(1 Suppl.):S26.
Damude S, Murali R, Wevers KP, Hoekstra H, Bastiaannet E. The
Cruz C, Bustos L, Gris A, Palafox M, Castroviejo M, Llop A, Morancho B, additional value of S-100B in a risk stratifying model for the prediction
Diez O, Gutiérrez S, Caratú G, Prudkin L, Bruna A, Caldas C, O’Connor of non-sentinel node positivity in melanoma patients. Annals of Surgical
MJ, Rubio IT, Arribas J, Baselga J, Cortes J, Serra V, Balmaña J. PARP Oncology. 2016;23(1 Suppl.):S128-S129.
inhibition in breast and ovarian patient-derived tumor xenografts
(PDX) harboring germline BRCA1/2 mutations unveils mechanisms of Dancsok AR, Banito A, Lowe S, Nielsen T. KDM2B—Setting the stage for
primary and acquired resistance that restore homologous recombination aberrant silencing in synovial sarcoma. Modern Pathology. 2016;29(Suppl.
(HR). Cancer Research. 2016;76(4 Suppl.) 2):16A.
Curran KJ, Silverman LB, Kobos R, Kernan NA, Margossian SP, Park Dancsok AR, Banito A, Lowe S, Nielsen TO. KDM2B—Setting
JH, Sauter CS, Szenes V, Wang XY, O’Reilly RJ, Sadelain M, Riviere the stage for aberrant silencing in synovial sarcoma. Laboratory
I, Brentjens RJ. Chimeric antigen receptor T cells for cancer Investigation. 2016;96(Suppl. 1):16A.
immunotherapy. Cancer Research. 2016;76(5 Suppl.)
Dannaoui A, McMillan L, Sokoli D, Szul A, Brown S, Burke M, Cruz
Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo C, Oh SA, Toure T, Findley K, Gadsden C, Hamilton C, Harris A, Malcolm D, Saulan
A, Pritykin Y, Huse M, Leslie CS, Li MO. Cancer immunosurveillance by MM, Swift L, Walsh JP, Wilson R, Woody K, Yee S. T minus 15 minutes:
tissue-resident innate lymphoid cells and innate-like T cells. Journal of A peri-operative countdown to safety. Journal of PeriAnesthesia
Immunology. 2016;196(1 Suppl.) Nursing. 2016;31(4):e24-e25.
265 OF 324
Meeting Abstracts
Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Direito de Morais DeSelm CJ, Hamieh M, Sadelain M. Radiation sensitizes tumor cells to
Guerreiro M, Xu YY, Xiang JY, Yan S, Veomett N, Dubrovsky L, Curcio CAR T cell immunotherapy. International Journal of Radiation Oncology,
M, Doubrovina E, Liu C, O’Reilly RJ, Scheinberg DA. Potent therapeutic Biology, Physics. 2016;96(2 Suppl.):S127.
and immunological effects of the first T-BiTE derived from a TCR-mimic
antibody targeting intracellular oncoprotein WT1. Cancer Immunology DeSelm CJ, Yang TJ, Tisnado J, Wilgucki M, Pei X, Siu CT, McCormick
Research. 2016;4(Suppl.) B, Cahlon O, Powell SN, Ho AY. Regional patterns of breast
cancer failure after definitive therapy: A large, single-institution
Das DK, Osborne JR, Park JY, Ogunwobi OO. miR-1207-3p, a novel analysis. International Journal of Radiation Oncology, Biology,
biomarker of aggressive prostate cancer, displays differential Physics. 2016;96(2 Suppl.):S145.
expression in Caucasian men versus men of African ancestry. Cancer
Research. 2016;76(6 Suppl.) DeSimone RA, Goel R, Berlin DA, Avecilla ST, Cushing MM, Goss
CA. Compassionate, investigational use of SANGUINATE(TM)
Davids MS, Gerecitano J, Potluri J, Cerri E, Kim SY, Steinberg M, Verdugo (PEGylated carboxyhemoglobin bovine) in a Jehovah’s Witness patient
M, Busman T, Enschede SH, Mobasher M, Best A, Desai M, Wierda with hematemesis. Transfusion. 2016;56(Suppl. S4):177A.
WG. Integrated safety analysis of venetoclax monotherapy in chronic
lymphocytic leukemia (CLL). Haematologica. 2016;101(Suppl.):59. Di Cosimo S, Campbell C, Hazim HA, Curigliano G, Criscitiello C,
Crescenzo R, de la Pena L, Piccart-Gebhart MJ, Eidtmann H, Baselga
de Lima M, Oran B, Papadopoulos EB, Scott BL, William BM, Giralt J, de Azambuja E. Breast ultrasound and mammography and response
SA, Champlin RE, Hetzer J, Tosolini A, Laille E, Skikne BS, Craddock to neoadjuvant lapatinib, trastuzumab and their combination in HER2
C. CC-486 (oral azacitidine) maintenance therapy is well tolerated after positive breast cancer: Results from Neo-ALTTO (BIG 1-06). Cancer
allogeneic hematopoietic stem cell transplantation (AlloHSCT) in patients Research. 2016;76(4 Suppl.)
with myelodysplastic syndromes (MDS) or acute myeloid leukemia
(AML). Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl. Dickler M. Longitudinal strategies in ER plus disease. Cancer
1):S312-S313. Research. 2016;76(4 Suppl.)
de Velasco G, Miao D, Shukla S, Voss MH, Wu C, Murray B, Meyerson M, Diéras V, Miles D, Verma S, Pegram M, Welslau M, Baselga J, Krop I,
Signoretti S, Motzer RJ, Van Allen EM, Choueiri TK. Integrated genomic Blackwell K, Kang B, Xu J, Green M, Gianni L. Trastuzumab emtansine
correlates of response to PD-1 inhibitor nivolumab in metastatic renal cell improves overall survival versus capecitabine plus lapatinib in patients
carcinoma (mRCC). Journal of Clinical Oncology. 2016;34(2 Suppl.) with previously treated HER2-positive advanced breast cancer: Final
results from the phase 3 EMILIA study. Cancer Research. 2016;76(4
DeLaney TF, Chen YLE, Adams JA, Hickey S, Wang D, Baldini EH, Suppl.)
Bernstein K, Yeap BY, Hahn SM, Nielsen GP, Choy E, Mullen JT, Yoon
SS. Phase 1 trial of preoperative image guided intensity modulated Dierov D, Hilden P, Ponce DM, Prockop SE, Featherstone C, Wills
proton radiation therapy (IMPT) with simultaneously integrated boost J, Devlin SM, Collum K, Ciolino C, Garfinkle R, Hoover E, Perales
to the high risk margin for retroperitoneal sarcomas. International MA. Leveraging technology and education improves acute graft-versus-
Journal of Radiation Oncology, Biology, Physics. 2016;96(2 host disease assessment and data capture. Biology of Blood and Marrow
Suppl.):S23. Transplantation. 2016;22(3 Suppl. 1):S105-S106.
266 OF 324
Meeting Abstracts
Dittamore R V, Louw J, Schreiber NA, Graf R, Jendrisak A, Johnson regional nodal irradiation (RNI). International Journal of Radiation
A, Dugan L, McLaughlin B, Heller G, Fleisher M, Wang Y, Marrinucci Oncology, Biology, Physics. 2016;96(2 Suppl.):E681.
DC, Scher H I. Clinical validation of CTC subtype frequency to prognosis
OS in mCRPC patients. Journal of Clinical Oncology. 2016;34(2 Suppl.) Eastham JA. Is surgery superior to radiotherapy for high-risk prostate
cancer?. International Journal of Urology. 2016;23(5):438.
Dong Y, Manley B, Hakimi AA, Coleman JA, Russo P, Hsieh
J. Comparing surgical tissue versus biopsy tissue in the development Eberhardt WEE, Borghaei H, Brahmer JR, Horn L, Ready N, Steins M,
of a clear cell renal cell carcinoma xenograft model. Journal of Clinical Felip E, Paz-Ares LG, Arrieta O, Barlesi F, Antonia SJ, Fayette J, Rizvi
Oncology. 2016;34(2 Suppl.) NA, Crino L, Reck M, Hellmann M, Desai K, Li A, Healey D, Spigel
DR. CheckMate 017 and 057 studies of nivolumab vs docetaxel in
Donovan M, Eastham JA, Patel V, McKiernan JM, Noerholm M, Belzer S, patients with advanced NSCLC: 2-year-update and exploratory cytokine
Bentink S, O’Neill V. A non-invasive urine exosome gene expression assay profile analyses. Oncology Research and Treatment. 2016;39(Suppl. 3):33.
(ExoIntelliScore Prostate) to predict pathologic stage and grade in the
prostatectomy specimen. Journal of Clinical Oncology. 2016;34(2 Suppl.) Edelweiss M, Riaz N, Piscuoglio S, Ng CKY, Weigelt B, Mutter
RW, Delsite R, Giri D, King T, Reis JS, Powell S. A functional assay
Downey RJ, Wu HJ, Riester M, Moreira A, Michor F. A stem cell oriented for homologous recombination (HR) DNA repair assessment in breast
phylogeny of cancers derived novel cancer gene expression signature cancers. Modern Pathology. 2016;29(Suppl. 2):41A.
in all undifferentiated cancers as a therapeutic target. Human Gene
Therapy. 2016;27(11):A36-A37. Edelweiss M, Riaz N, Piscuoglio S, Ng CKY, Weigelt B, Mutter
RW, Delsite R, Giri D, King T, Reis-Filho JS, Powell S. A functional assay
Drilon A, Hofmann N, Flynn D, Smith B, Davare M. The type II for homologous recombination (HR) DNA repair assessment in breast
switch control kinase inhibitor, DCC-2701 (altiratinib) effectively cancers. Laboratory Investigation. 2016;96(Suppl. 1):41A.
inhibits resistant NTRK kinase domain mutants. European Journal of
Cancer. 2016;69(Suppl. 1):S138. Elias AD, Burris HA, Patel MR, Schwartzberg LS, Richer JK,
Kavalerchik E, Stopatschinskaja S, Gibbons J, Markova D, Steinberg
Drilon A, Marwan F, Fu S, Patel MR, Olszanski AJ, Lockhart AC, Liu JL, Traina TA. MDV3100-08: A phase 1 study evaluating the safety
S V, Bazhenova L, Seery T, Nikolinakos P, Patel R, Oliver JW, Multani and pharmacokinetics of enzalutamide plus fulvestrant in women
PS, Wang D. A phase 1/1b study of RXDX-105, an oral RET and BRAF with advanced hormone receptor-positive breast cancer. Cancer
inhibitor, in patients with advanced solid tumors. European Journal of Research. 2016;76(4 Suppl.)
Cancer. 2016;69(Suppl. 1):S143.
Emile JF, Cohen-Aubart F, Baillou C, Roos-Weil D, Papo M, Helias-
Droppelmann N, Lee AY, Panageas K, Ariyan CE, Brady MS, Balakrishna Rodzewicz Z, Miyara M, Abdel-Wahab O I, Bernard OA, Amoura
S, Coit DG. Patterns and timing of first relapse in pathologic stage II Z, Lemoine FM, Haroche J. BRAF mutations in bone marrow and
melanoma patients. Annals of Surgical Oncology. 2016;23(1 Suppl.):S29. blood of patients with Erdheim Chester disease. Pediatric Blood and
Cancer. 2016;63(Suppl. 2):S60-S61.
Dumane VA, Saksornchai K, Zhou Y, Hong L, Ho AY. Quantifying the
effects of combining deep inspiration breath hold (DIBH) with volumetric Engel-Nitz NM, Byfield SD, Bancroft T, Anderson AJ, Reyes CM, Ravelo
modulated arc therapy (VMAT) in breast cancer patients receiving A, Ogale S, Matasar MJ, Chen MC. Understanding disease progression
267 OF 324
Meeting Abstracts
and treatment patterns in metastatic breast, colorectal, and lung cancer: novel, well-tolerated regimen with high remission rate in older patients
Implications for evaluating value and quality of care. Journal of Clinical with AML. Haematologica. 2016;101(Suppl.):186-187.
Featherstone C, Hylton HM. Age-stratified comparison of incidence of
Engert A, Santoro A, Shipp M, Zinzani PL, Timmerman J, falls and altered mental status in older adult transplant patients. Biology
Ansell S, Armand P, Fanale M, Ratanatharathorn V, Kuruvilla of Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S106-S107.
J, Cohen J, Collins G, Savage K, Trneny M, Kato K, Farsaci B,
Parker S, Rodig S, Younes A. Checkmate 205: A phase 2 study Featherstone C, Krist N. A multidisciplinary approach to improving
of nivolumab in patients with classical Hodgkin lymphoma communication across the care continuum. Biology of Blood and Marrow
following autologous stem cell transplantation and brentuximab Transplantation. 2016;22(3 Suppl. 1):S439-S440.
vedotin. Haematologica. 2016;101(Suppl.):319.
Feustel J, Dutton I, Tran J, Reilly L, Callahan C, Dykhne E, Bromme
Ermoian RP, Breneman JC, Walterhouse DO, Meza JL, Anderson J, E, Lichtman S. Easing the transition from graduate nurse to confident
Hawkins DS, Hayes-Jordan AA, Yock T I, Donaldson SS, Wolden SL. Is 45 bone marrow transplant staff nurse: Creation of an enrichment program
Gy a sufficient radiation therapy dose for unresected orbital embryonal to supplement existing unit orientation. Biology of Blood and Marrow
rhabdomyosarcoma? A report from the Soft Tissue Sarcoma Committee Transplantation. 2016;22(3 Suppl. 1):S464-S465.
of the Children’s Oncology Group. International Journal of Radiation
Oncology, Biology, Physics. 2016;96(2 Suppl.):E548. Fine SW, Sarungbam J, Al-Ahmadie HA, Chen YB, Gopalan
A, Sirintrapun SJ, Reuter VE, Tickoo SK. Assessing % Gleason
Escudier BJ, Motzer RJ, Powles T, Tannir NM, Davis ID, Donskov F, pattern (GP) 4 in needle biopsies: An interobserver reproducibility
Grünwald V, Heng DYC, Hutson T, Melichar B, Nosov D, Rini B I, Salman study. Laboratory Investigation. 2016;96(Suppl. 1):229A.
P, Sternberg CN, Szczylik C, Wolter P, Arroyo AM, Mangeshkar M,
Agarwal N, Choueiri TK. Subgroup analyses of METEOR, a randomized Fine SW, Sarungbam J, Al-Ahmadie HA, Chen YB, Gopalan
phase 3 trial of cabozantinib versus everolimus in patients (pts) A, Sirintrapun SJ, Reuter VE, Tickoo SK. Assessing % Gleason pattern
with advanced renal cell carcinoma (RCC). Journal of Clinical (GP) 4 in needle biopsies: An interobserver reproducibility study. Modern
Oncology. 2016;34(2 Suppl.) Pathology. 2016;29(Suppl. 2):229A.
Eyquem J, Mansilla-Soto J, Odak A, Sadelain M. One-step generation of Fingerhood M, Khutti S, Diamond E, Geyer A. Pulmonary overlap
universal CAR T cells. Molecular Therapy. 2016;24(Suppl. 1):S109. histiocytosis: A rare case of interstitial lung disease due to Erdheim
Chester Disease in a patient with Langerhans Cell Histiocytosis and
Fair DB, Kirchhoff AC, Nipp RD, Leisenring WM, Nathan PC, Oeffinger Myelodisplastic Syndrome. Chest. 2016;150(4 Suppl.):1062A.
KC, Armstrong GT, Robison LL, Park E. Impact of health care costs on
utilization of needed health care in the Childhood Cancer Survivor Study Fischer M, Wulff B, Baruchel S, Berlanga P, Trahair T, Mechinaud F, Schulte
(CCSS). Journal of Clinical Oncology. 2016;34(3 Suppl.) J, Modak S, Merks JH, Zwaan CM, Marshall L V, Casanova M, Branle F,
Malet I, Emeremni AC, Geoerger B. Phase 1 study of ceritinib in pediatric
Fathi A, Erba H, Lancet J, Stein E, Ravandi F, Faderl S, Walter R, Advani patients with malignancies harboring activated anaplastic lymphoma
A, DeAngelo D, Kovacsovics T, Jillella A, Bixby D, Levy M, O’Meara M, Ho kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed
P, Stein A. Sgn-CD33A in combination with hypomethylating agents: A population. European Journal of Cancer. 2016;69(Suppl. 1):S49-S50.
268 OF 324
Meeting Abstracts
Flaig TW, Smith MR, Saad F, Rathkopf DE, Mulders PFA, Small EJ, Shore Friedman DN, Wolden SL, Antal Z, Moskowitz CS, Hilden P, Cheung
ND, Fizazi K, De Porre P, Kheoh T, Li J, Todd MB, Griffin TW, Ryan CJ, De NK V, Kushner BH, Tonorezos ES, Carlow D, Oeffinger KC, Sklar
Bono JS. Treatment patterns after abiraterone acetate in patients (pts) CA. Insulin and glucose homeostasis in childhood cancer survivors
with metastatic castration-resistant prostate cancer (mCRPC): Post hoc treated with abdominal radiation: A pilot study. Journal of Clinical
analysis of COU-AA-302. Journal of Clinical Oncology. 2016;34(2 Suppl.) Oncology. 2016;34(3 Suppl.)
Fleischhauer K, Shaw B, Ahn KW, Wang HL, Crivello P, Verneris M, Hsu K, Friedrich HC, Gerber PA, Kislat A, Schindler K, Klossowski N, Braun
Pidala J, Lee S, Spellman S. Prospective assignment of HLA-DPB1 T cell SA, Chapman P, Lacouture ME, Homey B, Meller S. Skin rashes induced
epitope group mismatches by functional distance scores is significantly by vemurafenib are caused by a non-allergic mechanism. Experimental
associated with outcome of 8/8 matched unrelated donor HCT. Bone Dermatology. 2016;25(3):E32.
Marrow Transplantation. 2016;51(Suppl. 1):S189-S190.
Fuchs CS, Tabernero J, Al-Batran SE, Chau I, Ilson DH, Van Cutsem E,
Fluchel M, Diamond EL, Abdel-Wahab O, Brody L, Arcila M, Bowers Shitara K, Ferry D, Emig M, Vanvoorden V, Hsu YZ, Xu YH, Sashegyi
C. Anakinra as efficacious therapy for intracranial Erdheim-Chester A, Das M, Shah MA. A randomized, double-blind, placebo-controlled
disease in a child. Pediatric Blood and Cancer. 2016;63(Suppl. 2):S62. phase III study of cisplatin plus a fluoropyrimidine with or without
ramucirumab as first-line therapy in patients with metastatic gastric
Forero A, Burris H 3rd, Mita M, Specht J, Weise A, Liu MC, Modi S, Pusztai or gastroesophageal junction (GEJ) adenocarcinoma (RAINFALL,
L, Kostic A, Yang J, Li M, Hengel S, Miller K. Interim analysis of a phase NCT02314117). Journal of Clinical Oncology. 2016;34(4 Suppl.)
1 study of the antibody-drug conjugate SGN-LIV1A in patients with
metastatic breast cancer. Cancer Research. 2016;76(4 Suppl.) Ganesh K, Raj NP, Yaeger RD, Berger MF, Shia J, Reidy DL. BRAF
mutations in patients with large cell neuroendocrine carcinoma of the
Francica J, Lynn G, Laga R, Aussedat B, Meyerhoff R, Alam colon (LCNECC). Journal of Clinical Oncology. 2016;34(4 Suppl.)
M, Danishefsky S, Haynes B, Seder R. Synthetic biocompatible polymers
are an effective delivery platform that elicits potent antibody responses Ganesh K, Shah R, Vakiani E, Kemeny NE, Lincoln A, Tran C, Varghese
against HIV-1 glycopeptide immunogens. AIDS Research and Human AM, Yaeger RD, Cercek A, Segal NH, Reidy DL, Epstein AS, Weiser
Retroviruses. 2016;32(Suppl.):221. MR, Garcia-Aguilar J, Berger MF, Saltz L, Stadler ZK. Clinical prognostic
factors and genomic analysis of ovary metastases (mets) from colorectal
Franko J, Shi Q, Meyers JP, Heinemann V, Falcone A, Tebbutt NC, cancer (CRC). Journal of Clinical Oncology. 2016;34(4 Suppl.)
Maughan T, Seymour M, Saltz L, Tournigand C, Diaz-Rubio E, Sougklakos
I, Chibaudel B, Moen J, De Gramont A, Adams RA, Sargent DJ, Grothey Ganly I. Nomograms for predicting survival and recurrence in patients
A. Prognostic value of isolated peritoneal versus other metastatic sites with adenoid cystic carcinoma. International Journal of Radiation
in colorectal cancer (CRC) patients treated by systemic chemotherapy: Oncology, Biology, Physics. 2016;94(4):946-947.
Findings from 9,265 pts in the ARCAD database. Journal of Clinical
Oncology. 2016;34(4 Suppl.) Gao P, Ascano M, Zillinger T, Barchet W, Tuschl T, Patel DJ. Structure-
function studies of cytosolic DNA sensing pathway. Cancer Immunology
Freites-Martinez A, Barrios D, Lacouture M. Inflammatory skin Research. 2016;4(Suppl.)
conditions in patients under anticancer therapies: Observations from an
oncodermatology clinic. Experimental Dermatology. 2016;25(Suppl. 4):38.
269 OF 324
Meeting Abstracts
Garner TP, Reyna DE, Priyadarshi A, Chen HC, Malashkevich VN, Almo adenosis and breast acinic cell carcinomas related lesions?. Laboratory
SS, Cheng EH, Gavathiotis E. An autoinhibited dimeric form of pro- Investigation. 2016;96(Suppl. 1):42A.
apoptotic BAX regulates apoptosis. Protein Science. 2016;25(Suppl.
1):132. PMCID: PMC5081090 Geyer FC, Piscuoglio S, Ng CKY, Guerini-Rocco E, Marchio C, Hodi
Z, Rakha E, Ellis IO, Schnitt S, Weigelt B, Reis JS. Are microglandular
Gay HA, Deasy JO, Apte A, Daly MD, Adkins D, Rich JT, Michel L, Wildes adenosis and breast acinic cell carcinomas related lesions?. Modern
T, Dyk PT, Mullen D, Eschen L, Chin R I, Nussenbaum B, Haughey BH, Pathology. 2016;29(Suppl. 2):42A.
Thorstad WL, Oh JH. Predictors of acute throat or esophageal pain
during radiation therapy for head and neck cancer. International Journal Geyer M, Park J, Rivière I, Senechal B, Hsu M, Wang X, Purdon
of Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E392-E393. T, Sadelain M, Brentjens R. Phase I trial: CD19-targeted CAR T-cells
in patients with residual CLL following initial purine analog-based
Geissmann F. Mechanisms that control specification and in vivo functions therapy. Clinical Lymphoma, Myeloma and Leukemia. 2016;16(Suppl.
of tissue resident macrophages. Experimental Hematology. 2016;44(9 2):S48.
Suppl.):S27.
Ghebrehiwet B, Pednekar L, Kishore U, Kandov E, Nanda J, Hosszu
Germain RN, Laemmermann T, Uderhardt S, Liu Z, Rudensky AY, Levine KH, Peerschke E I. Engagement of gC1qR with C1q or mAb induces
AG, Li W, Radtke A, Yu W, Baptista APD, Gerner MY. Imaging immunity: tumor cell apoptosis. Immunobiology. 2016;221(10):1198-1199.
Developing a spatiotemporal understanding of host defense and
disease. European Journal of Immunology. 2016;46(Suppl. 1):751. Ghia P, Cheson BD, Furman RR, Hallek M, Hillmen P, O’Brien SM,
Sharman JP, Dubowy RL, Velasco B, Waldapfel CC, Zelenetz AD, Brown
Getta B, Devlin S, Park J, Tallman M, Berman E. Very young JR. Patterns of idelalisib treatment-emergent lymphocytosis in patients
patients with chronic lymphocytic leukemia have lower incidence with CLL or SLL. Haematologica. 2016;101(Suppl.):439.
of adverse cytogenetics and improved overall survival: 10-
year experience from Memorial Sloan Kettering Cancer Ghia P, Coutre S, Flinn IW, Gopal AK, O’Brien SM, Salles
Center. Haematologica. 2016;101(Suppl.):435. GA, Newcomb T, Waldapfel CC, Ye W, Zelenetz AD, Wierda
WG. Management of transaminase elevations associated with
Geyer FC, Ng CKY, Piscuoglio S, Burke K, Wen YH, Vincent- idelalisib. Haematologica. 2016;101(Suppl.):59-60.
Salomon A, Reis JS, Weigelt B. Metaplastic breast carcinomas and
gynecologic carcinosarcomas: Variations of the same theme or distinct Giaddui T, Bollinger D, Glick A, Zhong H, Phillips H, Nunez F, Infante
entities?. Modern Pathology. 2016;29(Suppl. 2):454A. R, Hames S, Linnemann N, Lee R, Chan ATC, Yom SS, Hara W, Baxi SS,
Chakravarti A, Lee N, Xia P, Xiao Y. Toward improving treatment planning
Geyer FC, Ng CKY, Piscuoglio S, Burke K, Wen YH, Vincent-Salomon quality and efficiency using knowledge engineering and autoplanning:
A, Reis-Filho JS, Weigelt B. Metaplastic breast carcinomas and A study based on NRG-HN001 clinical trial. International Journal of
gynecologic carcinosarcomas: Variations of the same theme or distinct Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E656-E657.
entities?. Laboratory Investigation. 2016;96(Suppl. 1):454A.
Gibson D, Pinero MC. Outpatient methotrexate-partnership between
Geyer FC, Piscuoglio S, Ng CKY, Guerini-Rocco E, Marchio C, Hodi health care team and patients. Oncology Nursing Forum. 2016;43(2):79.
Z, Rakha E, Ellis IO, Schnitt S, Weigelt B, Reis JS. Are microglandular
270 OF 324
Meeting Abstracts
Gil-Cupello M, Shah GL, Maloy MA, Goldman DA, Devlin SM, Matasar Gofter L, Hodge M, Rodriguez W, Sokoli D, Bivona J, Dannaoui
MJ, Giralt SA, Sauter CS, Moskowitz CH, Perales MA. Outcomes of A, DiFortuna K, Gillins-White C, Irwin M, Kitzler R, Lombardo K, Paul
diffuse large B-cell lymphoma (DLBCL) patients progressing after N, Smykowski L, Szul A. Now read this! The development of a presurgical
autologous hematopoietic stem cell transplant. Biology of Blood and manual to faclitate the orientation process. Journal of PeriAnesthesia
Marrow Transplantation. 2016;22(3 Suppl. 1):S232-S233. Nursing. 2016;31(4):e49.
Gilheeney S, Ackerman J, De Luca J, Robinson D, Muller R, Sklarin Goh R, Dal Cin P, Chiang S, Young RH, Oliva E. Myxoid smooth muscle
N. Patient safety may be improved using a dose calculating-and- tumors of the uterus: Clinicopathologic study of 40 cases. Laboratory
rounding electronic chemotherapy order entry and verification system Investigation. 2016;96(Suppl. 1):285A.
with clinical decision support system (CDSS) features in the pediatric
setting. Neuro-Oncology. 2016;18(Suppl. 3):iii137-iii138. Goh R, Dal Cin P, Chiang S, Young RH, Oliva E. Myxoid smooth muscle
tumors of the uterus: Clinicopathologic study of 40 cases. Modern
Gilheeney S, Haque S, De Braganca K, Khakoo Y, Lyden D, Souweidane Pathology. 2016;29(Suppl. 2):285A.
M. Radiographic findings in pediatric patients with diffuse intrinsic
pontine glioma (DIPG) surviving one year post-diagnosis. Neuro- Golan T, Raitses-Gurevich M, Kelley RK, Bocobo AG, Borgida A, Shroff
Oncology. 2016;18(Suppl. 3):iii74. RT, Holter S, Gallinger S, Lowery MA, Abou-Alfa GK, Ahn DH, Jain A,
Bekaii-Saab TS, Friedman E, Javle MM. Overall survival and clinical
Ginex P, Hernandez M. Supporting clinical research at the characteristics of BRCA germline/somatic cholangiocarcinoma
bedside: A clinical librarian-nursing partnership. Oncology Nursing (CCA). Journal of Clinical Oncology. 2016;34(4 Suppl.)
Forum. 2016;43(2):110.
Golby B. Addressing the psychosocial needs of adult survivors of
Ginex P, Montefusco M, Burns J, Zecco G, Trocchia N, Tan childhood cancer. Journal of Psychosocial Oncology. 2016;34(1-2):124-125.
KS. Animal-facilitated therapy improves outcomes for patients
and staff on an inpatient surgical oncology unit. Oncology Nursing Gomez-Gelvez J, Royston D, Arcila ME, Pichardo J, Moskowitz
Forum. 2016;43(2):E89. AJ, Horwitz SM, Dogan A. Routine comprehensive genomic profiling of
T-cell neoplasms improves diagnostic accuracy and identifies actionable
Ginex P, Ross M, Lugar T, Tan KS, Atkinson T. From prescription therapeutic targets. Laboratory Investigation. 2016;96(Suppl. 1):347A.
to action: A mixed methodology approach to identify facilitators
and barriers to adherence to oral cancer medications. Nursing Gomez-Gelvez J, Royston D, Arcila ME, Pichardo J, Moskowitz
Research. 2016;65(2):E110. AJ, Horwitz SM, Dogan A. Routine comprehensive genomic profiling of
T-cell neoplasms improves diagnostic accuracy and identifies actionable
Goetz MP, Beeram M, Beck T, Conlin AK, Dees EC, Dickler MN, Helsten therapeutic targets. Modern Pathology. 2016;29(Suppl. 2):347A.
TL, Conkling PR, Edenfield WJ, Richards DA, Turner PK, Cai N, Chan
EM, Pant S, Becerra CH, Kalinsky K, Puhalla SL, Rexer BN, Burris HA, Gomez-Gelvez JC, Ho C, Yu W, Syed MH, Zehir A, Baldi T, Dogan
Tolaney SM. Abemaciclib, an inhibitor of CDK4 and CDK6, combined A, Ladanyi M, Yao J, Nafa K, Arcila M. Assessment of immunoglobulin
with endocrine and HER2-targeted therapies for women with metastatic heavy variable gene usage and somatic hypermutation status in splenic
breast cancer. Cancer Research. 2016;76(4 Suppl.) marginal zone lymphomas using next-generation sequencing. Journal of
Molecular Diagnostics. 2016;18(6):965.
271 OF 324
Meeting Abstracts
Gordon R, Kasler M, Stasi K. Start, pause, stop: A dedicated ambulatory Grünwald V, Motzer RJ, Sharma P, Escudier B, McDermott DF, George S,
phase I immunotherapy clinic’s approach to managing patients on Srinivas S, Tykodi SS, Sosman JA, Plimack ER, Nathan P, Tomita Y, Zhao
immune modulators. Oncology Nursing Forum. 2016;43(2):6. H, Waxman IM, Hammers HJ. Correlation of response with overall survival
(OS) for nivolumab vs everolimus in advanced renal cell carcinoma
Gowrishankar B, Janakiraman M, Padmanabhan R, Thodima VJ, Spaliviero (aRCC): Results from the phase III CheckMate 025 study. Oncology
M, Stratton KL, Soni R, Durack JC, Chaganti RSK, Solomon SB, Coleman Research and Treatment. 2016;39(Suppl. 3):264-265.
JA, Kamalakaran S, Houldsworth J. Clinical utility of a custom next-
generation sequencing panel in the diagnosis of needle biopsies from Gucalp A, Hudis C, Norton L, Patil S, Kurman MR, Eisner JR, Moore
renal masses. Journal of Clinical Oncology. 2016;34(2 Suppl.) WR, Traina TA. A phase 1/2 study of once-daily oral VT-464 in patients
with advanced androgen receptor (AR) positive triple negative
Gowrishankar B, Janakiraman M, Lee CH, Thodima VJ, Molina (TNBC) or estrogen receptor (ER) positive breast cancer (BC). Cancer
AM, Patel PH, Gold TM, Motzer RJ, Chaganti RSK, Kamalakaran Research. 2016;76(4 Suppl.)
S, Houldsworth J. Metastasis-associated mutations in clear cell renal cell
carcinoma. Journal of Clinical Oncology. 2016;34(2 Suppl.) Gucalp A, Proverbs-Singh TA, Razavi P, Chandarlapaty S, Patil S, Ross
DS, Zehir A, Baselga J, Hudis CA, Traina TA. Androgen receptor (AR)
Grant-Navarro P, Wallace MH, Choo K, Feustel J. A novel approach mutations in a cohort of patients with breast cancer (BC) who have
to reducing nurse caregiver burden and patient’s social isolation: A undergone tumor genomic profiling. Cancer Research. 2016;76(4 Suppl.)
pilot program utilizing volunteers on an adult hematologic transplant
unit. Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl. Gupta GP, Ho AY, Feng W, Fan C, Akram M, Brogi E, Powell SN, Perou
1):S448. CM, Wen YH, Petrini JHJ. Mre11 dysfunction is associated with triple-
negative breast cancer and confers sensitivity to DNA damaging
Green D, Zhu L, Chemaitilly W, Srivastava D, Kutteh W, Ke R, Sklar therapy. International Journal of Radiation Oncology, Biology,
C, Pui CH, Kun L, Ribeiro R, Robison L, Hudson M. Effect of cranial Physics. 2016;96(2 Suppl.):S43.
irradiation and alkylating agent chemotherapy on sperm concentration
of survivors of childhood ALL: A report from the St. Jude Lifetime Cohort Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P,
Study. Pediatric Blood and Cancer. 2016;63(Suppl. 3):S15. Beach JR, Hussey GS, Egelhoff TT, Howe PH, Hansel D. TGF beta is an
upstream regulator of mTORC2-dependent bladder cancer migration and
Groarke J, Mahmood SS, Jones LW, Klein J, Hainer J, Stevenson LW, invasion. Laboratory Investigation. 2016;96(Suppl. 1):454A.
Di Carli M, Mehra MR, Nohria A. Prevalence and functional significance
of cardiac autonomic dysfunction among women with breast Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P,
cancer. European Heart Journal. 2016;37(Suppl. 1):425. Beach JR, Hussey GS, Egelhoff TT, Howe PH, Hansel D. TGF beta is an
upstream regulator of mTORC2-dependent bladder cancer migration and
Grünwald V, Cella D, Nathan P, Doan J, Dastahi H, Taylor F, Bennett B, invasion. Modern Pathology. 2016;29(Suppl. 2):454A.
DeRosa M, Berry S, Broglio K, Berghorn E, Motzer RJ. Improvements
in quality of life and overall survival in patients with advanced Gur D, Batlevi C, Rapaport F, Wang L, Jungbluth A, Pichardo J, Arcila
renal cell carcinoma treated with nivolumab vs everolimus in ME, Zelenetz AD, Younes A, Dogan A. SNP arrays and targeted genomic
the phase Ill CheckMate 025 study. Oncology Research and sequencing identify distinctive genomic alterations in testicular diffuse
Treatment. 2016;39(Suppl. 3):265. large B-cell lymphoma. Laboratory Investigation. 2016;96(Suppl. 1):349A.
272 OF 324
Meeting Abstracts
Gur D, Batlevi C, Rapaport F, Wang L, Jungbluth A, Pichardo J, Arcila Hao X, Chang MT, Penson A V, Desai N, Iyer G, Reuter VE, Tickoo
ME, Zelenetz AD, Younes A, Dogan A. SNP arrays and targeted genomic SK, Gopalan A, Sirintrapun S, Fine S, Chen YB, Rosenberg JE, Schultheis
sequencing identify distinctive genomic alterations in testicular diffuse AM, Weigelt B, Scott SN, Cha EK, Bajorin DF, Berger MF, Bochner
large B-cell lymphoma. Modern Pathology. 2016;29(Suppl. 2):349A. BH, Dalbagni G, Solit DB, Taylor BS, Al-Ahmadie HA. Comprehensive
molecular analysis of small cell carcinoma of the bladder. Modern
Habtes I, Shah P, Harris B, Stover D, Feinstein M. Bronchoalveolar lavage Pathology. 2016;29(Suppl. 2):236A.
among hematopoietic stem cell transplant recipients: Diagnostic yield
and change in management. American Journal of Respiratory and Critical Hao X, Chang MT, Penson A V, Desai N, Iyer G, Reuter VE, Tickoo
Care Medicine. 2016;193 SK, Gopalan A, Sirintrapun SJ, Fine S, Chen YB, Rosenberg JE, Schultheis
AM, Weigelt B, Scott SN, Cha EK, Bajorin DF, Berger MF, Bochner
Hamlin P, Flinn I, Wagner-Johnston N, Burger J, Michelson G, Pandey BH, Dalbagni G, Solit DB, Taylor BS, Al-Ahmadie HA. Comprehensive
A, Birrell M, Coffey G, Leeds J, Sabalvaro-Torres A, Kim Y, Curnutte J, molecular analysis of small cell carcinoma of the bladder. Laboratory
Patel M. Phase 1 final results and phase 2a dose selection for cerdulatinib Investigation. 2016;96(Suppl. 1):236A.
(Prt062070) a dual SYK/JAK inhibitor in patients with relapsed/
refractory B cell malignancies. Haematologica. 2016;101(Suppl.):446. Harding JJ, Bendell JC, Fuchs CS, Wang XJ, Wacheck V, Zhu
AX. Emibetuzumab plus ramucirumab: Simultaneous targeting of MET and
Hammers HJ, Plimack ER, Infante JR, Rini B I, McDermott DF, Lewis VEGFR-2 in patients with advanced hepatocellular cancer in a phase 1b/2
LD, Voss MH, Sharma P, Pal SK, Razak A, Kollmannsberger C, Heng study. Journal of Clinical Oncology. 2016;34(4 Suppl.)
DYC, Spratlin J, McHenry MB, Gagnier P, Amin A. Updated results
from a phase I study of nivolumab in combination with ipilimumab Harmon S, Perk T, Eickhoff JC, Staab MJ, Choyke PL, Dahut WL, Apolo
in metastatic renal cell carcinoma: The CheckMate 016 study. BJU AB, Humm J, Larson SM, Morris MJ, Perlman S, Liu G, Jeraj R. [18F] NaF
International. 2016;118(Suppl. 5):20-21. PET/CT imaging biomarkers of progression-free survival in metastatic
prostate cancer. Journal of Clinical Oncology. 2016;34(2 Suppl.)
Hanson SM, Rodriguez L, Behr JM, Rizzi A, Parton DL, Beauchamp KA, Fass
JH, Prinz JH, Boyce SE, Seeliger MA, Levinson NM, Chodera JD. Dissecting Harshman LC, Kaag M, Efstathiou JA, Apolo AB, Hoffman-Censits JH,
the contribution of kinase conformational reorganization energies to Stadler WM, Yu EY, Bochner BH, Skinner EC, Downs T, Kiltie AE, Bajorin
inhibitor selectivity. Biophysical Journal. 2016;110(3 Suppl. 1):545A. DF, Guru K, Shipley WU, Steinberg GD, Hahn NM, Sridhar SS. Exploring
multidisciplinary practice patterns in the management of muscle invasive
Hao X, Al-Ahmadie HA, Gopalan A, Sirintrapun SJ, Fine S, Tickoo bladder cancer (MIBC) across the US and Canada in 2015. Journal of Clinical
SK, Reuter VE, Chen YB. Succinate dehydrogenase (SDH)-deficient Oncology. 2016;34(2 Suppl.)
renal cell carcinoma, a report of 7 cases with an emphasis on high grade
morphologic features. Laboratory Investigation. 2016;96(Suppl. 1):236A. Hauschild A, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D,
Hamid O, Ascierto PA, Testori A, Lorigan P, Dummer R, Sosman JA, Flaherty
Hao X, Al-Ahmadie HA, Gopalan A, Sirintrapun SJ, Fine S, Tickoo KT, Wongchenko MJ, Yan Y, Chang I, Coleman S, Caro I, McArthur GA. Impact
SK, Reuter VE, Chen YB. Succinate dehydrogenase (SDH)-deficient of key prognostic factors on long-term overall survival in BRAF(V600)-
renal cell carcinoma, a report of 7 cases with an emphasis on high grade mutated metastatic melanoma patients treated with vemurafenib in the
morphologic features. Modern Pathology. 2016;29(Suppl. 2):236A. BRIM-3 study. Melanoma Research. 2016;26(e-Suppl.):e39-e40.
273 OF 324
Meeting Abstracts
Hawley ST, Janz NK, Jagsi R, Griffith KA, Friese CR, Kurian AW, Morrow Hicks AM, O’Reilly EM, Capanu M, Lowery MA, Yu KH. Presentation,
M, Wallner LP, Katz SJ. Recurrence risk perception and quality of life after clinical behavior, outcomes and therapies for patients with advanced
treatment of breast cancer. Journal of Clinical Oncology. 2016;34(7 Suppl.) pancreas adenocarcinoma (PAC) who present with or develop
ascites. Journal of Clinical Oncology. 2016;34(4 Suppl.)
Hechtman J, Javier BM, Vakiani E, Shia J, Zehir A, Iacobuzio-Donahue
C. Recurrent, truncating SOX9 mutations are associated with KRAS Hillmen P, Ferra C, Garcia-Marco J, Jacob A, Jurczak W, Lamanna N,
and PI3K pathway mutations and may be oncogenic in colorectal MacDonald D, Marlton P, Mayer J, Morchauser F, Nathwani A, Schuh
carcinoma. Laboratory Investigation. 2016;96(Suppl. 1):455A. A, Stilgenbauer S, Wierda W, Ysebaert L, Adewoye A, Kim Y, Zelenetz
A, Delgado J. Idelalisib in combination with bendamustine/rituximab
Hechtman J, Javier BM, Vakiani E, Shia J, Zehir A, Iacobuzio-Donahue improves overall survival in patients with relapsed/refractory CLL:
C. Recurrent, truncating SOX9 mutations are associated with KRAS Interim results of a phase 3 randomized double-blind placebo-controlled
and PI3K pathway mutations and may be oncogenic in colorectal study. Haematologica. 2016;101(Suppl.):433.
carcinoma. Modern Pathology. 2016;29(Suppl. 2):455A.
Hissong E, Fernandes H, Zhang P, Klimstra D, Shia J, Yantiss RK. EBV
Heidegger S, Wintges A, Kreppel D, Bscheider M, Bek S, Fischer J, status and molecular alterations in gastric carcinomas with lymphoid
Schmickl M, Ruland J, van den Brink M, Peschel C, Haas T, Poeck stroma. Laboratory Investigation. 2016;96(Suppl. 1):175A.
H. Activation of the cytosolic RNA receptor RIG-I in tumor and immune
cells triggers efficient anti-tumor immunity and synergizes with checkpoint Hissong E, Fernandes H, Zhang P, Klimstra D, Shia JR, Yantiss RK. EBV
blockade. Oncology Research and Treatment. 2016;39(Suppl. 1):165. status and molecular alterations in gastric carcinomas with lymphoid
stroma. Modern Pathology. 2016;29(Suppl. 2):175A.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Puck J, Fleisher T,
Griffith LM, Kohn DB, Pulsipher MA, Shearer W, Hanson IC, Kapoor Hissong EM, Zhang P, Shia J, Yantiss RK, Fernandes H. Molecular
N, O’Reilly RJ, Boyer M, Pai SY, Parikh S, Goldman F, Burroughs L, prognosticators and structural variants in gastric carcinoma with
Marsh RA, Kletzel M, Thakar M, Connelly JA, Cuvellier G, Loechelt B, lymphoid stroma. Journal of Molecular Diagnostics. 2016;18(6):1013.
Shereck E, Knudsen A, Sullivan K, DeSantes K, Gillio AP, Haddad E,
Petrovic A, Quigg TC, Smith AR, Stenger E, Dvorak CC, Buckley RH. Poor Ho A, Wei G, Maneval EC, Esquibel V, Berger MF, Haque S, Patel R, Walsh
T cell reconstitution at 100 days after T cell-replete hematopoietic C, Hornby Z, Multani P, Li G, Drilon A. Overcoming drug resistance to Trk
cell transplantation (HCT) for SCID is associated with later risk of inhibition by rational combination of entrectinib and trametinib: From
death or need for 2nd transplant in the 6901 prospective study of the bench to bedside. European Journal of Cancer. 2016;69(Suppl. 1):S5-S6.
PIDTC. Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl.
1):S101-S102. Ho AY, Ballangrud A, Li G, Gupta G, Siu CT, Phung A, Forrest K, Freeman
N, Pei X, Powell SN. Early results of a pilot study of multibeam intensity
Herrera D, Perales MA, Shah G, Scordo M, Devlin S, Maloy M, Nieves modulated radiation therapy in breast cancer patients receiving
J, Avecilla S, Meagher R, Gyurkocza B, Castro-Malaspina H, Shaffer comprehensive nodal irradiation. International Journal of Radiation
B, Tamari R, Giralt S, Kosuri S. Acute toxicities in patients receiving ex- Oncology, Biology, Physics. 2016;96(2 Suppl.):E43-E44.
vivo CD34+ selected allogeneic stem cell transplantation for hematologic
malignancies. Bone Marrow Transplantation. 2016;51(Suppl. 1):S219. Ho C, Benayed R, Sukhadia P, Mullaney KA, Rios KM, Wang L, Berger
MF, Ladanyi M, Arcila ME. Detection of fusion transcripts in hematologic
274 OF 324
Meeting Abstracts
malignancies with archer FusionPlex, a targeted RNA-sequencing (RNA- Hoang L, McConechy M, Nakonechny Q, Leo JM, Cheng A, Leung S,
Seq) assay using next generation sequencing (NGS) technology. Journal Talhouk A, Lee CH, Kobel M, Huntsman DG, McAlpine JN, Soslow R, Gilks
of Molecular Diagnostics. 2016;18(6):962. B. Endometrial biopsies can be used reliably to predict final endometrial
carcinoma classification using both histopathologic and molecular based
Ho C, Gomez-Gelvez JC, Syed MH, Zehir A, Yu W, Baldi T, Ladanyi strategies. Modern Pathology. 2016;29(Suppl. 2):286A-287A.
M, Dogan A, Yao J, Nafa K, Arcila ME. Minimal residual disease
detection of lymphoid and plasma cell neoplasms using a next- Hobday T, Yin J, Pettinger A, Strosberg J, Reidy-Lagunes D,
generation sequencing (NGS)-based assay. Journal of Molecular Chen H, Erlichman C. Multicenter prospective phase II trial of
Diagnostics. 2016;18(6):961-962. bevacizumab (bev) for progressive pancreatic neuroendocrine tumor
(PNET). Pancreas. 2016;45(3):477.
Ho C, Mullaney K, OReilly C, Jour G, Sukhadia P, Wang L, Berger
MF, Arcila ME, Ladanyi M, Hameed M, Benayed R. Detection of Hoffman-Censits JH, Grivas P, Van der Heijden MS, Dreicer R, Loriot
sarcoma oncogenic fusion transcripts using Archer(TM) sequencing Y, Retz M, Vogelzang NJ, Perez-Gracia JL, Rezazadeh A, Bracarda S,
technology. Laboratory Investigation. 2016;96(Suppl. 1):18A. Yu EY, Hoimes CJ, Bellmunt J, Quinn D I, Petrylak DP, Hussain SA, Cui
N, Mariathasan S, Abidoye OO, Rosenberg JE. IMvigor 210, a phase
Ho C, Mullaney K, OReilly C, Jour G, Sukhadia P, Wang L, Berger II trial of atezolizumab (MPDL3280A) in platinum-treated locally
MF, Arcila ME, Ladanyi M, Hameed M, Benayed R. Detection of advanced or metastatic urothelial carcinoma (mUC). Journal of Clinical
sarcoma oncogenic fusion transcripts using Archer(TM) sequencing Oncology. 2016;34(2 Suppl.)
technology. Modern Pathology. 2016;29(Suppl. 2):18A.
Holtmaat K, Van der Spek N, Breitbart W, Cuijpers P, Verdonck de Leeuw
Hoang L, Kinloch MA, Grondin K, Lee CH, Ewanowich C, I. Moderators of the effect of meaning-centred group psychotherapy
Kobel M, Huntsman DG, McAlpine JN, Soslow R, Gilks B. Inter- for cancer survivors on meaning, psychological well-being, and
observer agreement in endometrial carcinoma (EC) diagnosis distress. Psycho-Oncology. 2016;25(Suppl. 3):62-63.
varies depending on TCGA subgroup assignment. Laboratory
Investigation. 2016;96(Suppl. 1):286A. Hoppe BS, Hill-Kayser CE, Tseng YD, Flampouri S, Elmongy
H, Cahlon O, Mendenhall NP, Maity A, McGee LA, Plastaras JP. The
Hoang L, Kinloch MA, Grondin K, Lee CH, Ewanowich C, Kobel M, use of consolidative proton therapy after first-line therapy among
Huntsman DG, McAlpine JN, Soslow R, Gilks B. Inter-observer agreement patients with Hodgkin lymphoma at academic and community
in endometrial carcinoma (EC) diagnosis varies depending on TCGA proton centers. International Journal of Radiation Oncology, Biology,
subgroup assignment. Modern Pathology. 2016;29(Suppl. 2):286A. Physics. 2016;96(2 Suppl.):S39.
Hoang L, McConechy M, Nakonechny Q, Leo JM, Cheng A, Leung S, Hsieh J, Chen D, Wang P, Chen Y, Marker M, Patel P, Chevinsky
Talhouk A, Lee CH, Kobel M, Huntsman DG, McAlpine JN, Soslow R, M, Bhanot U, Pinciroli P, Berger MF, Cheng E, Lee W, Knox JJ, Voss
Gilks B. Endometrial biopsies can be used reliably to predict final MH, Voi M, Motzer RJ. Differential overall survival (OS) results in
endometrial carcinoma classification using both histopathologic and RECORD-3 study based on three distinct mRCC molecular subgroups
molecular based strategies. Laboratory Investigation. 2016;96(Suppl. classified by BAP1 and/or PBRM1 mutations. Journal of Clinical
1):286A-287A. Oncology. 2016;34(2 Suppl.)
275 OF 324
Meeting Abstracts
Hsieh J, Chen D, Wang P, Chen YB, Mahtab M, Pate P, Bhanot U, Berger E, Jakubowski AA, Papanicolaou GA. Challenges of cytomegalovirus
M, Cheng E, Knox J, Voss M, Voi M, Motzer R. Differential overall survival (CMV) management after CD34+ selected, T-cell depleted (TCD)
results in RECORD-3 study based on three distinct clear cell metastatic hematopoietic cell transplantation (HCT): A five-year experience
renal cell carcinoma molecular subgroups classified by BAP1 and/or at Memorial Sloan Kettering. Biology of Blood and Marrow
PBRM1 mutations. BJU International. 2016;118(Suppl. 5):10. Transplantation. 2016;22(3 Suppl. 1):S172.
Hu G, Chen R, Deng X, Li Z, Mo L, Hao S, Shaw GM, Stevenson DK, Cohen Hyman D, Chatterjee M, Langenberg MHG, Lin CC, Suarez C, Tai D,
HJ, Jiang X, Sylvester KG, Ling XB. A multi-omics analysis of human Cassier P, Yamamoto N, De Weger VA, Jeay S, Meille C, Halilovic E,
nucleus-coded mitochondrial genes with mouse extraembryonic tissue/ Mariconti L, Guerreiro N, Kumar A, Wuerthner JU, Bauer S. Dose-
placenta phenotypes: Implications in mitochondria-mediated maternal and regimen-finding phase I study of NVP-HDM201 in patients (pts)
and fetal complications. Reproductive Sciences. 2016;23(1 Suppl.):320A. with TP53 wild-type (wt) advanced tumors. European Journal of
Cancer. 2016;69(Suppl. 1):S128-S129.
Hu W, Arpaia N, Bos PD, Green J, Rudensky A. Tissue repair function
of regulatory T cells during infection and cancer progression. Cancer Hyman DM, Piha-Paul SA, Rodón J, Saura C, Puzanov I, Shapiro G I, Loi
Immunology Research. 2016;4(Suppl.) S, Joensuu H, Hanrahan AJ, Modi S, Lalani AS, Xu F, Garza SJ, Cutler
RE, Bryce R, Meric-Bernstam F, Baselga J, Solit DB. Neratinib for ERBB2
Huang SC, Alaggio R, Sung YS, Agaram NP, Antonescu C. Frequent mutant, HER2 non-amplified, metastatic breast cancer: Preliminary
HRAS mutations in ectomesenchymoma (ECM): Overlapping genetic analysis from a multicenter, open-label, multi-histology phase II basket
abnormalities with embryonal rhabdomyosarcoma (ERMS). Laboratory trial. Cancer Research. 2016;76(4 Suppl.)
Investigation. 2016;96(Suppl. 1):463A.
Hyslop T, Alvarado M, Forero A, Golshan M, Hieken T, Horton J, Hudis
Huang SC, Alaggio R, Sung YS, Agaram NP, Antonescu C. Frequent C, McGuire K, Meric-Bernstam F, Nanda R, Zagar T, Hwang S. Treatment
HRAS mutations in ectomesenchymoma (ECM): Overlapping genetic outcomes in patients with invasive breast cancer treated with
abnormalities with embryonal rhabdomyosarcoma (ERMS). Modern neoadjuvant systemic therapy and breast MR imaging: Results of a
Pathology. 2016;29(Suppl. 2):463A. secondary analysis of TBCRC 017. Cancer Research. 2016;76(4 Suppl.)
Huang SC, Zhang L, Sung YS, Kao YC, Agaram NP, Antonescu Im EO, Ko Y, Chee E, Chee W, Mao JJ, Tsai HM. A cluster analysis
C. Recurrent novel CIC gene abnormalities in angiosarcoma: A molecular of cardiovascular symptoms experienced during menopausal
study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and transition. Menopause - The Journal of the North American Menopause
FLT4 gene alterations. Laboratory Investigation. 2016;96(Suppl. 1):18A. Society. 2016;23(12):1384.
Huang SC, Zhang L, Sung YS, Kao YC, Agaram NP, Antonescu Imnadze M, Sjoberg D, Lee J, Jenkins LC, Vickers A, Mulhall JP, Ehdaie
C. Recurrent novel CIC gene abnormalities in angiosarcoma: A molecular B. Improved recovery of erectile function in younger men after radical
study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, prostatectomy: Does it justify immediate intervention in low-risk
and FLT4 gene alterations. Modern Pathology. 2016;29(Suppl. 2):18A. patients?. Journal of Sexual Medicine. 2016;13(5 Suppl.):S24.
Huang YT, Kim SJ, Lee YJ, Burack D, Nicols P, Maloy M, Tamari Inoue Y, Kitaichi M, Akira M, Johkoh T, Hebisawa A, Yamadori I, Arai T,
R, Perales MA, Giralt SA, Castro-Malaspina H, Papadopoulos Sugimoto C, Matsumuro A, Hirose M, Tachibana K, Kasai T, Wallace W,
276 OF 324
Meeting Abstracts
Hansell D, Travis W. Idiopathic interstitial pneumonias: The roles of serial metastatic urothelial cancer (mUC): Efficacy (by PD-L1 expression) and
multidisciplinary discussions. Respirology. 2016;21(Suppl. 3):34. safety results from the CheckMate 032 study. Oncology Research and
Treatment. 2016;39(Suppl. 3):269.
Inoue Y, Kitaichi M, Akira M, Johkoh T, Hebisawa A, Yamadori I, Arai
T, Sugimoto C, Matsumuro A, Hirose M, Tachibana K, Kasai T, Wallace Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC, Hamilton
WD, Hansell DM, Travis WD. Diagnosis by multi disciplinary discussion AS, Katz SJ, Morrow M. Contralateral prophylactic mastectomy decision-
of idiopathic interstitial pneumonias in a real world; Japanese multi making in the population-based iCanCare study of early-stage breast
center cohort study. American Journal of Respiratory and Critical Care cancer patients. Journal of Clinical Oncology. 2016;34(7 Suppl.)
Medicine. 2016;193
Janku F, Murthy R, Wang-Gillam A, Shepard D, Helgason T, Henry
Irwin M, DeLince L, McMillan L. I’ll be there: Enhancing the patient T, Rudin C, Huang S, Sakamuri D, Solomon S, Collins A, Kreider B, Miller
experience during epidural placement. Journal of PeriAnesthesia M, Saha S, Tung D, Varterasian M, Zhang L, Zhang H, Gounder M. Phase
Nursing. 2016;31(4):e27. I clinical study of intratumoral injection of oncolytic Clostridium novyi-
NT spores in patients with advanced cancers. European Journal of
Iyengar NM, Argolo D, Smyth L, Chen MF, Hudis CA, Dang CT. Phase Cancer. 2016;69(Suppl. 1):S94.
II study of gemcitabine, trastuzumab, and pertuzumab in the
treatment of metastatic HER2-positive breast cancer after prior Javle MM, Shroff RT, Zhu A, Sadeghi S, Choo S, Borad MJ, Lowery
trastuzumab/pertuzumab- or pertuzumab-based therapy. Cancer MA, El-Khoueiry A, Macarulla T, Philip PA, Oh DY, Van Cutsem E, Yeh
Research. 2016;76(4 Suppl.) KH, Isaacs R, McGarry C, Sen S, Bekaii-Saab TS. A phase 2 study of
BGJ398 in patients (pts) with advanced or metastatic FGFR-altered
Jackisch C, Piccart MJ, Gelber RD, Procter M, Goldhirsch A, DeAzambuja cholangiocarcinoma (CCA) who failed or are intolerant to platinum-
E, Castro G Jr, Untch M, Smith I, Gianni L, Baselga J, Al-Sakaff N, Lauer S, based chemotherapy. Journal of Clinical Oncology. 2016;34(4 Suppl.)
McFadden E, Leyland-Jones B, Bell R, Dowsett M, Cameron D. HERA trial:
10 years follow up of trastuzumab after adjuvant chemotherapy in HER2 Jelinic P, Eccles L, Powell SN, Levine DA. EMSY impairs DNA damage
positive early breast cancer - Final analysis. Cancer Research. 2016;76(4 repair in a phosphorylation-dependent manner. Clinical Cancer
Suppl.) Research. 2016;22(2 Suppl.)
Jacquelot N, Enot D, Flament C, Vimond N, Blattner C, Pitt J, Yamazaki Jenkins L, Marcovich R, Gomez C. Urology chief resident perception of
T, Roberti MP, Daillère R, Vétizou M, Poirier-Colame V, Semeraro M, their residency training. Neurourology and Urodynamics. 2016;35(Suppl.
Caignard A, Slingluff CL, Sallusto F, Rusakiewicz S, Weide B, Marabelle A, 1):S28-S29.
Kohrt H, Dalle S, Cavalcanti A, Kroemer G, Di Giacomo AM, Maio M, Wong
P, Yuan J, Wolchok J, Umansky V, Eggermont A, Zitvogel L. Chemokine Jenkins LC, Nelson CJ, Mulhall JP. Assessing the impact of change in
receptor patterns in lymphocytes mirror metastatic spreading in penile rigidity on degree of penile curvature in men with Peyronie’s
melanoma. European Journal of Immunology. 2016;46(Suppl. 1):222-223. Disease (PD). Journal of Sexual Medicine. 2016;13(5 Suppl.):S57-S58.
Jaeger D, Sharma P, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai Jenkins LC, Nelson CJ, Mulhall JP. Impact of diabetes on erectile
RN, Ott PA, de Braud F, Morse M, Le D, Chan E, Harbison C, Lin CS, function recovery (EFR) after radical prostatectomy(RP). Journal of
Tschaika M, Azrilevich A, Rosenberg J. Nivolumab monotherapy in Sexual Medicine. 2016;13(5 Suppl.):S3.
277 OF 324
Meeting Abstracts
Jenkins LC, Udeh N, Nelson CJ, Mulhall JP. Preliminary data in a Kahn J, Mar B, Chu H, Graumann P, Zon R, Boettger K, Chu
longitudinal analysis of the psychological and relationship impact S, Armstrong S, Ebert B. Loss of function SETD2 mutations
of Peyronie’s Disease (PD). Journal of Sexual Medicine. 2016;13(5 lead to resistance to DNA damaging chemotherapy in
Suppl.):S55. leukemia. Haematologica. 2016;101(Suppl.):166-167.
Jhaveri K, Teplinsky E, Chandarlapaty S, Solit D, Cadoo K, Speyer Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, Helenowski I, Rigsby
J, D’Andrea G, Adams S, Patil S, Haque S, Friedman K, Neville D, Esteva C, Kessel S, Laurie F, Katzenstein H, Ulin K, Rademaker A, Followill D,
F, Hudis C, Modi S. A phase I trial of ganetespib (heat shock protein 90 Morano K, Marcus KJ, Esiashvili N, Wolden SL, Mahajan A, Fitzgerald
inhibitor) in combination with paclitaxel and trastuzumab in patients with T. Final report of a prospective clinical trial of cardiac sparing whole-
human epidermal growth factor receptor-2 positive (HER2+) metastatic lung intensity modulated radiation therapy in patients with metastatic
breast cancer (MBC). Cancer Research. 2016;76(4 Suppl.) pediatric tumors. International Journal of Radiation Oncology, Biology,
Physics. 2016;96(2 Suppl.):S118-S119.
Johnsen H, Hanrahan A, Jones A, Solit D. Functional characterization
of ERBB2 mutations and response to targeted therapies. Clinical Cancer Kane J, Coonerty E, Spellman-Foley P. “How sweet it is”: Taking
Research. 2016;22(1 Suppl.) the fear away from managing insulin infusions. Critical Care
Nurse. 2016;36(2):E32.
Jordan E, Basturk O, Leach SD, Klimstra DS, Allen PJ, Berger MF, Askan
G, Yu KH, O’Reilly EM, Lowery MA. Assessment of genomic alterations in Kao YC, Huang SC, Argani P, Chung C, Graf N, Alaggio R, Antonescu
adenosquamous carcinoma of the pancreas (ASCOP). Journal of Clinical C. Recurrent BCOR internal tandem duplication (ITD) and YWHAE-
Oncology. 2016;34(4 Suppl.) NUTM2B fusions in undifferentiated round cell sarcoma (URCS) of
infancy—Overlapping genetic features with clear cell sarcoma of kidney
Jour G, Zehir A, Gounder MM, Abdel-Wahab O, Casanova (CCSK). Laboratory Investigation. 2016;96(Suppl. 1):19A-20A.
J, Dogan A, Ladanyi M, Klimstra D, Arcila ME. Follicular dendritic
cell sarcomas: Insights into its molecular landscape. Laboratory Kao YC, Huang SC, Argani P, Chung C, Graf N, Alaggio R, Antonescu
Investigation. 2016;96(Suppl. 1):19A. C. Recurrent BCOR internal tandem duplication (ITD) and YWHAE-
NUTM2B fusions in undifferentiated round cell sarcoma (URCS) of
Jour G, Zehir A, Gounder MM, Abdel-Wahab O, Casanova J, Dogan A, Ladanyi infancy—Overlapping genetic features with clear cell sarcoma of kidney
M, Klimstra D, Arcila ME. Follicular dendritic cell sarcomas: Insights into (CCSK). Modern Pathology. 2016;29(Suppl. 2):19A-20A.
its molecular landscape. Modern Pathology. 2016;29(Suppl. 2):19A.
Karam I, Yao M, Heron DE, Poon I, Koyfman S, Yom SS, Siddiqui F,
Kachnic LA, Moughan J, Suntharalingam M, Ilson DH, Konski AA, Burrows Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo J, Lee VH,
W, Anker C, Bar Ad V, Thakrar H V, Hayes JP, Gore EM, Kavadi VS, Komaki Foote RL, Harter KWW, Lee N, Sahgal A, Lo SS. Consensus statement
RU, Raben A, Giguere JK, Pollock J, Greenberger JS, Videtic GM, Roof from the International Stereotactic Body Radiotherapy Consortium
KS, Bruner DW. Patient-reported outcomes (PROs) in NRG oncology/ for head and neck carcinoma—Patient selection and pre- and
RTOG 0436: A phase 3 trial evaluating the addition of cetuximab post-stereotactic body radiation therapy evaluation. International
to paclitaxel, cisplatin, and radiation for esophageal cancer treated Journal of Radiation Oncology, Biology, Physics. 2016;96(2
without surgery. International Journal of Radiation Oncology, Biology, Suppl.):E364-E365.
Physics. 2016;96(2 Suppl.):S31.
278 OF 324
Meeting Abstracts
Karam I, Yao M, Heron DE, Poon I, Koyfman S, Yom SS, Siddiqui F, Kernan N, Richardson P, Smith A, Triplett B, Grupp S, Antin J, Lehmann L,
Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo J, Lee VH, Liang W, Hume R, Hannah A, Soiffer R. Efficacy and safety of defibrotide
Foote RL, Harter KWW, Lee N, Sahgal A, Lo SS. Consensus statement (DF) in the treatment of hepatic veno-occlusive disease/sinusoidal
from the International Stereotactic Body Radiotherapy Consortium for obstruction syndrome (VOD/SOS) following chemotherapy in an ongoing
head and neck carcinoma—Technical factors. International Journal of study. Bone Marrow Transplantation. 2016;51(Suppl. 1):S478-S479.
Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E382-E383.
Kernan N, Richardson P, Smith A, Triplett B, Grupp S, Antin J, Lehmann L,
Karnezis A, Hoang L, Almadani N, Tessier-Cloutier B, Irving JA, Messinger Y, Liang W, Hume R, Hannah A, Soiffer R. Efficacy and safety
Djordjevic B, Soslow R, Huntsman DG, Gilks CB, Kobel M, Lee of defibrotide for treatment of hepatic veno-occlusive disease/sinusoidal
CH. Loss of SWI/SNF complex protein expression is associated obstruction syndrome (VOD/SOS) in adult and pediatric patients
with dedifferentiation in endometrial carcinomas. Laboratory following chemotherapy. Haematologica. 2016;101(Suppl.):414.
Kernan NA, Grupp SA, Banerjee K, Hannah AL, Hume R, Nejadnik B,
Karnezis A, Hoang L, Almadani N, Tessier-Cloutier B, Irving JA, Djordjevic Richardson PG. Pooled treatment analysis of pediatric patients with
B, Soslow R, Huntsman DG, Gilks CB, Kobel M, Lee CH. Loss of SWI/ defibrotide for hepatic veno-occlusive disease/sinusoidal obstruction
SNF complex protein expression is associated with dedifferentiation in syndrome and multi-organ dysfunction following hematopoietic stem
endometrial carcinomas. Modern Pathology. 2016;29(Suppl. 2):290A. cell transplant. Biology of Blood and Marrow Transplantation. 2016;22(3
Suppl. 1):S188-S189.
Kashan M, Ghanaat M, Becerra M, Chiok M, Hötker AM, Manley
B, Benfante N, Coleman J, Russo P, Akin O, Hakimi AA. Cystic renal Kernan NA, Richardson PG, Triplett BM, Grupp SA, Antin JH, Lehmann
cell carcinoma: Radiologic evaluation, management and clinical L, Liang W, Hume R, Hannah AL, Nejadnik B, Soiffer RJ. Defibrotide
outcomes. BJU International. 2016;118(Suppl. 5):19-20. for the treatment of patients with hepatic veno-occlusive disease/
sinusoidal obstruction syndrome with/without multi-organ
Kashikar S, Gelber Z, Bin X, Ozkaya N, Diamond E, Yom S, Estilo dysfunction following chemotherapy: Subset analysis results from an
C. Erdheim-chester disease presenting in the oral cavity: Report of ongoing expanded access program. Biology of Blood and Marrow
two cases and review of literature . Oral Surgery, Oral Medicine, Oral Transplantation. 2016;22(3 Suppl. 1):S188.
Pathology and Oral Radiology. 2016;122(5):e170.
Kernan NA, Richardson PG, Triplett BM, Grupp SA, Antin JH, Messinger
Kawabata KC, Hayashi Y, Inoue D, Mizuno H, Kitaura J, Tanaka Y, Y, Liang W, Hume R, Hannah AL, Soiffer RJ. Efficacy and safety of
Goyama S, Harada Y, Harada H, Aburatani H, Ishii M, Kitamura T. Higher defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal
expression of ATP-binding cassette transporter G2 (ABCG2) is specific obstruction syndrome (VOD/SOS) following chemotherapy. Pediatric
to advanced MDS and promotes inefficient hematopiesis via conversions Blood and Cancer. 2016;63(Suppl. 1):S92-S93.
of tumor microenvironments in mouse bone marrow transplantation
model. Experimental Hematology. 2016;44(9 Suppl.):S110. Kernan NA, Boulad F, Prockop SE, Scaradavou A, Kobos R, Lehrman
R, Klein E, Wolden S, Curran KJ, Hasan AN, Bleau S, Ruggiero JM, Zakak
Keller L, Taylor J. PET/CT guided interventions in oncologic patients: A N, Casson A, Torok-Castanza J, O’Reilly RJ. T- cell depleted peripheral
nursing perspective. Journal of Radiology Nursing. 2016;35(2):151. blood stem cell (TCD-PBSC) transplants secure consistent engraftment
279 OF 324
Meeting Abstracts
with low risk of acute or chronic GVHD and favorable disease free Kimbrell H, Clarke LE, Flake DD, Busam K, Cockerell CJ, Helm KF,
survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) McNiff JM, Reed JA, Tschen J, Kim J, Barnhill R, Elenitsas R, Prieto
with AML in CR1. Biology of Blood and Marrow Transplantation. 2016;22(3 VG, Nelson J, Kolquist KA, Brown K, Warf MB, Roa BB, Wenstrup
Suppl. 1):S251-S252. RJ. An independent validation of a gene expression signature to
differentiate malignant melanoma from benign melanocytic nevi. Modern
Kerns SL, Fung C, Williams A, Abu Zaid M I, Sesso HD, Feldman DR, Pathology. 2016;29(Suppl. 2):130A.
Hamilton RJ, Vaughn DJ, Beard C, Liu H, Herrmann D, Sahasrabudhe DM,
Fossa SD, Einhorn LH, Travis LB, The Platinum Study Group. Cumulative Kimmick G, Pitcher B, Mandelblatt J, Clapp J, Balman K, Barginear M,
burden of morbidity (CBM) among testicular cancer survivors (TCS) in Freedman R, Artz A, Klepin H, Lafky J, Hopkins J, Winer E, Hudis C, Muss
the Platinum Study. Journal of Clinical Oncology. 2016;34(3 Suppl.) H, Cohen H, Jatoi A, Hurria A. All-cause survival estimates compared to
observed survival in older women with breast cancer in CALGB 49907
Keske R, Armstrong GT, Davine J, Gibson TM, Mertens A, McDonald and 369901 (Alliance A151503). Cancer Research. 2016;76(4 Suppl.)
A, Marghoob AA, Daniel C, Geller A. Advancing survivors’ knowledge
(ASK) about skin cancer study: A randomized intervention within King M, Xiong G, Maxim PG, Diehn M, Loo BW, Xing L. Vesselness-based
the Childhood Cancer Survivor Study (CCSS). Journal of Clinical deformable registration algorithms can reduce landmark errors in the
Oncology. 2016;34(3 Suppl.) registration of pulmonary computed tomography images before and
after radiation therapy. International Journal of Radiation Oncology,
Khasraw M, Murphy C, Mukaro V, West L, White K, Brandt C, Baron- Biology, Physics. 2016;96(2 Suppl.):S227.
Hay SE, Collins I, Tobler R, Ashley DM, Patil S. Tailored neoadjuvant
epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound Knowles K, Glaser S. Survivor guilt in cancer survivorship: Existential,
paclitaxel (Nab-P) in breast cancer. Asia-Pacific Journal of Clinical emotional, and cognitive dimensions. Journal of Psychosocial
Oncology. 2016;12(Suppl. 4):44. Oncology. 2016;34(1-2):131-132.
Killian J, Arcila ME, Batlevi C, Ladanyi M, Meltzer P, Ptashkin R, Younes Knowles K. Creating clinically relevant program evaluations: A pilot
A. Utility of oral fluid (saliva) for molecular profiling in hematologic within post treatment survivorship programs. Journal of Psychosocial
malignancy. Laboratory Investigation. 2016;96(Suppl. 1):455A. Oncology. 2016;34(1-2):123-124.
Killian J, Arcila ME, Batlevi C, Ladanyi M, Meltzer P, Ptashkin R, Younes Kobos R, Egan G, Fischer C, Dunkel I, Khakoo Y, Gilheeney S, Shukla
A. Utility of oral fluid (saliva) for molecular profiling in hematologic N, Trippett T, Steinherz P, Kernan N. Response to vaccination in
malignancy. Modern Pathology. 2016;29(Suppl. 2):455A. childhood cancer survivors. Pediatric Blood and Cancer. 2016;63(Suppl.
1):S35.
Kimbrell H, Clarke LE, Flake DD, Busam K, Cockerell CJ, Helm KF,
McNiff JM, Reed JA, Tschen J, Kim J, Barnhill R, Elenitsas R, Prieto VG, Kodiyan J, Samstein R, Trichter S, Nedialkova L, Taube S, Sabbas
Nelson J, Kolquist KA, Brown K, Warf MB, Roa BB, Wenstrup RJ. An AM, Gupta D, Parashar B, Caputo TA, Holcomb KM, Nori D, Wernicke
independent validation of a gene expression signature to differentiate AG. Partial length vaginal brachytherapy for endometrial carcinoma
malignant melanoma from benign melanocytic nevi. Laboratory with high-risk features is as effective as full length with reduced
Investigation. 2016;96(Suppl. 1):130A. toxicity. International Journal of Radiation Oncology, Biology,
Physics. 2016;96(2 Suppl.):E288-E289.
280 OF 324
Meeting Abstracts
Koehne G, Kosuri S, Doubrovina ES, Orlando E, Giralt SA, Jungbluth CS, Scaradavou A, Shaffer B, Tamari R, van den Brink MRM, Young
AA, O’Reilly RJ. Targeting Wilms’ tumor 1 protein following CD34- JW, Ponce DM, Barker JN. High progression-free survival (PFS) in adult
selected allografts by adoptive transfer of donor-derived CTLs in double unit cord blood (dCB) transplant recipients with high risk disease
patients with advanced multiple myeloma. Biology of Blood and Marrow after a novel intermediate intensity conditioning regimen. Biology of
Transplantation. 2016;22(3 Suppl. 1):S141. Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S76-S77.
Kohutek ZA, Blasberg RG, Humm J, Blumberg LE, Brennan CW, Tabar Kosuri S, Wolff T, Lauer E, Byam C, Yoo Y, Davis E, Paulson J, Sideroff
V, Gutin PH, Beattie B, Rosenblum M, Huse JT, Schoder H, Beal K. [(18) M, Wells DS, Perales MA, Scaradavou A, Giralt SA, Ponce DM, Barker
F]-fluorocholine uptake correlates with pathologic evidence of recurrent JN. Prospective evaluation of cord blood (CB) and haplo-identical
tumor after SRS for brain metastases. International Journal of Radiation (haplo) donor availability reveals compromised donor access for both
Oncology, Biology, Physics. 2016;96(2 Suppl.):S181-S182. CB and haplo grafts in minority patients. Biology of Blood and Marrow
Transplantation. 2016;22(3 Suppl. 1):S371-S372.
Kollmeier M, Harneja N, Lin M, McBride SM, Zelefsky MJ. Salvage
brachytherapy for locally recurrent prostate cancer following definitive Kousteni S, Nakagawa M, Berman E. Genetic basis of the effects
radiation therapy. Journal of Clinical Oncology. 2016;34(2 Suppl.) of bone on hematopoietic aging and disease. Experimental
Hematology. 2016;44(9 Suppl.):S30.
Konno F, Bullock N, Riedel E, Aggarwal G, Akram M, Edelweiss
M. Establishing recommendations for Her2 staining in cytology cell block Kowanetz M, Koeppen H, Zou W, Mariathasan S, Hellmann M, Kockx M,
material. Laboratory Investigation. 2016;96(Suppl. 1):51A-52A. Chappey C, Kadel E, Smith D, Miley N, Leveque V, Funke R, Sandler A,
McCaffery I, Amler L, Chen D, Hegde P. PD-L1 as a predictive biomarker
Konno F, Bullock N, Riedel E, Aggarwal G, Akram M, Edelweiss for atezolizumab (MPDL3280A; anti-PDL1) in non-small cell lung cancer
M. Establishing recommendations for Her2 staining in cytology cell block (NSCLC). Cancer Immunology Research. 2016;4(Suppl.)
material. Modern Pathology. 2016;29(Suppl. 2):51A-52A.
Krebs S, Dunphy M, Humm J, Chaft J, Fredrickson J, Weber WA. Delayed
Korc-Grodzicki B, Sun SW, Shahrokni A, Alexander K, Kim SJ, McMillan 18F-FDG PET imaging can improve detection of lesions in patients
S, Bosl GJ. The role of a geriatrician in a cancer center. Journal of Clinical with advanced non-small cell lung cancer. European Journal of Nuclear
Oncology. 2016;34(3 Suppl.) Medicine and Molecular Imaging. 2016;43(1 Suppl.):S309.
Kosuri S, Gyurkocza B, Devlin SM, Maloy M, Ciolino C, Borrill Krepper M, Amit M, Gil Z, Shah J, Rothamel D, Scheer M, Patel S,
T, Jakubowski AA, Papadopoulos E, Castro-Malaspina H, Koehne Zoller J. Improvement in survival in patients with oral squamous cell
G, Perales MA, Giralt SA. Fractionated infusion of hematopoietic carcinoma. Oncology Research and Treatment. 2016;39(Suppl. 1):102.
progenitor cells (HPC) does not improve neutrophil recovery or survival
in patients undergoing allogeneic. Biology of Blood and Marrow Krull KR, Chemaitilly W, Li C, Cheung YT, Brinkman TM, Wilson CL,
Transplantation. 2016;22(3 Suppl. 1):S384-S385. Armstrong GT, Khan RB, Sabin ND, Srivastava D, Merchant T, Pui CH,
Robison LL, Hudson MM, Sklar CA. The impact of growth hormone
Kosuri S, Hilden P, Devlin SM, Yoo Y, Lauer E, Peled JU, Avecilla deficiency on neurocognitive function in adult survivors of childhood
S, Castro-Malaspina H, Dahi P, Giralt SA, Gyurkocza B, Jakubowski acute lymphoblastic leukemia treated with cranial radiation. Pediatric
AA, Meagher R, Papadopoulos E, Perales MA, Reich L, Sauter Blood and Cancer. 2016;63(Suppl. 3):S18.
281 OF 324
Meeting Abstracts
Krystel-Whittemore M, Brogi E, Bowser ZL, Dickler M, Hudis stem cells (Remestemcel-L) on clinical response and survival confirmed
C, Wen HY. Distant metastases in breast cancer patients with in a large cohort of pediatric patients with severe high-risk steroid
Oncotype Dx recurrence score lower than 18. Laboratory refractory acute graft versus host disease. Biology of Blood and Marrow
Investigation. 2016;96(Suppl. 1):52A. Transplantation. 2016;22(3 Suppl. 1):S59.
Krystel-Whittemore M, Brogi E, Bowser ZL, Dickler M, Hudis C, Wen Landtblom AR, Bower H, Andersson TML, Dickman PW, Bjorkholm M,
HY. Distant metastases in breast cancer patients with Oncotype Dx Kristinsson SY, Hultcrantz M. Increased risk of second malignancies
recurrence score lower than 18. Modern Pathology. 2016;29(Suppl. 2):52A. in patients with myeloproliferative neoplasms diagnosed in
Sweden 1973-2009. A population-based cohort study of 9,379
Kudva A, Kushner B, Modak S. Phase II study of arsenic trioxide in patients. Haematologica. 2016;101(Suppl.):6-7.
neuroblastoma and other paediatric solid tumors. Pediatric Blood and
Cancer. 2016;63(Suppl. 3):S198. Langenberg MH, Gluck L, Weger V, Frank R, Eskens F, Blay JY, Soria
JC, Chawla S, Gounder M, Wagner A, Zhang Y, Kambuj P, Loberg R,
Kugler MC, Loomis CA, Ramos J, Joyner AL, Rom WN, Rifkin DB, Munger Henary H. A phase I study of the MDM2 inhibitor AMG 232 in patients
J. Sonic hedgehog (SHH) signaling regulates myofibroblast function with advanced p53 wild type (p53WT) solid tumors or multiple
during alveolar septum formation in postnatal lung. American Journal of myeloma. European Journal of Cancer. 2016;69(Suppl. 1):S34.
Respiratory and Critical Care Medicine. 2016;193
LaPlant Q, Li JG, Venigalla P, Leeman JE, Setton J, Sherman
Kühn MW, Song E, Feng Z, Sinha A, Chen CW, Deshpande EJ, Higginson DS, McBride S, Riaz N, Lee N, Tsai CJ. Patterns of nodal
AJ, Cusan M, Farnoud NR, Koche R, Bradner JE, de Stanchina failure after intensity modulated radiation therapy for patients with
E, Vassiliou GS, Hoshii T, Armstrong SA. Targeting chromatin nasopharyngeal carcinoma. International Journal of Radiation Oncology,
regulators inhibits leukemogenic gene expression in NPM1 mutant Biology, Physics. 2016;96(2 Suppl.):E352-E353.
leukemia. Haematologica. 2016;101(Suppl.):323.
Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD,
Kühn MWM, Song E, Feng Z, Sinha A, Chen CW, Deshpande AJ, Cusan Wagstaff J, Hogg D, Hill A, Carlino MS, Wolter P, Lebbe C, Schachter J,
M, Farnoud NR, Koche RP, Bradner JE, De Stanchina E, Vassiliou Thomas L, Hassel JC, Lorigan P, Walker D, Jiang J, Hodi FS, Wolchok
GS, Hoshii T, Armstrong SA. Synergistic inhibition of chromatin modifiers JD. Efficacy and safety in key patient subgroups of nivolumab
reverses a leukemogenic gene expression program in NPM1 mutant (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in
leukemia. Oncology Research and Treatment. 2016;39(Suppl. 3):108. treatment-naive patients with advanced melanoma (MEL) (CheckMate
067). Oncology Research and Treatment. 2016;39(Suppl. 1):40.
Kumar A, Medlin E, Suidan R, Cobb L, Wu E, Ducie J, Dicksong L,
Rullo L, Bakkum-Gamez J. Gynecologic oncology providers’ attitudes Lastra RR, Park KJ, Schoolmeester J. Invasive stratified mucin-producing
and practices regarding sexuality in cancer survivors: A Gynecologic carcinoma and stratified mucin-producing intraepithelial lesion (SMILE):
Oncology Fellow Research Network (GOFRN) study. Gynecologic 15 cases presenting a spectrum of cervical neoplasia with description
Oncology. 2016;143(1):208. of a distinctive variant of invasive adenocarcinoma. Laboratory
Kurtzberg J, Prockop SE, Prasad VK, Chaudhury S, Teira P, Nemecek
ER, Horn B, Burke E, Hayes J, Skerrett D. Effect of human mesenchymal
282 OF 324
Meeting Abstracts
Lastra RR, Park KJ, Schoolmeester J. Invasive stratified mucin-producing Lee LH, Cavalcanti MS, Segal N, Hechtman J, Vakiani E, Klimstra
carcinoma and stratified mucin-producing intraepithelial lesion D, Shia JR. An intimate dance: Patterns and clinical relevance of
(SMILE): 15 cases presenting a spectrum of cervical neoplasia with PD-L1 and PD-1 expression in colorectal carcinoma. Laboratory
description of a distinctive variant of invasive adenocarcinoma. Modern Investigation. 2016;96(Suppl. 1):181A.
Lee LH, Cavalcanti MS, Segal N, Hechtman J, Vakiani E, Klimstra
Lazarev S, Todorov B, Tam J, Lee N, Gupta V, Bakst RL. Adjuvant D, Shia JR. An intimate dance: Patterns and clinical relevance
radiation in the TORS era - Is there a benefit to omitting the of PD-L1 and PD-1 expression in colorectal carcinoma. Modern
primary site?. International Journal of Radiation Oncology, Biology, Pathology. 2016;29(Suppl. 2):181A.
Lee LH, Ren B, Yantiss RK, Sadot E, Vakiani E, Hechtman J, Ivelja
Le DT, Bendell JC, Calvo E, Kim JW, Ascierto PA, Sharma P, Ott PA, Bono S, Stadler Z, Weiser M, Klimstra D, Shia JR. Diagnosing colorectal
P, Jaeger D, Evans TRJ, De Braud FG, Chau I, Christensen O, Harbison C, medullary carcinoma: Interobserver variability and clinicopathological
Lin CS, Janjigian YY. Safety and activity of nivolumab monotherapy in implication. Laboratory Investigation. 2016;96(Suppl. 1):182A.
advanced and metastatic (A/M) gastric or gastroesophageal junction
cancer (GC/GEC): Results from the CheckMate-032 study. Journal of Lee LH, Ren B, Yantiss RK, Sadot E, Vakiani E, Hechtman J, Ivelja
Clinical Oncology. 2016;34(4 Suppl.) S, Stadler Z, Weiser M, Klimstra D, Shia JR. Diagnosing colorectal
medullary carcinoma: Interobserver variability and clinicopathological
Leduc C, Tan KS, Tian SZ, Dogan S, Ladanyi M, Travis W, Rekhtman implication. Modern Pathology. 2016;29(Suppl. 2):182A.
N. Bilateral invasive mucinous adenocarcinomas (former mucinous
bronchioloalveolar carcinoma): Molecular analysis confirms Lee YJ, Kim SJ, Huang YT, Burack D, Papadopoulos EB, Jakubowski
intrapulmonary spread rather than separate primary tumors. Laboratory AA, Papanicolaou GA. Efficacy of brincidofovir (BCV) prophylaxis
Investigation. 2016;96(Suppl. 1):474A. against herpes simplex virus (HSV) and varicella zoster virus (VZV) in
hematopoietic cell transplantation (HCT) recipients. Biology of Blood
Leduc C, Tan KS, Tian SZ, Dogan S, Ladanyi M, Travis W, Rekhtman and Marrow Transplantation. 2016;22(3 Suppl. 1):S172-S173.
N. Bilateral invasive mucinous adenocarcinomas (former mucinous
bronchioloalveolar carcinoma): Molecular analysis confirms Leeman JE, Li JG, Venigalla P, Zumsteg ZS, Romesser PB, Katabi
intrapulmonary spread rather than separate primary tumors. Modern N, McBride S, Tsai CJ, Higginson DS, Sherman EJ, Roman BR, Riaz
Pathology. 2016;29(Suppl. 2):474A. N, Lee N. Patterns of regional nodal failure following intensity
modulated radiation therapy for head and neck squamous cell
Lee CH, Carlo M, Chen Y, Chaim J, Coskey D, Woo K, Voss M, Hsieh carcinoma. International Journal of Radiation Oncology, Biology,
J, Feldman D, Motzer R. Medullary renal cell carcinoma (RCC): Genomics Physics. 2016;96(2 Suppl.):E338.
and treatment outcomes. BJU International. 2016;118(Suppl. 5):6-7.
Leeman JE, Li JG, Venigalla P, Romesser PB, Zumsteg ZS, McBride
Lee DJ, Najari BB, Schulster ML, Bach P V, Kashanian JA, Paduch SM, Tsai CJ, Higginson DS, Katabi N, Boyle JO, Roman BR, Sherman
DA, Mulhall JP, Chughtai B, Lee RK. National trends in the diagnosis EJ, Lee N, Riaz N. Comparison of outcomes following recurrence or
and management of psychogenic erectile dysfunction. Journal of Sexual metastasis in HPV+ and HPV- oropharyngeal carcinoma treated with
Medicine. 2016;13(5 Suppl.):S26-S27.
283 OF 324
Meeting Abstracts
definitive chemoradiation using IMRT. International Journal of Radiation Levine DA, Schlappe B. Molecular characterization of mucinous ovarian
Oncology, Biology, Physics. 2016;96(2 Suppl.):E355. carcinoma. Clinical Cancer Research. 2016;22(2 Suppl.)
Leeman JE, Li JG, Venigalla P, Romesser PB, Zumsteg ZS, McBride Levine DA, Schlappe B. Molecular characterization of mucinous ovarian
SM, Tsai CJ, Higginson DS, Katabi N, Boyle JO, Roman BR, Sherman carcinoma. Clinical Cancer Research. 2016;22(2 Suppl.)
EJ, Lee N, Riaz N. Natural history following recurrence after definitive
locoregional treatment in 1000+ cases of locally advanced head and neck Levy J, Saviola A, Halaban R, Bacchiocchi A, Magro C, Saab J, Merghoub
squamous cell carcinoma. International Journal of Radiation Oncology, T, Zhou D, Zippin JH. Loss of soluble adenylyl cyclase is a marker
Biology, Physics. 2016;96(2 Suppl.):E383-E384. of invasive melanoma and facilitates melanomagenesis. Journal of
Investigative Dermatology. 2016;136(5 Suppl. 1):S111.
Leeman JE, Rimner A, Montecalvo J, von Reibnitz D, Panchoo
K, Travis W, Adusumilli P, Wu AJ. Histologic subtype of early-stage Liedtke M, Comenzo RL, Landau H, Sanchorawala V, Weiss B, Zonder
lung adenocarcinoma predicts failure patterns in patients treated with J, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie SD, Liu E, Gertz
stereotactic body radiation therapy. International Journal of Radiation MA. NEOD001 demonstrates cardiac responses in patients with light
Oncology, Biology, Physics. 2016;96(2 Suppl.):S11. chain amyloidosis and persistent organ dysfunction in a phase 1/2 study
expansion. Journal of Cardiac Failure. 2016;22(8 Suppl.):S64.
Lendvai N, Vij R, Martin TG, Baz R, Campana F, Mazuir F, Charpentier E,
Benson DM. A phase IB dose-escalation trial of isatuximab (SAR650984, Liedtke M, Comenzo RL, Landau H, Sanchorawala V, Weiss BM, Zonder
anti-CD38 MAB) plus lenalidomide and dexamethasone in relapsed/ JA, Walling J, Kinney GG, Koller M, Gertz MA. NEOD001 demonstrates
refractory multiple myeloma (RRMM): Interim results from 2 new dose cardiac biomarker responses in patients with light chain amyloidosis
cohorts. Haematologica. 2016;101(Suppl.):84. and persistent organ dysfunction: Results from the expansion phase of a
phase 1/2 study. European Heart Journal. 2016;37(Suppl. 1):220.
Leo MB, King K, McGlynn C, Donlon D, Kenworthy L, Hanley M. Quiet!
Noise reduction on a hematology oncology unit. Oncology Nursing Liedtke M, Comenzo RL, Landau H, Seldin D, Weiss B, Zonder J, Walling
Forum. 2016;43(2):107-108. J, Kinney G, Koller M, Gertz MA. Neod001 demonstrates renal biomarker
responses in a phase 1/2 study in patients with immunoglobulin light
Lerner SP, Kim J, Kwiatkowski DJ, Getz G, Weinstein JN, Cherniack A, chain amyloidosis and persistent renal dysfunction. Nephrology Dialysis
Guo G, Akbani R, Hoadley KA, Kim WY, Robertson G, Mungall AJ, Hinoue Transplantation. 2016;31(Suppl.):103.
T, Laird PW, Al-Ahmadie H, Rosenberg JE, Bellmunt J, Bajorin DF, Hansel
DE, Creighton CJ, TCGA Bladder Cancer Working Group. Comprehensive Lin M, Panditharatna E, Kambhampati M, Ho CY, Magge S, Keating R,
characterization of 412 muscle invasive urothelial carcinomas: Final Packer R, Souweidane M, Nazarian J. Topographic histological and
analysis of The Cancer Genome Atlas (TCGA) project. Journal of Clinical molecular studies of diffuse intrinsic pontine glioma treated with
Oncology. 2016;34(2 Suppl.) convection enhanced delivery. Neuro-Oncology. 2016;18(Suppl. 3):iii69.
LeVasseur N, Clemons MJ, Mazzarello S, Vandermeer L, Jones L, Lin O, Scott SN, Bouvier N, Lin CM, Bochner BH, Berger MF. Genetic
Joy AA, Smith S, Hutton B, Hilton JF. Weight control strategies alterations detected in urine cytology specimens from patients with
in breast cancer patients: A systematic review. Journal of Clinical high risk non-muscle invasive urothelial carcinoma treated with
Oncology. 2016;34(3 Suppl.) BCG. Laboratory Investigation. 2016;96(Suppl. 1):107A.
284 OF 324
Meeting Abstracts
Lin O, Scott SN, Bouvier N, Lin CM, Bochner BH, Berger MF. Genetic with trastuzumab and paclitaxel in women with HER2-positive,
alterations detected in urine cytology specimens from patients with high PIK3CA mutant and PIK3CA wild-type primary breast cancer -
risk non-muscle invasive urothelial carcinoma treated with BCG. Modern NeoPHOEBE. Cancer Research. 2016;76(4 Suppl.)
Lok BH, Feng Y, Gardner EE, Yu GK, Ru YK, Riaz N, deStanchina
Lindau ST, Abramsohn EM, Carpenter K, Carter J, Faubion S, Feltmate E, Powell SN, Shen YJ, Poirier JT, Rudin CM. SLFN11 is necessary for
C, Flynn K, Haseotes D, Jeffery D, Jhingran A, Joslin I, Kennedy V, single agent sensitivity to talazoparib, a potent PARP inhibitor, but not
Kushner D, Lynn M, Mumby P. Development of a harmonized multi-site, for radiosensitization in small cell lung cancer (SCLC) cell lines and
prospective research registry to accelerate evidence-based treatment patient-derived xenografts (PDX). International Journal of Radiation
of sexual disorders in women and girls with cancer. Journal of Sexual Oncology, Biology, Physics. 2016;96(2 Suppl.):S75.
Medicine. 2016;13(6):S261.
Lok BH, Cai X, Riaz N, Leeman JE, Tsai CJ, McBride SM, Higginson
Lindemans CA, Calafiore M, O’Connor M, Mertelsmann A, van den Brink DS, Baxi SS, Sherman EJ, Roman BR, Wong RJ, Lee N. Irradiation
MRM, Hanash AM. Interleukin-22 treatment promotes intestinal stem for regionally only recurrent, never-irradiated oral cavity
cell mediated epithelial regeneration via Stat3 activation and reduces GI cancers. International Journal of Radiation Oncology, Biology,
GVHD. Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl. Physics. 2016;96(2 Suppl.):E368.
1):S56-S57.
Lok BH, Chelius MR, Yahalom J. Langerhans cell histiocytosis
Livingston V. “Avoid the cracks”: Enhanced communication across the (LCH) in the modern era: Excellent local control with radiation
disciplines as part of the WOC nurse preoperative preparation of the therapy (RT). International Journal of Radiation Oncology, Biology,
client with a total pelvic exenteration. Journal of Wound Ostomy and Physics. 2016;96(2 Suppl.):E494.
Continence Nursing. 2016;43(3 Suppl.):S65.
Long G, Larkin J, Ascierto P, Hodi S, Rutkowski P, Chiarion-Selini V, Hassel
Lockney N, Yang TJ, Chan T, Yamada Y, Beal K. PIK3 mutations J, Lebbe C, Pavlick A, Wagstaff J, Schadendorf D, Dummer R, Hogg
are associated with increased local failure in patients with brain D, Haanen J, Corrie P, Hoeller C, Horak C, Wolchok J, Robert C. PD-L1
metastases treated with stereotactic radiation. Journal of Radiation expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI)
Oncology. 2016;5(2):112-113. and nivo alone in advanced melanoma (MEL): A pooled analysis. Asia-
Pacific Journal of Clinical Oncology. 2016;12(Suppl. 5):126.
Lockney NA, Pei X, Blumberg LE, Chan TA, Yamada Y, Yang
TJ, Beal K. PIK3CA activating mutations are associated with Lowe MC, Son S, Strong VE, Coit DG, Yoon S, Park D. Overall survival
decreased local control in lung cancer brain metastases treated after surgical resection of diffuse type gastric adenocarcinoma
with radiation. International Journal of Radiation Oncology, Biology, is equivalent in Caucasians and Asians. Annals of Surgical
Physics. 2016;96(2 Suppl.):S178-S179. Oncology. 2016;23(1 Suppl.):S169.
Loibl S, de la Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Lowe MC, Chou JF, Capanu M, Coit DG. Evaluation of the effects
Rezai M, Bermejo B, Lee SC, Turri S, Urban P, Kummel S, Lux M, Piccart of neoadjuvant therapy on stage specific outcome estimates in
M, von Minckwitz G, Baselga J, Loi S. Phase II, randomized, parallel- patients with completely resected gastric cancer. Journal of Clinical
cohort study of neoadjuvant buparlisib (BKM120) in combination Oncology. 2016;34(4 Suppl.)
285 OF 324
Meeting Abstracts
Lowe T, Ng V, Horlick M. Using the modified Iowa Model to implement Luis I V, O’Neill A, Sepucha K, Miller KD, Baker E, Dang CT, Northfelt DW,
text message appointment reminders in a pediatric and maternal home Winer EP, Sledge GW, Schneider BP, Partridge A. Survival benefit needed
care population. Nursing Research. 2016;65(2):E82. to undergo chemotherapy: Patients and physicians preferences. Cancer
Lowery MA, Goff LW, Jordan E, Wang R, Bocobo AG, Chou JF, O’Reilly
EM, Harding JJ, Kemeny NE, Capanu M, Griffin A, McGuire JP, Venook Lynch S. The future is here: What you need to know about
AP, Abou-Alfa GK, Kelley RK. Second-line chemotherapy (CTx) biosimilars. Oncology Nursing Forum. 2016;43(2):95-96.
outcomes in advanced biliary cancers (ABC): A retrospective multicenter
analysis. Journal of Clinical Oncology. 2016;34(4 Suppl.) Ma J, Setton J, Albornoz PBC, Barker CA, Lok BH, Beal K, Powell SN, Lee
N, Chan TA, Riaz N. Genomic analysis of exceptional responders to low-
Lowery MA, You D, Samoila A, Peerschke E, Viale A, Patel R, Selcuklu dose radiation therapy reveals somatic mutations in ATM. International
D, Rusek M, Cercek A, Kemeny N, Harding J, Mellinghoff I, Tap W, Abou- Journal of Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):S196.
Alfa GK, Moynahan M. Detection of IDH1 mutations in circulating
free DNA in patients with cholangiocarcinoma. European Journal of Macarulla T, Tabernero J, Palmer DH, Sharma S, Yu KH, Sellami
Cancer. 2016;69(Suppl. 1):S141-S142. DB, Zhou J, Yi W, Boss H, Kwak EL. A phase Ib dose escalation,
safety, and tolerability study of sonidegib in combination with
Lu LF, Cho S, Wu CJ, Yasuda T, Cruz LO, Khan AA, Lin LL, Nguyen gemcitabine in patients with locally advanced or metastatic pancreatic
DT, Miller M, Lee HM, Kuo ML, Broide DH, Rajewsky K, Rudensky adenocarcinoma. Journal of Clinical Oncology. 2016;34(4 Suppl.)
AY. MiR-23~27~24 clusters control effector T cell differentiation and
function. Journal of Immunology. 2016;196(1 Suppl.) Mahmoud Omee, Green WR, Chokshi R, Jabbour SK, Alektiar
KM. Survival outcome and radiation therapy utilization pattern in
Lu SH, Tan KS, Kadota K, Eguchi T, Bains S, Adusumilli P, Travis abdominal nonretroperitoneal sarcoma: A national cancer data
W. Spread through air spaces (STAS) is an independent predictor base analysis. International Journal of Radiation Oncology, Biology,
of recurrence in lung squamous cell carcinoma. Laboratory Physics. 2016;96(2 Suppl.):E713.
Mahmoud Omee, Tunceroglu AS, Benevenia J, Kathleen B, Patterson
Lu SH, Tan KS, Kadota K, Eguchi T, Bains S, Adusumilli P, Travis W. Spread F, Chokshi R, Parikh RR, Alektiar KM. Juggling chemotherapy and/or
through air spaces (STAS) is an independent predictor of recurrence in radiation therapy in the perioperative management of large high-grade
lung squamous cell carcinoma. Modern Pathology. 2016;29(Suppl. 2):475A. soft tissue sarcoma: The debate continues. International Journal of
Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):S24-S25.
Lu Z, Orozco AF, Yang H, Sutton MN, Wang Y, Mao W, Levine DA, Bast
RC Jr. Survival of ARHI-induced dormant autophagic cell death in Mamtani A, Barrio A, King TA, Plitas G, Van Zee KJ, Pilewskie M, El-
vivo requires permissive levels of VEGF, IL-8, and IGF-1 in the tumor Tamer MB, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody
microenvironment. Clinical Cancer Research. 2016;22(2 Suppl.) HS 3rd, Morrow M. How often does neoadjuvant chemotherapy
avoid axillary dissection in patients with histologically confirmed
Lubimov E, Srikumar C, Rojas C, Llerandi D, Miale-Mayer D, Dowling nodal metastases? Results of a prospective study. Annals of Surgical
M. Chemotherapy admissions: An opportunity to improve the patient Oncology. 2016;23(1 Suppl.):S15.
experience. Oncology Nursing Forum. 2016;43(2):20.
286 OF 324
Meeting Abstracts
Mamtani A, van Zee KJ, Cody HS 3rd, Pilewskie M, Barrio A, Heerdt cell carcinoma to provide new perspectives. Journal of Clinical
AS, Patil S, Morrow M. Age and receptor status do not indicate the need Oncology. 2016;34(2 Suppl.)
for axillary dissection in patients meeting ACOSOG Z0011 criteria. Annals
of Surgical Oncology. 2016;23(1 Suppl.):S52-S53. Manley P, Trippett T, Smith AA, Macy ME, Leary SE, Boklan J, Cohen
KJ, Goldman S, Kilbrun LB, Dhall G, Devin J, Herzog CE, Bernard JP, Chi
Mandelker D, Li Y, Prasad M, Syed A, Balakrishnan AR, Chandramohan SN. Phase 2 study of cabazitaxel in paediatric patients with recurrent
R, Delair D, Argueta S, Yang C, Arnold A, Walsh M, Stadler Z, Robson or refractory high grade glioma or diffuse instrinsic pontine glioma: A
M, Offit K, Berger M, Zehir A, Ladanyi M, Zhang L. A two-for-one poetic group study. Pediatric Blood and Cancer. 2016;63(Suppl. 3):S9.
deal: Detecting germline cancer predisposition variants concurrently
with tumor somatic mutations in 777 patients analyzed by MSK- Mannan AASR, Hernandez-Prera JC, Antonescu C, Bacchi CE, Falconieri
IMPACT. Journal of Molecular Diagnostics. 2016;18(6):938. G, Cataldi P, Wenig BM. Sinonasal tract cribriform adenocarcinoma of
minor salivary glands (CAMSG): Description of a recently recognized
Manders P, Joshua AM, Kefford R, Robert C, Ribas A, Hamid O, Daud neoplasm in a previously unrecognized anatomic location. Laboratory
A, Wolchok JD, Hwu WJ, Weber JS, Gangadhar TC, Joseph R, Dronca Investigation. 2016;96(Suppl. 1):326A.
R, Patnaik A, Zarour H, Hersey P, Li XN, Diede SJ, Ebbinghaus S, Hodi
FS. Three-year overall survival for patients with advanced melanoma Mannan AASR, Hernandez-Prera JC, Antonescu C, Bacchi CE, Falconieri
treated with pembrolizumab in KEYNOTE-001. Asia-Pacific Journal of G, Cataldi P, Wenig BM. Sinonasal tract cribriform adenocarcinoma of
Clinical Oncology. 2016;12(Suppl. 4):47-48. minor salivary glands (CAMSG): Description of a recently recognized
neoplasm in a previously unrecognized anatomic location. Modern
Manley B, Pal S, Shapiro M, Dixon A, Wells JC, Ruiz-Morales JM, Choueiri Pathology. 2016;29(Suppl. 2):326A.
T, Heng D, Gore J. CLOVIS: Clinical outcomes visualization of IMDC
criteria in metastatic renal cell carcinoma for patient-centered decision Marchio C, Ng CKY, Piscuoglio S, Schultheis AM, Guerini-Rocco
making. BJU International. 2016;118(Suppl. 5):5. E, Cupo M, Geyer FC, Sapino A, Weigelt B, Reis JS. The genetic
landscape of neuroendocrine breast carcinomas. Laboratory
Manley B, Casuscelli J, Tennenbaum D, Hakimi AA, Hsieh J. Analysis Investigation. 2016;96(Suppl. 1):56A.
of mutational status in recurrently mutated genes in clear cell renal cell
carcinoma and overall survival in patients with metastatic disease at time Marchio C, Ng CKY, Piscuoglio S, Schultheis AM, Guerini-
of nephrectomy. Journal of Clinical Oncology. 2016;34(2 Suppl.) Rocco E, Cupo M, Geyer FC, Sapino A, Weigelt B, Reis JS. The
genetic landscape of neuroendocrine breast carcinomas. Modern
Manley B, Reznik E, Becerra M, Casuscelli J, Tennenbaum Pathology. 2016;29(Suppl. 2):56A.
D, Ghanaat M, Kashan M, Redzematovic A, Sato Y, Arcila M, Voss
M, Feldman D, Motzer R, Russo P, Coleman J, Hsieh J, Hakimi Margolis J, Princic N, Doan J, Lenhart G, Motzer RJ. Analysis of real-
A. Characterizing recurrent and lethal small renal masses in clear world treatment adherence in a cohort of 2,395 patients with metastatic
cell renal cell carcinoma using recurrent somatic mutations. BJU renal cell carcinoma (mRCC). Journal of Clinical Oncology. 2016;34(2
International. 2016;118(Suppl. 5):4-5. Suppl.)
Manley B, Tennenbaum D, Casuscelli J, Hsieh J. Assessing the Martelotto LG, Baslan T, Kendall J, Rodgers L, Cox H, King TA, Weigelt
frequency of somatic mutations in high-risk clear cell renal B, Hicks J, Reis-Filho JS. Single cell sequencing analysis of formalin-
287 OF 324
Meeting Abstracts
fixed paraffin-embedded ductal carcinomas in situ and invasive breast ultra-low density cancer epitopes. Clinical Lymphoma, Myeloma and
cancers reveals clonal selection in the progression from in situ to invasive Leukemia. 2016;16(Suppl. 2):S8.
disease. Cancer Research. 2016;76(4 Suppl.)
Mathias MD, Abramson D, Riedel E, Marr B, Francis J, Brodie SE,
Martin PL, Steinbach G, Chen AR, Krishnan A, Kernan NA, Avigan DE, Gobin YP, Dunkel IJ. Ophthalmic artery chemosurgery for intraocular
Spitzer TR, Richardson PG. Pooled dose response analysis of defibrotide retinoblastoma: Are three agents better than one?. Pediatric Blood and
in >1600 patients for the treatment of hepatic veno-occlusive disease/ Cancer. 2016;63(Suppl. 3):S94.
sinusoidal obstruction syndrome. Biology of Blood and Marrow
Transplantation. 2016;22(3 Suppl. 1):S337-S338. Mauro M, McGarry L, Inguilizian A, du Moulin R, Huang H. A chart
review of lower dosing of ponatinib in patients with chronic myeloid
Martinez-Barricarte R, Kong XF, Kennedy J, Lazarov T, Deenick E, leukemia (CML): Preliminary findings. Clinical Lymphoma, Myeloma and
Ma C, Mele F, Trouillet C, Bousfiha A, Aytekin C, Picard C, Salem S, Leukemia. 2016;16(Suppl. 2):S57-S58.
Langlais D, Lasseau T, Migaud M, Abel L, Boisson-Dupuis S, Hambleton
S, Schroder B, Geissmann F, Tangye S, Sallusto F, Bustamante J, Mauro M, McGarry L, Inguilizian A, du Moulin R, Huang H. Preliminary
Gros P, Casanova JL. Mycobacterial disease and myeloid dendritic findings from a chart review of lower dosing of ponatinib in chronic myeloid
cells defects in patients with SPPL2a deficiency. European Journal of leukemia (CML) patients. Haematologica. 2016;101(Suppl.):458-459.
Immunology. 2016;46(Suppl. 1):777-778.
Mauro M, McGarry L, Yang M, Lustgarten S, Huang H. Ponatinib
Marty FM, Winston DJ, Chemaly RF, Boeckh MJ, Mullane KM, Shore therapy for Philadelphia-positive ALL (Ph+ ALL) patients: Real-world
TB, Papanicolaou GA, Morrison ME, Brundage TM, Mommeja- clinical practice vs the PACE trial. Clinical Lymphoma, Myeloma and
Marin H. Brincidofovir for prevention of cytomegalovirus (CMV) Leukemia. 2016;16(Suppl. 2):S5-S6.
after allogeneic hematopoietic cell transplantation (HCT) in CMV-
seropositive patients: A pandomized, double-blind, placebo- Mauro M, McGarry L, Yang M, Lustgarten S, Huang H. The PACE
controlled, parallel-group phase 3 trial. Biology of Blood and Marrow clinical trial vs the real-world: Comparison of ponatinib prescribing
Transplantation. 2016;22(3 Suppl. 1):S23. and duration of therapy in chronic-phase chronic myeloid
leukemia (CP-CML) patients. Clinical Lymphoma, Myeloma and
Marziliano A, Pessin H, Moyer A, Fenn N, Rosenfeld B, Breitbart Leukemia. 2016;16(Suppl. 2):S58.
W. Predicting patient preferences for individual meaning-centered
psychotherapy. Psycho-Oncology. 2016;25(Suppl. 3):156. Mauro M, McGarry LJ, Yang M, Lustgarten S, Huang H. Characteristics of
ponatinib therapy for Philadelphia-positive acute lymphoblastic leukemia
Mass E, Ballesteros I, Farlik M, Halbritter F, Klughammer J, Bock (Ph + ALL) patients in real-world clinical practice compared to the pace
C, Geissmann F. Establishment of tissue-resident macrophage core trial. Haematologica. 2016;101(Suppl.):355.
and tissue specific programs during embryogenesis. Journal of
Immunology. 2016;196(1 Suppl.) Mauro M, McGarry LJ, Yang M, Lustgarten S, Huang H. Comparison
of pace clinical trial vs real-world ponatinib prescribing and duration
Mathias M, Sockolosky J, Chang A, Liu C, Garcia K, Scheinberg D. CD47 of therapy in chronic-phase chronic myeloid leukemia (CP-CML)
blockade enhances therapeutic activity of TCR mimic antibodies to patients. Haematologica. 2016;101(Suppl.):458.
288 OF 324
Meeting Abstracts
Mazzola C, Teloken PE, Matsushita K, Nelson CJ, Mulhall JP. Orgasm in Van der Kogel AJ. Spinal nerve tolerance to single-session stereotactic
men on androgen deprivation therapy (ADT) for prostate cancer. Journal ablative radiation therapy (SABR). International Journal of Radiation
of Sexual Medicine. 2016;13(5 Suppl.):S50. Oncology, Biology, Physics. 2016;96(2 Suppl.):S216.
McArthur HL, Page D, Proverbs-Singh T, Solomon S, Hudis C, Norton Mehta D, Patel A, Sao R, Gollapudi LA, Chugh P, Sharma NH, Simoes
L, Patil S, Barrett JA, Lebel F. Phase 1b/2 study of intratumoral P, Patel S, Busayavalasa D, Sanaka MR. National trends of endoscopic
Ad-RTS-hIL-12 + veledimex in patients with chemotherapy- retrograde cholangiopancreatography utilization and outcomes In
responsive locally advanced or metastatic breast cancer. Cancer decompensated cirrhosis. Gastrointestinal Endoscopy. 2016;83(5
Research. 2016;76(4 Suppl.) Suppl.):AB249.
McCabe MS, Economou D, Grant M. Preparing nurses for cancer Melchiori L, Lowther DE, Binder-Scholl GK, Williams DD, Peretz Y, Fortin
survivorship care. Journal of Clinical Oncology. 2016;34(3 Suppl.) M, Tap WD, Rapoport AP, Mackall CL, Jakobsen BK. Deep phenotyping
of manufactured enhanced-affinity NY-ESO-1-specific T cells reveals
McCartan D, Eaton A, Stempel M, Morrow M, Pilewskie M. Does a pattern of effector and memory programming that correlates
body mass index affect the accuracy of preoperative clinical axillary with clinical outcome in observed cancer indications. Molecular
nodal assessment in breast cancer patients?. Annals of Surgical Therapy. 2016;24(Suppl. 1):S75.
Oncology. 2016;23(Suppl. 3):105-106.
Mendez LC, Moraes FY, Suh JH, Taunk NK, Souhami L, Slotman
McMillan S, Grodzicki BK, Shahrokni A. Building a BJ, Weltman E, Marta GN Sr. Trial sponsorship and self-reported
comprehensive educational model for nurse practitioner conflicts of interest in clinical trials of central nervous system
students in geriatric oncology. Journal of the American Geriatrics malignancies. International Journal of Radiation Oncology, Biology,
Society. 2016;64(Suppl.):S180. Physics. 2016;96(2 Suppl.):E117.
McMillan SS, Shahrokni A. Building a comprehensive Meric-Bernstam F, Tannir N, Harding J, Voss M, Mier J, DeMichele A,
educational model for nurse practitioner students in geriatric Munster P, Patel M, Iliopoulos O, Owonikoko T, Whiting S, Orford K,
oncology. Gerontologist. 2016;56(Suppl. 3):675. Bennett M, Carvajal R, McKay R, Fan A, Telli M, Infante J. Phase 1 study of
CB-839, a small molecule inhibitor of glutaminase, in combination with
McNeish IA, Lin KK, Sun JX, Goble S, Oza A, Coleman RL, Scott CL, everolimus in patients (pts) with clear cell and papillary renal cell cancer
Konecny G, Tinker A V, O’Malley DM, Kristeleit R, Ma L, Brenton JD, Bell- (RCC). European Journal of Cancer. 2016;69(Suppl. 1):S12-S13.
McGuinn K, Oaknin A, Leary A, Mann E, Giordano H, Yelensky R, Raponi
M, Swisher E. NGS-based tumor genomic profiling to identify ovarian Meyerholz S, Dowling ME. Elective chemotherapy admissions:
cancer patients who benefit from the PARP inhibitor rucaparib. Clinical An opportunity to improve wait times. Journal of Clinical
Cancer Research. 2016;22(2 Suppl.) Oncology. 2016;34(7 Suppl.)
McTague Allen P, Laffey M. Healing the healers. Oncology Nursing Middleton LP, Mayo TL, Spinks TE, Cheney R, Chu PG, Cooper HS, Dintzis
Forum. 2016;43(2):105. S, Ehya H, Fletcher CD, Gerwirtz A, Magliocco AM, Martin SE, Rosenberg
AE, Sherrod A, Tan LK, Wood BL, Walters RS. The value of secondary
Medin PM, Hrycushko BA, Vernino S, Foster RD, Sayre J, Yamada Y, pathology review. Journal of Clinical Oncology. 2016;34(7 Suppl.)
289 OF 324
Meeting Abstracts
Millard N, Becher O, Modak S, Haque S, Spasojevic I, Trippett Diamond JM, Cantu E, Christie JD, Pearce EL, Artis D. Innate lymphoid
T, Gilheeney S, Khakoo Y, Lyden D, De Braganca K, Kolesar J, Huse cell function in allergic inflammation: Arginase 1 is a critical metabolic
J, Kramer K, Dunkel I. A phase I study of single-agent perifosine checkpoint controlling type 2 inflammation. Cytokine. 2016;87:56.
for recurrent/refractory pediatric CNS and solid tumors. Neuro-
Oncology. 2016;18(Suppl. 3):iii25. Montoro J, Guerreiro M, O’Reilly RJ, Koehne G. CD34 negative fractions
of leukophereses collections permit generation of highly functional
Miller K, Krop I, Schwartzberg L, Abramson V, Garcia-Estevez L, donor-derived CMV-specific cytotoxic T lymphocytes. Bone Marrow
Eakle J, Nanda R, Yardley D, Ademuyiwa F, Chan S, Crown J, Danso Transplantation. 2016;51(Suppl. 1):S119-S120.
M, Gelmon K, Ma L, Martinez-Janez N, Gradishar W, Steinberg J,
Tudor IC, Uppal H, Paton VE, Parker J, Hudis CA, Traina TA. Improved Mookerjee V, Fernandez M, Acharya S, Glassman R, Gonzalez
clinical outcomes on enzalutamide observed in patients with PREDICT J, Nonaillada J, Gangai N, Korc-Grodzicki B. Educational needs
AR+ triple-negative breast cancer: Prognosis or prediction?. Cancer of the caregivers of older adults in the South Asian community of
Research. 2016;76(4 Suppl.) Queens. Gerontologist. 2016;56(Suppl. 3):400.
Miranda E, Tal R, Guhring P, Parker M, Mulhall J. An assessment of the Moraes FY, Mendez LC, Suh JH, Taunk NK, Souhami L, Slotman BJ,
impact of testosterone supplementation therapy on hemoglobin A1C Weltman E, Marta GN. Funding source, self-reported conflicts of interest,
(HbA1C) levels in diabetic and non-diabetic men. Journal of Sexual and the interpretation of conclusions of phase 1, 2, and 3 trials in
Medicine. 2016;13(5 Suppl.):S16-S17. neuro-oncology. International Journal of Radiation Oncology, Biology,
Physics. 2016;96(2 Suppl.):S177-S178.
Mizrachi A, Shamay Y, Shah JK, Brook S, Rajasekhar VK, Humm
JL, Baselga J, Heller DA, Haimovitz-Friedman A, Scaltriti M. Tumor- Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Warshaw AL,
specific PI3K inhibition by targeted delivery in head and neck squamous Lillemoe KD, Pergolini I, Attiyeh M, Rezaee N, Allen PJ, Wolfgang CL,
cell carcinoma. European Journal of Cancer. 2016;69(Suppl. 1):S66. Fernandez-Del Castillo C. Intraductal papillary mucinous neoplasms
in young patients exhibit distinct biology, clinicopathological
Montecalvo J, Leduc C, Rekhtman N, Moreira A, Arcila M, Berger characteristics, and favorable prognosis. Pancreas. 2016;45(10):1526-1527.
M, Rudin C, Rusch V, Jones D, Travis W. Lessons learned from next
generation sequencing in use of immunohistochemistry (IHC) for Morikawa A, De Stanchina E, Patil S, Chandarlapaty S, Li BT, Norton
EGFR L858R and ALK in lung cancer predictive testing. Laboratory L, Seidman AD. Optimization of intermittent high dose lapatinib
Investigation. 2016;96(Suppl. 1):477A. administration with or without capecitabine: A rational approach to
drug dosing and scheduling using Norton-Simon modeling. Cancer
Montecalvo J, Leduc C, Rekhtman N, Moreira A, Arcila M, Berger Research. 2016;76(4 Suppl.)
M, Rudin C, Rusch V, Jones D, Travis W. Lessons learned from next
generation sequencing in use of immunohistochemistry (IHC) for Morris MJ, Beer TM, Loriot Y, Higano CS, Armstrong AJ, Sternberg CN,
EGFR L858R and ALK in lung cancer predictive testing. Modern De Bono JS, Tombal BF, Parli T, Bhattacharya S, Krivoshik AP, Phung
Pathology. 2016;29(Suppl. 2):477A. D, Rathkopf DE. Correlation between radiographic progression-free
survival (rPFS) and overall survival (OS): Results from PREVAIL. Journal
Monticelli LA, Buck MD, Flamar AL, Saenz SA, Wojno EDT, Yudanin NA, of Clinical Oncology. 2016;34(2 Suppl.)
Osborne LC, Hepworth MR, Tran S V, Rodewald HR, Shah H, Cross JR,
290 OF 324
Meeting Abstracts
Morris MJ, Martinez DF, Durack JC, Slovin SF, Danila DC, O’Donoghue lymphography maps sentinel lymph nodes in early-stage cervical
JA, Parada NA, Lyashchenko SK, Carrasquillo JA, Ruan S, Lewis JS, and endometrial cancer. International Journal of Gynecological
Keppler J, Wu AM, Reuter VE, Weber W, Scher H I, Larson SM, Pandit- Cancer. 2016;26(Suppl. 3):582-583.
Taskar N. A phase I/IIa trial of prostate specific membrane antigen
(PSMA) positron emission tomography (PET) imaging with (89) Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu XC, Adekola K,
Zr-Df-IAB2M in metastatic prostate cancer (PCa). Journal of Clinical Aljurf MD, Artz AS, Bajel A, Ballen KK, Battiwalla M, Beitinjaneh A,
Oncology. 2016;34(2 Suppl.) Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea SO, Copelan EA,
D’Souza A, Edwards J, Freytes CO, Fung HC, Gale RP, Giralt SA, Hashmi
Morrow M. DCIS: Surgical treatment. Menopause - The Journal of the SK, Hematti P, Hildebrandt GC, Ho VT, Jakubowski AA, Lazarus HM,
North American Menopause Society. 2016;23(12):1364-1365. McCarthy PL, Olin RL, Olsson R, Rezvani A, Rizzieri DA, Seftel M, Seo S,
Sorror ML, Szer J, Wood WA. Increasing use of allogeneic hematopoietic
Moryl N, Dave V, Glare P, Malhotra V, Gulati A, Hung J, Puttanniah cell transplantation (HCT) in patients age 70 years and older: A
V, Griffo Y, Tickoo R, Wiesenthal A, Johnson C, Horn S, Inturrisi C. The CIBMTR study of trends and outcomes. Biology of Blood and Marrow
influence of age and gender on opioid dosage in cancer pain clinic Transplantation. 2016;22(3 Suppl. 1):S68-S69.
patients. Journal of Pain. 2016;17(4 Suppl.):S71.
Mukku RB, Verma S, Liu J, Steingart R, Hudis C, Yu AF, Dang C. Cardiac
Moskowitz C, Zinzani PL, Fanale MA, Armand P, Johnson N, Ribrag V, safety of trastuzumab without an anthracycline in patients with HER2-
Radford J, von Tresckow B, Tomita A, Shipp MA, Wang Y, Ricart AD, positive early stage breast cancer: A single center experience. Cancer
Balakumaran A, Chen R. Multicohort phase 2 study of pembrolizumab Research. 2016;76(4 Suppl.)
for relapsed/refractory classical Hodgkin lymphoma (R/R cHL):
Keynote-087. Haematologica. 2016;101(Suppl.):319. Mulhall J, Brock G, Glina S, Baygani S, Donatucci C, Maggi M. Impact
of endogenous hormonal status on successful treatment of sexual
Motzer RJ, Sharma P, McDermott DF, George S, Hammers HJ, Srinivas S, dysfunction in men taking once-daily tadalafil 5mg for LUTS/
Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano DE, Gurney BPH. Journal of Sexual Medicine. 2016;13(5 Suppl.):S51-S52.
H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Zhao HY, Waxman
IM, Escudier B. CheckMate 025 phase III trial: Outcomes by key baseline Mulhall JP, Luo X, Zou KH, Stecher V, Galaznik A. Relationship
factors and prior therapy for nivolumab (NIVO) versus everolimus between age and erectile dysfunction diagnosis or treatment using
(EVE) in advanced renal cell carcinoma (RCC). Journal of Clinical real-world observational data in the United States. Journal of Sexual
Oncology. 2016;34(2 Suppl.) Medicine. 2016;13(5 Suppl.):S45.
Moung C, Liu Y, Intrieri J, Borsu L, Nafa K, Arcila ME. Detection of Mungovan S, Sandhu J, Akin O, Smart N, Graham P, Patel M. Membranous
BRAF V600E mutation in hairy cell leukemia: Comparison of digital urethral length measurement prior to prostatectomy: A systematic review
PCR and sanger sequencing utilizing high sensitivity locked nucleic acid and meta analysis. BJU International. 2016;117(Suppl. 3):48-49.
probes. Journal of Molecular Diagnostics. 2016;18(6):967.
Muraki T, Bedolla G, Jang KT, Bagci P, Mittal P, Reid M, Memis
Mueller J, Soslow R, Jewell E, Dauer L, John H, Pandit-Taskar N, Abu- B, Basturk O, Bandyopadhyay S, Sarmiento J, Krasinskas A, Adsay
Rustum N, Grimm J. First in-human study: 18F-FDG PET/CT positron V. Undifferentiated carcinoma with osteoclast-like giant cells of the
291 OF 324
Meeting Abstracts
pancreas: Clinico-pathological analysis of 20 cases highlights a more Murali R, De Filippo M, Weigelt B, Park KJ. Genomic characterization
protracted clinical course than currently appreciated. Laboratory of gastric-type endocervical adenocarcinomas. Laboratory
Investigation. 2016;96(Suppl. 1):445A-446A. Investigation. 2016;96(Suppl. 1):298A.
Muraki T, Bedolla G, Jang KT, Bagci P, Mittal P, Reid M, Memis Murali R, De Filippo M, Weigelt B, Park KJ. Genomic characterization
B, Basturk O, Bandyopadhyay S, Sarmiento J, Krasinskas A, Adsay of gastric-type endocervical adenocarcinomas. Modern
V. Undifferentiated carcinoma with osteoclast-like giant cells of Pathology. 2016;29(Suppl. 2):298A.
the pancreas: Clinico-pathological analysis of 20 cases highlights a
more protracted clinical course than currently appreciated. Modern Murphy J, Rosowicz A, Saltz L, Paty P, La Quaglia MP, Reidy
Pathology. 2016;29(Suppl. 2):445A-446A. DL. Recurrence rates of resected appendix carcinoid tumors: A 20-year
experience at Memorial Sloan Kettering Cancer Center. Journal of Clinical
Murali R, van de Nes J, Gessi M, Sucker A, Moeller I, Stiller M, Horn S, Oncology. 2016;34(4 Suppl.)
Scholz S, Pischler C, Stadler N, Schilling B, Zimmer L, Hillen U, Scolyer
RA, Buckland M, Lauriola L, Pietsch T, Waha A, Schadendorf D, Griewank Murugan P, Cha EK, Chen YB, Sirintrapun SJ, Gopalan A, Fine SW, Tickoo
K. Targeted next generation sequencing reveals unique mutation profile SK, Reuter VE, Sfakianos JP, Scott SN, Iyer G, Bagrodia A, Shah
of primary melanocytic tumors of the central nervous system. Laboratory R, Bajorin DF, Rosenberg JE, Berger M, Bochner BH, Coleman JA, Solit
Investigation. 2016;96(Suppl. 1):434A. DB, Al-Ahmadie HA. Clonality of urothelial carcinoma developing
in the bladder following radical nephroureterectomy. Laboratory
Murali R, van de Nes J, Gessi M, Sucker A, Moeller I, Stiller M, Horn S, Investigation. 2016;96(Suppl. 1):251A.
Scholz S, Pischler C, Stadler N, Schilling B, Zimmer L, Hillen U, Scolyer
RA, Buckland M, Lauriola L, Pietsch T, Waha A, Schadendorf D, Griewank Murugan P, Cha EK, Chen YB, Sirintrapun SJ, Gopalan A, Fine SW, Tickoo
K. Targeted next generation sequencing reveals unique mutation profile SK, Reuter VE, Sfakianos JP, Scott SN, Iyer G, Bagrodia A, Shah R, Bajorin
of primary melanocytic tumors of the central nervous system. Modern DF, Rosenberg JE, Berger M, Bochner BH, Coleman JA, Solit DB, Al-
Pathology. 2016;29(Suppl. 2):434A. Ahmadie HA. Clonality of urothelial carcinoma developing in the bladder
following radical nephroureterectomy. Modern Pathology. 2016;29(Suppl.
Murali R, Burke KA, De Filippo MR, Berman SH, Park KJ, Weigelt B. The 2):251A.
genomic landscape of gastric-type cervical adenocarcinomas. International
Journal of Gynecological Cancer. 2016;26(Suppl. 3):412. Nack E, Rosenberg JE, Bochner BH, Dalbagni G, Zelefsky MJ, Kollmeier
M. External beam radiotherapy and concurrent gemcitabine for muscle-
Murali R, Chandramohan R, Soslow R, Cheng D, McCluggage invasive bladder cancer: Toxicities and early outcomes. Journal of Clinical
WG. Genomic analysis of low-grade serous ovarian tumors associated with Oncology. 2016;34(2 Suppl.)
high-grade serous carcinoma or undifferentiated carcinoma. Laboratory
Investigation. 2016;96(Suppl. 1):298A. Nagase R, Inoue D, Saika M, Hou HA, Chou WC, Kawabata K, Harada
H, Kanai A, Goyama S, Honda H, Tien HF, Kitamura T. Analysis of MDS
Murali R, Chandramohan R, Soslow R, Cheng D, McCluggage mice model induced by ASXL1 and RUNX1 mutants. Experimental
WG. Genomic analysis of low-grade serous ovarian tumors associated Hematology. 2016;44(9 Suppl.):S90.
with high-grade serous carcinoma or undifferentiated carcinoma. Modern
Pathology. 2016;29(Suppl. 2):298A. Nahar B, Punnen S, Zappala SM, Sjoberg D, Parekh D. Among men with
292 OF 324
Meeting Abstracts
low-grade prostate cancer on prostate biopsy, the 4Kscore to predict distress and career satisfaction. Biology of Blood and Marrow
prostate cancer aggressiveness at prostatectomy. Journal of Clinical Transplantation. 2016;22(3 Suppl. 1):S29-S30.
Ng CKY, Bidard FC, Piscuoglio S, Lim RS, Pierga JY, Cottu P, Vincent-
Nahar B, Punnen S, Sjoberg D, Zappala SM, Parekh D. The 4Kscore Salomon A, Viale A, Norton L, Sigal B, Weigelt B, Reis JS. Capturing
to predict the grade and stage of prostate cancer in the radical intra-tumor genetic heterogeneity in cell-free plasma DNA from patients
prostatectomy specimen: Results from a multi-institutional prospective with oligometastatic breast cancer. Cancer Research. 2016;76(4 Suppl.)
trial. Journal of Clinical Oncology. 2016;34(2 Suppl.)
Nonaillada J, Grodzicki BK. Get a GRIP on geriatrics education. Journal
Naing A, Pant S, Infante J, Papadopoulos K, Autio K, Wong D, Ott P, of the American Geriatrics Society. 2016;64(Suppl.):S45.
Falchook G, Patel M, Whiteside M, Colen R, Bendell J, Bauer T, Janku F,
Javle M, Tannir N, Oft M, Chan I, Rasco D, Hong D, Patnaik A, Moore K, Ntiamoah P, Ayob GH, Clarke RR, Nafa D, Salazar PA, Viale A, Dogan
Korn M, Van-Vlasselaer P, Brown G. Anti-tumor activity of PEGylated A, Hameed M. EDTA-based decalcification of bone and bone
human IL-10 (AM0010) in renal cancer alone and in combination with marrow-ideal tool for protein and nucleic acid preservation - A pilot
anti-PD1. BJU International. 2016;118(Suppl. 5):25. study. Laboratory Investigation. 2016;96(Suppl. 1):519A.
Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS V, Panageas Ntiamoah P, Ayob GH, Clarke RR, Nafa D, Salazar PA, Viale A, Dogan
KS, DeAngelis LM. Risk of arterial thromboembolism in patients with A, Hameed M. EDTA-based decalcification of bone and bone
breast cancer. Thrombosis Research. 2016;140(Suppl. 1):S169. marrow-ideal tool for protein and nucleic acid preservation - A pilot
study. Modern Pathology. 2016;29(Suppl. 2):519A.
Nelson C, Mulhall J. Erectile function and urinary bother following
radical prostatectomy (RP). Journal of Sexual Medicine. 2016;13(5 Ohri N, Ho AY, Green S, Rhome R, Tsai CJ. Postmastectomy radiation in
Suppl.):S31-S32. breast cancer patients with pathologically positive lymph nodes after
neoadjuvant chemotherapy: An analysis of treatment and survival trends
Nelson J, Tulsky J, Ferrell B, Mulkerin C, Voigt L, Stabler from the National Cancer Data Base. International Journal of Radiation
S. Pairing palliative care with cutting-edge oncologic care: Oncology, Biology, Physics. 2016;96(2 Suppl.):S208.
Challenges and opportunities. Journal of Pain and Symptom
Management. 2016;51(2):309-310. Oliveira M, de Azambuja E, Saura C, Dubsky P, Zardavas D, Fesl C,
Bardia A, Soberino J, Gil EC, Ng V, Fredrickson J, Stout TJ, Singel
Nemieboka BE, Thapi D, Bitton A, Lewis JS. Preclinical evaluation of SM, Hsu JY, Piccart M, Gnant M, Baselga J. LORELEI: A phase II
radiolabeled MUC16 antibodies for PET imaging of epithelial ovarian randomized, double-blind study of neoadjuvant letrozole plus taselisib
carcinoma. Clinical Cancer Research. 2016;22(2 Suppl.) (GDC-0032) versus letrozole plus placebo in postmenopausal women
with ER-positive/HER2-negative, early-stage breast cancer. Cancer
Neumann JL, Mau LW, Denzen EM, Boyle DA, Dabney J, Lofthus AD, Research. 2016;76(4 Suppl.)
Kalbacker M, Khan T, Majhail NS, Murphy EA, Paplham P, Parran L, Perales
MA, Rockwell T, Schmit-Pokorny K, Shanafelt TD, Stenstrup E, Virani S, Olm-Shipman M, Gelblum D, Lacouture ME, Zhang Z, Porinchak M, Siu
Wood WA, Burns LJ. Hematopoietic cell transplantation multidisciplinary CT, Wilgucki M, Berrett E, Ginex P, Gupta GP, Cahlon O, McCormick
care teams: National survey of transplant provider burnout, moral B, Powell SN, Ho AY. Efficacy of mometasone furoate in the reduction of
293 OF 324
Meeting Abstracts
moderate/severe radiation dermatitis in breast cancer patients following preferentially in KRAS/BRAF wild type colorectal carcinoma. Laboratory
mastectomy. International Journal of Radiation Oncology, Biology, Investigation. 2016;96(Suppl. 1):458A.
Pagan C, Ptashkin R, Zehir A, Berger MF, Shia JR, Vakiani E, Ladanyi
Ortega-Molina A, Boss IW, Canela A, Pan H, Jiang YW, Zhao CY, Jiang M, Hechtman J. 20q gain is an oncogenic driver event that occurs
M, Hu DQ, Lee JE, Chen HT, Ennishi D, Scott DW, Hother C, Liu SC, Cao preferentially in KRAS/ BRAF wild type colorectal carcinoma. Modern
XJ, Tam WN, Shaknovich R, Garcia BA, Gascoyne RD, Ge K, Shilatifard Pathology. 2016;29(Suppl. 2):458A.
A, Elemento O, Nussenzweig A, Melnick AM, Wendel HG. Functional
characterization of the tumor suppressor lysine-specific methyltransferase Palomba ML, Till BG, Park S I, Morschhauser F, Cartron G, Marks
KMT2D in lymphoma. Cancer Research. 2016;76(2 Suppl.) R, Penuel E, Chitra S, Byon JCH, Popplewell L. A phase IB study
evaluating the safety and clinical activity of atezolizumab combined
O’Sullivan TE, Rapp M, Bhardwaj P, Fan X, Dannenberg A, Sun with obinutuzumab in patients with relapsed or refractory non-Hodgkin
JCY. Adipose-resident group 1 innate lymphoid cells promote obesity- lymphoma. Haematologica. 2016;101(Suppl.):102.
associated insulin resistance. Journal of Immunology. 2016;196(1 Suppl.)
Pankuch M, Gao M, Gans S, Kaplan D, Schmidt S, McGee LA, Chang
O’Toole MS, Zachariae RS, Renna ME, Mennin D, Applebaum A. Cognitive JHC, Hartsell WF, Cahlon O, MacDonald S, Lu HM. A novel proton
behavioral therapies for informal caregivers of patients with cancer and therapy technique for treatment of postmastectomy breast cancer
cancer survivors: A systematic review and meta-analysis. Psychosomatic patients with tissue expanders containing high-density metallic
Medicine. 2016;78(3):A99-A100. filling ports. International Journal of Radiation Oncology, Biology,
Owosho AA, Yom SH, Huryn JM, Lee NY, Estilo CL. Comparative
analysis of mandibular dosimetric-distribution of PBRT/IMRT: A Paolilli D, Hydzik C. Trending nurse encounters demonstrate that despite
pilot study. Oral Surgery, Oral Medicine, Oral Pathology and Oral the decrease in the number of treatments delivered, the role of the
Radiology. 2016;122(4):e110-e111. radiation oncology nurse continues to expand beyond supportive care
and education. International Journal of Radiation Oncology, Biology,
Ozkaya N, Durham BH, Park C, Rosenblum M, Diamond E, Dogan Physics. 2016;96(2 Suppl.):E507.
A. Clinicopathologic features of Erdheim-Chester disease (ECD): A
histiocytic neoplasm characterized by deregulation of RAS/RAF/MEK/ Papanastasiou AD, Wen HC, Schultheis AM, Ng CK, Edelweiss
ERK pathway. Laboratory Investigation. 2016;96(Suppl. 1):366A. M, Piscuoglio S, Martelotto LG, Geyer FC, Burke K, De Filippo
MR, Macedo GS, Varga Z, Rakha E, Ellis IO, Rubin BP, Weigelt B, Reis
Ozkaya N, Durham BH, Park C, Rosenblum M, Diamond E, Dogan JS. The mutational landscape of breast adenomyoepitheliomas. Modern
A. Clinicopathologic features of Erdheim-Chester disease (ECD): A Pathology. 2016;29(Suppl. 2):64A.
histiocytic neoplasm characterized by deregulation of RAS/RAF/MEK/
ERK pathway. Modern Pathology. 2016;29(Suppl. 2):366A. Papanastasiou AD, Wen HC, Schultheis AM, Ng CKY, Edelweiss
M, Piscuoglio S, Martelotto LG, Geyer FC, Burke K, De
Pagan C, Ptashkin R, Zehir A, Berger MF, Shia J, Vakiani E, Ladanyi Filippo MR, Macedo GS, Varga Z, Rakha E, Ellis IO, Rubin
M, Hechtman J. 20q gain is an oncogenic driver event that occurs
294 OF 324
Meeting Abstracts
BP, Weigelt B, Reis JS. The mutational landscape of breast of the intestinal microbiota are associated with relapse after allogeneic
adenomyoepitheliomas. Laboratory Investigation. 2016;96(Suppl. 1):64A. hematopoietic stem cell transplantation. Biology of Blood and Marrow
Parada LF. Glioma stem cells: What are they?. Cancer
Research. 2016;76(5 Suppl.) Perloff T, Shen MJ, Rigney M, King JC. Survivor guilt: The secret burden
of cancer survivorship. Journal of Clinical Oncology. 2016;34(3 Suppl.)
Pareja F, Brennan S, Murray M, Bowser ZL, Morris E, Brogi E, Corben
AD. Papillomas without atypia: Can excision be spared?. Laboratory Pessin H, Nelson C, Lacey S, Mulhall J. Acceptance and commitment
Investigation. 2016;96(Suppl. 1):65A. therapy: A novel approach for adherence to an erectile rehabilitation
program (ERP) after radical prostatectomy (RP). Psycho-
Pareja F, Brennan S, Murray M, Bowser ZL, Morris E, Brogi E, Corben Oncology. 2016;25(Suppl. 3):163.
AD. Papillomas without atypia: Can excision be spared?. Modern
Pathology. 2016;29(Suppl. 2):65A. Petrova-Drus K, Chiu A, Margolskee E, Orazi A. Bone marrow fibrosis
in chronic myelomonocytic leukemia is associated with increased
Pareja F, Brogi E, Fu L, Bowser ZL, Akram M, Norton L, Wen bone marrow cellularity and megakaryopoiesis, spleen size and
HY. Tumor infiltrating lymphocytes (TILs) in triple negative breast with a shorter median time to disease progression. Laboratory
cancer (TNBC): A three-tier system predicts survival. Laboratory Investigation. 2016;96(Suppl. 1):368A.
Petrova-Drus K, Chiu A, Margolskee E, Orazi A. Bone marrow fibrosis
Pareja F, Brogi E, Fu L, Bowser ZL, Akram M, Norton L, Wen HY. Tumor in chronic myelomonocytic leukemia is associated with increased bone
infiltrating lymphocytes (TILs) in triple negative breast cancer (TNBC): A marrow cellularity and megakaryopoiesis, spleen size and with a shorter
three-tier system predicts survival. Modern Pathology. 2016;29(Suppl. 2):65A. median time to disease progression. Modern Pathology. 2016;29(Suppl.
2):368A.
Park J, Riviere I, Wang X, Sadelain M, Brentjens R. Impact of disease
burden on long-term outcome of CD19-targeted CAR modified T cells in Philip M, Fairchild L, Sun L, Viale A, Leslie C, Schietinger A. Deciphering
adult patients with relapsed B-ALL. Haematologica. 2016;101(Suppl.):184. the epigenetic programming underlying CD8 T cell dysfunction in solid
tumors. Journal of Immunology. 2016;196(1 Suppl.)
Patel P, Lee R, Pillai M, Stover D. A troubling trifecta: Pulmonary
alveolar proteinosis and pneumocystis pneumonia in acute myeloid Pilewskie M, Stempel M, Rosenfeld H, Eaton A, Van Zee KJ, Morrow
leukemia. Chest. 2016;150(4 Suppl.):138A. M. Do LORIS trial eligibility criteria identify a ductal carcinoma in
situ (DCIS) patient population at low-risk of upgrade to invasive
Patterson J, McKenzie C, Battiato K, Llerandi D, Miale-Mayer D, Dowling carcinoma?. Annals of Surgical Oncology. 2016;23(1 Suppl.):S25-S26.
ME. The clinical protocol coordinator: Essential role in the integration of
phase 1 clinical trials on a hematology oncology unit. Oncology Nursing Piscuoglio S, Ng CKY, Cowell CF, Mariani O, Martelotto L, Natrajan
Forum. 2016;43(2):90. R, Lim RS, Maher CA, Vincent-Salomon A, Weigelt B, Reis
JS. Genomic and transcriptomic heterogeneity in metaplastic breast
Peled JU, Ling LL, Littman E, Kosuri S, Maloy M, Giralt SA, Barker carcinomas. Cancer Research. 2016;76(4 Suppl.)
JN, Perales MA, Taur Y, Pamer EG, van den Brink MRM, Jenq R. Members
295 OF 324
Meeting Abstracts
Piscuoglio S, Ng CKY, Marchio C, Eberle CA, Guerini-Rocco E, Mariani O, regulatory T cells (Treg) infiltrating human breast cancers represents a
Vincent-Salomon A, Reis JS, Weigelt B. Distinct repertoires of somatic novel immunotherapeutic target. Cancer Research. 2016;76(4 Suppl.)
mutations affecting driver genes in mucinous and neuroendocrine
carcinomas of the breast. Cancer Research. 2016;76(4 Suppl.) Politikos I, McMasters M, Bryke C, Avigan DE, Boussiotis VA. Possible
reactivation of chromosomally integrated Human Herpes Virus 6
Piscuoglio S, Ng CKY, Murray M, Geyer FC, Edelweiss M, Weigelt (ciHHV-6) after treatment with HDAC inhibitor and correlation of
B, Brogi E, Reis JS. Clonal relationship among synchronous ipsilateral HHV-6 viral load with host chimerism after allogeneic stem cell
fibroepithelial lesions: Progression from fibroadenomas to phyllodes transplantation in a ciHHV-6 recipient. Biology of Blood and Marrow
tumors. Laboratory Investigation. 2016;96(Suppl. 1):66A-67A. Transplantation. 2016;22(3 Suppl. 1):S173.
Piscuoglio S, Ng CKY, Murray M, Geyer FC, Edelweiss M, Weigelt Politikos I, Devlin SM, Yoo Y, Lauer E, Ciolino C, Dierov D, Herman
B, Brogi E, Reis JS. Clonal relationship among synchronous ipsilateral D, Mosesso K, Nieves J, Giralt SA, Perales MA, Kernan NA, Scaradavou
fibroepithelial lesions: Progression from fibroadenomas to phyllodes A, Ponce DM, Barker JN. Double unit cord blood transplantation (dCBT)
tumors. Modern Pathology. 2016;29(Suppl. 2):66A-67A. progression-free survival (PFS) is unaffected by grade III-IV acute graft-
versus-Host disease (aGVHD) and survivors are likely to discontinue
Plastaras JP, Vogel J, Elmongy H, Zeng C, Svoboda J, Both S, Maity immunosuppression (IS) and reconstitute T-cells. Biology of Blood and
A. First clinical report of pencil beam scanned proton therapy for Marrow Transplantation. 2016;22(3 Suppl. 1):S79-S80.
mediastinal lymphoma. International Journal of Radiation Oncology,
Biology, Physics. 2016;96(2 Suppl.):E497. Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott
D, Linette G, Meyer N, Giguere J, Agarwala SS, Shaheen M, Ernstoff MS,
Plichta J, Reyes S, Frank E, Gonen M, Voci A, Boafo C, Hwang S, Rugo Minor DR, Salama A, Taylor MH, Ott PA, Jiang J, Horak C, Wolchok JD,
H, Alvarado M, Liu M, Boughey J, Jacobs L, Krontiras H, McGuire K, Hodi S. Two-year overall survival (OS) rates from a randomized phase
Storniolo A, Nanda R, Golshan M, Isaacs C, Meszoely I, Van Poznak 2 trial evaluating the combination of nivolumab (NIVO) and ipilimumab
C, Babiera G, Norton L, Morrow M, Winer E, Wolff A, Hudis C, King (IPI) Versus IPI in patients with advanced melanoma (MEL). Asia-Pacific
T. Factors associated with the decision to pursue elective surgery Journal of Clinical Oncology. 2016;12(Suppl. 5):130-131.
among women enrolled in TBCRC013: A prospective registry of surgery
in patients presenting with stage IV breast cancer. Annals of Surgical Powell SN, Riaz N, Mutter RW, Ng CKY, Delsite R, Piscuoglio S, King
Oncology. 2016;23(Suppl. 3):131-133. TA, Martelotto L, Sakr R, Brogi E, Edelweiss M, Lim R, Higginson
D, Weigelt B, Lee W, Reis JS. A functional assay for homologous
Plimack ER, Motzer RJ, Escudier B, Sharma P, McDermott DF, George S, recombination (HR) DNA repair and whole exome sequencing reveal
Hammers HJ, Carducci M, Tykodi SS, Sosman JA, Choueiri TK, Donskov that HR-defective sporadic breast cancers are enriched for genetic
F, Gurney H, Gauler TC, Ueda T, Zhao HY, Berghorn E, Wagstaff J. Two- alterations in DNA repair genes. Cancer Research. 2016;76(4 Suppl.)
year efficacy and safety update from the phase III CheckMate 025 study
of nivolumab versus everolimus in patients with advanced renal cell Powles T, Escudier B, Motzer RJ, Tannir NM, Scheffold C, Aftab
carcinoma (aRCC). BJU International. 2016;118(Suppl. 5):11-12. DT, Chouieri TK. Clinical outcomes based on MET expression
level in METEOR, a randomized phase 3 trial of cabozantinib
Plitas G, Konopacki C, Wu K, Paula B, Morrow M, Rudensky versus everolimus in advanced renal cell carcinoma (RCC). BJU
A. Preferential expression of the chemokine receptor 8 (CCR8) on International. 2016;118(Suppl. 5):4.
296 OF 324
Meeting Abstracts
Prat A, Ortega V, Paré L, Galván P, Oliveira M, Nucíforo P, Lluch A, Puca L, Gao D, Kossai M, Cyrta J, Marotz C, Mosquera JM, MacDonald TY,
Morales S, Amillano K, Lopez R, González R, Manso L, Martínez J, Sboner A, Rao RM, Chen Y, Rubin MA, Beltran H. Targeting androgen-
Llombart A, de la Peña L, di Cosimo S, Rubio IT, Harbeck N, Baselga J, independent prostate cancer through epigenetic reprogramming. Cancer
Cortés J. Efficacy and gene expression results from eribulin SOLTI1007 Research. 2016;76(2 Suppl.)
neoadjuvant study. Cancer Research. 2016;76(4 Suppl.)
Pusztai L, Shi W, Jiang T, Nuciforo P, Holmes E, Harbeck N, Sotiriou C,
Preise D, Kudinova N, Lindner U, Sasson K, Uzana R, Coleman J, Rimm D, Hatzis C, de la Pena L, Armour A, Piccart-Gebhart M, Baselga
Salomon Y, Scherz A. Immunomodulated VTP enables cure of metastatic J. Whole exome sequencing of pre-treatment biopsies from the
prostate and breast cancers in animal models. Cancer Immunology neoALTTO trial to identify DNA aberrations associated with response to
Research. 2016;4(Suppl.) HER2-targeted therapies. Cancer Research. 2016;76(4 Suppl.)
Premsrirut P, Martin G, Dow L, Kim SY, Zuber J, Lowe S, Hannon G. RNAi Qian X, Tang X. An initial study of quasimonochromatic X-ray sources for
and CRISPR/Cas9 based in vivo models for drug discovery. Transgenic stationary digital breast tomosynthesis. International Journal of Radiation
Research. 2016;25(2):218. Oncology, Biology, Physics. 2016;96(2 Suppl.):E633-E634.
Prendergast EN, Holzapfel M, Mueller JJ, Leitao MM, Gunderson CC, Qian X, Tang X. Early detection of breast cancer using stationary
Moore KN, Erickson BK, Leath CA, Diaz ES, Cohen J, Walsh C. Three digital breast tomosynthesis with quasimonochromatic x-ray
versus six cycles of adjuvant carboplatin and paclitaxel in early stage sources. International Journal of Radiation Oncology, Biology,
clear cell ovarian carcinoma - A multi-institutional cohort. Gynecologic Physics. 2016;96(2 Suppl.):S168.
Oncology. 2016;143(1):214-215.
Quinones FLR, Dogan A, Roshal M. Flow cytometric characterization of
Prockop S, Doubrovina E, Sauter C, Suser S, O’Reilly R. Banked EBV- PD1 expression in tumor infiltrating T-cells in B-cell lymphoproliferative
specific T-cells for treatment of rituximab refractory EBV plus B-cell disorders identifies distinct, disease specific patterns. Laboratory
lymphoma in solid organ transplantation recipients. American Journal of Investigation. 2016;96:373A-374A.
Transplantation. 2016;16(Suppl. 3):332.
Quinones FLR, Dogan A, Roshal M. Flow cytometric characterization of
Proli AJ, Tamari R, Zheng J, Jakubowski AA, Papadopoulos E, Ponce PD1 expression in tumor infiltrating T-cells in B-cell lymphoproliferative
DM, Devlin SM, Sauter CS, Perales MA, Young JW, Giralt SA, Castro- disorders identifies distinct, disease specific patterns. Modern
Malaspina H. Impact of busulfan exposure on transplant outcomes for Pathology. 2016;29(Suppl. 2):373A.
patients with advanced myelodysplastic syndrome undergoing CD34
selected allogeneic hematopoietic stem cell transplantation. Biology of Quinones FLR, Jungbluth A, Rampal RK, Levine R, Sen F, Dogan
Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S348. A. Identification of mutated CALR protein is useful in the diagnosis
and prognostic stratification of JAK-2 negative, MPL-negative
Ptashkin RN, Pagan C, Middha S, Yaeger R, Ladanyi M, Berger M, Zehir myeloproliferative neoplasms. Laboratory Investigation. 2016;96(Suppl.
A, Hechtman JF. Chromosome 20q gain defines a molecular subtype 1):374A.
associated with microsatellite stability, wild-type RAS/RAF, mutant TP53,
left-sided tumors, and better overall survival in metastatic colorectal Quinones FLR, Jungbluth A, Rampal RK, Levine R, Sen F, Dogan
carcinoma. Journal of Molecular Diagnostics. 2016;18(6):1013-1014. A. Identification of mutated CALR protein is useful in the diagnosis
297 OF 324
Meeting Abstracts
and prognostic stratification of JAK-2 negative, MPL-negative differentiated pancreatic neuroendocrine tumors (WD panNETs): Results
myeloproliferative neoplasms. Modern Pathology. 2016;29(Suppl. 2):374A. of a prospective study utilizing MSK-IMPACT (Memorial
Raciti P, Hu WH, Stranahan A, Woolthuis C, Devlin S, Park Sloan Kettering Integrated Mutation Profiling of Actionable Cancer
C. Leukemic stem cell responses to induction chemotherapy identify Targets). Pancreas. 2016;45(3):468-469.
novel prognostic biomarkers in acute myeloid leukemia. Laboratory
Investigation. 2016;96(Suppl. 1):371A. Raj N, Valentino E, Tang L, Capanu M, Basturk O, Klimstra D, Reidy-
Lagunes D. Treatment response and outcomes of metastatic grade
Raciti P, Hu WH, Stranahan A, Woolthuis C, Devlin S, Park 3 (G3) pancreatic neuroendocrine carcinomas (HGNEC) based on
C. Leukemic stem cell responses to induction chemotherapy identify pathologic differentiation (well differentiated (WDNEC) versus poorly
novel prognostic biomarkers in acute myeloid leukemia. Modern differentiated (PDNEC)). Pancreas. 2016;45(3):480.
Raj NP, Soumerai T, Valentino E, Hechtman JF, Berger MF, Reidy
Raffin C, Zhou Y, Piccoli L, Lanzavecchia A, Sadelain M, Bluestone DL. Next-generation sequencing (NGS) in advanced well differentiated
JA. Development of citrullinated-vimentin-specific CAR for pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-
targeting Tregs to treat autoimmune rheumatoid arthritis. Journal of IMPACT. Journal of Clinical Oncology. 2016;34(4 Suppl.)
Immunology. 2016;196(1 Suppl.)
Ramos J, Wong YN, Crabb SJ, Niegisch G, Bellmunt J, Ladoire S, Hussain
Rafikh S. Bladder cancer and nephrostomy tubes: Role of the oncology SA, Baniel J, Golshayan AR, Powles T, Rosenberg JE, De Giorgi U,
nurse. Oncology Nursing Forum. 2016;43(2):87. Vaishampayan UN, Agarwal N, Pal SK, Harshman LC, Necchi A, Recine F,
Galsky MD, Yu EY, RISC Investigators. Venous thromboembolism (VTE)
Rafiq S, Purdon T, Dao T, Liu C, Scheinberg D, Brentjens RJ. Engineering risk in patients with localized urinary tract tumors (UTT). Journal of
armored T cell receptor-mimic (TCRm) chimeric antigen receptor Clinical Oncology. 2016;34(2 Suppl.)
(CAR) T cells specific for the intracellular protein Wilms tumor 1
(WT1) for treatment of hematologic and solid malignancies. Molecular Ramrup N, Koo D, Davis M. A case report of Cushing’s syndrome due
Therapy. 2016;24(Suppl. 1):S156. to ectopic adrenocorticotropic hormone secondary to pancreatic
neuroendocrine cancer. Oncology Nursing Forum. 2016;43(2):67.
Raghunathan NJ, Thom B, Friedman DN, Benedict C, Kelvin JF. Young
adult female cancer survivors’ concerns about genetic cancer risk in Ramrup N, Koo D. When do we treat portal vein thrombosis in
offspring. Journal of Clinical Oncology. 2016;34(3 Suppl.) patients with gastrointestinal malignancies? Educating for better
patient outcomes - Implications for nursing. Oncology Nursing
Raj N, Soumerai T, Valentino E, Reidy-Lagunes D. Identification Forum. 2016;43(2):30-31.
of SETD2 genetic alterations in patients with advanced
well differentiated pancreatic neuroendocrine tumors (WD Reardon DA, Dietrich J, Kaley T, Gan H, Dunn GP, Cloughesy T, Lim M,
panNETs). Pancreas. 2016;45(3):480. Clarke J, Park A, Pang L, Lai DW, Karakunnel J, Robbins P, Narwal R,
Venhaus R. Phase 2 study to evaluate the clinical efficacy and safety of
Raj N, Soumerai T, Valentino E, Reidy-Lagunes D. Is next-generation MEDI4736 in patients with glioblastoma (GBM). Cancer Immunology
sequencing (NGS) ready for routine clinical practice in advanced well Research. 2016;4(Suppl.)
298 OF 324
Meeting Abstracts
Reid M, Balci S, Xue Y, Ohike N, Tajiri T, Basturk O, Muraki T, Kim depot 120 mg in patients with well differentiated, advanced lung, or
GE, Krasinskas AM, Quigley B, Saka B, Bagci P, El-Rayes B, Kooby D, thymus neuroendocrine tumors (NETs). Pancreas. 2016;45(3):480-481.
Sarmiento J, Maithel S, Adsay V. Significant prognostic factors in invasive
ampullary adenocarcinoma (AC): Clinicopathologic analysis of 367 Reis JS, Piscuoglio S, Ng CKY, Murray M, Burke K, Edelweiss M, Macedo
cases. Laboratory Investigation. 2016;96(Suppl. 1):194A. GS, Geyer FC, Inagaki A, Papanastasiou AD, Martelotto LG, Marchio
C, Lim R, De Bruijn I, Smyth L, Akram M, Ross DS, Norton L, Solit
Reid M, Balci S, Xue Y, Ohike N, Tajiri T, Basturk O, Muraki T, Kim DB, Baselga J, Brogi E, Ladanyi M, Weigelt B. TERT hotspot promoter
GE, Krasinskas AM, Quigley B, Saka B, Bagci P, El-Rayes B, Kooby D, mutations and TERT gene amplification in phyllodes tumors of the
Sarmiento J, Maithel S, Adsay V. Significant prognostic factors in invasive breast. Laboratory Investigation. 2016;96(Suppl. 1):69A.
ampullary adenocarcinoma (AC): Clinicopathologic analysis of 367
cases. Modern Pathology. 2016;29(Suppl. 2):194A. Reis JS, Piscuoglio S, Ng CKY, Murray M, Burke K, Edelweiss M, Macedo
GS, Geyer FC, Inagaki A, Papanastasiou AD, Martelotto LG, Marchio
Reid M, Basturk O, Shaib W, Balci S, Choi H, Akkas G, Robinson B, C, Lim R, De Bruijn I, Smyth L, Akram M, Ross DS, Norton L, Solit
Memis B, El-Rayes B, Staley C, Staley C, Winer J, Russell M, Knight JH, DB, Baselga J, Brogi E, Ladanyi M, Weigelt B. TERT hotspot promoter
Goodman M, Krasinskas A, Adsay V. Adenocarcinoma ex-goblet cell mutations and TERT gene amplification in phyllodes tumors of the
carcinoid (XGC) is a morphologically distinct “appendiceal-type crypt breast. Modern Pathology. 2016;29(Suppl. 2):69A.
cell” adenocarcinoma with highly aggressive behavior and frequent
association with peritoneal/intra-abdominal dissemination: An analysis of Reis JS, Schizas M, Piscuoglio S, Sakr RA, Ng CKY, Lim RS, Carniello
77 cases. Laboratory Investigation. 2016;96(Suppl. 1):194A. JVS, Towers R, Martelotto L, Giri DD, de Andrade VP, Viale A, Solit
DB, Weigelt B, King TA. Lobular carcinoma in situ displays intra-
Reid M, Basturk O, Shaib W, Balci S, Choi H, Akkas G, Robinson B, lesion genetic heterogeneity and its progression to invasive disease
Memis B, El-Rayes B, Staley C, Staley C, Winer J, Russell M, Knight JH, involves clonal selection and variations in mutational processes. Cancer
Goodman M, Krasinskas A, Adsay V. Adenocarcinoma ex-goblet cell Research. 2016;76(4 Suppl.)
carcinoid (XGC) is a morphologically distinct “appendiceal-type crypt
cell” adenocarcinoma with highly aggressive behavior and frequent Rekhtman N, Naidoo J, Pietanza M, Hellmann MD, Arora A, Shen
association with peritoneal/intra-abdominal dissemination: An analysis of R, Halpenny DF, Won H, Berger MF, Tian S, Poirier JT, Paik PK, Moreira
77 cases. Modern Pathology. 2016;29(Suppl. 2):194A. A, Rudin CM, Travis WD, Ladanyi M. Next-generation sequencing of
pulmonary large cell neuroendocrine carcinoma reveals clinically-relevant
Reidy-Lagunes D, Kulke M, Wolin E, Mirakhur B, Massien C, Caplin subsets with small cell carcinoma-like and non-small cell carcinoma-
M, Baudin E. Design of a phase 3, international, prospective, like molecular profiles. Laboratory Investigation. 2016;96(Suppl.
randomized, double-blind, placebo (PBO) controlled study assessing 1):480A-481A.
efficacy and safety of lanreotide autogel/depot (LAN) 120 mg in
patients with well-differentiated, advanced typical and atypical lung Rekhtman N, Naidoo J, Pietanza M, Hellmann MD, Arora A, Shen
NETs. Neuroendocrinology. 2016;103(Suppl.):118. RL, Halpenny DF, Won H, Berger MF, Tian SZ, Poirier JT, Paik PK, Moreira
A, Rudin CM, Travis WD, Ladanyi M. Next-generation sequencing of
Reidy-Lagunes D, Wolin EM, Pitman-Lowenthal S, Cox D, Kulke pulmonary large cell neuroendocrine carcinoma reveals clinically-relevant
MH. Design of a phase 2, prospective, randomized, double-blind, subsets with small cell carcinoma-like and non-small cell carcinoma-like
placebo-controlled study assessing the efficacy and safety of lanreotide molecular profiles. Modern Pathology. 2016;29(Suppl. 2):480A-481A.
299 OF 324
Meeting Abstracts
Remark R, Merghoub T, Damotte D, Wolchok JD, Merad M, Gnjatic historically controlled, phase 3 trial. Biology of Blood and Marrow
S. In-depth tissue analysis using multiplexed immunohistochemical Transplantation. 2016;22(3 Suppl. 1):S25.
consecutive staining on single slide. Cancer Immunology
Research. 2016;4(Suppl.) Rimner A, Yorke ED, Lee R, Chawla M, Gelb E, Gelblum D, von Reibnitz
D, Wu AJ, Lovelock M. Implanted electromagnetic transponders for
Reyes SA, Sakr RA, Schizas M, Towers R, Park AY, Ng CKY, Weigelt monitoring deep inspiration breath hold: Interim results of a prospective
B, Reis-Filho JS, King TA. Germline CDH1 mutations in lobular carcinoma feasibility study. International Journal of Radiation Oncology, Biology,
in situ. Cancer Research. 2016;76(4 Suppl.) Physics. 2016;96(2 Suppl.):E472-E473.
Richardson P, Smith A, Triplett B, Kernan N, Grupp S, Antin J, Lehmann Ritchie E, Deininger M, Erba H, Savona M, Paley C, Dautaj I, Mauro
L, Miloslavsky M, Hume R, Hannah A, Soiffer R. Early initiation of M. Rapid achievement of MR(4.5) after switching from imatinib to
defibrotide (DF) improves survival in hepatic veno-occlusive disease/ nilotinib in patients with chronic myeloid leukemia in chronic phase
sinusoidal obstruction syndrome (VOD/SOS) with or without multi-organ (CML-CP): Preliminary results from ENESTgoal. Clinical Lymphoma,
dysfunction (MOD) post hematopoietic stem cell transplantation (HSCT): Myeloma and Leukemia. 2016;16(Suppl. 2):S63.
Updated interim results. Bone Marrow Transplantation. 2016;51(Suppl.
1):S75-S77. Roa JC, Basturk O, Torres J, Mucientes F, Del Pozo M, Villaseca MA,
Aguayo G, Bellolio ER, Araya JC, Endo I, Jang KT, Lee K, Jang JY,
Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Ohike N, Shimizu M, Hirabayashi K, Terris B, Zamboni G, Reid M, Xue
Termuhlen AM, Arai S, Grupp SA, Miloslavsky M, Nejadnik B, Hannah AL, Y, Bedolla G, Quigley B, Krasinskas AM, Akkas G, Memis B, Klimstra D,
Soiffer RJ. Defibrotide for hepatic veno-occlusive disease/sinusoidal Hruban RH, Zhu B, Van Dyke AL, Koshiol J, Adsay V. Marked geographic
obstruction syndrome with multi-organ dysfunction: A concordance differences in the pathologic diagnosis of non-invasive (Tis) vs minimally
analysis between Day+100 complete response and survival. Biology of invasive (T1) gallbladder cancer: Santiago Consensus Conference
Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S351. highlights the need for the unifying category “early gallbladder cancer”
(EGBC). Laboratory Investigation. 2016;96(Suppl. 1):447A.
Richardson PG, Triplett BM, Kernan NA, Grupp SA, Antin JH, Lehmann
L, Miloslavsky M, Hume R, Hannah AL, Nejadnik B, Soiffer RJ. Early Roa JC, Basturk O, Torres J, Mucientes F, Del Pozo M, Villaseca MA,
initiation of defibrotide in patients with hepatic veno-occlusive disease/ Aguayo G, Bellolio ER, Araya JC, Endo I, Jang KT, Lee K, Jang JY,
sinusoidal obstruction syndrome following hematopoietic stem cell Ohike N, Shimizu M, Hirabayashi K, Terris B, Zamboni G, Reid M, Xue
transplantation improves Day +100 survival. Biology of Blood and Marrow Y, Bedolla G, Quigley B, Krasinskas AM, Akkas G, Memis B, Klimstra D,
Transplantation. 2016;22(3 Suppl. 1):S82-S83. Hruban RH, Zhu B, Van Dyke AL, Koshiol J, Adsay V. Marked geographic
differences in the pathologic diagnosis of non-invasive (Tis) vs minimally
Richardson PG, Kernan NA, Brochstein JA, Mineishi S, Arai S, Grupp invasive (T1) gallbladder cancer: Santiago Consensus Conference
SA, Guinan E, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Duerst highlights the need for the unifying category “early gallbladder cancer”
RE, Antin JH, Lehmann L, Gillio AP, Bajwa R, Miloslavsky M, Hume R, (EGBC). Modern Pathology. 2016;29(Suppl. 2):447A.
Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Defibrotide for the
treatment of hepatic veno-occlusive disease/sinusoidal obstruction Robak T, Zelenetz AD, Mato A, Jones JA, Pagel JM, Barrientos JC, Brown
syndrome with multi-organ dysfunction: Final results from a pivotal, JR, Montillo M, Dubowy R, Xing G, Li JJ, Kipps TJ, Hillmen P. Idelalisib plus
300 OF 324
Meeting Abstracts
an anti-Cd20 antibody in patients with chronic lymphocytic leukemia Rooper LM, Huang SC, Antonescu C, Westra WH, Bishop JA. Nuclear
(CLL) who are HBV core antibody positive: Similar patterns of liver test B-catenin expression provides a consistent immunohistochemical
abnormalities. Haematologica. 2016;101(Suppl.):437. correlate for PAX3 rearrangements in biphenotypic sinonasal
sarcoma. Laboratory Investigation. 2016;96(Suppl. 1):328A.
Roberts LR, Farshidfar F, Zheng SY, Gingras MC, Newton Y, Shih J,
Robertson AG, Hinoue T, Hoadley KA, Gibbs R, Roszik J, Covington K, Rooper LM, Huang SC, Antonescu C, Westra WH, Bishop JA. Nuclear
Wu CC, Shinbrot E, Stransky N, Hegde AM, Yang JD, Reznik E, Sadeghi S, B-catenin expression provides a consistent immunohistochemical
Pedamallu CS, Ojesina A I, Hess J, Auman JT, Rhie SK, Bowlby R, Borad correlate for PAX3 rearrangements in biphenotypic sinonasal
MJ, Stuart J, Sander C, Akbani R, Cherniack AD, Laird PW, Deshpande sarcoma. Modern Pathology. 2016;29(Suppl. 2):328A.
V, Mounajjed T, Foo WC, Torbenson M, Kleiner DE, Wheeler DA, McRee
AJ, Bathe OF, Andersen JB, Bardeesy N, Kwong LN. Integrative genomic Rosenberger L, Mamtani A, Fuzesi S, Stempel M, Eaton A, Morrow
analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular M, Gemignani M. Early adoption of the SSO-ASTRO Consensus
profiles. Hepatology. 2016;64(Suppl.):227A. Guidelines on margins for breast-conserving surgery with whole-
breast irradiation in stages I and II invasive breast cancer: Initial
Roberts SS, Ogando Y, Ostrovnaya I, Fattahi F, Cheung I, Cheung NK experience. Annals of Surgical Oncology. 2016;23(Suppl. 3):139-140.
V, Studer L, Tomishima M. Using directed differentiation of human
pluripotent stem cells and gene expression profiling to characterize the Rosenthal K, Choueiri T, Motzer R, Ryan C, Obholz K, Hutson T, Rini
cell of origin of neuroblastoma. Cancer Research. 2016;76(5 Suppl.) B. Treatment variance between experts and community clinicians:
Analysis of an online decision tool for renal cell carcinoma (RCC). BJU
Robson M. Management of non-BRCA breast cancer International. 2016;118(Suppl. 5):19.
predisposition. Cancer Research. 2016;76(4 Suppl.)
Roshal M, Chiu A. Near bi-phenotypic antigen expression defines an acute
Robson ME, Gaissert P, Salo-Mullen EE, Amoroso K, Sheehan M, Berliner myeloid leukemia (AML) cohort with high-risk molecular genetic and
JL, Trottier M, Arnold AG, Sekhri N, Marcell V, Siegel B, Fleischut cytogenetic features. Laboratory Investigation. 2016;96(Suppl. 1):374A.
MH, Hay JL, Walsh MF, Kauff ND, Stadler ZK, Offit K, Hamilton
JG. Information preferences and short-term psychological responses to Roshal M, Chiu A. Near bi-phenotypic antigen expression defines an
multiplex genetic testing among individuals at risk for hereditary breast acute myeloid leukemia (AML) cohort with high-risk molecular genetic
cancer. Cancer Research. 2016;76(4 Suppl.) and cytogenetic features. Modern Pathology. 2016;29(Suppl. 2):374A.
Rognvaldsson S, Lund SH, Hultcrantz M, Eiriksdottir G, Rosillo C, Barba P, Huang YT, Avila AM, Montoro J, Maloy
Harris TB, Gudnason V, Kristinsson SY. High hemoglobin M, Papanicolaou GA, Perales MA. Systematic anti-mold prophylaxis
concentrations and risk of thrombosis: Causality or results in very low incidence of invasive fungal infections in patients
confounding?. Haematologica. 2016;101(Suppl.):141-142. undergoing allogeneic hematopoietic cell transplantation. Biology of
Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S159-S160.
Romanienko PJ, Giacalone J, Ingenito J, Wang YJ, Isaka
M, Johnson T, You Y, Mark WH. A vector with a single promoter Ross DS, Konno F, Brogi E, Zehir A, Berger MF, Chandarlapaty
for in vitro transcription and mammalian cell expression of CRISPR S, Razavi P, Baselga J, Wen HY. Analysis of estrogen receptor (ER)
gRNAs. Transgenic Research. 2016;25(2):259. immunohistochemistry (IHC) in breast cancer with ESR1 mutations
301 OF 324
Meeting Abstracts
detected by hybrid capture-based next generation sequencing Saddawi-Konefka R, Seelige R, Gross ETE, O’Sullivan TE, Harismendy
(NGS). Laboratory Investigation. 2016;96(Suppl. 1):69A. O, Bui JD. Nrf2 induces IL-17D to mediate tumor and virus
surveillance. Journal of Immunology. 2016;196(1 Suppl.)
Ross DS, Konno F, Brogi E, Zehir A, Berger MF, Chandarlapaty
S, Razavi P, Baselga J, Wen HY. Analysis of estrogen receptor (ER) Sadimin ET, Chen YB, Argani P, Epstein J I. Chromosomal abnormalities
immunohistochemistry (IHC) in breast cancer with ESR1 mutations of tumors with features of mucinous tubular and spindle cell
detected by hybrid capture-based next generation sequencing carcinoma of the kidney yet with high grade cytology. Laboratory
(NGS). Modern Pathology. 2016;29(Suppl. 2):69A. Investigation. 2016;96(Suppl. 1):259A.
Ross M, LeWinn A, Sarov T, Tarplin S, Wilson D, Fischer-Cartlidge Sadimin ET, Chen YB, Argani P, Epstein J I. Chromosomal abnormalities
E. Safety and efficacy of scalp cooling for chemotherapy- of tumors with features of mucinous tubular and spindle cell
induced alopecia: Forty years of literature. Oncology Nursing carcinoma of the kidney yet with high grade cytology. Modern
Forum. 2016;43(2):14. Pathology. 2016;29(Suppl. 2):259A.
Royston D, Gao Q, Tavakkoli M, Chung SS, Devlin S, Roshal M, Park Sadot E, Nash G, Smith JJ, Guillem JG, Paty PB, Temple LK, Garcia-
C. CD164: A novel marker distinguishing hematopoietic stem/ Aguilar J, Weiser M. Hypophosphatemia as a novel early predictor
progenitor cells (HSPC) from leukemic stem cells. Laboratory of intra-abdominal infections in 7,423 patients undergoing colorectal
Investigation. 2016;96(Suppl. 1):374A-375A. surgery. Annals of Surgical Oncology. 2016;23(1 Suppl.):S36-S37.
Royston D, Gao Q, Tavakkoli M, Chung SS, Devlin S, Roshal Sae-Ow W, Pichardo J, Ying Z, Kumar A, Zelenetz AD, Younes A, Dogan
M, Park C. CD164: A novel marker distinguishing hematopoietic A. A unique variant of indolent mantle cell lymphoma exclusively
stem/progenitor cells (HSPC) from leukemic stem cells. Modern involving gastrointestinal tract. Laboratory Investigation. 2016;96(Suppl.
Pathology. 2016;29(Suppl. 2):374A-375A. 1):375A-376A.
Rutgers JKL, Roma AA, Park KJ, Zaino R, Daya D, Rasty G, Johnston Sae-Ow W, Pichardo J, Ying Z, Kumar A, Zelenetz AD, Younes A, Dogan
A, Longacre TA, Ronnett BM, Silva EG. Validation of pattern-based A. A unique variant of indolent mantle cell lymphoma exclusively
classification of endocervical adenocarcinoma (EAC). Laboratory involving gastrointestinal tract. Modern Pathology. 2016;29(Suppl.
Investigation. 2016;96(Suppl. 1):307A. 2):375A-376A.
Rutgers JKL, Roma AA, Park KJ, Zaino R, Daya D, Rasty G, Johnston Sales R, Carrow M. HPV: A nursing challenge from top to
A, Longacre TA, Ronnett BM, Silva EG. Validation of pattern-based bottom. Oncology Nursing Forum. 2016;43(2):98.
classification of endocervical adenocarcinoma (EAC). Modern
Pathology. 2016;29(Suppl. 2):307A. Samstein R, Barker CA, Carvajal RD, Postow MA, Callahan
MK, Shoushtari AN, Patel SG, Lee N. Localized ainonasal mucosal
Rwigema JC, Lee N, Chen AM, Heron DE. Salvage therapy for melanoma: Outcomes and associations with stage, radiation therapy,
locoregionally recurrent head and neck cancer occurring in a previously and positron emission tomography response. International Journal of
irradiated field: A national survey of practice patterns. International Radiation Oncology, Biology, Physics. 2016;94(4):949.
Journal of Radiation Oncology, Biology, Physics. 2016;94(4):931-932.
302 OF 324
Meeting Abstracts
Samstein R, Leeman JE, Li JG, Venigalla P, Ganly I, Wong RJ, Higginson Patel PH, Baselga J, Oliveira M. FAIRLANE: A phase II randomized,
DS, Riaz N, Lee N, McBride SM. Outcomes for locally advanced laryngeal double-blind, study of the Akt inhibitor ipatasertib (ipat, GDC-0068)
cancer treated with definitive chemoradiation with intensity modulated in combination with paclitaxel (pac) as neoadjuvant treatment
radiation therapy. International Journal of Radiation Oncology, Biology, for early stage triple negative breast cancer (TNBC). Cancer
Physics. 2016;96(2 Suppl.):E391. Research. 2016;76(4 Suppl.)
Sanford NN, Chen MH, Loffredo M, Renshaw A, Kantoff PW, D’Amico Sawyers CL. Reflections on precision medicine. Clinical Cancer
A V. Duration of the anti-androgen in men undergoing 6 months of an Research. 2016;22(1 Suppl.)
LHRH agonist and radiation therapy for unfavorable-risk prostate cancer
and the risk of death. International Journal of Radiation Oncology, Scaltriti M, Carmona FJ, Toska E, Cocco E, Hyman D, Cutler R,
Biology, Physics. 2016;96(2 Suppl.):E226-E227. Avogadri-Connors F, Wick MJ, Papadopoulos KP, Lalani AS, Baselga
J. Neratinib induces estrogen receptor function and sensitizes HER2-
Santos N, Chin C. Navigating the complexities of patients with substance mutant breast cancer to anti-endocrine therapy. European Journal of
use disorders through stem cell transplant: The role of the social Cancer. 2016;69(Suppl. 1):S125.
worker. Journal of Psychosocial Oncology. 2016;34(1-2):140-141.
Scardino PT, Cuzick JM, Stone S, Evans B, Jorgensen MR, Eastham
Sarungbam J, Reznik E, Hakimi AA, Bialik A, Sirintrapun SJ, Al JA, Keane TE, Davis JW, Lin DW, Moul JW, Brawer MK, Crawford
Ahmadie H, Gopalan A, Fine SW, Chen YB, Sander C, Reuter VE, Tickoo ED. Application of active surveillance threshold to series of
SK. Clear cell papillary renal cell carcinoma shows marked depletion samples submitted for commercial testing. Journal of Clinical
of mitochondrial content: A comparative differential diagnostic Oncology. 2016;34(2 Suppl.)
study. Laboratory Investigation. 2016;96(Suppl. 1):260A-261A.
Schadendorf D, Larkin J, Chiarion-Sileni V, Gonzalez R, Rutkowski
Sarungbam J, Reznik E, Hakimi AA, Bialik A, Sirintrapun SJ, Al P, Grob JJ, Cowey CL, Lao C, Taylor F, Sabater J, Walker D, Bhore
Ahmadie H, Gopalan A, Fine SW, Chen YB, Sander C, Reuter VE, Tickoo R, Wolchok J, Hodi FS. Efficacy and quality of life outcomes in patients
SK. Clear cell papillary renal cell carcinoma shows marked depletion with advanced melanoma (MEL) who discontinued treatment with
of mitochondrial content: A comparative differential diagnostic nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase 3 trial
study. Modern Pathology. 2016;29(Suppl. 2):260A-261A. (CheckMate 067). Melanoma Research. 2016;26(e-Suppl.):e4.
Satagopan JM, Iasonos A. Quantifying treatment benefit in Scher H I, Graf R, Louw J, Jendrisak A, Johnson A, Greene S, Rodriguez
molecular subgroups to assess a predictive biomarker. Genetic A, Schreiber NA, McLaughlin B, Dugan L, Fleisher M, Lee J, Wang Y,
Epidemiology. 2016;40(7):618. Marrinucci DC, Landers M, Dittamore R V. Single CTC characterization
to identify phenotypic and genomic heterogeneity as a mechanism
Saulan M. Post-operative compartment syndrome: Can we prevent of resistance to AR signaling directed therapies (AR Tx) in mCRPC
it?. Oncology Nursing Forum. 2016;43(2):46. patients. Journal of Clinical Oncology. 2016;34(2 Suppl.)
Saura C, Isakoff SJ, Calvo I, Patt D, Andersen J, Gonzalez-Martin A, Schiavone M, Scelzo C, Straight C, Zhou Q, Leitao M Jr, Alektiar K, Makker
Fisher J, Ciruelos E, Gil-Gil M, De la Pena L, Choi Y, Jia S, Singel S, V, Soslow R, Iasonos A, Abu-Rustum N. Survival in patients with serous
303 OF 324
Meeting Abstracts
uterine carcinoma undergoing sentinel lymph node mapping. International Sebastiano C, Gennaro L, Brogi E, Morris E, Akram M, Bowser
Journal of Gynecological Cancer. 2016;26(Suppl. 3):74-75. ZL, Corben AD, Brennan S, Murray M. Benign vascular lesions of the
breast do not require excision. Modern Pathology. 2016;29(Suppl. 2):71A.
Schlappe B, Mueller JJ, Olvera N, Dao F, Kandoth C, Bogomolniy
F, Viale A, Huberman K, Nanjangud G, Hussein Y, Taylor B, Soslow Sebastiano C, Iyer S, Cordero A, Plitas G, Giri D. Sentinel lymph
R, Levine DA. Molecular characterization of mucinous ovarian node status and patterns of invasion in microinvasive breast
carcinoma. Clinical Cancer Research. 2016;22(2 Suppl.) carcinoma. Laboratory Investigation. 2016;96(Suppl. 1):71A.
Schoen M, Manasia M, Ehdaie B, Spaliviero M. Validation of American Sebastiano C, Iyer S, Cordero A, Plitas G, Giri D. Sentinel lymph
Urologic Association best practice guidelines for prostate biopsy node status and patterns of invasion in microinvasive breast
infectious complications: A quality improvement initiative. Oncology carcinoma. Modern Pathology. 2016;29(Suppl. 2):71A.
Nursing Forum. 2016;43(2):62.
Selby L V, DeMatteo RP, Jarnagin WR, Garcia-Aguilar J, Allen
Schostak M, Oh WK, Tombal B, Delacruz A, Tomlinson I, Ripley A V, P, Kingham PT, Weiser M, Brennan MF, Strong VE. Evolution of
Drudge-Coates L, Mastris K, O’Sullivan JM, Shore ND. Recognizing minimally invasive surgery at a tertiary cancer center: Analysis of
symptom burden in advanced prostate cancer: A global patient and 10,000 intraabdominal cases. Annals of Surgical Oncology. 2016;23(1
caregiver survey. Oncology Research and Treatment. 2016;39(Suppl. 3):320. Suppl.):S134.
Scordo M, Bhatt V, Hsu M, Omuro AM, Matasar MJ, DeAngelis L, Dahi Sequist L V, Goldman JW, Wakelee H, Camidge DR, Gadgeel S, Yu HA,
P, Moskowitz CH, Giralt SA, Sauter CS. Toxicities and outcomes Varga A, Solomon B, Oxnard GR, Ou SH I, Papadimitrakopoulou V, Liu
for patients with CNS lymphoma (CNSL) consolidated with high- S V, Reckamp KL, Spira A I, Despain D, Karlovich CA, Yurasov S, Soria
dose therapy and autologous stem cell transplantation (HDT-ASCT) JC. Efficacy of rociletinib (CO-1686) in centrally confirmed T790M-
using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), positive and T790M-negative non-small cell lung cancer (NSCLC)
cyclophosphamide (TBC) conditioning. Biology of Blood and Marrow patients (Pts). Oncology Research and Treatment. 2016;39(Suppl. 1):121.
Serra V, Cruz C, Bruna A, Ibrahim YH, Vivancos A, Vivancos A, Nuciforo
Scordo M, Shah GL, Devlin S, Maloy M, Kosuri S, Herrera DA, Nieves P, Bellet M, Gómez P, Pérez JM, Saura C, Vidal M, Serres X, Rueda OM,
J, Avecilla ST, Meagher RC, Gyurkocza B, Castro-Malaspina H, Tamari Peg V, Caldas C, O’Connor MJ, Baselga J, Cortés J. PARP1/2 inhibition in
R, Perales MA, Giralt SA, Shaffer B. Late toxicities in long-term survivors a subset of triple negative breast cancer (TNBC) patient-derived tumor
of adult allogeneic hematopoietic cell transplantation (allo-HCT) using xenografts (PDX) identifies predictive biomarkers of response. Cancer
ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) Research. 2016;76(4 Suppl.)
prophylaxis. Bone Marrow Transplantation. 2016;51(Suppl. 1):S419-S420.
Setton J, Riaz N, Higginson DS, McBride S, Kollmeier M, Zelefsky
Sebastiano C, Gennaro L, Brogi E, Morris E, Akram M, Bowser MJ, Powell SN. Localized prostate cancers with genetic defects in
ZL, Corben AD, Brennan S, Murray M. Benign vascular DNA repair display evidence of functional deficit in homologous
lesions of the breast do not require excision. Laboratory recombination. International Journal of Radiation Oncology, Biology,
Investigation. 2016;96(Suppl. 1):71A. Physics. 2016;96(2 Suppl.):E594.
304 OF 324
Meeting Abstracts
Shah GL, Scordo M, Kosuri S, Herrera DA, Maloy M, Nieves JL, Devlin Shih AR, Muzikansky A, Bozkurtlar E, Chung JH, Minami Y, Hariri LP, Moreira
S, Avecilla ST, Meagher R, Shaffer B, Perales MA, Gyurkocza B, Castro- A, Uruga H, Wang H, Yoshizawa A, Mino-Kenudson M. Reproducibility
Malaspina H, Giralt SA, Tamari R. Toxicities in older adult patients in classification of small lung adenocarcinomas: An international
undergoing CD34+ selected allogeneic hematopoietic stem cell interobserver study. Laboratory Investigation. 2016;96(Suppl. 1):483A.
transplantation (allo-HCT). Bone Marrow Transplantation. 2016;51(Suppl.
1):S226-S227. Shih AR, Muzikansky A, Bozkurtlar E, Chung JH, Minami Y, Hariri
LP, Moreira A, Uruga H, Wang H, Yoshizawa A, Mino-Kenudson
Shah GL, Weltz J, Zhou Q, Devlin SM, Landau H, Chung DJ, Lendvai M. Reproducibility in classification of small lung adenocarcinomas: An
N, Lesokhin AM, Korde N, Koehne G, Giralt SA, Hassoun H. A response international interobserver study. Modern Pathology. 2016;29(Suppl. 2):483A.
adapted approach to induction treatment in patients with multiple
myeloma undergoing autologous stem cell transplantation. Biology of Shor A, Klang M, Abramova I. Lidocaine and bupivacaine syringe stability
Blood and Marrow Transplantation. 2016;22(3 Suppl. 1):S40-S41. study. Pharmacotherapy. 2016;36(7):e96.
Shahrokni A, Pournaki SM, Grodzicki BK. Older cancer patients’ Short K, Chung Y, Browne K, Rosamilia M. Reinventing alarm
perception of their own health and its relationship with geriatric management: Using smartphone technology to care for telemetry
assessment outcomes. Journal of the American Geriatrics patients. Critical Care Nurse. 2016;36(2):E38.
Society. 2016;64(Suppl.):S84.
Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney
Shia JR, Kuk D, Schultz N, Berger M, Middha S, Vakiani E, Hechtman SM, Somlo G, Port ER, Qamar R, Sturtz K, Mamounas E, Golshan M,
J, Stadler Z, Weiser M, Gonen M, Klimstra D. Comprehensive Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP. Event-
morphological assessment of colorectal cancers characterized by The free and overall survival following neoadjuvant weekly paclitaxel and
Cancer Genome Atlas (TCGA) identifies specific morphology-molecular dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative
alteration associations. Laboratory Investigation. 2016;96(Suppl. 1):200A. breast cancer: Outcomes from CALGB 40603 (Alliance). Cancer
Shia JR, Kuk D, Schultz N, Berger M, Middha S, Vakiani E, Hechtman
J, Stadler Z, Weiser M, Gonen M, Klimstra D. Comprehensive Simoes PK, Woo K, Shike M, Mendelsohn RB, Gerdes H, Markowitz
morphological assessment of colorectal cancers characterized by The AJ, Ludwig E, Shah P, Schattner MA. Direct percutaneous endoscopic
Cancer Genome Atlas (TCGA) identifies specific morphology-molecular jejunostomy—Procedural and nutritional outcomes in a large patient
alteration associations. Modern Pathology. 2016;29(Suppl. 2):200A. cohort. Gastrointestinal Endoscopy. 2016;83(5 Suppl.):AB475.
Shih AR, Liu XL, Silva A, Pesci A, Soslow R, Deshpande V, Oliva Singh J, Mendelsohn R, Winawer S, Zauber A, Kantor E, Ahnen D,
E. Refined characterization of hepatoid differentiation in gynecologic Lowery J, Bal D, Molmenti CS, Weber T. Increases in the global incidence
tract neoplasms. Laboratory Investigation. 2016;96(Suppl. 1):309A. of young adult colorectal cancer (YA CRC) pose critical challenges
for the international surgical oncology community. Annals of Surgical
Shih AR, Liu XL, Silva A, Pesci A, Soslow R, Deshpande V, Oliva Oncology. 2016;23(1 Suppl.):S141-S142.
E. Refined characterization of hepatoid differentiation in gynecologic
tract neoplasms. Modern Pathology. 2016;29(Suppl. 2):309A. Singhi A, Shia J, Nikiforova M, Hornick JL, Klimstra D, Syngal S, Dudley
B, Brand RE, Zeh HJ, Hruban RH. Clinicopathologic and molecular
305 OF 324
Meeting Abstracts
analysis of pancreatic ductal adenocarcinoma in patients with lynch oncogenes by modulation of the fusion oncogene pre-mRNA. Cancer
syndrome. Laboratory Investigation. 2016;96(Suppl. 1):448A. Research. 2016;76(5 Suppl.)
Singhi A, Shia J, Nikiforova M, Hornick JL, Klimstra D, Syngal S, Dudley Solit DB. Clinical application of next-generation sequencing as a guide to
B, Brand RE, Zeh HJ, Hruban RH. Clinicopathologic and molecular treatment selection. Clinical Cancer Research. 2016;22(1 Suppl.)
analysis of pancreatic ductal adenocarcinoma in patients with lynch
syndrome. Modern Pathology. 2016;29(Suppl. 2):448A. Sondhi D, Rosenberg JB, De BP, Monette S, Chen A, Flagiello T, Caffrey
E, Kaminsky SM, Aubourg P, Crystal RG. Long-term toxicology evaluation
Sirintrapun SJ, Zhao TH, Stamelos E, Tsividakis G, Gurman J, Mitchell of AAVrh.10hARSA administration to the CNS of nonhuman primates to
MJ, Reuter VE, Klimstra D. An enterprise approach for pathology treat metachromatic leukodystrophy. Molecular Therapy. 2016;24(Suppl.
reporting utilizing PDF functionality for the electronic medical 1):S146.
record. Laboratory Investigation. 2016;96(Suppl. 1):400A.
Song Y, Mueller BA, Laguna J, Obcemea CH, Saleh Z, Tang X, Both
Sirintrapun SJ, Zhao TH, Stamelos E, Tsividakis G, Gurman J, Mitchell S, Mychalczak BR. Considerations in bilateral lung treatment planning
MJ, Reuter VE, Klimstra D. An enterprise approach for pathology with volumetric modulated arc therapy. International Journal of Radiation
reporting utilizing PDF functionality for the electronic medical Oncology, Biology, Physics. 2016;96(2 Suppl.):E684.
record. Modern Pathology. 2016;29(Suppl. 2):400A.
Song Y, Mueller BA, Laguna J, Obcemea CH, Saleh Z, Tang X, Both
Sirintrapun SJ, Rudomina D, Feratovic R, Alago W, Siegelbaum S, Mychalczak BR. Investigation of MLC dose leakage in volumetric
R, Lin O. Robotic telecytology for successful remote cytologic modulated arc therapy head and neck treatment. International Journal of
evaluation without on-site cytopathology staffing. Laboratory Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E595-E596.
Investigation. 2016;96(Suppl. 1):400A-401A.
Soslow R, Gilks B, Levine DA. The Cancer Genome Atlas-based
Sirintrapun SJ, Rudomina D, Feratovic R, Alago W, Siegelbaum molecular classifier identifies prognostically significant subgroups
R, Lin O. Robotic telecytology for successful remote cytologic of grade 3 endometrioid carcinoma of the endometrium. Laboratory
evaluation without on-site cytopathology staffing. Modern Investigation. 2016;96(Suppl. 1):311A.
Pathology. 2016;29(Suppl. 2):400A-401A.
Soslow R, Gilks B, Levine DA. The Cancer Genome Atlas-based
Sirintrapun SJ, Rudomina D, Feratovic R, Lin O. Successful secure HD molecular classifier identifies prognostically significant subgroups
streaming telecytology for remote cytologic evaluation. Laboratory of grade 3 endometrioid carcinoma of the endometrium. Modern
Investigation. 2016;96(Suppl. 1):401A. Pathology. 2016;29(Suppl. 2):311A.
Sirintrapun SJ, Rudomina D, Feratovic R, Lin O. Successful secure Soslow R, Hoang L, Cheng A, Bisogna M, Olvera N, McAlpine JN,
HD streaming telecytology for remote cytologic evaluation. Modern Huntsman DG, Levine DA, Gilks B. Immunohistochemical characterization
Pathology. 2016;29(Suppl. 2):401A. of endometrial carcinomas grouped by the TCGA molecular classification
scheme. Laboratory Investigation. 2016;96(Suppl. 1):311A.
Slotkin E, de Stanchina E, Cartegni L, Ladanyi M, Spraggon
L. Therapeutic targeting of sarcomas driven by EWSR1 fusion Soslow R, Hoang L, Cheng A, Bisogna M, Olvera N, McAlpine JN,
306 OF 324
Meeting Abstracts
Huntsman DG, Levine DA, Gilks B. Immunohistochemical characterization A population-based study including 13,034 patients diagnosed in 1982-
of endometrial carcinomas grouped by the TCGA molecular classification 2013 in Sweden. Haematologica. 2016;101(Suppl.):432-433.
scheme. Modern Pathology. 2016;29(Suppl. 2):311A.
Stern CD, Perez-Aguilar JM, Blanchard SC, Weinstein H, Chodera
Soumerai JD, Barrientos JC, Hallek M, Kipps TJ, Jones JA, Xing G, JD. Bridging the gap between computation and experiments in
Yao NS, Ysebaert L, Stilgenbauer S, Zelenetz AD. An evaluation GPCRs. Biophysical Journal. 2016;110(3 Suppl. 1):324A-325A.
of the CLL-IPI score and comprehensive prognostic factor
analysis in patients with R/R CLL in idelalisib phase 3 randomized Stewart M. Achieving spiritual maturity: Exploring the common ground
studies. Haematologica. 2016;101(Suppl.):53-54. between advancing age and life-limiting illness. Journal of Psychosocial
Oncology. 2016;34(1-2):129-130.
Sperduto PW, Jiang W, Brown PD, Braunstein SE, Sneed PK, Wattson
DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Stutte S, Schulz AM, Kugler I, Imhof A, Brakebusch C, Brocker T. Cell
Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris division cycle 42 (Cdc42) regulates functions of plasmacytoid dendritic
JK, Masucci L, Roberge D, Yu JB, Chiang VL, Mehta MP. The effect of cells. Journal of Immunology. 2016;196(1 Suppl.)
gene mutations on aurvival in patients with melanoma following the
development of brain metastases. International Journal of Radiation Swain SM, Schneeweiss A, Gianni L, Stein A, McNally V, Heeson S,
Oncology, Biology, Physics. 2016;96(2 Suppl.):S178. Portera C, Yoo B, Cortes JC, Baselga J. Incidence and management
of diarrhea in patients with HER2-positive breast cancer treated with
Spratt DE, Osborne J, Zumsteg ZS, Rebiez K, Leeman JE, Rivera pertuzumab. Cancer Research. 2016;76(4 Suppl.)
A, Zelefsky MJ. Radium-223 outcomes after multiple lines of metastatic
castration-resistant prostate cancer therapy in clinical practice: Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Giordano SH, Hunt
Implication of pretreatment spinal epidural disease. International Journal KK, Pusic AL, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Population-
of Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E224. based assessment of patient-reported cosmetic outcomes in older breast
cancer survivors. International Journal of Radiation Oncology, Biology,
Spratt DE, Vargas HA, Zumsteg ZS, Golia Pernicka J, Osborne Physics. 2016;96(2 Suppl.):E14.
J, McBride SM, Kollmeier MA, Pei X, Zelefsky MJ. Patterns of lymph
node failure after dose-escalated radiation therapy in patients who did Sweetenham JW, Walewski J, Nadamanee A, Masszi T, Agura E, Holowiecki
not undergo pelvic lymph node irradiation: Implications for extended J, Abidi MH, Chen AL, Stiff P, Viviani S, Carella A, Osmanov D, Bachanova
pelvic lymph node coverage. International Journal of Radiation V, Sureda A, Huebner D, Larsen EK, Hunder NN, Moskowitz CH. Updated
Oncology, Biology, Physics. 2016;96(2 Suppl.):E239-E240. efficacy and safety data from the AETHERA trial of consolidation with
brentuximab vedotin after autologous stem cell transplant (ASCT) in
Staible A, Meyerholz S, Beyer K. Improving the medication delivery Hodgkin lymphoma patients at high risk of relapse. Biology of Blood and
system in the outpatient bone marrow transplant setting at Memorial Marrow Transplantation. 2016;22(3 Suppl. 1):S36-S37.
Sloan Kettering Cancer Center. Biology of Blood and Marrow
Transplantation. 2016;22(3 Suppl. 1):S284-S285. Syed M, Zehir A, Arcila M, Casanova J, Baldi T, Haque M, Razumova
A, Kiecka I, Benayed R. Implementation of Laboratory
Steingr-Msson V, Lund SH, Dickman PW, Weibull C, Bjorkholm Information Management System (LIMS) achieve performance
M, Landgren O, Kristinsson SY. Survival in chronic lymphocytic leukemia: improvement across diverse molecular assays. Journal of Molecular
307 OF 324
Meeting Abstracts
Diagnostics. 2016;18(6):993. Tao R, Tsai CJ, Eng C, Kopetz S, Overman M, Skibber J, Rodriguez-
Bigas M, Chang G, You YN, Bednarski B, Minsky BD, Delclos ME,
Sznol M, Ferrucci P, Hogg D, Atkins M, Wolter P, Guidoboni M, Lebbe Koay EJ, Krishnan S, Crane CH, Das P. Hyperfractionated accelerated
C, Kirkwood J, Schachter J, Daniels G, Hassel J, Cebon J, Gerritsen W, reirradiation for rectal cancer: A large single-institution retrospective
Atkinson V, Thomas L, McCaffrey J, Power D, Jiang J, Hodi S, Wolchok analysis. International Journal of Radiation Oncology, Biology,
J. Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination Physics. 2016;96(2 Suppl.):S105.
therapy in patients with advanced melanoma (MEL). Asia-Pacific Journal
of Clinical Oncology. 2016;12(Suppl. 5):118. Tap W, Jones RL, Chmelowski B, Elias AA, Adkins D, Van Tine BA, Agulnik
M, Cooney M, Livingston MB, Pennock G, Quin A, Shahir A, Ilaria R, Conti
Tabar V. Human ES cells for modeling brain cancer. Cancer I, Schwartz GK. A randomized phase 1b/2 study evaluating the safety
Research. 2016;76(5 Suppl.) and efficacy of doxorubicin (Dox) with or without olaratumab (IMC-
3G3), a human anti-platelet-derived growth factor a (pdgfra) monoclonal
Tabernero J, van Geel R, Guren T, Yaeger R, Spreafico A, Faris antibody, in advanced soft tissue sarcoma (sts). Oncology Research and
J, Yoshino T, Yamada Y, Kim Tae W, Bendell J, Schuler M, Lenz Treatment. 2016;39(Suppl. 1):174.
HJ, Eskens F, Desai J, Hochster H, Avsar E, Demuth T, Sandor V,
Elez E, Schellens J. Combination of encorafenib and cetuximab Taunk NK, Laughney A, Ghossein R, Lee N, Chung C, Bakhoum
with or without alpelisib in patients with advanced BRAF-mutant SF. The relationship of numerical chromosomal instability with clinical
colorectal cancer (BRAFm CRC): Phase 2 results. Annals of characteristics and outcomes in head and neck cancers treated with
Oncology. 2016;27(Suppl. 2):127-128. multimodality therapy. International Journal of Radiation Oncology,
Biology, Physics. 2016;96(2 Suppl.):E594.
Tal R, Deveci S, Kennison T, Guhring P, Parker M, Narus J, Mulhall JP. The
prevalence and predictors of vasovagal reactions in men being trained in Taunk NK, Zhang H, Carlin S, Weber W. Monitoring prostate cancer
penile injection therapy. Journal of Sexual Medicine. 2016;13(5 Suppl.):S48. treatment response to radiation therapy and androgen deprivation with
novel radiolabeled and dual-labeled gastrin-releasing peptide receptor
Tang L, Yu R. A novel hereditary pancreatic neuroendocrine tumor (GRPr) antagonists. International Journal of Radiation Oncology, Biology,
syndrome associated with biallelic inactivation of the glucagon Physics. 2016;96(2 Suppl.):E579.
receptor. Neuroendocrinology. 2016;103(Suppl.):9.
Taylor BS. Clinical genomics alters care, informs new science. Clinical
Tannir NM, Figlin RA, Gore ME, Michaelson D, Motzer RJ, Porta C, Cancer Research. 2016;22(1 Suppl.)
Rini B I, Hoang CJ, Lin X, Escudier B. Long-term response to sunitinib
treatment in metastatic renal cell carcinoma (mRCC). Journal of Clinical Teich A, Tomljanovic Z, Patel M. ZCCHC17 is a potential driver of synaptic
Oncology. 2016;34(2 Suppl.) dysfunction in Alzheimer’s Disease. Journal of Neuropathology and
Experimental Neurology. 2016;75(6):573.
Tannir NM, Pressey J, Roche M, Rodstrom J, Blakemore S, Clawson A,
Daigle S, Gounder M. A phase II, multi-center study of the EZH2 inhibitor, Tempero MA, Cardin DB, Goldstein D, O’Reilly EM, Philip PA, Riess
tazemetostat, in adult subjects with INI1-negative tumors including H, Macarulla T, Yung L, Li MY, Lu BD, Biankin A. APACT: Phase
renal medullary carcinoma (RMC), or relapsed/refractory synovial III randomized trial of adjuvant treatment with nab-paclitaxel
sarcoma. BJU International. 2016;118(Suppl. 5):14. (nab-P) plus gemcitabine (Gem) versus Gem alone in patients
308 OF 324
Meeting Abstracts
(pts) with resected pancreatic cancer (PC). Journal of Clinical Thordardottir M, Lindqvist E, Lund S, Costello R, Torfadottir J,
Oncology. 2016;34(4 Suppl.) Burton D, Steingrimsdottir L, Korde N, Mailankody S, Eiriksdottir G,
Launer L, Harris T, Landgren O, Gudnason V, Kristinsson S. Dietary
Tergas A I, Angarita A, Cristello A, Lippitt M, Fader AN, Long K. The habits across the lifespan and risk of monoclonal gammopathy
“little big things”: A qualitative study of ovarian cancer survivors of undetermined significance: A population based screening
and their experiences with the health care system. Journal of Clinical study. Haematologica. 2016;101(Suppl.):780-781.
Thorsteinsdottir S, Lund SH, Lindqvist E, Sigurdsson G, Costello
Tewari K, Abrouk N, Coleman R, Aghajanian C, Couchenour R, Nelson J, R, Burton D, Steingrimsdottir H, Launer LJ, Gudnason V,
Mannel R, Disilvestro P, Mutch D, Randall L, Farley J, Rubin S, Method M, Eiriksdottir G, Siggeirsdottir K, Harris TB, Landgren O, Kristinsson
Stehman F, Monk B. Improved progression-free survival among women SY. Bone disease in monoclonal gammopathy of undetermined
with measurable recurrent ovarian carcinoma treated with CA4P plus significance: Results from a screened population-based
bevacizumab: A post-hoc analysis of GOG-0186I. International Journal of study. Haematologica. 2016;101(Suppl.):518-519.
Gynecological Cancer. 2016;26(Suppl. 3):651-652.
Tian SZ, Arcila ME, Moreira A, Sadowska J, Middha S, Lin
Thachuthara-George J, Chawla M, Lee R. A novel capnography monitoring O. Cytology waste or molecular treasure? A proposed algorithm
technique during bronchoscopy. Chest. 2016;150(4 Suppl.):982A. for molecular-oriented cytology specimen utilization. Laboratory
Investigation. 2016;96(Suppl. 1):522A-523A.
Thayaparan T, van der Stegen SJC, Puri Acpp, Petrovic RM, Spicer J,
Maher J. Immunotherapy of malignant pleural mesothelioma using cMET Tian SZ, Arcila ME, Moreira A, Sadowska J, Middha S, Lin
specific T-cells. Cancer Immunology Research. 2016;4(Suppl.) O. Cytology waste or molecular treasure? A proposed algorithm
for molecular-oriented cytology specimen utilization. Modern
Thom B. Impact of income and other socioeconomic and Pathology. 2016;29(Suppl. 2):522A-523A.
demographic factors on decisions about fertility preservation
among young adult female cancer survivors. Journal of Psychosocial Tizi K, Wembacher E, Thomson R, Donzelli M, Vaconcellos
Oncology. 2016;34(1-2):97-99. E, Souweidane M. Deformational changes in the human brain
stem from convection enhanced delivery (CED). Neuro-
Thong AE, Lee JK, Carlsson S V, Ehdaie B. Cost-effectiveness analysis Oncology. 2016;18(Suppl. 3):iii72.
of initial management strategies for low-risk prostate cancer. Journal of
Clinical Oncology. 2016;34(2 Suppl.) Tochon-Danguy H, Ackermann U, Poniger S, Chan G, Morris M, Lewis J,
Lyashchenko S, Scott A. Synthesis and in vivo imaging of 16β-[18F]fluoro-
Thor M, Olsson CE, Oh JH, Pauli N, Johansson M, Deasy JO, 5α-dihydrotestosterone in castration resistant prostate cancer. Internal
Finizia C. What to ask/when to act — Patient-reported trismus Medicine Journal. 2016;46(Suppl. 1):42.
and mouth-opening distances in head and neck cancer radiation
therapy. International Journal of Radiation Oncology, Biology, Tonorezos ES, Barnea D, Abou-Alfa GK, Bromberg J, D’Angelica M
Physics. 2016;96(2 Suppl.):E530. I, Sklar CA, Oeffinger KC. Hepatic adenoma among adult survivors of
childhood cancer. Journal of Clinical Oncology. 2016;34(3 Suppl.)
309 OF 324
Meeting Abstracts
Trippett T, Simko S, Ye C, Caron H, Geoerger B. iMATRIXcobi: A Tyagi N, Sutton E, Hunt MA, Zhang J, Apte A, Mechalakos JG, Mehrara
phase I/II, dose-escalation study of the safety, pharmacokinetics, B, Matros E, Ho AY. Morphological features of magnetic resonance
and preliminary efficacy of cobimetinib in paediatric and young imaging as a correlate of capsular contracture in breast cancer patients
adult patients with refractory/relapsed tumours. Pediatric Blood and with implant-based reconstructions. International Journal of Radiation
Cancer. 2016;63(Suppl. 3):S210. Oncology, Biology, Physics. 2016;96(2 Suppl.):S97-S98.
Tsai CJ, McBride S, Riaz N, Leeman JE, Roman BR, Baxi SS, Sherman Unnikrishnan A, Papaemmanuil E, Beck D, Verma A, Kumari A, Woll P,
EJ, Wong RJ, Lee N. Number of lymph nodes examined is associated Richards L, Knezevic K, Chandrakanthan V, Thoms J, Tursky M, Huang
with overall survival in clinically node-negative oral cavity cancer patients Y, Ali Z, Olivier J, Galbraith S, Kulasekararaj A, Tobiasson M, Karimi M,
receiving definitive surgery—A population-based analysis using the Pellagatti A, Wilson S, Lindeman R, Young B, Ramakrishna R, Arthur
National Cancer Data Base. International Journal of Radiation Oncology, C, Stark R, Crispin P, Curnow J, Warburton P, Roncolato F, Boultwood
Biology, Physics. 2016;96(2 Suppl.):E338-E339. J, Lynch K, Jacobsen S, Mufti G, Hellstrom-Lindberg E, MacKenzie K,
Wong J, Campbell P, Pimanda J. Integrative genomics identifies the
Tseng J, Sonoda Y, Gardner G, Zivanovic O, Abu-Rustum N, Leitao M molecular basis of resistance to Azacitidine therapy in Myelodysplastic
Jr. Fertility-sparing surgery in stage IA2 cervical cancer: Associated Syndromes. Haematologica. 2016;101(Suppl.):157-158.
factors and long-term survival. International Journal of Gynecological
Cancer. 2016;26(Suppl. 3):938-940. Van Laar E, Fagerlie S, Landgren O. Diagnosis, prognosis
and risk assessment of multiple myeloma: Identifying gaps
Tseng J, Sonoda Y, Gardner G, Zivanovic O, Abu-Rustum N, Leitao and addressing education needs for hematologists and
M. Long-term oncologic outcomes of fertility-sparing surgery in oncologists. Haematologica. 2016;101(Suppl.):799-800.
young women with stage IB1 cervical cancer. International Journal of
Gynecological Cancer. 2016;26(Suppl. 3):70-73. Van Loon K, Hu CY, Cuddy A, Bekaii-Saab TS, Benson A, Hall MJ, Lai
LL, Nurkin SJ, Skibber JM, Weiser MR, Schrag D, Chang GJ. How are
Tseng JH, Jelinic P, Schlappe BA, Conlon N, Olvera N, Dao F, Mueller colorectal cancer (CRC) patients treated following cancer recurrence
JJ, Hussein Y, Soslow RA, Levine DA. Concomitant loss of SMARCA2 and during follow-up?. Journal of Clinical Oncology. 2016;34(4 Suppl.)
SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic
type. Clinical Cancer Research. 2016;22(2 Suppl.) Vanak JM, Bello C, Dixit P, Nguyen V, Landau H, Giralt SA. Pilot trial of
homebound stem cell transplantation at Memorial Sloan Kettering Cancer
Turner NC, Balmana J, Fasching PA, Hurvitz SA, Rugo HS, Telli ML, Visco Center. Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl.
F, Wardley AM, Yang X, Lokker NA, Lounsbury DL, Robson ME. ABRAZO: 1):S137.
An international phase 2 (2-stage, 2-cohort) study of the oral PARP
inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally Vanak JM, Cheavers C, Duggan E, Duck E, Radzyner M, Nelson
advanced and/or metastatic breast cancer. Cancer Research. 2016;76(4 P, Perales MA. Progress towards value in healthcare: Implementation
Suppl.) of Time-Driven Activity-Based Costing (TDABC) in hematopoietic
stem cell transplantation. Biology of Blood and Marrow
Tuttle M. Is immediate surgery really necessary in every patient Transplantation. 2016;22(3 Suppl. 1):S87.
with primary or recurrent papillary thyroid cancer?. Clinical
Endocrinology. 2016;84(Suppl. 1):8.
310 OF 324
Meeting Abstracts
Varda M, Long E, De La Ossa M. Preventing the fire, so you don’t of combining immune checkpoint inhibition and thoracic radiation
burnout!. Oncology Nursing Forum. 2016;43(2):108. therapy. International Journal of Radiation Oncology, Biology,
Vargo J, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ,
Dault J, Awan MJ, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, von Reibnitz D, Yorke ED, Oh JH, Apte A, Wu AJ, Fleisher M, Gelb
Trotti A, Lee N, Koyfman S, Heron DE. Optimal treatment selection of E, Deasy JO, Rimner A. Alpha-2-macroglobulin as a radioprotective
stereotactic body radiation therapy and intensity modulated radiation factor in patients undergoing thoracic radiation. International Journal of
therapy for reirradiation of head and neck cancer: A multi-institution Radiation Oncology, Biology, Physics. 2016;96(2 Suppl.):E469.
comparison. International Journal of Radiation Oncology, Biology,
Physics. 2016;96(2 Suppl.):S114-S115. Voss M, Hutson TE, Hussain A, Vaishampayan U, Vogelzang NJ, Crowell
T, Li J, Downing W, Senderowicz A, Stone E. A randomized phase 2 trial
Vasconcellos E, Wembacher-Schröder E, Thomson R, Rube M, Souweidane of CRLX101 in combination with bevacizumab in patients with metastatic
M. A flexible step design infusion catheter for prolonged drug delivery into renal cell carcinoma (mRCC) versus standard of care (SOC). BJU
the brain stem of children. Neuro-Oncology. 2016;18(Suppl. 3):iii128. International. 2016;118(Suppl. 5):5-6.
Velez AM, Okada T, Singer S. Aberrant expression of epigenetic modifiers Voss MH, Hellmann MD, Chen Y, Gold TM, Lambert CR, VanAllen
in dedifferentiated liposarcoma (DDLS) and the effects of dual Inhibition E, Choueiri TK, Charen AS, Motzer RJ. Mutation burden and tumor
of DNA and histone methylation in DDLS cell lines. Annals of Surgical neoantigens in RCC patients (pts) treated with nivolumab. Journal of
Oncology. 2016;23(1 Suppl.):S37-S38. Clinical Oncology. 2016;34(2 Suppl.)
Vercauteren K, Hoshida Y, Pilet J, Xiao JW, Ly M, Chiriboga L, Jessurun Vusirikala M, Naik S, Maziarz RT, Baumeister S, Aquino V, Ma H,
J, Rice CM, Abou-Alfa G, De Jong YP. Hepatocellular carcinoma Moseley A, Woolfrey AE, Krishnamurti L, Chen GL, Sandmaier BM,
patient derived xeno-engraftment is enhanced by murine liver Bertaina A, Perales MA, Williams DA, Kapoor N. BPX-501 cells
injury. Hepatology. 2016;64(Suppl.):243A-244A. (donor T cells transduced with iC9 suicide gene) treatment following
TCR alpha beta depleted stem cell transplantation in adults and
Vieth JA, Das J, Ranaivoson F, Comoletti D, Denzin LK, Sant’Angelo children with hematological disorders. Biology of Blood and Marrow
DB. Induction of adipose-resident NKT cells can be instructed Transplantation. 2016;22(3 Suppl. 1):S361.
by non ligand-binding motifs of the TCR ß chain. Journal of
Immunology. 2016;196(1 Suppl.) Wallace MH, Grant-Navarro P, Feustel J, Choo K. A “Be the Match”
inpatient walk: Boosting morale for patient’s and staff, celebrating
Vij R, Martin T, Richter J, Cole C, Atanackovic D, Zonder J, Kaufman J, donors. Biology of Blood and Marrow Transplantation. 2016;22(3 Suppl.
Mikhael J, Bensinger W, Dimopoulos M, Zimmerman T, Lendvai N, Hari 1):S460-S461.
P, Ocio EM, Gasparetto C, Kumar S, Oprea C, Charpentier E, Strickland
S, San Miguel J. Updated data from a phase II dose finding trial of single Walradt T, Makarov V, Doumani R, Riaz N, Stafstrom K, Moshiri A,
agent isatuximab (SAR650984, Anti-CD38 Mab) in relapsed/refractory Yelistratova L, Levinsohn J, Chan T, Nghiem P, Lifton R, Choi J. Mutational
multiple myeloma (RRMM). Haematologica. 2016;101(Suppl.):82-83. landscape of MCPyV-positive and MCPyV-negative Merkel cell
carcinomas with implications for immunotherapy. Journal of Investigative
von Reibnitz D, Wu AJ, Barker CA, Panchoo K, Rimner A. Safety Dermatology. 2016;136(5 Suppl. 1):S15.
311 OF 324
Meeting Abstracts
Walsh M, Shukla N, Joseph V, Kentsis A, Curran K, Kobos R, Arnold Wang W, Yorke ED, Campbell J, Martel MK, Moiseenko V, Marks LB, Kong
A, Harlan M, Kennedy J, Schrader K, Stadler Z, Cheung NK, Modak FM. Radiation-induced proximal bronchial tree and heart toxicity after
S, Kushner B, Roberts S, LaQuaglia M, Dunkel I, Khakoo Y, Kramer stereotactic body radiation therapy of the thorax: Differences between
K, Wexler L, Meyers P, Chou A, Mandelker D, Zhang L, Solit central and peripheral diseases. International Journal of Radiation
D, Armstrong S, Ladanyi M, Robson M, O’Reilly R, Berger M, Offit Oncology, Biology, Physics. 2016;96(2 Suppl.):E475-E476.
K. Germline mutations in cancer predisposition genes in a subset
of pediatric oncology patients undergoing targeted solid tumor Wang X, Qu J, Stefanski J, Borquez-Ojeda O, Hack A, He
sequencing using matched normal DNA. Pediatric Blood and Q, Wasielewska T, Du F, Sadelain M, Rivière I. Evaluation of
Cancer. 2016;63(Suppl. 1):S10. Miltenyi ExpAct and TransAct CD3/28 beads for CAR-T cell
manufacturing. Molecular Therapy. 2016;24(Suppl. 1):S182.
Walsh MF, Harlan M, Kennedy J, Musinsky J, LaQuaglia M, Stadler
Z, Gilheeney S, Offit K. Novel SUFU splice mutation in a child with Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J,
multiple tumors. Cancer Research. 2016;76(5 Suppl.) Awan MJ, Vargo J, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay
M, Siddiqui F, Trotti A, Lee N, Koyfman S. Multi-institution analysis of
Wang E, Stone R, Tallman M, Thompson J, Ontiveros E, Olson G, intensity modulated radiation therapy-based reirradiation for head and
Galinsky I, Pond B, Uchida A, Urity V, Xhori O, Macaraeg M, Vusirikala neck cancer: Prognostic factors and recursive partitioning analysis for
M, Patel P, Walter R, Collins R. Safety study of crenolanib, a Type I overall survival. International Journal of Radiation Oncology, Biology,
FLT3 inhibitor, with cytarabine/daunorubicin or cytarabine/idarubicin Physics. 2016;96(2 Suppl.):S115.
induction and high-dose cytarabine consolidation in newly diagnosed
FLT3+AML. Haematologica. 2016;101(Suppl.):41. Weber D, Jenq R, Hiergeist A, Oefner P, Dettmer K, Weber M,
Koestler J, Gessner A, Taur Y, van den Brink M, Pamer E, Wolff D,
Wang L, Wang J, Rao M, Cimera R, Aryeequaye R, Cao L, Benayed Hahn J, Herr W, Holler E. Early systemic broad spectrum antibiotic
R, Ladanyi M, Hollmann T, Busam K, Hameed M. Oligonucleotide- treatment increases risk of graft versus host disease and treatment-
based FISH (oFISH) probes improve the precision and accuracy of related mortality after allogeneic stem cell transplantation — Possible
FISH analysis for structural abnormalities detected by array and next- role of indirect effects by microbiome disruption. Bone Marrow
generation sequencing-based technologies. Journal of Molecular Transplantation. 2016;51(Suppl. 1):S3-S4.
Diagnostics. 2016;18(6):1045.
Weber J, Eaton A, Stempel M, Burgan I, Jochelson M, Barrio A, Capko
Wang Q, Zou Y, Nowotschin S, Kim SY, Li Q, Soh CL, Xi Q, Zhang D, Cody H, Gemignani M, Heerdt A, Morrow M, Pilewskie M, George
C, Su J, Huangfu D, Hadjantonakis AK, Massague J. A p53-Wnt- P, Sacchini V, Sclafani L, Van Zee K, El-Tamer M. How reliably does
Nodal network driving mesendoderm specification. Human Gene magnetic resonance imaging predict pathologic complete response in
Therapy. 2016;27(11):A169. the breast and axilla following neoadjuvant chemotherapy for breast
cancer?. Annals of Surgical Oncology. 2016;23(Suppl. 3):170-171.
Wang W, Dai P, Shuman S, Merghoub T, Wolchok JD, Deng
L. Recombinant replication competent attenuated vaccinia virus Weigelt B, Geyer FC, Burke K, Ng CK, Murray M, Ross DS, Soslow R,
expressing human Flt3L for cancer immunotherapy. Journal of Rubin BP, Ladanyi M, Brogi E, Reis JS. Uterine adenosarcoma and
Investigative Dermatology. 2016;136(5 Suppl. 1):S6. Phyllodes tumor of the breast have similar repertoires of somatic genetic
alterations. Laboratory Investigation. 2016;96(Suppl. 1):460A.
312 OF 324
Meeting Abstracts
Weigelt B, Geyer FC, Burke K, Ng CKY, Murray M, Ross DS, Soslow Wertheim G, Luskin M, Gimotty PA, Smith C, Loren AW, Figueroa M,
R, Rubin BP, Ladanyi M, Brogi E, Reis JS. Uterine adenosarcoma and Harrison J, Sun ZX, Tallman MS, Paietta EM, Litzow MR, Levine R, Melnick
Phyllodes tumor of the breast have similar repertoires of somatic genetic AM, Fernandez HF, Luger SM, Carroll M, Master SR. Integration of multi-
alterations. Modern Pathology. 2016;29(Suppl. 2):460A. locus DNA methylation and genetic alterations outperforms genetic
assessment alone for outcome prediction in adult patients with acute
Weigelt B, Piscuoglio S, Burke K, Ng CKY, Papanastasiou myeloid leukemia. Modern Pathology. 2016;29(Suppl. 2):384A.
AD, Geyer FC, Macedo GS, Martelotto LG, De Bruijn I, De Filippo
MR, Schultheis AM, Ioris R, Levine DA, Soslow R, Rubin BP, Reis-Filho Wertheimer T, Velardi E, Xiao S, Palikuqi B, Ottmuller K, Beilhack A,
JS. Uterine adenosarcomas are mesenchymal neoplasms. Laboratory Butler J, Manley N, Rafii S, van den Brink M, Dudakov J. Production
Investigation. 2016;96(Suppl. 1):314A. of BMP4 by endothelial cells is crucial for endogenous thymic
regeneration. European Journal of Immunology. 2016;46(Suppl. 1):311.
Weigelt B, Piscuoglio S, Burke K, Ng CKY, Papanastasiou
AD, Geyer FC, Macedo GS, Martelotto LG, De Bruijn I, De Filippo Wild AT, Jackson A, Kohutek ZA, Wu AJ, Gelblum D, von Reibnitz
MR, Schultheis AM, Ioris R, Levine DA, Soslow R, Rubin BP, Reis-Filho D, Gelb E, Panchoo K, Yan M, Yorke ED, Rimner A. Planning target
JS. Uterine adenosarcomas are mesenchymal neoplasms. Modern volume and FDG-PET maximum standardized uptake value, but
Pathology. 2016;29(Suppl. 2):314A. not dosimetric parameters of target coverage, predict for local
recurrence after stereotactic body radiation therapy for non-small
Weigelt B. Rare types of breast cancer: Deconstructing the cell lung cancer. International Journal of Radiation Oncology, Biology,
complexity and heterogeneity of breast cancer. Journal of Physics. 2016;96(2 Suppl.):E484.
Pathology. 2016;238(Suppl. 1):S4.
Williamson SR, Gadde R, Trpkov K, Hirsch M, Srigley JR, Reuter
Weinreb I, Seethala RR, Chiosea S I, Perez-Ordonez B, Hyrcza VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O,
M, Zhang L, Chen CL, Sung YS, Assaad A, Thompson LDR, Antonescu Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon
C. Molecular analysis of low-grade cribriform cystadenocarcinoma DJ, Moch H, Gupta NS. Diagnostic criteria for oncocytic renal
& related in-situ and invasive carcinomas. Laboratory neoplasms: A survey of specialist renal tumor pathologists. Laboratory
Investigation. 2016;96(Suppl. 1):331A. Investigation. 2016;96(Suppl. 1):270A.
Weinreb I, Seethala RR, Chiosea S I, Perez-Ordonez B, Hyrcza M, Zhang Williamson SR, Gadde R, Trpkov K, Hirsch M, Srigley JR, Reuter VE,
L, Chen CL, Sung YS, Assaad A, Thompson LDR, Antonescu C. Molecular Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN,
analysis of low-grade cribriform cystadenocarcinoma & related in-situ Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H,
and invasive carcinomas. Modern Pathology. 2016;29(Suppl. 2):331A. Gupta NS. Diagnostic criteria for oncocytic renal neoplasms: A survey of
specialist renal tumor pathologists. Modern Pathology. 2016;29(Suppl.
Wertheim G, Luskin M, Gimotty PA, Smith C, Loren AW, Figueroa M, 2):270A.
Harrison J, Sun ZX, Tallman MS, Paietta EM, Litzow MR, Levine R, Melnick
AM, Fernandez HF, Luger SM, Carroll M, Master SR. Integration of multi- Winer AG, Senbabaoglu Y, Gejman R, Ostrovnaya I, Kaffenberger
locus DNA methylation and genetic alterations outperforms genetic SD, Voss MH, Coleman JA, Russo P, Hsieh J, Sander C, Hakimi AA. The
assessment alone for outcome prediction in adult patients with acute immune landscape of renal cell carcinoma and its association with
myeloid leukemia. Laboratory Investigation. 2016;96(Suppl. 1):384A. intratumoral clonality. Journal of Clinical Oncology. 2016;34(2 Suppl.)
313 OF 324
Meeting Abstracts
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey R. Prognostic significance of perineural invasion (PNI) in oral tongue
CL, Lao CD, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, squamous cell carcinoma (OTSCC): A clinicopathologic study of 381
Haanen J, Maio M, McArthur G, Walker D, Jiang J, Horak C, Larkin J, Hodi patients. Modern Pathology. 2016;29(Suppl. 2):332A.
S. Updated results from a phase 3 trial of nivolumab (NIVO) combined
with ipilimumab (IPI) in treatment-naive patients with advanced Xu B, Ghossein R, Katabi N. Prognostic histological features in the
melanoma (MEL) (CheckMate 067). Asia-Pacific Journal of Clinical phenotypic spectrum of polymorphous low grade adenocarcinoma
Oncology. 2016;12(Suppl. 5):127-128. (PLGA) and cribriform adenocarcinoma of minor salivary gland
(CAMSG): A unicenter retrospective study of 69 patients. Laboratory
Wolchok JD. Combination checkpoint blockade. Cancer Immunology Investigation. 2016;96(Suppl. 1):332A.
Research. 2016;4(Suppl.)
Xu B, Ghossein R, Katabi N. Prognostic histological features in the
Wongchenko MJ, Larkin J, McArthur GA, Ribas A, Dreno B, Chapman phenotypic spectrum of polymorphous low grade adenocarcinoma
PB, Maio M, Garbe C, Robert C, Lu W, Diala I, Darbonne WC, Chang I, (PLGA) and cribriform adenocarcinoma of minor salivary gland
Hsu JJ, Caro I, Rooney I, Ascierto PA, Yan Y. TERT promoter mutations (CAMSG): A unicenter retrospective study of 69 patients. Modern
in patients with BRAF(V600)-mutated melanoma treated with Pathology. 2016;29(Suppl. 2):332A.
vemurafenib or cobimetinib combined with vemurafenib. Melanoma
Research. 2016;26(e-Suppl.):e40-e41. Xu B, Ghossein R, Lane J, Lin O, Katabi N. The utility of p16
immunostaining in fine needle aspiration (FNA) material in human
Wu K, Davis M, Gonzalez-Diaz J, Ramrup N. Abdominal compartment papilloma virus (HPV)-related head and neck squamous cell carcinoma
syndrome: Rediscovering an old syndrome to prevent further (HNSCC). Laboratory Investigation. 2016;96(Suppl. 1):331A.
mortality. Oncology Nursing Forum. 2016;43(2):19.
Xu B, Ghossein R, Lane J, Lin O, Katabi N. The utility of p16
Xie Z, Hutt K, Panganiban J, Huang W, Zheng S, Duong D, Jacobsen A, immunostaining in fine needle aspiration (FNA) material in human
Pawlowsky G, Thorne J, Arcila M, Miller J, Stenzel T. A NGS IGK assay papilloma virus (HPV)-related head and neck squamous cell carcinoma
for the detection of clonality and the monitoring of minimal residual (HNSCC). Modern Pathology. 2016;29(Suppl. 2):331A.
disease. Haematologica. 2016;101(Suppl.):397-398.
Xu B, Ibrahimpasic T, Wang L, Tuttle RM, Ganly I, Ghossein
Xu AJ, DeSelm CJ, Ho AY, McCormick B, Powell SN. Overall survival R. Clinico-pathologic features of fatal non-anaplastic follicular
of breast cancer patients with recurrent disease involving internal cell-derived thyroid carcinomas (non-ANA FCDCs). Laboratory
mammary nodes. International Journal of Radiation Oncology, Biology, Investigation. 2016;96(Suppl. 1):157A.
Xu B, Ibrahimpasic T, Wang L, Tuttle RM, Ganly I, Ghossein R. Clinico-
Xu B, Cracchiolo J, Migliacci JC, Patel S, Katabi N, Wong R, Ghossein pathologic features of fatal non-anaplastic follicular cell-derived thyroid
R. Prognostic significance of perineural invasion (PNI) in oral tongue carcinomas (non-ANA FCDCs). Modern Pathology. 2016;29(Suppl. 2):157A.
squamous cell carcinoma (OTSCC): A clinicopathologic study of 381
patients. Laboratory Investigation. 2016;96(Suppl. 1):332A. Xu B, Wang L, Borsu L, Katabi N, Ganly I, Dogan S. High risk human
papillomavirus in primary squamous cell carcinoma of the parotid
Xu B, Cracchiolo J, Migliacci JC, Patel S, Katabi N, Wong R, Ghossein gland. Laboratory Investigation. 2016;96(Suppl. 1):332A.
314 OF 324
Meeting Abstracts
Xu B, Wang L, Borsu L, Katabi N, Ganly I, Dogan S. High risk human JC. Superresolution microscopy reveals staggered arrangement of
papillomavirus in primary squamous cell carcinoma of the parotid mammalian distal appendages. Biophysical Journal. 2016;110(3 Suppl.
gland. Modern Pathology. 2016;29(Suppl. 2):332A. 1):166A.
Xu M, Maity A, Kirk ML, Zhai H, Both S, Lin LL. Proton therapy reduces Yang TJ, Barrio A, Morrow M, Wilgucki M, Krause K, McCormick
normal tissue dose compared to intensity modulated radiation B, Powell SN, Mehrara B, Ho AY. Neoadjuvant chemotherapy,
therapy in extended field pelvic radiation therapy for gynecologic postmastectomy radiation therapy, and immediate reconstruction:
malignancies. International Journal of Radiation Oncology, Biology, Patient selection and outcomes. International Journal of Radiation
Physics. 2016;96(2 Suppl.):E634. Oncology, Biology, Physics. 2016;96(2 Suppl.):E23.
Yan SQ, Seyboth B, Kobos R, Cohen N, Seo S. Voriconazole dosing Yap TA, Krebs MG, Postel-Vinay S, Bang YJ, El-Khoueiry A, Abida W,
in children younger than 3 years undergoing cancer chemotherapy Harrington K, Sundar R, Carter L, Castanon-Alvarez E, Im SA, Berges
or hematopoietic stem cell transplantation. Pediatric Blood and A, Khan M, Stephens C, Ross G, Soria JC. Phase I modular study of
Cancer. 2016;63(Suppl. 1):S33. AZD6738, a novel oral, potent and selective ataxia telangiectasia
Rad3-related (ATR) inhibitor in combination (combo) with
Yang JC, Kumar A, Chapman KL, Constine LS, Moskowitz CH, Yahalom carboplatin, olaparib or durvalumab in patients (pts) with advanced
J. Brentuximab vedotin and AVD chemotherapy followed by ISRT: A cancers. European Journal of Cancer. 2016;69(Suppl. 1):S2.
safe primary treatment regimen for early-stage, unfavorable Hodgkin
lymphoma. International Journal of Radiation Oncology, Biology, Yelskaya Z, Salo-Mullen EE, Somar J, Bacares R, Lehrich DA, Fasaye
Physics. 2016;96(2 Suppl.):S21. G, Coit DG, Tang LH, Stadler ZK, Zhang L. Functional studies aid in
classification of CDH1 missense variant c.1679C>G (p.T560R). Journal of
Yang Q, Bavi P, Wang JY, Roehrl MH. Immuno-proteomics of colon Molecular Diagnostics. 2016;18(6):940-941.
cancer: PSMA1 is implicated in colorectal carcinogenesis and has
prognostic significance. Laboratory Investigation. 2016;96(Suppl. 1):461A. Yelskaya Z, Somar J, Bacares R, Salo-Mullen EE, Yang C, Ahmed
S, Stadler ZK, Zhang L. CDH1 splice site variant c.387+1G>a
Yang Q, Bavi P, Wang JY, Roehrl MH. Immuno-proteomics of colon emphasizes the importance of functional studies. Journal of Molecular
cancer: PSMA1 is implicated in colorectal carcinogenesis and has Diagnostics. 2016;18(6):941.
prognostic significance. Modern Pathology. 2016;29(Suppl. 2):461A.
Yoon JY, Bavi P, Liang SB, Roehrl MH. High FAK in the background
Yang Q, Liang SB, Wang JY, Roehrl MH. Comprehensive proteomic of low c-MET and low RON levels is associated with worse survival
characterization of pancreatic adenocarcinoma. Laboratory in stage I-III colorectal adenocarcinoma patients. Laboratory
Investigation. 2016;96(Suppl. 1):209A. Investigation. 2016;96(Suppl. 1):210A.
Yang Q, Liang SB, Wang JY, Roehrl MH. Comprehensive proteomic Yoon JY, Bavi P, Liang SB, Roehrl MH. High FAK in the background
characterization of pancreatic adenocarcinoma. Modern of low c-MET and low RON levels is associated with worse
Pathology. 2016;29(Suppl. 2):209A. survival in stage I-III colorectal adenocarcinoma patients. Modern
Yang T, Chong WM, Wang WJ, Chen YD, Tsou MFB, Liao
315 OF 324
Meeting Abstracts
Yoon JY, Bavi P, Yang Q, Oldfield L, Wang JY, Roehrl MH. High PSB7 Zelenetz A, Robak T, Coiffier B, Delgado J, Marlton P, Adewoye
expression in colorectal cancer predicts poor overall survival among A, Kim Y, Dreiling L, Hillmen P. Idelalisib plus bendamustine and
older female patients and female patients treated with adjuvant rituximab (BR) is superior to BR alone in patients with relapsed/
chemotherapy. Laboratory Investigation. 2016;96(Suppl. 1):210A. refractory chronic lymphocytic leukemia: Results of a phase 3
randomized double-blind placebo-controlled study. British Journal of
Yoon JY, Bavi P, Yang Q, Oldfield L, Wang JY, Roehrl MH. High PSB7 Haematology. 2016;173(Suppl.):10.
expression in colorectal cancer predicts poor overall survival among
older female patients and female patients treated with adjuvant Zhang M, Scott SN, Bouvier N, Berger MF, Lin O. Cigarette smoke
chemotherapy. Modern Pathology. 2016;29(Suppl. 2):210A. associated genetic alterations found in urine specimens from
patients with superficial non-muscle invasive high grade urothelial
Yorke ED, Ojo A, Kuo L, Jackson A, Wu AJ, Yan M, Rimner A. Dosimetric carcinoma. Laboratory Investigation. 2016;96(Suppl. 1):461A.
predictors of radiation pneumonitis after hemithoracic pleural intensity
modulated radiation treatment. International Journal of Radiation Zhang M, Scott SN, Bouvier N, Berger MF, Lin O. Cigarette smoke
Oncology, Biology, Physics. 2016;96(2 Suppl.):S173. associated genetic alterations found in urine specimens from
patients with superficial non-muscle invasive high grade urothelial
Younes A, Berdeja J, Patel M, Kelly K, Flinn I, Gerecitano J, Neelapu carcinoma. Modern Pathology. 2016;29(Suppl. 2):461A.
S, Copeland A, Wang J, Gong L, Clancy M, Ma A, Sun K, Wang J,
Viner J, Oki Y. Phase 1 trial of CUDC-907, a novel, oral dual inhibitor Zheng X, Ren Q, Sarungbam J, Jordan EJ, Tickoo SK, Fine S, Chen
of HDAC and Pi3k: Updated assessment of patients with relapsed or YB, Berger MF, Gopalan A, Sirintrapun SJ, Iyer G, Lee BH, Cha
refractory diffuse large B-cell lymphoma, including double expressor EK, Solit DB, Reuter VE, Al-Ahmadie H. The correlation of TP53 and
lymphoma. Haematologica. 2016;101(Suppl.):175. RB1 genetic alterations and immunohistochemical (IHC) expression
in invasive and non-invasive urothelial carcinoma. Laboratory
Zabierowski S, Hill E, Dubose B, Wang Y, Tabar V, Henchcliffe C, Studer Investigation. 2016;96(Suppl. 1):271A-272A.
L, Riviere I, Irion S, Tomishima M. Manufacturing MSK-DA01: A human
embryonic stem cell-based cell therapy for Parkinson’s disease. Human Zheng X, Ren Q, Sarungbam J, Jordan EJ, Tickoo SK, Fine S, Chen
Gene Therapy. 2016;27(11):A158-A159. YB, Berger MF, Gopalan A, Sirintrapun SJ, Iyer G, Lee BH, Cha EK, Solit
DB, Reuter VE, Al-Ahmadie H. The correlation of TP53 and RB1 genetic
Zappasodi R, Budhu S, Liu C, Draleau K, Schaer D, Zhong H, Yang alterations and immunohistochemical (IHC) expression in invasive and
X, Merghoub T, Wolchok JD. Treg inhibition by anti-GITR therapy non-invasive urothelial carcinoma. Modern Pathology. 2016;29(Suppl.
evokes therapeutic antitumor responses selectively in the context of 2):271A-272A.
a pro-inflammatory tumor microenvironment. Cancer Immunology
Research. 2016;4(Suppl.) Zinzani PL, Ribrag V, Moskowitz CH, Michot JM, Kuruvilla J,
Balakumaran A, Thompson S, Marinello P, Chlosta S, Shipp MA,
Zelenetz A, Lamanna N, Kipps T, Coutre S, O’Brien S, Graves J, Ye Armand P. Phase 1b study of pembrolizumab in patients with
W, Dubowy R, Flinn I. A phase 2 study of idelalisib monotherapy in relapsed/refractory primary mediastinal large B-cell lymphoma:
previously untreated patients ≥ 65 years with chronic lymphocytic Keynote-013. Haematologica. 2016;101(Suppl.):320-321.
leukemia (CLL) or small lymphocytic lymphoma (SLL). British Journal of
Haematology. 2016;173(Suppl.):97.
316 OF 324
Meeting Abstracts
Zou XP, Zhang S, Leach S. GSK3ß inhibition leads to partial redifferen- Zumsteg ZS, Cook-Wiens G, Yoshida EJ, Shiao S, Lee N, Mita A, Jeon C,
tiation of ductal neoplasia towards a more acinar phenotype in mouse Goodman MT, Ho AS. The increasing incidence of oropharyngeal cancer
pancreatic tumor organoids. Journal of Gastroenterology and Hepatolo- among elderly patients in the United States. International Journal of Ra-
gy. 2016;31(Suppl. 3):246. diation Oncology, Biology, Physics. 2016;96(2 Suppl.):E379.
Zumsteg ZS, Beadle BM, Spratt DE, Rivera A, Skinner HD, Osborne J, Zumsteg ZS, Spratt DE, Pei X, Zhang Z, Woo K, Kollmeier M, McBride S,
Garden AS, Lee N. The influence of diabetes mellitus and metformin on Sandler HM, Zelefsky MJ. Redefining unfavorable risk prostate cancer:
distant metastases in oropharyngeal cancer: A multicenter study. Interna- A novel risk stratification paradigm for enhanced outcome prediction
tional Journal of Radiation Oncology, Biology, Physics. 2016;94(4):877. via harmonization and unification of risk stratification criteria. Interna-
tional Journal of Radiation Oncology, Biology, Physics. 2016;96(2 Sup-
pl.):E221-E222.
317 OF 324
Title
Book
Sections
(37)
318 OF 324
Book Sections
Chow K, Koranteng L. Bowel symptoms: Constipation, diarrhea, and Hibler BP, Dusza SW, Wang SQ. Photoprotection and skin cancer
obstruction. In: Dahlin C, Coyne PJ, Ferrell BR, editor(s). Advanced prevention. In: Wang SQ, Lim HW, editor(s). Principles and Practice of
Practice Palliative Nursing. 1st Ed. New York, NY: Oxford University Photoprotection. Cham, Switzerland: Springer; 2016. p. 23-38.
Press; 2016. p. 243-253.
Hibler BP, Wang SQ. Education, motivation, and compliance. In: Wang
Christison-Lagay ER, La Quaglia MP. Neuroblastoma and other adrenal SQ, Lim HW, editor(s). Principles and Practice of Photoprotection. Cham,
tumors. In: Carachi R, Grosfeld JL, editor(s). The Surgery of Childhood Switzerland: Springer; 2016. p. 463-475.
Tumors. 3rd ed. London, UK: Springer Berlin Heidelberg; 2016. p. 231-256.
Huerga I, Lauruhn MP. Linked data implications for authority
Danishefsky S. Foreword. In: Witczak ZZ, Bielski R, editor(s). Domino and control and vocabularies: An STM perspective.In: Jones E, Seikel M,
Intramolecular Rearrangement Reactions as Advanced Synthetic Methods editor(s). Linked Data for Cultural Heritage. Chicago, IL: American Library
in Glycoscience. Hoboken, NJ: John Wiley & Sons; 2016. p. xiii-xiv. Association; 2016. p. 55-72.
Dudakov JA, Perales MA, van den Brink MRM. Immune reconstitution Javdan B, Cassileth B. Cancer care among immigrants to North
following hematopoietic cell transplantation. In: Forman SJ, Negrin America. In: Silbermann M, editor(s). Cancer Care in Countries
RS, Antin JH, Appelbaum FR, editor(s). Thomas’ Hematopoietic Cell and Societies in Transition: Individualized Care in Focus. Cham,
Transplantation - Stem Cell Transplantation. 5th ed. Chichester, UK: Wiley Switzerland: Springer; 2016. p. 461-471.
Blackwell; 2016. p. 160-169.
Kearney J, Bartell AS, Pao M. Psychiatric issues in pediatric oncology:
Fisicaro R, Brennan NP, Holodny A. Functional magnetic resonance Diagnosis and management. In: Abrams AN, Muriel AC, Wiener L,
imaging. In: Newton HB, editor(s). Handbook of Neuro-Oncology editor(s). Pediatric Psychosocial Oncology: Textbook for Multidisciplinary
Neuroimaging. 2nd ed. Amsterdam, Netherlands: Academic Press, Care. Cham, Switzerland: Springer; 2016. p. 119-141.
Elsevier Inc; 2016. p. 317-325.
Kirk TW, Coyle N, Doolittle M. Communication ethics. In: Wittenberg
Friedman BJ, Lim HW, Wang SQ. Photoprotection and E, Ferrell BR, Goldsmith J, Smith T, Ragan SL, Glajchen M, Handzo G,
photoaging. In: Wang SQ, Lim HW, editor(s). Principles and Practice of editor(s). Textbook of Palliative Care Communication. Oxford, UK: Oxford
Photoprotection. Cham, Switzerland: Springer; 2016. p. 61-74. University Press; 2016. p. 27-34.
Gerhardt CA, Salley CG, Lehmann V. The impact of pediatric cancer Krishnan A, Giralt SA. Hematopoietic cell transplantation for multiple
on the family. In: Abrams AN, Muriel AC, Wiener L, editor(s). Pediatric myeloma. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR,
Psychosocial Oncology: Textbook for Multidisciplinary Care. Cham, editor(s). Thomas’ Hematopoietic Cell Transplantation - Stem Cell
Switzerland: Springer; 2016. p. 143-155. Transplantation. 5th ed. Chichester, UK: Wiley Blackwell; 2016. p. 625-639.
González S, Gilaberte Y, Juarranz A. Oral and systemic Landau HJ, Gertz MA, Comenzo RL. Autologous hematopoietic cell
photoprotection. In: Wang SQ, Lim HW, editor(s). Principles and Practice transplantation for systemic light chain (AL-) amyloidosis. In: Forman SJ,
of Photoprotection. Cham, Switzerland: Springer; 2016. p. 387-403. Negrin RS, Antin JH, Appelbaum FR, editor(s). Thomas’ Hematopoietic
Cell Transplantation - Stem Cell Transplantation. 5th ed. Chichester,
UK: Wiley Blackwell; 2016. p. 724-741.
319 OF 324
Book Sections
Lantos J, Young RJ, Miranda PC, Wenger C, Wong ET. TTFields therapy: MA, editor(s). Management of Sexual Dysfunction in Men and Women: An
Preclinical and clinical data. In: Newton HB, editor(s). Handbook Interdisciplinary Approach. New York, NY: Springer; 2016. p. 83-86.
of Neuro-Oncology Neuroimaging. 2nd ed. Amsterdam,
Netherlands: Academic Press, Elsevier Inc; 2016. p. 243-256. Nelson CJ. Commentary: Peyronie’s disease and other anatomical
disorders. In: Lipshultz L I, Pastuszak AW, Goldstein AT, Giraldi A,
Leal JN, D’Angelica M I. Modern locoregional treatment of colorectal Perelman MA, editor(s). Management of Sexual Dysfunction in Men and
cancer liver metastases. In: Morgan KA, editor(s). Current Controversies in Women: An Interdisciplinary Approach. New York, NY: Springer; 2016. p.
Cancer Care for the Surgeon. Cham, Switzerland: Springer; 2016. p. 67-109. 95-97.
Lichtenthal WG, Corner GW, Sweeney C, Roberts KE. Grieving O’Reilly RJ, Friedrich W. Hematopoietic cell transplantation for
the traumatic death of a child. In: Black BP, Wright PM, Limbo R, immunodeficiency diseases. In: Forman SJ, Negrin RS, Antin JH,
editor(s). Perinatal and Pediatric Bereavement in Nursing and Other Appelbaum FR, editor(s). Thomas’ Hematopoietic Cell Transplantation
Health Professions.New York, NY: Springer; 2016. p. 249-285. - Stem Cell Transplantation. 5th ed. Chichester, UK: Wiley
Blackwell; 2016. p. 866-889.
Lichtenthal WG, Breitbart W. Who am I?. In: Neimeyer RA,
editor(s). Techniques of Grief Therapy: Assessment and Intervention. New Patel KP, Hale K, Pastores SM. Critical care issues in oncologic surgery
York, NY: Routledge/Taylor & Francis Group Us; 2016. p. 182-185. patients. In: O’Donnell JM, Nácul FE, editor(s). Surgical Intensive Care
Medicine. 3rd ed. Cham, Switzerland: Springer; 2016. p. 759-769.
McAuliffe JC, Christein JD. Incidentalomas of the pancreas. In: Morgan
KA, editor(s). Current Controversies in Cancer Care for the Quartuccio N, Wexler L, Schöder H. Pediatric sarcomas. In: Mansi L,
Surgeon. Cham, Switzerland: Springer; 2016. p. 111-120. Lopci E, Cuccurullo V, Chiti A, editor(s). Clinical Nuclear Medicine in
Pediatrics. Cham, Switzerland: Springer; 2016. p. 279-300.
Montoto S, Noy A, Ribera JM. Burkitt lymphoma. In: Hentrich M, Barta
SK, editor(s). HIV-Associated Hematological Malignancies. Heidelberg, Rice TW, Klotz A, Neville-Webbe HL, Ahn S, Adkins EJ. Models
Germany: Springer; 2016. p. 67-72. of care for cancer emergencies. In: Todd KH, Thomas CR Jr,
editor(s). Oncologic Emergency Medicine: Principles and Practice. Cham,
Morris EA. Contrast-enhanced digital mammography. In: Hodler Switzerland: Springer; 2016. p. 3-12.
J, Kubik-Huch RA, von Schulthess GK, editor(s). Diseases of the
Brain, Head and Neck, Spine 2016-2019: Diagnostic Imaging. [Cham, Schweitzer AD, Krol G. Imaging of plexopathy in oncologic
Switzerland]: Springer; 2016. p. 339-342. patients. In: Newton HB, editor(s). Handbook of Neuro-Oncology
Neuroimaging. 2nd ed. Amsterdam, Netherlands: Academic Press,
Morris EA. Mammography: BI-RADS® update and Elsevier Inc; 2016. p. 763-775.
tomosynthesis. In: Hodler J, Kubik-Huch RA, von Schulthess GK,
editor(s). Diseases of the Brain, Head and Neck, Spine 2016-2019: Setton J, Bindra RS, Powell SN. DNA double-strand repair by
Diagnostic Imaging. [Cham, Switzerland]: Springer; 2016. p. 347-349. nonhomologous end joining and its clinical relevance. In: Kelley MR,
Fishel ML, editor(s). DNA Repair in Cancer Therapy: Molecular Targets
Nelson CJ. Commentary: Erectile dysfunction in the setting of prostate and Clinical Applications. 2nd ed. Amsterdam, Netherlands: Elsevier
cancer. In: Lipshultz L I, Pastuszak AW, Goldstein AT, Giraldi A, Perelman Inc.; 2016. p. 277-302.
320 OF 324
Book Sections
Small TN. Vaccination of allogeneic and autologous hematopoietic Wang SQ, Lim HW. Preface. In: Wang SQ, Lim HW, editor(s). Principles
cell recipients. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, and Practice of Photoprotection. Cham, Switzerland: Springer; 2016. p. v.
editor(s). Thomas’ Hematopoietic Cell Transplantation - Stem Cell
Transplantation. 5th ed. Chichester, UK: Wiley Blackwell; 2016. p. 1297-1306. Xavier JB. Sociomicrobiology and pathogenic bacteria. In: Kudva
IT, Cornick NA, Plummer PJ, Zhang Q, Nicholson TL, Bannantine JP,
Thacker D, Keeney S. Homologous recombination during Bellaire BH, editor(s). Virulence Mechanisms of Bacterial Pathogens. 5th
meiosis. In: DNA Replication, Recombination, and Repair: Molecular ed.Washington, DC: ASM Press; 2016. p. 89-102.
Mechanisms and Pathology. Tokyo, Japan: Springer; 2016. p. 131-151.
Tortora S. Dance/movement psychotherapy in early childhood treatment

and in pediatric oncology. In: Chaiklin S, Wengrower H, editor(s). The Art
and Science of Dance/Movement Therapy: Life Is Dance. 2nd ed.New
York, NY: Routledge/Taylor & Francis Group Us; 2016. p. 159-181.
321 OF 324
Title
Book
Wholes
(4)
322 OF 324
Book Wholes
Pathology of melanocytic nevi and melanoma. Barnhill RL, Wang SQ, Lim HW. Principles and practice of photoprotection. Cham,
Piepkorn MW, Busam KJ, editor(s). Heidelberg, Germany: Springer Switzerland: Springer; 2016. 487 p.
Verlag; 2016. 648 p.
Wilkes G, Barton-Burke M. 2016 Oncology nursing drug
Mitchell MG. Cell biology: Translational impact in cancer biology handbook. Burlington, MA: Jones & Bartlett Learning; 2016. 1564 p.
and informatics. Amsterdam, Netherlands: Academic Press, Elsevier
Inc; 2016. 337 p.
323 OF 324
Contact Information
For more information about this report, contact
Bernadette Joe at (212) 639-5427 or [email protected].
Visit Synapse to view works from 1998 to present
(excluding in-press papers) at https://synapse.mskcc.org.
324 OF 324

2016 SynapsePublicationsReport

Uploaded by

Copyright:

Available Formats

2016 SynapsePublicationsReport

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

2016 SynapsePublicationsReport

Uploaded by

Copyright:

Available Formats

2016 SYNAPSE PUBLICATIONS REPORT

Title MEMORIAL SLOAN KETTERING CANCER CENTER

Director’s Welcome. . . . . . . . . . . . . . . . . . . . . . . . . . 3 Works. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

It is my pleasure to share with staff and the communities we support, the

Librarians have always been a part of the scholarly communication process --

To populate Synapse, the following commercial databases

• Scopus – technical and medical science 2,893

• Biosis Citation Index – biomedical and life science

• PsycINFO – behavioral and social science

Librarians then manually vet each record to eliminate

In 2016, the following features were added to Synapse:

• Search Works by the Date Ingested into Synapse

Michael F. Berger, PhD. . . . . . . . . . . . . . . . . . . . . 72 David S. Klimstra, MD. . . . . . . . . . . . . . . . . . . . . . 52

Jedd D. Wolchok, MD, PhD . . . . . . . . . . . . . . . . . 57

José Baselga, MD, PhD. . . . . . . . . . . . . . . . . . . . . 54 Robert J. Motzer, MD . . . . . . . . . . . . . . . . . . . . . . 52

Miguel-Angel Perales, MD. . . . . . . . . . . . . . . . . . 54

Adams, Nicholas M (Graduate Studies) Ayash, Claudia Lori (Counseling Center)

Agostini, Andrea (SKI - Radiology) Ayob, George (Pathology)

Akalay, Intissar (Cell Biology) Azevedo, Mafalda (Developmental Biology)

Al Efishat, Mohammad (SKI - Surgery) Balakrishna, Shreya (SKI - Surgery)

Alex, Deepu (Graduate Medical Education) Ballesteros, Ivan (Immunology)

Alexander, Aeri Joannah (Medicine) Balletti, Jennifer (Medicine)

Aliyev, Nurlan (SKI - Surgery) Balmer, Sophie (Developmental Biology)

Allen Jr, Robert J (Surgery) Bandyopadhyay, Urmi (Cell Biology)

Allen, Jennifer D (Pediatrics/Nurses) Baradaran, Rozbeh (Structural Biology)

Alperovich, Anna (SKI - Medicine) Barrios, Dulce M (Graduate Medical Education)

Amaya, Beau (Urology Outpatient Center) Barton-Burke, Margaret (Nursing)

Amir, Jawaria (Graduate Medical Education) Basal, Coby R (Integrative Medicine)

Aneja, Amandeep (Graduate Medical Education) Battiato, Kristen Evelyn (Nursing)

Argueta, Stephanie (Pathology) Becattini, Simone (Immunology)

Bekes, Miklos (Structural Biology) Brady, Paul James (Radiation Oncology)

Bhagavath, Anita (Graduate Medical Education) Briggs, Andrew (SKI - Epidemiology-Biostatis)

Bhatt, Trusha (Human Oncology & Pathogenesis) Brite, Jennifer (Medicine)

Boccamazzo, Donna M (Disease Management) Brown, Sabrina (Nursing)

Bohm, Mathieu (Immunology) Buechel, Gabriel Emanuel (SKI - Radiology)

Borg, Kim L (Nursing) Bugov, Dona (Graduate Medical Education)

Borgheresi, Alessandra (SKI - Radiology) Buonocore, Darren Joseph (Pathology)

Borrill, Taylor Wray (Medicine) Burias, Clare Tanallon (Nursing)

Bose, Rohit (Medicine) Burke, Michelle (Nursing)

Both, Stefan (West Harrison) Burns, Jacquelyn (Nursing)

Canonica, Carolyn Marie (Medicine) Chhangawala, Sagar (Graduate Studies)

Carroll, Courtney M (Graduate Studies) Chin, Chelsea Carrie (Social Work)

Carroll, Cristi Ann (Medicine) Chintala, Navin Kumar (SKI - Surgery)

Castillo, Carmen (Case Management) Chiok, Michael (Graduate Medical Education)

Cavuoto, Michelle (Nursing) Choi, Wookjin (SKI - Medical Physics)

Chang, Aaron (Graduate Studies) Chung, Ja Young (Graduate Medical Education)

Chang, Kevin (SKI - Surgery) Chung, Sun Young (Developmental Biology)

Chapman, Katherine Logan (Medical Physics) Cimera, Robert Sime (Pathology)

Clarke, Richard (Pathology) De La Ossa, Michelle Varona (Nursing)

Cleary, Cristian Ryan (Radiation Oncology) Dela Cruz, Filemon (Pediatrics)

Connors, Scott W (Neurosurgery) DeLuca, Jennifer M (Disease Management)

Correa Geyer, Felipe (SKI - Pathology) Di Gialleonardo, Valentina (SKI - Radiology)

Crane, Christopher (Radiation Oncology) DiMattia, Michael Alfred (Structural Biology)

Crozet, Lucile (Immunology) Dixit, Payal G (Medicine)

Cunanan, Kristen (SKI - Epidemiology-Biostatis) Do, Mytrang (Graduate Studies)

Curtin, Christina Elise (SKI - Surgery) Donlon, Danielle Mary (Nursing)

Da Silva, Edaise Maria (SKI - Pathology) Du, Mengmeng (Epidemiology-Biostatistics)

Dannaoui, Aimee (Pediatrics/Nurses) Elias, Harold Kunal (Graduate Medical Education)

Das, Tuhin (Cell Biology) Encarnacion, Elizabeth Marie (SKI - Surgery)